Genomic_Coordinate(ENIGMA),Comment_on_clinical_significance(ENIGMA),Submitter(ClinVar),Origin_of_variant(LOVD),Functional_analysis_result(LOVD),Functional_analysis_technique(LOVD),Variant_frequency(LOVD),Variant_haplotype(LOVD),Minor_allele_frequency(ESP),polyPhen2_result(ESP),EUR_Allele_frequency(1000_Genomes),AFR_Allele_frequency(1000_Genomes),AMR_Allele_frequency(1000_Genomes),EAS_Allele_frequency(1000_Genomes),SAS_Allele_frequency(1000_Genomes),Patient_nationality(BIC),Number_of_family_member_carrying_mutation(BIC),Ethnicity(BIC),Mutation_type(BIC),IARC_class(exLOVD),Segregation_LR(exLOVD),Co_occurrence_LR(exLOVD),Sum_family_LR(exLOVD),Posterior_probability(exLOVD),Missense_analysis_prior_probability(exLOVD),Combined_prior_probablility(exLOVD),Consequence(VEP),IMPACT(VEP),EXON(VEP),INTRON(VEP),STRAND(VEP),TSL(VEP),SIFT(VEP),PolyPhen(VEP),SOMATIC(VEP),PHENO(VEP),Allele_frequency(1000g_exac),labels
chr17:43073208:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43092777:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32387053:C>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 1 (Asian)| 0.9 (African)| 1 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43095356:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32353757:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1661 (Asian)| 0.3516 (African)| 0.3206 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3082,0.3177,0.3386,0.1657,0.2965,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.283946,benign
chr17:43093647:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43118751:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32337196:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),benign(0-005),,,8.237e-06,
chr13:32340217:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),benign(0-005),,,,pathogenic
chr13:32319074:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/26,1,,,,,,,
chr17:43071184:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-512),,1,,
chr13:32339181:CTG>C,,,,,,,,0.0363|0.047|0.04,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337423:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43097249:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,1.0,,,,,,
chr13:32327832:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32341018:->AAAG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32326497:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,4/1658,,,,,,,,,Western Europe|-|American,,Western European|-|None Specified|Italian/English/Dutch?Welsh/Irish/French,Splice|IVS,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&1,,pathogenic
chr13:32340799:ATTTTC>T,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326497:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&1,,
chr17:43094777:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr17:43071149:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr17:43094585:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,0.0233|0.0|0.0154,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43071012:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-012),,,1.647e-05,
chr13:32399160:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00119808,benign
chr13:32339939:TCTCC>G,,,,,,,,,,,,,,,,,Western European|None Specified|Chezck & American,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32316431:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32316463:A>T,,,,,,,,,,,,,,,,,None Specified|Near East/Mid East,M,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,0&0&0&1&1,1&1&1&1&1,,
chr13:32322620:T>C,,,,,,,,,,0.004,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr13:32398634:G>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,Western Europe|-,,Latin American/Caribbean| Central/Eastern Europe|Western European|-| Native Americ|African| African|African American|None Specified,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0006804015,
chr17:43045761:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-982),,1&1&1,,
chr17:43063439:A>T,,,,,,,,,,,,,,,Italian,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43093955:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43060672:A>GT,,,,,,,,,,0.002,0.0008,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00119808,
chr13:32338034:TAT>C,,,,,,-|1/1658,,,,,,,,,,,White North American|Western European|None Specified|Hispanic,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32363441:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-05),possibly_damaging(0-512),,1,,
chr13:32359327:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000998403,
chr17:43053869:TCCAGGCT>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32332537:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.238e-06,
chr17:43094212:T>G,,,,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,stop_lost,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43093530:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32326556:AT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340779:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-126),,1,,
chr17:43065024:A>T,,,,,,,,,,0.0288,0.0023,0.0216,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0101837,
chr13:32329496:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,8/26,1,,,,,1,,
chr13:32362591:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-03),possibly_damaging(0-547),,,,
chr17:43070926:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/22,-1,,,,,1&1,,
chr13:32387247:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32395817:C>T,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00179712,
chr17:43067677:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-964),,1&1&1&1,8.237e-06,
chr17:43092223:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093176:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32347200:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32398276:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.236e-06,
chr13:32354934:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,,,
chr17:43099827:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,1.647e-05,
chr13:32383956:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32332934:G>T,,,,,,,,,,,,,,,,,Western European|-|None Specified,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr17:43093401:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379495:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32379495:C>A,,,,,,1/1658,,,,,,,,,,1,,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,
chr17:43071272:C>T,,,,,,,,0.0117|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,
chr17:43090914:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0233|0.0227|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32329301:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43074471:GTG>C,,,,,,,,,,,,,,,German|Austria|-,,Western-European|Western European|-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32327981:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr17:43068303:G>A,,,,,,,,,,0.003,0.1483,0.0173,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.0421326,
chr17:43045686:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,probably_damaging(0-932),,,8.236e-06,
chr13:32338472:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-64),benign(0-03),,,8.237e-06,
chr17:43099334:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32392371:A>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,
chr17:43092506:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1,1,,
chr13:32334688:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.02 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1,1,,benign
chr13:32319208:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32332778:ATAAA>A,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,German|Danish|Dutch?|-|Spanish,1|-,Latin American/Caribbean|Western European|-|Ashkenazi|African American|None Specified|Caucasian|Ecuador,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,8.237e-06,
chr13:32379775:TCCTG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr13:32395562:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr13:32348357:A>T,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00219649,
chr17:43124116:->AT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,,,
chr13:32355270:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-35),benign(0-424),1&1,1&1,,
chr13:32340142:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr13:32379720:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32354271:C>A,,,,,,,,,,0.5169,0.5961,0.5389,0.5347,0.4673,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.534744,
chr17:43072934:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43058657:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32340264:T>A,,,Unknown|Germline (inherited),,,5/1658|1/238 patients,,,,,,,,,Western Europe|-,,Western European|-| Italian| Irish Canadian|None Specified|Italian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32379513:A>G,,,,,,,,,,,,,,,,,,N,,,,,,,,splice_region_variant&stop_retained_variant,LOW,,,1,,,,,1&1,,
chr13:32332245:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.254e-06,
chr13:32339698:TTT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43056290:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43123261:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr17:43100560:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| 0.2602 (African)| 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr17:43092169:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,1.647e-05,
chr17:43067489:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43094809:T>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,1,,
chr13:32332934:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32371061:C>G,,,In vitro (cloned),predicted neutral|as wildtype control,Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe,,,M,3 - Uncertain,,1.02,0.776,0.2443,0.29,0.29,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43092242:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,,pathogenic
chr17:43122904:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43058801:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43093008:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,benign
chr17:43092169:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32323929:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43050538:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32362658:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,1,,benign
chr17:43093008:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398543:C>G,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32398381:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32318924:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32339156:GAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,
chr17:43093220:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.3721|18.7699|27.7641,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,benign
chr13:32379850:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,pathogenic
chr13:32380146:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32380146:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32379455:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43115834:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr17:43097228:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,1.647e-05,
chr13:32379921:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,1.648e-05,
chr17:43093754:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32330967:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1&1,8.237e-06,
chr17:43094765:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr17:43104166:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,benign
chr13:32379872:C>G,,Ambry_Genetics,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,Ashkenazi/Western Europe,,,M,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,1.648e-05,
chr13:32380015:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr13:32340756:ATCTCT>A,,,Unknown|Germline (inherited),,,1/238 patients|-|6/1658|1/1658,,,,,,,,,German|-|Italian,-|4, Central/Eastern Europe|Western European|English/Irish|French-Canadian/English|Japanese|-|African American|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,8.24e-06,
chr13:32388541:G>A,,,,,,,,,,0.0,0.0,0.0,0.0099,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00199681,
chr13:32368453:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0407,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00898562,benign
chr17:43089503:A>G,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32367127:T>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00139776,
chr13:32338492:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,0&1,1.647e-05,
chr17:43039999:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379872:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Not Specified|-,,Western European|-|Asian,N,,,,,,,,stop_gained,HIGH,,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32340286:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32362545:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-985),,1,,
chr17:43104166:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32370412:TC>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr17:43123064:C>GA,,,,,,,,,,0.3539,0.1558,0.3689,0.37,0.4959,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.334665,
chr13:32337148:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32336517:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),possibly_damaging(0-894),,1,,
chr17:43067445:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000599042,
chr17:43092341:ATC>TC,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094724:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0908|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092550:GC>C,,,,,,,,,,,,,,,Greek,,Greek,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337509:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-64),benign(0-006),,1,,
chr17:43072162:G>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr17:43067626:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr17:43106492:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,stop_lost,HIGH,,,-1,,,,,,0.0001039595,
chr13:32336957:AC>A,,,,,,,,,,,,,,,German/Polish,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,0&1&1,1&1&1,,
chr13:32370877:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.000199681,
chr13:32319433:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr17:43093276:GGA>A,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32326495:C>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,1,,
chr13:32344572:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32380137:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr17:43094546:A>TG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32398356:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr13:32356418:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,benign
chr17:43071179:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-11),possibly_damaging(0-63),,1,8.236e-06,
chr13:32332404:T>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,,,
chr13:32370565:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1,,
chr13:32370813:T>A,,,,,,,,,,0.001,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.000798722,
chr13:32340201:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-159),,1,,
chr13:32319300:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32379045:T>G,,,,,,,,,,0.1252,0.0091,0.1758,0.0556,0.0501,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.0728834,
chr13:32379854:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43089373:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2195 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353435,benign
chr17:43090966:GAA>T,,,,,,,,,,,,,,,Czech|-,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32337193:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.0001163155,
chr13:32333028:T>G,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,-|Spanish,,Western European|Caucasian|Central/Eastern European,M,2 - Likely not pathogenic or of little clinical significance,,,2.89,0.0254,0.02,0.02,missense_variant,MODERATE,10/27,,1,,tolerated(0-87),benign(0),0&1&1,1&1&1,8.237e-06,
chr13:32371049:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43096544:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0149,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00319489,
chr17:43051212:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43092854:A>G,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43074349:C>T,,,,,,,,,,,,,,,,,Western-European|-England/Scotland,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.236e-06,
chr13:32339932:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43091623:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32379906:G>AACT,,,,,,,,,,,,,,,,,Latin American/Caribbean,IFI,,,,,,,,protein_altering_variant,MODERATE,,,1,,,,,,2.472e-05,
chr17:43070892:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,8.236e-06,
chr17:43077756:A>C,,,,,,,,,,0.3579,0.2194,0.3761,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.353634,
chr13:32337015:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-447),,1,,
chr13:32330189:C>T,,,,,,,,,,0.004,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000998403,
chr13:32370463:A>T,,,Germline (inherited),,,,,,,,,,,,Malaysian,,Indian,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32380141:AACA>TT,,Sharing_Clinical_Reports_Project_(SCRP)|Curoverse|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43091900:AGC>A,,,,,,,,,,,,,,,Columbian,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43098661:->T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.32 (Asian)| 0.22 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43082509:AC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32340889:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32338356:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,2,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32352925:C>AAT,,,,,,,,,,0.0,0.0242,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00638978,
chr13:32319145:A>T,,,,,,,,,,,,,,,African American,,,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,8.237e-06,
chr13:32382030:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32367579:->GATGGCTTG,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.51 (Asian)| 0.44 (African)| 0.5 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32336843:A>G,,Ambry_Genetics|Invitae,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-009),,1,0.0001492655,
chr13:32337312:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093968:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.237e-06,
chr13:32363510:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,,pathogenic
chr13:32337190:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-253),,1&1&1,,
chr17:43119131:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000998403,
chr13:32333278:C>G,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr17:43091783:T>A,,,,,,,,,,,,,,,French?|Western Europe/Native American|Canadian|-|Dutch?|American|Dutch|Western Europe|Italian,540|-,"Western Europe/Native American| Native American""""|Central/Eastern European|Not Specified|Western European|None-Specified|-|Caucasian|Western/Central/Eastern Europe/Irish/Eng|-Central/Eastern-Europe|German/English/Irish/Scottish/French|Unknown|Western-European|Western Europe|""""Western European|Central/Eastern-European|Haitian|None Specified|-Indian",N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,1.647e-05,
chr13:32392545:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43077743:AA>A,,,,,,,,,,0.3598,0.2201,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.354233,
chr13:32362594:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43104844:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,1.647e-05,
chr13:32336685:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-23),,1,8.236e-06,
chr13:32316585:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0235,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00459265,
chr17:43045761:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-92),,1&1&1,,
chr17:43044804:CC>C,,,,,,,,,,0.5358,0.4924,0.464,0.4583,0.5521,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.501997,
chr13:32337680:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32340439:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,1.647e-05,
chr13:32379238:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr17:43124068:TAGGTGATGC>T,,,,,,,,,,,,,,,Italian,,Caucasian,IFD,,,,,,,,stop_lost&inframe_deletion,HIGH,,,-1,1.0,,,,1,8.237e-06,
chr17:43106455:T>A,,,In vitro (cloned)|Unknown,-|?,-|?,1/1658|-,,,,,,,,,German|China|-,2|-,None Specified|-|None-Specified|Chinese|Caucasian,S|IVS,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,
chr13:32332343:G>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?,Grantham score|-|Allele frequency analysis in controls|Prevalence in normal controls|evolutionary conservation analysis|?,64/1658|-,,,,0.0348,0.0325,0.0922,0.0962,0.1329,Danish|USA|German|-|Austria|Sri Lankan|Belgian,1|0|-,Global|-|Caucasian|Sinhalese,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-05),benign(0-052),0&1,1&1,0.06234105,
chr13:32394705:CTCAA>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr17:43093512:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,pathogenic
chr13:32362516:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,
chr17:43043076:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32336794:AT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43092760:GTGCA>T,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43093729:T>C,,Invitae,In vitro (cloned),,,,,0.0|0.0227|0.0077,possibly-damaging:0.604|None|None|possibly-damaging:0.604|possibly-damaging:0.604,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43115799:C>A,,,,,,,,,,,,,,,,,None-Specified,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,,
chr17:43049112:C>G,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr13:32340218:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr13:32332892:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092791:T>A,,,,,,,,,,,,,,,,,Western-European,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338040:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-31),,1,,
chr13:32340495:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-001),,1,,
chr17:43074658:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340015:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-197),0&0&1&1,1&1&1&1,2.471e-05,
chr17:43081192:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32338256:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-331),,,8.267e-06,
chr17:43094343:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-331),,,,pathogenic
chr13:32398190:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326104:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32356572:A>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr17:43126899:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.71 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr13:32333245:GACCT>G,,,,,,1/1658|-,,,,,,,,,Australian|-,,Western European|-|British,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43056880:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43104134:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43070981:G>C,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-002),,1,,
chr13:32363510:G>A,,,In vitro (cloned)|Unknown,inconclusive|no evidence for aberrant splicing|-,-|mRNA analysis|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,0.41,1,,0.015,0.03,0.03,missense_variant,MODERATE,18/27,,1,,tolerated(0-08),probably_damaging(0-998),,1&1&1,,
chr13:32340817:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43044804:CCCCCG>CTTTTTT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.015,
chr13:32369612:T>A,,,,,,,,,,0.0,0.0318,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00838658,
chr17:43104865:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,,,pathogenic
chr13:32337492:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-99),,1,,
chr17:43099738:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,8.236e-06,
chr13:32354958:GCG>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43057052:G>T,,,,,,,,,,,,,,,Dutch,2,Caucasian,Syn,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/22,,-1,,,,,1,8.236e-06,
chr17:43057605:C>G,,,,,,,,,,0.0,0.0,0.0029,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32327943:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.056,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0157748,benign
chr13:32341112:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-037),,1,,
chr17:43092693:CGT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43068283:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43092046:T>-,,GeneDx|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Curoverse|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr17:43070706:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1301 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,66/1658,,,,0.3579,0.1619,0.3646,0.372,0.499,,,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.33746,benign
chr13:32394715:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,,,
chr17:43094794:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,,,pathogenic
chr17:43098760:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32332724:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-016),,,,
chr17:43124037:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr13:32336954:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-526),,1,,
chr13:32337681:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-526),,1,,pathogenic
chr17:43063418:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr13:32363191:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43045780:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr13:32362509:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,293/1658|-,,,,0.5179,0.584,0.5389,0.5337,0.4673,German|Dutch|-|Austria|Spanish|Belgian,1|0|3|2|-,Austria|Causian|-,IVS,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,0.525775,
chr13:32326300:T>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,
chr17:43103085:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43096376:A>CAAAAAAAAAAA,,,,,,,,,,0.3241,0.1573,0.3501,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.327077,
chr17:43121520:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2175 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43071235:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-213),,1,,
chr13:32332537:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.238e-06,
chr17:43092245:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32332234:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.265e-06,
chr17:43124000:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000103959,
chr17:43094365:TG>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32370963:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,,0.0001071,
chr17:43092770:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43109923:C>T,,,,,,,,,,0.002,0.0038,0.0058,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00838658,
chr13:32355136:GG>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32338629:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-007),,1,,
chr17:43092245:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-007),,1,,pathogenic
chr13:32356757:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr13:32353138:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr17:43056683:T>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr13:32325100:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.003,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32357209:T>GC,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.00239617,
chr17:43094130:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338632:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094243:G>CT,,,,,,,,,,,,,,,Western Europe|-|Dutch,, Western European| Native American|-|Western European|Dutch,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32321623:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32338986:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337086:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394538:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32338104:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),,,1,,
chr13:32360462:A>T,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32319285:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr13:32350055:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| 0.1332 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1213,0.0015,0.0591,0.0635,0.0787,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0611022,benign
chr13:32398189:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32370338:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,
chr17:43090997:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,Western-European|-,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,7.413e-05,
chr13:32378309:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0,0.0043,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00678914,benign
chr13:32356586:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr13:32384118:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43091903:C>CT,,,,,,,,,,,,,,,German|-,,Latin American/Caribbean|Western European|-|Caucasian|Asian|Western-European|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,8.237e-06,
chr13:32316413:GG>G,,,,,,,,,,,,,,,,,Western European|-|None Specified,IVS,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr17:43092949:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32338104:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-956),,1,,
chr13:32365254:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43094223:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32387908:T>C,,,,,,,,,,0.5159,0.5038,0.5331,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.509185,
chr17:43104856:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr17:43086602:A>T,,,,,,,,,,0.0328,0.003,0.0216,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0115815,
chr13:32338260:T>A,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-747),,1,,
chr13:32370517:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-991),,1,,
chr17:43045498:CG>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.311e-05,
chr13:32340651:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-109),,1,,
chr13:32370164:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43063793:GT>A,,,,,,,,,,,,,,,Portuguese,,Portuguese,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43094875:C>T,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338570:ATCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,8.242e-06,
chr13:32398608:G>CT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0003459,
chr17:43104224:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,,,,1,8.236e-06,
chr17:43103976:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000998403,
chr13:32380142:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32362637:CTAAGAG>GAG,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,17/27,,1,,,,,,,
chr17:43093463:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43091688:CTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32337881:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),,,1,,
chr17:43099996:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000399361,
chr17:43071101:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.0681|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,
chr13:32339793:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr17:43071101:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,,,
chr17:43094073:T>C,,,,,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32323773:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32354971:A>C,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),benign(0-187),,1,,
chr17:43092897:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43088665:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43071101:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,,
chr13:32337855:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,,pathogenic
chr13:32340323:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,,pathogenic
chr13:32326166:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,,benign
chr17:43093745:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093745:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332616:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32339793:T>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-017),,1,,
chr17:43057601:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0492,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0131789,benign
chr13:32339013:G>T,,,,,,,,,,,,,,,West/Cental/East Europe,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-006),,1,,
chr17:43104121:G>T,,,In vitro (cloned),predicted deleterious|as variant control,Splicing reporter minigene|mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,5/21,-1,,,,,1&1,,
chr17:43094795:T>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?|inconclusive,Multifactorial likelihood-ratio model|co-occurrence with deleterious variant|-|Grantham score|mRNA analysis (RT-PCR)|?|Thermostability assay|evolutionary conservation analysis,1/1658|-,,,,0.001,0.0,0.0,0.0,0.0,Central/Eastern Europe|Not Specified|Spanish|-|British|Dutch|Austrian|Western Europe,," Native American""""|-French-Canadian|Central/Eastern Europe|Not Specified|Western European|-French|-|None-Specified| Central/Eastern European""""|African American|Western-European|Austrian|Western Europe|""""Western European|Central/Eastern-European|Caucasian|None Specified| French Canadian""""",M,1 - Not pathogenic or of no clinical significance,,2.60E-05,,0.0,0.02,0.02,missense_variant,MODERATE,,,-1,,,,,1&1&1,0.0002068905,
chr13:32362500:ATTA>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr13:32324175:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43045803:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43063876:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43091556:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43094609:G>T,,,In vitro (cloned),predicted deleterious|?,Grantham score|?,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32380050:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43092576:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32340399:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43064398:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32380424:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5386 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32380050:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32337656:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-019),,1,,
chr13:32326263:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,,,
chr17:43092990:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398715:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,Western European| Native American|African,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,0.0001163155,
chr13:32339451:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-043),,1,0.0001039635,
chr13:32339789:C>T,,,,,,,,,,,,,,,Western Europe|-,,Western European|-,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,
chr17:43091882:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.482|None|None|possibly-damaging:0.482|possibly-damaging:0.482,,,,,,Austria,1,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,4.942e-05,
chr17:43094477:T>A,,,,,,,,,,,,,,,Not Specified|Malaysian|-,,Indian|-|French-Canadian|None Specified,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,1.647e-05,
chr13:32340728:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32321218:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32398787:TTAA>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.239e-06,
chr17:43106075:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000399361,
chr17:43091450:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32347225:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43104860:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.1589|0.0538,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1,,
chr17:43063353:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/23,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32394786:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-38),benign(0-011),,,,
chr13:32337121:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32353080:C>G,,,,,,,,,,0.0,0.0076,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00219649,
chr17:43079354:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.595e-06,
chr17:43063808:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,136/1658|-,,,,0.3598,0.2179,0.2925,0.371,0.499,German|U.S.A.|-|American|Austria|Spanish,-|1|0|2|412|6,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1&1,0.342452,
chr13:32341111:A>TC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339174:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-006),,1,,
chr13:32337923:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000109,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-54),0&1&1,1&1&1,,
chr17:43091516:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340981:TA>TATA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,0&1,,pathogenic
chr13:32379360:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,1.647e-05,
chr13:32379360:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32340020:G>T,,,,,,,,,,,,,,,,,Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-281),,1&1,,
chr17:43074397:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43045850:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,8.236e-06,
chr13:32393199:T>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00119808,
chr17:43091516:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340388:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43054586:A>C,,,,,,,,,,0.0,0.0023,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00139776,
chr13:32338444:CAG>C,,,,,,,,,,,,,,,Sweden|-,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32336321:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-027),,1,,
chr13:32327154:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32329484:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1&1,,
chr17:43070978:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1&1,,pathogenic
chr17:43094541:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,
chr13:32337619:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|2.2323|0.7556,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43094019:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32349323:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32370498:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43091012:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32339453:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-016),,1,,
chr17:43094307:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43125317:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43091564:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western-European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,8.236e-06,pathogenic
chr17:43091683:A>C,,,,,,,,,,,,,,,,,Western-European|Swedish Dutch English Native American|-Irish,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr13:32340372:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-193),,1,1.647e-05,
chr13:32340753:ATGAT>C,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32333131:CC>C,,,,,,,,,,,,,,,Not Specified|-,,Western European|Western Europe|-,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1&1,,
chr17:43117298:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32363516:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),benign(0-187),,1&1,,
chr13:32338709:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-75),benign(0-004),,1,0.000199681,
chr17:43115725:G>A,,,,,,,,,,,,,,,Malaysian,,Chinese,IVS,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1,,
chr13:32373397:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43091435:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43111801:G>A,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00159744,
chr13:32363516:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr13:32397008:CAT>TCT,,,,,,,,,,,,,,,,," Central/Eastern European|-| Greek""""|None Specified| Ireland/ Greece""""|""""Central/Eastern European|Native American|""""Western European",M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43079339:A>G,,,,,,,,0.0|0.0571|0.0175,benign:0.043|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337575:TAGTGG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32339488:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.244e-06,
chr17:43115789:CC>GA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,1.647e-05,
chr17:43084706:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32380007:T>A,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1,,
chr17:43092412:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|_NHGRI|Division_of_Genomic_Diagnostics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,2.186|0.6128|1.6531,probably-damaging:0.974|None|None|probably-damaging:0.974|probably-damaging:0.974,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1,1&1&1,,
chr13:32363209:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,,,,1,8.236e-06,
chr13:32370560:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1&1&0,,
chr17:43097346:TT>T,,,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|-|?,mRNA analysis (RT-PCR)|-|?,188/1658|-,,,,0.3529,0.1573,0.3646,0.371,0.498,Turkish|German|-|American|Austria|Spanish,10|-|1|0|2|9,-|Caucasian|Turkish,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,0&1,0.334864,
chr17:43092758:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32337416:CTTACC>G,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332940:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-32),benign(0-002),,,,
chr17:43092758:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000326,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0908|0.0308,benign:0.034|None|None|benign:0.034|benign:0.034,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32383177:C>A,,,,,,,,,,0.0,0.0272,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00758786,
chr17:43092238:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32354875:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-171),,,,
chr17:43093556:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43123586:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32356535:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr13:32371062:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr13:32333292:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-217),,1,,
chr13:32340630:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-217),,1,,pathogenic
chr13:32319057:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.249e-06,
chr13:32354920:TTC>T,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43124044:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr13:32337887:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-036),,1,,
chr17:43095918:CAGAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,
chr17:43094393:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32337609:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-676),,1,,
chr17:43092434:T>A,,,,,,,,,,,,,,,Western Europe|-,,Western European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr17:43093184:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093803:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338494:TT>TTTT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43104114:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,,,,,,8.236e-06,
chr13:32336561:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-06),,1,,
chr13:32335141:CAAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-06),,1,,benign
chr13:32341110:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-767),,,,
chr17:43045552:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.522e-05,
chr17:43091042:G>T,,,,,,,,,,,,,,,,,Native American,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.239e-06,
chr13:32370463:AAGA>CAA,,,,,,,,,,,,,,,-|Italian,,Western European|Western Europe|Caucasian,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr13:32337466:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32337311:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-713),,,8.238e-06,
chr17:43048391:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000399361,
chr13:32385099:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32344645:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr17:43106453:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted deleterious|-|as variant control|deletion 22 nt from 3' end exon 5,Splicing reporter minigene|mRNA analysis (RT-PCR)|-|Multifactorial likelihood-ratio model|splicing reporter minigene/patient RNA analysis,,,,,,,,,,French?|German|Belgian|-|Belgian?,1|2|-,-|Caucasian|Native American|caucasian,IVS,5 - Definitely pathogenic,1.0,1.32,1100.0,1.0,,0.97,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1&1,,pathogenic
chr13:32316497:C>GT,,,,,,,,,,,,,,,,2,,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,1,,
chr13:32350083:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43070704:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr13:32352880:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09763 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32355247:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-04),,1,,
chr13:32338933:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32339003:A>T,,,Germline (inherited),,,,FA FANCD1_00017,,,,,,,,,,Western European|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,
chr17:43092004:C>T,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,Chinese,,Chinese Hans,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338954:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-059),0&1&1,1&1&1,,
chr17:43120455:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43093459:AAT>C,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43090914:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,American,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001493405,
chr17:43093330:TTCTC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43092764:AG>C,,,,,,,,,,,,,,,Singaporean,,Indian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43104165:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr17:43076488:A>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1&1,,
chr17:43105483:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43061103:A>C,,,,,,,,,,0.0,0.0,0.0,0.0198,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00399361,
chr13:32333427:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,5.892e-05,
chr17:43056975:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,1,,
chr13:32339324:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-539),,1,,
chr17:43076488:A>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1&1,,
chr17:43121994:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32339324:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-036),,1,,
chr13:32356608:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/27,,1,,deleterious(0-03),benign(0-041),,1,1.647e-05,
chr13:32322826:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43092218:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091490:TCTT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43106535:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1,,pathogenic
chr13:32355077:C>G,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1&1,,
chr13:32338698:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(0-92),,,8.243e-06,
chr17:43091011:GAA>T,,,,,,,,,,,,,,,,,Western-European|Western European|-Central/Eastern-Europe|None Specified,F,,,,,,,,stop_gained&frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32337664:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32370513:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-01),possibly_damaging(0-778),,1,,
chr13:32359927:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43094543:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32344691:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.258e-06,
chr17:43091003:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,0.000199681,
chr13:32319154:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43091437:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32323269:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32355805:C>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000399361,
chr13:32337426:TTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,
chr17:43093263:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319154:A>T,,,In vitro (cloned)|Unknown|Germline (inherited), exon 3 skipping|-|ESE disruption|?, hybrid minigenes|-|ESEfinder/ESRsearch|?,,,,,,,,,,Latin American/Caribbean|Danish|Western Europe|-|Spanish,2|-,"Latin American/Caribbean|Central/Eastern European| Latin American/Caribbean""""|Western European| Central/Eastern Europe|-|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43093225:A>T,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.885|None|None|possibly-damaging:0.885|possibly-damaging:0.885,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339620:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338113:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43115705:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,
chr17:43093492:T>TGG,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32386560:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094002:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32339010:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-49),benign(0-108),0&1&1,1&1&1,,
chr17:43074371:G>A,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr13:32332739:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr13:32338640:A>T,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32370380:GT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.237e-06,
chr17:43092212:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43063888:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-895),,1&1,,
chr17:43078507:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1626 (Asian)| 0.122 (African)| 0.2731 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32394932:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,25/27,,1,,deleterious(0-02),benign(0-046),,1,,
chr17:43098983:AG>A,,,,,,,,,,0.2018,0.2496,0.1902,0.127,0.1677,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.191094,
chr13:32371097:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43093420:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr13:32332739:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),possibly_damaging(0-624),,1&1,,
chr17:43106929:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.378 (African)| 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32376717:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32333296:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,4.12e-05,
chr17:43093579:T>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32386106:T>A,,,,,,,,,,0.0,0.0136,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00359425,
chr17:43098010:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.313 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32360560:C>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr17:43052344:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43085427:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43071254:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Caucasian|Scottish/Irish/English,IVS,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,1,8.238e-06,
chr17:43120601:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43091783:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0002471,
chr13:32319207:T>G,,,Unknown|Germline (inherited),,,1/1658|-,,,,0.001,0.0,0.0,0.0,0.0092,Malaysian,,Indian,Syn,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,0&1&1,1&1&1,0.001533905,
chr13:32358855:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02098 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32315666:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32363229:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-3),benign(0-076),,1,,
chr17:43093460:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-3),benign(0-076),,1,,pathogenic
chr17:43093958:A>T,,,,,,,,,,,,,,,American,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32374180:TC>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000599042,
chr17:43093647:ACTG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32356478:C>AT,,,,,,,FA FANCD1_00041,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43076103:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,benign
chr13:32336468:G>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-12),,,,
chr13:32388542:C>A,,,,,,,,,,0.0487,0.0552,0.1931,0.1081,0.1544,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.103035,
chr17:43070983:G>C,,,In vitro (cloned),as wildtype control,Transcription activation in human cells,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-01),,1,,
chr13:32362691:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43123682:G>A,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00119808,
chr13:32339845:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32340042:C>A,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-431),,1,,
chr13:32362668:TT>A,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32396995:A>G,,,,,,,,,,,,,,,Central/Eastern Europe,,,N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32332502:AA>G,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,8.238e-06,
chr17:43092113:G>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,-|?|Multifactorial likelihood-ratio model,,,,,0.001,0.0356,0.0029,0.0,0.0,USA|Not Specified|-|American|Austria|African American,0|-,African American|-,M,1 - Not pathogenic or of no clinical significance,,2.90E-04,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,0.006544515,
chr13:32368808:C>G,,,,,,,,,,0.9533,0.8926,0.9683,0.9782,0.955,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.944688,
chr13:32325188:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/26,1,,,,,1,,
chr13:32380111:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,0.0001121955,
chr17:43109543:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr13:32320782:C>A,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00239617,
chr13:32396948:T>C,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32319134:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 1.22E-18. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.04021 (Asian)| 0.1016 (African)| 0.04749 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.3256|0.0908|0.246,benign:0.09,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr13:32321778:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43093763:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091771:G>TA,,,,,,,,,,,,,,,Not Specified|Western Europe|-,,White-NonHispanic|Central/Eastern Europe|Not Specified|Western European|-|Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093201:CT>T,,,,,,,,,,,,,,,Austria|-,,Western-European|-Central/Eastern-Europe|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32363505:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-985),,1,,
chr17:43122772:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06098 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43106514:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,benign
chr17:43093578:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43063345:TGGTT>T,,,,,,,,,,,,,,,Not Specified|-,,-Native-American|-German|Central/Eastern European|Not Specified|Western European|-Scottish|-|Western Europe|Asian|African American|African|Western-European|Western Europe/African American|None-Specified|None Specified|-Iris,F,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,1,8.237e-06,
chr17:43092088:TA>T,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43091827:TTTAC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43125347:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32330918:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43093829:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394975:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,2.471e-05,
chr13:32330889:G>C,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.001453735,
chr17:43082517:CA>T,,,,,,,,,,,,,,,,,Western European|Slovak/German,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/22,,-1,,,,,,8.236e-06,
chr13:32363294:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0,0.0,0.0,0.0,,,Africa,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(1),benign(0-003),0&1&1,1&1&1,1.6475e-05,
chr13:32333303:A>T,,,,,,,,,,,,,,,,,Pacific Islands,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr17:43094838:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,3.298e-05,
chr13:32340020:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-281),,1&1,,
chr17:43116191:C>CT,,,,,,,,,,0.331,0.2179,0.3617,0.371,0.4949,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.345447,
chr13:32346892:TTTCG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32316458:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32316496:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr17:43092094:A>G,,,,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091567:G>A,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32330657:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32332532:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43074016:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01399 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00159744,benign
chr13:32394413:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0109,0.0008,0.0029,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00459265,benign
chr13:32379859:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32338297:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43093529:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000194,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338707:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),probably_damaging(0-939),,1,,
chr17:43093745:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),probably_damaging(0-939),,1,8.237e-06,
chr13:32337160:CAGCG>CAAAC,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr13:32358241:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32379800:C>A,,,In vitro (cloned),predicted deleterious|no rescue ES cell lethality|?,Protein likelihood ratio model|Embryonic stem cell assay|?,,,,,,,,,,-|Spanish,, French Canadian|Western European|-|Western Europe|Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,,
chr13:32319126:TGAAA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr17:43092616:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,pathogenic
chr17:43093342:G>TC,,,,,,,,,,,,,,,,,Unknown|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43118002:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32333264:G>C,,CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0465|0.0227|0.0385,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-864),,1&1,,benign
chr17:43091006:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-864),,1&1,,pathogenic
chr17:43092973:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32356539:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,,0.0001245505,
chr17:43074412:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32398251:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,0.0002306,
chr13:32398422:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43093054:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000203,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0|0.0231,probably-damaging:0.987|None|None|probably-damaging:0.987|probably-damaging:0.987,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43071236:G>A,,,,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_gained&splice_region_variant,HIGH,15/23,,-1,,,,,1,,
chr13:32332812:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),probably_damaging(0-971),1&1,1&1,,
chr17:43091746:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43076437:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,1.647e-05,
chr13:32337282:A>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-23),,,0.001572935,
chr13:32328939:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43094681:GTAATGA>GTAATGAGTAATGA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340065:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000209,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0454|0.0154,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-016),,1&1,,
chr17:43099688:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000399361,
chr17:43044586:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43053314:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43118338:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32336991:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43091765:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32336563:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340065:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-9),benign(0),,1&1,,
chr13:32394936:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,1&1,,
chr17:43093054:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,1&1,,pathogenic
chr17:43051050:C>A,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43056579:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43108270:C>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr17:43094692:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000767,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094798:C>A,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,0.0001039585,
chr13:32348708:A>C,,,,,,,,,,0.001,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00139776,
chr13:32378476:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43092616:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43091751:TA>T,,,,,,,,,,,,,,,Greek|-,8|-,Greek|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,
chr13:32333081:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-01),,,0.0001039585,
chr13:32339535:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-01),,,,pathogenic
chr17:43063873:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,, Western European|Western European|-Western-European|Western-European,IVS,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr17:43049685:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1301 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32350749:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr17:43063873:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned)|Unknown,predicted deleterious|-,-|Multifactorial likelihood-ratio model,-|3/1658,,,,,,,,,,B217|-,Western-European|-|None Specified,IVS,5 - Definitely pathogenic,12.87,1.15,,1.0,,0.97,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32338175:AAGA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32397150:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,
chr13:32338127:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-003),,1&1&1,8.237e-06,
chr13:32332100:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr17:43063873:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Czech,,central Europe,IVS,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32338125:CT>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,0&1&1,1&1&1,,
chr17:43074305:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32336283:AC>T,,,,,,-|1/1658,,,,,,,,,Not Specified|Western Europe|-|Canadian,,"White-NonHispanic|Irish|Central/Eastern European| Central/Eastern European""""| Irish|Western European|-|Western Europe|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43096751:C>CA,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000798722,
chr13:32319314:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Ashkenazi,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32389701:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04881 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0606,0.0008,0.0144,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0159744,benign
chr17:43094824:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43053726:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32332319:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-928),0&1&1&1&1,1&1&1&1&1,,
chr17:43063960:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|Central/Eastern Europe,IVS,1 - Not pathogenic or of no clinical significance,1.0,3.72E-03,1.23,0.0,,0.04,intron_variant,MODIFIER,,15/21,-1,,,,,1,8.237e-06,
chr17:43105441:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr17:43076583:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,,,,,1,8.237e-06,
chr13:32346896:T>C,,,Germline (inherited),,,,FA FANCD1_00035,,,,,,,,,,"Western European| Syrian Sephardic Jewish""""|-|""""Ashkenazi| Ashkenazi| Near Eastern| Syrian Jewish""""|""""Western European",M,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-07),possibly_damaging(0-456),,1&1&1&1&0&0,,
chr13:32326656:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-07),possibly_damaging(0-456),,1&1&1&1&0&0,0.0005189,
chr13:32346896:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),SD disruption|aberrant splicing|-|predicted deleterious| HR deficient| exon 13 skipping,-|mRNA analysis (RT-PCR)|Multifactorial likelihood-ratio model| RNA analysis|Embryonic stem cell assay|NNSPLICE and lymphocyte RT-PCR,1/1658|-,-|FA FANCD1_00023,,,,,,,,Czech|-,,White-NonHispanic|Central/Eastern European| Central/Eastern Europe|Western European| French Canadian|-| Italian|Western Europe|Caucasian|None Specified|Italian,M,4 - Likely pathogenic,1.0,2.46,20.33,0.962,0.02,0.34,missense_variant&splice_region_variant,MODERATE,13/27,,1,,deleterious(0-01),possibly_damaging(0-517),,1&1&1&1&0&0,,
chr13:32357828:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr13:32340748:ATTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,pathogenic
chr17:43104264:C>A,,,In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1&1,,
chr17:43071148:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(1),benign(0),0&1&1,1&1&1,,
chr13:32379290:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,
chr17:43094410:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32363231:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43090921:->CA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092918:G>CA,,,,,,,,,,,,,,,-|French,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43059936:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0212,0.0058,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0129792,benign
chr17:43093316:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr17:43092251:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43069408:G>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000798722,
chr13:32352814:A>TA,,,,,,,,,,0.001,0.0,0.0,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32342795:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0235,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00459265,
chr17:43051149:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,1.647e-05,
chr13:32336967:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43063937:T>G,,,In vitro (cloned),predicted deleterious|uncertain|as variant control|?,Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|Proteolytic degradation|?,,,,,,,,,,Danish|Denmark,3|-,-|Caucasian,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr13:32370408:GATCT>G,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr13:32366868:AA>C,,,,,,,,,,0.5179,0.3585,0.4971,0.4752,0.544,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.469449,
chr17:43084232:T>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr17:43109088:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02639 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43112329:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43053755:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2186,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342652,benign
chr17:43094410:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43092417:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337191:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43091989:GG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337185:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32379413:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.5698|0.1816|0.4383,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,0&0&1,1&1&1,,
chr13:32318587:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43064188:A>T,,,,,,,,,,0.2744,0.146,0.2248,0.371,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.290935,
chr13:32370437:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,benign
chr17:43063369:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,pathogenic
chr13:32398686:AG>C,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32371598:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32333247:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-971),,1,,
chr17:43092600:G>C,,,,,,,,,,,,,,,Malaysian,,Chinese,S,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,2.471e-05,
chr13:32340139:A>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-185),,1,,
chr17:43118425:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32360061:C>T,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43111194:A>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000798722,
chr13:32360774:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32329273:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32370941:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.236e-06,
chr17:43057356:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00499201,benign
chr17:43093796:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32398092:GAGAT>A,,,,,,,,,,,,,,,, -,,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32384512:T>A,,,,,,,,,,0.2078,0.1853,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.225639,
chr17:43092201:C>CT,,,,,,,,,,,,,,,German|Dutch?,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43050648:C>A,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000798722,
chr17:43093701:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091931:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.2724|0.0923,probably-damaging:0.998|None|None|probably-damaging:0.998|probably-damaging:0.998,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43090998:C>T,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,8.237e-06,
chr17:43091931:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43088200:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32357913:CCAG>A,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,protein_altering_variant,MODERATE,16/27,,1,,,,,,,
chr17:43057054:AGTCCCAC>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost&splice_region_variant,HIGH,18/22,,-1,,,,,,,
chr17:43095838:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned)|Unknown,predicted neutral|no splicing defect|-,Splicing reporter minigene|-|splicing reporter minigene/patient RNA analysis|mRNA analysis and splicing reporter minigene,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1&1,,
chr17:43095838:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,"""""Central/Eastern European| Greek""""",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1&1,,
chr17:43094692:A>C,,,In vitro (cloned),predicted neutral|inconclusive|?,Multifactorial likelihood-ratio model|?|evolutionary conservation analysis,,,,,,,,,,-|USA,,Latin American/Caribbean|Latina,M,1 - Not pathogenic or of no clinical significance,1.0,0.00324,1.15,8e-05,0.02,0.02,missense_variant,MODIFIER,,,-1,,,,,1,0.0001235,
chr13:32339907:A>G,,,,,,,,,,,,,,,,,Latin American/Caribbean| Hispanic|None Specified|Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-454),,1,3.295e-05,
chr13:32341007:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-117),0&1&1,1&1&1,,
chr17:43085514:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43095838:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1&1,,
chr13:32340258:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-059),,1,,
chr17:43124013:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr13:32338886:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,3.295e-05,
chr13:32370438:G>T,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European|None Specified|Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-22),benign(0-384),,1,,
chr17:43094652:A>C,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,
chr13:32379375:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,,
chr13:32379881:C>A,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,-|Ashkenazi,,Ashkenazi/Central/Eastern Europe|-|Ashkenazi|None Specified|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,4.943e-05,
chr13:32323238:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32326237:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,,8.237e-06,
chr17:43047448:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr17:43090930:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.241e-06,benign
chr13:32380165:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr13:32332603:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43093053:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32338378:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32333358:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),possibly_damaging(0-466),,1,,
chr13:32379766:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Canadian,,,N,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,pathogenic
chr17:43094194:T>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32336978:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),,,1,,
chr13:32339102:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-002),,1,,
chr13:32333072:G>C,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.868,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-471),,1,,
chr13:32333358:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-023),,1,,
chr13:32347009:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43091851:CAGCT>T,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094032:TCTCTTTGCCAAGGAGA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363492:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-998),,,,
chr13:32377487:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43095924:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|as variant control,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,-|1/1658,,,,,,,,,Western Europe|-|Italian,,Not Specified|Western European|Western Europe|-|None-Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1&1,1.647e-05,
chr17:43107299:C>A,,,,,,,,,,0.0,0.0507,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.013778,
chr17:43071060:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,,,,8.236e-06,
chr13:32318623:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1667 (African)| 0.281 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2644,0.2148,0.232,0.3681,0.2526,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.265375,benign
chr13:32326566:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,,,
chr17:43092304:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32396968:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32370396:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,1,1.647e-05,
chr13:32398595:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,7.413e-05,
chr17:43105033:C>T,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr17:43054039:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32332606:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43092622:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43104865:G>TA,,,,,,,,,,,,,,,,,Western Europe/African American,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,,,
chr17:43115723:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,1&1&1,,
chr17:43106443:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,1.648e-05,
chr13:32332974:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,pathogenic
chr17:43092466:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43047671:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,,,,,8.236e-06,
chr17:43094488:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32336879:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-011),,1,3.295e-05,
chr13:32340277:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32324311:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43091701:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32364660:A>T,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000998403,
chr17:43092170:CAT>T,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332756:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43097235:G>C,,,,,,,,,,,,,,,Western Europe|-,,Western-European|-,IVS,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,1.647e-05,
chr13:32338631:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43099098:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32352134:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32338626:A>G,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,Western Europe|-,,Western European|-|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-002),,1&1,,
chr17:43097281:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1,,
chr13:32340323:AT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32349428:T>A,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00678914,
chr13:32342791:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32380071:G>A,,,,,,,,,,,,,,,,,Western European|None Specified,N,,,,,,,,stop_retained_variant,LOW,,,1,,,,,1,,
chr13:32389726:A>T,,,,,,,,,,0.001,0.0,0.0,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,
chr13:32326569:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&1&1,1&1&1,,
chr17:43066127:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000599042,
chr13:32338947:AAATG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092695:TAC>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32326569:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&1&1,1&1&1,,
chr17:43092805:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32383776:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32337038:GG>G,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43063867:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1,,
chr13:32339211:A>G,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-007),,1,,
chr17:43094573:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,MODIFIER,,,-1,,,,,,,
chr13:32376774:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,8.236e-06,
chr13:32333328:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32333328:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104071:A>G,,,,,,,,,,0.002,0.0015,0.0029,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00080698,
chr17:43106501:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32371568:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43046985:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01979 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0189,0.0023,0.0072,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00559105,benign
chr13:32338890:T>C,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-164),0&0&0&1&1,1&1&1&1&1,,
chr13:32319130:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32319266:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32339231:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,pathogenic
chr17:43094322:A>G,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32363384:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43068741:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32363384:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?,co-occurrence with deleterious variant|-|Protein likelihood ratio model|Prevalence in normal controls|Cell viability (in BRCA-/- cells)|?,-|13/1658,,,,0.002,0.0,0.0014,0.0,0.0,West/Central/East Europe|German|-|Not Specified|Austria|Dutch|French Canadian|Western Europe|Native American,0|-,Western Europe/Native American|Central/Eastern Europe|Not Specified|-|Ashkenazi|Western Europe|Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-78),benign(0-015),,1&1,0.001316521,
chr17:43092063:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr13:32337342:T>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.437,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-599),,1,,
chr13:32355267:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-599),,1,,pathogenic
chr13:32336828:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-05),,1,,
chr17:43047678:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-909),0&0&1,1&1&1,,
chr17:43061669:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32315519:A>T,,,,,,,,,,0.0,0.0023,0.0,0.002,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32376774:G>C,,,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,,
chr13:32354948:T>A,,Invitae,,,,,,0.0116|0.0|0.0077,benign:0.325,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-05),,,,,
chr17:43049066:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr17:43092491:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43074553:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32339759:G>T,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32337126:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-915),,1&1,,
chr13:32326112:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,0.0001039605,
chr13:32339327:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32336472:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,,,8.237e-06,
chr17:43093054:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|-,-|evolutionary conservation analysis|Multifactorial likelihood-ratio model,1/1658|-,,,,0.001,0.0,0.0,0.0,0.0,Not Specified|Western Europe|-,,Central/Eastern European|Not Specified|Western European|-|None-Specified|-Central/Eastern-Europe|-Italian|Western-European|Western Europe|Latin-American/Caribbean|None Specified,M,1 - Not pathogenic or of no clinical significance,0.4985,0.0000002,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,0.0001904405,
chr13:32333241:ATAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43093808:A>T,,,In vitro (cloned),as variant control,Host Cell End-Joing assay,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,1.647e-05,
chr13:32380042:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,8.236e-06,
chr17:43092597:G>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43092597:G>C,,,,,,,,,,,,,,,Not Specified|-,1|-,Near-Eastern|Irish|White-NonHispanic|German|Western European|-|-Iran|Not Specified|Western-European|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32338981:TG>G,,,,,,,,,,,,,,,,," Native American""""|Filipino| Filipino""""|Philipeno|""""Asian|Asian|Western Europe|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092695:TAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32362508:CA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,1.647e-05,
chr13:32337254:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,pathogenic
chr13:32391462:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43045792:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|uncertain,Computational analysis|transcription activation/PS/BA/BS|Transcription activation in human cells,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-922),,1,8.236e-06,
chr13:32340118:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-105),,1,,
chr17:43093619:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32345295:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32366651:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43093649:A>TGG,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43093619:C>T,,Pathway_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43105778:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43117696:G>A,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43092113:GG>T,,,,,,,,,,,,,,,Spanish,1,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092263:C>A,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093172:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339594:G>AT,,,,,,,,,,,,,,,,,-|German/Mennonite,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32336971:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43094515:T>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&0&1,,
chr17:43082434:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&0&1,1.647e-05,
chr17:43093235:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326638:C>T,,,,,,,,0.093|0.0|0.0615,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr13:32386567:ACAGACACAAACATACACAGAACCATGTCACA>A,,,,,,,,,,0.2087,0.1838,0.2003,0.3661,0.1708,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.22524,
chr13:32366863:A>G,,,,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00259585,
chr13:32340515:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-444),,1,,
chr13:32340515:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-315),,1,,
chr17:43106496:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43093535:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32345500:A>G,,,,,,,,,,0.2793,0.2156,0.2406,0.369,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.269569,
chr17:43092200:C>GT,,,,,,,,,,,,,,,,3,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094515:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326238:CCAG>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,5/26,1,,,,,1,,pathogenic
chr13:32379747:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,8.238e-06,
chr13:32394792:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,pathogenic
chr13:32335967:C>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00119808,
chr13:32356594:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,8.236e-06,
chr17:43087611:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2093 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43094194:TGC>C,,,,,,,,,,,,,,,British,,English,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32347715:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32331009:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,Western Europe,,,N,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1&1,,pathogenic
chr17:43093831:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32371035:T>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?|predicted deleterious,Histopathology|-|Co-localization to predicted ESEs|Protein likelihood ratio model|Multifactorial likelihood-ratio model|Cell viability (in BRCA-/- cells)|?,-|18/1658,,,,0.001,0.0,0.0,0.0,0.0,Irish/Welsh/English/German|Central/Eastern Europe|German|-|Not Specified|Austria|Scandinavian/English/Norwegian/French|Western Europe|Italian|Near East/Mid East,1|0|-," French Canadian""""| Irish| Native American""""| Central/Eastern European|Central/Eastern European|Central/Eastern Europe| Central/Eastern Europe|Not Specified|Western European|-|caucasian| Central/Eastern European""""|Ashkenazi| Italian""""|African|Western Europe|None Specified|Caucasian|Native American|""""Western European",M,2 - Likely not pathogenic or of little clinical significance,1.05,1.064,,0.0398,0.03,0.03,missense_variant,MODERATE,20/27,,1,,deleterious(0-03),probably_damaging(0-968),,1&1,0.0005404905,
chr17:43124030:A>C,,,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,1.0,,,0&1,0&1,,
chr13:32329427:A>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,,
chr13:32398251:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32333105:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-015),,1,,
chr17:43123065:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3 (Asian)| 0.12 (African)| 0.32 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32357794:TTT>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,Western European|Western Europe|-,F,,,,,,,,frameshift_variant&stop_lost,HIGH,16/27,,1,,,,,,,
chr13:32329418:A>G,,,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr17:43093619:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32332408:AT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32339195:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-017),,1,,
chr13:32332814:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,8.237e-06,
chr13:32340118:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,,pathogenic
chr13:32331135:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0198,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00419329,
chr13:32333105:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-61),benign(0-004),,1,,
chr17:43092785:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326085:T>CT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43115797:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32339439:A>G,,Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-105),,1,,
chr13:32386680:T>A,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00179712,
chr13:32340107:ACA>TAT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-019),,,4.118e-05,
chr17:43048720:TTTTTAGTACAGACATGGTTTCACCATGTTG>C,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,German|Dutch?|-|Dutch,,"-non-jewish-ger|Unknown|Dutch|-|Western European| Ashkenazi""""|Caucasian|Caucasion|Western-European|Central/Eastern-European|None-Specified|""""Western European",IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr17:43092440:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340561:A>G,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1&1,,
chr17:43092440:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092460:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092563:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339252:C>G,,,,,,,,,,,,,,,Italian,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-03),,1,,
chr13:32336898:AT>A,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339283:A>C,,,In vitro (cloned)|Unknown,inconclusive|-,Histopathology|-,,,,,,,,,,Western Europe|-,,-|Ashkenazi|Central/Eastern European,M,3 - Uncertain,,,7.92,0.1391,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-02),,1,4.943e-05,
chr13:32338294:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-02),,1,,pathogenic
chr13:32339810:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-02),,1,0.0001894,
chr17:43123945:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32376476:T>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000798722,
chr13:32349324:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32362626:ATTGAG>G,,,Unknown|Germline (inherited),,,,,,,,,,,,German|Czech|Austria|-|Danish,1|-,"Western European|-| Poland""""|Western Europe|""""Central/Eastern European|Caucasian",F,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr17:43094289:G>A,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32329446:GA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332548:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-801),,1,,
chr17:43092375:GA>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339810:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-637),,1,8.236e-06,
chr17:43092865:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43121362:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32344676:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.249e-06,
chr17:43105884:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43113565:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32338226:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43091445:CT>A,,,,,,,,,,,,,,,,,Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43091448:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43092798:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0581|0.0227|0.0461,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363317:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-756),,1,,
chr17:43093882:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-756),,1,,pathogenic
chr17:43045715:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),benign(0-021),,1,,
chr17:43047657:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0-03),benign(0-007),,1&1,,
chr17:43092140:CA>C,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,
chr17:43071076:CT>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,0&0&0&0&1,1&1&1&1&1,,
chr17:43063321:AC>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.237e-06,
chr17:43076645:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.237e-06,
chr17:43093734:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43106435:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr13:32332737:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-176),,,,
chr13:32340680:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-176),,,,pathogenic
chr17:43093492:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082429:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,0&1,1.647e-05,
chr17:43077808:T>G,,,,,,,,,,0.0,0.0008,0.0922,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0129792,
chr17:43090921:GCA>G,,,,,,,,5.9729|5.4409|5.7917,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43071175:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),possibly_damaging(0-453),,1,,
chr13:32339658:TT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),possibly_damaging(0-453),,1,,pathogenic
chr13:32336667:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32338294:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43093006:A>C,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,1.0,0.00347,0.0603,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32352881:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32338496:CTAG>A,,,In vitro (cloned)|Unknown,as wildtype control|predicted deleterious|-|as variant control,-|Nuclear localisation|Homology-directed repair assay|Centrosome amplification|Survival assay with VC8 (after MMC treatment)|evolutionary conservation analysis,-|1/1658,,,,,,,,,,," Ireland/England""""|Western European|-| Scottish| English|Western Europe|None Specified|""""Western European",IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.237e-05,
chr13:32338294:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32323006:C>G,,,,,,,,,,0.0,0.0197,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00559105,
chr13:32397940:TCTCT>T,,,,,,,,,,0.0,0.0136,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00379393,
chr13:32389796:G>C,,,,,,,,,,0.0,0.0204,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00559105,
chr17:43090937:TTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr17:43044427:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43093135:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32376755:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32332905:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western Europe|African,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-946),,1,,
chr17:43106484:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr17:43071049:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-012),,,,
chr13:32363369:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32333228:AATTAA>A,,,,,,,,,,,,,,,,," Native American| Native American""""|Not Specified|Western European|-|Unknown|Western Europe|None Specified|""""Western European",F,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,
chr13:32370541:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43063379:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000901,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1,,
chr17:43071020:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-13),benign(0-013),,1,8.236e-06,
chr17:43091734:A>G,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|Western Europe/Native American|-,,Western European|-|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,0.00407,0.01349,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43120142:G>T,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00139776,
chr17:43070977:TT>A,,,,,,1/1658|-,,,,,,,,,-|British,1|-,Caucasian|Latin-American/Caribbean|-|None-Specified|Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr13:32328571:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43071020:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-002),,1,,
chr13:32394546:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32398558:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000919,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339068:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-043),,1,1.647e-05,
chr13:32338544:T>A,,,,,,1/1658,,,,,,,,,,,Western European|None Specified,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32336564:A>T,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-193),,1,,
chr13:32344248:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43073766:G>T,,,,,,,,,,0.4563,0.1936,0.451,0.377,0.5194,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.382588,
chr17:43094774:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32340107:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000575,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-019),,1,,
chr13:32336381:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-019),,1,,pathogenic
chr13:32326205:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,3.296e-05,
chr13:32340802:T>TA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32344638:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43067700:C>T,,,In vitro (cloned),predicted deleterious,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32343207:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32339705:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr17:43091613:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336381:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-002),,1&1,,
chr13:32394978:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,1.647e-05,
chr17:43093770:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,
chr13:32398678:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32344702:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.268e-06,
chr13:32358101:CT>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00159744,
chr17:43045779:CC>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr13:32370522:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-13),benign(0-052),,1,8.237e-06,
chr13:32339459:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-03),,1,0.0001163305,
chr17:43125449:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43096454:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32332753:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.9773|0.3309,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43047484:AAGCC>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000798722,
chr13:32375622:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32338778:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-006),,1&1,,
chr17:43093666:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,"Central/Eastern Europe| Central/Eastern European""""|Western European|Western-European|Western Europe|Central/Eastern-European|None-Specified|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,2.82,0.00037,2e-05,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,4.942e-05,
chr13:32380776:T>A,,,,,,,,,,0.0,0.0,0.0,0.0268,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00559105,
chr13:32363440:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,
chr17:43093963:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43104878:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/22,,-1,,,,,1,,
chr13:32321021:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32354908:A>T,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-978),,1,8.236e-06,
chr13:32324887:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32332680:T>G,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&1&1,1&1&1,,
chr17:43082446:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,0&1&1,0&1&1,1.647e-05,
chr13:32339011:A>C,,,,,,,,,,,,,,,,-| -,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,4.942e-05,
chr17:43115791:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,co-occurrence with deleterious variant|-,,,,,0.0,0.0023,0.0,0.0,0.0,,,African American|-|None Specified|African,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1&1,0.000439571,
chr17:43090905:CCA>C,,,,,,,,0.2787|0.1407|0.2317,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43124031:G>TAA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43097321:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr17:43105072:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32385702:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5113,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511781,benign
chr13:32326631:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.236e-06,
chr13:32398942:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32352117:C>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00199681,
chr17:43092108:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43082551:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32328941:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32340714:AGA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32338402:ACACA>T,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32358197:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43106560:A>T,,,,,,,,0.0117|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr13:32338311:ATGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32358062:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32337099:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr17:43092353:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),,,,,,,,,,,,Not Specified|Norwegian|Sweden|-,,Western-European|Western European|-|Caucasian|Western Europe/Sweden,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43091496:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43124061:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,3.295e-05,
chr13:32371722:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43093880:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32356411:C>G,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,
chr17:43093451:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,pathogenic
chr13:32319771:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43094425:G>C,,,,,,,,,,,,,,,,,Ashkenazi,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340373:T>A,,,In vitro (cloned),predicted pathogenic,HR assay,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-193),,1&1,,
chr13:32337241:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,1&1,1&1,,
chr13:32341031:CT>G,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32337717:G>A,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,,
chr13:32341140:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-99),benign(0-004),,1,,
chr13:32339511:C>AT,,,,,,,,,,,,,,,,,-|Italy|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32341177:AGCA>A,,,,,,,,,,,,,,,Malaysian,,Chinese,IFD,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,1,,
chr13:32336862:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-072),,1,,
chr13:32329548:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,53/1658|-,,,,0.1938,0.2746,0.2176,0.0794,0.1452,German|Austria|-,1|0|2|-|6," Oceania""""|-|""""Africa| Asia",IVS,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,0.185903,
chr17:43093163:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0681|0.0231,probably-damaging:0.961|None|None|probably-damaging:0.961|probably-damaging:0.961,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43096738:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr17:43093183:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43063890:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,-|Irish/Scottish,1|-,Not Specified|Western European|Caucasian,N,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1,,pathogenic
chr17:43093637:C>TA,,,,,,,,,,,,,,,,,,F,,,,,,,,stop_gained&frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43104363:A>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,
chr13:32340006:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,1,,
chr13:32336466:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),,,,8.237e-06,
chr13:32390432:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32340515:A>C,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-315),,1,,
chr17:43054221:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32356392:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,8.238e-06,
chr13:32337854:C>G,,,,,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-63),benign(0-012),,1,8.236e-06,
chr17:43093970:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,benign:0.36|None|None|benign:0.36|benign:0.36,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332243:A>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,1.652e-05,
chr17:43092337:C>TC,,,,,,,,,,,,,,,,,Western-European|Western European|None-Specified|Central/Eastern European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32316396:C>A,,,,,,19/1658,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32340203:C>A,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-03),,1,,
chr17:43066450:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00499201,benign
chr17:43093324:G>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094112:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,2.471e-05,benign
chr17:43112732:C>G,,,,,,,,,,0.3429,0.7065,0.3689,0.3343,0.4939,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.470248,
chr13:32371012:TGGAA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr17:43044880:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001432,
chr17:43095919:CACA>-,,University_of_Washington_Center_for_Mendelian_Genomics|_University_of_Washington,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332657:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43074517:T>C,,,In vitro (cloned),as variant control|?,Peptide binding ability|?,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32331011:AAGAGAA>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,9/27,,1,,,,,,,
chr17:43093373:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,-|Italy- W. Europe,,Caucasian|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,1.647e-05,
chr17:43091322:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.321e-06,
chr17:43092970:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339950:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336796:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-042),0&1&1,1&1&1,,
chr17:43096211:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32330972:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0454|0.0154,benign:0.085,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43097149:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr13:32316449:A>C,,,,,,,,,,,,,,,,,Western European,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32398248:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32339645:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32316449:A>G,,,,,,,,,,,,,,,,,Oceania,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32329416:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,2.476e-05,
chr17:43093373:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,-|Venezuela,,Western European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32317638:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32363289:T>G,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),probably_damaging(0-922),,1&1,,
chr13:32363289:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43093551:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32363390:G>C,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-97),,1,,
chr17:43093313:TCC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43064312:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32332991:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-52),benign(0-023),,1,8.237e-06,benign
chr13:32343305:A>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000599042,
chr13:32337819:GGT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398468:CCTG>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43092712:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32336538:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-085),,,8.237e-06,
chr13:32338495:CCTA>T,,,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr13:32333310:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr13:32336771:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00008,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,,1,,
chr13:32325029:A>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,
chr17:43117310:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43045764:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1&1&1,,pathogenic
chr13:32315655:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1836 (Asian)| 0.126 (African)| 0.1636 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32391658:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43045962:G>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000599042,
chr17:43091881:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43094394:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics,,,,,,0.0|0.6355|0.2153,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43092915:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32379238:T>A,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Asia,IVS,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr13:32338800:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),possibly_damaging(0-844),,,,
chr13:32356483:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr13:32333266:A>C,,,,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,Syn,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,0.00516445,
chr17:43045764:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-917),,1&1&1&1,,
chr13:32341421:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0136,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00399361,benign
chr17:43073367:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32332394:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(1),,,8.238e-06,
chr17:43053924:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2886 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32332803:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-5),benign(0-006),,1&1,,
chr13:32337990:G>T,,,,,,,,,,,,,,,,,Asian| Hawaiian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr13:32339950:AT>C,,Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124028:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,0&1,8.241e-06,
chr13:32394784:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,0&1,,pathogenic
chr17:43060530:A>T,,,,,,,,,,0.3598,0.2179,0.2925,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.342452,
chr17:43063918:G>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-996),,,,
chr13:32363289:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-996),,,,pathogenic
chr13:32339923:TTTATA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,8.237e-06,
chr17:43092436:CCTGTAATCCCA>C,,,,,,,,,,,,,,,Norwegian|Western Europe,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32326240:T>G,,,In vitro (cloned)|Unknown,predicted deleterious|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Czech|-,, Polish/Russian|-|Caucasian|None Specified|Central/Eastern European,IVS,5 - Definitely pathogenic,1.0,1.17,18.2,0.999,,0.97,splice_acceptor_variant,HIGH,,5/26,1,,,,,1&1,,
chr13:32362678:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,African American,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32338082:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,1,,
chr13:32329054:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43100559:TA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (Asian)| 0.45 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43060222:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32398583:A>T,,,,,,,,,,,,,,,African American,,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1&1,1&1&1&1,,
chr17:43092478:C>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43066880:G>T,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32363348:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-31),benign(0-1),,,8.236e-06,
chr13:32396958:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398583:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1&1,1&1&1&1,8.237e-06,
chr13:32330162:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0356,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00958466,benign
chr17:43092659:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32384942:C>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr17:43106578:CCTGCAT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,8.277e-06,
chr13:32332365:C>G,,,,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-002),,1,3.295e-05,
chr13:32340037:A>G,,,Unknown|Germline (inherited),,,-|10/1658,-|FA FANCD1_00009,,,,,,,,Not Specified|-|British|Dutch?|German|Austria|Western Europe|Australian|Belgian,1|-,"Irish| Native American""""|English/Scottish| Central/Eastern Europe|Not Specified|Western European|African|-|British| Scottish""""| Ashkenazi|English|Western Europe|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&0,,
chr13:32387360:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04895 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43110550:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,7.469e-05,
chr17:43100594:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| 0.3049 (African)| 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr17:43065534:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32333156:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-013),,1,,
chr13:32344629:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-01),probably_damaging(0-914),,1,,
chr13:32379849:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32339468:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-03),,1,,
chr13:32370422:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,benign
chr13:32340037:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&0,2.471e-05,
chr17:43093057:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063440:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000199681,
chr17:43091675:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,pathogenic
chr13:32332877:AAGA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,pathogenic
chr13:32341020:T>G,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-081),,1&1,1.647e-05,
chr13:32357130:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32333020:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32319305:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32320728:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43093330:TTCTCTTCTTTTTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr17:43093712:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,-|British,,Western-European|None-Specified|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43063946:CAG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32380117:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,
chr17:43092133:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32330966:TGAT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32338772:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-222),,1,,
chr17:43092596:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43070993:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-052),,1,,
chr13:32357892:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-34),benign(0-082),,1,,
chr13:32337364:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-34),benign(0-082),,1,,pathogenic
chr13:32381545:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32332798:C>TA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32336488:A>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&1&1&1,1&1&1&1,0.0002079155,
chr17:43104918:TCAACAAGTTG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr13:32330980:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43092596:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43094327:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32340575:CAC>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43116729:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32337722:T>G,,,,,,,,,,,,,,,,,Near Eastern| Saudi Arabia,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-997),,1,,
chr17:43097270:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,0&1&1,1&1&1,,
chr17:43045689:T>TGGGGGGGGT,,,,,,,,16.913|21.7636|18.5653,None|None|None|None|None|None|None|None|None|None,,,,,,,,,,,,,,,,,inframe_insertion,MODERATE,22/22,,-1,,,,,,,
chr13:32319168:GTGG>A,,,,,,,,,,,,,,,,,Western European|-|None Specified,IFD,,,,,,,,protein_altering_variant,MODERATE,3/27,,1,,,,,,2.471e-05,
chr13:32356575:T>A,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,African American,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-75),benign(0-04),,1,,
chr17:43125088:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32331082:TTCTG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr13:32356585:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32394925:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-54),benign(0-006),,1,3.295e-05,
chr13:32324693:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43063952:A>G,,,In vitro (cloned),predicted deleterious|?,Splicing reporter minigene|?,,,,,,,,,,Latin American/Caribbean/West Europe,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1,,
chr17:43094797:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.236e-06,
chr17:43063295:T>C,,,,,,,,0.0|0.0908|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr13:32398184:C>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32332428:C>CA,,,,,,,,,,,,,,,Not Specified|Malaysian|-,,Western European|-|Chinese,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,8.238e-06,
chr17:43090931:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,benign
chr13:32340356:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32356487:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-13),benign(0-023),,,,
chr17:43093915:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43047705:G>A,,,,,,,,,,,,,,,Colombian,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,
chr13:32340945:ATG>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Italian|Dutch|-|Belgian,1|-,White-NonHispanic|Central/Eastern European| Italy|Not Specified|Western European|-|French|Caucasian|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43047705:G>C,,,In vitro (cloned),predicted deleterious,cDNA analysis,,,,,,,,,,Spanish,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,
chr17:43049174:G>GT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,1,,
chr17:43075589:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00259585,benign
chr17:43071239:G>T,,,In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,Swiss|-,,-|Caucasian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,0&1&1,1&1&1,,
chr13:32334659:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43093915:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,0.0116|0.0|0.0077,benign:0.005|None|None|benign:0.005|benign:0.005,0.0,0.0,0.0,0.0,0.001,,,Not Specified|Western European|Western Europe|-|Central/Eastern Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,0.0001451455,
chr17:43074422:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr17:43091711:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43093583:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43091015:TG>A,,,Unknown|Germline (inherited),,,1/238 patients|1/1658,,,,,,,,,Not Specified|-,,Western-European|-,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32351870:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339894:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-388),,1,,
chr13:32332343:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-388),,1,8.239e-06,
chr13:32336552:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-099),,,,
chr13:32344514:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,1.659e-05,
chr13:32346481:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4353 (Asian)| 0.3415 (African)| 0.4683 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43077891:G>A,,,,,,,,,,0.3658,0.8964,0.4308,0.371,0.5307,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.548123,
chr17:43092839:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32321189:A>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32318557:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43080381:CCCCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTCCACAACCCAC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,
chr13:32332518:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),benign(0-245),,1,,benign
chr17:43106454:C>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1,,
chr13:32336709:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-121),,,8.237e-06,
chr13:32338804:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-121),,,,pathogenic
chr17:43092967:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092114:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43071240:G>C,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,,1,,
chr13:32329455:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,,,
chr13:32363210:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,,8.236e-06,
chr13:32379902:C>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,0.0,0.0,0.0,0.001,0.0,Malaysian,,Chinese,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,0.0001163155,
chr13:32339403:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),possibly_damaging(0-454),,1,,
chr13:32379902:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32340252:T>G,,,,,,1/1658,,,,,,,,,,," Central/Eastern European""""|Western European|None Specified| Venezuelan""""|Caucasian|""""Latin American/Caribbean|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-001),0&1&1,1&1&1,1.647e-05,
chr13:32332863:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000293,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0|0.0231,probably-damaging:0.998,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),benign(0-033),,1&1,,
chr17:43067406:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43051085:A>T,,,,,,,,,,,,,,,Malaysian,,Chinese,S,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&0&1,5.765e-05,
chr17:43091709:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.942e-05,
chr13:32332978:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,4.119e-05,
chr13:32340570:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,1.647e-05,
chr13:32340413:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-541),0&0&1&1,1&1&1&1,,
chr13:32370993:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32356536:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|inconclusive|?,?|-|Nuclear localisation|Protein likelihood ratio model|Prevalence in normal controls|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model|Survival assay with VC8 (after MMC treatment)|Co-segregation in families|cDNA analysis,2/1658|-,,,,,,,,,Central/Eastern Europe|German|-|Not Specified|Austria|Ashkenazi|Spanish|Polish|Western Europe|Italian,1|0|-," Central/Eastern Europe|Western European|Ashkenazi|Caucasian|Latin American/Caribbean|Central/Eastern Europe|Not Specified|-| Italian|""""Western European| Central/Eastern European| Polish|None Specified|Central/Eastern European| Near Eastern""""| full greek|Austria| Dutch|Asian| Ashkenazi|Western Europe|Near East/Mid East/Western Europe| Ashkenazi""""",M,1 - Not pathogenic or of no clinical significance,0.932,1.86E-03,,6e-05,0.03,0.03,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-979),,1&1&1,0.0007495,
chr13:32355003:TGG>C,,,,,,,,,,,,,,,Czech,2|-,central Europe|Caucasian,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32398464:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32394890:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-27),possibly_damaging(0-744),,1&1&1,,
chr13:32338040:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-27),possibly_damaging(0-744),,1&1&1,,pathogenic
chr13:32332837:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43070487:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32363866:C>G,,,,,,,,,,0.0,0.0582,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0155751,
chr13:32380111:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr13:32337751:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1646 (African)| 0.2942 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,30.7397|22.6055|27.9837,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr13:32370993:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000259,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32354877:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32336629:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,2.471e-05,benign
chr13:32353487:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32336629:T>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-063),,1,1.647e-05,
chr13:32394890:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-63),benign(0-098),,1&1&1,,
chr17:43094021:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-63),benign(0-098),,1&1&1,,pathogenic
chr13:32353975:T>A,,,,,,,,,,0.2734,0.2791,0.2478,0.0704,0.1605,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.208466,
chr13:32332889:A>T,,,,,,,,,,,,,,,,,Western European|Western Europe,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr13:32325741:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32333363:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-7),probably_damaging(0-943),,1,,
chr13:32339205:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-253),,1,,benign
chr17:43092235:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000309,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|0.0227|0.0308,probably-damaging:0.989|None|None|probably-damaging:0.989|probably-damaging:0.989,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,,
chr13:32326076:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,8.24e-06,
chr17:43083089:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32338982:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-444),1&1,1&1,,
chr17:43090965:G>CT,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,1&1,1&1,,
chr13:32346886:T>GT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,13/27,,1,,,,,1,8.239e-06,
chr17:43092928:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr13:32319227:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32398186:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32332644:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-021),,1,5.77e-05,
chr13:32356553:AAA>A,,,,,,,,,,,,,,,African American,,,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43108968:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43091832:T>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43079681:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43119034:T>A,,,,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0179712,
chr13:32379900:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1,,
chr17:43071202:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-392),,1,,
chr13:32379900:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1,,
chr17:43057032:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,benign
chr13:32363603:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,
chr13:32332703:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,pathogenic
chr13:32332644:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0051,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-169),,1,0.0007465015,
chr17:43092540:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32316412:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32338394:A>GT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43095829:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001163155,
chr13:32330863:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32337885:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,,8.236e-06,
chr17:43093334:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32398411:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr17:43091832:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr13:32363189:TA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,18/27,,1,,,,,,,
chr13:32332651:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,0.000103961,
chr13:32388595:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32370973:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32339149:AATC>C,,,,,,,,,,,,,,,South African,,Mixed Ancestry,UV,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32339912:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43093452:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43067662:CCCA>T,,,,,,,,,,,,,,,,,,IFD,,,,,,,,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,
chr13:32337550:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,pathogenic
chr17:43091948:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,pathogenic
chr17:43093392:C>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43049164:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-887),0&0&0&1&1,1&1&1&1&1,,
chr13:32338309:CTCCA>A,,,,,,,,,,,,,,,German,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332703:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-046),,1&1&1,,
chr13:32340437:GAAGA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-046),,1&1&1,,pathogenic
chr13:32340728:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-046),,1&1&1,,pathogenic
chr13:32357836:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,0.0,0.0008,0.0,0.0,0.0,,,Western European|None Specified|African,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-944),,1,0.0001204305,
chr17:43093718:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091818:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,Austria|-|Ashkenazi,1|-,Central/Eastern European|Western European|-|Caucasian|Ashkenazi|None-Specified|None Specified,M,1 - Not pathogenic or of no clinical significance,3.47,0.049,1e-05,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&0&1&1,1&1&1&1&1&1,0.0001647,
chr17:43058895:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43094021:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned)|Germline (inherited),predicted deleterious|-|inconclusive,-|evolutionary conservation analysis,,,0.0|0.0227|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,0.0,0.0008,0.0,0.0,0.0,,,German Norway Wales Hungary,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,0.000103959,
chr13:32326300:A>G,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,
chr17:43094489:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32370399:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,1,,
chr13:32337104:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43092235:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr13:32341068:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-96),benign(0),,1,,
chr13:32339766:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-185),,1,,
chr13:32338072:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1&1,8.237e-06,
chr13:32338140:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43106462:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,USA,,Caucasian,UV,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32332243:T>TA,,,,,,,,0.0123|0.0|0.0082,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr17:43057151:C>T,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr13:32332833:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),benign(0-032),,,8.237e-06,
chr13:32339842:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-177),,,8.236e-06,
chr13:32353849:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339834:A>G,,,,,,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-012),,1,,
chr13:32383282:T>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000798722,
chr13:32370998:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-01),probably_damaging(0-999),,,5.765e-05,
chr13:32370969:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-01),probably_damaging(0-999),,,,pathogenic
chr17:43093115:A>T,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32340851:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-027),,0&1,8.238e-06,
chr17:43096768:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr13:32396977:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394898:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,
chr13:32346833:TAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32397082:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,9.884e-05,
chr17:43092796:T>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43073637:AG>T,,,,,,,,,,0.1252,0.0038,0.036,0.0,0.1493,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0603035,
chr13:32340096:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),benign(0-029),,1,8.237e-06,
chr17:43057090:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr17:43097292:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,1&1,8.238e-06,
chr13:32317748:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43045743:T>G,,,In vitro (cloned),predicted neutral|predicted deleterious|moderately destabilizing|Moderate functional effect,Thermodynamic stability prediction|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|evolutionary conservation analysis,,,,,,,,,,Asian,,,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-941),,1,,
chr13:32319128:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr13:32331008:TCAAA>-,,GeneReviews|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr17:43071022:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-005),,1,,
chr17:43094072:C>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0454|0.0154,possibly-damaging:0.832|None|None|possibly-damaging:0.832|possibly-damaging:0.832,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063859:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr17:43074502:C>A,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32340307:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43091039:A>C,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr13:32363274:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32346806:G>TATA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.244e-06,
chr13:32338329:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43093049:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32359876:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43070924:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,pathogenic
chr17:43093343:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093285:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43092896:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32347807:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32357875:G>A,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1&1&1,,
chr13:32397012:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1&1&1,1.647e-05,
chr17:43091904:TC>T,,,,,,,,,,,,,,,Sweden|-,,Western European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,8.237e-06,
chr13:32394864:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,8.236e-06,
chr13:32380131:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43092349:AC>A,,,,,,,,,,,,,,,Thai,,Thai,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43092896:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32315532:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43053691:C>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43091000:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32362494:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.238e-06,
chr13:32390824:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32326089:GTTTT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr17:43089089:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32394898:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr17:43094465:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Spanish|Dutch,,-|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32394928:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-99),benign(0-015),,1,,
chr17:43093448:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,-|evolutionary conservation analysis,,,0.0116|0.0|0.0077,probably-damaging:0.997|None|None|probably-damaging:0.997|probably-damaging:0.997,,,,,,,,Western European|Central/Eastern Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,4.942e-05,
chr17:43088727:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43051066:C>TG,,,,,,,,,,,,,,,Malaysian|Dutch,,Malay|Caucasian,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,
chr17:43082422:T>A,,,,,,,,,,,,,,,Czech|-,,Caucasian|African,N,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,
chr17:43060902:G>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000798722,
chr13:32332848:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-576),,,8.237e-06,
chr17:43092141:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.236e-06,
chr13:32398510:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,0.000199681,
chr13:32326143:TCTTCC>T,,,,,,1/1658,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,5/27,,1,,,,,,,
chr17:43093448:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,2,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,3.295e-05,
chr13:32339674:G>A,,Ambry_Genetics|Invitae,,,,1/1658,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr17:43091002:T>C,,,,,,,,,,,,,,,,,Western European|None-Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,1.647e-05,
chr17:43074489:GG>T,,,,,,,,,,,,,,,Lithuanian,1,Lithuanian-Belarusian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43089260:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32379332:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,, Portuguese|Western European,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32333028:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-87),benign(0),0&1&1,1&1&1,,
chr13:32356448:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-04),,,1,,
chr17:43063345:TTTTC>T,,,,,,,,0.0|0.0235|0.0080,None|None|None|None|None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,1,,
chr13:32386788:T>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr17:43093865:T>G,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333853:A>C,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32338401:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000088,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-193),,1,,
chr13:32319256:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr17:43094309:G>C,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,,Western-European|Western European|None Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338425:T>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-056),,1,,
chr13:32338149:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),,,1,,
chr13:32362522:C>T,,,,,,,,,,,,,,,Western Europe,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,
chr17:43082398:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,11/21,-1,,,,,1&1&1,,
chr17:43093487:A>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32352807:C>G,,,,,,,,,,0.0348,0.053,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0790735,
chr13:32398385:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32351798:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43083822:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05894 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0348,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00938498,benign
chr17:43093914:C>T,,Ambry_Genetics,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43083822:T>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000599042,
chr13:32340163:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-72),benign(0-009),0&1&1,1&1&1,,
chr13:32362522:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,
chr17:43091686:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363526:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-18),possibly_damaging(0-865),,1,,
chr13:32319190:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,0&1&1,0&1&1,8.237e-06,
chr13:32338518:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,1/1658,,,,0.0,0.0,0.0,0.0,0.001,-|British?,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-998),,1&1,0.0001039595,
chr17:43076581:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-998),,1&1,,pathogenic
chr13:32363526:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),benign(0-076),,1,,
chr17:43092164:G>A,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,1.647e-05,
chr17:43093653:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,3.295e-05,
chr17:43093638:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340889:G>TG,,,,,,,,,,,,,,,Australian,2,NW European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338833:C>G,,,,,,,,,,,,,,,,,African American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-059),,1&1,8.237e-06,
chr17:43074394:C>GC,,,,,,,,,,,,,,,African American|-,,-|African,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,0&0&1,1&1&1,,
chr17:43092659:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093607:A>G,,,In vitro (cloned),predicted neutral|inconclusive,Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,Western-European|Western European|None-Specified| Native American,M,1 - Not pathogenic or of no clinical significance,0.00324,1.17,0.178,1e-05,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093123:CT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32371030:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32317110:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32338833:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),possibly_damaging(0-452),,1&1,8.237e-06,
chr17:43070444:G>A,,,,,,,,,,0.0,0.0363,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00998403,
chr13:32337933:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-126),,1,,
chr13:32337834:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,0.0001121955,
chr13:32324066:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43082440:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,8.236e-06,
chr17:43117726:G>C,,,,,,,,,,0.0,0.0106,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00279553,
chr13:32370469:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32363368:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr13:32370995:C>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-02),probably_damaging(0-979),,,,
chr13:32330132:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr13:32381236:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32375457:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43094731:CAC>G,,,,,,2/1658|-,,,,,,,,,Not Specified|Spanish|-|Italian,,Latin American/Caribbean| Italian|Not Specified|Western European|-|Latin-American/Caribbean|Galician|-Latin-American/Caribbe|Unknown|Western-European|Western Europe|Central/Eastern-European|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,MODIFIER,,,-1,,,,,,,
chr17:43058845:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43091332:GTTAAG>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0001243,
chr17:43046604:C>G,,,,,,,,,,0.3588,0.2186,0.2925,0.372,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.342452,
chr13:32326533:G>C,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32338482:TA>G,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326527:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32363303:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-16),benign(0-178),,1,,
chr13:32319226:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32371016:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr13:32330991:CA>G,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr17:43092661:TGAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr17:43119074:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43094175:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32398431:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32397013:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337709:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43063349:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0-02),benign(0-171),,,,
chr17:43116680:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0079,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00199681,
chr13:32362573:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,pathogenic
chr13:32362573:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32354950:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,pathogenic
chr13:32355648:A>C,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000399361,
chr17:43104869:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,4/22,,-1,,,,,,,
chr13:32390482:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32398435:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43104134:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.236e-06,
chr13:32363211:AAAACGTTTCATCTCAACACCATT>C,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,18/27,,1,,,,,,,
chr13:32350832:G>T,,,,,,,,,,0.0,0.0023,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr17:43094179:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32363547:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr17:43094426:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000568,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32345189:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000399361,
chr13:32355149:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),benign(0-001),,,,
chr17:43091859:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),benign(0-001),,,,pathogenic
chr13:32337709:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr13:32350688:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32342452:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32379308:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,4.942e-05,
chr17:43104967:G>C,,,,,,,,,,,,,,,Not Specified|Western Europe|-|African American|Central/Eastern Europe,,Scottish/French|Not Specified|Western European|-|caucasian|French/Englis/W.-Europe|Unknown|African|Western-European|Western Europe|Central/Eastern-European|None-Specified|None Specified|Central/Eastern European,IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,8.237e-06,
chr13:32329455:AAG>-,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,
chr13:32337566:G>T,,,,,,,,,,,,,,,Not Specified|-,,Western European|-| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,8.239e-06,
chr17:43101665:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43109515:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32379905:G>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,
chr17:43092666:->A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338774:CA>C,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32363244:C>G,,Ambry_Genetics|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-971),,1&1,,
chr17:43091449:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43094703:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338649:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-105),,1,,
chr17:43073858:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32333234:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1,8.238e-06,
chr17:43094550:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0581|0.0227|0.0461,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43047106:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3821 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr17:43051059:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,1,,
chr17:43093250:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338426:A>C,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.227|0.0769,None,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.000373671,benign
chr17:43091955:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32370975:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-02),probably_damaging(0-922),,,,
chr13:32319192:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,8.237e-06,benign
chr13:32343229:A>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000399361,
chr13:32333021:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-228),,1,8.237e-06,
chr17:43092893:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093250:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32353467:TGG>C,,,,,,,,,,0.2097,0.2413,0.2003,0.3681,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.241813,
chr13:32338194:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000286,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,, Italy|Western European|-| Scotland|Western Europe|None Specified,M,1 - Not pathogenic or of no clinical significance,5.24807,0.09772,0.00269,3e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-511),,1,8.254e-06,
chr13:32339594:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr17:43077983:CTCACACCCCACTCCACTCACTGTGAGGAACCCAGAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr13:32322223:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32326497:AG>A,,,,,,,,0.0|0.0235|0.0080,None,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&0,,
chr17:43092977:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357741:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/26,1,,,,,1&1&1,,pathogenic
chr13:32339989:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-147),0&1&1,1&1&1,,
chr17:43097240:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,8/22,-1,1.0,,,,1,,
chr13:32377092:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32341161:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-92),benign(0-023),,1,,
chr13:32316471:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32316471:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr13:32326074:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,8.24e-06,
chr17:43093300:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43097266:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000157,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0681|0.0308,possibly-damaging:0.745|possibly-damaging:0.745|possibly-damaging:0.745|possibly-damaging:0.745|possibly-damaging:0.745,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1,,
chr13:32339989:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43100558:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3077 (Asian)| 0.1118 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32329790:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr13:32333178:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-8),benign(0-002),,1,8.237e-06,
chr13:32363376:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr13:32346566:G>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000998403,
chr17:43078477:C>A,,,,,,,,,,0.001,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000998403,
chr13:32375101:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43092761:TAAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43104888:TGAAAAGCACAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32319338:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,4.944e-05,
chr13:32370456:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.023,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-33),benign(0-184),,1,,benign
chr13:32369612:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32337238:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1745|0.0454|0.1307,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32356526:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,-|1/1658,,,,,,,,,,,Western European|-|Near East/Mid East,M,2 - Likely not pathogenic or of little clinical significance,0.11,,,0.003,0.03,0.03,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-999),,1,4.118e-05,
chr13:32362481:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.238e-06,
chr17:43106507:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43106497:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32369059:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43091401:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32398745:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43091928:T>C,,,,,,,,,,,,,,,,1,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43095904:T>G,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,-|French,,"Western European|-|Caucasian| English""""|None-Specified|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.237e-05,
chr13:32395918:A>G,,,,,,,,,,0.0,0.0,0.0,0.0238,0.0041,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00559105,
chr17:43099851:AG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43099815:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,8.236e-06,benign
chr13:32330925:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43104293:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.0001039595,
chr17:43113054:G>C,,,,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00499201,
chr17:43078886:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr17:43063417:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr17:43094908:C>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.453e-06,
chr13:32340412:A>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,0&1,1&1,0.001449335,
chr17:43052234:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43115724:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32339472:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-687),,1,,
chr17:43064189:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43115724:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|None-Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32323448:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32340412:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,1.647e-05,
chr17:43104276:A>C,,,In vitro (cloned),predicted neutral,Splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,
chr17:43106467:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr13:32398666:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32362312:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43123674:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32333022:AA>C,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32380063:TT>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,1,,,,,,,
chr13:32370452:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-933),,1,,
chr17:43099850:CCT>T,,,,,,2/1658,,,,,,,,,Hong Kong|China|-|Malaysian|Spanish,,Chinese |-|Caucasian|Chinese|Latin-American/Caribbean,N|F,,,,,,,,frameshift_variant&stop_retained_variant,HIGH,,,-1,1.0,,,,,,
chr13:32369218:AC>A,,,,,,,,,,0.0457,0.0575,0.1009,0.1101,0.1493,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0896565,
chr13:32380138:C>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European,M,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,1.647e-05,
chr13:32398438:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0908|0.0308,probably-damaging:0.968,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43048520:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2832 (Asian)| 0.185 (African)| 0.3127 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr17:43091748:A>C,,,,,,,,,,,,,,,American,,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32362675:T>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr17:43084231:C>T,,,,,,,,,,0.003,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000798722,
chr17:43065090:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32332886:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32398755:T>TA,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43111027:T>G,,,,,,,,,,0.3539,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.352236,
chr13:32340432:ATTATT>CAAAGAG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32337491:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-821),,,8.237e-06,
chr17:43095807:GTA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.238e-06,
chr13:32360876:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43071244:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,13/21,-1,,,,,,0.000199681,
chr17:43111780:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32380604:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32371053:T>TT,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43100403:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr13:32365149:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3293 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340789:ATAATCAC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43115724:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr17:43090981:T>C,,,,,,,,,,,,,,,Malaysian|-,,Asian|Chinese,N,,,,,,,,stop_retained_variant,LOW,,,-1,1.0,,,,1,,
chr13:32340038:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),0&0&1&1,1&1&1&1,,
chr13:32332977:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),0&0&1&1,1&1&1&1,,pathogenic
chr13:32340992:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),probably_damaging(0-975),,1,,
chr13:32319224:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1&1,,
chr13:32337521:CAAAA>C,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43126360:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr17:43093646:CCCAC>T,,,,,,,,,,,,,,,-|Dutch,,Western Europe|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32389651:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43092068:ACTTTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43076611:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1,8.237e-06,
chr13:32397173:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32348194:T>C,,,,,,,,,,0.1213,0.0015,0.0591,0.0635,0.0787,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0611022,
chr17:43094711:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32370421:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|-,Protein likelihood ratio model|-|family history|Co-segregation in families,,,,,,,,,,,," Hungarian""""| Central/Eastern European|Central/Eastern European| German|Western European|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,8.236e-06,
chr13:32340940:ATG>T,,,,,,2/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340510:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1&1&1,1&1&1&1,,pathogenic
chr13:32340785:CA>G,,,,,,,,,,,,,,,,,Russian/English/Irish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43091405:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32357842:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,,,pathogenic
chr13:32337563:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-64),benign(0-012),,1,,
chr17:43047684:C>G,,,In vitro (cloned),predicted neutral|predicted deleterious|uncertain,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc),,,,,,,,,,-|Central/Eastern Europe,,Western European|-,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1&1,,
chr13:32379818:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr17:43113908:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32394808:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32337685:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-966),,1,0.0001039595,
chr13:32385891:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32337563:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-57),benign(0-021),,1,,
chr13:32388181:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5041 (African)| 0.533 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5106,0.536,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511382,benign
chr13:32330876:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.258e-06,
chr17:43091928:TGCGCCAC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332465:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32340804:C>A,,,,,,2/1658|-,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32319654:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5629 (Asian)| 0.5467 (African)| 0.5317 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32319180:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,stop_lost,HIGH,3/27,,1,,,,,1&1,0.000199681,
chr17:43082539:T>A,,,,,,,,,,,,,,,German|Not Specified|-,1|-,"-caucasian| Central/Eastern European""""|Not Specified|Western European|-|None-Specified| Ashkenazi""""|Dutch/German|Western-European|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,8.236e-06,
chr17:43115750:A>T,,,In vitro (cloned),predicted deleterious,Statistical prediction model,,,,,,,,,,American,,,M,5 - Definitely pathogenic,,,72.68,0.9996,0.81,0.81,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32339657:AAA>C,,,Germline (inherited),,,1/238 patients,,,,,,,,,Nicaragua|-,,Western European|hispanic/latino|None Specified| Native American,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32319889:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43082433:G>T,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,benign(0-001),,1,8.236e-06,
chr13:32326521:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1,,
chr17:43074587:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43077477:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32326182:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,8.24e-06,
chr13:32340239:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-02),,,1.647e-05,
chr13:32357812:AA>A,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,
chr13:32358218:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr17:43115750:A>C,,,In vitro (cloned)|Unknown,predicted deleterious|no binding|impact on protein function|-|as variant control,protein binding ability BARD1|E3 Ub-ligase activity assay|Radiation sensitivity|E3 Ub-ligase activity assay BRCA1/RING-BARD1|Homology directed recombination|-|evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32326521:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr17:43094443:CAG>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32397662:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43093784:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,2.471e-05,
chr13:32375245:G>C,,,,,,,,,,0.5159,0.5703,0.5389,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.527556,
chr13:32380069:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.236e-06,
chr17:43092430:C>TTTTCTCTAATGTTA,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32354267:G>C,,,,,,,,,,0.2734,0.2791,0.2478,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.208267,
chr17:43078359:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.126 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32344558:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),,1,8.254e-06,
chr17:43101627:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000599042,
chr13:32354943:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-187),,1,,
chr17:43093526:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0002202705,
chr17:43095893:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,2.471e-05,
chr13:32338318:TACT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,1.649e-05,
chr17:43092763:CAGGG>A,,,,,,,,,,,,,,,,,African American|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32380094:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.236e-06,
chr13:32329490:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,8/27,,1,,,,,1,,
chr13:32340433:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,2.471e-05,
chr13:32394808:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,pathogenic
chr17:43111588:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr13:32379436:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr13:32326394:G>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,0.000399361,
chr13:32340433:T>A,,,,,,2/1658|-,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,
chr13:32351608:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43063868:T>C,,,,,,,,,,,,,,,,,-|Ashkenazi,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,,,
chr17:43092717:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.6128|0.2076,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43063941:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|as wildtype control|no functional effect|as variant control|predicted deleterious,Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Multifactorial likelihood-ratio model|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,tolerated(1),possibly_damaging(0-815),,1&1&1,,
chr13:32379812:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,tolerated(1),possibly_damaging(0-815),,1&1&1,,pathogenic
chr13:32339791:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,tolerated(1),possibly_damaging(0-815),,1&1&1,,pathogenic
chr13:32332325:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,West/Central/East Europe|American|-,,Western European|-|Caucasian,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-39),benign(0-004),,1,,
chr17:43092722:TATC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-39),benign(0-004),,1,,pathogenic
chr17:43106469:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000029,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,no splicing defect|predicted neutral|-|as wildtype control|no impact on protein function|?,Homology directed recombination|splicing reporter minigene|E3 Ub-ligase activity assay BRCA1/RING-BARD1|protein binding ability BARD1|-|Multifactorial likelihood-ratio model|?,,,0.0233|0.0|0.0154,possibly-damaging:0.877|possibly-damaging:0.877|possibly-damaging:0.877|possibly-damaging:0.877|possibly-damaging:0.877,0.001,0.0,0.0,0.0,0.0,-|Central/Eastern Europe,,Not Specified|Western European|-|Dutch|None-Specified|None Specified,M,1 - Not pathogenic or of no clinical significance,0.0832,1.91,0.00059,0.0,0.03,0.03,missense_variant,MODERATE,,,-1,,,,,1&1,0.0001369105,
chr13:32319337:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,0.0001986905,
chr13:32316528:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,,,Western Europe|-,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32370464:TAG>AA,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32350731:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32398623:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.2791|0.0908|0.2153,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340293:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-999),,,8.237e-06,
chr13:32371946:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32398706:A>G,,,,,,,,0.0116|0.0|0.0077,benign:0.001,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32316528:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32352676:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43091752:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,
chr17:43093217:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr17:43094633:GA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32362497:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,1.648e-05,
chr17:43074585:T>C,,,,,,,,,,,,,,,Malaysian,,Indian|Malay|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092517:AG>T,,,,,,,,,,,,,,,,,Western Europe|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091823:T>C,,,In vitro (cloned)|Unknown,predicted neutral|inconclusive|-|?,-|?|Multifactorial likelihood-ratio model,2/1658|-,,,,0.0,0.0,0.0029,0.0,0.0,Not Specified|German|Western Europe|-|Spanish,1|3|-,Latin American/Caribbean|Central/Eastern European| French Canadian|Western European|-|Caucasian|french canadian|Native American|Western-European|Western Europe|French Canadian|None Specified,M,3 - Uncertain,0.2975,11.4654,,0.0651,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,0.0003191305,
chr17:43045811:AG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43092825:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32368169:T>G,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00179712,
chr13:32372193:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32364619:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.19 (Asian)| 0.1 (African)| 0.25 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32336893:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43098204:GG>A,,,,,,,,,,0.0129,0.0,0.0086,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00419329,
chr17:43123134:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32394576:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,predicted neutral|-,-|mRNA analysis and splicing reporter minigene,,,,,0.0109,0.0,0.0029,0.0,0.0,,,,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00259585,benign
chr13:32379849:TTC>G,,,,,,,,,,,,,,,,,Western Europe|Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43092901:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340119:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-043),,1,,
chr13:32326536:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32316522:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr17:43094299:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332552:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.24e-06,
chr17:43076283:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,0.000199681,
chr13:32338502:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-003),,1,,
chr13:32355166:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-15),benign(0-027),,1,,
chr17:43086485:C>G,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00119808,
chr13:32362520:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,,,
chr13:32337091:GAAGAG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43092115:G>A,,,,,,,,,,,,,,,,,"None Specified| Central/Eastern European""""|""""Western European",M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32340564:AAAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32363356:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32339927:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-7),benign(0-017),,,8.237e-06,
chr13:32325290:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000199681,
chr13:32363209:A>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,
chr13:32398279:AATAT>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43091886:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32354859:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/26,1,,,,,1&1&1,,pathogenic
chr13:32340024:G>C,,,,,,,,,,,,,,,,,Not Specified|Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-004),,1,,
chr13:32343569:A>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000798722,
chr13:32339425:T>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,-|Ashkenazi,,"Western/Central/Eastern Europe|Central/Eastern European| Central/Eastern European""""|Central/Eastern Europe|Not Specified|Western European|Russia Hungary|-|Ashkenazi| Polish|Western Europe|None Specified| Irish/Italian""""|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,0.29512,3e-05,0.0,0.02,0.02,synonymous_variant,LOW,11/27,,1,,,,,1&1,0.0002144,
chr13:32363209:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32336319:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|inconclusive,Histopathology|Prevalence in normal controls|-|Embryonic stem cell assay|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-|Ashkenazi|Poland/Hungary/Latvia,,"Ashkenazi Jewish| Central/Eastern European|Central/Eastern Europe| Central/Eastern European""""|Not Specified|Western European|-| Sephardic Jewish|""""Ashkenazi| Gre|Ashkenazi| Ashkenazi|Western Europe|""""Western European|White|None Specified| Ashkenazi""""",M,1 - Not pathogenic or of no clinical significance,0.48,0.007,,7e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,0&1,1&1,0.0007249,
chr13:32340307:A>AA,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32354859:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/26,1,,,,,1&1&1,,pathogenic
chr13:32373717:A>G,,,,,,,,,,0.0,0.0303,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00798722,
chr13:32398465:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337339:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-702),,1,,
chr17:43047680:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/22,,-1,,,,,,,benign
chr13:32339358:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-086),,1,,
chr17:43091950:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,
chr13:32326520:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr17:43071032:A>C,,,In vitro (cloned),predicted neutral|as wildtype control,Transcription activation in yeast (GAL4-fusions)|Transcription activation in human cells|evolutionary conservation analysis,,,,,,,,,,-|Spanish,,Western European|-|Caucasian|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1&1,8.236e-06,
chr13:32336634:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32333333:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43091495:GG>TT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.942e-05,
chr17:43093962:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32367148:ATGG>T,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00119808,
chr13:32375243:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43093571:G>A,,,,,,,,,,,,,,,,,Latin American/Caribbean|Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32398231:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398403:A>CATTT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43046253:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr17:43106441:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,benign
chr17:43070980:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-02),possibly_damaging(0-701),,1&1,,
chr17:43051669:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43115725:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1,,pathogenic
chr17:43115725:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1,,pathogenic
chr17:43070980:C>G,,Ambry_Genetics|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.2|benign:0.2|benign:0.2|benign:0.2|benign:0.2,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-13),benign(0-006),,1&1,,
chr17:43093411:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European|-Italian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32317215:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32356593:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.499,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-12),,0&1&1,1&1&1,,
chr13:32380173:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,9.894e-05,
chr13:32339204:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-328),,1,,
chr17:43073680:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43092204:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr17:43092204:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000307,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,0.0116|0.0227|0.0154,probably-damaging:0.995|None|None|probably-damaging:0.995|probably-damaging:0.995,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,benign
chr13:32357762:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr13:32337767:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124022:C>A,,,,,,1/1658|-,,,,,,,,,American,,,Syn,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,3.295e-05,
chr17:43076567:T>A,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32325112:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Polish|-,,None Specified|Polish (Wielkopolska Region),M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1&1,4.942e-05,
chr17:43094466:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43063940:CAG>C,,,,,,,,,,,,,,,,,"Western-European|""""Ashkenazi| Central/Eastern European""""",F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,1,,
chr17:43091043:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000542,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092202:TTT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340414:AACA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340977:ATT>A,,,,,,-|1/1658,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32319232:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000928,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0465|0.0|0.0308,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr13:32336913:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-043),,1,,
chr17:43094736:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1&1,,
chr13:32338639:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091569:G>C,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32339999:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-234),,1,,
chr13:32356651:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.0001204355,
chr13:32394752:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-46),benign(0-331),,1,8.237e-06,
chr13:32355282:A>T,,,,,,,,,,,,,,,,,Not Specified|None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-26),benign(0-377),,1,,
chr13:32354949:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-5),,,1,1.647e-05,
chr13:32332500:G>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-68),benign(0-002),,1,,
chr17:43070980:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-68),benign(0-002),,1,,pathogenic
chr17:43094020:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|inconclusive,-|evolutionary conservation analysis|Multifactorial likelihood-ratio model,,,,,0.0,0.0,0.0,0.0,0.001,,," Native American""""|Western European|-|Western Europe/German|Western-European|Western Europe|""""Western European|None-Specified|None Specified|Italian",M,1 - Not pathogenic or of no clinical significance,0.0218,3.72,0.00065,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.000199681,
chr17:43091569:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338269:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-335),,1,,
chr17:43120293:T>C,,,,,,,,,,0.0,0.0159,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00419329,
chr17:43063882:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-869),,1&1,,
chr13:32340318:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-883),,,,
chr17:43092821:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43092821:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092953:T>C,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.939|None|None|possibly-damaging:0.939|possibly-damaging:0.939,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32380116:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1&1,,
chr17:43065990:G>C,,,,,,,,,,0.0,0.0174,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00479233,
chr13:32339549:AC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093419:TTC>A,,,,,,,,,,,,,,,,2|-,Western European|-|Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43071218:C>AT,,,,,,,,,,,,,,,Hong Kong,,Chinese,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,
chr13:32356480:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,2.471e-05,
chr17:43057617:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32329471:CTT>A,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,,
chr17:43091522:AGCTACTCGGG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32380116:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1&1,,
chr13:32318656:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43075821:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32355250:A>C,,,,,,,,,,0.999,0.9107,0.9971,1.0,1.0,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0),,1&1,0.9849195,
chr17:43110532:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| 0.03166 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43092685:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398743:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Western Europe|-|Italian,,Western European|-|Caucasian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326267:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,6/27,,1,,,,,,1.647e-05,
chr13:32346871:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,13/27,,1,,,,,,,
chr17:43092289:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32370410:TAAC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338078:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,8.237e-06,
chr13:32332382:TT>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43093436:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32355250:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|no splicing defect|-,splicing reporter minigene|Prevalence in normal controls|-|Allele frequency analysis in controls,-|682/1658,,,,,,,,,Latin American/Caribbean|Western Europe/Native American/African A|USA|Not Specified|Asian/Native American/African American|-|Austria|Asian|Spanish|African American|Western Europe|Omanis,0|-|4| -,Western Europe/Latin American/Caribbean|Latin American/Caribbean|-|Africa|Arab|Scotch Irish|African American|Caucasian,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1&1,,
chr13:32338013:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),possibly_damaging(0-73),,1,,
chr17:43094522:T>CT,,,,,,,,,,,,,,,French,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43101311:G>T,,,,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00299521,
chr17:43063644:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000199681,
chr13:32338673:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-526),,1,,
chr13:32329403:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.259e-06,
chr13:32326278:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/27,,1,,,,,1,,pathogenic
chr13:32339338:AAAAC>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340975:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32363464:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),probably_damaging(0-999),,1,,
chr13:32341836:A>G,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0738818,
chr13:32349772:C>A,,,,,,,,,,0.004,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32323592:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43076662:T>C,,,,,,,,0.0349|0.0227|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr17:43111682:G>T,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00159744,
chr17:43118908:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43122729:GC>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00159744,
chr13:32363353:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32333192:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-05),possibly_damaging(0-466),,1,,
chr17:43048245:G>T,,,,,,,,,,0.0,0.0,0.0014,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000399361,
chr17:43093331:CT>T,,,,,,,,,,,,,,,,,Western-European|Not Specified|Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43107254:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32341187:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,1.648e-05,
chr13:32332881:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-81),benign(0-023),1&1,1&1,,
chr17:43115726:TT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-81),benign(0-023),1&1,1&1,,pathogenic
chr17:43076522:G>T,,,,,,,,,,,,,,,German,2,Caucasian,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32333039:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-055),,,,
chr17:43091906:T>AT,,,,,,,,,,,,,,,German|Greek,,Greek|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43089609:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32363385:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),possibly_damaging(0-801),,1,,
chr17:43093652:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,,Western-European|-,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43099786:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted no impact on protein function|predicted impact on protein function|predicted neutral|inconclusive|-|as variant control|as wildtype control|?,Recombination rate|Clonogenic assay|co-occurrence with deleterious variant|Homology directed recombination|-|Random plasmid integration assay|Multifactorial likelihood-ratio model|?,2/1658|-,,,,0.0,0.0,0.0,0.0,0.001,Not Specified|-,,"""""Near Eastern|Western European| Sephandic""""|Ashkenazi|Near East/Mid East| Central/Eastern European""""|Western/Central/Eastern Europe|-|-Italian|Western-European|""""Western European|African|Central/Eastern-European|None Specified| Egypt""""|-Near-Eastern|Central/Eastern European|""""Ashkenazi| Yemen - Sephardic""""|Asian|Near Eastern|French Canadian|Western Europe|None-Specified",M,1 - Not pathogenic or of no clinical significance,0.0007,8.49E-07,,0.0,0.02,0.02,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1&1,0.0002357405,
chr17:43092882:CAAA>T,,,,,,,,,,,,,,,-|Dutch,-|5,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340159:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,1&1,,
chr13:32340468:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-006),,,,
chr17:43093567:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32375831:A>ATTAC,,,,,,,,,,0.0567,0.0023,0.013,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.0147764,
chr17:43090935:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43111889:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000798722,
chr17:43125426:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32379432:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr13:32363325:TCAC>C,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,18/27,,1,,,,,,,
chr17:43097597:G>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000998403,
chr13:32336779:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32340032:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-089),,,,
chr13:32338072:A>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1&1,,
chr17:43052527:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32339618:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43124031:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32337756:G>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,1,,benign
chr13:32344652:T>A,,,,,,,,,,,,,,,West/Central/East Europe,,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,tolerated(0-15),possibly_damaging(0-603),,1,,
chr13:32330989:C>G,,Ambry_Genetics,In vitro (cloned),no LOH,LOH analysis,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43076664:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.237e-06,
chr17:43070958:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000148. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,1.5233|0.2043|1.0764,benign:0.166|benign:0.166|benign:0.166|benign:0.166|benign:0.166,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-017),0&0&1,1&1&1,,
chr13:32326541:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&1&1&1,1&1&1&1,,
chr17:43104138:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000103,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr13:32344625:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,1&1,1&1,,
chr17:43124169:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332899:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-022),,1,,
chr17:43071151:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-07),benign(0-007),,,3.295e-05,
chr13:32340023:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,8.237e-06,
chr13:32351841:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43104957:G>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,-|Dutch,,Western-European|-,IVS,,,,,,,,splice_acceptor_variant,HIGH,,4/22,-1,,,,,1&1,,
chr13:32398447:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43093857:TT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43070020:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43093309:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398142:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,-|Italian,,Central/Eastern European|Central/Eastern Europe|Not Specified|Western European|-|Asian| Ashkenazi|Western Europe|Caucasian|None Specified,IVS,1 - Not pathogenic or of no clinical significance,3.39,1.95E-04,0.05,0.0,,0.04,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0001318,
chr13:32332987:CAA>G,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32357750:C>A,,,,,,,,,,0.0,0.0136,0.0043,0.0,0.0,Austria|-,0|-,,Syn,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,1,0.002463145,
chr13:32333970:C>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32397799:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32329603:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr13:32337312:C>AG,,,,,,,,,,,,,,,,, African|Western European|Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32396905:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000264,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092035:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43115727:A>G,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Statistical prediction model,,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,,,1.344,0.0008,0.03,0.03,stop_lost&splice_region_variant,HIGH,,,-1,1.0,,,,1,8.237e-06,
chr17:43090905:CCAAGCCCAGCTGTCAGGC>CCACACACGCATGTGCA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,3.303e-05,
chr13:32319165:GAC>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr17:43082473:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,,
chr13:32333146:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-228),,,8.236e-06,
chr17:43093567:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-228),,,,pathogenic
chr13:32336358:G>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-3),,1,,
chr13:32330984:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,,2.471e-05,
chr17:43093604:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43104195:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32365330:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32340955:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),possibly_damaging(0-834),,1&1,,
chr17:43091622:A>CA,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337567:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-037),,1,,
chr13:32333436:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,8.423e-06,
chr17:43092620:CA>G,,,,,,,,,,,,,,,Swedish,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43106487:T>C,,,In vitro (cloned)|Unknown,predicted deleterious|predicted neutral|-|as variant control|as wildtype control|impact on protein function|?,Recombination rate|Clonogenic assay|protein binding ability BARD1|Survival assay with HCC1937 (after MMS treatment)|E3 Ub-ligase activity assay BRCA1/RING-BARD1|Homology directed recombination|-|Prevalence in normal controls|Multifactorial likelihood-ratio model|Micronuclei formation|Bayesian statistics|?,-|8/1658,,,,,,,,,Swedish|French?|Central/Eastern Europe|Canadian|Czech|U.S.A.|Italian|-|Austria|French|German|American|Latvian|Austrian|Danish|Western Europe|Not Specified|Native American|Near East/Mid East,-|1|0|3|2|5,"White-NonHispanic|German/Uruguayan| Central/Eastern Europe|Western European| Swedish Ukranian Norwegian Belgian""""|Caucasian| Central/Eastern European""""|Central/Eastern Europe|Not Specified|Western/Central/Eastern Europe|-|-Central/Eastern-Europe|Native American|Unknown|Western-European|caucasian|""""Western European|Latvian|Central/Eastern-European|None Specified|Central/Eastern European|Czech| Ashkenazi|Austrian|Western Europe|None-Specified|Ashkenazi",M,5 - Definitely pathogenic,,,147.7,0.9998,0.81,0.81,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,6.59e-05,
chr13:32333124:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-066),,1,,
chr13:32354841:ATAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-066),,1,,
chr13:32340123:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,Western European|-| Native Americ|African| African|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),possibly_damaging(0-897),,1,0.0002398405,
chr17:43099929:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,8.236e-06,
chr13:32397033:T>G,,,,,,,,,,,,,,,,,Western European|Native American,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32385025:A>G,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr17:43091481:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32336817:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,,1,,
chr13:32332771:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.237e-06,
chr13:32394766:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-03),possibly_damaging(0-905),,,8.236e-06,
chr13:32319330:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/26,1,,,,,1&1,,
chr17:43124021:GCC>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43094787:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr13:32337736:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,pathogenic
chr17:43093517:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32332875:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-027),,1,8.236e-06,
chr17:43094837:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,,Latin American/Caribbean|African American|African,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.246e-06,
chr17:43058315:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43092341:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091017:->AGAT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32340173:CCGTTAATAGCATAT>G,,,,,,,,,,,,,,,,,Irish/Scottish/English/German,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049594:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000599042,
chr17:43092077:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,,Western-European|-|Central/Eastern European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr13:32398536:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43119770:CATC>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43067294:G>T,,,,,,,,,,0.002,0.0091,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00339457,
chr17:43093150:T>GC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43097270:C>G,,,,,,,,,,,,,,,Greek,,Greek,Syn,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32371052:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,
chr13:32340084:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-056),0&1&1,1&1&1,,
chr17:43045769:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-983),,1,8.236e-06,
chr13:32340670:T>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-061),,1,8.237e-06,
chr13:32355232:ACAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-061),,1,,pathogenic
chr13:32340826:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32340608:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-019),,1,,
chr17:43061103:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32351799:C>AT,,,,,,,,,,0.001,0.0537,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0147764,
chr13:32379859:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr13:32340084:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-8),benign(0-001),0&1&1,1&1&1,,
chr13:32332631:G>T,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,
chr13:32326259:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,,,
chr17:43094414:T>C,,,,,,,,0.0116|0.0|0.0077,benign:0.26|None|None|benign:0.26|benign:0.26,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43058585:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32379520:G>-,,Genetic_Services_Laboratory|_University_of_Chicago,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr17:43091617:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr17:43106420:T>A,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,
chr17:43050241:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000399361,
chr13:32316477:CGG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr13:32392335:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43082475:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/22,,-1,,,,,,,pathogenic
chr13:32343689:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32325066:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,Asian|None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,0.000103959,
chr17:43092357:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43051110:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-562),,1,,
chr17:43094530:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000271,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.584|None|None|possibly-damaging:0.584|possibly-damaging:0.584,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32319181:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr13:32340941:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394671:TG>CTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0001483,
chr17:43071249:G>C,,,,,,,,,,,,,,,Not Specified|-,,Western European|-,IVS,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,1,,
chr17:43093309:A>C,,,In vitro (cloned),predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,Western European,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43051779:G>C,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr17:43093142:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32318532:A>T,,,,,,,,,,0.0,0.0348,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00958466,
chr17:43067605:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,
chr13:32340121:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32371795:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1906 (Asian)| 0.09959 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32370531:A>AT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,8.237e-06,
chr17:43091292:GC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.537e-06,
chr17:43093142:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43056687:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,benign
chr13:32338608:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-02),,,8.248e-06,
chr13:32362580:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,pathogenic
chr13:32354934:CCCAGCAGTGC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43099794:G>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,7.413e-05,
chr13:32340499:AAAG>T,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr13:32339745:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-177),,1&1,8.237e-06,
chr13:32338911:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-859),,1&1&1,,
chr17:43049179:C>G,,,In vitro (cloned)|Unknown,predicted deleterious|uncertain|predicted neutral|inconclusive|-|as wildtype control|?|moderately destabilizing,Thermodynamic stability prediction|Protein binding capacity|Peptide binding ability|Multifactorial likelihood-ratio model|-|transcription activation/PS/BA/BS|?|Thermostability assay|Proteolytic degradation|evolutionary conservation analysis,,,,,0.0,0.0008,0.0,0.0,0.0,,,Latin American/Caribbean|Western European|-|Latin-American/Caribbean|African,M,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-5),,1&1,0.0001863405,
chr13:32337314:AAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-5),,1&1,,
chr17:43091630:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32355055:ATTTC>G,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,8.236e-06,
chr17:43071235:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-213),,1,0.000103959,
chr13:32398430:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333030:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093299:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32326498:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&0,,pathogenic
chr17:43093299:T>G,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.000369521,
chr13:32343810:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43107166:G>A,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr13:32355046:A>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-17),benign(0-133),,1,,
chr17:43113673:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32370609:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.24e-06,
chr13:32340007:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr17:43045793:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,tolerated(0-06),possibly_damaging(0-559),,1&1,,
chr13:32350982:G>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32363187:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),benign(0-003),,1,,
chr17:43045359:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.731e-05,
chr13:32361504:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43091638:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32333030:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-735),,1,,
chr17:43084208:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32325098:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr13:32363253:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-999),0&1&1,1&1&1,,
chr17:43057037:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,
chr17:43051104:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.99,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-951),,1&1,,
chr13:32339881:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-951),,1&1,,pathogenic
chr17:43095891:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32338964:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000424,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-881),,,,benign
chr17:43090110:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43057045:CTCCAGT>G,,,,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,18/21,-1,,,,,,,
chr17:43104947:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32319275:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,pathogenic
chr13:32337611:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0117|0.0|0.0077,benign:0.003,,,,,,,, Chinese|Asian|Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-061),,1,2.472e-05,
chr13:32332793:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-149),,1,,
chr13:32340432:ATT>C,,,,,,1/1658,,,,,,,,,,,Unknown|Western Europe|Ashkenazi,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32339799:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-177),,1,,
chr17:43062225:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43042868:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.72 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43117210:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43115785:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/22,-1,1.0,,,,1&1,,
chr13:32337387:A>G,,,In vitro (cloned)|Unknown,predicted neutral| no LOH|-,HR assay|-| LOH assay,,,,,,,,,,,,Western European|Western Europe|-|Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,2.471e-05,
chr13:32369206:AA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.12 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,,benign
chr17:43107505:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr17:43070280:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32337647:A>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr17:43047696:C>G,,,In vitro (cloned),no functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,,benign(0-222),,1&1,,
chr13:32325111:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43094538:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339853:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093351:C>A,,,In vitro (cloned)|Unknown,inconclusive|-,-|evolutionary conservation analysis,-|1/1658,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43050569:G>T,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000599042,
chr13:32340887:C>G,,,,,,,,0.0116|0.0|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-048),,,,
chr17:43084625:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.025,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00658946,benign
chr17:43051044:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,8.237e-06,
chr17:43082489:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr17:43104952:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43051111:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr13:32380079:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr17:43071076:CT>GGC,,Strand_Center_for_Genomics_and_Personalized_Medicine|Strand_Life_Sciences_Pvt_Ltd,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32393237:TA>T,,,,,,,,,,0.2336,0.0106,0.0965,0.248,0.2403,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.159944,
chr13:32332631:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-027),,1&1,,
chr13:32334381:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr17:43094270:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43049284:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr13:32379814:T>A,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,
chr13:32330970:C>T,,,,,,,,,,,,,,,,,Native American| Ashkenazi| Central/East,N,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1,,
chr13:32347997:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32380079:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European|Central/Eastern European|None Specified| German,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.236e-06,
chr13:32336579:CA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326144:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32338674:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-234),,1,,
chr13:32339741:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-234),,1,,pathogenic
chr17:43082447:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,,
chr17:43094020:AG>C,,,,,,,,,,,,,,,Czech|-,,-|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32337445:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,2.471e-05,
chr13:32340072:TTGCT>A,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340244:AT>G,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32355085:T>C,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Not Specified|Near Eastern| Iraq|Asian|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,0.05754,0.14454,0.00026,0.03,0.03,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-999),,1,4.942e-05,
chr13:32339637:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-236),0&1&1,1&1&1,,
chr17:43071088:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,1,,
chr13:32337817:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,1,5.765e-05,
chr17:43115774:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,8.236e-06,
chr17:43045734:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr13:32356339:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43093745:C>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.0002079155,
chr13:32330883:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,1.65e-05,
chr13:32338378:T>C,,,,,,,,,,,,,,,Italian,,Caucasian,P,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.238e-06,
chr17:43045803:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,8.236e-06,
chr13:32346927:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.246e-06,
chr17:43071351:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32337137:G>GT,,,,,,,,,,,,,,,-|Spanish,,Western European|-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337676:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43094366:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr17:43093859:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082287:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08566 (Asian)| 0.03862 (African)| 0.07916 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,,
chr17:43076658:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.237e-06,
chr17:43093193:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32338208:T>GA,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32344830:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.311 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32339853:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-268),,1&1,1.647e-05,
chr17:43097307:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1&1,,
chr13:32363535:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1,,pathogenic
chr13:32363130:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,8.244e-06,
chr13:32339986:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32379757:GAGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32333183:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-095),,1&1&1,,pathogenic
chr13:32331082:TT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.036,
chr17:43092124:T>C,,,In vitro (cloned),predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,Western Europe,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32333394:AAT>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,10/26,1,,,,,,0.0007339515,
chr13:32316425:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32379479:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|inconclusive|predicted deleterious,Histopathology|-|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,Not Specified|-|Central/Eastern Europe,,Italian German|Western European|-|None Specified| Central/Eastern Europe,M,1 - Not pathogenic or of no clinical significance,0.002,1.82,0.041,0.0,0.03,0.03,missense_variant,MODERATE,22/27,,1,,,,,1,1.647e-05,
chr17:43095001:C>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338279:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-388),,,,
chr17:43082422:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr17:43076569:TTCTGGCTTATAG>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43056450:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32347225:G>C,,,,,,,,,,0.0348,0.0333,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0740815,
chr17:43105003:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,1.647e-05,
chr17:43083827:AGGC>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr17:43060529:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32376731:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,1,,benign
chr17:43064450:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32344658:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,12/26,1,,,,,1,,
chr13:32360521:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0386,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0101837,benign
chr17:43093245:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,Malaysian,,Malay|Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.0001574905,
chr13:32362663:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32355268:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000163,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-12),possibly_damaging(0-523),,1,,
chr13:32336756:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-061),,,1.648e-05,
chr13:32363255:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),possibly_damaging(0-887),,1&0,8.236e-06,
chr13:32338913:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-017),,1,,
chr13:32368233:T>A,,,,,,,,,,0.0,0.0,0.0014,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr17:43091680:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),,,,,,,,,,,,Spanish,,Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43094170:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338566:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,1.648e-05,
chr13:32339654:AAACTTGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,,
chr17:43090946:GA>GAGA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32394806:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43082467:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0),,1,,
chr13:32387356:C>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr17:43051078:G>A,,,In vitro (cloned),as wildtype control|Low functional effect|predicted neutral|mildly destabilizing|predicted deleterious,Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Thermodynamic stability prediction|evolutionary conservation analysis,,,,,,,,,,Central/Eastern Europe,,,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,8.236e-06,
chr13:32338993:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,pathogenic
chr13:32339295:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,pathogenic
chr13:32362688:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,,,benign
chr13:32333222:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-539),,1&1,,
chr13:32333338:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-38),benign(0-013),,,,
chr17:43104233:C>CT,,,,,,,,,,,,,,,Western Europe|-,,Western-European|Western European|Western Europe|-|None-Specified,F,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,1,8.236e-06,
chr13:32337320:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32332416:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-824),0&1&1,1&1&1,,
chr13:32363376:GGTATGCTGTTA>TT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32340729:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-017),,1,,
chr13:32319231:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,
chr13:32395918:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32397156:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43049053:T>G,,,,,,,,,,0.0,0.0393,0.0014,0.0,0.0,Austria|-|American,1|-,-|Ashkenazi,IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,0.0105831,
chr17:43060163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43082456:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,,
chr13:32341127:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,
chr13:32356535:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,pathogenic
chr13:32332227:A>G,,,,,,,,0.0119|0.0|0.0080,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,1.654e-05,
chr13:32357725:CAAAT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,1.647e-05,
chr17:43124011:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,,,
chr17:43091772:AGAC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,,,pathogenic
chr17:43104263:G>A,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,
chr13:32358668:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32339986:C>T,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr13:32398426:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32384512:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1423 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43124016:TGTTTGCCCACG>C,,,,,,4/1658,,,,,,,,,,,"White-NonHispanic| Native American""""|-|Western-European|Western Europe|None-Specified|None Specified|""""Western European",F,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,,,-1,1.0,,,,,,
chr17:43074411:->GA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43091590:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32325226:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr13:32375396:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32338892:C>A,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Australia,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-159),,1,,
chr13:32319077:GGGCAGATCGCCTGAGGTCAGAAGTTT>A,,,,,,,,,,,,,,,,,Russian/Austrian,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,3/27,,1,,,,,,,
chr17:43092845:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43094781:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr13:32340624:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-138),,1,8.237e-06,
chr13:32329478:AGAG>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,8/27,,1,,,,,,,
chr17:43124036:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1&1&1,,
chr13:32398566:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43063892:T>AT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr13:32381972:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3293 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32398593:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32325975:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43092541:TT>TTTT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43071877:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32337684:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr17:43100574:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.26 (Asian)| 0.16 (African)| 0.23 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32362551:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,tolerated(0-08),probably_damaging(1),,,8.236e-06,
chr17:43093356:T>A,,,,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092699:C>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43097189:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr13:32339341:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32394470:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43054734:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32363445:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|-|as variant control,Protein likelihood ratio model|Homology-directed repair assay|-|Centrosome amplification|Multifactorial likelihood-ratio model,,FA FANCD1_00038|-,,,,,,,,Not Specified|-,,Western European|-|Central/Eastern European|None Specified|Western Europe/Ashkenazi,M,5 - Definitely pathogenic,6.761,1.445,257.04,1.0,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1&0,,
chr13:32367536:T>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43102706:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00419329,benign
chr17:43117215:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000998403,
chr17:43093274:G>TTA,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43094702:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43074362:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,4.118e-05,
chr17:43074584:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32335744:T>A,,,,,,,,,,0.0,0.0272,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00778754,
chr13:32319611:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43059763:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32355165:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),,,,8.237e-06,
chr13:32333332:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,1,,pathogenic
chr13:32363259:A>C,,,In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43115744:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1,,
chr17:43081082:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32399624:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43094422:GGTG>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,co-occurrence with deleterious variant|-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,Not Specified|Western European|-|-Ashkenazi|Western-European|None-Specified,IFD,1 - Not pathogenic or of no clinical significance,1.0,6.17E-03,0.05,1e-05,0.02,0.02,protein_altering_variant,MODIFIER,,,-1,,,,,,4.118e-05,
chr13:32330895:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,2.472e-05,
chr17:43115744:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1,,
chr13:32364744:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32333032:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32326113:T>G,,,,,,1/1658|-,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,0.0001039605,
chr17:43092549:AC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr13:32357803:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr17:43092845:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr17:43124096:G>C,,,,,,,,,,,,,,,German|Norwegian|-|French,,-Ashkenazi|-|Western European|Caucasian|African|Western-European|None-Specified,M,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,0&0&1,1&1&1,,
chr13:32338032:C>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32337477:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-036),,1,,
chr17:43087944:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32386098:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr17:43102171:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43092202:TTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43093006:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000043,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43108991:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0121,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00319489,benign
chr13:32359363:ACT>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr17:43124036:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr13:32340331:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32341096:C>A,,,,,,,,,,,,,,,,,German|Western European||British| French,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-032),,1,,
chr17:43094407:CCCC>AA,,,,,,,,,,,,,,,-|French|Spanish,,Caucasian|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32319268:CCA>A,,,,,,1/1658|-,,,,,,,,,Malaysian|Spanish,,Malay|Caucasian non-Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32339546:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,8.24e-06,
chr13:32323155:T>C,,,,,,,,,,0.007,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00159744,
chr17:43058216:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43092809:G>A,,,,,,,,,,,,,,,Central/Eastern Europe|German|Western European|-|British|Native American/Central/Eastern Europe|Dutch|Western Europe,1|2|-|4,Western Europe|Sicilian|English/German/Pennsylvanian Dutch|Not Specified|Western European|-|None-Specified|German|-Irish|-English|Western-European|Scot/Irish/English|Caucasian|None Specified|-French,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32337279:GATA>T,,,In vitro (cloned),Loss of variant allele,LOH analysis,,,,,,,,,,-|Spanish,,Caucasian|None Specified,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32398209:TTGTA>T,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092836:A>CT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr17:43110183:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43102469:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1321 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32366360:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32380203:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43108075:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32343207:A>C,,,,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0061901,
chr17:43093241:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43070968:CC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,0&1,,
chr13:32340840:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-013),,,2.471e-05,
chr13:32340195:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-029),,,,
chr17:43060223:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43092070:TTT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092740:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32331003:CCACCT>A,,,,,,,,,,,,,,,-|English/Icelandic,1|-,Latin American/Caribbean| Cuban|Central/Eastern European|Western European|-|None Specified|Native American/Central/Eastern Europe/L|Native American,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,1.647e-05,
chr13:32339283:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-02),,1,,
chr13:32336658:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western/Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-067),,1,,
chr13:32338441:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr13:32375224:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43060476:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32398739:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43051308:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32336658:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-067),,1,,
chr17:43045881:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000399361,
chr17:43091439:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43063864:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,
chr13:32363238:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43095848:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32340084:T>G,,,,,,,,,,,,,,,Western European,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-8),benign(0-001),0&1&1,1&1&1,,
chr17:43059944:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr17:43056243:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43092284:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092284:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43071124:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-058),,1,,
chr17:43123506:T>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000998403,
chr13:32379993:A>C,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32340684:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-02),,1,,
chr13:32336448:CA>T,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43124065:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),as wildtype control|as variant control|?,peptide binding ability BRCA1/RING-BARD1|E3 Ub-ligase activity assay BRCA1/RING-BARD1|?,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1,,
chr13:32340290:A>AT,,,Germline (inherited),,,,FA FANCD1_00042,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43091483:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43113362:GAAGGA>A,,,,,,,,,,0.005,0.3956,0.0274,0.0,0.0327,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.115615,
chr13:32376800:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,8.237e-06,
chr13:32340274:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr17:43093619:T>A,,,,,,,,,,,,,,,11B,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32338327:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32370597:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.239e-06,
chr13:32394718:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1&1,8.237e-06,
chr13:32355097:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-081),0&0&1&1,0&1&1&1,8.237e-06,
chr17:43106518:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-081),0&0&1&1,0&1&1&1,,pathogenic
chr13:32316307:A>G,,,,,,,,,,,,,,,Spanish,,Caucasian,IVS,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32355053:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,8.236e-06,
chr17:43045699:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,tolerated(0-09),benign(0-099),,1,,
chr17:43093171:TG>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339600:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),possibly_damaging(0-676),,,,
chr13:32398263:A>C,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32333398:TGA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0004951,
chr13:32339625:ATA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,
chr13:32336300:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394718:G>T,,,In vitro (cloned),predicted deleterious|?,Co-localization to predicted ESEs|?,,,,,,,,,,Latin American/Caribbean,,,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,
chr17:43083162:G>TTTTC,,,,,,,,,,0.0,0.0356,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00978435,
chr13:32388406:C>G,,,,,,,,,,0.001,0.0303,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00838658,
chr13:32329081:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43104895:CA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32398388:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32339086:ATTAGC>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092962:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32355119:G>A,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,0&1&1,1&1&1,,
chr13:32338598:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32398875:T>C,,,,,,-|25/1658,,,,0.2356,0.0113,0.0965,0.248,0.2413,Austria|-,1|0|2|-,,3'UTR,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,0.160743,
chr13:32338330:TGCT>TGCTTGCT,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43094007:T>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,0.0002120355,
chr17:43089486:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2236 (African)| 0.3628 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43045770:GGGCC>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43092857:A>G,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43094285:GAACGTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338106:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338634:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-001),,1,,
chr13:32333283:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-625),,1&1&1,,
chr13:32397267:T>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00139776,
chr17:43063362:CTAT>A,,,,,,,,,,,,,,,French?|German,1|2,-|Caucasian,IFD,,,,,,,,protein_altering_variant,MODERATE,18/23,,-1,,,,,,,
chr13:32332843:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|56/1658,,3.677|1.9764|3.101,None,0.0348,0.0325,0.0922,0.0962,0.1329,USA|German|-|Austria|Sri Lankan|Belgian,1|0|-| -,Global|-|Caucasian|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1,1&1,0.06234105,benign
chr17:43104086:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,0&1,,
chr13:32338746:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-793),,1,,
chr17:43124095:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr17:43099838:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32338447:AT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,pathogenic
chr17:43124095:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr13:32336315:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32330886:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.249e-06,
chr17:43079653:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000599042,
chr17:43120540:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43051850:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32316292:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.001,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43106476:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43090988:CCC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43049156:C>A,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,probably-damaging:0.998|None|probably-damaging:0.998|probably-damaging:0.998|probably-damaging:0.998,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-102),,1,,
chr13:32355283:A>CT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,1&1,1&1,8.238e-06,
chr17:43082492:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,1,1,,benign
chr13:32358454:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43064324:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.376 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.3949,0.0274,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.115216,benign
chr13:32340479:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,, African|Western European| Native Americ|African,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,8.237e-06,pathogenic
chr17:43067635:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr13:32326615:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|no rescue ES cell lethality|-|as variant control, RNA analysis|mRNA analysis (RT-PCR)|-|Co-segregation in families|Mouse ES cell assay,1/1658|-,-|FA FANCD1_00002,,,,,,,,,, Norwegian German|Not Specified|Western European|-|Native American| Central/Eastern Europea|Western Europe|None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,7/26,1,,,,,1&1&1&0,,pathogenic
chr13:32326151:C>T,,,,,,,,,,,,,,,,,Central/Eastern European,IVS,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,,
chr13:32379431:A>T,,,,,,,,,,,,,,,Malaysian,,Indian,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,
chr13:32319271:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr17:43082546:CT>T,,,,,,,,,,,,,,,Czech,,central Europe,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr13:32317621:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32350510:A>C,,,,,,,,,,0.2753,0.2095,0.2378,0.3661,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.266174,
chr13:32356557:A>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,-|USA,,Western European|White|Caucasian|White-NonHispanic,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-986),,1&1,8.236e-06,
chr17:43099795:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,
chr13:32351784:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32338571:AAA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32340077:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32333210:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-084),,,,
chr13:32332710:T>TA,,,,,,,,,,,,,,,Central/Eastern Europe,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32340946:TG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32339981:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43072875:A>GT,,,,,,,,,,0.2922,0.0545,0.1873,0.0327,0.2035,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.145367,
chr13:32316529:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32316529:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32317191:T>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000599042,
chr13:32374741:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32339097:A>ATG,,,,,,,,,,,,,,,Chilean,1,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32397751:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43045406:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0002103405,
chr17:43104108:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,8.236e-06,
chr17:43092176:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,benign:0.027|None|None|benign:0.027|benign:0.027,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32371124:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,
chr13:32332887:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-05),benign(0-311),,,8.236e-06,
chr13:32398801:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001122055,
chr13:32340004:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0),,1,,
chr17:43094012:TT>T,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr13:32319327:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,,1,,pathogenic
chr13:32356554:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-05),probably_damaging(0-963),,1,,
chr17:43092336:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32355265:TAC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32336340:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43106531:TGTAACAGCGCTCAGGA>A,,,,,,,,,,,,,,,,,Caucasian,F,,,,,,,,splice_acceptor_variant&coding_sequence_variant&intron_variant,HIGH,,3/22,-1,,,,,,,
chr13:32332788:ATTTG>A,,,Germline (inherited),,,,FA FANCD1_00028,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43065832:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000599042,
chr17:43092731:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,2/1658|-,,,,,,,,,Australian|-,,Turkish|None-Specified|Asian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43094712:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32363522:C>CT,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32340547:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32319238:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32326244:G>A,,,,,,,,0.0|0.0227|0.0077,benign:0.132,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,6/27,,1,,,,,,,
chr13:32367646:C>G,,,,,,,,,,0.0,0.0129,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00339457,
chr17:43086542:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32338321:T>G,,,,,,,,,,,,,,,,,Latin American/Caribbean|Hispanic,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-373),,1,,
chr13:32347734:T>AT,,,,,,,,,,0.001,0.0242,0.0072,0.002,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0081869,
chr13:32399599:G>T,,,,,,,,,,0.001,0.003,0.0029,0.005,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00239617,
chr17:43094468:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr13:32339862:T>C,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-196),,1,,
chr13:32361269:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.01626 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2734,0.0151,0.2349,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.136781,benign
chr17:43100863:A>T,,,,,,,,,,0.0169,0.0023,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.00439297,
chr17:43092986:T>A,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379321:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr17:43091727:A>G,,Ambry_Genetics|GeneDx|Invitae,Unknown|Germline (inherited),,,,,0.0|0.0227|0.0077,None|None|None|None|None,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001121955,benign
chr17:43057056:CTGTC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43068528:T>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32333398:->T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,benign
chr17:43104881:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/22,,-1,,,,,1,,benign
chr17:43074427:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32345193:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000399361,
chr13:32332804:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.237e-06,
chr13:32327467:A>T,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00159744,
chr13:32379820:ATTTTT>T,,,,,,,,,,,,,,,Spanish|-|Italian,,Latin American/Caribbean|Western European|-| Italian|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32379326:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0227|0.0077,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32344588:AA>A,,,Germline (inherited),,,,FA FANCD1_00034,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/27,,1,,,,,,,
chr13:32333267:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32398143:C>A,,,Unknown|Germline (inherited),,,1/1658|-,,,,0.0,0.0,0.0,0.0169,0.002,,,,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.002564465,
chr17:43093876:GGGGCCGCACATCTCCCTGC>C,,,,,,,,,,,,,,,,,"""""Latin American/Caribbean| Grerada""""| Tobago| Trinidad|African",F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32379563:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32377317:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.04472 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32332959:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-073),1&1,1&1,,
chr13:32316529:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-073),1&1,1&1,,pathogenic
chr13:32346842:T>A,,,In vitro (cloned)|Unknown,inconclusive|predicted pathogenic|-,cell survival by crystal violet staining and CDDE|-|Multifactorial likelihood-ratio model,2/1658|-,,,,,,,,,,,Central/Eastern Europe|None Specified|Near East/Mid East,M,2 - Likely not pathogenic or of little clinical significance,0.1264,1.0294,,0.00265,0.02,0.02,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1&1,1.648e-05,
chr13:32354960:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),possibly_damaging(0-775),,1,,
chr17:43118971:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43094763:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32394724:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000349,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(1),benign(0-006),,1&1,,
chr17:43067380:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32370498:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-01),probably_damaging(0-998),,1,8.237e-06,
chr13:32398160:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32377216:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43071215:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-03),possibly_damaging(0-868),,,0.000199681,
chr13:32399324:T>AT,,,,,,,,,,0.0,0.0008,0.0,0.0,0.002,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr17:43092448:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-|?,-|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,1/1658|-,,,,0.0,0.0,0.0058,0.0,0.0,Not Specified|-,,Latin American/Caribbean|Columbia|-|None-Specified|Hispanic|Near Eastern|-Nicaragua|Latin-American/Caribbean|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,0.00832,0.0589,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.000485861,
chr13:32339294:AT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32376902:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr13:32376978:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32338039:GT>T,,,,,,,,,,,,,,,,,Pakistani,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43110245:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43094148:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32333282:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,,Western European|Western Europe|-|None Specified,M,1 - Not pathogenic or of no clinical significance,0.00026,1.479,0.129,0.0,0.02,0.02,synonymous_variant,LOW,10/27,,1,,,,,1,3.295e-05,
chr13:32339809:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32332303:A>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),possibly_damaging(0-842),,1,,
chr13:32370432:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43066555:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3646,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.335863,benign
chr13:32363218:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-95),0&1&1,1&1&1,,
chr17:43093896:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1,1&1,8.237e-06,benign
chr13:32326656:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0581|0.0|0.0384,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,,
chr17:43093570:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319289:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32355131:T>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.0681|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr17:43091255:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43045636:C>T,,,,,,,,,,,,,,,Singaporean,,Chinese,IVS,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,,
chr13:32338607:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-205),,1,8.248e-06,
chr13:32393972:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32340094:T>A,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32340644:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-384),,1,,
chr17:43045729:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr17:43094148:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093175:A>GT,,,,,,,,,,,,,,,,1,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32337554:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43094640:G>T,,,In vitro (cloned),predicted neutral,co-occurrence with deleterious variant|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,African American|-,,-|African,M,1 - Not pathogenic or of no clinical significance,,0.00316,1.0,6e-05,0.02,0.02,synonymous_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32399611:C>G,,,,,,,,,,0.001,0.0,0.0086,0.0,0.0153,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00439297,
chr17:43066707:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43119569:A>G,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr13:32337852:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-64),benign(0-007),,1,,
chr13:32319282:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,3/27,,1,,,,,1&1,8.237e-06,
chr17:43115728:T>A,,,In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,stop_lost&splice_region_variant,HIGH,,,-1,1.0,,,,,,
chr13:32398629:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43057069:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,benign(0-158),,1,3.295e-05,
chr13:32340848:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,8.238e-06,
chr17:43074385:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32336608:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43049181:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,21/23,,-1,,,,,1&1,,
chr13:32338907:TG>G,,,,,,,,,,,,,,,German,2|-,German|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43091842:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32338969:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32376644:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,
chr17:43063485:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000199681,
chr17:43094556:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43091709:T>G,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43091660:ATTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32339773:G>C,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-359),,1,,
chr13:32326252:GAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-359),,1,,
chr13:32337198:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-166),,1,,
chr17:43047465:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr17:43061557:T>A,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00179712,
chr17:43094317:A>T,,,,,,,,,,,,,,,,,Western-European|-Native-American,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,
chr13:32334223:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32377318:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32341043:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-997),,1&1,,
chr13:32340000:A>G,,,,,,,,,,,,,,,Dutch,2|-,-|European,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,
chr17:43071933:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr13:32344956:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32339570:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr13:32326271:A>C,,,,,,,,0.0|0.0227|0.0077,probably-damaging:0.997,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,,,
chr13:32376700:C>T,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,1&1,1&1,,
chr17:43049088:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Splicing reporter minigene|-,,,,,0.0,0.0,0.0,0.0099,0.001,American|-,,,IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1&1,0.001472995,
chr13:32336511:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-085),,,0.000103959,
chr13:32380044:T>A,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|-|inconclusive,Sensitivity to DNA damaging agents|family history|Structure-based prediction (crystallography etc)|-|Protein likelihood ratio model|Multifactorial likelihood-ratio model|Cell viability (in BRCA-/- cells)|Co-segregation in families,,,,,,,,,,,,Western European|None Specified,M,2 - Likely not pathogenic or of little clinical significance,1.0,0.049,0.0575,0.00544,0.66,0.66,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,3.295e-05,
chr13:32332818:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),probably_damaging(0-951),,1,,
chr13:32336306:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-05),,1,,
chr13:32316027:C>A,,,,,,,,,,0.0,0.0272,0.0,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.0071885,
chr13:32340801:TTAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43066920:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr17:43115727:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0008,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,benign
chr17:43094087:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,pathogenic
chr13:32331003:CC>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr13:32339312:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-017),,1,,
chr17:43104185:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32380748:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr13:32339373:C>T,,,,,,,,0.0|0.0228|0.0077,probably-damaging:0.981,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-943),,,,
chr13:32352925:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32398333:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336569:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32356516:A>CA,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr13:32346776:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.282e-06,
chr17:43064906:C>T,,,,,,,,,,0.002,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000798722,
chr13:32337930:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-917),0&1&1,1&1&1,,
chr17:43093693:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357803:T>C,,,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,0&1,,
chr17:43115777:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1,,
chr17:43071124:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-058),,1,1.647e-05,
chr17:43095989:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32371052:C>CT,,,,,,,,,,,,,,,,,Not Specified|Western European|None Specified,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,1,,
chr17:43124026:C>CT,,,,,,,,,,,,,,,,2,,F,,,,,,,,stop_gained&frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,
chr17:43066690:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32336692:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32369919:A>T,,,,,,,,,,0.2078,0.1861,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.225839,
chr13:32357718:C>TTTGTGTGTG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,8.239e-06,
chr17:43091520:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092159:G>A,,Ambry_Genetics,In vitro (cloned),predicted neutral|as wildtype control|as variant control,Recombination rate|Clonogenic assay|Proliferation in yeast|Homologous recombination in yeast,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1&1,1&1,,benign
chr13:32344697:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,2.48e-05,
chr13:32399018:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32336725:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094335:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045810:AGG>CAAG,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,,8.236e-06,
chr13:32372964:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32338981:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.237e-06,
chr13:32338968:TAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43067603:G>A,,,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,8.237e-06,
chr13:32394717:A>G,,,In vitro (cloned),predicted deleterious|no rescue ES cell lethality|inconclusive|as variant control,Co-localization to predicted ESEs|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model|Embryonic stem cell assay,,,,,,,,,,,,Not Specified|Western European| Centr|-| Native American,M,4 - Likely pathogenic,0.427,1.66,31.623,0.9775,0.66,0.66,synonymous_variant,LOW,25/27,,1,,,,0&0&1&1&1,1&1&1&1&1,,
chr17:43067603:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,8.237e-06,
chr17:43127865:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32340304:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32342233:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32332182:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,1,,
chr13:32342652:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43091302:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.453e-06,
chr17:43045677:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43090961:->CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32355055:GACCA>G,,,,,,,,0.0|0.0469|0.016,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32332309:A>G,,,Unknown|Germline (inherited),,,,,,,,,,,,Western Europe|-,,Central/Eastern Europe|Western European|Western/Central/Eastern Europe|-|Western Europe|None Specified,M,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1&1,5.767e-05,
chr17:43055008:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32357818:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-04),,,,
chr13:32333288:C>G,,,,,,,,,,,,,,,-|Ashkenazi,,Western Europe|-|Ashkenazi|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-005),0&1&1,1&1&1,3.296e-05,
chr17:43092518:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-005),0&1&1,1&1&1,,pathogenic
chr17:43039818:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32355232:A>AG,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,1,,
chr17:43045639:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32340498:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000319,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Not Specified|Western European|Western Europe|None Specified| Near Eastern,M,1 - Not pathogenic or of no clinical significance,0.16596,0.05248,0.17783,3e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-854),,1,,
chr17:43059411:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43113759:C>G,,,,,,,,,,0.3579,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.353035,
chr17:43091600:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32363172:AAG>C,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/26,1,,,,,,,
chr13:32366759:A>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00159744,
chr13:32329444:GCA>C,,,,,,,,,,,,,,,Dutch,,Caucasian,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,8/27,,1,,,,,,,
chr13:32340498:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-093),,1,8.237e-06,
chr13:32332788:AAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-093),,1,,pathogenic
chr17:43091637:AAAA>T,,,,,,,,,,,,,,,-|Dutch,,Western-European|-,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,2.471e-05,
chr13:32336366:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-373),,,8.237e-06,
chr17:43091891:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000689,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32319276:G>A,,Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,benign
chr17:43093705:TTC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,
chr13:32337925:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,pathogenic
chr13:32333332:G>CA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32340369:A>T,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-631),,,,
chr17:43091931:CT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-631),,,,pathogenic
chr13:32337801:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-023),,1,,
chr17:43091891:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32355184:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-055),,1,0.0001236,
chr13:32322026:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43124062:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,,
chr17:43092531:TA>C,,,,,,1/1658,,,,,,,,,Australian|-,,-|Central/Eastern-European|British,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43115746:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,0&0&1,1&1&1,,
chr17:43106534:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1&1&1,,pathogenic
chr17:43051071:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-908),,1&1&1,,
chr17:43106534:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1&1&1,,pathogenic
chr13:32340336:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-333),,1,,
chr13:32336708:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43099865:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr17:43099865:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32356577:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-1),possibly_damaging(0-465),,1,,
chr17:43080681:G>T,,,,,,,,,,0.1879,0.0174,0.1527,0.0863,0.3231,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.14397,
chr17:43076555:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1&1,,
chr17:43096246:T>A,,,,,,,,,,0.002,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000798722,
chr17:43051071:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-774),,1&1&1,,pathogenic
chr17:43092872:ACA>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338745:GGAA>TTT,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43115746:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05769 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,0&0&1,1&1&1,,benign
chr13:32336982:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43118446:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2163,0.3732,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.352636,benign
chr13:32363410:T>CAG,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32337209:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,1,,
chr17:43063246:AA>T,,,,,,,,,,,,,,,U.S.A.,,African American,IVS,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr17:43094289:C>GT,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43093121:AT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43091832:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,7.413e-05,
chr17:43082414:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,0.0,0.0,0.0,0.001,0.0,American,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,0.0001327855,benign
chr13:32339706:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338514:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-966),,1,,
chr17:43115430:C>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00139776,
chr17:43093931:G>C,,,,,,,,0.0116|0.0|0.0077,benign:0.008|None|None|benign:0.008|benign:0.008,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32340995:G>AC,,,,,,,,,,,,,,,,,Western/Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337039:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43051110:AT>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,
chr17:43093064:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43067513:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr17:43094965:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32331064:TTTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,3.308e-05,
chr13:32362674:C>T,,,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32339332:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,1/1658|-,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001154,benign
chr17:43091772:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Greek,,Greek,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr17:43092786:AG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr17:43093703:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32337360:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-373),,1,,
chr13:32362589:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43104964:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,
chr13:32370484:TAT>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32363928:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32339276:GAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43127544:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.87 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32337521:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Latin American/Caribbean|Western European|None Specified| Asian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43057026:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,
chr17:43071145:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-03),benign(0-002),,,8.236e-06,
chr17:43071074:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000703,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.1589|0.0538,benign:0.013|benign:0.013|benign:0.013|benign:0.013|benign:0.013,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,1,,benign
chr13:32340279:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-138),,,8.237e-06,
chr17:43091772:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-138),,,,pathogenic
chr17:43104331:G>T,,,,,,,,,,0.0,0.0,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.00159744,
chr13:32332262:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,1.649e-05,
chr17:43076560:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1,,
chr13:32337702:->TA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32336458:TATT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339821:A>TA,,,,,,,,,,,,,,,English/Canadian,1,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326298:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,,
chr13:32337681:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32348269:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000599042,
chr13:32354909:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr13:32354909:G>A,,,,,,,,,,,,,,,German,,Caucasian,UV,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr17:43091763:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32362507:G>C,,,,,,,,,,,,,,,Austria,1|0,,IVS,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr17:43094802:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43091000:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32366979:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43120938:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32316520:TT>C,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,1,,,,,,,
chr13:32346044:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32346203:C>T,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.0738818,
chr17:43124044:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr17:43091536:C>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43073959:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000599042,
chr17:43094402:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093317:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092643:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379723:GGCTCACTAC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr17:43096147:G>T,,,,,,13/1658,,,,0.3529,0.1581,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.335064,
chr13:32326602:A>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr17:43117562:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32370502:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe/Native American|-|Near Eastern,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-02),probably_damaging(0-999),,1&1,8.237e-06,
chr13:32331014:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,
chr17:43061084:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32396878:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32396878:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43063920:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32325213:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43094605:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43124156:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.967e-06,
chr13:32326517:GGA>C,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,,,
chr17:43099181:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32354875:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),benign(0-014),,,,
chr13:32355004:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),benign(0-014),,,,pathogenic
chr13:32353509:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32382025:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43072284:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32339915:GT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,pathogenic
chr13:32340027:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-373),,1,8.237e-06,
chr13:32356272:A>G,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.00139776,
chr17:43093279:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43080685:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32349713:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43106018:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32338642:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32393874:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00678914,benign
chr13:32395532:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr17:43070922:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1&1,,pathogenic
chr17:43045779:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-024),,,8.236e-06,
chr13:32339892:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,8.237e-06,
chr17:43070922:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1&1,,pathogenic
chr13:32332807:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-117),0&1&1,1&1&1,,
chr17:43091484:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32326410:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,0.000199681,
chr13:32394788:A>G,,,,,,,,,,,,,,,Not Specified,,,N,,,,,,,,stop_retained_variant,LOW,25/27,,1,,,,,1&1,,
chr17:43091370:GC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.241e-06,
chr13:32319035:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.258e-06,
chr17:43095981:GA>C,,,,,,3/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337999:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,,1.647e-05,
chr13:32351117:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43071185:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-806),,1&1,,
chr17:43093813:AATGTT>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43074519:A>C,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,
chr13:32363156:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.0001245555,
chr17:43092621:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,8.236e-06,
chr13:32380102:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32338808:TTCAA>A,,,,,,,,,,,,,,,Surinam|Dutch,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339741:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43095587:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2073 (African)| 0.3443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32325869:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43074519:A>T,,,,,,,,,,,,,,,,,Asian|Central/Eastern Europe,N,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,
chr17:43093682:TAGA>T,,,,,,,,0.0364|0.3994|0.16,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370387:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.237e-06,
chr17:43124027:GGT>A,,,,,,16/1658|-,,,,,,,,,USA|Ashkenazi|Dutch|Central/Eastern Europe|Not Specified|-|French|Norwegian|French?|Chilean|Western Europe/Ashkenazi|Canadian|Malaysian|British|Hispanic|American|Latvian|Native American|Italian|Ashkenazi/Central-Eastern Europe|German|Ashkenazi/Central-Eastern European|Mexican American|Czech|Austria|Spanish|Ditch,21|16|--|-|1|3|2|5|4," Sephardic|White-NonHispanic|Unknown| poland| Central/Eas|-India|Ashkenazi/Western/Central/Eastern Europe|British/Jewish|Ashkenazi/Dutch/Italian| Denmark|Mid/Near East| Ashkenazi""""|Russian-Jewish| English|Spain|Russian/Ashkenazi-Jewish|Ashkenazi Jewish|-Native-American| Sephardic Jewish""""|-Latin-American/Caribbe|None Specified|Ashkenazi/Sephardic|Central/Eastern Europe/Russia|""""Ashkenazi|Romanian/Jewish|None-Specified|English| Latin|-New-Mexico|-Ashkenazi|Mediteranean|-Central/Eastern-European|Latin American/Caribbean|Near-Eastern| Germany|-Spanish|Not Specified|""""Caucasian|Jewish?|-Central/Eastern-Europe|-Sephardic-Jewish|-Italian| Austria""""| Irish| Central/Eastern European|Ukraine German| Neth|Patient not Ashkenazi Jewish|Asian/Ashkenazi/Western Europe|African|Central/Eastern European|Irish/German/Scot/English/Welsh| Non-Ashkenazi""""|""""Asian|Ashkenazi/Western Europe|""""Central/Eastern European|Latvian| Latin American/Caribbean""""|Western European|Native-American|-English/Dut|Indian|Ashkenazi-Jewish| Central/Eastern European""""|West Europe/Near East-Mid East|Chile|W. Europe/French Canadian|Austrian/Jewish/Polish|-Russia/Poland|Russian/Polish|Central/Eastern-European|Native American| Native American| Nea| Turkish|Romanian/Ashk-Jewish|-Centr|Native American/Western Europe| French| Greek""""|Ashkenazi|Caucasian|Jewish/-Mixed|Jewish|-|""""African|Western-European|-French|""""Western European|Ashkenazi/Scandinavian|Near Eastern| Latin American/Caribbe|-Ukraine| Indian""""|Latin-American/Caribbean|Western Europe/Spain Mexico|Western Europe/Jewish|Central/Eastern Europe|Ashkenazi/Central/Eastern Europe|Ashkenazi/Greek|Gypsy|Asian| Ashkenazi|Western Europe",F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,0.0002389,
chr17:43124476:T>A,,,,,,,,,,0.0,0.0083,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00239617,
chr13:32333415:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,4.2065e-06,
chr13:32394846:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,Syn,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,
chr13:32336218:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0001039615,
chr17:43088673:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32363300:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Not Specified|None Specified,M,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,8.236e-06,
chr13:32325331:A>T,,,,,,7/1658,,,,0.0686,0.003,0.0288,0.0,0.0184,,,,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0221645,
chr17:43056191:G>T,,,,,,,,,,0.2843,0.3139,0.2882,0.246,0.2832,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.284744,
chr13:32336245:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr13:32338043:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-607),,,,
chr13:32377873:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32370919:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,3.295e-05,
chr13:32333398:CT>C,,,,,,,,13.6266,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1&0,,
chr13:32336574:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-275),,,,
chr17:43090954:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,1.0,,,,,8.237e-06,
chr13:32332917:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-52),benign(0),,1,,
chr17:43091636:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43124102:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43093004:G>C,,,,,,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337236:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,8.237e-06,
chr17:43045712:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious|very destabilizing|as variant control|?|strong functional effect,Multifactorial likelihood-ratio model|Peptide binding ability|Bayesian statistics|transcription activation/PS/BA/BS|evolutionary conservation analysis|Thermodynamic stability prediction|Proteolytic degradation|?,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-968),,1&1,,
chr17:43093691:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43106462:G>GT,,,,,,,,,,,,,,,Austria,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43103736:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43123815:C>A,,,,,,,,,,0.0,0.0204,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00539137,
chr17:43091486:A>G,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32385099:G>T,,,,,,,,,,0.0467,0.0008,0.0274,0.0,0.0102,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0153754,
chr13:32332765:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Pakistan,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,2.471e-05,
chr17:43093830:C>AT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43090921:GGC>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.006325,
chr13:32360969:C>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr17:43094266:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338728:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-01),,1,,
chr13:32398186:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363550:C>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,1.648e-05,
chr17:43106551:T>C,,,Germline (inherited),,,,,,,,,,,,,,Not Specified|-,IVS,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,1,8.249e-06,
chr17:43094291:C>CC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339573:TTTTT>T,,,,,,,,,,,,,,,,,Near Eastern,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43109088:T>C,,,,,,,,,,0.0219,0.0,0.0072,0.0,0.0419,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0135783,
chr13:32357932:T>C,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,
chr17:43099819:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32326255:G>TG,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,6/27,,1,,,,,1,,
chr13:32340690:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/27,,1,,,,,1,,pathogenic
chr17:43052360:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2194,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342851,benign
chr17:43076551:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,,,
chr13:32364948:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0295,0.0908,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0726837,benign
chr13:32379821:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43051122:ATA>A,,,In vitro (cloned),predicted neutral,cDNA analysis,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/21,-1,,,,,,,
chr13:32337704:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-773),,1,,
chr13:32360137:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43124054:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,
chr13:32339833:AAAACA>C,,,,,,,,,,,,,,,,,"Western European|Asian| Portuguese""""|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32380140:ATTAC>ATT,,,,,,,,,,,,,,,,,"""""Western Europe|Western Europe| Latin American/Caribbean""""",F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,1,,,,,1,,
chr17:43093819:T>G,,,In vitro (cloned),predicted neutral|?,evolutionary conservation analysis|?,,,,,0.0,0.0,0.0014,0.0,0.0,,,-|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.0001080755,
chr13:32340648:A>T,,,,,,,,,,,,,,,Northern Irish,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),possibly_damaging(0-861),,1,1.647e-05,
chr13:32398608:->GAATTATATCT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43093216:GG>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32363222:TCT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32336825:TATGTAC>T,,,,,,,,,,,,,,,Indonesian,1,Javanese,N,,,,,,,,stop_gained&inframe_deletion,HIGH,11/27,,1,,,,,1,,
chr13:32339096:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,benign:0.335,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-169),,1,,
chr13:32394671:TG>AT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,8.239e-06,
chr17:43067617:AGTC>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,,,,,,-|Italian,3|-,Not Specified|Western Europe|-|Caucasian|None Specified,IFD,5 - Definitely pathogenic,16.98,1.17,13.49,0.99312,0.35,0.35,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,
chr13:32358600:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32397081:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32355038:CTTGAT>AG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,1,,pathogenic
chr17:43094570:TGC>A,,,,,,,,,,,,,,,Hong Kong,,Chinese,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43074349:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.236e-06,
chr17:43092434:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,pathogenic
chr17:43053629:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43079887:T>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000998403,
chr13:32337762:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-086),,1,,
chr13:32333292:G>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-217),,1,,
chr17:43071168:GC>G,,,,,,,,,,,,,,,-|Western Europe/Norway,,,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1&1,,
chr17:43092434:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32378753:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43045711:C>T,,,Germline (inherited),,,,,,,,,,,,,,Indian,N,,,,,,,,stop_retained_variant,LOW,22/22,,-1,,,,,1&1,,
chr17:43089157:G>C,,,,,,,,,,0.0,0.0144,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00399361,
chr13:32319272:A>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr13:32340470:T>A,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.689,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-105),,1,,
chr13:32360293:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43093547:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32338228:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32363501:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43079430:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.525e-06,
chr17:43087963:A>C,,,,,,,,,,0.0089,0.0008,0.0086,0.0,0.0174,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00658946,
chr17:43093631:C>A,,,,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32396591:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32397149:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333278:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32374396:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000798722,
chr17:43094025:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333278:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32340301:T>-,,GeneReviews|_NHGRI|Biesecker_Laboratory_-_ClinSeq_Project|Emory_Genetics_Laboratory|Ambry_Genetics|Curoverse|Counsyl|Invitae|Pathway_Genomics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43094695:T>C,,,,,,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336588:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,0.0001039585,
chr17:43093819:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093383:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339027:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-096),,1,,
chr13:32340330:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-557),,1,,
chr17:43094708:C>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43047665:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr17:43080356:G>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000599042,
chr13:32379885:CC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,0&1&1,0&1&1,0.0001153,
chr13:32354895:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-034),,,8.236e-06,
chr17:43092362:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43049120:G>T,,,In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,None-Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,20/21,-1,,,,,1,,
chr17:43091987:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43074522:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32339571:TTTTTTTT>A,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,Norwegian|-,1|2|-," Latin American/Caribbean| canadian""""|Not Specified|Western European|-|Norwagian|German|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32337849:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-028),,1,8.236e-06,benign
chr17:43093272:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093250:TCAAGGTCATATAGCCAGGAAGGGGTGGAGGCCCAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32362240:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32356409:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,
chr13:32333349:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-015),,,8.258e-06,
chr13:32372472:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32317354:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43092749:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370585:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.238e-06,
chr13:32370552:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-53),benign(0-01),,1,8.237e-06,
chr13:32337365:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-53),benign(0-01),,1,,pathogenic
chr17:43094459:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,0&1&1,8.236e-06,
chr13:32337963:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-894),,,8.236e-06,
chr17:43101311:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43052991:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43094243:G>C,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32398438:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43045783:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-122),,,,
chr13:32325082:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43045852:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,8.236e-06,
chr17:43079331:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.598e-06,
chr13:32332455:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),benign(0-311),,1,,
chr13:32334544:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32333396:G>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr13:32340845:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32356593:A>T,,,In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,0.0,0.0023,0.0,0.0,0.0,,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-12),,0&1&1,1&1&1,0.000348941,
chr13:32393830:A>G,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43093650:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32370985:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32363319:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Protein likelihood ratio model|-,,,,,0.0,0.0,0.0,0.0,0.0041,Austria|-,0|-, Ashkenazi|Central/Eastern Europe|Western European|-| Near Easter|Ashkenazi|Near Eastern|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(1),benign(0-007),,1&1,0.000448781,
chr13:32346312:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32356500:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,
chr13:32338597:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093314:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363526:C>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-18),possibly_damaging(0-865),,1,,
chr13:32337098:ACTTG>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-18),possibly_damaging(0-865),,1,,pathogenic
chr13:32316406:GTCT>G,,,,,,,,0.2181|0.0704|0.1678,None,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32346848:G>C,,,,,,,,,,,,,,,,,Near Eastern,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(0-988),,1&1,,
chr13:32357820:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-996),,1,,
chr17:43095904:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32319095:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32394688:A>C,,,In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European,IVS,4 - Likely pathogenic,1.0,1.16,47.5,0.966,,0.34,splice_acceptor_variant,HIGH,,24/26,1,,,,,1&1&1,,
chr13:32331059:ACTC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.253e-06,
chr13:32317629:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43124476:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32336881:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32376669:A>GA,,,,,,,,,,,,,,,,,,F,,,,,,,,splice_acceptor_variant,HIGH,,20/26,1,,,,,1,,
chr17:43092264:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32345424:G>C,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00139776,
chr13:32339680:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.647e-05,
chr13:32340845:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43057122:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-733),,1&1&1&1,,
chr13:32379369:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43057122:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-194),,1&1&1&1,,
chr13:32316386:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32333072:CTACTC>G,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32337365:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),possibly_damaging(0-611),,1&1,8.238e-06,
chr13:32371647:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43124592:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32338901:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43074611:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32341188:TCTTA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43071162:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32338493:A>ATT,,,,,,,,,,,,,,,Serbian,,Serbian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32340588:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-996),,,8.237e-06,
chr13:32339410:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32363555:G>C,,,In vitro (cloned),predicted neutral,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr13:32338501:AGA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr17:43079008:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32397265:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43108442:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43074813:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43094238:TT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,MODIFIER,,,-1,,,,0&0&0&1,1&1&1&1,,
chr17:43091551:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43049145:C>G,,,In vitro (cloned)|Unknown,as wildtype control|predicted neutral|no functional effect|-,transcription activation/PS/BA/BS|-|Transcription activation in human cells|Structure-based prediction (crystallography etc),,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0-05),benign(0-001),,1&1,8.236e-06,
chr13:32338534:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43079069:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.00499201,benign
chr13:32338236:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasion,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091781:C>G,,Ambry_Genetics|GeneDx,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.651|None|None|possibly-damaging:0.651|possibly-damaging:0.651,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43070925:A>G,,,,,,,,,,,,,,,,3|-,Western European|Native-American|-|-Central/Eastern-Europe|Western-European|Western Europe,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32341123:G>A,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr17:43091906:T>C,,,,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,1.647e-05,
chr17:43110587:GGCTT>CAAAAAA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0004557,
chr13:32341155:C>T,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.807,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-297),0&0&1&1,1&1&1&1,,
chr13:32363187:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-47),benign(0),,1,,
chr17:43091034:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43097273:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr17:43091034:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32357889:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,,1.647e-05,
chr13:32340140:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000521,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.004,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-74),benign(0-03),,1&1,,benign
chr17:43092175:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32338179:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|Central/Eastern European| Irish,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),,,1&1,8.245e-06,
chr17:43093225:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32388266:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43057236:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32394831:AC>A,,,,,,,,,,,,,,,-|Italian,,Western European|Caucasian,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32379495:C>CA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43099887:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,1.0,,,,,,
chr13:32322052:A>AT,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43093950:A>G,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,Not Specified,,,M,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32374398:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43116676:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00119808,
chr17:43053964:G>T,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43115719:CGCTC>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,8.237e-06,
chr17:43076553:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,1,,benign
chr13:32319275:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,0&1,1.647e-05,
chr17:43092646:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.236e-06,
chr13:32398689:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,,
chr13:32337197:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338732:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-193),,1,,
chr17:43102743:G>A,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00379393,
chr13:32357388:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32376731:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,8.236e-05,
chr13:32337359:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-029),,,1.648e-05,
chr17:43063374:A>G,,,In vitro (cloned),predicted deleterious|?,Multifactorial likelihood-ratio model|?,,,,,,,,,,Not Specified|Sweden|-|Spanish,3|-,Western-European|Western European|-,IVS,5 - Definitely pathogenic,1.0,1.15,20.42,0.999,,0.97,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,
chr13:32398485:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32380094:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32336764:A>G,,,,,,,,,,,,,,,British,1,Caucasian,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,,
chr13:32380094:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43063374:A>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,Western Europe|Dutch|-|Spanish,,Western-European|Western Europe|-|Caucasian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,
chr17:43067695:G>A,,,In vitro (cloned),predicted neutral|Low functional effect|not destabilizing,transcription activation/PS/BA/BS|Thermodynamic stability prediction|Multifactorial likelihood-ratio model,,,,,,,,,,,,Latin-American/Caribbean,M,,,,,,,,splice_region_variant&synonymous_variant,LOW,15/22,,-1,,,,,1,,
chr13:32355263:TCTACCTGATG>C,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32398485:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32345247:A>G,,,,,,,,,,0.0,0.0,0.0144,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,0.00199681,
chr13:32325455:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000199681,
chr17:43093088:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,pathogenic
chr17:43047724:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,1.647e-05,
chr17:43047724:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr13:32370972:AA>C,,,,,,,,,,,,,,,,,Near Eastern,F,,,,,,,,frameshift_variant&stop_lost,HIGH,20/27,,1,,,,,,,
chr13:32396988:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000368,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.412,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43066220:G>C,,,,,,,,,,0.0,0.0,0.036,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00499201,
chr17:43045820:C>T,,,,,,,,,,,,,,,,,Western European|Western Europe,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,
chr13:32362647:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),possibly_damaging(0-666),,1,8.236e-06,
chr13:32371796:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32330991:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,0.000103959,
chr13:32336642:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-721),,1&1,,
chr17:43082562:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr17:43122087:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43072157:C>A,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr13:32347418:T>G,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32331778:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00678914,benign
chr13:32363427:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-67),benign(0-046),,1,,
chr17:43071166:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-005),,,1.647e-05,
chr17:43094083:ATA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-005),,,,
chr17:43094720:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,co-occurrence with deleterious variant|-|evolutionary conservation analysis,,,,,0.0,0.0,0.0,0.001,0.0,,,-|Asian,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,0.0001492605,
chr17:43094153:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337511:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00025883,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32363534:A>T,,,,,,,,,,,,,,,Not Specified,,,IVS,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1&1&1,,
chr13:32326137:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1&1&1,,pathogenic
chr13:32379464:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32366385:T>C,,,,,,,,,,0.0,0.0272,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00738818,
chr17:43057074:C>A,,,In vitro (cloned),uncertain,transcription activation/PS/BA/BS,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-091),,1,,
chr17:43099865:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-091),,1,1.647e-05,
chr17:43047698:C>A,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/22,,-1,,,,,1,8.236e-06,
chr17:43118649:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3559,0.1566,0.3631,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.335064,benign
chr17:43093809:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,0.000103959,
chr13:32340237:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43099856:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43046253:T>A,,,,,,,,,,0.0169,0.0,0.0043,0.0,0.0378,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.0113818,
chr13:32325217:A>G,,,Unknown|Germline (inherited),,,,,0.0468|0.0|0.031,None,0.001,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000466521,
chr13:32336675:T>G,,,,,,,,,,,,,,,Not Specified|-,,Not Specified|Western European|Western Europe| Irish Norwegian|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-061),,1,4.118e-05,
chr17:43094732:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,1.647e-05,
chr13:32379508:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32341074:T>A,,GeneDx,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32337195:G>TG,,,,,,,,,,,,,,,,,Western European| Latin American/Caribbe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43063413:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,3.295e-05,
chr13:32341073:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.236e-06,
chr13:32337909:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32339625:A>G,,Ambry_Genetics|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-029),,1,,
chr17:43098734:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32396961:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32355189:C>G,,,In vitro (cloned)|Unknown,-|normal RNA splicing,RNA analysis|-,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-002),,,,
chr13:32339696:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-335),,1,,
chr13:32356517:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr17:43063330:AG>T,,,In vitro (cloned)|Germline (inherited),-|as variant control,mRNA analysis (RT-PCR)|-,,,,,,,,,,-|Belgian,,-|Caucasian,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,18/22,-1,,,,,,,
chr13:32333398:TGA>CT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.138,
chr13:32332251:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.251e-06,
chr17:43056288:G>T,,,,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00499201,
chr13:32355085:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-999),,1,,
chr17:43124077:C>T,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,benign:0.279|benign:0.279|benign:0.279|None|benign:0.279,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,1&1,1&1,8.237e-06,
chr13:32336642:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32338825:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43096571:CA>C,,,,,,,,,,0.4006,0.4554,0.438,0.3869,0.4796,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.432907,
chr13:32337209:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),,,1,,
chr13:32330977:->AG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr17:43074431:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr17:43090941:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1&1,,
chr13:32398535:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32333046:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-017),,1,,
chr13:32398376:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32325168:TG>T,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,4/27,,1,,,,,1&1,,
chr17:43093841:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32340212:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,German|Not Specified|Western Europe|-|Dutch,,"White-NonHispanic| French Canadian""""|Italian/French|-|British|Unknown|French-Canadian|Western European|French Canadian|Western Europe|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,8.237e-06,pathogenic
chr17:43091888:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32339122:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32346875:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43049129:ATTCTTCTGCCTCAGCCTCCCGAAGAGCT>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,,
chr13:32333046:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-125),,1,,benign
chr13:32337423:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.238e-06,
chr13:32336764:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32338612:TC>A,,,Germline (inherited),,,,,,,,,,,,Swedish|Sweden|-|Italian,2|-|4,Western European|Western Europe|-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.247e-06,
chr13:32380424:T>A,,,,,,,,,,0.5159,0.556,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.523562,
chr13:32379557:T>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.242e-06,
chr13:32333019:A>AG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr17:43093106:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340339:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-016),,1,,
chr13:32330991:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43110628:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,7.32e-05,
chr17:43092998:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43094569:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340449:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-001),,,,
chr17:43092207:TA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-001),,,,pathogenic
chr13:32329440:CA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-001),,,,
chr17:43086946:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32398443:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001039585,
chr13:32327472:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr13:32333119:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43094273:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,0.0116|0.0|0.0077,probably-damaging:0.998|None|None|probably-damaging:0.998|probably-damaging:0.998,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32328452:G>A,,,,,,,,,,0.0089,0.0008,0.0029,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00299521,
chr17:43092774:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32337870:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000315,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0581|0.0|0.0384,probably-damaging:0.97,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),,0&0&1,1&1&1,,
chr13:32376909:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr17:43093155:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,pathogenic
chr17:43104083:TTTC>A,,,,,,,,,,0.3559,0.3321,0.4006,0.3899,0.5204,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.394768,
chr13:32337870:C>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-982),0&0&1,1&1&1,,
chr17:43093857:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-982),0&0&1,1&1&1,,pathogenic
chr13:32364618:T>CT,,,,,,,,,,0.2435,0.0862,0.2968,0.2004,0.2935,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.210463,
chr13:32376910:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32356439:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-04),,0&1&1,1&1&1,,
chr13:32319160:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-04),,0&1&1,1&1&1,,pathogenic
chr13:32379398:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,0.0001080755,
chr13:32339017:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-452),,1,,
chr13:32370490:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-02),probably_damaging(1),,1,,
chr17:43094300:A>T,,,In vitro (cloned),predicted neutral|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063350:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,,benign(0-004),,1,,
chr17:43094832:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32398567:AG>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32379957:G>T,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr13:32339228:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,4.12e-05,
chr17:43074457:G>A,,,,,,,,0.0116|0.0|0.0077,probably-damaging:0.998|probably-damaging:0.998|probably-damaging:0.998|probably-damaging:0.998|probably-damaging:0.998,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32317575:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43091614:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32396903:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr13:32339268:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-848),0&1&1,0&1&1,8.239e-06,
chr13:32329520:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,8.255e-06,
chr13:32354904:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-1),benign(0-186),0&1&1,1&1&1,,
chr17:43067343:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43064413:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43063404:T>C,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43057171:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr13:32338765:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32364579:C>G,,,,,,,,,,0.005,0.0008,0.0043,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00279553,
chr17:43054476:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32333150:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-004),,1&0&1,8.236e-06,
chr13:32370447:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,
chr13:32396938:T>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43124428:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32354904:C>A,,,,,,,,,,,,,,,,,Latin American/Caribbean|Not Specified| Cuba|Western European,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-05),possibly_damaging(0-586),0&1&1,1&1&1,5.765e-05,
chr17:43063505:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000199681,
chr13:32339596:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32362549:T>G,,,In vitro (cloned),predicted neutral|predicted deleterious,Protein likelihood ratio model|Co-localization to predicted ESEs,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-976),,1,,
chr17:43074342:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32346872:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0-04),possibly_damaging(0-801),,,0.000199681,
chr13:32398447:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394701:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43070973:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,pathogenic
chr13:32398418:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338904:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,8.237e-06,
chr13:32341029:CTC>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32380134:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32398370:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32379463:TTTTTCATTGTTT>ATCCC,,,,,,2/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,
chr17:43092509:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.227|0.0769,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43092509:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32332544:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-4),possibly_damaging(0-466),,1,,
chr13:32346651:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr17:43045804:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr13:32370415:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-955),,,8.236e-06,
chr17:43082499:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0-04),,,1&1,,
chr17:43117794:G>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32321757:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32346890:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,,1.648e-05,
chr13:32339620:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.238e-06,
chr17:43070973:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-006),,1&1,,
chr17:43045792:CGCGGCTCT>C,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,22/22,,-1,,,,,1,,
chr13:32385743:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0112,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00219649,
chr17:43067698:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32354965:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-996),,,,
chr13:32335723:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0151,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00439297,benign
chr17:43093881:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43098877:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.0155751,benign
chr13:32341058:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr17:43056726:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32338669:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,4.122e-05,
chr17:43104193:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000139,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,Austria|-,1|-,Western European|-,M,1 - Not pathogenic or of no clinical significance,1.0,1.1,0.00617,0.00014,0.02,0.02,missense_variant,MODERATE,6/23,,-1,,,,,1,,
chr17:43045807:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,1,,
chr17:43092600:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43091813:GGTC>GG,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43097444:A>T,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00199681,
chr17:43048263:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr17:43053353:TG>G,,,,,,,,,,0.0,0.0,0.0014,0.0526,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0109824,
chr13:32362689:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-03),possibly_damaging(0-613),,,,
chr17:43093979:CA>T,,,,,,,,,,,,,,,French,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43115780:GG>C,,,,,,,,,,,,,,,,,Asian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,,,
chr13:32340864:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,,,pathogenic
chr13:32377950:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43070923:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32376769:G>T,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32338914:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,8.237e-06,
chr13:32363326:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43124125:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43093877:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43123784:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43091918:GA>C,,,,,,,,,,,,,,,German|-|French,,Not Specified|Western European|-|Caucasian|Western-European|Western Europe|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092823:->AT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr13:32339501:TATG>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr17:43058431:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32357942:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,0.0001286655,
chr17:43124548:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43093324:GT>T,,,,,,,,,,,,,,,,,Western-European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092696:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32360930:G>A,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32339067:AG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43076550:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,1,,benign
chr13:32346801:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,1.65e-05,
chr13:32337008:CTG>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43092197:TG>C,,,,,,,,,,,,,,,,,Mongolian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43115737:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32336925:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094815:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32347258:T>C,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32333283:GA>G,,,,,,,,1.178|1.243|1.2002,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,0&1&1,1&1&1,,
chr17:43094775:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32356587:G>CTT,,,,,,,,,,,,,,,,,Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,1&1,1&1,,
chr17:43091724:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43044897:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091724:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32398452:GA>G,,,,,,,,0.0|0.1173|0.0399,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43094108:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43119205:G>T,,,,,,,,,,0.001,0.0,0.0,0.0109,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00279553,
chr17:43063937:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-995),,1&1,,
chr17:43110084:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32398604:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr13:32319207:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32337342:C>G,,,,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-599),,1,4.942e-05,
chr17:43124137:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.682e-05,
chr13:32340124:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43067683:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr13:32337538:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32341100:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-081),,1,,
chr13:32399029:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32340334:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43091859:T>GGGAA,,,,,,,,,,,,,,,-|British,, Latin American/Caribbe|Western European|-|Caucasian|Ashkenazi|Western Europe|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43067625:T>TG,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,1,,
chr13:32326480:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|2.1788|0.7381,None,0.001,0.0303,0.0,0.0,0.0,Latin American/Caribbean|Not Specified|-|Asian|African American|Western Europe,,Western Europe/Latin American/Caribbean|Latin American/Caribbean|African American|-,IVS,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,0.00515995,
chr17:43091983:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.4419|23.8311|29.5248,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1,1&1&1,,
chr13:32319116:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,1.647e-05,
chr17:43092609:TTA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338903:TTTAT>C,,,,,,,,,,,,,,,,,Western/Central/Eastern Europe|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32339992:TGAAC>G,,,,,,-|3/1658,,,,,,,,,Austria|Pakistani/Indian,1|-,-|Asian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32356465:CAT>G,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43074351:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32380611:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43124089:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,1.0,,,,1,8.237e-06,
chr13:32379516:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32339428:A>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32333309:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32355106:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-45),,0&1&1&1&1,1&1&1&1&1,,
chr13:32395894:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08392 (Asian)| 0.3069 (African)| 0.285 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2744,0.2436,0.2882,0.0804,0.1503,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.204872,benign
chr13:32349298:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093961:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&1,1&0&1&1,8.237e-06,
chr17:43058585:A>C,,,,,,,,,,0.0,0.0,0.0,0.0278,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0061901,
chr13:32323935:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32319224:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1&1,2.471e-05,
chr17:43092043:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,Chinese,,Chinese Hans,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,0.000199681,
chr17:43092695:T>TA,,,,,,,,,,,,,,,,,Western-European| Italian|-|Western European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32391514:A>C,,,,,,,,,,0.999,0.9138,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.976637,
chr17:43094095:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337813:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43102059:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43070980:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr13:32382531:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43051309:G>A,,,,,,,,,,0.002,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr13:32338037:AATG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32341376:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43092368:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,0&1&1,8.237e-06,
chr17:43092241:AAG>C,,,,,,,,,,,,,,,French?|Malaysian|-,,Chinese|Western European|Western/Central/Eastern Europe|-|Western-European|Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32341151:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),probably_damaging(0-982),,1,,
chr17:43094198:G>A,,,In vitro (cloned),,,,,,,,,,,,Spanish|Italian,,Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32326616:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,
chr13:32337813:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Not Specified|-,,Europe|Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,,1&1,8.236e-06,
chr13:32377390:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32339947:GAA>C,,,,,,,,,,,,,,,-|Dutch,,Western European|-| Irish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094042:AA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43093511:GC>G,,,Unknown|Germline (inherited),,,2/1658|-,,,,,,,,,-|Dutch,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32379401:C>A,,,In vitro (cloned)|Unknown,-|normal RNA splicing,RNA analysis|-,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32326664:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,2.471e-05,
chr17:43092620:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092418:CTGGCAT>T,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337580:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32380644:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32355044:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,8.236e-06,
chr17:43047161:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1098 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr13:32355044:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,8.236e-06,
chr17:43074522:A>T,,,,,,,,,,,,,,,,,Pakistani|-India|Asian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,1.647e-05,
chr13:32336493:A>C,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),,,1&1,,
chr17:43093835:A>TC,,,,,,,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091594:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43104295:A>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,1,,
chr13:32397033:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379516:G>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43071104:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-344),0&0&1&1,1&1&1&1,,
chr13:32339951:A>C,,,,,,,,,,,,,,,Sweden,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-065),,1,,
chr17:43093586:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,-|Brazilian,,Western European|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43048885:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32336493:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,-|?,-|?,,,0.0|0.4312|0.1461,benign:0.143,0.0,0.0091,0.0,0.0,0.0,African American|-,,African American|-|None Specified|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-333),,1&1,0.001449285,
chr13:32338835:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093586:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32398722:GGC>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43071104:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32322152:A>T,,,,,,,,,,0.0,0.0234,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00658946,
chr13:32346896:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,deleterious(0-03),benign(0-082),,1&1&1&1&0&0,,pathogenic
chr17:43092406:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr17:43051659:A>T,,,,,,,,,,0.007,0.0008,0.0101,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00299521,
chr13:32342166:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43049068:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr13:32357813:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr13:32339997:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-759),,1,,
chr17:43052916:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32338229:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43091443:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43104887:CCCACACCCACTGA>C,,,,,,,,,,,,,,,,,Western-European|Western European,F,,,,,,,,frameshift_variant,HIGH,4/22,,-1,,,,,1,,
chr17:43091443:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32346896:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,deleterious(0-01),possibly_damaging(0-517),,1&1&1&1&0&0,,
chr13:32355009:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-002),,,8.237e-06,
chr13:32346896:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-07),possibly_damaging(0-456),,1&1&1&1&0&0,,pathogenic
chr17:43091833:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32325142:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Spanish,,,M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32343004:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43094135:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337163:CGAGT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32336953:A>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-043),,1,,
chr13:32338259:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),,,1&1,,
chr13:32332465:TAC>G,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32330993:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32341000:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32330978:A>T,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,
chr17:43082464:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),,,,0.0001039585,
chr13:32316487:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,benign
chr17:43095590:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0015,0.0029,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00239617,benign
chr17:43092068:A>CT,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093268:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32339169:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-149),,,,
chr17:43072517:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32329493:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,8/26,1,,,,,1,,pathogenic
chr13:32354836:CTT>C,,,,,,,,0.0122|0.0|0.0081,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43080091:T>C,,,,,,,,,,0.0,0.0,0.0,0.0109,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00219649,
chr17:43092283:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336984:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-087),,1,,
chr13:32398233:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.227|0.0769,None,,,,,,,,African American|Latina,Syn,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,7.413e-05,
chr13:32355049:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-12),benign(0-081),,,,
chr17:43082407:T>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1,,pathogenic
chr13:32338466:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32370482:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,,8.237e-06,
chr17:43093035:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32336984:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43109867:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32339378:AAAC>T,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.244e-06,
chr17:43093268:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43095900:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr13:32339699:TT>C,,,,,,,,,,,,,,,,,-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32339485:TCACA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43092968:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43051316:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43067387:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43071125:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1,,
chr17:43045757:CG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43093313:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092131:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,-|?,-|?,-|3/1658,,,,,,,,,Danish|-,,Not Specified|Western European|-|Caucasian|Western Europe|None-Specified|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093313:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092342:GG>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43049111:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr13:32394839:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(1),benign(0),,1,,
chr13:32336667:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094473:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,,,Not Specified|-,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092271:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32357531:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32337315:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000741,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,0.0116|1.0667|0.3695,possibly-damaging:0.744,0.0,0.0076,0.0,0.0,0.0,Latin American/Caribbean|African American|-,,"| Native American""""| Latin American/Caribbean""""|Western European|-| Native Americ|""""African|African| African|African American|""""Western European| Jamaican (Africian) Scottish""""|None Specified|Trinidad",M,1 - Not pathogenic or of no clinical significance,,0.001,4.97,7e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,benign(0-373),,1,0.001443255,benign
chr17:43070931:ATAGTGGCAGGGCTGGGGGA>T,,,,,,,,,,,,,,,Central/Eastern Europe|Not Specified|-|American|Western Europe|Italian,2|-,Central/Eastern European|Not Specified|Western European|-|Italian/Irish/German|-Central/Eastern-Europe|Ashkenazi|Western-European|Western Europe|Central/Eastern-European|Caucasian|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,8.236e-06,
chr17:43091823:TGT>A,,,,,,1/1658,,,,,,,,,,,None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43091733:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.000199681,
chr13:32398251:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32338090:TA>G,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43095316:G>A,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00199681,
chr17:43111831:G>A,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00119808,
chr13:32338368:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32371067:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-917),,1,,
chr17:43074305:T>C,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357881:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr13:32339745:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-177),,1&1,,
chr17:43106524:C>T,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr13:32396903:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32352517:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.02846 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32332691:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,,,
chr17:43099762:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,8.237e-06,
chr13:32355271:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-016),,1,,benign
chr17:43092667:G>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32379759:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.238e-06,
chr13:32337970:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.236e-06,
chr17:43093408:C>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,-|evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,Western European|-|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,7.413e-05,
chr13:32338417:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093687:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32380085:A>T,,,Unknown|Germline (inherited),,,1/1658|-,FA FANCD1_00005|-,,,,,,,,,,Not Specified|Western European|Western Europe|None Specified|Native American,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1&0,,
chr17:43067716:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr17:43097236:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/21,-1,1.0,,,,,,benign
chr17:43044804:CCCCCG>CT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.02,
chr17:43093513:CT>T,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338674:T>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-234),,1,8.246e-06,
chr13:32363305:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,
chr13:32380085:A>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&0,,
chr13:32325140:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr13:32338671:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-013),,1,0.0001080855,
chr17:43074350:A>C,,,,,,,,,,,,,,,-|Hong Kong,,Western-European|Chinese,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,
chr13:32340921:A>AA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092171:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32371038:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-2),benign(0-058),,,8.236e-06,
chr17:43066598:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32351120:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06469 (Asian)| 0.3191 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2723,0.2176,0.0714,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.183706,benign
chr17:43088733:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0086,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0157748,benign
chr13:32339380:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,8.244e-06,
chr13:32340816:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-001),,1,,
chr13:32398663:G>T,,,,,,,,,,,,,,,China,,Chinese,N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,1.647e-05,
chr13:32341207:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr17:43078973:C>G,,,,,,,,,,0.3638,0.7398,0.4092,0.371,0.5286,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.502995,
chr13:32363261:A>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-977),,1,,
chr13:32371016:GAAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-977),,1,,pathogenic
chr13:32356602:C>G,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-967),,1,,
chr13:32332725:A>G,,,,,,,,,,,,,,,,,Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-029),,1,,
chr13:32394815:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-09),benign(0-124),,1,8.236e-06,
chr13:32379793:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr17:43094005:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339745:C>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091014:G>T,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,-|Ashkenazi,,-|White|Central/Eastern-European|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,
chr13:32340841:ACAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,pathogenic
chr13:32332680:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32394707:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),probably_damaging(0-999),,1,8.237e-06,
chr17:43053909:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000599042,
chr17:43106524:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32363456:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-96),,1,,
chr17:43124001:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.118e-05,
chr17:43113790:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32394707:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Latin American/Caribbean|Western European|Western Europe|-|None Specified,M,2 - Likely not pathogenic or of little clinical significance,1.023,1.2883,0.00457,0.025,0.81,0.81,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),probably_damaging(1),,1,6.59e-05,
chr17:43091018:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32378007:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43093010:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000229,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.314|0.0908|0.2384,possibly-damaging:0.715|None|None|possibly-damaging:0.715|possibly-damaging:0.715,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr17:43094766:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0116|0.3177|0.1153,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32340327:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-209),,1,,
chr13:32337034:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32336645:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-3),0&1&1,1&1&1,,
chr17:43091688:ATA>C,,,,,,,,,,,,,,,French,2,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338004:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32354836:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43092540:T>ATT,,,,,,,,,,,,,,,Dutch?|-|Dutch,5|-,Western-European|Western European|-|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32380006:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,,,,
chr13:32338277:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,pathogenic
chr13:32340789:C>G,,,,,,,,,,,,,,,Not Specified|-,,-|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-034),,1&1,8.239e-06,
chr17:43057153:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,IVS,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,0.000324231,
chr13:32341199:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,11/26,1,,,,,1,,
chr13:32336883:A>T,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-108),0&1&1,1&1&1,,
chr13:32336369:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-037),,1,,
chr13:32337458:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,2/1658,,,,,,,,,Not Specified|-,,Western Europe|-|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43091960:ACG>T,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43088125:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43063879:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0-02),probably_damaging(0-989),,1,,
chr13:32389008:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43091990:G>T,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,0.0,0.0015,0.0,0.0,0.0,,,-|Central/Eastern European|Central/Eastern Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0002449805,
chr17:43063879:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-998),,1,,
chr13:32336735:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43057153:G>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,
chr17:43076593:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,pathogenic
chr13:32340486:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-23),,1&1,,
chr13:32326614:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,7/26,1,,,,,1&1&0,,pathogenic
chr13:32326108:GTT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,7/26,1,,,,,1&1&0,,
chr17:43076593:C>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43093567:C>A,,,,,,,,,,,,,,,American,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43072249:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32345245:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr13:32395948:TTTAG>TTTTCTTTC,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.096,
chr13:32363381:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-1),probably_damaging(0-925),,1,,
chr13:32347169:T>A,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0738818,
chr17:43050473:G>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000998403,
chr17:43094580:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,benign
chr13:32324497:C>A,,,,,,,,,,0.0,0.025,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00698882,
chr13:32376724:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32337312:C>G,,,,,,,,,,,,,,,,,Not Specified|Western European|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-098),,1,8.238e-06,
chr13:32334137:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43092669:T>C,,Ambry_Genetics|Invitae,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001163155,benign
chr17:43092842:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32338750:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.0001039595,
chr17:43049139:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/23,,-1,,,,,,,benign
chr17:43124016:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr17:43124016:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr17:43049053:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr17:43063936:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-997),,1,,
chr13:32337956:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43124016:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32399065:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0081869,benign
chr13:32357749:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0),1&1,1&1,,
chr13:32379723:G>T,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43104968:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted deleterious|-,mRNA analysis (RT-PCR)|-,,,,,,,,,,Not Specified|-|Western/Central/Eastern Europe|Malaysian|German|Dutch|Western Europe|Russian/German/Italian,," Ashkenazi|Chinese|Not Specified|Western European|-| Japanese""""|None-Specified|North Europe| Asian|Western-European|Western Europe|Caucasian|None Specified|""""Western European",IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr13:32372801:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32340531:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),possibly_damaging(0-814),,1,,
chr13:32316406:TTTG>G,,,,,,,,,,,,,,,Italy (both sides)|-|Italian,,Western European|Caucasian|None Specified,IVS,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32323709:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32357749:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(1),benign(0),1&1,1&1,,
chr13:32362621:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,,,1&1,1&1,,
chr17:43048322:A>G,,,,,,,,,,0.005,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.00119808,
chr13:32371105:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,,8.237e-06,
chr13:32336933:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-203),,,,
chr13:32339261:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),benign(0-044),,1,,
chr13:32398886:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43094170:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340235:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32339697:A>G,,,,,,,,,,,,,,,African American,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-085),,1,1.647e-05,
chr17:43094627:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-085),,1,,pathogenic
chr13:32338157:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-584),,,2.472e-05,
chr17:43093429:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-584),,,,pathogenic
chr17:43088875:T>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00159744,
chr13:32323188:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32340593:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32346832:A>C,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,,,,,,,,,,,Western Europe|-,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,tolerated(0-14),benign(0-02),,1,8.239e-05,
chr13:32394797:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,,,
chr13:32346832:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,tolerated(0-35),benign(0-034),,1,,
chr17:43050800:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32339087:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),possibly_damaging(0-462),,1,,
chr13:32338163:GTT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),possibly_damaging(0-462),,1,,
chr13:32356610:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1&1,,
chr13:32319210:GG>G,,,,,,,,,,,,,,,-|Italian,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32341011:ATCAA>C,,,,,,,,,,,,,,,British,,Eglish (paternal) and Polish (maternal)|English/Polish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339259:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32354879:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094174:TC>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32339979:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-253),,1&1,8.237e-06,
chr13:32337846:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-188),,,8.236e-06,
chr17:43067728:G>A,,,,,,,,0.0349|0.0|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,2.471e-05,
chr13:32336576:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,0&1&1,1&1&1,,
chr17:43067647:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,0&1&1,1&1&1,,pathogenic
chr17:43093496:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,Not Specified|Western Europe|-|American,,"Central/Eastern Europe| Central/Eastern European""""|Western European|-|Western-European|Western Europe|None-Specified|None Specified|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094688:->CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32394749:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr17:43044346:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340624:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-138),,1,,
chr17:43094170:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,0.0|0.0227|0.0077,benign:0.041|None|None|benign:0.041|benign:0.041,,,,,,,,African American,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,8.237e-06,
chr13:32340746:C>AT,,,,,,,,,,,,,,,,,-|Ukranian/British,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43045652:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43092626:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43097356:TT>T,,,,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,,
chr13:32316450:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02236 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|1.7022|0.5843,None,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32362612:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-997),,,,
chr17:43091960:AC>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32364385:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32337996:T>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43051077:T>A,,,In vitro (cloned),uncertain,transcription activation/PS/BA/BS,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,tolerated(0-13),possibly_damaging(0-734),,1,,
chr13:32376686:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr17:43091874:C>G,,CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral|inconclusive,evolutionary conservation analysis,,,0.0116|0.0|0.0077,probably-damaging:0.995|None|None|probably-damaging:0.995|probably-damaging:0.995,,,,,,,,Western European|-|None-Specified| Central/Eastern Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,2.471e-05,
chr13:32322589:T>A,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00179712,
chr13:32366257:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0265,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0081869,benign
chr13:32330958:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,,,
chr13:32319155:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32316416:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr17:43099761:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr17:43093325:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32380043:A>T,,,In vitro (cloned)|Unknown,as wildtype control|predicted deleterious|-|as variant control,Multifactorial likelihood-ratio model|Multifactorial likelihood model|Structure-based prediction (crystallography etc)|-|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|family history|Cell viability (in BRCA-/- cells)|Co-segregation in families,-|3/1658,,,,,,,,,,,Latin American/Caribbean| Central/Eastern Europe|Western European| Dutch|Asian|None Specified,M,5 - Definitely pathogenic,3981.0,1.48,1.62,1.0,0.81,0.81,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,8.236e-06,
chr13:32398403:A>G,,,,,,,,,,,,,,,,,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332778:AAAAG>A,,,,,,,,0.0|0.0705|0.024,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43092492:TTC>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43123011:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32329527:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,8.26e-06,
chr17:43091093:C>T,,,,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363487:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-981),,1&1,,
chr17:43071521:C>GAATGTTCACTGTAACAATGCTTGT,,,,,,,,,,0.3598,0.2209,0.3746,0.372,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.354633,
chr17:43092284:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr17:43093798:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43099103:G>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000798722,
chr13:32349267:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339421:CA>C,,,,,,,,0.1703|0.4044|0.2495,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1&0,1&1&0,,
chr17:43120426:G>T,,,,,,,,,,0.007,0.0,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00199681,
chr17:43067605:A>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Dutch,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,
chr13:32339485:TGTA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr17:43070395:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43091432:T>C,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094023:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.993|None|None|probably-damaging:0.993|probably-damaging:0.993,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32334867:T>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32336490:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-26),,1,,
chr13:32394726:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32340461:ACATTG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32394726:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32370391:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,1.647e-05,
chr13:32354799:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,1&1,,
chr13:32396932:A>AG,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32380142:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43092318:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32379528:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43095870:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32336677:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43093141:TC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43063870:A>TA,,,,,,,,,,,,,,,Austria,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,
chr13:32337605:A>G,,,,,,,,0.0|0.0227|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,,
chr17:43053829:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43092643:GG>G,,,,,,1/1658,,,,,,,,,,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339880:AC>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051871:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32394867:GT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32379822:TT>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32333243:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-961),,1&1,,
chr13:32319355:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,4.949e-05,
chr17:43065110:A>G,,,,,,,,,,0.001,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000798722,
chr17:43124026:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338055:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-869),,1,,
chr13:32337936:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|Western Europe|-,,Western European|Western Europe|-,M,1 - Not pathogenic or of no clinical significance,0.05754,1.41254,0.0389,6e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-236),,1,9.884e-05,
chr17:43093614:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43106465:T>C,,,,,,,,,,,,,,,,,"""""Western European| English/German""""",M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr13:32339249:T>C,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-029),,1&1,,
chr17:43062512:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32357830:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),possibly_damaging(0-88),,1,,
chr13:32340341:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-985),,1,,
chr13:32372082:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32339636:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43100671:TC>T,,,,,,,,,,0.003,0.0015,0.0014,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.00159744,
chr13:32339217:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-022),,1,,
chr13:32376791:T>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,Syn,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32338293:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-011),,1,,
chr13:32340341:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-682),,1,,
chr13:32340029:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-049),,,,
chr13:32339862:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-196),,1,,
chr13:32378030:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32337085:GA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43111549:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2317 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340363:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-009),,1,,
chr13:32336781:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340466:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-023),,,,
chr13:32340191:T>TA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43092941:T>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340321:T>CA,,,,,,,,,,,,,,,Malaysian,,Malay,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094139:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1&1,0.0002326255,benign
chr13:32376666:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,
chr17:43104104:GAA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,benign
chr13:32333395:TG>-,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,benign
chr17:43047728:G>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr13:32332396:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,1.648e-05,benign
chr13:32357885:GGGT>CTT,,,Unknown|Germline (inherited),,,2/1658|-,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr13:32333094:AG>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32337008:GACA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43090737:->GTGCGC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093666:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000212,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.871|None|None|possibly-damaging:0.871|possibly-damaging:0.871,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr13:32340256:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,0.0001451405,
chr13:32337625:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32339508:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-32),benign(0-098),,1,,
chr17:43057137:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1&1,,pathogenic
chr17:43094237:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr17:43071138:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-006),,1,,
chr17:43093988:T>A,,,,,,,,,,,,,,,,,,M,,,,,,,,stop_gained,MODIFIER,,,-1,,,,1&1,1&1,,
chr17:43092689:CCG>C,,,,,,,,,,,,,,,,,Western-European|Central/Eastern European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43107309:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32325137:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr17:43082471:G>AG,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr13:32333303:A>G,,,,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-027),,1,8.241e-06,
chr13:32333343:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),possibly_damaging(0-549),,1,,
chr17:43125443:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.001,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.00519169,benign
chr13:32363280:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-917),,1,,
chr17:43074331:T>G,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43092200:CCA>G,,,,,,,,,,,,,,,-|Spanish,,Western Europe|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32370433:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32339787:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-089),,,,
chr13:32370433:G>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr17:43091792:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000251,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,benign:0.154|None|None|benign:0.154|benign:0.154,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr13:32355264:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-45),,,1,,
chr13:32346833:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-864),,1,,
chr13:32326502:A>T,,,In vitro (cloned)|Unknown,major exon skipping|-,splicing reporter minigene| patient RNA analysis|-,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32319080:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32346895:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,
chr17:43118827:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43108484:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43061731:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| 0.1715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.172,0.0151,0.2262,0.001,0.0542,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0806709,benign
chr17:43047725:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr13:32338832:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32346895:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-15),benign(0-082),0&1&1,1&1&1,,benign
chr13:32339820:C>AT,,,,,,,,,,,,,,,,2,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43094423:CAT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32337109:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32356297:A>T,,,,,,,,,,0.001,0.0212,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.00599042,
chr17:43099859:T>C,,,In vitro (cloned),predicted neutral,co-occurrence with deleterious variant|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,Western-European|Western European|-Native-American|None-Specified|-Centr,M,1 - Not pathogenic or of no clinical significance,1.0,0.00355,0.537,4e-05,0.02,0.02,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1&1,,
chr13:32341140:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,"Western European|""""Ireland| Germany""""",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-7),benign(0-005),,1,,
chr13:32371055:T>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,20/27,,1,,,,,,,
chr17:43099847:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,,
chr17:43045810:AGG>C,,,,,,,,,,,,,,,,,Western-European|African,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,,8.236e-05,
chr13:32339555:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43054524:A>T,,,,,,,,,,0.001,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32346818:TCTAT>G,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,12/26,1,,,,,,,
chr17:43049187:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/23,,-1,,,,,,8.236e-06,
chr13:32337945:A>AA,,Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32372453:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32337035:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,Not Specified|-|Ashkenazi,,Western European|Western Europe|-|Native American/African American|None Specified,M,1 - Not pathogenic or of no clinical significance,0.03311,0.09772,0.12589,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(1),,,1,4.119e-05,
chr17:43091773:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32326255:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,6/27,,1,,,,,1,,pathogenic
chr13:32336314:C>G,,,,,,,,,,,,,,,German,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43092793:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32338066:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32332752:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),benign(0-027),,,8.238e-06,
chr17:43093324:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43056991:C>GAAAGTATTCAAC,,,In vitro (cloned),as wildtype control|?,mRNA analysis (RT-PCR)|?,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32338066:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr13:32391713:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43104283:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,8.238e-06,
chr13:32340454:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-036),,1,,
chr13:32357901:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43091687:TATA>C,,,,,,,,,,,,,,,French,2,,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43049140:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,21/23,,-1,,,,,1,,
chr17:43092848:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092491:G>A,,,,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43082676:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr13:32388868:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43067606:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1,,pathogenic
chr17:43047896:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1362 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr13:32355136:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43045749:C>G,,,In vitro (cloned),strong functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,"Western European| French Canadian""""|""""Western European",M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-988),,1&1&1,,
chr17:43074861:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094888:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000104005,
chr13:32336248:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr13:32340014:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-03),,,,
chr13:32330949:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.237e-06,
chr13:32362606:AA>AAAA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr17:43091488:TTA>C,,,,,,,,,,,,,,,,, Central/Eastern Europe|Not Specified|Western European|African|Western-European|Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32398802:G>A,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32363198:G>T,,,,,,,,,,,,,,,German,,Caucasian,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1,,
chr13:32337056:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32326468:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.237e-06,
chr13:32396117:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.59e-05,
chr13:32336944:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,African American|African,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1&1,0.0001121955,
chr13:32335206:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32363432:AAAGT>A,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32363519:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,probably-damaging:0.994,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-923),,1&1,,
chr13:32338103:C>T,,,,,,,,,,,,,,,Dutch?,,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32396969:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43056719:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32337167:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),,,0&1,8.237e-06,
chr17:43094151:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093558:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43099472:C>G,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000399361,
chr13:32337203:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),,,,1.647e-05,
chr13:32326516:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr13:32387788:G>T,,,,,,,,,,0.0,0.0,0.0101,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr13:32379837:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32342769:A>T,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000399361,
chr17:43093362:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,0&1,8.237e-06,
chr13:32332406:ACT>T,,,,,,,,,,,,,,,,,Western European| Italian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43091746:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43106451:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,,,
chr13:32340306:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(1),,,8.237e-06,
chr17:43094132:C>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32336943:AG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1&1,8.238e-06,
chr13:32339306:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-106),,,8.238e-06,
chr13:32340868:T>C,,,Germline (inherited),,,,,,,0.999,0.9024,0.9971,1.0,1.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,0.983321,
chr17:43061629:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32333051:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,
chr13:32339518:TCA>C,,,,,,,,,,,,,,,,1|-,-|Asian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32394881:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious|inconclusive,Protein likelihood ratio model|Co-localization to predicted ESEs,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32376693:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr17:43071030:G>A,,,,,,,,,,,,,,,,,African,M,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,
chr13:32397006:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339040:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-187),,,0.000203799,
chr13:32347011:C>TTTTATAAAA,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0738818,
chr13:32393329:T>G,,,,,,,,,,0.5159,0.5113,0.536,0.5337,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511781,
chr13:32340868:T>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0002285155,
chr13:32339850:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-099),,1,0.0001121955,
chr13:32375391:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,7.196e-05,
chr17:43070082:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr17:43093449:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,469/1658|-,,,,0.3002,0.2103,0.353,0.371,0.4969,German|Malaysian|Spanish|-|Austria|Greek|American|U.S.A.,14|-|1|0|2|412,Greek|-|Malay|Chinese|Caucasian,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,0.342231,
chr17:43091485:A>C,,,In vitro (cloned),no LOH,LOH analysis,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43082460:G>CT,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,8.236e-06,
chr17:43095587:GGGAA>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr13:32339450:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-043),,1,,
chr13:32379399:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32325206:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43084221:C>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32332082:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000199681,
chr13:32340799:T>TT,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340992:TC>T,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,0&1&1,,
chr17:43063399:A>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,
chr13:32339228:TAA>G,,,,,,1/1658,,,,,,,,,Not Specified|-,,Western European|Scottish/German|-|Caucasian|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340686:AGG>A,,,,,,,,,,,,,,,,,Western European|Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063946:T>A,,,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control,mRNA analysis (RT-PCR)|Assessment of ESS|-|evolutionary conservation analysis,,,,,,,,,,,1|-,"German/Swiss|Western European|-|""""Asian|-Central/Eastern-Europe| Korean""""|Western-European|Western Europe|None Specified",N,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1&1&1,,
chr17:43099876:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,5.765e-05,
chr13:32398737:GT>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32336632:TAGCCC>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32375786:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43093028:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32331652:TTCTC>A,,,,,,,,,,0.004,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00119808,
chr13:32397098:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319174:CAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340702:A>G,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|_NHGRI,,,,,,0.0465|0.9532|0.3538,possibly-damaging:0.93,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-613),0&0&1,1&1&1,,
chr13:32339555:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-147),,,,
chr13:32331861:T>G,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0736821,
chr13:32340896:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.238e-06,
chr13:32368937:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32337832:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338533:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-124),0&1&1,1&1&1,,
chr17:43063366:G>C,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,,,
chr13:32340571:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32354893:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),probably_damaging(0-986),,1&1,,
chr13:32339967:C>A,,,In vitro (cloned),,,,,,,0.0,0.0008,0.0,0.0,0.0,Latin American/Caribbean|-,,-|Native American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-72),benign(0-003),,1,0.0001204355,
chr13:32381694:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43093368:AAATTCTTT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43092180:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32337537:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43097127:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr17:43071080:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32339826:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-196),,1&1&1,,
chr17:43092142:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Western Europe|-,,German|Western Europe|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32337654:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.993,0.0,0.0,0.0014,0.0,0.0,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,0.0001080805,
chr17:43049181:C>T,,Ambry_Genetics|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr17:43091690:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1,1&1&1,,pathogenic
chr13:32376645:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.237e-06,
chr13:32370848:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.00259585,benign
chr13:32340571:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,pathogenic
chr13:32337422:AACAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,pathogenic
chr13:32338819:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-003),,1,,
chr13:32336611:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,2.471e-05,benign
chr17:43082541:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1&1,8.236e-06,
chr13:32316561:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.246e-06,
chr13:32357776:GAACT>A,,,,,,,,,,,,,,,Polish,,Polish (Wielkopolska Region),F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr13:32370401:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/26,1,,,,,1&1,,pathogenic
chr17:43093103:T>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000000233,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082541:A>G,,,In vitro (cloned),predicted deleterious|as variant control,Transcription activation in yeast (GAL4-fusions)|evolutionary conservation analysis,,,,,,,,,,Western Europe/Ashkenazi,,,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1&1,,
chr17:43118218:C>A,,,,,,,,,,0.0,0.0915,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0241613,
chr13:32381645:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43064696:G>A,,,,,,,,,,0.0,0.0,0.0,0.0377,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0081869,
chr13:32340280:A>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32337792:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),,,1,8.236e-06,
chr13:32340078:TA>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43098444:C>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000599042,
chr17:43060321:G>C,,,,,,,,,,0.3598,0.2179,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.342652,
chr13:32398717:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32393659:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32372668:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.04268 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32338543:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43049126:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,benign(0-001),,1,,
chr17:43091772:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332534:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,,,
chr17:43071218:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-056),,1,,
chr17:43082440:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32357857:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43091673:A>G,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32336961:G>T,,,,,,1/1658,,,,,,,,,,,None Specified,M,3 - Uncertain,9.43,1.156,,0.1037,0.02,0.02,stop_lost,HIGH,11/27,,1,,,,,1,,
chr17:43082500:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32338160:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-096),,,8.24e-06,
chr13:32363365:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr13:32340456:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&0&1&1,1&1&1&1,,
chr17:43091272:TT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32317275:T>G,,,,,,,,,,0.005,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000998403,
chr13:32330932:AT>A,,,,,,,,,,,,,,,,,Western European|-|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32341030:T>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,7.413e-05,
chr17:43119403:GA>T,,,,,,,,,,0.001,0.0053,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00199681,
chr13:32331007:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43099760:TG>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Splicing reporter minigene|-,,,,,,,,,,Austria,1|0,,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.0001235,
chr17:43091669:ATAAT>C,,,,,,,,,,,,,,,Singaporean|China|-,,-|Chinese,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339462:A>T,,,,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32340592:AG>G,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398156:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363217:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-928),,,0.0001039585,
chr13:32338249:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338416:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-|Ashkenazi,,Western European|-|Ashkenazi|None Specified|White-NonHispanic,M,1 - Not pathogenic or of no clinical significance,0.02754,1.86209,0.07586,8e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-466),0&0&1&1,1&1&1&1,0.0001236,
chr13:32332309:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-576),,1&1,,
chr13:32339462:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),probably_damaging(0-996),,1&1,,
chr13:32356559:CT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),probably_damaging(0-996),,1&1,,pathogenic
chr13:32367486:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43065024:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43104878:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32341046:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-991),,1,8.236e-06,
chr13:32394785:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,0.0,0.0008,0.0,0.0,0.0,African American|-,,-|None Specified,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-73),benign(0-011),,1&1,0.0001163155,
chr13:32390265:A>T,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00379393,
chr17:43125083:G>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000998403,
chr17:43082378:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.236e-06,
chr17:43093084:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.009|None|None|benign:0.009|benign:0.009,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336291:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-108),,1,,
chr13:32357804:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr13:32370491:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43045788:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0-04),possibly_damaging(0-798),,,,
chr13:32332771:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32376673:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,1,,pathogenic
chr17:43088781:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43082533:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0-02),,,1&1,,
chr17:43049685:G>T,,,,,,,,,,0.3569,0.1589,0.2839,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.32508,
chr13:32333108:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-49),benign(0-004),,1,,
chr13:32375412:GG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,7.194e-05,
chr13:32340108:C>G,,,,,,,,,,,,,,,,,Western European|-|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-036),,1,3.295e-05,
chr17:43091905:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-036),,1,,pathogenic
chr17:43111683:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr13:32338901:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-253),,,,
chr17:43082594:T>A,,,,,,,,,,,,,,,,,Western Europe|None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,1,8.236e-06,
chr17:43093471:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43051071:T>C,,,In vitro (cloned),predicted no impact on protein function|as wildtype control|predicted no effect on protein function|strong functional effect|predicted neutral|inconclusive|as variant control|predicted deleterious|mildly destabilizing|?,Clonogenic assay|Homologous recombination in yeast|structure-based prediction (crystallography etc) BRCA1-CtIP|Homology directed recombination|transcription activation/PS/BA/BS|Thermostability assay|Microsatellite analysis|Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|Random plasmid integration assay|evolutionary conservation analysis|peptide binding ability BRCA1:BACH1|Recombination rate|Transcription activation in human cells|Structure-based prediction (crystallography etc)|Far Western BRCA1/Cterm-BACH1|Proliferation in yeast|Proteolytic degradation|co-immunoprecipitation BRCA1-ER|?|Thermodynamic stability prediction|Nuclear foci formation|Gel filtration chromatography,,,,,,,,,,Latin American/Caribbean|African American|-,,Western European|-Native-American|-|Native American|African|Western-European|African American|-Caribbean|Latin-American/Caribbean|None Specified,M,5 - Definitely pathogenic,229.0,,,0.9978,0.66,0.66,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-908),,1&1&1,,
chr13:32325188:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/26,1,,,,,1,1.648e-05,
chr13:32340206:AGTT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/26,1,,,,,1,,pathogenic
chr17:43093236:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339486:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-121),,1&1&1,,
chr13:32340118:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32319283:G>CA,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1,,
chr13:32388542:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1084 (Asian)| 0.04065 (African)| 0.05277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43076025:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0014,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00139776,benign
chr13:32363197:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,,,,,2.471e-05,
chr13:32337275:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-043),,1,,
chr17:43092275:G>AT,,,,,,,,,,,,,,,Italian,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43100586:AT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32363204:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-07),probably_damaging(0-928),,1&1,3.295e-05,
chr17:43092995:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339744:GT>G,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32369699:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0139,0.0008,0.1009,0.0,0.0153,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0199681,benign
chr13:32319070:T>TT,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/26,1,,,,,1,,benign
chr13:32356546:T>GC,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43104879:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,deleterious(0),,,1,,
chr13:32332315:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),probably_damaging(0-922),,1,,
chr13:32326500:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),probably_damaging(0-922),,1,,pathogenic
chr17:43044394:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43104879:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,deleterious(0-04),,,1,,
chr13:32338686:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-169),,1,,
chr13:32356501:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr13:32355152:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,8.237e-06,
chr13:32353468:TA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.38 (Asian)| 0.17 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,,benign
chr17:43052761:G>C,,,,,,,,,,0.0,0.0378,0.0086,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0117812,
chr13:32376794:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr17:43063331:GG>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,,,
chr17:43093075:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.000103959,
chr17:43092327:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32323775:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32394707:ATTT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32340798:A>CT,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32394315:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339971:AGTAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32346859:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(0-963),,,8.238e-06,
chr17:43079334:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001858405,
chr13:32379730:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32370436:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-03),benign(0-178),0&1,1&1,,
chr13:32314943:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.14 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32337315:AG>A,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43091937:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32370430:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,-| -,Not Specified|-,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-07),possibly_damaging(0-696),0&1&1&1&1,1&1&1&1&1,3.295e-05,
chr17:43093459:AA>C,,,,,,2/1658|-|3/1658,,,,,,,,,Western Europe/Native American/Central-E|Western Europe|-|British,,GERMAN|Western European|-|English/Irish/Welsh|English|Western-European|Western Europe|Caucasian|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32326500:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1,,
chr13:32322585:A>T,,,,,,,,,,0.0348,0.0325,0.0922,0.0972,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0738818,
chr13:32332537:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32349216:ATCCCAAAACAT>C,,,,,,,,,,0.8101,0.6528,0.8012,0.8938,0.8211,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.786342,
chr17:43092128:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.647e-05,
chr13:32332738:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,8.238e-06,
chr17:43092128:C>A,,,,,,-|1/1658,,,,,,,,,-|Italian,,Western-European|Western Europe|-Central/Eastern-Europe|None-Specified|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,8.236e-06,
chr17:43071229:C>A,,,,,,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-076),,1&1,,
chr17:43072931:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43044391:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3339 (Asian)| 0.2114 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,46/1658,,,,0.3588,0.2179,0.2911,0.373,0.498,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.333126,benign
chr13:32336948:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,4.942e-05,
chr13:32369642:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32379850:TC>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43106517:TG>G,,,,,,,,,,,,,,,Malaysian,,Indian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32357590:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32370543:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-02),benign(0-407),,1,,
chr13:32316419:GTG>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr17:43094003:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32321936:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0234,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0061901,benign
chr13:32397288:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.911 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9145,0.9971,1.0,1.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.976837,benign
chr13:32346835:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-886),0&1&1,0&1&1,8.238e-06,
chr13:32338492:GATTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-886),0&1&1,0&1&1,,pathogenic
chr17:43076884:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr13:32356575:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-75),benign(0-04),,1,,
chr13:32363269:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-75),benign(0-04),,1,,pathogenic
chr17:43071171:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1,,benign
chr13:32325169:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1,,pathogenic
chr13:32333768:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43099829:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr17:43067646:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,,possibly_damaging(0-711),,0&1,,
chr17:43090942:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43071023:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),possibly_damaging(0-77),,,,
chr17:43057093:TCC>GCC,,,In vitro (cloned),as wildtype control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,,,,,
chr17:43045945:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32394955:A>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,,
chr17:43077946:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43093601:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32337177:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-043),,1,,
chr13:32325696:A>G,,,,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0061901,
chr13:32340722:AA>G,,,,,,,,,,,,,,,Not Specified|-,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43100158:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr13:32370434:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,
chr13:32337521:CCTGGA>CAG,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32339963:TTG>TAG,,,Unknown|Germline (inherited),,,,FA FANCD1_00024|-,,,,,,,,Western Europe|-|Austria,0|-,Western European|-,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32338255:GACTAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43079074:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32339355:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341669:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.02642 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0738818,benign
chr17:43061743:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43092552:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43093422:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.4768|0.1692,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32330967:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1&1,,
chr17:43099853:C>G,,,,,,,,,,,,,,,,," Ukranian""""|""""Central/Eastern European|Central/Eastern European",M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,
chr17:43124230:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,93/1658,,,,0.3579,0.2171,0.379,0.371,0.498,,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.353634,
chr17:43093536:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32390979:C>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32336540:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-49),,,1,,
chr13:32354821:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32371315:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43093665:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,2.471e-05,
chr13:32348740:T>C,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00159744,
chr13:32356878:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32394897:TA>T,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1&1&1,,
chr13:32332656:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-156),,,8.241e-06,
chr13:32326147:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,0&1&1,0&1&1,8.24e-06,
chr17:43092419:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093665:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,Syn,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32344366:CT>C,,,,,,,,,,0.0,0.0204,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00559105,
chr13:32338052:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-953),,1,,
chr17:43053229:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32340016:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32348750:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43094795:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000531,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|0.0|0.0231,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1&1,,
chr13:32331004:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1&1,,pathogenic
chr13:32356430:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/27,,1,,,benign(0-256),,1,,
chr17:43096887:T>A,,,,,,,,,,0.0089,0.0015,0.0086,0.0,0.0174,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.00678914,
chr13:32363269:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43050180:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43097297:AT>A,,,,,,,,0.0|0.0469|0.016,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1&1,,
chr17:43093179:C>T,,Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339623:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.119e-05,benign
chr13:32339194:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32337772:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32326495:A>G,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0,0.0,0.0,0.0,,,Africa|African,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,1,1.2355e-05,
chr13:32367487:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32337305:C>GA,,,,,,,,,,,,,,,-|Dutch?,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32398546:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333396:GT>-,,GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32354986:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr17:43071021:T>G,,,,,,,,,,,,,,,Greek,,Greek,Syn,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,,,1,,
chr17:43104083:TTTCCTC>AAAG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.008787,
chr13:32340420:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32363351:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-12),benign(0-081),,1&1,8.236e-06,
chr13:32340027:C>T,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-267),,1,,
chr17:43114356:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43046757:G>CA,,,,,,,,,,0.3191,0.2133,0.2349,0.2649,0.4284,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.289936,
chr13:32363293:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,,,,1,4.118e-05,
chr13:32355172:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,Unknown|Germline (inherited),,,,,0.0|3.1094|1.0535,benign:0.002,0.0,0.0393,0.0,0.0,0.0,Latin American/Caribbean|African American|-|Western Europe,,Latin American/Caribbean| Latin American/Caribbean|Western Europe/Native American/African A|Not Specified|Western European|African|-|African American/Latin American/Caribbea| Native Americ| Jamaican|Spanish| African|African American|Africian/American|None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-27),,,1,0.0067197,
chr13:32333148:C>G,,,,,,,,,,,,,,,,,Western European|-,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1,,
chr13:32362716:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1,0.0001318,
chr13:32331135:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr13:32337281:TC>AT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,,1,,
chr13:32354990:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr13:32344539:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr13:32333932:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32362716:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,0.0001039585,
chr17:43115736:A>C,,,In vitro (cloned),predicted neutral|as wildtype control|no impact on protein function|predicted deleterious,protein binding ability BARD1|E3 Ub-ligase activity assay|Radiation sensitivity|E3 Ub-ligase activity assay BRCA1/RING-BARD1|Homology directed recombination|evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1&1,,
chr17:43076487:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,Western-European|-Western-European| East Indian|Asian| Asian,IVS,,,,,,,,splice_donor_variant,HIGH,,12/21,-1,,,,0&0&0&0&1,1&1&1&1&1,,pathogenic
chr13:32340353:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-924),,1,,
chr13:32339699:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-924),,1,,pathogenic
chr13:32330092:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr17:43064043:T>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr13:32315540:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32337953:CA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32378219:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32319159:TA>T,,,,,,,,,,,,,,,,,Western Europe|Irish/Native American/English,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1&1,,
chr17:43078696:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32326656:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,1.647e-05,
chr13:32340633:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-138),,,,
chr13:32338630:A>TA,,,,,,,,,,,,,,,,,Central-E. Europe/Irish|Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43065020:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32363268:AA>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,18/27,,1,,,,,,,
chr13:32316531:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,8.237e-06,
chr13:32379914:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32332654:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43104433:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000199681,
chr13:32319289:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,8.237e-06,
chr13:32364405:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32356385:T>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,1.648e-05,
chr13:32337786:A>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-096),,1,8.236e-06,
chr13:32379914:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr17:43109216:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32368935:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1259 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32318683:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.03252 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32386531:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32332343:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,3.6787|2.0209|3.1168,probably-damaging:0.991,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-05),benign(0-052),0&1,1&1,,
chr13:32398337:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338434:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-272),,1,,
chr13:32332343:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-022),0&1,1&1,,
chr17:43043694:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339627:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-004),,1,8.239e-06,
chr17:43126870:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32332368:TTTGTTTTTG>AGATACTTCAG,,,,,,,,,,,,,,,Scottish/Canadian|-,1|-,Western European|Western Europe|Caucasian|Unknown,F,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,
chr13:32355107:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43091540:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32339939:GTGA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32355031:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-52),benign(0-009),,1,,
chr13:32379929:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32374103:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32332739:TC>C,,,,,,,,,,,,,,,Western Europe|-,,Western European|Western Europe|-|None Specified|Native American,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,1.648e-05,
chr13:32336880:A>TA,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093316:AG>T,,,,,,,,,,,,,,,,,African,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32332638:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-56),benign(0-006),,,1.649e-05,
chr17:43094376:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,,,
chr13:32332638:T>G,,,,,,,,0.0|0.023|0.0077,possibly-damaging:0.543,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-311),,,,
chr13:32370492:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-998),,,,
chr13:32344637:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,0.0001080805,
chr13:32365148:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32350516:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32356539:AGA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,15/27,,1,,,,,,,
chr13:32358468:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32398701:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091335:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0001242,
chr13:32339546:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-029),,1,8.24e-06,
chr17:43104104:TG>AA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,2.471e-05,
chr13:32342160:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1853 (Asian)| 0.1972 (African)| 0.1755 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2008,0.1846,0.1527,0.1726,0.1196,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.168331,benign
chr17:43092380:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43049164:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32363312:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-942),,,8.236e-06,
chr13:32339912:TG>CT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-003),,1,,
chr13:32329587:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr13:32380034:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.236e-06,
chr17:43082510:C>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,,
chr13:32318074:TTTCCAC>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00179712,
chr13:32329463:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,8/27,,1,,,,,1,,pathogenic
chr13:32338929:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-926),,1,1.647e-05,
chr13:32385303:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32370983:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-944),,1,,
chr17:43049112:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr17:43091465:CCAT>G,,,,,,,,,,,,,,,-|Italian,,Western-European|Caucasian,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43049164:A>T,,,In vitro (cloned),predicted deleterious|inconclusive|uncertain|moderately destabilizing,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|Transcription activation in human cells|evolutionary conservation analysis|Thermodynamic stability prediction,,,,,,,,,,Not Specified|-,,Western European|-|Latin-American/Caribbean,M,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-887),0&0&0&1&1,1&1&1&1&1,8.236e-06,
chr17:43060810:T>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00119808,
chr17:43094707:CCACATGGCT>CCACATGGCTCCACATGGCT,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43114178:GGGTCATGGCTTAAAGGAGTCATCTGATCATGTCA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,
chr13:32374737:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43063869:T>G,,,In vitro (cloned)|Unknown,predicted deleterious|-,-|cDNA analysis,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,
chr17:43093454:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?,Allele frequency analysis in controls|-|Multifactorial likelihood-ratio model|?|evolutionary conservation analysis,136/1658|-,,,,0.0835,0.0113,0.0576,0.0,0.0297,German|Greek|Austria|-|Spanish,1|0|-,Greek|-|Caucasian,M,1 - Not pathogenic or of no clinical significance,,1.00000E-10,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,0.04527315,
chr13:32360320:G>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32339847:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-02),,1,8.236e-06,
chr13:32319272:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr17:43093173:AG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43057114:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-631),,1&1&1,,
chr17:43063415:C>T,,,,,,,,,,,,,,,German,1,,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr13:32337898:TTA>A,,,Unknown|Germline (inherited),,,1/238 patients|-|1/1658,,,,,,,,,,2|-,"Irish| French Canadian|German|Western European| English| Aboriginal| French Canadian`""""| German|French Canadian|Western Europe|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,3.295e-05,
chr13:32398337:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32338885:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,2.471e-05,
chr17:43083782:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4056 (Asian)| 0.07114 (African)| 0.3773 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3748,0.9486,0.4582,0.4435,0.5481,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.585463,benign
chr13:32336796:A>T,,,,,,,,,,,,,,,,,Not Specified|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-042),0&1&1,1&1&1,,
chr17:43093615:C>T,,,,,,1/1658,,,,,,,,,Austria|-,,Western-European|Western European|-|None-Specified|Central/Eastern European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32379795:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43123137:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32398283:AAGA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32326292:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,
chr13:32338673:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32336958:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124056:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,,
chr17:43076308:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,0.000199681,
chr17:43076473:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,8.237e-06,
chr13:32357797:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,pathogenic
chr13:32398541:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43071212:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-33),benign(0-003),,1,,
chr17:43095839:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral,co-occurrence with deleterious variant,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,
chr13:32337798:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-878),,1,,
chr13:32338355:TT>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-878),,1,,pathogenic
chr13:32394782:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-25),possibly_damaging(0-87),,1,,
chr13:32376646:TTTC>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,1.647e-05,
chr13:32375662:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0164,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00339457,
chr13:32385055:A>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32340999:ACTC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32354837:ATTGC>T,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43124000:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43094706:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32376668:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/26,1,,,,,1&1,,pathogenic
chr13:32341112:ATG>C,,,,,,,,,,,,,,,Not Specified|-,,-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32352243:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32340972:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-02),,,,
chr13:32379914:A>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,
chr17:43092937:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32316325:T>A,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr17:43092972:G>AT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32374518:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000599042,
chr13:32357716:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,9.887e-05,
chr13:32331035:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,9/26,1,,,,,,8.237e-06,
chr17:43067764:A>T,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,
chr17:43051076:G>GG,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,pathogenic
chr13:32316408:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32337943:AT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340618:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-962),,,8.237e-06,
chr13:32333124:C>AG,,,,,,,,,,,,,,,,,Central/Eastern European| Near Eastern,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32362547:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,,,benign
chr13:32357930:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,, Greek|Central/Eastern European|African,IVS,,,,,,,,splice_donor_variant,HIGH,,16/26,1,,,,0&1&1,1&1&1,8.236e-06,pathogenic
chr17:43099814:T>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1,8.236e-06,
chr17:43092923:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32362632:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32362632:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43092772:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,inconclusive|-,-|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,,,None Specified,M,1 - Not pathogenic or of no clinical significance,0.002,,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32348653:A>T,,,,,,,,,,0.006,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00159744,
chr13:32379754:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32337985:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32357930:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,16/26,1,,,,0&1&1,1&1&1,,
chr13:32333271:CCAGGA>C,,,,,,-|1/1658,,,,,,,,,Norwegian|Sweden|Italian|-|Brazilian,5|2|-,Western European|-|Caucasian|None Specified| Italy,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,0&1&1,1&1&1,,
chr13:32398283:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0681|0.0231,benign:0.046,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332861:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32340043:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32337513:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32336654:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-281),,,2.471e-05,
chr17:43074492:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr17:43103038:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000399361,
chr17:43092401:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000234,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094794:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr17:43071062:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-06),possibly_damaging(0-449),,,8.236e-06,
chr17:43093467:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43093969:GC>TA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32394089:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43067654:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,,,,,,
chr13:32336625:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),,,,8.237e-06,
chr13:32340717:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-275),,1&1,,benign
chr17:43082516:G>C,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,-|Belgian,,,Syn,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,3.295e-05,
chr13:32340455:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000571,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.5117|0.1816|0.3999,possibly-damaging:0.876,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-002),0&0&1,1&1&1,,
chr17:43076642:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,2.471e-05,
chr13:32363292:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European|Western Europe|Ashkenazi| German Danish,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-43),benign(0-001),,1,4.942e-05,
chr17:43126708:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339565:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-743),,1,,
chr13:32340959:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr17:43124031:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43063953:C>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1&1,,
chr17:43079885:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43102841:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43045758:GCCCCCTCGGCCGGG>C,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr13:32317661:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.281 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32354016:A>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00159744,
chr17:43099245:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000599042,
chr13:32333061:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-056),,,,
chr13:32356844:C>A,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.00139776,
chr13:32335478:A>C,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00678914,
chr13:32339360:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-233),,,1.649e-05,
chr13:32325094:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,,8.237e-06,
chr13:32355294:T>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,Western Europe/French Canadian|-,, Central/Eastern Europe|Western European|SIcily|-|Ethiopian|African|African American|None Specified|Near East/Mid East,IVS,2 - Likely not pathogenic or of little clinical significance,0.09,3.09,0.11,0.015,,0.34,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,1,0.0006392515,
chr17:43074465:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,,,
chr13:32337768:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria|-,1|-,Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,1,,
chr17:43047735:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,2.471e-05,
chr13:32379768:T>A,,,In vitro (cloned),predicted neutral|predicted deleterious|no evidence for aberrant splicing,Protein likelihood ratio model|splicing reporter minigene assay|Co-localization to predicted ESEs,,,,,,,,,,,," Irish & German""""|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,4.943e-05,
chr17:43074461:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.236e-06,
chr13:32325102:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32333172:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),benign(0-076),,1,,
chr13:32349323:G>AC,,,,,,,,,,0.003,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00179712,
chr17:43106457:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr13:32337288:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-085),,,8.238e-06,
chr13:32333071:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43071101:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,Syn,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,,,,0.0001451405,
chr13:32396907:TCTGA>A,,,,,,,,,,,,,,,,,Western European|Western Europe|-,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32329433:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43074461:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32339976:TTAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32337424:GTTG>AATT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32350875:C>G,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr17:43051055:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,,1.647e-05,
chr17:43071752:A>T,,,,,,,,,,0.004,0.0,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00139776,
chr13:32339451:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-043),,1,,
chr17:43094139:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337031:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-036),,1,,
chr13:32329433:T>G,,,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,0&1,,
chr17:43099816:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr13:32338533:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,8.238e-06,
chr17:43045963:GCCTGGGCAGCATAGGGAGATCCTGGCGTTGTGGC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr13:32372283:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43093514:T>A,,,,,,,,,,,,,,,African American,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr13:32357794:T>CAG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,0&1&1,0&1&1,8.236e-06,
chr13:32337464:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,HKSAR|-|Italian,,Chinese|Pakistani|Asian|Chinese |Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32337192:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-059),,1,,
chr17:43090936:ACCA>C,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,,,
chr17:43092245:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,8.236e-06,
chr17:43110340:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43051574:A>C,,,,,,,,,,0.3588,0.2194,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342851,
chr17:43104942:CTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32347267:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339481:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-476),,,,
chr13:32326281:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,6/27,,1,,,,,1,,
chr13:32330977:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr13:32371086:A>G,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32362543:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32326493:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,,8.236e-06,
chr13:32362543:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32336321:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-027),,1,8.237e-06,
chr17:43092534:GAA>TTA,,,,,,,,,,,,,,,Italian,,Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338402:A>TC,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338534:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,8.238e-06,
chr13:32332476:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092690:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32370976:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32370967:G>A,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,1,0.0001039585,benign
chr13:32341046:TG>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339948:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-012),,1,,
chr17:43093015:CA>T,,,,,,,,,,,,,,,,,Not Specified| German| Belgian|-Central/Eastern-Europe|Western European|Western-European|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43090946:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|-|?,-|evolutionary conservation analysis|?,14/238 patients|-|3/1658,,,,,,,,,German|Austrian|Western Europe|-|French,1|3|2|-|540,Not Specified|Western European|-|Caucasian|Western-European|Austrian|Western Europe|None-Specified|None Specified,N,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,1.0,,,,1&1,,
chr13:32337923:A>T,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Latin American/Caribbean|Western European|-|Ashkenazi|None Specified,M,1 - Not pathogenic or of no clinical significance,0.00759,0.06761,0.01023,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-54),0&1&1,1&1&1,0.0001071,
chr17:43091516:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32367304:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43109381:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43094429:C>A,,,,,,1/1658,,,,,,,,,Not Specified,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,
chr13:32379480:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,, Native American|Central/Eastern European|Not Specified|Western European| Dutch|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,4.118e-05,
chr17:43094097:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,pathogenic
chr17:43093743:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.237e-06,
chr17:43106527:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,0&1&1&1,1&1&1&1,8.24e-06,
chr13:32340830:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-007),0&1&1&1&1,1&1&1&1&1,,
chr13:32396909:ACT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-007),0&1&1&1&1,1&1&1&1&1,,
chr17:43092806:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338397:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-006),,,0.000103959,
chr17:43079417:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.541e-06,
chr17:43064722:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32369645:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01829 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32338613:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000102,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.5376|0.1153|0.3956,benign:0.03,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-063),0&0&0&0&1&1&1,1&1&1&1&1&1&1,,
chr13:32340830:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1&1&1,1&1&1&1&1,,pathogenic
chr17:43093154:AT>T,,,,,,,,,,,,,,,,,"""""Western European| Turkish""""",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32332731:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32329240:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32339190:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-001),,,1.648e-05,
chr13:32337477:C>A,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-036),,1,,
chr13:32356479:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-977),,1,,
chr13:32339291:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-977),,1,,pathogenic
chr13:32382146:T>A,,,,,,,,,,0.2734,0.2368,0.245,0.0714,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.196885,
chr13:32338613:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43091906:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43091935:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32384695:G>TAA,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr13:32326620:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,
chr17:43123561:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32340380:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43112271:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr13:32336581:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32376782:TTAC>TTACTTAC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,,,pathogenic
chr13:32340772:ATTCTCCTTCAGCAAAACAGAGACAAGAACATCTACCTGAT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32325156:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43092595:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43076588:C>T,,Emory_Genetics_Laboratory,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.894|possibly-damaging:0.894|possibly-damaging:0.894|possibly-damaging:0.894|possibly-damaging:0.894,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32378027:T>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr17:43093997:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32349062:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093997:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43088583:A>T,,,,,,,,,,0.0,0.0,0.0,0.0258,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00519169,
chr17:43097231:AAGGG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,1.647e-05,
chr13:32339575:TTTTTTG>A,,,,,,,,,,,,,,,Italian,,Caucasian,UV,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr13:32386366:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43045257:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.126 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,46/1658,,,,0.3569,0.1566,0.2839,0.372,0.498,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,0.3077405,benign
chr13:32361848:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43090998:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,8.237e-06,
chr13:32398184:C>TA,,,Unknown|Germline (inherited),,,,-|FA FANCD1_00022,,,,,,,,Western Europe|-|Dutch,,Not Specified|-|Caucasian|Central/Eastern Europe,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43093094:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43091850:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&0,,
chr13:32399139:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3435 (African)| 0.277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43092412:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,-|Multifactorial likelihood-ratio model|?|evolutionary conservation analysis,52/1658|-,,,,0.0288,0.0023,0.0202,0.0,0.0031,Danish|German|-|Austria|French|American|Spanish|Austrian|Italian,1|0|2|-,Austrian|-|Caucasian,M,1 - Not pathogenic or of no clinical significance,,<1e-10,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1,1&1&1,0.011392175,
chr13:32333109:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.704,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-015),,1,8.236e-06,
chr13:32325081:G>C,,,In vitro (cloned)|Unknown,predicted neutral|-|?,Prevalence in normal controls|-|?,,,,,0.0,0.0008,0.0,0.0,0.0,,,-|Africa|African,M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,0.0001369055,
chr13:32339805:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-132),,,8.237e-06,
chr17:43057113:G>A,,,In vitro (cloned)|Unknown,-|strong functional effect,transcription activation/PS/BA/BS|-,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-492),,1&1&1,,
chr17:43092103:T>A,,,,,,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32379752:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,,8.238e-06,
chr17:43125258:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,,4.704e-05,
chr13:32333102:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-009),,1,,
chr17:43127867:AC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.37 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-009),,1,,benign
chr17:43051686:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32339114:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43093290:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,pathogenic
chr17:43093174:AGTAACG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,pathogenic
chr13:32376120:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.503,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.509585,benign
chr17:43094221:A>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092478:C>TTCTCA,,,,,,,,,,,,,,,Swedish|Norwegian|Sweden|-|Western Europe,,"West Swedish|Not Specified|Western European|Western Swedish|-Scandanavian|-|None-Specified| Italian""""|Western-European|Western Europe|Caucasian|None Specified|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,3.295e-05,
chr13:32326517:G>CAT,,,,,,,,,,,,,,,,,Western European|Western Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,,,
chr17:43087374:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32340382:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32316413:GGAG>G,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr17:43093045:TTAG>A,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43094071:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,4.942e-05,
chr13:32356521:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Germline (inherited),-|reduced complementation|inconclusive| HR deficient,embryonic stem cell assay reduced DSS1 binding|Protein likelihood ratio model|-,,-|FA FANCD1_00018,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1&1&0,,
chr13:32369488:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32340011:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32380037:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43045802:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,22/22,,-1,,,benign(0-004),,,8.236e-06,
chr17:43074300:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,1,,
chr13:32317130:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000399361,
chr17:43063893:T>-,,Strand_Center_for_Genomics_and_Personalized_Medicine|Strand_Life_Sciences_Pvt_Ltd,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32396943:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.002,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43067610:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-982),,,,
chr17:43082542:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32337609:C>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,Western European|Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-676),,1,2.472e-05,
chr17:43092527:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43067610:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-992),,,,
chr13:32326520:AT>ATAT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,1&1,,pathogenic
chr13:32337466:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43099107:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000399361,
chr17:43045642:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,0.0|4.6074|1.5608,None|None|None|None|None,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,,
chr13:32330812:G>T,,,,,,,,,,0.005,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32333140:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000396,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-893),,1&1,,
chr13:32355247:A>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-04),,1,1.647e-05,
chr13:32340234:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.1362|0.0461,benign:0.014,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-001),,1,,
chr13:32344085:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.03049 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0552,0.0937,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0800719,benign
chr17:43091906:TC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43052636:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0393,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0105831,benign
chr17:43092004:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32362651:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32341203:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32354903:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,0&1&1,1&1&1,8.236e-06,benign
chr17:43075166:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43092764:CTGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091931:G>A,,,,,,,,,,,,,,,,," Latin American/Caribbean""""|Latin-American/Caribbean|""""Western European",M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,4.118e-05,
chr17:43092350:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093374:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091558:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43074327:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,1&1,1&1,,
chr17:43091931:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,1&1,1&1,0.000313,
chr17:43124747:CTCAGG>T,,,,,,,,,,0.002,0.0166,0.0043,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00559105,
chr13:32319374:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,8.274e-06,
chr13:32339958:ACAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr17:43076488:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1&1,,
chr17:43067614:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,
chr17:43092947:G>C,,,In vitro (cloned)|Unknown,predicted neutral|inconclusive|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,Hispanic|Western Europe|Central/Eastern-European|Ashkenazi|Western European,M,1 - Not pathogenic or of no clinical significance,0.269,1.55,0.00117,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,9.884e-05,
chr13:32337948:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-087),,1&0&1,8.236e-06,
chr17:43118260:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3631,0.372,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.335463,benign
chr13:32338050:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-222),,,8.237e-06,
chr13:32371874:T>G,,,,,,,,,,0.999,0.9115,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.976038,
chr17:43091033:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European,IVS,5 - Definitely pathogenic,1.0,1.02,22.91,0.999,,0.97,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43076488:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr17:43063888:CT>A,,,,,,,,,,,,,,,-|Central/Eastern Europe|Dutch,3|-,White-NonHispanic|Not Specified|Western European|-|None-Specified|-Central/Eastern-Europe|Western-European|Western Europe|Caucasian|Native American,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,8.237e-06,
chr13:32394865:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,8.236e-06,
chr13:32339931:CTTTT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43099806:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,8.236e-06,
chr17:43114335:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340059:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|1.8384|0.6306,benign:0.055,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-072),,1,,benign
chr13:32353018:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43097592:GG>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00119808,
chr13:32386269:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32352524:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32340059:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-967),,1,,
chr13:32394671:T>CT,,,,,,,,,,,,,,,,,Latin American/Caribbean|Western European| New Mexico,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr13:32338200:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-037),,,,
chr17:43092486:T>TC,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43068829:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32341186:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32333619:C>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32340136:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43092969:->GC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32389236:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr13:32330907:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr17:43104262:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr17:43094815:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,German|-,,Western Europe|-,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43091876:A>T,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091674:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43091756:AATT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319198:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32356455:T>A,,,In vitro (cloned)|Unknown,predicted neutral|no splicing defect|-,Protein likelihood ratio model|-|splicing reporter minigene/patient RNA analysis,,,,,,,,,,Western Europe/Latin American/Caribbean|-,,,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,0&0&1&1,1&1&1&1,8.236e-06,
chr13:32336826:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-714),,1&1,,
chr13:32340041:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-067),,1,,
chr17:43104262:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr13:32338640:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32326120:A>G,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,,,
chr13:32357714:GC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,2.472e-05,
chr13:32342323:C>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000599042,
chr17:43073675:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr13:32338902:G>A,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-132),,1,8.237e-06,
chr13:32362563:GC>T,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32363337:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Not Specified|Western European|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-898),,1,,
chr17:43099773:C>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,1/1658|-,,,,,,,,,-|Italian,,-|Non-Jewish|Western-European|Western Europe|Caucasian|None Specified|Italian,IVS,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,
chr17:43092919:GG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32383538:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32332615:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32337371:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43099837:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32332439:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr13:32326154:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,
chr17:43099773:C>G,,,In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,
chr17:43055945:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32339908:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,0&1&1,1&1&1,0.000103959,
chr17:43093704:ATATT>A,,,,,,2/1658|-,,,,,,,,,Australian|-,,Not Specified|Western European|-|Caucasian|Western Europe|None-Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43104952:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32330951:AAG>AAGAAG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,inframe_insertion,MODERATE,,,1,,,,,,,
chr17:43082413:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32351909:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32357850:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,16/27,,1,,,,,,,
chr13:32340385:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32345631:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03846 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0591,0.0317,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.014976,benign
chr13:32385652:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43082469:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,8.236e-06,
chr17:43115706:T>CA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,1.647e-05,
chr13:32357806:AAA>GGT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,,1.647e-05,
chr13:32398370:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379814:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32380098:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32332602:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-178),,1,,
chr13:32338570:ATCTT>T,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32332449:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-16),,1,,
chr13:32383682:C>A,,,,,,,,,,0.2087,0.1846,0.2003,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.225839,
chr13:32332449:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,
chr17:43094345:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32336938:CCAAAAGT>A,,,,,,,,,,,,,,,,,-|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43091813:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,-|1/1658,,,,,,,,,-|Central/Eastern Europe,,Western-European|Western European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32394144:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr17:43052001:A>C,,,,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00499201,
chr13:32356611:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1,,pathogenic
chr13:32335313:A>T,,,,,,,,,,0.0,0.0212,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00579073,
chr17:43090921:G>GCA,,,,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32326115:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,-|1/1658,,,,,,,,,Malaysian|-,," Native American""""|Chinese| Filipino""""|-|Malay|Philipeno|""""Asian|Asian|Western Europe|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,0.0002472,
chr13:32328393:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32316458:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,2.471e-05,
chr17:43094567:T>G,,,In vitro (cloned),predicted neutral|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western Europe|Central/Eastern Europe,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,2.471e-05,
chr17:43092094:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340333:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43104863:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1,,
chr13:32399609:A>C,,,,,,,,,,0.005,0.0,0.0072,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00219649,
chr13:32355268:CTG>A,,,,,,1/1658|-,,,,,,,,,Not Specified|-,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32339908:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,8.237e-06,
chr13:32326115:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32386165:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339102:A>G,,,,,,,,0.0|0.0227|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43092094:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337306:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-001),,,8.238e-06,
chr13:32344647:C>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,
chr17:43070962:C>A,,,In vitro (cloned),no functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43094838:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,
chr13:32340677:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Counsyl|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0465|0.0|0.0308,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0),,1&1,,
chr13:32394703:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,predicted deleterious|predicted pathogenic| no LOH|-,Protein likelihood ratio model|HR assay|-| LOH assay,,,,,,,,,,,,Caucasian,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-06),benign(0-083),,1&1,,
chr17:43091901:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-06),benign(0-083),,1&1,,pathogenic
chr13:32357942:A>G,,GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,,
chr13:32332622:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-386),,1,8.248e-06,
chr17:43093286:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332944:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-893),,1,,
chr13:32354907:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-939),0&1&1,0&1&1,8.236e-06,
chr17:43093286:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094600:AG>G,,,,,,,,,,,,,,,Not Specified|Sweden|-,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43104083:TTTCCTC>AAAGAAGAAG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0002063,
chr13:32329687:C>G,,,,,,,,,,0.0,0.0234,0.0043,0.0,0.0,,,,IVS,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00678914,
chr17:43092940:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin-American/Caribbean,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr17:43092940:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340503:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-55),benign(0-015),,1,,
chr13:32338417:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr17:43048242:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32394812:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43105418:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000399361,
chr17:43104895:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr17:43047754:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr13:32339319:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093261:TA>A,,,,,,1/1658|-,,,,,,,,,Not Specified|-|Italian,1|-,Western Europe|Pakistani|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43091679:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091394:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.238e-06,
chr13:32337006:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32319343:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,1.648e-05,
chr17:43092115:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32367764:G>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000798722,
chr17:43093408:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32357754:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43057078:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,1/238 patients|-|1/1658,,,,,,,,,Malaysian|Austria|Austrian|-|Greek,2|-,"""""Native American| Latin American/Caribbean""""|Western European|-|Caucasian|Greek| Greek|Indian|Asian|African American|African|Western-European|Austrian|Western Europe|None-Specified|None Specified",N,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,0&0&1&1,1&1&1&1,,
chr17:43082515:C>T,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,,
chr13:32357797:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-95),,1&1,,
chr17:43113610:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr17:43111337:T>A,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32397570:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.55 (Asian)| 0.51 (African)| 0.54 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340575:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-8),benign(0-037),0&0&1&1,1&1&1&1,8.237e-06,
chr17:43044355:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0005769015,
chr13:32395994:CAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001884,
chr17:43082518:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340065:A>T,,,,,,,,,,,,,,,,,Asian| India,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-9),benign(0),,1&1,,
chr17:43090943:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43062179:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43076580:AG>A,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1,,
chr13:32333076:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-037),,1,,
chr13:32344539:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Latin American/Caribbean|French Canadian,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr17:43091764:T>GT,,,,,,,,,,,,,,,,,Native American/African American,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340065:A>G,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,0.0,0.0008,0.0,0.0,0.0,Latin American/Caribbean|-,,Latin American/Caribbean| Portugese|Cuban|Central/Eastern European| Canadian| Irish|Western European|-| French |African| Engl,M,1 - Not pathogenic or of no clinical significance,0.03802,0.05754,0.46774,0.00015,0.02,0.13,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-016),,1&1,0.0001204305,
chr17:43090943:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32336976:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,1&1,1&1,,
chr17:43093941:AGCACACA>T,,,,,,,,,,,,,,,Pakistani|-,,Pakistani,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32339512:TTCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43073828:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43094549:AT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,pathogenic
chr13:32340108:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-036),,1,,
chr13:32344539:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,8.273e-06,
chr17:43104167:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000166,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr17:43097347:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,benign
chr17:43121006:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08537 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43095761:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43093682:T>C,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332274:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,10/27,,1,,tolerated(1),benign(0),,1,4.121e-05,
chr13:32341625:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000599042,
chr13:32332347:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-49),,1,,
chr17:43093408:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093445:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32396296:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333072:CT>G,,,,,,,,,,,,,,,Spanish,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32326065:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,3.296e-05,
chr13:32391173:C>A,,,,,,,,,,0.2376,0.2141,0.1628,0.2688,0.2423,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.228235,
chr13:32346591:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32367752:C>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00139776,
chr13:32366755:A>GAGGT,,,,,,,,,,0.0,0.053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0141773,
chr13:32364438:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32376795:C>G,,,In vitro (cloned),predicted deleterious|as variant control,mRNA analysis (RT-PCR)|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-|Italian,, Italian|Western European|Western Europe|-|Caucasian,IVS,3 - Uncertain,12.09,1.34,2.22,0.949,,0.34,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr17:43091587:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338265:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-003),,1,,
chr13:32339541:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),probably_damaging(0-978),,,8.24e-06,
chr17:43091447:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092654:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063368:ACG>T,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,,,
chr17:43045691:T>G,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0),,1,0.036,pathogenic
chr17:43082496:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,8.236e-06,
chr17:43045573:ACAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,pathogenic
chr17:43064188:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1179 (African)| 0.2744 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43078211:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43124135:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340554:GG>T,,,,,,,,,,,,,,,Not Specified|-,,Not Specified|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332484:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,1.647e-05,
chr17:43111348:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43091587:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32318598:A>C,,,,,,,,,,0.6998,0.553,0.6326,0.6954,0.637,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.638578,
chr13:32397045:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43102845:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43082397:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,11/21,-1,,,,,1,,benign
chr13:32336595:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,1,,
chr17:43054845:C>T,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00199681,
chr13:32356496:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.3404|0.1153,benign:0.022,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1&1,,
chr13:32319132:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,benign
chr17:43106489:T>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr13:32336328:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-997),,,8.237e-06,
chr13:32340363:ATTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,8.237e-06,
chr13:32340434:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr17:43051086:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-056),,,,
chr13:32395948:TTTAG>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0003902,
chr17:43099984:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,1,,
chr13:32344161:G>A,,,,,,,,,,0.0,0.0,0.0,0.0129,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00259585,
chr13:32357910:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr13:32380577:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32354841:C>G,,,,,,,,,,,,,,,Ashkenazi,,,IVS,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,1,8.246e-06,
chr13:32359696:A>C,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00119808,
chr13:32398179:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43106489:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32344386:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32332793:A>G,,,,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-149),,1,,
chr13:32394803:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32338840:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43095915:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43094512:G>AC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32326153:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1&1,,
chr17:43091831:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32363431:CAGACTGACAGTTGG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43045714:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,
chr13:32355265:CAAAGTGTGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,pathogenic
chr17:43097298:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1&1,,
chr17:43063685:A>AT,,,,,,,,,,0.0,0.0106,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.00279553,
chr13:32346796:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.253e-06,
chr17:43092544:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43067628:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.999,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-989),,1&1,,
chr13:32336390:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-959),,,,
chr17:43049068:C>A,,,,,,,,,,,,,,,Malaysian,,Malay,IVS,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr13:32332619:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-126),,1,6.599e-05,
chr13:32336839:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.119e-05,benign
chr13:32375451:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43104239:GGTGCAC>T,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,6/23,,-1,,,,,,8.236e-06,
chr17:43094397:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32363237:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43094020:AG>TG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,6.589e-05,
chr13:32316853:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43092610:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43047704:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32339320:C>R,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr17:43093656:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32379727:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32333376:G>ATT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32398753:T>G,,,,,,,,,,,,,,,,,Not Specified|Western European|Central/Eastern European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43093017:CA>G,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32336746:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32379980:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,1.647e-05,
chr17:43092610:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43071228:CCA>A,,,In vitro (cloned),predicted deleterious,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr13:32370420:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,
chr13:32394790:AG>A,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr17:43082385:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.236e-06,
chr17:43071143:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1,8.236e-06,
chr17:43061042:C>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000998403,
chr17:43109636:G>C,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr17:43119113:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32373250:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000798722,
chr17:43078938:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43066275:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32362236:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43071011:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1,,pathogenic
chr17:43067668:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,,benign(0-001),,1,,
chr13:32344804:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.311 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43099800:T>C,,Ambry_Genetics|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,
chr13:32396449:C>G,,,,,,,,,,0.2455,0.087,0.2968,0.1984,0.2904,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.210064,
chr13:32325134:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43067655:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,,,pathogenic
chr17:43086571:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr17:43045704:C>A,,,In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,Greek|-,,Greek|None-Specified,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,possibly_damaging(0-901),,1,1.647e-05,
chr13:32317968:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000399361,
chr17:43115753:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,,0.0001039585,
chr13:32339428:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43082556:A>C,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32362693:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted deleterious|in frame deletion exon 17|-|as variant control|inconclusive,-|mRNA analysis|Nuclear localisation|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model|Survival assay with VC8 (after MMC treatment)|evolutionary conservation analysis,,,,,,,,,,Western Europe|-,,Not Specified|Western European|-|Irish Dutch English/Native American|Germany|Western Europe,M,5 - Definitely pathogenic,,2.19,1550.0,0.99943,0.29,0.34,missense_variant&splice_region_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-983),,1&1&1&1,8.236e-06,
chr13:32319100:G>C,,,In vitro (cloned)|Unknown,no rescue ES cell lethality|-,-|Embryonic stem cell assay,,,,,,,,,,-|Spanish,,Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32362693:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.997,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted deleterious|inconclusive|-|as variant control,Protein likelihood ratio model|Homology-directed repair assay|-|Centrosome amplification|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,,,None Specified,M,5 - Definitely pathogenic,14.7,1,1.0,0.998,0.81,0.97,missense_variant&splice_region_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-995),,1&1&1&1,,
chr13:32340704:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32363237:A>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43093656:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32370992:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),0&1&1&1,1&1&1&1,,
chr13:32354964:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-16),,,,8.237e-06,
chr17:43091731:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32325172:G>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32337632:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,pathogenic
chr13:32340050:G>A,,,,,,,,0.0|0.0227|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-044),,,,
chr17:43074462:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,benign
chr13:32362580:C>A,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,
chr17:43092168:AT>A,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093705:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Not Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093111:C>T,,,,,,,,,,,,,,,P.R. China,1,Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093873:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094534:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43094222:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.237e-06,
chr13:32338626:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-002),,1&1,,
chr13:32319044:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.257e-06,
chr13:32375903:G>T,,,,,,,,,,0.0089,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00199681,
chr13:32326084:C>A,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,1.648e-05,
chr13:32332619:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-126),,1,,benign
chr17:43047156:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32337060:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr13:32381563:G>A,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00678914,
chr17:43106194:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000599042,
chr17:43086979:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32319130:A>T,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43075066:->GGAA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379802:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43091456:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43104057:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,
chr13:32357158:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr13:32394577:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43092648:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32349851:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32363417:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Protein likelihood ratio model|-,-|1/1658,,,,,,,,,,, Japanese/Filipino/Hawaiian|Western European|None Specified|Asian| Asian,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),benign(0-001),,,1.647e-05,
chr13:32354995:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),benign(0-001),,,,pathogenic
chr17:43114893:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43094534:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43094684:CTCTA>A,,,,,,,,,,,,,,,German|Austrian|Western Europe|-|Italian,1|-,Central/Eastern European|Western European|-|Ashkenazi|Austrian|Caucasian|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32363449:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32331024:A>AA,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr13:32362633:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32340102:A>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-32),benign(0-019),,1,,
chr13:32382620:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32339383:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32370576:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,0.0233|3.7222|1.2763,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,
chr13:32337684:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32394884:C>AAG,,,,,,,,,,,,,,,,,"Western European| German""""|""""Western European| German",F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32327601:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32354995:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-989),,1&0,8.237e-06,
chr13:32338730:T>G,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-56),benign(0-017),,,,
chr13:32357893:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-974),,,,
chr13:32337305:CA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,
chr17:43094748:T>C,,,,,,,,,,,,,,,,,Western-European|White-NonHispanic,N,,,,,,,,stop_retained_variant,LOW,,,-1,,,,,1&1,,
chr17:43093687:A>GAC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32372594:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43093808:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr13:32319385:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43049877:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43093098:G>-,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,pathogenic
chr17:43091663:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32330603:G>A,,,,,,,,,,0.006,0.0008,0.0101,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00299521,
chr17:43091663:T>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32326633:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr13:32330198:A>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000798722,
chr13:32338626:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,pathogenic
chr13:32337440:T>G,,,,,,,,,,,,,,,,,Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-051),,1,8.238e-06,
chr17:43092068:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32336712:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-225),,1,,
chr17:43092068:A>G,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,,M,1 - Not pathogenic or of no clinical significance,0.0025,,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43079340:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,2.579e-05,
chr17:43094491:TG>TG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr17:43094696:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32372719:C>G,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00139776,
chr17:43094721:CA>A,,,,,,,,,,,,,,,,,Central/Eastern Europe,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32376712:CC>G,,,,,,,,,,,,,,,French Canadian|-,,Western European|-| French Canadian,F,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,,,
chr13:32396999:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32320378:A>T,,,,,,,,,,0.0,0.0008,0.0,0.003,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000998403,
chr13:32398211:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32337853:TCA>C,,,,,,,,,,,,,,,Not Specified|-,,Western European|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43102805:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43117512:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32387470:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,
chr17:43073762:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43095879:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32351669:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43094776:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,tolerated(1),benign(0),,1,,
chr17:43093452:T>A,,,,,,,,,,,,,,,,,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43104076:CTATAG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.002029,
chr13:32333316:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-865),0&1&1,1&1&1,3.298e-05,
chr13:32357761:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,1,1.647e-05,
chr13:32341176:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),probably_damaging(0-959),,1,,
chr17:43095913:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43070445:C>G,,,,,,,,,,0.3598,0.2254,0.3746,0.372,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.355831,
chr13:32340062:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-017),,1,,
chr17:43082434:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43082434:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,0&0&0&1&1,1&1&1&1&1,,
chr17:43045593:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,2.472e-05,
chr17:43066409:A>C,,,,,,,,,,0.007,0.0,0.0072,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00339457,
chr17:43071159:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr17:43093198:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32337475:T>A,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43093919:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340147:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-132),,,,
chr17:43094848:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,0.0001039665,
chr13:32368955:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32357763:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-106),,1,,
chr17:43072816:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3417 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32363164:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,,
chr13:32337302:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-006),,1,,
chr17:43057131:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-04),benign(0-013),,1,,
chr13:32372881:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32329487:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1,,
chr13:32385249:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339699:TTT>C,,,,,,1/1658|-,,,,,,,,,-|Central/Eastern Europe|Dutch,," Native American""""|Central/Eastern Europe| Latin American/Caribbe| Central/Eastern Europe|Western European|-| Dutch| German|Western Europe|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43101265:C>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000798722,
chr17:43060092:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32339705:T>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,,
chr13:32340317:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-329),0&1,1&1,,
chr13:32337937:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.236e-06,
chr13:32379387:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,8.236e-06,
chr13:32321693:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43082585:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,1&1,,
chr13:32355302:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,8.239e-06,
chr17:43056521:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43091755:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001080755,
chr13:32340423:ACCAG>-,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32332750:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32332601:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,-|Multifactorial likelihood-ratio model|?,,,,,0.001,0.0,0.0058,0.0,0.0,Austria|-|Spanish,1|-,Latin American/Caribbean|Native American/Latin American/Caribbean| Latin American/Caribbe|Western European|-| Puerto Rican|Caucasian,M,1 - Not pathogenic or of no clinical significance,1.0,0.05754,0.05495,6e-05,0.02,0.02,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),possibly_damaging(0-804),,1&1,0.0005157015,
chr17:43094538:A>G,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,-|Ashkenazi/Western Europe,M,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43100097:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000399361,
chr13:32380123:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,8.237e-06,
chr17:43083079:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43076536:TT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/22,,-1,,,,,,,
chr17:43118123:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32316490:C>AT,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr17:43114022:C>CC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32337253:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32320776:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32390841:C>A,,,,,,,,,,0.005,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000998403,
chr13:32325129:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1&1&1,,
chr13:32339633:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,inconclusive|-,-|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,1.17,1.0253,,0.0121,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-22),,1,1.648e-05,
chr13:32326266:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,,,
chr13:32334699:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr17:43091492:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.6744|0.1135|0.4844,benign:0.255|None|None|benign:0.255|benign:0.255,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093742:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32340352:GA>G,,,,,,,,,,,,,,,,,Western European| Ashkenazi| Sephardic,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43071046:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Germline (inherited),predicted deleterious|-|119 bp deletion exon 16,RNA analysis|-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|-,,Western-European|Western Europe|-|Latin-American/Caribbean|None Specified,M,5 - Definitely pathogenic,27.72,1.09,10.47,0.9986,0.02,0.64,missense_variant,MODERATE,15/23,,-1,,tolerated(0-08),benign(0-211),,1&1,8.236e-06,
chr17:43057065:G>GG,,GeneReviews|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,,pathogenic
chr17:43092511:A>C,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr17:43063883:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious|very destabilizing|uncertain,transcription activation/PS/BA/BS|Thermodynamic stability prediction|Multifactorial likelihood-ratio model,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),benign(0-279),,1&1&1,,
chr13:32357244:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr17:43093742:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000692,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Germline (inherited),predicted neutral|predicted deleterious|-,Histopathology|-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,0.0233|0.0454|0.0308,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,"Central/Eastern European|Western European|Native-American|-| Irish""""| Irish/German""""|Western-European|Western Europe|None-Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,0.01202,2.82e-07,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,5.766e-05,
chr17:43063883:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.99,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted deleterious|as variant control|strong functional effect,Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|Prevalence in normal controls|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Denmark,,,M,5 - Definitely pathogenic,1.0,1.23,36.31,0.9948,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-991),,1&1&1,,pathogenic
chr13:32339651:GATATAAAAG>A,,,,,,,,,,,,,,,Thai,, Thai,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43125376:G>A,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr17:43051063:T>A,,,In vitro (cloned),no functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-871),,1&1&1,,
chr17:43093563:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32362648:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,tolerated(0-25),benign(0-031),,1,,
chr13:32328976:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43091312:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.384e-06,
chr13:32364532:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00998403,benign
chr17:43088583:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43099836:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr13:32376634:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,
chr17:43055023:C>G,,,,,,,,,,0.0,0.0,0.0,0.0119,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00239617,
chr13:32338587:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-23),,,,
chr17:43090940:GCTGC>T,,,,,,,,,,,,,,,,,,,4 - Likely pathogenic,2.09,1.05,,0.986,,0.97,splice_donor_variant&coding_sequence_variant&intron_variant,HIGH,,,-1,1.0,,,,,,
chr17:43071206:G>A,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),probably_damaging(0-915),,,8.236e-06,
chr17:43057240:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43104092:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0001401,
chr17:43093638:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32396972:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32347011:->TTTATAAAA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1 (Asian)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43087587:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr17:43104867:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,8.237e-06,
chr13:32339157:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-037),,1,,
chr13:32376634:C>G,,,,,,,,0.0|0.0227|0.0077,None,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000315996,
chr17:43108433:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32376634:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.237e-06,
chr13:32340610:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-026),,1,,
chr13:32341120:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32389321:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43051084:GC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32339274:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-196),0&1&1,0&1&1,,
chr13:32391506:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32346869:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,13/27,,1,,,,,,8.239e-06,
chr13:32339100:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-209),,,1.647e-05,
chr17:43093115:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092456:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32383753:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32338294:A>G,,,,,,,,,,,,,,,,,Latin American/Caribbean,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1&1,,
chr13:32339288:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43063348:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32397919:A>G,,,,,,,,,,0.0,0.0,0.0,0.0437,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00878594,
chr13:32370497:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,,,benign
chr13:32379947:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,1.648e-05,
chr13:32379415:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43067608:G>T,,,In vitro (cloned)|Unknown,as wildtype control|Low functional effect|-|mildly destabilizing,Transcription activation in yeast (GAL4-fusions)|transcription activation/PS/BA/BS|-|Thermodynamic stability prediction,,,,,,,,,,,-|6,-|Latin-American/Caribbean|African|Western-European|Western Europe|African American,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-704),0&0&1,1&1&1,,
chr13:32338409:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),0&1&1,1&1&1,,
chr17:43116729:C>A,,,,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0155751,
chr17:43073766:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3392 (Asian)| 0.1748 (African)| 0.4182 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32372990:C>G,,,,,,,,,,0.0,0.0068,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00179712,
chr13:32326012:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,
chr17:43091734:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337110:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-22),,1,,
chr17:43091734:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000113,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32368879:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0109,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00259585,
chr13:32338918:A>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr17:43067608:G>A,,,In vitro (cloned),as wildtype control|predicted deleterious|very destabilizing|uncertain|inconclusive,Thermodynamic stability prediction|Peptide binding ability|Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Multifactorial likelihood-ratio model|Proteolytic degradation,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-961),0&0&1,1&1&1,,
chr17:43094774:A>T,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43049498:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01573 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0129,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00259585,benign
chr17:43091432:G>C,,,,,,,,,,,,,,,Not Specified|-,,Western-European|-,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340107:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,-|Ashkenazi|Native American|Central/Eastern Europe,M,1 - Not pathogenic or of no clinical significance,1.0,0.05623,0.00501,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-019),,1,,
chr17:43091432:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32398537:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr13:32394799:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43092423:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,1,,pathogenic
chr17:43104867:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,8.237e-06,pathogenic
chr13:32340760:CTTAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,,pathogenic
chr17:43066690:T>T,,,,,,,,,,0.0,0.0514,0.0029,0.0,0.0,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,0.0139776,
chr13:32339068:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-043),,1,,
chr13:32356799:G>A,,,,,,,,,,1.0,0.9947,1.0,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.998602,
chr17:43092610:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32339045:G>GC,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398537:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32325762:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43045292:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,5.213e-05,
chr17:43090589:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32338293:CA>A,,,,,,,,,,,,,,,Czech,1,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43066690:T>G,,,,,,,,,,0.0,0.0212,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00559105,
chr13:32339882:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),possibly_damaging(0-474),,,,
chr17:43091994:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43090945:T>TGA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,1.0,,,,1,8.238e-06,
chr13:32350747:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.243 (Asian)| 0.1016 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43081537:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000599042,
chr13:32357911:A>GA,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr13:32338942:G>GG,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32319567:C>G,,,,,,,,,,0.0,0.0023,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr13:32340958:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32379368:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32334084:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32341096:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-032),,1,,
chr13:32368690:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32356539:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-999),,,,
chr13:32389695:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43049347:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43090961:C>CCT,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,
chr17:43090999:CCC>C,,,,,,,,,,,,,,,,,Central/Eastern-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43051406:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32376741:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,,
chr13:32340594:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32380471:T>G,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00139776,
chr13:32342037:G>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00239617,
chr13:32326609:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr17:43089371:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32319244:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32396918:TG>AT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091641:AT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32363301:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-34),benign(0-046),,1,,
chr13:32326114:C>T,,,In vitro (cloned),ESE disruption/ESS creation| exon 5 skipping,ESEfinder/ESRsearch. RT-PCR /hybrid minigenes,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,5/27,,1,,,,,1&1,,
chr13:32340790:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43079299:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.6e-06,
chr13:32394677:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr13:32379367:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43076570:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000918,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr17:43125362:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,9.557e-05,
chr17:43124055:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32326609:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr13:32330918:T>C,,,,,,,,,,,,,,,-|Sri Lankan,,Western European|Sinhalese,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,,1,,
chr13:32344642:G>A,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),possibly_damaging(0-842),,,,
chr13:32332323:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-2),benign(0-022),,,8.239e-06,
chr13:32397006:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094758:T>C,,,,,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32338212:ATTAC>A,,,,,,,,,,,,,,,,,Western Europe|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337620:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43093301:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338816:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43073428:C>A,,,,,,,,,,0.0089,0.0295,0.0274,0.0724,0.0164,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0311502,
chr13:32327292:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32338191:GG>A,,,,,,,,,,,,,,,Not Specified|-,,Not Specified|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339761:A>C,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,probably-damaging:0.989,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-992),,1,,
chr17:43072810:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32363921:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32394884:CTA>A,,,,,,,,,,,,,,,-|Italian,,Not Specified|Caucasian,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr17:43106712:CT>C,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32355195:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,,,
chr13:32338541:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43105241:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000399361,
chr13:32329501:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,,
chr13:32332667:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,,,
chr13:32345892:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32340763:AAATGTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr17:43067642:GTCAGG>A,,,,,,-|1/1658,,,,,,,,,,,"-| Ashkenazi""""|-Italian|Western-European|Central/Eastern-European|None-Specified| Irish/Italian""""|""""Western European",F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32343676:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32340753:ATGA>C,,,,,,,,,,,,,,,-|W. Europe,,Caucasian|None Specified| None Specified,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,1.648e-05,
chr13:32365244:C>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00119808,
chr17:43045696:CCTCC>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,4.943e-05,
chr17:43097355:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr17:43082552:G>A,,Ambry_Genetics|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,
chr17:43094862:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43091495:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.36|None|None|benign:0.36|benign:0.36,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32332532:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0),,1,,
chr13:32337720:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-99),,,0.000103959,
chr17:43092941:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093294:G>TC,,,,,,,,,,,,,,,Dutch,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32341122:C>A,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-032),,1,,
chr13:32339972:TCAAA>G,,,,,,,,,,,,,,,-|Native American,,Not Specified|Western European|English|-|English/Scottish/Irish/Welsh|Ashkenazi|African|Western Europe|Native American,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32357794:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.236e-06,
chr17:43098141:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32370910:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.237e-06,
chr13:32337625:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-006),,1,,
chr17:43093554:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32363511:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32385412:G>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32338126:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32357767:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-984),,1,,
chr17:43115747:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-984),,1,,pathogenic
chr17:43104245:CA>A,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,,
chr17:43115723:CA>T,,,,,,,,,,,,,,,Malaysian,,Chinese,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,3/22,-1,1.0,,,,,,
chr17:43091818:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000194,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&0&1&1,1&1&1&1&1&1,,
chr17:43103597:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32357829:AAAAGACTTC>G,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,16/27,,1,,,,,,8.236e-06,
chr13:32341025:AT>G,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32357767:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-956),,1,,
chr17:43052140:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32376667:ATA>T,,,,,,,,,,,,,,,China,,Chinese,F,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,20/26,1,,,,,,,
chr17:43106440:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,
chr17:43093360:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32394963:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,8.236e-06,
chr13:32398496:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32340123:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43094211:AT>T,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32380099:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,
chr17:43045794:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-476),,1,,
chr13:32394857:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),probably_damaging(0-981),,1&1,,
chr17:43074488:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,0.000199681,
chr17:43109361:TGGT>A,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr17:43111259:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32332930:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43064004:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,
chr17:43071232:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-445),,1&1,8.237e-06,
chr17:43094081:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43124045:AC>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43116071:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43116143:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32360795:A>G,,,,,,,,,,0.001,0.0038,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00159744,
chr13:32394742:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32336973:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43072954:T>CA,,,,,,,,,,0.002,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000798722,
chr17:43091843:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32384329:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32337990:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32398556:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43071113:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr13:32379741:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.238e-06,
chr13:32397042:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339582:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-187),0&1&1,1&1&1,,
chr13:32362536:T>C,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43051761:T>C,,,,,,,,,,0.007,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00139776,
chr17:43116664:C>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000798722,
chr17:43094280:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32356379:G>A,,,,,,,,0.0|0.0227|0.0077,None,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.0002151905,
chr13:32333153:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-034),,,,
chr17:43073768:G>A,,,,,,,,,,0.0,0.0091,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00299521,
chr13:32394937:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,no splicing defect|-,-|splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,Western European|None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,1,8.236e-06,
chr17:43093137:GT>T,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43080841:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32329507:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr17:43092963:G>C,,,,,,,,,,,,,,,-|Uruguayan,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32359885:GA>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000998403,
chr13:32380051:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,1.647e-05,
chr17:43073764:C>T,,,,,,,,,,0.3529,0.1498,0.3646,0.3611,0.4928,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.329872,
chr13:32333729:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32324515:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43094113:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094113:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000337,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,probably-damaging:0.988|None|None|probably-damaging:0.988|probably-damaging:0.988,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337573:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-844),,1,4.943e-05,
chr13:32343208:G>C,,,,,,,,,,0.0,0.0008,0.0591,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00878594,
chr13:32380145:GG>TA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43094638:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32379316:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/26,1,,,,,1&1,,
chr17:43103105:G>T,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00159744,
chr13:32336603:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,,1,8.236e-06,
chr13:32357875:C>A,,,In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,,,,,,West/Central/East Europe,,,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1&1&1,8.236e-06,
chr13:32398763:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32338456:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr13:32340202:TCCTC>T,,,,,,,,,,,,,,,Western Europe|Spanish|-|Colombian|Italian,," Central/Eastern European""""| Central/Eastern Europe|Not Specified|Western European| Italian/French Canadia|-|Colombian| Italian|Unknown|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32355092:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,,2.471e-05,
chr17:43093922:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32325971:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr13:32329088:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32340570:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-891),0&0&1&1,1&1&1&1,,
chr17:43091462:ACCCC>C,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,-|13/1658,,,,,,,,,Central/Eastern Europe|German|Western European|-|British|Norwegian|W. Europe/French Canadian|Western Europe|Hong Kong,1|540|-,"White-NonHispanic|Western European|-Native-American|Pakistani|Caucasian|Central/Eastern Europe|Not Specified|-|""""African|Unknown|Western-European|Dominican Republic|Native American|Canadian|Chinese |Irish/Polish| Caucasian""""|African|Latin-American/Caribbean|None Specified|Central/Eastern European|Ashkenazi/Western Europe|French Canadian|Western Europe|-Hispanic/Mexic|None-Specified",F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr17:43096467:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3529,0.1573,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.334864,benign
chr13:32339062:AGA>C,,,,,,1/1658,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32374890:T>G,,,,,,,,,,0.007,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00159744,
chr17:43092183:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332840:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43094697:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43107110:A>C,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00119808,
chr17:43105300:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32332821:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32336488:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1&1,1&1&1&1,,benign
chr17:43094450:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370583:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,
chr17:43078359:T>G,,,,,,,,,,0.3559,0.1558,0.3646,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.334864,
chr13:32337312:C>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-23),,1,,
chr17:43092369:CAGAGCGAGACTCCGTCTCAAA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr17:43051068:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),possibly_damaging(0-507),,1,8.236e-06,
chr17:43094736:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),possibly_damaging(0-507),,1,,pathogenic
chr17:43070924:C>G,,,,,,,,,,,,,,,Western Europe|-,,Western-European|-|None Specified|-Italian,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr17:43124030:C>G,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|None|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,0&1,0&1,,
chr13:32332434:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43079400:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,8.551e-06,
chr13:32338167:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32339609:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-022),0&0&0&1&1,1&1&1&1&1,,
chr13:32337428:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43053354:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,benign
chr13:32340668:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-034),,1,,
chr13:32325049:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,8.238e-06,
chr13:32376502:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32339097:->TG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32333274:G>C,,,,,,,,,,,,,,,Austria,1|0|2,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1&1,,
chr17:43091771:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093910:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,-|1/1658,,,,,,,,,German|-,1|3|-,Western Europe|-|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337428:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.811,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-253),,1,,
chr13:32385544:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32357807:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-98),,,,
chr13:32330985:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-98),,,,pathogenic
chr13:32337751:G>C,,,,,,,,,,,,,,,Austria,1,,Syn,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-982),0&1,1&1,,
chr13:32340962:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-009),,1,,
chr17:43078965:A>T,,,,,,,,,,0.0,0.0582,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0163738,
chr13:32339852:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr17:43054571:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43094064:C>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340862:TTA>C,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43093267:GG>T,,,,,,1/1658,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43070957:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-991),,1,,
chr17:43093494:A>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&0&1,0.0002079155,
chr13:32391462:G>C,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00119808,
chr17:43085792:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000599042,
chr17:43076578:ATAG>AAA,,,,,,,,,,,,,,,American|-,,Western-European|Western European|-|Armenian|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,
chr17:43051336:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32340373:TA>TATA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32337850:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001071,benign
chr13:32367440:CA>G,,,,,,,,,,0.0408,0.0356,0.0994,0.0972,0.1391,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0780751,
chr13:32336636:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,1,,
chr17:43106418:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,8.238e-06,
chr13:32398429:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43082557:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000187,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted neutral|as wildtype control|-,co-occurrence with deleterious variant|Transcription activation in yeast (GAL4-fusions)|-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,Western Europe|-,,Western European|-,M,1 - Not pathogenic or of no clinical significance,1.95,0.00355,0.851,0.00012,0.02,0.02,missense_variant,MODERATE,11/22,,-1,,deleterious(0-04),,,1,,
chr17:43049088:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01224 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1&1,,
chr17:43092873:AG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1&1,,pathogenic
chr17:43115792:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr13:32341230:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.262e-06,
chr13:32339163:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32332226:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.27e-06,
chr13:32333276:A>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-015),,1,0.0007422515,
chr17:43099808:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-015),,1,,pathogenic
chr13:32332757:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-887),,1,8.237e-06,
chr17:43115792:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000301. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.1816|0.0615,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr13:32339575:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,
chr17:43065084:C>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000998403,
chr17:43106508:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1&1,,pathogenic
chr17:43091042:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337984:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,1,,
chr17:43094839:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,1,,
chr17:43112539:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43099808:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32329474:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Ashkenazi/Western/Eastern/Central Europe,M,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1,,
chr13:32356536:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000643,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0581|0.0227|0.0461,possibly-damaging:0.9,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-979),,1&1&1,,
chr13:32337009:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),,0&1,1&1,,
chr13:32316435:T>C,,,In vitro (cloned),,,,,,,,,,,,,1,,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32363435:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-998),,,,
chr13:32388063:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43072950:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32340998:A>TA,,,,,,,,,,,,,,,,,Western European|-|None Specified,F,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32337984:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-676),,1,0.000103959,
chr13:32399302:C>G,,,,,,,,,,0.2087,0.0825,0.1902,0.3661,0.1728,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.197484,
chr13:32394900:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,8.236e-06,
chr17:43049135:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,8.236e-06,
chr13:32341030:A>G,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32387197:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32340747:AATTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43067324:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1626 (Asian)| 0.1138 (African)| 0.2704 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,benign
chr13:32332973:GAG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32340081:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-072),,1,,
chr17:43051083:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-764),,1,,
chr17:43051083:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-584),,1,,
chr17:43091999:T>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32363866:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32326112:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr17:43082586:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,1,,
chr13:32379549:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000103961,
chr13:32353317:C>A,,,,,,,,,,0.0,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr17:43071118:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-015),,,8.236e-06,
chr13:32337090:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-012),,1,,
chr17:43093198:->CA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32339136:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-067),,1,,
chr13:32319307:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European,N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32354874:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-006),,1,2.471e-05,
chr13:32326638:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0004283,
chr13:32338516:TTCAGA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32332603:TC>C,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32379336:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,,,Near Eastern|Near East/Mid East,M,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43106433:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,no splicing defect|-,exon inclusion|-,,,0.0|3.1349|1.0625,None|None|None|None|None,0.0,0.0393,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,0.00687755,benign
chr13:32325828:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000399361,
chr13:32339466:TAGCC>G,,,,,,,,,,,,,,,Spanish,2,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.244e-06,
chr13:32319307:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32338762:TCTGAT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32366777:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr17:43091760:CT>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43097077:C>G,,,,,,,,,,0.3549,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.352636,
chr13:32398766:TCTA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,,
chr17:43098906:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1341 (African)| 0.3654 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32340168:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-32),benign(0-233),,1,,
chr17:43092531:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32355196:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-108),,1,,
chr13:32337556:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-108),,1,,pathogenic
chr13:32341179:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-004),,,,
chr13:32321240:A>C,,,,,,,,,,0.999,0.9047,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.974241,
chr17:43092718:GG>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32356473:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-999),0&1&1,1&1&1,,
chr13:32340167:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32340300:AATAA>G,,,,,,,,,,,,,,,Danish,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32336465:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32341055:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-999),,0&1,8.236e-06,
chr17:43093557:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0349|0.0|0.0231,benign:0.016|None|None|benign:0.016|benign:0.016,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43099853:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,
chr17:43045684:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,benign
chr13:32339200:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,pathogenic
chr17:43094051:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094031:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32371106:T>G,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,
chr17:43091766:A>GT,,,,,,,,,,,,,,,,,-|None Specified|African,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32338048:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32371400:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2012 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32367486:T>G,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00898562,
chr17:43092937:AAGGTGAGA>T,,,,,,,,,,,,,,,Irish,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092632:GT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43064222:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43097484:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32338280:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-037),,1,,
chr17:43093855:T>A,,,,,,,,,,,,,,,,,"""""Western European| German/English""""",M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43071179:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32340224:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-02),,1,,
chr13:32337236:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-253),,1,,
chr17:43063328:AG>C,,,,,,,,,,,,,,,French?,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,18/22,-1,,,,,,,
chr13:32332326:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-23),benign(0-108),,1,8.239e-06,
chr13:32344611:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-01),possibly_damaging(0-851),,,8.24e-06,
chr13:32392154:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32339412:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32337236:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124157:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.967e-06,
chr13:32338648:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43082434:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),-|inconclusive,-|Transcription activation in human cells,,,,,,,,,,Western Europe|-,, Native American|Western European|-|Western-European|Western Europe|None Specified,M,,,,,,,,stop_lost,HIGH,11/22,,-1,,,,0&0&0&1&1,1&1&1&1&1,2.471e-05,
chr13:32338652:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),possibly_damaging(0-519),,,,
chr13:32325741:A>T,,,,,,,,,,0.998,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.973842,
chr13:32398684:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32355035:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr13:32376803:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32344544:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr17:43091491:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32394898:A>T,,,,,,,,,,,,,,,Spanish,1,Mediterranean,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,
chr13:32338140:A>G,,,,,,1/1658,,,,,,,,,Western Europe|-,,Western Europe|-,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,8.238e-06,
chr17:43100609:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.15 (Asian)| 0.12 (African)| 0.17 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr17:43093450:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32344544:A>T,,Invitae,,,,,,0.012|0.0|0.0079,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr13:32363172:A>G,,,In vitro (cloned),Insertion 6 nt from 3' end intron 17,splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/26,1,,,,,1&1,,
chr13:32338930:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,8.237e-06,
chr13:32338192:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,,pathogenic
chr13:32319060:CT>ATT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0009567,
chr17:43093607:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000014,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32356048:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.00119808,
chr13:32373103:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43091450:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000196,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32398329:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43106541:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr13:32333222:C>G,,,,,,,,,,,,,,,,,Western European| Norwegian|Western Europe| German,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-539),,1&1,,
chr13:32398625:A>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43122039:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43104936:AG>C,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32333262:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0),,1,,
chr17:43094697:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,1.647e-05,benign
chr17:43067693:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,15/22,,-1,,,,,,1.647e-05,
chr13:32363253:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,American,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-999),0&1&1,1&1&1,,
chr13:32333077:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-999),0&1&1,1&1&1,,pathogenic
chr13:32398211:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43068502:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32340191:T>C,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-008),,1,0.0001121955,
chr17:43092896:A>T,,,,,,,,,,,,,,,American,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32333424:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,8.417e-06,
chr13:32340479:C>CA,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43115033:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3539,0.2171,0.3775,0.371,0.5061,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.354233,benign
chr13:32337013:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43074794:C>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr17:43095586:T>G,,,,,,,,,,0.0,0.0098,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00299521,
chr17:43095926:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,
chr17:43094060:C>A,,,,,,1/1658,,,,,,,,,,,African|-|Caucasian|Ashkenazi,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32326653:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.236e-06,
chr13:32398144:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32332483:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,
chr13:32338788:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),possibly_damaging(0-596),,,,
chr17:43106203:G>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000798722,
chr13:32346949:G>A,,,,,,,,0.0|0.1445|0.044,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32333329:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,
chr13:32353471:C>G,,,,,,,,,,0.2087,0.2428,0.2003,0.369,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.242212,
chr13:32319125:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43093571:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43074370:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000284,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,,,
chr17:43062593:G>T,,,,,,,,,,0.0,0.0008,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000798722,
chr13:32326588:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,,8.236e-06,
chr17:43093773:AC>A,,,,,,,,,,,,,,,,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43104225:TTAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43064909:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32329430:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.248e-06,
chr17:43095801:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Turkish,11,Turkish,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379479:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32379284:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,
chr17:43093317:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43045708:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr13:32337556:GT>T,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340622:GCAT>GCATGCAT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32357920:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,,8.236e-06,
chr17:43097235:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,,
chr17:43094533:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32375336:G>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32340752:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-02),,,,
chr17:43091758:TTT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32335919:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43071232:C>A,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|no splicing defect|-|?,splicing reporter minigene|co-occurrence with deleterious variant|-|?|Transcription activation in yeast (GAL4-fusions),,,,,0.0,0.003,0.0058,0.0,0.0,African American|-,,Latin American/Caribbean|-Near-Eastern|Not Specified|-|Latin-American/Caribbean|-Central/Eastern-Europe| Jamaican|African|Western-European|None-Specified|None Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-367),,1&1,0.00099227,
chr13:32398751:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32355027:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),benign(0-117),,,8.237e-06,
chr17:43099813:C>T,,Ambry_Genetics|Invitae,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),0&1,1&1,6.589e-05,
chr17:43117319:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr13:32336400:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-049),,1,,
chr13:32355192:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),possibly_damaging(0-72),,1,,
chr17:43091491:G>T,,,,,,,,,,,,,,,-|Spanish,,-|Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43058822:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43055053:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32337188:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32394706:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43125113:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32319184:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32340799:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&0&1,2.471e-05,
chr17:43093461:TGCCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43053400:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32319184:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.2951|0.1,possibly-damaging:0.666,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32371757:G>ACCGC,,,,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00199681,
chr17:43092477:A>GTCTCA,,,,,,,,,,,,,,,Sweden|Norway,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43111432:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03322 (Asian)| 0.04472 (African)| 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32337426:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,1.648e-05,
chr17:43074397:C>A,,,,,,,,,,,,,,,,,Near-Eastern,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr13:32397569:CA>A,,,,,,,,,,0.5159,0.5121,0.536,0.5327,0.4693,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.511981,
chr17:43057053:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/22,,-1,,deleterious(0-01),benign(0-004),,1&1,,
chr17:43074347:AGCAA>C,,,,,,,,,,,,,,,,,Not Specified|Western-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43063808:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1&1,,benign
chr13:32337607:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32376960:C>G,,,,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00199681,
chr13:32339058:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-067),,1,,
chr13:32398437:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,-|inconclusive|as variant control,Cell viability (in BRCA-/- cells)|Homology-directed repair assay|-|Nuclear foci formation BRCA2/BRC3 domain - Rad51,2/1658|-,,,,,,,,,Western Europe|-,,"Latin American/Caribbean| Central/Eastern European""""|Western European|-| Irish & German""""|Western Europe| M & P|None Specified|""""Western European",N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,1.647e-05,pathogenic
chr13:32355341:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,17/1658|-,,,,0.0348,0.0295,0.0908,0.0952,0.1329,German|Danish|Austria|-,1|0|-,Global|-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,0.072484,
chr17:43052188:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32322539:T>A,,,,,,,,,,0.0398,0.0325,0.0922,0.0972,0.1288,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0740815,
chr13:32380107:T>G,,,In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.236e-06,
chr17:43071071:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,Greek|-,,Greek|None Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-033),,1,,
chr17:43093234:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-033),,1,,pathogenic
chr13:32355272:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-033),,1,,pathogenic
chr13:32395183:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr13:32398437:C>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,0.0|0.0681|0.0231,None,,,,,,,,Africa,Syn,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,8.236e-05,
chr17:43093181:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43115796:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32340648:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),possibly_damaging(0-861),,1,,
chr13:32379479:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000178,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32340036:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32356610:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,In vitro (cloned)|Unknown,Aberrant splicing|-| skip exon 15,-|cDNA analysis,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1&1,,pathogenic
chr17:43082527:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,8.236e-06,
chr13:32339247:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-257),,1,,
chr17:43092263:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32332296:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32339404:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,1.649e-05,
chr17:43092784:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32319059:AC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.247e-06,
chr17:43115968:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00499201,benign
chr17:43067620:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),benign(0-041),,,,
chr13:32371076:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32316457:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32379428:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0454|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43063340:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,pathogenic
chr13:32353301:T>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32344537:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.274e-06,
chr17:43091466:ATT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr17:43113743:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32362600:A>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32355088:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,1,,pathogenic
chr17:43093691:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr17:43093691:C>A,,,,,,,,,,,,,,,,,Estonian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32326553:AA>GCT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,,,
chr17:43057086:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-156),,1&1&1,,
chr13:32362714:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,8.236e-06,
chr13:32339390:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32332849:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32336600:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-029),,1,1.647e-05,
chr13:32343014:A>C,,,,,,,,,,0.003,0.003,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00179712,
chr13:32397936:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32383229:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr17:43093575:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43096921:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000399361,
chr13:32339991:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-085),,1,,
chr17:43091005:CCT>T,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32379251:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,35/1658|-,,,,0.5159,0.5113,0.536,0.5327,0.4683,South African|-|Austria,12|-|1|0|3|2,Global|White South African|-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,0.511581,benign
chr17:43094467:G>C,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,USA,,African American,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370565:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,Western European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1,0.0001204355,
chr17:43045689:T>TGGGGGGGGG,,,,,,,,16.913|21.7636|18.5653,None|None|None|None|None|None|None|None|None|None,,,,,,,,,,,,,,,,,inframe_insertion,MODERATE,22/22,,-1,,,,,,,
chr13:32339390:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-138),,1&1,,
chr13:32394965:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,1.647e-05,
chr13:32382599:G>GG,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32339390:A>G,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-004),,1&1,,
chr17:43093712:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,0.000103959,
chr13:32338284:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,,1&1,,
chr17:43067598:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr13:32360418:T>A,,,,,,,,,,0.001,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr17:43057086:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43092108:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32370565:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32325251:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,20/1658|-,,,,0.0348,0.0325,0.0965,0.0962,0.1329,Austria|-,1|0|-,,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,0.0742812,
chr17:43047681:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),possibly_damaging(0-525),,1&1,,
chr13:32340524:A>T,,,,,,,,,,,,,,,,2,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43050246:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43047681:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),possibly_damaging(0-697),,1&1,,
chr17:43110614:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,7.627e-05,
chr13:32325064:G>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Irish/German,IVS,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,
chr13:32357883:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43072816:A>C,,,,,,,,,,0.3569,0.1604,0.3646,0.372,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.336462,
chr17:43063340:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0),,,1&1,,
chr17:43092173:GA>C,,,Germline (inherited),,,,,,,,,,,,,1,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319173:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32337713:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,1.647e-05,
chr13:32396907:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32356497:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-08),,1&1,1&1,,
chr13:32356497:T>A,,,In vitro (cloned)|Unknown,predicted neutral|inconclusive|-,Histopathology|Protein likelihood ratio model|-,,,,,0.0,0.0,0.0,0.0,0.001,German|-,1|-,Western European|-|None Specified,M,3 - Uncertain,,,2.07,0.12,0.03,0.03,missense_variant,MODERATE,15/27,,1,,tolerated(0-5),,1&1,1&1,0.0001369055,
chr13:32398763:ATATC>A,,,,,,,,0.0|0.0235|0.0080,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32396979:C>G,,,,,,,,,,,,,,,,,Western European|Ashkenazi/Central/Eastern Europe|-|Native American,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43069579:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32338023:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-97),benign(0-001),,1,,
chr13:32339930:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-79),benign(0-023),,1,,
chr17:43067735:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,
chr17:43093784:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.209|None|None|benign:0.209|benign:0.209,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093784:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337008:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-16),,,,
chr17:43092125:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32315643:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43079015:C>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43127820:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32336453:T>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-3),,1,,
chr13:32338490:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43082529:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32338832:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-539),0&1&1,1&1&1,,
chr17:43092490:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,4.942e-05,
chr17:43045764:CTCGGGTCACC>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1,,pathogenic
chr13:32338969:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001574905,
chr13:32332507:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32379745:AACA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43094453:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43098243:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr17:43124331:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093426:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32344690:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,
chr17:43047702:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/22,,-1,,tolerated(0-13),benign(0-085),,1,,
chr13:32398202:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32346860:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,tolerated(0-1),possibly_damaging(0-869),,1,,
chr13:32336719:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.647e-05,
chr13:32379747:C>T,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,
chr17:43093080:CT>A,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092522:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339924:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43096433:A>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32379882:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43094549:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr17:43092818:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43058655:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32351187:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32396854:CA>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43104222:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0),,,,,
chr17:43065589:T>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32337685:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43071198:AGAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32337280:ATA>CAT,,,,,,,,,,,,,,,Latin American/Caribbean|African American|-,,"Latin American/Caribbean| Latin American/Caribbean| Bahamian""""| Latin American/Caribbe|Western European|African|-|Asian| Trinidad West Indies| African American|None Specified|""""African",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43094546:T>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32341596:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43113156:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43104263:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr17:43060158:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43057084:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-002),0&0&1&1,1&1&1&1,8.236e-06,
chr17:43104263:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr17:43124010:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin-American/Caribbean|-Nicaragua,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr17:43093651:A>C,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333367:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336954:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-526),,1,,
chr17:43093073:TA>T,,,,,,,,,,,,,,,Western Europe|-|Central/Eastern Europe,,Central/Eastern European| Central/Eastern Europe|Not Specified|Western European|English/Irish|-|-Central/Eastern-Europe|Western-European|Western Europe|Central/Eastern-European|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,1.647e-05,
chr13:32338986:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337528:A>G,,Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-913),,1,1.648e-05,
chr17:43093110:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339472:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-687),,1,,
chr17:43090967:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-687),,1,,pathogenic
chr13:32321537:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09615 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43124010:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,8.237e-06,benign
chr13:32337752:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-508),,,,
chr17:43092449:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32393238:C>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.23 (Asian)| 0.02 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,benign
chr13:32337141:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000741,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,0.0116|1.0894|0.3769,benign:0.091,0.0,0.0076,0.0,0.0,0.0,Latin American/Caribbean|African American|-,," Native American""""| Latin American/Caribbean""""|Western European|-| Native Americ|""""African|African| African|African American|""""Western European| Jamaican (Africian) Scottish""""|None Specified|Trinidad",M,1 - Not pathogenic or of no clinical significance,,0.001,4.97,7e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,,,1&1&1,0.001447305,benign
chr13:32336452:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),possibly_damaging(0-452),,1,,
chr13:32362716:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,,
chr17:43115708:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,
chr13:32362728:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,1.647e-05,
chr13:32353196:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32340375:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-283),,1,,
chr13:32379774:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1&1&1,,pathogenic
chr17:43111691:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32325166:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43092726:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43079499:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2194,0.3746,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.353435,benign
chr17:43111972:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32332942:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-264),,,0.000103959,
chr13:32340566:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-924),,1&1,,
chr17:43105332:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43094245:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43083270:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43119943:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32319105:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,
chr13:32333227:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,3.295e-05,
chr13:32326284:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/26,1,,,,,1&1,,
chr13:32333365:A>TA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32319170:G>C,,,,,,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32325185:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/26,1,,,,,1,,pathogenic
chr13:32340798:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.362,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-99),possibly_damaging(0-61),,1&1,,
chr13:32339763:ATG>C,,,,,,,,,,,,,,,Western Europe|-,,Not Specified|Western European|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43082516:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0233|0.0227|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,,
chr13:32370937:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,4.942e-05,
chr13:32326153:TC>A,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,,,
chr13:32371007:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43106515:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr13:32342723:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32363258:GA>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Western Europe|Dutch,,,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43092854:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43123969:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0001492655,
chr17:43104263:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43092854:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094029:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32333367:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000121,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Counsyl|Invitae|_University_of_Chicago|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,0.0118|0.0|0.0078,possibly-damaging:0.728,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-03),benign(0-104),0&0&0&1&1,1&1&1&1&1,,
chr13:32362585:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43094722:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32320840:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0582,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0157748,benign
chr13:32338986:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-426),,1&1&1,,
chr17:43090950:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,1.648e-05,
chr13:32339246:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-089),,,8.24e-06,
chr13:32319219:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,8.236e-06,
chr17:43106524:TT>C,,,,,,,,,,,,,,,,,Western-European|Western European|Western Europe,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32315728:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0041,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32370639:G>A,,,,,,,,,,0.004,0.0,0.0058,0.0,0.0174,,,,IVS,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.00499201,
chr13:32337172:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,6.59e-05,
chr13:32350201:C>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00159744,
chr13:32357726:TGTT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32336973:TA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32337678:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-584),,,2.471e-05,
chr17:43110694:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32367541:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43093391:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000103959,
chr17:43052675:T>C,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00159744,
chr13:32339592:A>C,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32337907:TGG>T,,,,,,,,,,,,,,,,,Sephardic Jewish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43047684:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1&1,,
chr17:43091565:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1&1,,pathogenic
chr17:43045545:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.517e-06,
chr13:32363642:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43072995:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32355114:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,
chr13:32330989:CTC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr13:32338566:CAAAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr17:43093277:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr17:43064742:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32341131:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-023),,,,
chr13:32398582:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32387908:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5061 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32340775:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43072015:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43082623:C>G,,,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,9.885e-05,
chr13:32323063:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43093658:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32383569:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43051131:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Splicing reporter minigene|Histopathology|-,,,,,,,,,,,,"Not Specified|Western European|Ashkenazi| Dutch""""|""""Western European",IVS,2 - Likely not pathogenic or of little clinical significance,,1.58,0.14,0.009,,0.04,intron_variant,MODIFIER,,18/21,-1,,,,,1,3.295e-05,
chr13:32357780:TGAA>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,16/27,,1,,,,,,8.236e-06,
chr17:43115677:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,8.237e-06,
chr13:32338482:GAAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32354910:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:0.986,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),probably_damaging(0-964),,1&1,,
chr13:32340633:AAAATGCCA>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32319262:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr17:43090963:CT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr13:32341167:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-984),,,0.000199681,
chr13:32332445:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-69),benign(0-003),,,,
chr17:43060129:T>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000998403,
chr13:32394739:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,Not Specified|East and Western Europe,,-|Caucasian,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-42),benign(0-155),,1,,
chr17:43091752:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32336348:A>G,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.816,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-059),,1,,
chr13:32391514:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43092918:GCC>C,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32364848:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43045773:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|very destabilizing|uncertain|predicted neutral|inconclusive|-|as wildtype control,peptide binding ability BRCA1-CtIP|Computational analysis|Multifactorial likelihood-ratio model|Transcription activation in human cells|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Thermostability assay|Thermodynamic stability prediction,-|1/1658,,,,,,,,,Greek|-,,Central/Eastern-European|Western European|-|Greek,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-98),,1,,
chr13:32329671:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr13:32326151:C>A,,,,,,,,,,,,,,,-|Italian,,Not Specified|Caucasian,IVS,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,8.24e-06,
chr13:32379883:G>A,,Ambry_Genetics|GeneDx|Invitae,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,4.943e-05,benign
chr13:32340579:GGAGT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43104234:T>TT,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,,pathogenic
chr17:43118212:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32339524:G>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32354859:G>T,,,In vitro (cloned)|Unknown,predicted deleterious|-|inconclusive,mRNA analysis (RT-PCR)|-|cDNA analysis,,,,,,,,,,Not Specified|-|Italian,,Western European|Western Europe|-|Caucasian|None Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,13/26,1,,,,,1&1&1,,
chr17:43053190:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32320545:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32354870:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx,,,,,,0.0|2.3853|0.8076,benign:0.105,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-09),benign(0-02),0&0&1&1,1&1&1&1,,
chr17:43123134:A>C,,,,,,,,,,0.3559,0.1566,0.3631,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.335064,
chr13:32319337:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr13:32337858:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Austria|-,0|-,Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.236e-06,
chr13:32337750:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian| Japanese,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-99),,1,,
chr13:32394810:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,,benign
chr17:43082208:TTAAGGCATT>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32346848:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(0-988),,1&1,,
chr13:32338726:G>C,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-099),,1,,
chr13:32346848:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,13/27,,1,,,,,1&1,,pathogenic
chr13:32338726:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.239e-06,benign
chr13:32333076:TCG>C,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32319223:CT>ATT,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32362695:ATT>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant&intron_variant,HIGH,,17/26,1,,,,,,,
chr17:43091951:T>C,,,,,,,,0.0116|0.0|0.0077,benign:0.004|None|None|benign:0.004|benign:0.004,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.237e-06,
chr17:43123081:C>G,,,,,,,,,,0.003,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr13:32339640:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,German|-,,Western European|Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-03),,1,,
chr17:43099807:TT>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,1/1658|-,,,,,,,,,Western Europe|-|Italian,," Central/Eastern European|Central/Eastern European| Central/Eastern Europe|Not Specified|Western European|-|None-Specified|-Italian/Sicily| Italian""""|Western-European|Italian|Central/Eastern-European|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1&1&1,8.236e-06,
chr13:32339997:AATC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr17:43063337:A>C,,,In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc),,,,,,,,,,,,Asian/Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,18/23,,-1,,,,,1,1.647e-05,
chr13:32374058:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000798722,
chr17:43049196:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32326602:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,1.647e-05,
chr13:32363286:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.603,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),benign(0-155),0&0&1&1,1&1&1&1,,
chr17:43057873:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43072002:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43092731:GA>G,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43056991:C>GGGAGTGGAATAC,,,,,,,,,,,,,,,-|French,1|-,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32339583:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-029),,1,,
chr17:43063898:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,,probably_damaging(0-999),,1&1,0.0001080755,
chr17:43049179:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.1816|0.0615,probably-damaging:0.999|None|probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-5),,1&1,,
chr13:32363286:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43099814:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1,,
chr17:43091951:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1,,pathogenic
chr13:32337339:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-331),,1,,
chr13:32337619:A>C,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,African American|-|Latina,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.00455657,
chr13:32388519:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43123532:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr17:43110292:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32363829:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43092273:C>TA,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32355312:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,
chr13:32339474:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-008),,1,,
chr17:43077761:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.98 (Asian)| 0.96 (African)| 0.98 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32340409:T>C,,Invitae,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.000103959,benign
chr13:32340499:TGTG>T,,,,,,,,0.0485|0.0235|0.04,None,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32333271:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Africian/American,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),possibly_damaging(0-549),,1,8.238e-06,
chr17:43090934:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32339285:TA>G,,,Unknown|Germline (inherited),,,,,,,,,,,,Flemish/Canadian|-,1|-,Unknown|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32333327:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-022),,1,,
chr17:43104271:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,1.647e-05,
chr13:32358436:A>G,,,,,,,,,,0.0,0.0121,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00319489,
chr13:32371101:C>A,,,In vitro (cloned)|Unknown,-|as variant control,mRNA analysis (RT-PCR)|-,1/1658|-,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/26,1,,,,,1&1,,
chr13:32379885:C>CA,,,,,,,,,,,,,,,HKSAR|-,,White-NonHispanic|Chinese,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43092847:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr13:32329420:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.251e-06,
chr17:43094459:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43084405:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr17:43119076:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43090962:TCTGG>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32332645:G>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.023|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,4.946e-05,benign
chr13:32356565:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-37),benign(0-009),,,,
chr17:43093441:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093650:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,6.589e-05,
chr17:43063932:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,4.118e-05,benign
chr13:32360864:G>A,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00239617,
chr17:43063922:CCC>T,,,,,,,,,,,,,,,French Canadian|-,,Western-European|-|-French-Canadian|None Specified,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,8.237e-06,
chr13:32370475:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-988),,1,,
chr17:43048440:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000599042,
chr13:32340212:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32397171:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43108806:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43103440:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32341836:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43106475:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,0&1,8.238e-06,
chr13:32340979:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092338:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43106455:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32398162:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43066316:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32395531:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr17:43094001:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,,pathogenic
chr17:43094535:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394459:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,
chr13:32333221:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,
chr17:43092986:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43104173:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr17:43104173:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1&1,0.000199681,
chr13:32394312:C>A,,,,,,,,,,0.0,0.0,0.0,0.0188,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00379393,
chr13:32337623:AC>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr17:43106455:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr13:32327919:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43048825:G>T,,,,,,,,,,0.0,0.0106,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.00359425,
chr17:43098583:T>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00159744,
chr17:43104173:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,8.236e-06,pathogenic
chr13:32385401:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32341116:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),possibly_damaging(0-804),,,,
chr17:43106455:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr17:43094316:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43106455:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr13:32385062:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5113,0.536,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511581,benign
chr17:43094459:G>A,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,0&1&1,,
chr17:43103557:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43054622:C>A,,,,,,,,,,0.006,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00139776,
chr13:32339025:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.068,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-253),0&1&1,1&1&1,,
chr13:32336799:TA>T,,,,,,,,,,,,,,,,,Pakistani,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43070980:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-13),benign(0-006),,1&1,0.0001121955,
chr13:32338624:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32336641:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43094279:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43048588:TGTGGTGGTGGTGGTGATAGTGATGGAGGTGATGTTGGTAATGATGGT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr17:43115729:A>T,,,,,,,,,,,,,,,,,Latin-American/Caribbean,M,5 - Definitely pathogenic,,,28.25,0.9972,0.81,0.81,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr17:43082572:TCT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr13:32331120:T>A,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00139776,
chr17:43092302:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32379464:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,8.236e-06,
chr17:43074523:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,
chr13:32336452:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,0.000103959,
chr13:32338964:C>A,,,,,,1/1658,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.004,,,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-881),,,,
chr13:32344562:CC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/27,,1,,,,,,8.251e-06,
chr13:32391252:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32338769:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,0&1,8.238e-06,
chr17:43088797:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00119808,
chr13:32338235:T>C,,Ambry_Genetics|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43121078:C>A,,,,,,,,,,0.3588,0.2179,0.3732,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353035,
chr13:32337227:T>G,,,,,,,,,,,,,,,,,Central/Eastern Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43117057:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32330946:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.237e-06,
chr17:43090058:CGGA>A,,,,,,,,,,0.3549,0.2194,0.3746,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.352835,
chr17:43095855:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,0.0116|0.0|0.0077,possibly-damaging:0.573|possibly-damaging:0.573|possibly-damaging:0.573|possibly-damaging:0.573|possibly-damaging:0.573,,,,,,,,Western-European|Not Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.237e-06,
chr17:43092801:TTGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43094695:TT>T,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32332844:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),benign(0-093),,,8.237e-06,
chr13:32338473:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-053),,,8.237e-06,
chr17:43124027:G>ACT,,,,,,,,,,,,,,,,,Latin American/Caribbean|Latin-American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,
chr13:32379893:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&0&1,1.648e-05,
chr17:43117950:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43078319:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3234 (Asian)| 0.128 (African)| 0.3522 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43057124:T>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32398389:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32334661:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32372278:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43091818:GGTATATT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43091018:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr17:43094515:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32396934:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063978:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,1.647e-05,
chr17:43092666:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43071527:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr17:43066655:A>T,,,,,,,,,,0.0089,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00239617,
chr17:43093033:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32341120:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.236e-06,
chr13:32398664:G>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43104205:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0),,,1,,
chr17:43094239:T>C,,,Unknown|Germline (inherited),,,,,,,,,,,,French?,,,N,,,,,,,,stop_retained_variant,MODIFIER,,,-1,,,,0&0&0&1,1&1&1&1,,
chr13:32356530:A>CA,,,,,,,,,,,,,,,,,Western European|None Specified,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,
chr17:43097344:CC>G,,,,,,,,,,,,,,,Malaysian|Greek|Austria|-|U.S.A.,1|-|7,Chinese|Greek|-|Malay|Hispanic|Indian,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr17:43092781:A>AT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338445:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-54),benign(0-03),,1,,
chr13:32340557:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-005),,,8.237e-06,
chr13:32340324:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-923),,1&1,0.0001204355,
chr13:32338445:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02236 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|1.8384|0.6306,benign:0.001,0.0,0.0166,0.0,0.0,0.0,Not Specified|Latin American/Caribbean|-,,Latin American/Caribbean| Latin American/Caribbean|Western Europe/Native American| Latin American/Caribbe|Not Specified|Western European|-|African|Asia/Latin American/Caribbean|African American|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-51),benign(0-029),,1,0.003052985,
chr17:43057124:T>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-022),,1&1,,
chr17:43094389:AGCAGCCTCTAGAGGTCACCCCAGGCTGGGTGTGGTGACTCATGCCTGCAATCCCAG>T,,,,,,,,,,,,,,,,, Latin American/Caribbe|Not Specified|Western European|-Latin-American/Caribbe|Western-European|Latin-American/Caribbean,F,,,,,,,,frameshift_variant&stop_lost,MODIFIER,,,-1,,,,,,,
chr17:43092669:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43104685:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000399361,
chr13:32339204:G>C,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-328),,1,,
chr17:43092107:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32319335:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,
chr13:32382396:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32381266:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32338981:G>GA,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339584:TAG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32329494:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,8/26,1,,,,,1,,
chr17:43092256:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,0&1&1,8.236e-06,
chr13:32336480:A>G,,,,,,,,,,,,,,,,,Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-098),,1,1.647e-05,
chr17:43101016:T>A,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00199681,
chr13:32398156:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,
chr17:43091748:AC>T,,,,,,,,,,,,,,,-|Italian,,Western Europe|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32342490:G>T,,,,,,,,,,0.008,0.0,0.0043,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00239617,
chr17:43092436:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43090832:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.285 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32349587:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43103399:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32325054:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,0.0|0.0227|0.0077,None,,,,,,,,Africa,IVS,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,8.237e-06,
chr13:32332504:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32337756:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,1,1.647e-05,
chr13:32338299:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-011),,1,,
chr17:43047599:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.0001121955,
chr17:43091654:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32330965:CCAGG>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr13:32339036:T>A,,,Unknown|Germline (inherited),,,,,,,0.0,0.0061,0.0,0.0,0.0,Latin American/Caribbean|-,,Latin American/Caribbean| Latin American/Caribbean|Western European|-|African|African American|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-193),0&1,1&1,0.00116112,
chr13:32347343:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43092965:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00018. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01399 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43104260:G>C,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained&splice_region_variant,HIGH,6/23,,-1,,,,,1&1,,
chr13:32340988:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,African American,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr13:32380462:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32319285:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32326469:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,2.471e-05,
chr17:43091757:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32338913:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-017),,1,,
chr17:43071163:CCA>G,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr17:43057229:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43070965:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-104),,,1.647e-05,
chr17:43076522:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32333304:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-2),benign(0-045),,1,,
chr17:43091460:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339706:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338675:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.246e-06,
chr17:43047629:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr17:43122970:T>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32336783:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-036),,1,,
chr13:32379786:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.238e-06,
chr13:32343003:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43120592:C>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32397453:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0129,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00339457,benign
chr17:43094075:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43067690:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,1,0.0001574905,
chr17:43071056:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-006),,1,,
chr13:32380116:A>T,,,In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1&1,,
chr13:32340372:G>C,,Invitae,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.651,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-193),,1,,
chr17:43061987:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32336530:C>T,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43094294:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,0.0001121955,
chr17:43094150:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Invitae,In vitro (cloned),predicted deleterious|inconclusive,evolutionary conservation analysis,,,0.0116|0.0|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,Western European|-,,Western European|-|French-Canadian|Central/Eastern European,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr13:32370558:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/26,1,,,,,1&1,,pathogenic
chr13:32376023:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32337153:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43094075:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000186,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0227|0.0308,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319327:A>C,,,,,,,,,,,,,,,,,Western European| Asian,IVS,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,,1,,
chr13:32330949:G>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32337106:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32338361:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32370558:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/26,1,,,,,1&1,,pathogenic
chr13:32357884:TG>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1&1,,
chr13:32332697:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr17:43071232:G>A,,CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.5447|0.1845,probably-damaging:0.997|probably-damaging:0.997|probably-damaging:0.997|probably-damaging:0.997|probably-damaging:0.997,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),benign(0-367),,1&1,,
chr17:43049202:T>A,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,French Canadian|-,,French Canadian|-|None-Specified,IVS,1 - Not pathogenic or of no clinical significance,0.18,1.35,0.01,0.00012,,0.04,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,1,1.647e-05,
chr17:43094604:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,8.236e-06,
chr13:32370042:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32339475:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-086),,,,
chr13:32344587:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-09),probably_damaging(0-977),,1,,
chr17:43052001:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43115729:AA>C,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43093481:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43063358:TC>AAAA,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,,,
chr17:43092069:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43115781:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1&1,,
chr13:32363367:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32371474:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43051983:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0238,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00499201,
chr13:32384823:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32393779:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43057003:T>AGGAGTGGAATAC,,,,,,,,,,,,,,,,1|3|-,,IVS,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32374333:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,
chr17:43067614:T>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-788),,1&1,,
chr13:32336893:T>C,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0031,Sri Lankan,,Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0009028015,
chr13:32355261:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,,
chr13:32340981:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-82),benign(0-004),,1&1,,
chr17:43098205:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-82),benign(0-004),,1&1,,benign
chr13:32338966:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-881),,,,
chr17:43092662:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094113:G>A,,,,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32394672:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094530:A>T,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,,,9.65,0.0266,0.02,0.02,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43057137:G>C,,,,,,,,,,,,,,,,,Western-European|-Central/Eastern-Europe|-,IVS,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1&1,,
chr17:43095454:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32356550:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,-|1/1658,,0.0116|0.0|0.0077,None,,,,,,Not Specified|Malaysian|-,,"Latin American/Caribbean|Native American| Central/Eastern European""""|Chinese|Central/Eastern Europe|Not Specified|Western European|-| Ashkenazi""""|Asian|English|Western Europe|""""Western European|White|None Specified|Central/Eastern European",N,,,,,,,,stop_gained,HIGH,15/27,,1,,,,,1&1,2.471e-05,pathogenic
chr17:43093356:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43055445:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05145 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0586,0.003,0.0461,0.0,0.0133,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0215655,benign
chr13:32338043:AG>T,,,,,,1/1658,,,,,,,,,British?|-,,Western European|Western Europe|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332853:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),benign(0-056),,1,,
chr13:32329469:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),benign(0-056),,1,,pathogenic
chr17:43086012:A>C,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00199681,
chr13:32370986:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-41),benign(0-039),,1&1,1.647e-05,
chr13:32362566:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-03),benign(0-125),,1,,
chr13:32330992:AAGTA>A,,,,,,,,,,,,,,,,,Irish/English/Native American,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,
chr17:43094442:CC>A,,,,,,,,,,,,,,,-|Italian,,-|Latin-American/Caribbean|None Specified|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32398600:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43103340:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43093604:A>C,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339336:A>TG,,,,,,,,,,,,,,,Western European,,,F,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32354507:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32356449:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-13),benign(0-254),,,,
chr13:32326483:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,8.236e-06,
chr13:32370904:A>G,,,,,,,,0.0|0.5137|0.157,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,
chr13:32337580:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,2.472e-05,
chr13:32333277:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-009),,1,,pathogenic
chr17:43092449:C>A,,,In vitro (cloned)|Unknown,predicted deleterious|-,-|evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,Western-European|Western European|-,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,2.471e-05,
chr13:32379334:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43106131:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1463 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr13:32344563:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-01),possibly_damaging(0-742),,0&1&1,,
chr17:43093683:AGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-01),possibly_damaging(0-742),,0&1&1,,
chr17:43069161:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32394947:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,8.236e-06,
chr13:32332296:A>G,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_retained_variant,LOW,10/27,,1,,,,,1,,
chr17:43094152:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43097265:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,8.237e-06,
chr13:32336936:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,2.471e-05,
chr13:32338069:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43124028:CT>CTCT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32344563:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-09),benign(0-27),,0&1&1,,
chr17:43110548:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,7.465e-05,
chr13:32332829:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),benign(0-009),,1,,
chr13:32398238:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32339751:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-006),,,8.237e-06,
chr13:32394864:TG>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-006),,,,pathogenic
chr13:32341046:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),possibly_damaging(0-713),,1,,
chr17:43097331:TG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,8.257e-06,
chr13:32337048:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-193),,1,,
chr13:32331802:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000998403,
chr17:43091053:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32383835:T>C,,,,,,,,,,0.2078,0.1846,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.225439,
chr17:43093569:T>CT,,,,,,,,,,,,,,,,, Pakistan|Chinese|-|None-Specified|Asian|Near Eastern|Western-European|Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43115789:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43097292:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,1&1,,
chr17:43092845:TT>-,,Pathway_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32336433:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-092),,,8.238e-06,
chr13:32357755:T>A,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1&1,,
chr17:43093134:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32359789:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1606 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2087,0.208,0.1988,0.369,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.232827,benign
chr17:43054161:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43092113:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000592. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|3.0867|1.0534,benign:0.03|None|None|benign:0.03|benign:0.03,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr17:43091840:C>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0002161555,
chr13:32394887:AG>AGAG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,pathogenic
chr17:43084026:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43092844:CG>C,,,,,,,,,,,,,,,Argentinean/Italian-Spanish,4,Latin American/Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32347707:C>T,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000599042,
chr13:32333122:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32340450:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,,,
chr13:32380061:C>G,,,In vitro (cloned),predicted neutral|predicted deleterious|no evidence for aberrant splicing,Protein likelihood ratio model|splicing reporter minigene assay|Co-localization to predicted ESEs,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,benign(0-003),,1,,
chr17:43092465:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,benign(0-003),,1,,pathogenic
chr13:32394863:GAT>C,,,,,,,,,,,,,,,Czech|-,,Central/Eastern European|Not Specified|Western European|-|Unknown|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,25/27,,1,,,,,,,
chr17:43045028:A>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000333686,
chr17:43087611:C>G,,,,,,,,,,0.3588,0.2186,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.353634,
chr13:32336941:AAATCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr17:43093319:GAG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43071078:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-003),,1,,
chr17:43091596:CATTG>G,,,,,,,,,,,,,,,French?|-,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32371013:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),possibly_damaging(0-78),,1,,
chr13:32380095:G>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.236e-06,
chr17:43093705:TTCT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32379386:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43071078:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-003),,1,8.236e-06,
chr13:32339036:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.9759|0.3306,benign:0.261,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-193),0&1,1&1,,
chr13:32340754:AAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-193),0&1,1&1,,
chr17:43057135:A>C,,,In vitro (cloned),as wildtype control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/22,,-1,,tolerated(0-06),benign(0-176),,,,
chr17:43114939:G>T,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00119808,
chr17:43107996:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr17:43049117:CAGG>T,,,,,,,,,,,,,,,Hong Kong|China|-,,-|Chinese,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,20/21,-1,,,,,,,
chr17:43071091:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-02),,1,,
chr17:43093428:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32395988:T>TA,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0002089,
chr13:32398319:C>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43124120:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr13:32342540:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32338518:CA>C,,,,,,1/1658,,,,,,,,,-|British?,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092535:AG>TA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32371595:G>C,,,,,,,,,,0.007,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00199681,
chr17:43124013:C>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr17:43097292:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr17:43104938:G>A,,,,,,,,,,,,,,,,1,,Syn,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr13:32336446:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32355095:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,0.224,
chr17:43125258:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.704e-05,
chr13:32370576:T>G,,,In vitro (cloned)|Unknown,as wildtype control|-,mRNA analysis (RT-PCR)|-,,,,,0.0,0.0386,0.0,0.0,0.0,Austria|-,0|-,,IVS,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,0.00668985,
chr13:32337038:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr13:32356596:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-95),,,,,
chr17:43091663:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43063347:G>A,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,German|-,2|-,Western European|Western Europe|-|Caucasian|None-Specified,N,,,,,,,,stop_gained,HIGH,18/23,,-1,,,,,1&1,,
chr17:43091529:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32355212:C>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,
chr13:32340446:GA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43104086:CCTCTG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0008704,
chr13:32337038:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-037),,,,
chr17:43091456:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32330970:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1,,pathogenic
chr17:43097307:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1,,benign
chr13:32339720:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,1,,
chr17:43117621:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32339291:GAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32347169:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43124118:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,0.0,0.0,0.0,0.0,0.001,Malaysian,,Chinese,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,0.0001574905,
chr17:43093219:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091567:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43060152:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32339510:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-138),,1,,
chr13:32325099:TTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,4/27,,1,,,,,,,
chr13:32392235:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43097307:A>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1&1,,
chr13:32340512:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-036),,,0.000103959,
chr17:43096321:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32341093:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32398203:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332992:T>C,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,-|1/1658,,0.1047|0.0227|0.0769,possibly-damaging:0.842,0.002,0.0,0.0,0.0,0.0,Not Specified|Western Europe|-|Central/Eastern Europe,1|-,"|Russia/Hungary/Checkoslovakia/Ashkenazi| French Canadian|Western European| Central/Eas|Ashkenazi|Latin American/Caribbean|Western Europe/Native American|Not Specified| Central/Eastern Europe|-|None Specified| English""""| Ashkenazi""""| Central/Eastern European|Russia/Hungary/Czechoslovakia/Ashkenazi| Pol|African| Polish|Native American| Native American| Native American""""|Central/Eastern European| Ashkenazi|French Canadian|Western Europe|""""Western European",M,2 - Likely not pathogenic or of little clinical significance,0.16,,,0.004,0.02,0.02,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),benign(0-037),,1&1&1,0.0005579805,
chr17:43092800:CTGAGG>C,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32325083:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,1,8.237e-06,benign
chr17:43115721:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,pathogenic
chr17:43082287:A>T,,,,,,5/1658,,,,0.0845,0.025,0.0231,0.0913,0.0982,Malaysian|-,,-|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,0.0642971,
chr17:43060847:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43115721:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,pathogenic
chr17:43090065:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (Asian)| 0.05 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,benign
chr17:43105984:G>A,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.00119808,
chr13:32336343:T>C,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),,0&1&1,1&1&1,0.0001080755,
chr13:32398734:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43115721:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,
chr17:43082439:G>TC,,,,,,,,,,,,,,,,,Western European|None-Specified,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr13:32370429:A>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,Not Specified|Western Europe|-,,Not Specified| Turkey|-|Near Eastern|Western European,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-11),benign(0-005),,1,,
chr17:43045658:G>A,,GeneDx,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43039471:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32325111:A>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.001,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,0.000328351,
chr13:32355030:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),,,1,,
chr13:32381875:ACTT>C,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00159744,
chr13:32398099:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32339992:TGAA>G,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43063953:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43056288:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32339273:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-892),,0&1,1.648e-05,
chr13:32381563:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43074331:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43097280:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000782. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Counsyl|Invitae|Pathway_Genomics|_University_of_Chicago|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|slight enhancement del ex9-10|-|?,-|Multifactorial likelihood-ratio model|splicing reporter minigene/patient RNA analysis|?,,,0.0|0.6809|0.2307,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,0.0,0.0113,0.0,0.0,0.0,,," Sephardic|-Latin-American| Latin American/Caribbean""""|-Mediterranean|-Ashkenazi|-Native-American|-|None-Specified|Not Specified| Native American""""|Ashkenazi| Italian""""|African|Western-European|""""African|African American|-African|Latin-American/Caribbean|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.00501,0.00029,0.00027,0.0,0.02,0.13,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,0.001967155,
chr13:32344547:G>A,,,,,,,,,,,,,,,,,African,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr13:32337254:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),,,1&1,,
chr17:43104086:C>A,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,Intronic,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,0&1,,
chr13:32325175:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43079204:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3646,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.335463,benign
chr13:32337263:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.238e-06,
chr13:32376970:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43082564:GCC>G,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,1,,
chr17:43074331:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43092742:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338712:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&1&1,1&1&1,8.24e-06,
chr13:32368999:T>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00139776,
chr13:32357824:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-1),probably_damaging(0-999),,1,,
chr13:32338358:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32387438:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32340098:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-016),,1,,
chr13:32354896:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-09),possibly_damaging(0-544),,,8.236e-06,
chr13:32396874:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43118425:T>A,,,,,,,,,,0.0,0.0507,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.013778,
chr13:32339421:TTCCT>C,,,,,,,,,,,,,,,German,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338949:A>T,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-962),,1,,
chr13:32316108:CTATCTTGCGTTAACGTAATTA>G,,,,,,,,,,0.001,0.0061,0.0,0.0,0.002,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.00219649,
chr13:32332667:->TTAG,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr17:43091595:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32378476:G>C,,,,,,,,,,0.0,0.0363,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00998403,
chr13:32331064:TTTT>TTTGTTG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.27e-06,
chr17:43104959:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,"""""Latin American/Caribbean| Hispanic Columbia""""",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,pathogenic
chr13:32349851:T>G,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0736821,
chr13:32340677:TGA>C,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32326211:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,8.239e-06,
chr13:32379437:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32336805:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32341112:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32338638:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32396990:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32363439:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32362707:A>G,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr13:32363470:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr17:43074348:AAGT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43123419:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32340083:AAT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336675:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-061),,1,,
chr17:43049238:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr17:43049238:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr13:32357817:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),benign(0-028),,,8.236e-06,
chr13:32340680:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-73),benign(0-021),,1&1&1,,
chr13:32339520:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),possibly_damaging(0-674),,,8.243e-06,
chr17:43047645:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&coding_sequence_variant,LOW,21/22,,-1,,,,,,,
chr13:32340107:ACA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32364036:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0295,0.0908,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0726837,benign
chr17:43047692:CG>T,,,,,,,,,,,,,,,,,Western-European|Western European|-Germany,F,,,,,,,,frameshift_variant,HIGH,21/22,,-1,,,,,,,
chr13:32370946:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,1.647e-05,
chr17:43093139:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333004:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-093),,,,
chr13:32336222:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.9777|0.3311,None,0.0,0.0227,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00359271,benign
chr17:43093697:G>C,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Native-American|Central/Eastern Europe|-Indian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43049328:G>T,,,,,,,,,,0.003,0.0,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00119808,
chr17:43125260:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,0.002,0.0,0.0,0.0,0.0,Italian,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.000399361,
chr13:32338270:T>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32337625:AGCCT>G,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338218:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-106),,1,8.263e-06,
chr13:32377317:G>T,,,,,,,,,,0.2078,0.0825,0.1902,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.197284,
chr13:32328344:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32337531:TG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32326079:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,3.296e-05,
chr17:43095921:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,,,
chr13:32339850:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-099),,1,,
chr13:32339850:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-373),,1,,
chr13:32340005:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-477),,1&1,,
chr17:43072516:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32363238:C>G,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Latin American/Caribbean|Not Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,8.236e-06,
chr17:43092919:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,
chr17:43092361:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.237e-06,
chr13:32351657:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32340005:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-061),,1&1,,
chr17:43092919:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,benign
chr13:32370549:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-02),probably_damaging(1),,,,
chr17:43092919:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1362 (African)| 0.3654 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,33.593|19.9955|49.3157,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,
chr13:32363332:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,pathogenic
chr13:32363199:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-933),,1,,
chr17:43057075:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-276),,1&1,,
chr13:32340317:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-329),0&1,1&1,3.295e-05,
chr13:32394874:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-06),benign(0-258),,,,
chr13:32396088:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32356514:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1&1,,
chr17:43093412:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43066316:C>A,,,,,,,,,,0.3588,0.2179,0.3746,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.353634,
chr17:43093376:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.1135|0.0384,benign:0.016|None|None|benign:0.016|benign:0.016,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32394828:A>G,,Ambry_Genetics|Invitae,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,0.0001080755,benign
chr13:32318598:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.7063 (Asian)| 0.5183 (African)| 0.7084 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32340566:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43067324:C>T,,,,,,,,,,0.2734,0.146,0.2752,0.1786,0.4366,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,0.252796,
chr17:43057075:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-04),,1&1,,
chr17:43082487:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr13:32357623:ATTT>C,,,,,,,,,,,,,,,Austria,1|0,,IVS,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32398341:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43067403:A>T,,,,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00499201,
chr13:32332296:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1,8.238e-06,
chr17:43104148:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32332840:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,0.0,0.0,0.0,0.0069,0.0,Malaysian,,Chinese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1&1,0.00084713,benign
chr17:43093124:GCC>T,,,,,,,,,,,,,,,German|American|-|Dutch,1|2|-,Czech/German|Pakistani|Western Europe|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32337617:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,, Portuguese| Native American|Central/Eastern European|Western European|-|African|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-098),0&1&1,1&1&1,8.24e-06,
chr13:32376654:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,0.000199681,
chr13:32376654:C>G,,GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|Western Europe|-,,Western European|-,IVS,2 - Likely not pathogenic or of little clinical significance,0.17,1.86,0.02,0.003,,0.34,intron_variant,MODIFIER,,20/26,1,,,,,1,0.0001894,
chr13:32373077:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43094536:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32339987:AAC>-,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43045711:C>GT,,,,,,,,,,,,,,,,,Central/Eastern Europe|Unknown|-|Western European|Western-European|Western Europe|None-Specified,F,,,,,,,,frameshift_variant&stop_retained_variant,HIGH,22/22,,-1,,,,,1&1,,
chr17:43049178:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-124),,1,,
chr13:32340951:TCT>C,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43076486:GC>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,12/21,-1,,,,,,,
chr17:43093232:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43093232:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32319298:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32346846:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,8.238e-06,
chr13:32340684:G>C,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-02),,1,,
chr17:43049149:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,tolerated(0-09),benign(0-026),,1,,
chr13:32351338:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0367,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00798722,
chr17:43095820:G>C,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32355293:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,,2.471e-05,
chr13:32363211:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),0&0&0&1&1,1&1&1&1&1,,
chr13:32338760:GACAT>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32340283:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43083047:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43092733:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43052693:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32338542:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000895,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Pathway_Genomics|GeneDx|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.5677|0.1923,benign:0.02,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-089),,1&1,,
chr17:43106479:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),as variant control,E3 Ub-ligase activity assay BRCA1/RING-BARD1,,,,,,,,,,,,Caucasian,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,0&1&1,1&1&1,,
chr13:32328640:C>A,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00678914,
chr17:43082556:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr17:43092530:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32336399:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),,,1,,
chr17:43093565:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32347584:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32336399:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-66),,1,,
chr13:32380596:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32379440:A>T,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,Western Europe|-|Italian,,Western European|Western Europe|-|Caucasian,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,
chr17:43091944:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,"""""Western European| Central/Eastern European""""",M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092853:TTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32319099:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,8.237e-06,
chr17:43111593:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32337701:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-263),,,,
chr13:32336482:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-05,benign
chr13:32363429:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),possibly_damaging(0-836),,1,,
chr13:32340929:CTATAAGT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43115711:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32332696:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43091944:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43117575:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32333006:C>T,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43097306:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000319,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,,
chr17:43090918:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.246e-06,
chr13:32338306:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.251e-06,
chr17:43045814:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,8.236e-06,
chr17:43047657:G>C,,,In vitro (cloned),predicted neutral|affects RNA splicing|uncertain,transcription activation/PS/BA/BS|mRNA analysis|Multifactorial likelihood-ratio model,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0-03),benign(0-007),,1&1,,
chr17:43094274:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32326575:TAGC>AGG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,7/27,,1,,,,,,,pathogenic
chr17:43106515:GCT>AGC,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32389727:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32348561:T>G,,,,,,,,,,0.0,0.0083,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00219649,
chr17:43093232:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32398499:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,1.647e-05,
chr13:32383277:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43115779:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,,0&1,,
chr13:32344075:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43045717:C>T,,,In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European|-Central/Eastern-Europe,M,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,
chr13:32370337:CCA>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr13:32339572:TTTAAGT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32344446:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr13:32316504:->ATT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr13:32340659:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-037),,1,,
chr13:32340131:AAG>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398876:G>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43089551:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32318450:G>C,,,,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00199681,
chr13:32336987:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,1&1,1&1,,
chr13:32398558:T>G,,,Unknown|Germline (inherited),,,,,,,,,,,,-|Spanish,,"Latin American/Caribbean| native american""""|Central/Eastern European|Western Europe|Caucasian|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.0004,0.0589,0.195,0.0,0.02,0.02,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,4.942e-05,
chr13:32339514:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32370690:C>T,,Genetic_Services_Laboratory|_University_of_Chicago,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,
chr13:32337315:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-126),,1,,
chr13:32371043:CTG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr17:43091489:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr17:43093951:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32329467:ATA>C,,,Unknown|Germline (inherited),,,2/1658|-,-|FA FANCD1_00012,,,,,,,,Not Specified|Western Europe|-,,Latin American/Caribbean|Central/Eastern European|Central/Eastern Europe|Western European|-| Hispanic|Latina|Western Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,4.947e-05,
chr13:32344558:C>T,,,,,,,,,,,,,,,,,Not Specified|None Specified,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32339765:GT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr17:43091918:G>T,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43121448:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32338767:TTT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32340035:G>TA,,,,,,,,,,,,,,,German|-|Dutch,,Not Specified|Western European|German|Asian| Japan|Caucasian,F,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32319070:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),no splicing defect|-|as variant control,-|cDNA analysis|splicing reporter minigene/patient RNA analysis,-|6/1658,,,,0.003,0.0,0.0029,0.0,0.001,Austria|Italian|-|Spanish,1|0|-,-|Caucasian,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,2/26,1,,,,0&0&0&1&1&1,1&1&1&1&1&1,0.00176154,
chr13:32357845:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32339514:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43059207:G>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr17:43067677:C>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-788),,1&1&1&1,,
chr17:43092387:C>G,,,,,,,,,,,,,,,,,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093197:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,0&1,1.647e-05,
chr13:32340248:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-029),,1,,
chr13:32388406:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05894 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32341094:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.003,,,,,,,,Western European|Western/Central/Eastern Europe|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-013),,1,2.471e-05,
chr17:43097304:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,1.648e-05,
chr13:32332391:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-465),,1,,
chr13:32319055:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.25e-06,
chr17:43067677:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43090963:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,0.0,0.0,0.0,0.002,0.0,Malaysian,2,Malay,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1&1,0.0002120355,
chr17:43092353:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32325460:ACAAT>A,,,,,,,,,,0.0,0.0234,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00678914,
chr17:43063363:CTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr13:32322642:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43094275:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43065857:A>T,,,,,,,,,,0.3569,0.1573,0.3646,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.335863,
chr13:32340507:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-019),,1,,
chr13:32336801:TC>G,,,,,,,,,,,,,,,Danish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32319259:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr13:32362618:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32394695:A>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),benign(0-068),,1,,
chr17:43049270:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr13:32332941:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-28),benign(0-246),,1,,
chr17:43115738:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.995,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1&1,,
chr17:43063332:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32396960:T>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063332:C>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32360755:C>T,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00139776,
chr13:32338304:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-049),,1,,
chr13:32319176:G>C,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,,Western European|Western Europe|-|Central/Eastern European|None Specified,M,1 - Not pathogenic or of no clinical significance,0.0011,1.28825,0.10715,0.0,0.02,0.02,missense_variant,MODERATE,3/27,,1,,,,,1,2.471e-05,
chr13:32379431:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr13:32341125:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-108),,1,,
chr17:43063332:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32338208:TAT>G,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063869:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,
chr13:32386146:GCAC>A,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr17:43122911:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43092089:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32380123:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr17:43091999:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32370433:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,0.0001039585,
chr17:43080340:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32379506:TTGCCTTAGACA>A,,,,,,,,,,,,,,,,,-|None Specified,S,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,,,1,,,,,,,
chr17:43105840:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43104241:TG>C,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,,
chr17:43093385:GC>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43115163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00199681,benign
chr17:43093279:GGCCCAGGTTT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43052761:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05081 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32362664:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,1,,
chr13:32363525:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32351155:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32358476:G>CA,,,,,,,,,,0.2724,0.2897,0.2522,0.1062,0.1697,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.220647,
chr17:43063928:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32398734:TT>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr13:32392589:AG>C,,,,,,,,,,0.3559,0.2897,0.3573,0.374,0.364,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.34385,
chr13:32339933:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32376699:G>T,,,In vitro (cloned)|Germline (inherited),predicted neutral|no splicing defect|-,splicing reporter minigene|Protein likelihood ratio model|-|family history|Multifactorial likelihood-ratio model,,,,,,,,,,,,Not Specified|Western European|-,M,1 - Not pathogenic or of no clinical significance,0.22909,0.04467,0.07762,2e-05,0.03,0.03,missense_variant,MODERATE,21/27,,1,,,,,1,1.647e-05,
chr13:32319178:G>TA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,stop_gained&frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32315831:C>A,,,,,,,,,,0.7843,0.5552,0.732,0.875,0.817,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.741214,
chr13:32379810:CGC>G,,,,,,,,,,,,,,,Danish|-,,Western European|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32354960:G>C,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),possibly_damaging(0-775),,1,,
chr13:32399625:C>A,,,,,,,,,,0.0,0.0174,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00459265,
chr13:32319061:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333439:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,4.211e-05,
chr17:43094756:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32348066:AATT>T,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00678914,
chr17:43121231:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.003,0.149,0.0187,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0425319,benign
chr13:32363576:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.252e-06,
chr17:43093401:T>C,,,,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340945:AT>C,,,,,,,,,,,,,,,,,Western European|White-NonHispanic,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049140:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1,,pathogenic
chr13:32354863:G>T,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,14/27,,1,,deleterious(0-04),,,1,8.238e-06,
chr17:43071280:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,8.244e-06,
chr17:43068048:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43109114:G>T,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00139776,
chr17:43063928:T>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-998),,1&1&1,,
chr17:43071147:A>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,benign
chr13:32363313:C>T,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0233|0.0|0.0154,probably-damaging:0.966,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-05),benign(0-126),0&0&1&1,1&1&1&1,,
chr17:43063928:T>C,,,In vitro (cloned),predicted deleterious|as variant control|strong functional effect,transcription activation/PS/BA/BS|Transcription activation in human cells|Structure-based prediction (crystallography etc),,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-967),,1&1&1,,
chr13:32340221:T>C,,,,,,,,,,,,,,,,,Asian| India,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-452),,1,,
chr13:32383506:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32332297:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32332511:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-55),benign(0-117),,1,,
chr13:32395036:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr17:43067579:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,1.647e-05,
chr17:43054917:C>T,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32337620:A>T,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32398409:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32354890:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-26),benign(0-067),,1,,
chr13:32336754:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-49),,,1,,
chr17:43120979:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0129,0.0015,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00379393,benign
chr13:32330931:T>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.237e-06,
chr13:32355251:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr17:43123960:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43074435:TT>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32336703:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-085),,1,,
chr13:32381627:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43092671:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32380166:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,6.595e-05,
chr13:32345112:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr17:43091759:CC>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379894:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32356588:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr13:32340629:AAAGAAAA>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43104997:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,8.237e-06,
chr13:32363485:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32323908:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32380776:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43063875:GG>G,,,,,,,,,,,,,,,-|Italian,,Western-European|Caucasian,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,17/23,,-1,,,,,1,,
chr17:43104136:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|-,Recombination rate|-,-|6/1658,,,,,,,,,Not Specified|Western Europe|-,," Native American|Irish| Central/Eastern European""""|White-NonHispanic|-Italy|Western European|-|None-Specified|-Irish|Unknown|Western-European|Western Europe|""""Western European|Central/Eastern-European|Caucasian|None Specified| Ashkenazi""""",N,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1&1&1,1&1&1&1&1,,pathogenic
chr17:43074471:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000309,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.3953|0.0454|0.2768,possibly-damaging:0.879|possibly-damaging:0.879|possibly-damaging:0.879|possibly-damaging:0.879|possibly-damaging:0.879,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr17:43094083:TGTTT>A,,,,,,,,,,,,,,,Western Europe/Native American,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43092621:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32333258:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-228),,1,,
chr13:32387794:A>T,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000998403,
chr13:32340175:GAAAGTTTCTAAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32338838:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-002),,1,,
chr17:43104136:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000109,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,," Native American| Ashkenazi""""|-|Western-European|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.0813,1.32,0.00501,1e-05,0.02,0.02,missense_variant,MODERATE,,,-1,,,,0&0&1&1&1,1&1&1&1&1,9.884e-05,
chr17:43059364:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32365653:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43074380:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32398704:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32379544:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43092621:T>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43076582:ATTAGATTTGTCTTTTCT>G,,,,,,1/1658,,,,,,,,,New Zealander,,European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,,,,,,,
chr17:43092647:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43074454:T>A,,,,,,,,,,,,,,,,,Latin-American/Caribbean,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,
chr13:32338070:A>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,benign:0.046,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-526),,1,,
chr13:32371114:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,benign
chr13:32355212:CA>G,,,,,,1/1658,,,,,,,,,,,White-NonHispanic|-,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32337614:ATG>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094495:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32354836:CAT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,2.474e-05,
chr13:32337260:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32317314:AAAGA>C,,,,,,,,,,0.2942,0.1172,0.2968,0.2827,0.3599,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.258387,
chr13:32357866:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr13:32338800:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32333182:C>AG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32338800:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),possibly_damaging(0-844),,,1.647e-05,
chr13:32379298:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr13:32333320:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43091653:T>A,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr13:32320668:C>T,,,,,,,,,,0.0229,0.0,0.0043,0.001,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00638978,
chr13:32320222:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32357724:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000103959,
chr13:32383784:A>G,,,,,,,,,,0.001,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43074472:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-04),,,1&1,,
chr17:43091759:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-04),,,1&1,,pathogenic
chr17:43092501:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-04),,,1&1,,pathogenic
chr17:43094317:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32326499:G>T,,,In vitro (cloned),major exon skipping,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1,,
chr17:43081825:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32356588:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr17:43067651:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,1.647e-05,
chr13:32338889:CT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,
chr17:43063913:C>A,,,,,,,,,,,,,,,-|Italian,1|-,-|Caucasian,Syn,,,,,,,,missense_variant,MODERATE,17/23,,-1,,,,,1,,
chr17:43094317:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32354968:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr13:32382007:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32337864:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-049),,1,,
chr13:32339773:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Emory_Genetics_Laboratory|Counsyl|Invitae,,,,,,0.0|2.4512|0.8304,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32326499:G>C,,GeneDx,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1,,
chr17:43111828:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32393030:CT>T,,,,,,,,,,0.0,0.0393,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0105831,
chr17:43093171:T>TC,,,,,,,,,,,,,,,-|Belgian,1|-,Western-European|-|None-Specified|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32393945:A>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr17:43045782:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-927),,1,,
chr17:43106544:GGCCC>T,,,In vitro (cloned)|Unknown,as wildtype control|-,-|cDNA analysis,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr13:32333144:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-295),,1,,
chr17:43093772:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-295),,1,,pathogenic
chr13:32332334:G>C,,,In vitro (cloned)|Unknown,predicted neutral| no LOH|-,HR assay|-| LOH assay,,,,,,,,,,,,Western European|Western Europe|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),probably_damaging(0-929),,1,8.239e-06,
chr13:32390367:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32344535:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.277e-06,
chr17:43091909:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363266:GAA>C,,,,,,,,,,,,,,,Not Specified|HKSAR,,-|Chinese,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43091785:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43063946:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1&1&1,,pathogenic
chr17:43118386:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32394956:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,3.295e-05,
chr13:32316202:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32357096:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr17:43063862:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr13:32389392:A>G,,,,,,,,,,0.0378,0.0008,0.0115,0.0883,0.1227,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0511182,
chr13:32369919:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340246:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-26),,1&1,8.237e-06,
chr17:43093301:GATC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32340792:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-86),benign(0-034),,0&1,8.239e-06,
chr17:43092261:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43092261:T>A,,GeneDx,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091771:G>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43093620:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398123:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.247e-06,
chr17:43122187:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32338369:->GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32319283:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32326072:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,2.472e-05,
chr17:43063899:AA>T,,,,,,,,,,,,,,,French?,,,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr13:32340000:C>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32380121:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr17:43092659:C>AT,,,,,,,,,,,,,,,Republic-of-Turkey,,Turkish,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43074555:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32337438:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-997),,1,,
chr13:32333043:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),possibly_damaging(0-549),,,,
chr17:43124076:G>A,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.0|0.4995|0.1692,None|None|None|None|None,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,0&1&1,1&1&1,0.00105817,benign
chr13:32362638:GAATTT>AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43113759:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43094329:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43090555:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32329877:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr13:32384860:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32339185:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43117718:G>A,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr13:32332677:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-103),,1,,
chr17:43074390:A>G,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.837|possibly-damaging:0.837|possibly-damaging:0.837|possibly-damaging:0.837|possibly-damaging:0.837,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr17:43093732:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082373:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.236e-06,
chr13:32380071:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43094329:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32339185:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32336723:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43095942:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.238e-06,
chr17:43091958:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43099363:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32323883:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32355005:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr13:32346885:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1&1&1,1.648e-05,benign
chr13:32337638:A>T,,,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43052617:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32337022:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32326233:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,1,,
chr13:32338086:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-508),,1,,
chr17:43092869:T>A,,,,,,,,,,,,,,,,,Western-European|Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,4.118e-05,
chr17:43092040:CTAGTATCTTC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32379613:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.004,0.0,0.0043,0.0,0.0,German|Austria|-,1|0|-,Austria|-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,0.00139776,
chr17:43092111:ACT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32337975:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-028),,1,,
chr13:32355196:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-108),,1,,
chr13:32337059:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),possibly_damaging(0-574),,1,8.237e-06,
chr17:43074539:C>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43120547:C>T,,,,,,,,,,0.0,0.0,0.0014,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43092874:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092860:AG>A,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32360605:CT>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32338204:A>AT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32330937:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43091480:A>G,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092092:AACA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32326336:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,,
chr13:32338776:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-474),,,8.238e-06,
chr13:32337292:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-94),,1,,
chr17:43122627:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32315981:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32389155:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32398606:G>GTGAATTATA,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0003459,
chr13:32345694:G>C,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000599042,
chr13:32341020:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-081),,1&1,,
chr13:32339616:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-053),,,8.238e-06,
chr13:32399167:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0598,0.0029,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0165735,benign
chr17:43086340:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32341092:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-45),benign(0-032),,1,,
chr13:32338948:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32332694:AT>G,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32362516:CT>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,,8.237e-06,
chr13:32320625:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32332446:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-187),,1,,
chr17:43094861:G>A,,,,,,,,,,,,,,,,,Asian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1,,
chr17:43093053:AA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363390:T>C,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,African American|African,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-97),,1,,
chr13:32355995:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr13:32326575:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,7/27,,1,,,,,,,
chr17:43057010:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000340701,
chr17:43123966:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0002944305,
chr13:32326575:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,7/27,,1,,,,,,8.236e-06,
chr13:32386596:A>G,,,,,,,,,,0.007,0.0008,0.0043,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00299521,
chr17:43092476:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363229:AC>T,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32362674:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,,8.236e-06,
chr17:43074303:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32344544:T>G,,,,,,,,,,,,,,,,,Central/Eastern European,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr13:32337153:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,pathogenic
chr17:43092805:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,pathogenic
chr13:32333719:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.1203,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0323482,benign
chr17:43104910:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned),predicted neutral|as wildtype control,E3 Ub-ligase activity assay BRCA1/RING-BARD1|evolutionary conservation analysis,,,,,,,,,,,,-|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,1,,
chr13:32337527:G>T,,,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32398419:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32351783:->ATTTT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32370954:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/26,1,,,,,,8.236e-06,
chr13:32340148:A>G,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.118e-05,benign
chr17:43099384:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32339309:T>C,,,,,,,,,,,,,,,,,Native American| Indian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-061),,1,8.239e-06,
chr17:43086485:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43091631:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43112726:AG>C,,,,,,,,,,0.3598,0.7262,0.3977,0.3661,0.5225,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.494808,
chr13:32357731:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,4.942e-05,
chr13:32338914:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-373),,,8.237e-06,
chr13:32357798:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),possibly_damaging(0-593),,1,,
chr17:43092179:A>GA,,,,,,,,,,,,,,,,,Western European|None-Specified| Central/Eastern Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340078:TAGAT>-,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32341126:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32396121:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32358859:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32337211:CTGG>A,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43048170:T>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000399361,
chr13:32355041:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,7.413e-05,benign
chr17:43074410:T>AAG,,,,,,,,,,,,,,,Western Europe|-,,Unknown|-,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32340995:G>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43095861:G>T,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.237e-06,
chr17:43094575:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32355041:G>Y,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,1,,
chr13:32355041:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-38),possibly_damaging(0-731),,1,1.647e-05,benign
chr17:43060439:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000998403,
chr13:32326064:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,
chr13:32371121:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.239e-06,
chr13:32326064:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,0.0001154,
chr17:43097236:G>C,,,In vitro (cloned),predicted neutral|as wildtype control,Splicing reporter minigene|mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/21,-1,1.0,,,,,,
chr13:32339331:->G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32362509:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5507 (Asian)| 0.5589 (African)| 0.5409 (European)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Emory_Genetics_Laboratory|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl,,,,,,49.6279|44.7751|47.9849,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,benign
chr13:32370413:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,pathogenic
chr13:32359800:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.9065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32333000:C>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-023),,,,
chr13:32376704:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32325138:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43094634:AGC>T,,,,,,,,,,,,,,,-|British,,Indian/Pakistani|Pakistani|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43092791:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43117801:C>G,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43092805:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32371042:TC>A,,,,,,1/1658,,,,,,,,,Not Specified|Western Europe|Scottish/Irish|-,1|-,Danish/Finnish/Norwegian/Swedish|White-NonHispanic| Latin American/Caribbe|Central/Eastern Europe|Not Specified|Western European|-| German|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr13:32337153:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-002),,1&1&1&1,,
chr13:32356411:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,
chr13:32340133:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-373),,1,,
chr13:32325138:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32337191:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),,1&1&1&1,,
chr17:43104087:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,9.602e-06,
chr17:43115611:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43099491:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2236 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43104087:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,
chr13:32340551:TAG>G,,,,,,,,,,,,,,,,,-|Ashkenazi,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32363373:C>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32380601:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32388079:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43099864:CCT>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43094601:GT>C,,,,,,,,,,,,,,,Not Specified|-,,Western-European|Western European|Western Europe|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32349557:G>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32330360:G>A,,,,,,,,,,0.0089,0.0008,0.013,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00399361,
chr13:32316495:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr17:43093025:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr17:43105501:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,
chr17:43057020:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0001204305,
chr17:43047681:T>C,,,In vitro (cloned),predicted deleterious|uncertain,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc),,,,,,,,,,German,4,,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),possibly_damaging(0-697),,1&1,,
chr13:32397021:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43099792:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,
chr13:32394776:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Malaysian,,Indian,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-04),benign(0-206),,1,4.942e-05,
chr17:43074407:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32386522:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32330992:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32338491:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-559),,,,
chr13:32380084:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32371885:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43074357:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43074452:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32321228:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43100928:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32332442:A>C,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-869),,1&1,,
chr13:32366751:A>T,,,,,,,,,,0.2734,0.2821,0.2464,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.208866,
chr17:43091459:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338266:CT>C,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093018:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,0.0001039585,
chr13:32341057:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr13:32371000:TGA>A,,,,,,,,,,,,,,,Czech|German|Western Europe|-|Native American,2|-," Portuguese|White-NonHispanic| French Canadian""""| French Canadian|Western European|-| Native American|French-Canadian| Near Eastern""""|French Canadian|Western Europe|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,8.236e-06,
chr13:32338400:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-51),benign(0-03),,,8.237e-06,
chr17:43081633:ATGTT>C,,,,,,,,,,0.001,0.0008,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000998403,
chr17:43099808:T>A,,,,,,,,,,,,,,,,,-|Asian,N,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1&1&1,8.237e-06,
chr17:43074920:GGAGCTGGGGGCCAT>A,,,,,,,,,,0.0,0.025,0.0029,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0071885,
chr17:43094072:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.0001204305,
chr13:32339572:TTTA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32355095:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,21.3256|20.7671|21.1364,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,0&1,1&1,,benign
chr13:32333138:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-311),,,,
chr13:32398306:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43099739:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,1.647e-05,
chr13:32396995:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337191:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093169:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340362:TA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340425:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European| Greek,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338922:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-169),,1,,
chr17:43091783:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43071240:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,,1,,pathogenic
chr17:43093107:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,,1,,pathogenic
chr13:32339420:GC>AAA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32397073:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32354065:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06993 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2724,0.2799,0.2478,0.0754,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.209265,benign
chr17:43045819:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,
chr17:43102743:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32381038:CG>G,,,,,,,,,,0.0089,0.0,0.0014,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00359425,
chr13:32347683:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43094140:CG>G,,,,,,,,,,,,,,,French?|U.S.A.,,Mexican American|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32341240:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,2.479e-05,
chr17:43091783:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000204,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|0.0227|0.0308,possibly-damaging:0.84|None|None|possibly-damaging:0.84|possibly-damaging:0.84,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,benign
chr13:32320148:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43057069:CC>C,,,,,,,,,,,,,,,,,"""""Western European| Near Eastern""""",F,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,1&1,,
chr17:43094144:TA>T,,,,,,,,,,,,,,,,,-|African,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32371027:CT>A,,,,,,,,,,,,,,,Western Europe|-,,-|Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr17:43091834:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43070952:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,0.0001121955,
chr17:43092532:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr17:43082296:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32354908:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.997,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-978),,1,,
chr17:43094635:G>ACATT,,,,,,,,,,,,,,,,,Near-Eastern,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063923:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32363389:G>A,,,,,,,,,,,,,,,,1,,Syn,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,0&0&1&1&0,1&1&1&1&0,,
chr17:43106520:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,,,,,,8.238e-06,
chr17:43047669:CA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,21/22,,-1,,,,,,,
chr17:43103278:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32338035:TG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32341117:G>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,
chr13:32357857:CCAGGCT>GCTGATGGTG,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&protein_altering_variant,HIGH,16/27,,1,,,,,,,
chr13:32338240:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32379861:G>GAA,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43048494:C>T,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000599042,
chr13:32339572:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1&1&1&1,8.239e-06,benign
chr13:32316462:C>G,,,,,,,,,,,,,,,Western Europe|-,,-|Latina,M,,,,,,,,start_lost,MODIFIER,,,1,,,,,1&1,8.237e-06,
chr17:43119520:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43120759:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32338603:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32354813:A>TTA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.65e-05,
chr13:32370448:C>A,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,Austria|-,1|-,Western European|-|None Specified|Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43097346:TA>T,,,,,,,,32.2878|19.1233|27.8375,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,0&1,,
chr13:32330889:A>C,,,,,,,,0.0|0.7045|0.2386,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43044804:CCCCCG>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.006738,
chr17:43094356:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32326226:GG>C,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,,
chr13:32339609:CTACGTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr17:43092122:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32340800:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43123968:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339425:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000459,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx,,,,,,0.0233|0.0|0.0155,probably-damaging:0.989,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-875),,1&1,,
chr13:32338137:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-132),,1&1,,
chr17:43060745:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32340746:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-007),,,,
chr13:32334210:G>T,,,,,,,,,,0.3091,0.2489,0.33,0.4633,0.3824,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.341454,
chr17:43124107:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093802:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,8.237e-06,
chr13:32394939:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,,,
chr13:32376688:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr17:43074477:TG>A,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43093574:CCTGC>T,,,,,,1/1658,,,,,,,,,German|Western Europe|-|American,2|-,Western Europe/Native American|Central/Eastern European|Not Specified|-german/belgian|-|Western European|None-Specified|Asian|Unknown|Western-European| Italian German|Caucasian|Native American,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091039:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr17:43057066:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,,,,,
chr13:32362738:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.0006732805,
chr17:43123108:A>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00119808,
chr13:32355003:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000334,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.5447|0.1845,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-002),,1&1,,
chr13:32319061:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,1&0&1&0,8.8e-06,
chr13:32333062:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,8.236e-06,
chr17:43074380:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32340366:AAGATAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32379853:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32384764:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43099699:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr17:43119205:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32333140:C>G,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|Western Europe|White- American|None Specified,M,1 - Not pathogenic or of no clinical significance,0.0002,1.99526,0.04898,0.0,0.02,0.02,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-893),,1&1,4.118e-05,
chr13:32377900:A>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00159744,
chr17:43067379:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43101650:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32370972:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,0&0&1&1&0,1&1&1&1&0,,pathogenic
chr13:32339421:T>CA,,,Unknown|Germline (inherited),,,,FA FANCD1_00007|-,,,,,,,,Danish|Near East/Mid East|-|Italian,,Central/Eastern European|Not Specified|Western European|-| Malta|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.244e-06,
chr13:32398289:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43063941:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32397071:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32325148:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319354:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,8.248e-06,
chr13:32359302:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43094104:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown,predicted neutral|predicted deleterious|-|?,co-occurrence with deleterious variant|-|evolutionary conservation analysis|?,,,0.0|0.2043|0.0692,possibly-damaging:0.926|None|None|possibly-damaging:0.926|possibly-damaging:0.926,0.0,0.0023,0.0,0.0,0.0,,,African American|-|None Specified|African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.000439521,
chr17:43074454:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43099791:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43074454:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32338762:TCT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43049141:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32337549:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-006),,1,,
chr13:32340612:T>C,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-772),,1,,
chr13:32363436:TGAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-772),,1,,pathogenic
chr17:43091859:T>G,,,,,,2/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43057184:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr13:32363187:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-47),benign(0),,1,,
chr13:32337628:CT>A,,,,,,,,,,,,,,,Austria,1,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049193:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,21/23,,-1,,,,,1,,benign
chr13:32338063:A>AA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43106501:A>C,,,In vitro (cloned),inconclusive,Host Cell End-Joing assay,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr13:32338716:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,8.24e-06,
chr17:43126716:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338550:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-007),,1,,
chr13:32337619:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43124135:->AT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43080487:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32336579:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-205),,1&1,,
chr17:43066652:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32354951:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,0.0001080755,
chr17:43092486:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32394733:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-11),probably_damaging(0-997),,1,,
chr13:32355332:A>C,,,,,,,,0.0|0.0683|0.0231,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,
chr13:32336579:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Latin American/Caribbean|Latin American/Caribbean/Western Europe,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,8.236e-06,pathogenic
chr17:43063869:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,
chr13:32379853:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1&1&1,,
chr17:43118761:C>CT,,,,,,,,,,0.2515,0.1082,0.2882,0.2569,0.3364,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.236422,
chr17:43124026:C>CGACA,,,,,,,,,,,,,,,Spain,,Spanish?,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,
chr17:43093759:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338485:ATGTC>A,,,,,,,,,,,,,,,Western Europe|-,,Western European|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063532:G>A,,,,,,,,,,0.004,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000798722,
chr17:43074394:C>A,,,,,,,,,,,,,,,-|Asian,,Western European|-|Filipino,N,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1,1&1&1,,
chr17:43094204:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43063854:A>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,benign
chr13:32398142:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000116,Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32373717:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43087725:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32337953:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-059),,1,,
chr13:32326578:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32354863:C>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.221,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,14/27,,1,,deleterious(0-04),,,1,,
chr17:43091819:A>GTA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32340151:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-187),,1,,
chr13:32343360:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43125312:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,0.0001985905,
chr17:43090959:GTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43071150:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1&1,,benign
chr13:32337286:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.648e-05,
chr13:32340059:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0227,0.0014,0.0,0.0,Not Specified|Latin American/Caribbean|African American|-,," Central/Eastern Europe|Western European| Cajun""""|Latin American/Caribbean|Not Specified|-| Hispanic|""""African| African|Haiti|""""Western European| British West I| Irish| Central/Eastern European| Native""""|African|African American|None Specified| Native American| Native American""""|Africa|Ethiopian|Native American/African American|Native American| Ashkenazi",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-072),,1,0.00392305,
chr17:43093013:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-072),,1,,pathogenic
chr17:43092633:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32355154:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067543:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1402 (African)| 0.2744 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,6/1658,,,,0.2744,0.1611,0.3084,0.372,0.4693,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,0.306909,benign
chr17:43092887:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32343048:AA>G,,,,,,,,,,0.2495,0.3351,0.2939,0.1587,0.229,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.25599,
chr13:32340469:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32340337:A>T,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-981),,1,,
chr13:32326867:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32370959:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-68),benign(0-084),,,8.236e-06,
chr13:32356586:AGACCGCACTCAGGA>C,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr13:32336351:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-81),,,,,
chr17:43090981:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1,,pathogenic
chr13:32362717:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.0001327855,
chr17:43051308:G>A,,,,,,,,,,0.3588,0.2194,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342851,
chr17:43094132:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340592:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32353519:C>G,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00199681,
chr13:32356455:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32342608:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000599042,
chr13:32357805:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32376702:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr17:43093055:AA>T,,,Unknown|Germline (inherited),,,5/1658|-,,,,,,,,,Danish|Denmark|-|Sweden|British|Norwegian|American|Western Europe,1|-|4,"-German|Central/Eastern European| Central/Eastern European""""|Not Specified|Western European|Latin-American/Caribbean|Native-American|-|Caucasian|-Mexico|Western-European|Western Europe|None-Specified|None Specified|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357963:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,1.647e-05,
chr13:32394688:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,24/26,1,,,,,1&1&1,,pathogenic
chr13:32356608:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.997,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/27,,1,,deleterious(0-03),benign(0-041),,1,,
chr13:32341162:TA>T,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093759:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,"Western-European| Italian/Irish/German/ French Canadian""""|""""Western European",M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr17:43093138:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339067:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-043),,0&1,8.237e-06,
chr17:43093999:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337497:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),,,1,,
chr13:32362522:C>GGA,,,,,,,,,,,,,,,Austria|-,1|-,,F,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,
chr13:32326557:G>C,,,,,,,,,,,,,,,,,Not Specified|Western European,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32375245:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5407 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32339700:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-007),0&1&1,1&1&1,,
chr17:43112322:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32361089:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43079599:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32396957:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093786:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32355071:A>G,,,In vitro (cloned),as wildtype control,Embryonic stem cell assay,,,,,,,,,,,1,,M,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr13:32339205:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-253),,1,8.238e-06,
chr17:43063295:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0001245505,
chr13:32374920:C>T,,,,,,,,,,0.0,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000998403,
chr13:32380559:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32363244:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43093455:GAC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339644:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32356426:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,14/26,1,,,,,1&1&1,,
chr13:32339197:TGT>G,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43086697:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32325130:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,,,
chr17:43055791:T>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr17:43045665:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32356420:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,1,,benign
chr13:32346876:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,,benign
chr13:32375046:C>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00159744,
chr17:43108852:A>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000998403,
chr13:32339783:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-077),0&1&1,1&1&1,,
chr13:32327154:G>C,,,,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0081869,
chr13:32338826:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43097582:G>T,,,,,,,,,,0.0229,0.0023,0.0115,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00738818,
chr13:32362698:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/26,1,,,,,,,
chr17:43044565:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094832:AAT>T,,,Germline (inherited),,,,,,,,,,,,Norwegian|Western Europe|-,,Western European|Western Europe|-|None-Specified|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32371062:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43086990:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32357720:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,1.648e-05,
chr17:43092082:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094550:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32341083:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-178),1&1&1&1,1&1&1&1,,
chr13:32339320:T>G,,,,,,,,,,,,,,,-|Central/Eastern Europe|Spanish,," Native American""""|Central/Eastern European|Western European|-| irish/german|Western Europe|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,8.239e-06,
chr17:43094550:A>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,Austria|-,0|-,,Syn,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1,0.000723721,
chr17:43093689:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32380161:G>C,,,,,,,,,,,,,,,Belgian,2,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43106522:G>C,,,,,,,,,,,,,,,USA,2,Caucasian/Native Alaskan,UV,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32337525:AGAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,pathogenic
chr17:43093653:A>TACTA,,,,,,,,,,,,,,,Western Europe|-|Central/Eastern Europe,,Not Specified|Western European|-|-Central/Eastern-Europe|Unknown|Western-European|Western Europe,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43093689:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43071004:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000627,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-027),,1&1&1&1,,
chr17:43059636:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32379837:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32338668:GG>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340487:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43063374:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32370957:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,20/27,,1,,,,,1,,pathogenic
chr13:32362511:A>C,,,,,,,,,,,,,,,Spanish,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,,
chr13:32341183:GAGGAG>C,,,,,,,,,,,,,,,,,Western European| Irish|-| German,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339531:GA>G,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063374:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32371100:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,20/27,,1,,deleterious(0-02),possibly_damaging(0-801),,1,,
chr13:32355038:C>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),,,1,,
chr17:43069579:T>A,,,,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.0179712,
chr13:32357936:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,
chr17:43047645:G>TA,,,,,,,,,,,,,,,Uruguayan,,French-Portuguese,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,21/22,,-1,,,,,,,
chr17:43051093:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-678),,1,,
chr17:43094401:A>T,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43067638:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000976,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0-04),benign(0-254),0&1&1,1&1&1,,
chr13:32347630:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32336685:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337540:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,0.0001039595,
chr13:32340237:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-477),,1,8.237e-06,
chr17:43093481:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32341034:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-253),,1,,
chr13:32339380:T>C,,Ambry_Genetics,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43102440:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32340783:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1&1,8.239e-06,
chr13:32340035:G>T,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43045800:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,22/22,,-1,,deleterious(0),benign(0-427),,1,,
chr17:43091912:T>C,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32331431:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00678914,benign
chr17:43091912:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326521:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1,,
chr17:43093320:AG>T,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32376902:A>T,,,,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr13:32369332:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32338559:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-067),,,,
chr17:43099891:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,8.236e-06,
chr17:43112507:G>C,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00159744,
chr13:32337870:A>G,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&0&1,1&1&1,,
chr17:43094628:A>CA,,,,,,,,,,,,,,,Scottish,2|-,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43117163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0023,0.0202,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00958466,benign
chr17:43092173:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32326384:A>C,,,,,,1/1658,,,,0.001,0.0,0.0,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,0.00199681,
chr17:43093139:CCA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32394796:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32398626:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32332988:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-081),,,,
chr13:32363272:TT>TTTT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,pathogenic
chr13:32337334:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43107539:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32342260:G>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000399361,
chr17:43093829:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43082539:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr17:43126099:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.72 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,0&1,,benign
chr13:32394887:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-03),benign(0-106),,1,,
chr17:43057060:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-01),possibly_damaging(0-683),,,,
chr13:32340023:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,,
chr13:32340219:G>A,,,,,,-|1/1658,,,,,,,,,,,German|Western European|Western Europe|-|Central/Eastern Europe,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1&1,8.237e-06,
chr13:32317714:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32340433:A>G,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,
chr17:43093924:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063909:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious|as variant control|?|Moderate functional effect,Transcription activation in human cells|Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,,,,,,,,,,-|Spanish,,"Central/Eastern Europe| Central/Eastern European""""|-|Western Europe|Caucasian|None Specified|""""Western European",M,5 - Definitely pathogenic,1.95,1.35,223.87,0.9996,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32326533:T>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr17:43090648:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32379477:T>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1&1,,
chr13:32320513:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32366979:A>T,,,,,,,,,,0.0,0.0363,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00998403,
chr17:43091879:C>A,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,Scottish,,Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32316465:G>T,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,
chr13:32340057:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,pathogenic
chr17:43063909:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000495,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|no functional effect|predicted neutral|-|predicted deleterious|Loss of wild type allele|mildly destabilizing,Histopathology|Structure-based prediction (crystallography etc)|Transcription activation in yeast (GAL4-fusions)|Transcription activation in human cells|-|Loss of Heterozygosity|Grantham score|Nuclear localisation|mRNA analysis (RT-PCR)|transcription activation/PS/BA/BS|cDNA analysis|Thermodynamic stability prediction|Proteolytic degradation|evolutionary conservation analysis|Centrosome amplification,2/1658|-,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,0.001,0.0,0.0,0.0,0.0,-|Spanish,,Western Europe|-|None-Specified|None Specified,M,1 - Not pathogenic or of no clinical significance,0.00044,,,5e-05,0.66,0.66,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-941),,1&1&1,0.0001204305,
chr17:43078027:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0298,0.0023,0.0216,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0103834,benign
chr17:43047719:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,benign
chr13:32370392:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.237e-06,
chr17:43047635:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,1&1,,
chr17:43057060:->G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,18/22,,-1,,,,,,,pathogenic
chr13:32376783:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr17:43120293:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32338561:G>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43091043:C>G,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,Asian,IVS,1 - Not pathogenic or of no clinical significance,1.0,3.55E-03,0.43,0.0,,0.04,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092659:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43118283:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32341165:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43120422:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32370487:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,19/27,,1,,,,,1,0.0002306,
chr13:32344617:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-2),possibly_damaging(0-828),,1,,
chr13:32382679:A>G,,,,,,,,,,0.003,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32363407:CC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32354979:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-39),,,1,,
chr13:32398229:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32380005:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,-|?|as variant control,mRNA analysis (RT-PCR)|-|?,,,,,,,,,,Czech|-,,Finland|Caucasian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,0&0&1&1,1&1&1&1,3.295e-05,pathogenic
chr13:32379748:GGTT>AAA,,,,,,,,,,,,,,,,, Italian|Central/Eastern European|None Specified,IVS,,,,,,,,splice_acceptor_variant&coding_sequence_variant,HIGH,,,1,,,,,,,
chr17:43094818:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,8.238e-06,
chr13:32356651:T>A,,,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32379384:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr17:43082503:C>A,,,,,,,,,,,,,,,Malaysian|-,,-|Chinese,N,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,
chr17:43051072:GCC>TCC,,,In vitro (cloned),as wildtype control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,,,,,,
chr17:43063902:CG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,1&1&1,,
chr17:43091309:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.403e-06,
chr17:43092268:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr17:43092479:CTGA>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43063376:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1,8.237e-06,
chr13:32329303:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000599042,
chr13:32336630:G>T,,,,,,,,,,,,,,,German,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-91),benign(0-001),0&1&1,1&1&1,,
chr13:32348194:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| 0.1319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43045713:G>A,,,In vitro (cloned),predicted deleterious,Computational analysis|Transcription activation in human cells,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,,,,,
chr13:32332522:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32338392:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,pathogenic
chr13:32336705:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02797 (Asian)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),0&0&1,1&1&1,,
chr13:32379897:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,,
chr13:32339256:G>C,,,,,,,,,,,,,,,Western Europe|-,,Western Europe|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43119760:T>A,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43093023:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr13:32340567:C>T,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-996),,1,,
chr13:32371040:C>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-03),possibly_damaging(0-886),,1&1,,
chr17:43092164:GCG>C,,,,,,,,,,,,,,,,,Caribbean Black,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092191:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43104949:C>A,,,,,,,,,,,,,,,German,,Caucasian,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr17:43067628:T>A,,,In vitro (cloned),predicted deleterious|as variant control|normal RNA splicing|strong functional effect,Transcription activation in yeast (GAL4-fusions)|Multifactorial likelihood-ratio model|transcription activation/PS/BA/BS|Multifactorial likelihood model|RNA analysis|evolutionary conservation analysis,,,,,,,,,,,,Western-European|Western European|-,M,5 - Definitely pathogenic,1.0,1.1,125.89,0.9983,0.81,0.81,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-989),,1&1,,
chr17:43067602:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,
chr13:32316546:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32371040:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1&1,,pathogenic
chr13:32338475:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-267),,,,
chr13:32340431:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-073),,1,,
chr17:43045820:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,
chr13:32344651:A>T,,Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0-03),probably_damaging(0-991),,1&1,,
chr13:32340340:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32339565:AATGC>A,,,Unknown|Germline (inherited),,,,,,,,,,,,-|Dutch,2|-,Western European|-| Dutch,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43091807:A>C,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,8.236e-06,
chr17:43093159:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43074388:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32333291:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32339550:T>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32333251:TTAT>-,,Invitae|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32398575:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32370556:T>G,,,Unknown|Germline (inherited),,,1/238 patients|1/1658,,,,,,,,,Australian|-,,Caucasian|Native American,Syn,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32340251:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Histopathology|-,,,,,,,,,,,,Western/Cental/Eastern Europe|Western European|-|None Specified,M,3 - Uncertain,,,2.89,0.05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-024),,1,8.236e-06,
chr13:32398251:C>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32358518:A>G,,,,,,,,,,0.0,0.0,0.0014,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32341732:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000399361,
chr13:32339002:AGAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32333291:A>AA,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1&0,,pathogenic
chr13:32379337:T>C,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,1,,
chr13:32339426:A>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43076518:C>A,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,Latin American/Caribbean,,,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32398251:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32332866:C>G,,,,,,,,0.0116|0.0|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-8),possibly_damaging(0-509),,,,
chr17:43092804:G>AT,,,,,,,,,,,,,,,Singaporean|-|Dutch,,-|Asian|Malay,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32380141:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr13:32338485:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,pathogenic
chr13:32333366:TG>A,,,,,,,,,,,,,,,,,Western European|Native American/Central/Eastern Europe,F,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,
chr17:43063868:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,,,
chr13:32339922:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-017),,,,
chr13:32371056:AAG>AAGAAG,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,inframe_insertion,MODERATE,20/27,,1,,,,,,,
chr17:43063868:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,,,
chr13:32370661:T>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.00139776,
chr13:32340196:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32354837:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32362694:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|Chinese,IVS,,,,,,,,splice_donor_variant,HIGH,,17/26,1,,,,,1&1,,pathogenic
chr17:43063868:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,,,
chr13:32326496:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,,8.236e-06,
chr17:43092641:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,,,pathogenic
chr17:43123950:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332938:G>A,,,,,,,,,,,,,,,,, Central/Eastern Europe|Not Specified|Western European|None Specified|African|Western Europe|Denmark,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-311),0&1&1,1&1&1,4.942e-05,
chr17:43093289:TT>T,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43094195:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43057112:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|predicted deleterious|strong functional effect,Multifactorial likelihood-ratio model|transcription activation/PS/BA/BS|evolutionary conservation analysis|Structure-based prediction (crystallography etc),,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-031),,1&1,,
chr13:32332916:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-2),benign(0),,1,,
chr13:32345247:T>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,
chr17:43092204:C>G,,,,,,1/1658,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,1.0,0.00479,0.309,3e-05,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,9.061e-05,
chr13:32340432:ATTATT>C,,,Germline (inherited),,,,,,,,,,,,Danish,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32340092:G>C,,,,,,,,,,,,,,,,,Western European|Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-037),,1,2.471e-05,
chr17:43094786:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32333241:A>G,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|Invitae,In vitro (cloned),SD creation| deletion 147 nt from 3' end exon 10,NNSPLICE and lymphocyte RT-PCR,,,0.0|0.0227|0.0077,benign:0.13,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-047),,1&1&1,0.0001121955,
chr17:43063346:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-047),,1&1&1,,pathogenic
chr13:32398243:T>A,,,Unknown|Germline (inherited),,,,,,,0.0,0.0257,0.0,0.0,0.0,African American|-|Western Europe,,Latin American/Caribbean| Latin American/Caribbean|Not Specified|Western European|African|-|African American/Latin American/Caribbea| Native Americ|Latina|Spanish| African|African American|Africian/American|None Specified,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00456407,
chr17:43093584:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,8.237e-06,
chr17:43114641:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43071164:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western-European|-,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-214),,1,,
chr17:43092947:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000991,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32353411:C>T,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32398243:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.236e-06,
chr13:32398618:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339550:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-005),,1,,
chr13:32376745:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32396944:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32394827:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-23),possibly_damaging(0-849),,1,,
chr13:32358962:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32340419:AATACA>T,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43095712:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43070923:A>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32357715:C>A,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1&0,,
chr13:32338573:AGAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1&0,,pathogenic
chr13:32338471:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-026),,,,
chr13:32336948:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),possibly_damaging(0-607),,1,,
chr13:32370336:G>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0053,0.0,0.0,0.0,,,Africa,IVS,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,0.00139776,
chr13:32370557:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,,,1&1,1&1,,
chr17:43070947:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(1),,1,,
chr17:43106477:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr13:32325205:TCATCTGAGGTCAGGAGTTCAAGACCAGCCTGATTGAC>TTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43124033:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,pathogenic
chr13:32396858:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32332965:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-898),,1,,
chr17:43091634:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32343174:C>G,,,,,,,,,,0.008,0.0,0.0115,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00319489,
chr17:43091821:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr17:43106548:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,1,,
chr13:32398333:A>G,,,,,,,,,,,,,,,,,African,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339509:TTCTTA>T,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43092336:C>AC,,,,,,1/1658,,,,,,,,,,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340803:T>AAT,,,,,,,,,,,,,,,South African,,Mixed Ancestry,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32333399:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32357890:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43045691:TGGGGGATC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr13:32349172:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32374214:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32351909:T>G,,,,,,,,,,0.0348,0.0333,0.0922,0.0903,0.1268,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0714856,
chr13:32339873:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-132),,1,,
chr13:32355079:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-132),,1,,pathogenic
chr13:32316860:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr17:43056461:G>C,,,,,,,,,,0.001,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr13:32363370:A>ATGGG,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43056461:G>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000599042,
chr17:43077580:C>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr13:32326336:T>C,,,,,,,,0.0|0.0723|0.0219,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,,
chr13:32357492:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr13:32332930:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,2.471e-05,
chr13:32332663:CTTTGAAACACAAAT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32358336:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000798722,
chr17:43093612:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092801:TTGA>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091689:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,probably-damaging:0.996|None|None|probably-damaging:0.996|probably-damaging:0.996,,,,,,,,Western-European|-Native-American|African,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32330993:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,benign
chr17:43089539:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32372668:C>A,,,,,,,,,,0.2078,0.0825,0.1902,0.3661,0.1738,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.197484,
chr17:43067348:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43124018:T>ACAGATG,,,,,,,,,,,,,,,-|USA,,-|None-Specified|Caucasian,IFI,,,,,,,,protein_altering_variant&splice_region_variant,MODERATE,,,-1,1.0,,,,,,
chr13:32339383:TAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant&splice_region_variant,MODERATE,,,-1,1.0,,,,,,
chr13:32316486:G>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,
chr13:32338849:T>A,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32345500:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3829 (Asian)| 0.1728 (African)| 0.2942 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32337347:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-009),,,,
chr17:43051091:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-009),,,,pathogenic
chr17:43082519:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,
chr13:32376644:C>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,Thai,,Thai/Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,0.0007010015,
chr13:32344637:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,,benign
chr13:32338680:C>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32396963:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32371086:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32338680:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32337026:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),,,,,
chr13:32333386:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32333316:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-865),0&1&1,1&1&1,,
chr17:43045698:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000697,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,1.0,0.00316,0.724,7e-05,0.03,0.03,missense_variant,MODERATE,22/22,,-1,,,benign(0-014),,1,5.767e-05,benign
chr17:43093734:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32371043:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094011:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32340819:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-032),1&1,1&1,,
chr17:43045758:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-981),,0&1&1,,
chr17:43082607:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,8.236e-06,
chr13:32332473:G>TG,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32370571:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.237e-06,
chr13:32340313:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32333310:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1&1,8.243e-06,
chr17:43094408:GTG>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094655:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32371043:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1&1&1&1,,pathogenic
chr13:32362483:C>G,,,,,,-|1/1658,,,,0.0,0.0325,0.0,0.0,0.0041,,,,IVS,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,0.00620399,
chr17:43092020:C>A,,,Germline (inherited),,,2/238 patients,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32339924:GAAAC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32394722:G>A,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-25),benign(0-209),,1,,
chr13:32336266:A>C,,,,,,,,,,0.0,0.0083,0.0014,0.0,0.0,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,0.001399935,
chr17:43098424:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32338340:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-036),,1,,
chr13:32379344:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43103967:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43085568:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000599042,
chr13:32336307:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-502),,,8.237e-06,
chr13:32322152:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32329491:C>T,,GeneDx,,,,,,0.0|0.0227|0.0077,benign:0.01,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,8/27,,1,,,,,1,,
chr13:32338073:ACACT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063432:CAACC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43123815:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43041407:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43051091:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&1,0.000311876,benign
chr13:32329444:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,8/27,,1,,,,,,,benign
chr13:32338229:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.268e-06,
chr17:43076567:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32335478:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43050988:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32326289:T>G,,,,,,,,,,,,,,,,,Ashkenazi,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,1,,
chr13:32338886:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0|0.0227|0.0077,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-05),,1,,
chr17:43093719:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-05),,1,,pathogenic
chr13:32327584:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000599042,
chr13:32353602:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32332278:C>A,,,,,,,,,,,,,,,,,Central/Eastern European|Not Specified|Western European|Near Eastern|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-93),benign(0-092),0&1&1,1&1&1,3.296e-05,
chr17:43122889:C>A,,,,,,,,,,0.3658,0.879,0.428,0.371,0.5286,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.542732,
chr13:32350383:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339624:CGTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,4.943e-05,
chr17:43093638:A>TA,,,,,,,,,,,,,,,,,Western-European|Western Europe|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093200:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091492:CCAG>T,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43074483:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,,,
chr13:32354831:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.248e-06,
chr17:43091019:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,
chr17:43074391:GC>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32340556:T>C,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43094706:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32354831:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.248e-06,
chr13:32389113:G>A,,,,,,,,,,0.0,0.0,0.0,0.0099,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00199681,
chr13:32398389:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0001492605,
chr17:43092890:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32338731:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,0.0,0.0,0.0,0.001,0.0,Malaysian,,Chinese,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-053),,1,0.0001122005,
chr13:32336703:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-82),benign(0-036),,1,1.647e-05,
chr17:43091759:TTG>C,,,,,,,,,,,,,,,Chinese|Not Specified|-|Dutch|Malaysian|Spanish|Western Europe,1|-,Western Europe/Asian|Central/Eastern European|Chinese|Not Specified|Western European|-|Caucasian|Central/Eastern Europe/Poland|African|Western-European|Han|Ashkenazi-Jewish|Central/Eastern-European|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32340154:CCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32370528:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-01),benign(0-354),0&1&1,1&1&1,,
chr13:32370986:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-41),benign(0-039),,1&1,,
chr17:43067652:GTTAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-41),benign(0-039),,1&1,,pathogenic
chr17:43093052:AAA>C,,,,,,,,,,,,,,,Brazilian,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32333319:G>T,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,,
chr13:32336399:AGA>A,,,,,,,,,,,,,,,Italian,,Caucasian,UV|F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32317113:G>T,,,,,,,,,,0.0,0.0,0.0,0.0099,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00199681,
chr17:43106368:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000998403,
chr17:43115775:AGG>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant&stop_lost&splice_region_variant,HIGH,,,-1,1.0,,,,,,
chr13:32320678:C>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr17:43092848:CAACA>G,,,,,,1/1658,,,,,,,,,Western Europe|-|Austria,3|-|7, Native American|-Native-American|Western/Central/Eastern Europe|English/Irish|-|-Central/Eastern-Europe|Unknown|Ashkenazi|Western European|Western-European|Western Europe|None Specified|None-Specified|African,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32336306:A>T,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-05),,1,,
chr13:32344485:G>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00159744,
chr13:32332696:T>G,,,,,,,,,,,,,,,Malaysian,,Chinese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,4.119e-05,
chr13:32322709:T>A,,,,,,,,,,0.1978,0.0091,0.0836,0.1518,0.1176,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.107228,
chr17:43070943:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43071158:CTT>C,,,,,,,,,,,,,,,,,Western-European|Western European|Western Europe|Native American,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,
chr17:43094400:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43093509:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43091882:A>AT,,,,,,,,,,,,,,,,,Western-European|Latin American/Caribbean|-French-Canadian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32340636:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-022),,1&1,0.0001080755,
chr17:43092969:G>AGC,,,,,,,,,,,,,,,,,Western-European|-|None-Specified|English,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32371026:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-26),possibly_damaging(0-449),,,8.236e-06,
chr17:43112129:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1321 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32330986:GGCCT>T,,,,,,-|6/1658,,,,,,,,,Czech|Scottish/Canadian|Western Europe|-,1|-,White-NonHispanic|Irish| Central/Eastern Europe|Western European|Western/Central/Eastern Europe|-|English/Irish/Scott|Dutch|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr17:43070943:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32340571:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43063952:A>T,,,,,,,,,,,,,,,,,Ashkenazi,IVS,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1,,
chr13:32333318:A>AT,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32340762:C>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32357800:AGG>C,,,,,,,,,,,,,,,Brazilian,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,16/27,,1,,,,,,,
chr13:32376795:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr13:32380085:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&0,,
chr17:43094140:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32345093:A>T,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.0738818,
chr13:32363261:G>T,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-977),,1,,
chr13:32324101:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32340245:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32337176:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-26),,,,
chr13:32376795:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,pathogenic
chr17:43051162:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,1.648e-05,
chr13:32338633:A>AT,,,,,,,,0.0122|0.0|0.0081,None,,,,,,,,Western European|Western Europe|Caucasian|None Specified|Western Europe/Near East/Mid East,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32347999:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1941 (Asian)| 0.1972 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32338313:A>T,,,,,,,,,,,,,,,Sweden,,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43057131:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-384),,1,2.471e-05,
chr13:32380085:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1&0,,pathogenic
chr13:32339773:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-359),,1,,
chr13:32338918:A>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-359),,1,,benign
chr17:43047709:CTC>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,,,
chr17:43076556:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,,8.237e-06,
chr13:32356498:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,2.471e-05,
chr13:32340798:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,pathogenic
chr13:32333298:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),possibly_damaging(0-466),,1,,
chr17:43093515:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43099828:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43050152:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32387196:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32365659:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43077625:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32394909:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-09),benign(0-122),,1,,
chr13:32333409:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,0&1,0.000104037,
chr17:43045760:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|-|French,2|-,Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1&1,,pathogenic
chr17:43110520:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43092459:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr13:32336344:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),,,,8.237e-06,
chr17:43073238:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32379878:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32316497:C>T,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,
chr17:43103863:G>C,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000399361,
chr17:43079406:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.549e-06,
chr13:32340752:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32365952:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32339178:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-196),,,8.237e-06,
chr13:32336814:T>G,,,,,,,,,,,,,,,,,Western European|Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-003),,1,,
chr17:43094068:T>GT,,,,,,,,,,,,,,,,,Not Specified|Central/Eastern-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43071035:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-052),,,8.236e-06,
chr13:32332885:C>TG,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32399389:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32338068:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-037),,,,
chr17:43124135:AAT>CATAT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0002758,
chr13:32340007:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092511:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43107088:C>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr17:43091876:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43077775:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32336746:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43066409:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32337278:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),,,,,
chr13:32354884:G>TA,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32335238:C>A,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00239617,
chr13:32339209:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-335),,1,,
chr17:43104939:C>A,,,In vitro (cloned),as variant control,E3 Ub-ligase activity assay BRCA1/RING-BARD1,,,,,,,,,,-|Italian,,Western Europe|Caucasian,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,2.471e-05,
chr13:32336389:GC>T,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339568:GCTTT>C,,,,,,,,,,,,,,,,,"Western European|None Specified| Central/Eastern European""""|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094256:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337453:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-999),,,1.648e-05,
chr17:43106501:A>TTC,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1,,
chr13:32330894:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.242e-06,
chr13:32356515:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr17:43052373:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32340314:A>T,,,,,,,,,,,,,,,-|Italian,,Western European|Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43093046:AGC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32328596:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32340348:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-894),,1,,
chr17:43093704:ATAT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,3.295e-05,
chr13:32340348:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,German,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-196),,1,,
chr13:32337453:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43049180:A>G,,,In vitro (cloned),predicted deleterious|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European|Asian,M,,,,,,,,synonymous_variant,LOW,21/23,,-1,,,,,1,2.471e-05,
chr17:43071063:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43124115:G>ACT,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&5_prime_UTR_variant,LOW,,,-1,1.0,,,,,,
chr17:43074529:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,
chr17:43094038:TG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43090112:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32332345:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,8.238e-06,
chr13:32333233:GAAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,,pathogenic
chr17:43094303:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32330991:CAA>G,,,,,,,,,,,,,,,Not Specified|-,,Latin American/Caribbean|Not Specified|-,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr13:32339782:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32338217:ATT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43116482:G>T,,,,,,,,,,0.0,0.0023,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000798722,
chr13:32363417:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),benign(0-001),,,,
chr17:43082418:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0-001),,1,,
chr17:43094515:ATCTG>T,,,,,,,,,,,,,,,German|Western Europe|-,5|-,-|Western Europe|Central/Eastern-European|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32320347:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05769 (Asian)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32357907:A>T,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,possibly_damaging(0-853),,1,8.236e-06,
chr17:43044539:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32339858:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-49),benign(0-017),,1,,
chr17:43051113:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-262),,1,,
chr17:43104104:TG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,5.765e-05,
chr13:32340123:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),probably_damaging(0-972),,1,,
chr17:43068006:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32333352:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-893),,1,,
chr17:43050236:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32337543:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,,,
chr13:32357068:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000199681,
chr13:32333056:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,4.118e-05,
chr17:43094871:AG>A,,,,,,,,,,,,,,,,,Latin-American/Caribbean,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&0,0.0003561,
chr13:32350487:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32322750:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32338578:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),possibly_damaging(0-747),,1&0&1,8.243e-06,
chr13:32337543:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32370982:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,0.0001245505,
chr17:43072388:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43049980:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00119808,
chr17:43045739:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,2.471e-05,
chr13:32332751:T>A,,,,,,2/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,,,
chr13:32371079:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-05),benign(0-245),,1,,
chr13:32340822:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-178),,1,,
chr17:43089486:G>C,,,,,,,,,,0.3588,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353435,
chr13:32350182:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32336449:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,8.237e-06,benign
chr17:43104077:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00267,
chr17:43092202:T>TT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32328738:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43063930:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|not destabilizing|strong functional effect|predicted neutral|inconclusive|-|as variant control|predicted deleterious|?|Intermediate cancer risk,Transcription activation in yeast (GAL4-fusions)|Multifactorial likelihood-ratio model|Thermodynamic stability prediction|evolutionary conservation analysis|Peptide binding ability|Structure-based prediction (crystallography etc)|-|Prevalence in normal controls|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|family history| co-segregation|Proteolytic degradation|Co-segregation in families|?,1/238 patients|-|1/1658,,,,,,,,,Not Specified|-,,Not Specified|Western European|-|Near Eastern|Western-European|None-Specified,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-984),,1&1,2.471e-05,
chr13:32340789:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.008,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-034),,1&1,,
chr17:43080327:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8706 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,1.0,1.0,0.9986,0.9077,0.9949,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.980232,benign
chr17:43092274:A>ATC,,,,,,2/1658,,,,,,,,,,,Irish|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32331000:TCC>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr17:43060981:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32338320:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-196),,1,,
chr17:43092171:ATG>A,,,,,,,,,,,,,,,-|Central/Eastern Europe,,Western Europe|-|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43063930:G>A,,,In vitro (cloned),predicted deleterious|not destabilizing|Moderate functional effect,Thermodynamic stability prediction|transcription activation/PS/BA/BS|evolutionary conservation analysis|Structure-based prediction (crystallography etc),,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-913),,1&1,,
chr13:32340998:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-913),,1&1,,pathogenic
chr13:32346841:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,Sweden|-,,Not Specified|-|Asian|None Specified,N,,,,,,,,stop_gained,HIGH,13/27,,1,,,,,1&1,,pathogenic
chr13:32338464:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-011),,1,,
chr13:32363219:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,18/27,,1,,,,,,,
chr13:32338464:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-036),,1,,
chr17:43124096:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,0&0&1,1&1&1,,pathogenic
chr17:43091016:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.3631|0.123,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1&1,,benign
chr13:32315655:T>G,,,,,,,,,,0.1928,0.1188,0.1427,0.1696,0.1258,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.148562,
chr13:32356475:GC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr13:32355207:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-08),benign(0-047),,1,,
chr13:32388121:A>CT,,,,,,,,,,0.7525,0.6467,0.6657,0.5496,0.7137,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.664137,
chr17:43092823:G>CAT,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32339592:A>CT,,,,,,,,,,,,,,,HKSAR|Western/Central/Eastern Europe|-,,"White-NonHispanic| Irish|Western European|Chinese |-| German""""| English|Western Europe|""""Western European",N|F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43081527:A>C,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00379393,
chr17:43093315:->AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340342:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-986),0&1&1,1&1&1,,
chr13:32394797:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,,0.0001080755,
chr17:43094739:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43077831:T>A,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr13:32341229:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,2.478e-05,
chr13:32340619:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32362701:AG>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/26,1,,,,,,8.236e-06,
chr13:32333139:G>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),possibly_damaging(0-595),0&1&1,1&1&1,,
chr17:43104124:A>G,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,,,,,1,,
chr17:43124088:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,8.237e-06,
chr13:32340342:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-973),0&1&1,1&1&1,,
chr17:43091591:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094202:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43094407:CC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32397054:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43108095:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32340487:CA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338845:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-187),,1,,
chr13:32332825:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.237e-06,
chr13:32376686:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,
chr17:43057052:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/22,,-1,,,,,1,,pathogenic
chr13:32370508:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-02),probably_damaging(1),,1,,
chr13:32396933:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32320185:T>A,,,,,,,,,,0.0119,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00299521,
chr17:43094069:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063931:C>A,,,In vitro (cloned)|Unknown,predicted deleterious|strong functional effect|inconclusive|-|as variant control|as wildtype control|?|moderately destabilizing,Transcription activation in yeast (GAL4-fusions)|Thermodynamic stability prediction|structure-based prediction (crystallography etc) BRCA1-CtIP|Peptide binding ability|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|-|Proteolytic degradation|family history|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Thermostability assay|Transcription activation in human cells|Bayesian statistics|?,2/1658|-,,,,,,,,,Not Specified|German|Sweden|-,3|-,Western European|-| India|None-Specified|Near Eastern|Western-European|Western Europe|Caucasian|None Specified,M,5 - Definitely pathogenic,1.0,1.82,21877.62,1.0,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-995),,1&1,2.471e-05,
chr13:32339909:C>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-02),,1,4.118e-05,
chr13:32338939:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown,-|?,-|?,,,0.0|0.0681|0.0231,None,0.0,0.0015,0.0,0.0,0.0,Spanish,1|-,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0003026305,
chr13:32356648:G>A,,,,,,,,0.0|0.227|0.0769,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32346073:T>C,,,,,,,,,,0.001,0.0,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000998403,
chr17:43072047:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43051069:G>A,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,,benign(0-159),,,,
chr17:43104982:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,8.237e-06,
chr13:32316450:A>T,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,0.0,0.0166,0.0,0.0,0.0,Not Specified|Latin American/Caribbean|-,,Latin American/Caribbean| Latin American/Caribbean|Western Europe/Native American| Latin American/Caribbe|Not Specified|Western European|-|African|Asia/Latin American/Caribbean|African American|Western Europe|None Specified,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,0.002999485,
chr17:43080805:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43094134:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045748:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|predicted deleterious|very destabilizing|as variant control|strong functional effect,peptide binding ability BRCA1/BRCT2-p53|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|Microsatellite analysis BRCA2-R7/hBUBR1|transcription activation/PS/BA/BS|Thermodynamic stability prediction|Gel filtration chromatography|Colony formaztion in soft agar|evolutionary conservation analysis,,,,,,,,,,-|French|Central/Eastern Europe|Italian,,Western European|-|Caucasian,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-919),,1&1,,
chr13:32338211:AAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-919),,1&1,,pathogenic
chr13:32339575:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-38),,1,,
chr17:43091016:C>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-38),,1,,pathogenic
chr17:43088896:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43092611:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338350:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-002),,1,,
chr13:32362483:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-002),,1,8.237e-06,
chr13:32371071:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-17),possibly_damaging(0-589),,,2.471e-05,
chr17:43051067:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1,,benign
chr13:32386340:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr13:32363495:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32394867:GTTTTCTGC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32368521:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32327768:T>AT,,,,,,,,,,0.4513,0.2655,0.4107,0.4147,0.4243,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.383986,
chr13:32396959:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32319686:C>G,,,,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0061901,
chr17:43062193:AA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43066259:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43047666:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr17:43075975:T>A,,,,,,,,,,0.0,0.0053,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00179712,
chr17:43100574:C>CAT,,,,,,,,,,0.2256,0.1354,0.2651,0.2411,0.3538,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.235423,
chr17:43091538:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32354878:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32341069:TGA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32333284:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,
chr13:32398628:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.118e-05,
chr17:43092372:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43094090:T>GT,,,,,,,,,,,,,,,,,-|Scottish,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr17:43067630:GGC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32338906:AGAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr13:32388964:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0112,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00219649,
chr17:43067658:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,,benign(0-019),,,1.647e-05,
chr13:32362572:AA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32397678:G>C,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr13:32326613:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,as wildtype control|predicted deleterious|-|major exon skipping,splicing reporter minigene|Radiation sensitivity|-|cDNA analysis|mRNA analysis (RT-PCR),,,,,,,,,,Not Specified|-|Italian,,Central/Eastern European|Western European|-|Western Europe|Caucasian|None Specified,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1&1,,pathogenic
chr17:43076640:GTTTCT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,1.647e-05,
chr13:32355105:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-26),benign(0-056),,1,,
chr13:32332225:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.271e-06,
chr17:43051092:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-962),0&1&1,1&1&1,,
chr17:43095877:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32316296:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32394726:A>G,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,,," Native American|Central/Eastern European|Central/Eastern Europe|Western European|-| Central/Eastern European""""|African|None Specified|""""Western European",N,,,,,,,,stop_retained_variant,LOW,25/27,,1,,,,,1&1&1,8.237e-06,
chr13:32339493:GTCTG>A,,,,,,1/1658|-,,,,,,,,,Spanish,1|2|-,Caucasian non-Ashkenazi|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338826:GTCAT>C,,,Unknown|Germline (inherited),,,,FA FANCD1_00032|-,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337826:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-234),,,8.236e-06,
chr13:32376100:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43092967:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43104938:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr13:32380997:A>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00159744,
chr13:32325153:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,,8.237e-06,
chr13:32336872:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339134:T>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0,0.0,0.0,0.0051,Malaysian|-,,Indian|Pakistan|Pakistani,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.0007010015,
chr13:32338101:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),,,,,
chr17:43063902:C>T,,,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,,,
chr13:32337908:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,,,
chr13:32363447:AGA>C,,,,,,1/1658,,,,,,,,,Not Specified|Western Europe|-|Canadian,,Central/Eastern European|Not Specified|Western European|-|English|None Specified,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43049182:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr17:43091999:TG>T,,,,,,,,,,,,,,,Latvian,,Latvian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340000:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32396889:T>C,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32340722:GAAA>GAAAGAAA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32336524:A>CA,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32356427:C>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,14/26,1,,,,,,,
chr17:43092244:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43053704:C>A,,,,,,,,,,0.005,0.5136,0.0331,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.147364,
chr13:32341048:TG>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43089037:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32331031:C>T,,,,,,,,,,,,,,,,,Western European| Western European,IVS,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,
chr13:32339059:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-087),,,,
chr17:43084703:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32375142:G>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32327293:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1084 (Asian)| 0.02236 (African)| 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43092138:AT>TA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43106633:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32334347:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr13:32337840:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-006),,1,8.236e-06,
chr13:32340908:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-076),,1&1,8.238e-06,
chr17:43091710:T>AC,,,,,,,,,,,,,,,-|Dutch?,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32331031:C>A,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,
chr13:32332863:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-,Multifactorial likelihood-ratio model|evolutionary conservation analysis|co-occurrence with deleterious variant|-|Nuclear localisation|Homology-directed repair assay|Centrosome amplification|family history|Survival assay with VC8 (after MMC treatment)|Co-segregation in families,,,,,,,,,,German|Not Specified|Austria|-,0|-,"Lebanese|Central/Eastern European| Latin American/Caribbean""""|Not Specified|Western European|-|French/German/Native American|French Canadian|Western Europe|Western Europe/English|Caucasian|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.01514,0.22909,0.04074,0.0,0.02,0.02,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),benign(0-033),,1&1,0.0002389,
chr13:32363316:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),possibly_damaging(0-824),,,8.236e-06,
chr17:43055643:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43071225:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr13:32340292:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.898,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-714),,1,,
chr17:43074471:G>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?,Recombination rate|Clonogenic assay|Transcription activation in yeast (GAL4-fusions)|co-occurrence with deleterious variant|-|Prevalence in normal controls|?|Multifactorial likelihood-ratio model|evolutionary conservation analysis,9/1658|-,,,,0.001,0.0008,0.0014,0.0,0.0,French?|Danish|German|Dutch|-|Austria|French|American|Spanish|German/French|Western Europe|Italian,1|0|3|-,Western Europe|European|-|Celtic|Caucasian,M,1 - Not pathogenic or of no clinical significance,,<1e-10,,0.0,0.02,0.02,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,0.001374521,
chr17:43090915:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32367646:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02236 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43123764:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32337443:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-02),,1,,
chr13:32341200:GAA>A,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,11/26,1,,,,,,,
chr17:43056450:T>G,,,,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0155751,
chr13:32319102:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43093354:AC>A,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094743:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43067711:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,8.237e-06,
chr13:32394886:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),possibly_damaging(0-831),,1,,
chr17:43092877:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339851:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32316853:T>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00139776,
chr17:43047552:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr17:43092185:CTT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr17:43092185:T>G,,,In vitro (cloned),,,,,,,,,,,,,,African| Latin American/Caribbean,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,1.647e-05,
chr13:32340626:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-059),,1,8.237e-06,benign
chr13:32333118:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-03),benign(0-056),,1,,
chr13:32333137:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32326551:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,1&1,1&1,,
chr17:43091559:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,1&1,1&1,,pathogenic
chr13:32337777:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32362531:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43070515:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43093569:TT>CTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1,1,1.647e-05,
chr13:32362750:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr17:43053048:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43064327:T>A,,,,,,,,,,0.0,0.0363,0.0029,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0103834,
chr13:32375718:C>A,,,,,,,,,,0.0,0.0189,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00539137,
chr13:32351230:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32394840:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43093073:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.06098 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|?,co-immunoprecipitation BRCA1-FANCA|-|?|Multifactorial likelihood-ratio model,,,0.0|2.9732|1.0072,benign:0.013|None|None|benign:0.013|benign:0.013,0.0,0.0386,0.0014,0.0,0.0,Not Specified|-|Native American/African American|Austria|African American|Western Europe/African American,1|-,Latin American/Caribbean|African American|-,M,1 - Not pathogenic or of no clinical significance,,<1e-10,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.0103834,
chr17:43091012:C>A,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43094513:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43067648:CCAAG>A,,,,,,,,,,,,,,,French?|German|-|French|Western Europe|Italian,3|-|394,Not Specified|Western European|-|Caucasian|Western-European|Western Europe|None-Specified,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32325644:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000199681,
chr13:32326268:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-,Co-localization to predicted ESEs|-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,"Latin American/Caribbean| Latin American/Caribbean|Western European| Puerto Rico""""|None Specified| Asian|African|""""Latin American/Caribbean",M,1 - Not pathogenic or of no clinical significance,1.0,0.08128,0.01905,3e-05,0.02,0.02,missense_variant,MODERATE,6/27,,1,,,,,1,8.237e-06,
chr17:43071138:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-006),,1,2.471e-05,
chr13:32326268:T>G,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,,,Near Eastern,M,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,
chr17:43095846:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1,,
chr13:32341172:TATC>A,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43099501:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr17:43092887:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32340908:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398675:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092184:ACTT>A,,,,,,,,0.0606|0.0|0.0399,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32395465:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000399361,
chr13:32376791:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,21/27,,1,,,,,1,,pathogenic
chr13:32338889:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0),0&1&1,1&1&1,8.237e-06,
chr13:32399588:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32338882:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),possibly_damaging(0-575),,,8.237e-06,
chr17:43084298:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43086109:T>TACACAC,,,,,,,,,,0.0895,0.115,0.1182,0.1151,0.1687,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.120807,
chr13:32370465:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr13:32337109:A>T,,,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,2.471e-05,
chr13:32356297:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr13:32316737:G>T,,,,,,,,,,0.0,0.0,0.0014,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32337413:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-997),,,8.238e-06,
chr17:43093532:C>A,,,,,,,,,,,,,,,,,Central/Eastern Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340816:CTTTG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43067643:ATTAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32379490:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.237e-06,
chr17:43091835:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32338220:AAAT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338097:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),possibly_damaging(0-591),,1,,
chr17:43060996:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43094238:T>TA,,,,,,,,,,,,,,,-|Dutch,1|-,-|None-Specified|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093054:AA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338266:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32393166:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00998403,benign
chr13:32357836:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0454|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-944),,1,,
chr13:32379922:G>T,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,8.239e-06,
chr13:32340570:A>G,,,,,,,,,,,,,,,-|Spanish,,Western European|Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-891),0&0&1&1,1&1&1&1,1.647e-05,
chr17:43092761:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32316513:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00035,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32371704:A>G,,,,,,,,,,0.007,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00179712,
chr17:43094318:G>T,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32339641:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43099877:GAGT>C,,,,,,,,,,,,,,,China,,Chinese,IFD,,,,,,,,protein_altering_variant&splice_region_variant,MODERATE,,,-1,1.0,,,,,,
chr17:43045767:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Children's_Hospital_of_Philadelphia|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,14/1658|-,,,,,,,,,Not Specified|-|Dutch?|German|Dutch|Western Europe,1|3|-,White-NonHispanic|Western Europe/Central-Eastern Europe| Central/Eastern Europe|Not Specified|Western European|Philippines|-|None-Specified|German|Ashkenazi|Unknown|Western-European|Western Europe|Caucasian|None Specified,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr13:32332490:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,
chr13:32326554:A>T,,Ambry_Genetics,In vitro (cloned),predicted pathogenic| no LOH,HR assay| LOH assay,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1&1&1,,
chr17:43045142:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001247855,
chr17:43092301:ATT>C,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,Norwegian|Western Europe|-|French|Italian,,Central/Eastern European|Western European|-|-Central/Eastern-Europe|Western-European|Western Europe|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43093974:AG>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Norwegian|Western Europe|-|American|Western Europe/Northern Europe,," Danish|Caucasian (Norwegian)|Western European|-|None-Specified| Sweden""""|Western-European|Norwegian English|Western Europe| Germany|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43053704:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4919 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43117960:C>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32326554:A>G,,,In vitro (cloned),major exon skipping,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1&1&1,,
chr17:43076478:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1,,
chr13:32345383:A>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000798722,
chr17:43065037:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32340795:CAC>A,,,,,,,,,,,,,,,Spanish|Brazilian,,Galician|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338948:A>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),possibly_damaging(0-73),,1&1,,
chr13:32385853:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32333276:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.5455|0.1848,benign:0.013,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-015),,1,,
chr17:43060788:A>T,,,,,,,,,,0.3648,0.7307,0.3256,0.371,0.5307,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.489617,
chr17:43094305:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32332532:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0),,1,0.0001039595,
chr13:32332379:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32339280:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-044),,1,,
chr17:43093942:TCAGGAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-044),,1,,pathogenic
chr17:43092691:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43057128:C>G,,,In vitro (cloned),uncertain,transcription activation/PS/BA/BS,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-32),,1&1,,
chr13:32379848:T>A,,,,,,,,,,,,,,,Canadian,1,Sephardic,Splice,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32356604:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,benign(0-195),,1&1,,
chr17:43076624:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,co-occurrence with deleterious variant|-|?,,,,,0.0,0.0008,0.0014,0.0,0.0,Not Specified|Western Europe|-,,"-Sephardi|-Near-Eastern|Mexican|Central/Eastern Europe| Latin American/Caribbean""""|Western European|-|Latin-American/Caribbean|-Central/Eastern-Europe|Croatia|Ashkenazi/Western Europe|Western-European|-Greek|Central/Eastern-European|None-Specified|None Specified|""""Western European",IVS,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,0.0003149805,benign
chr13:32394685:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,24/26,1,,,,,,8.237e-06,
chr17:43057104:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-01),benign(0-011),,,,
chr17:43092128:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43099892:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,8.236e-06,
chr13:32326651:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.236e-06,
chr13:32363198:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32331128:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.974042,benign
chr13:32340580:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-991),,1,,
chr17:43073240:C>T,,,,,,,,,,0.003,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000798722,
chr17:43091831:AG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32345062:T>G,,,,,,,,,,0.0089,0.0,0.0014,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00319489,
chr17:43091896:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32338037:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000548,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|-,," Central/Eastern European|Central/Eastern European|Western European|-| Italian""""|Western Europe|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.00912,0.06607,0.44668,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-085),,1,4.942e-05,
chr13:32337158:AGCAG>G,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43110581:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,8.57e-05,
chr13:32337751:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-982),0&1,1&1,,benign
chr13:32358917:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32340246:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-26),,1&1,,
chr13:32369041:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01847 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43092964:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32363355:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-32),benign(0-023),,1,,
chr13:32339684:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-059),,1,,
chr17:43091889:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,2.471e-05,
chr13:32340663:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340663:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094045:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000891,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Grantham score|-|evolutionary conservation analysis|Multifactorial likelihood-ratio model,1/1658|-,,0.0116|0.0|0.0077,benign:0.019|None|None|benign:0.019|benign:0.019,,,,,,German|Native American/Central/Eastern Europe|-|Western Europe|French,,"Latin American/Caribbean| Ireland/England""""|Not Specified|Western European|-|caucasian| Dutch| England""""|Western-European|Western Europe|""""Western European|Central/Eastern-European|None-Specified|None Specified|Central/Eastern European",M,1 - Not pathogenic or of no clinical significance,1.95,0.0224,,0.00089,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.000173,
chr17:43104081:GATTTCC>AAAAAGA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0003181,
chr17:43092234:CA>A,,,,,,,,,,,,,,,,,Western-European|Italian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32380058:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43074370:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,1.647e-05,
chr13:32325220:A>G,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0001084755,
chr13:32379298:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,2.471e-05,
chr17:43082298:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32339573:TTAAGT>-,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,
chr13:32323802:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr17:43049191:AT>T,,,,,,,,,,,,,,,Philippines|-,,-|-Phillipino|Asian|Filipino| Phillipines,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,21/23,,-1,,,,,,8.236e-06,
chr13:32341316:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32320601:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43069166:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32346949:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32340532:CA>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32360244:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0072,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00139776,
chr13:32396980:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340251:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-024),,1,,
chr17:43049195:TTGT>C,,,,,,,,,,,,,,,Spanish,,Caucasian,IVS,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,19/21,-1,,,,,,,
chr13:32316565:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.25e-06,
chr17:43124078:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned)|Unknown,as wildtype control|-,E3 Ub-ligase activity assay BRCA1/RING-BARD1|-,,,0.0116|0.0|0.0077,probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999|None|probably-damaging:0.999,,,,,,Western Europe|-|Central/Eastern Europe,,Western-European|Western Europe|-,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,2.471e-05,
chr13:32332334:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.033,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-14),probably_damaging(0-929),,1,,
chr13:32398122:T>A,,,,,,,,0.0117|0.0|0.0078,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43106470:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr13:32339319:GT>A,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43070680:C>A,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32356646:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,8.237e-06,
chr13:32357772:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,8.236e-06,
chr13:32339292:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-611),,,8.238e-06,
chr13:32398417:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32384860:C>A,,,,,,,,,,0.0,0.0,0.0,0.0615,0.0716,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0263578,
chr17:43092028:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43094544:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,7.413e-05,benign
chr17:43082666:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43093598:AAC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,
chr13:32370398:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,,8.236e-06,
chr17:43092997:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr13:32319238:T>G,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,1.647e-05,
chr17:43057094:C>GT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,,
chr17:43091769:->AA,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32337600:C>G,,,,,,,,,,,,,,,-|Spanish,,Latin American/Caribbean|Caucasian|Asian| Hawaian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,1,8.24e-06,
chr17:43094491:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32338886:TT>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43074379:GTG>C,,,,,,,,,,,,,,,Western Europe|-|Italian,,Western European|-|Caucasian|Native American,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43101793:G>T,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00179712,
chr13:32340425:CA>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1&1,,
chr13:32362729:G>A,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr13:32326117:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32357952:G>A,,,,,,,,0.0|0.2497|0.0846,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr13:32342921:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32394172:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.126 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.003,0.1188,0.0605,0.0208,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0449281,benign
chr17:43057069:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,-|French,3|2|-,Western Europe/Latin American/Caribbean|South Loire River,N,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr17:43092201:CAACAT>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094845:AG>G,,,,,,,,,,,,,,,Singaporean|-,,Indian|Asian| India,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32360505:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr13:32360607:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43050878:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32398213:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340088:T>G,,Invitae,,,,,,0.0116|0.0|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43076509:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32340088:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340813:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-708),0&1&1,1&1&1,,
chr13:32340586:A>C,,,Germline (inherited),,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-571),,1,0.0001821905,
chr17:43092130:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43109062:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43079318:T>A,,,,,,,,,,0.0,0.0,0.0115,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,0.000811625,
chr13:32333132:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,pathogenic
chr17:43091763:TG>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,pathogenic
chr13:32344556:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,11/26,1,,,,,,,
chr13:32340378:G>AG,,,,,,,,,,,,,,,,, Spanish|Western European|Mexico,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340509:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32337275:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-063),,1,8.238e-06,
chr13:32379492:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.237e-06,
chr13:32398094:GATCC>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32340813:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32358127:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0153,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00299521,
chr17:43047680:CACAAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr13:32355175:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-11),possibly_damaging(0-834),,1&1,,
chr13:32337275:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-043),,1,0.0001163155,
chr13:32355154:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,India|Near Eastern,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-16),benign(0-108),,1,0.0001245505,
chr13:32363203:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43093262:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43092423:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32340385:AAC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32370432:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,8.236e-06,
chr13:32369381:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43107345:A>T,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00119808,
chr17:43092785:CAA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338134:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339032:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32362588:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,8.236e-06,
chr17:43093883:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted no impact on protein function|predicted deleterious|predicted neutral|inconclusive|-|as wildtype control|?,Recombination rate|Clonogenic assay|co-occurrence with deleterious variant|Grantham score|Homology directed recombination|-|Random plasmid integration assay|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,2/1658|-,,,,0.0,0.0,0.0,0.0,0.001,Not Specified|-,,"""""Near Eastern|Western European| Sephandic""""|Ashkenazi|Near East/Mid East| Central/Eastern European""""|Western/Central/Eastern Europe|-|-Italian|Western-European|""""Western European|African|Central/Eastern-European|None Specified| Egypt""""|-Near-Eastern|Central/Eastern European|""""Ashkenazi| Yemen - Sephardic""""|Asian|Near Eastern|French Canadian|Western Europe|None-Specified",M,1 - Not pathogenic or of no clinical significance,0.0007,0.0000008,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.0002357405,
chr13:32380076:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43082575:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,11/22,,-1,,deleterious(0),,,1&1,,
chr13:32398449:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092174:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32392193:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43082575:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr13:32348993:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32340300:A>C,,,,,,1/1658,,,,,,,,,,,Western European|Western Europe|-|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-944),,1,,
chr17:43057165:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,1.647e-05,
chr13:32337726:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-999),,,,
chr13:32382599:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43067262:GTCAGGAGGTCAAGACCAGCCTGGCCAACCTGGTGAAACCCCGTCTCTACGAAAA>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr13:32379784:ATA>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr17:43116863:G>C,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00119808,
chr13:32337713:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32336976:G>CT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,
chr13:32339938:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&0,1.647e-05,
chr13:32356582:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-06),,,,,
chr13:32380660:A>T,,,,,,,,,,0.0,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr17:43095531:A>AT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32363467:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32376737:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr17:43092310:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32357937:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,benign
chr17:43092782:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093653:T>C,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,
chr17:43079395:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.56e-06,
chr13:32331011:GCC>A,,,,,,1/1658,,,,,,,,,Western Europe|-,,Western European|-|Central/Eastern Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr17:43067645:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,2.471e-05,
chr17:43099890:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr13:32339342:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-089),,1&1,,
chr17:43061643:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32396989:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332446:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-187),,1,,
chr17:43092155:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-187),,1,,pathogenic
chr13:32355062:GCA>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32379416:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1,,
chr13:32339046:C>CC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339938:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32316435:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32331082:AT>A,,,,,,,,16.557|17.1059|16.7443,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr17:43094323:G>A,,,,,,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082377:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,1.647e-05,
chr17:43091030:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32351229:C>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32394446:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32316435:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3689 (Asian)| 0.04878 (African)| 0.2282 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,26.3256|10.2587|20.8827,None,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43054080:G>T,,,,,,,,,,0.0,0.059,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0161741,
chr13:32316435:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32377590:GT>C,,,,,,,,,,0.8231,0.7405,0.8012,0.8472,0.8252,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.803514,
chr13:32337113:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,0&0&1&1,1&1&1&1,,
chr13:32380151:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,,
chr13:32398734:TT>CA,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,9.06e-05,
chr13:32339669:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-03),,,,
chr13:32325022:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,
chr17:43071069:A>G,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32337911:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),,,1&1,,
chr17:43091627:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379324:CCGAGAGTGCA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,
chr13:32340274:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32326089:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Not Specified,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,
chr13:32370973:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,0&1,1.647e-05,
chr17:43063374:CT>C,,,,,,,,0.0121|0.0|0.0080,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,,1&1,,
chr13:32363177:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,,1&1&1,,
chr17:43051083:T>C,,,In vitro (cloned),predicted deleterious|Low functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-764),,1,,
chr13:32340643:T>G,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32379807:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43047628:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr17:43063366:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,,8.237e-06,
chr13:32332683:G>-,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,,,pathogenic
chr17:43092660:ACTCCA>C,,,,,,1/1658|-,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32315674:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32335140:GGAGT>T,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00678914,
chr13:32338092:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32332919:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-57),benign(0-023),,,8.237e-06,
chr13:32338469:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-428),,,,
chr17:43087202:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43067706:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,
chr13:32339164:G>CA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339209:G>A,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.238e-06,
chr13:32326393:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,0.000599042,
chr13:32363204:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,1,,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43092510:TGAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr13:32337113:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),,0&0&1&1,1&1&1&1,,
chr17:43091474:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European|Western Europe|Central/Eastern-European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32337870:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|-,Histopathology|-|Multifactorial likelihood-ratio model,2/1658|-,,,,0.004,0.0,0.0,0.0,0.0,German|Western Europe|-,1|-,Latin American/Caribbean|W. Europe/Hawaiian-Chinese/African Amer| Central/Eastern European|Central/Eastern European|Not Specified|Western European|-| Gre|Native American|W. Europe/Hawaiin-Chinese/African Amer|Western/Cental/Eastern Europe|Western Europe|Caucasian|None Specified|Ashkenazi,M,1 - Not pathogenic or of no clinical significance,0.12882,0.27542,0.00044,0.0,0.02,0.02,stop_lost,HIGH,11/27,,1,,,,0&0&1,1&1&1,0.001086861,
chr13:32398356:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr13:32338486:T>CTGAGGA,,,,,,,,,,,,,,,Uruguayan|-|Canadian,, Irish/Italian|Western European|-|Native American|Western Europe|None Specified|Italian,IFI,,,,,,,,stop_gained&inframe_insertion,HIGH,11/27,,1,,,,,,,
chr13:32396729:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43063889:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43073221:T>A,,,,,,,,,,0.002,0.0,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000998403,
chr17:43104898:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,,,
chr13:32397012:C>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43065535:G>C,,,,,,,,,,0.0507,0.0023,0.0231,0.002,0.092,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0323482,
chr13:32355152:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr17:43124035:CA>A,,,,,,,,,,,,,,,Malaysian,,Indian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32346842:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32338714:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.24e-06,
chr13:32326500:A>T,,,In vitro (cloned),predicted neutral| no LOH,HR assay| LOH assay,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1,1.647e-05,
chr13:32322585:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32325869:A>T,,,,,,,,,,0.0119,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00239617,
chr17:43071272:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,8.241e-06,
chr17:43063359:T>AAA,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,1,,pathogenic
chr13:32341107:A>AT,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32336881:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43051059:G>C,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,1,2.471e-05,
chr13:32367008:C>G,,,,,,,,,,0.0,0.0234,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00678914,
chr13:32354909:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,
chr17:43082500:T>A,,,In vitro (cloned),as wildtype control,Transcription activation in yeast (GAL4-fusions),,,,,,,,,,,," Latin American/Caribbean""""|-|Central/Eastern European|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,1.647e-05,
chr17:43093955:C>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32398634:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.3631|0.123,benign:0.002,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336838:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-006),,1,,
chr13:32357833:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-08),probably_damaging(0-997),,1,,
chr13:32363421:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr17:43099852:T>C,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1,,
chr13:32398263:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43049373:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32359308:C>G,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32380165:TGT>TTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.241e-06,
chr13:32335828:AA>G,,,,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00998403,
chr13:32354271:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.561 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43094737:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43104183:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr17:43104249:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000105,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,tolerated(0-06),,,1&1,,benign
chr13:32338044:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,tolerated(0-06),,,1&1,,pathogenic
chr17:43099867:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,8.236e-06,
chr13:32340841:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,0&1,1.648e-05,
chr13:32339176:TGA>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340946:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094309:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43104302:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0194,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.003013465,
chr17:43048225:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr17:43104183:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr17:43050609:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,benign
chr13:32378518:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43094566:GT>G,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43123983:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32333458:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0139,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00319489,
chr13:32368811:A>G,,,,,,,,,,0.2346,0.2073,0.1571,0.2639,0.2423,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.224042,
chr13:32339789:G>T,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32376640:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,1.647e-05,
chr13:32330615:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32339919:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32337774:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-038),,1,,
chr17:43093250:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43057003:->GGAGTGGAATAC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32341121:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-032),,,0.0001039585,
chr17:43091714:T>A,,,,,,,,,,,,,,,Not Specified|Chilean|-,1|2|-,,F|N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43104900:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),as wildtype control,E3 Ub-ligase activity assay BRCA1/RING-BARD1,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43063386:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000517,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,
chr17:43046070:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr13:32319189:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,
chr13:32398696:CT>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43112152:C>T,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr17:43106514:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),inconclusive|as variant control|no impact on protein function,Homology directed recombination|peptide binding ability BRCA1/RING-BARD1|E3 Ub-ligase activity assay BRCA1/RING-BARD1|protein binding ability BARD1,,,,,,,,,,,1|-,-|None-Specified|Asian,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,0.0001236,
chr13:32333302:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-027),,,,
chr13:32380146:C>A,,,In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,-|Belgian,2|-,Western European|-|Caucasian,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1,,
chr13:32359800:T>G,,,,,,,,,,0.999,0.9123,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.976238,
chr17:43078520:C>T,,,,,,,,,,0.3628,0.7383,0.4092,0.371,0.5286,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.502396,
chr17:43092980:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43124063:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,1.0,,,,1&1,,
chr13:32318738:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04675 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43093233:GAG>A,,,,,,,,,,,,,,,-|Italian,,-|Caucasian|Mexico,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43048092:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr17:43093180:T>A,,,In vitro (cloned)|Unknown,predicted deleterious|-|?,-|evolutionary conservation analysis|?,,,,,0.0,0.0,0.0014,0.0,0.0,,,Latin American/Caribbean|Asian|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,0.0001821905,
chr17:43123074:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43044928:G>C,,,,,,,,,,0.005,0.0015,0.0043,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.001522495,
chr13:32394698:A>CT,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32385874:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43093312:ATCCAG>ATTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32373331:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0325,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00898562,benign
chr17:43068303:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32331056:AG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,3.299e-05,
chr17:43093578:C>CT,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339259:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43070980:A>CTT,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1&1,,
chr13:32336967:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43092305:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32398672:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32356580:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063945:GTGA>T,,,In vitro (cloned),predicted deleterious,cDNA analysis,,,,,,,,,,-|Spanish,,-|Caucasian,IFD,,,,,,,,protein_altering_variant,MODERATE,17/23,,-1,,,,,,,
chr13:32354838:TATA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,17/23,,-1,,,,,,,benign
chr17:43116981:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32332759:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,3.295e-05,
chr13:32330879:G>C,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43044804:CCCCCG>CTTTT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.145,
chr13:32337656:A>T,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-019),,1,,
chr13:32394838:AT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32324795:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43094244:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32379439:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr13:32335084:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32363293:C>T,,Ambry_Genetics|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32339126:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-028),,,8.236e-06,
chr17:43109041:C>TCTATCTATCTACCTAC,,,,,,,,,,0.3529,0.2156,0.3674,0.3661,0.4816,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.346446,
chr13:32337955:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338449:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Not Specified|Western European|-|None Specified| Ireland,M,1 - Not pathogenic or of no clinical significance,0.41687,0.05888,0.26915,0.00013,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,8.237e-06,
chr13:32343694:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32371998:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43049193:T>G,,,In vitro (cloned)|Unknown,no splicing defect|-,-|splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/23,,-1,,,,,1,8.236e-06,
chr17:43106549:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,8.247e-06,
chr17:43070880:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,1.647e-05,
chr13:32340650:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-045),,1,,
chr17:43106549:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32316447:T>G,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32336807:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-281),,,8.238e-06,
chr17:43091891:T>A,,,,,,,,,,,,,,,-|Dutch,1|-,Western-European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32316447:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western Europe,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr17:43094439:AGGATTCTCTG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32338317:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-063),,1,8.246e-06,
chr13:32327089:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr13:32340996:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32336903:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43094626:TT>G,,,,,,,,,,,,,,,Austria,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32326139:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,0.0117|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,0&0&1&1&1&1,1&1&1&1&1&1,8.24e-06,
chr13:32340637:TTCACCTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,0&0&1&1&1&1,1&1&1&1&1&1,,pathogenic
chr13:32363438:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-08),possibly_damaging(0-762),,,,
chr17:43091052:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,Asian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32379895:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326139:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,0&0&1&1&1&1,1&1&1&1&1&1,,
chr13:32340858:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),possibly_damaging(0-592),,1,,
chr17:43104080:AG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,0&1,0.003317,
chr17:43102948:C>CT,,,,,,,,,,0.5169,0.1528,0.4164,0.1935,0.5706,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.352236,
chr13:32341179:CA>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339762:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-32),benign(0-026),,,8.237e-06,
chr17:43093316:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43073832:G>A,,,,,,,,,,0.0,0.0,0.0014,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr17:43082402:G>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1,,
chr17:43082563:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1&1,,
chr17:43074178:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000599042,
chr13:32368935:A>T,,,,,,,,,,0.001,0.003,0.0014,0.1111,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0239617,
chr17:43105578:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32319587:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32332925:G>GG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43067706:T>G,,,,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,
chr13:32323301:G>T,,,,,,,,,,0.0,0.0106,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00299521,
chr17:43091748:T>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094607:GCT>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091748:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32342270:GCT>C,,,,,,,,,,0.5785,0.6989,0.6758,0.5863,0.4816,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.60643,
chr13:32339837:AAATT>-,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|Sharing_Clinical_Reports_Project_(SCRP)|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32333234:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-697),,1,,
chr13:32319205:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32331045:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.24e-06,
chr13:32368807:->G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| 0.02 (African)| 0.04 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32336731:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32325156:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,0.000103959,
chr17:43092901:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43095879:G>C,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32340803:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32332473:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr17:43099792:CT>G,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32355226:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-385),,,,
chr13:32363234:T>G,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-938),0&1&1,1&1&1,,
chr13:32339957:TAG>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32339989:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.237e-05,
chr17:43044964:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32332757:G>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,probably-damaging:0.987,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-887),,1,,
chr13:32398459:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32337781:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.236e-06,
chr13:32339989:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-147),0&1&1,1&1&1,1.647e-05,
chr13:32379796:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,benign
chr17:43067961:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32339989:T>G,,,In vitro (cloned)|Unknown,predicted neutral|predicted pathogenic| no LOH|-,Histopathology|HR assay|-| LOH assay,,,,,,,,,,,,Western European|Western Europe|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-147),0&1&1,1&1&1,8.237e-06,
chr13:32359222:G>A,,,,,,,,,,0.9205,0.9743,0.9611,0.8948,0.9479,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.940495,
chr17:43063351:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,,,,1,3.295e-05,
chr17:43069880:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32339699:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-81),benign(0-002),,1,,
chr13:32339699:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-003),,1,,
chr13:32362710:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,8.236e-06,
chr17:43091867:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),,,,,,,,,,,,Western Europe|-,,Central/Eastern Europe|-|-Central/Eastern-Europe|Western-European|None-Specified|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32321432:T>C,,,,,,,,,,0.003,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43104157:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43108522:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32338125:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-042),,1,,
chr17:43109868:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32339699:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43057126:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,18/22,,-1,,,,,1&1,,
chr17:43064780:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43049164:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-031),0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43090319:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43067524:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43092533:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32357932:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,
chr13:32397956:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32348016:T>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32355140:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr17:43070924:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,pathogenic
chr13:32344579:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),possibly_damaging(0-898),,1,,
chr13:32338209:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,8.261e-06,
chr13:32337385:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43115799:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,,
chr13:32340895:G>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),probably_damaging(0-994),,1,,benign
chr13:32356497:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-5),,1&1,1&1,,
chr13:32356497:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-08),,1&1,1&1,,
chr17:43092471:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr17:43116383:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43095956:A>G,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43046509:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000599042,
chr17:43082398:AC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr13:32339184:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr17:43080723:C>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32319210:G>GA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32362498:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.238e-06,
chr17:43057085:TT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,,
chr13:32355170:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,3.295e-05,benign
chr17:43071169:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,pathogenic
chr17:43090997:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0233|0.0|0.0154,benign:0.297|benign:0.297|benign:0.297|benign:0.297|benign:0.297,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr17:43091660:ATA>A,,,,,,1/1658,,,,,,,,,,,Western-European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32322705:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43092125:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32338296:A>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-029),,,,
chr13:32338771:AA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094179:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32322909:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr13:32340250:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32398452:AG>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,1&1,1&1,2.471e-05,
chr17:43092697:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43079330:A>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0002340755,
chr13:32337273:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1,,
chr13:32354267:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32345389:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.3049 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2693,0.2176,0.0794,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.184505,benign
chr17:43054835:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4146 (African)| 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.007,0.5787,0.0447,0.001,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.166733,benign
chr17:43094364:GT>A,,,,,,,,,,,,,,,Slovakai,5,Central Europe,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43049125:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,benign(0-001),,1,0.0001204305,
chr13:32362481:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.238e-06,
chr13:32398553:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337273:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32323996:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32354843:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43091510:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr17:43056661:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32339337:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-7),benign(0-017),,,,
chr13:32339760:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-967),,1,,
chr13:32339964:TC>AG,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43106439:A>G,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr13:32316446:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.1135|0.0384,None,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32340240:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-83),benign(0-009),,,,
chr13:32338905:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-132),,1,,
chr17:43110587:GGCTT>CAAAAA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.005833,
chr13:32339309:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-006),,1,,
chr17:43045579:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,2.474e-05,
chr17:43082433:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,benign(0-001),,1,,
chr17:43082508:GGG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr13:32340558:C>TA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32352978:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32357683:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1,,
chr13:32340455:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|inconclusive|neutral|Loss of wild type allele|?,Histopathology|co-occurrence with deleterious variant|-|Prevalence in normal controls|Co-segregation in families|LOH analysis|?|co-ocurrence,14/1658|-,,,,0.003,0.0,0.0058,0.0,0.0,Irish|Northern Irish|Central/Eastern Europe|German|Brazilian|-|Ashkenazi/W. Europe/Central-E. Europe|spanish|English/French|Austria|Ashkenazi|Spanish|English|French Canadian|Western Europe|Not Specified|Native American,1|0|2|-,Central/Eastern Europe|Not Specified|-|caucasian|Austria|Ashkenazi|Western Europe|Caucasian,M,1 - Not pathogenic or of no clinical significance,,0.001,1.55,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-002),0&0&1,1&1&1,0.00231338,
chr13:32376751:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,2.471e-05,
chr17:43058399:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4959 (African)| 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32394681:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,24/26,1,,,,,1,8.237e-06,
chr17:43079435:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,7.665e-05,
chr13:32390504:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32362636:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),possibly_damaging(0-708),,1,,
chr13:32376714:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/27,,1,,,,,1&1,,pathogenic
chr17:43074420:TTTACGTTTTAT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,,,,,,,
chr17:43049188:C>G,,,In vitro (cloned)|Unknown,predicted deleterious|very destabilizing|-|strong functional effect,transcription activation/PS/BA/BS|-|evolutionary conservation analysis|Thermodynamic stability prediction,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-083),,1&1,,
chr13:32339147:GAAAT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32370534:ATT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32325082:T>G,,,,,,,,,,,,,,,Spanish,1|-,Caucasian,M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,2.471e-05,
chr13:32341178:GAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43047641:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43094628:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43047641:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr13:32337320:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43104258:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,6/23,,-1,,,,,1,,
chr13:32363319:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(1),benign(0-007),,1&1,,
chr13:32341103:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000203,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,0.001,0.0,0.0,0.0,0.0,Not Specified|-,,Western European|-|None Specified|African,M,1 - Not pathogenic or of no clinical significance,0.01047,1.94984,0.05012,2e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-004),,1,0.0001904405,
chr17:43098566:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0121,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00379393,benign
chr13:32333172:C>T,,GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),benign(0-076),,1,,
chr17:43066848:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0399,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00778754,
chr17:43093661:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern Europe,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32362536:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32316475:TAC>C,,,,,,,,,,,,,,,,,Western Europe|Central/Eastern European,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr13:32362536:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-997),,1,,
chr13:32368134:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43093661:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,German,,Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32323343:A>T,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr17:43076537:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1&1,,
chr13:32398510:CT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1&1,,
chr17:43110587:GGCTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.001914,
chr17:43091486:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43120123:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32368967:G>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000798722,
chr17:43125086:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43115960:A>T,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00159744,
chr17:43106508:C>A,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1&1,,
chr17:43092099:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32364761:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32398715:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr13:32376809:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,8.237e-06,
chr13:32319312:A>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32333398:TGA>CTTTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0003608,
chr13:32379369:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,22/27,,1,,,,,1,1.647e-05,
chr13:32377238:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32339579:AACAGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,
chr13:32346906:GTT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43072263:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07317 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32340284:G>AT,,,,,,,,,,,,,,,,,Slovak/Hungarian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32319060:C>AT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,
chr13:32337605:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,8.24e-06,
chr17:43094578:TGTTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,,pathogenic
chr13:32340026:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-044),,1,8.237e-06,
chr17:43071107:AC>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr13:32379467:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-,Protein likelihood ratio model|Prevalence in normal controls|-|Multifactorial likelihood-ratio model,-|1/1658,,,,0.0,0.0023,0.0,0.0,0.0,Not Specified|-|Central/Eastern Europe,,mixed european|Central/Eastern European|Canadian|Western European| Central/Eastern Europe|-|Asia| German|Western Europe|None Specified,M,1 - Not pathogenic or of no clinical significance,0.269,0.151,0.00871,1e-05,0.03,0.03,missense_variant,MODERATE,22/27,,1,,,,,1,0.000501321,
chr13:32337983:CATTGAC>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost&protein_altering_variant,HIGH,11/27,,1,,,,,,1.647e-05,
chr13:32398187:AA>A,,,,,,,,,,,,,,,-|Italian,,Western European|Caucasian,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43062893:C>A,,,,,,,,,,0.002,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00159744,
chr17:43045803:G>T,,,,,,,,,,,,,,,,,None-Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,
chr13:32330810:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32339463:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),probably_damaging(0-986),,,8.244e-06,
chr17:43082456:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,,benign
chr17:43050573:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1199 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32338724:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr17:43099774:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32366753:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43092507:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,co-occurrence with deleterious variant|-|Grantham score|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,2/1658|-,,,,0.002,0.0,0.0014,0.0,0.0,Central/Eastern Europe|Not Specified|-|Austria|Ashkenazi/Central/Eastern Europe|Ashkenazi,0|-,"-Ashkenazi| Puerto Rico""""|-Central/Eastern-European| hispanic""""|Ashkenazi|""""Latin American/Caribbean|Latin American/Caribbean| Central/Eastern European""""|Not Specified|Russia Hungary|-|-Central/Eastern-Europe|Western European|Western-European|-Cape-Verdean|""""Western European|Central/Eastern-European|None Specified|Central/Eastern European|""""Ashkenazi| Ashkenazi|Western Europe|None-Specified",M,1 - Not pathogenic or of no clinical significance,,9.60E-07,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.000727821,
chr13:32328583:G>C,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr17:43076710:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr17:43106865:C>A,,,,,,,,,,0.0,0.0,0.0101,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00139776,
chr17:43093488:A>C,,,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.78|None|None|possibly-damaging:0.78|possibly-damaging:0.78,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32376796:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr13:32376796:T>A,,,In vitro (cloned)|Unknown,-|as variant control,-|cDNA analysis,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr17:43049165:CAG>CCT,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,,,
chr17:43099774:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43063914:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32355165:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,8.237e-06,
chr17:43094464:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43093611:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43123697:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43125092:TGAACTTGTGACCTTGTGATCCGC>T,,,,,,,,,,0.003,0.0023,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00139776,
chr17:43049113:C>G,,,In vitro (cloned)|Unknown,predicted neutral|no splicing defect|-,Splicing reporter minigene|-|splicing reporter minigene/patient RNA analysis|mRNA analysis and splicing reporter minigene,,,,,0.0,0.0159,0.0058,0.0,0.0,Kuwait|African American|-|American,1|-|394,Arab|-,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,0.003262005,
chr17:43091817:TCACTCTGT>A,,,,,,,,,,,,,,,,,-|English,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092527:TCTCTAT>T,,,,,,,,,,,,,,,Western Europe|-,,,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43099810:A>AA,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32348201:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43054744:TT>A,,,,,,,,,,0.3857,0.8994,0.3862,0.4554,0.5562,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.56869,
chr17:43104295:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,1,,
chr17:43100560:C>G,,,,,,,,,,0.0149,0.1899,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.0541134,
chr13:32337247:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-043),,1,5.766e-05,
chr13:32340047:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-043),,1,,pathogenic
chr13:32380056:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43078008:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32398679:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32386265:T>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr17:43084171:C>T,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32316418:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,9.06e-05,
chr13:32333391:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,10/26,1,,,,,,8.376e-06,
chr13:32398679:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32333048:AT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340989:TGTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43092608:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32377040:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0159,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00419329,benign
chr13:32332956:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-89),benign(0-003),,,,
chr17:43082626:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,8.237e-06,
chr13:32379531:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,,,,,,,,Austria,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,9.061e-05,
chr17:43082024:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0212,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00559105,benign
chr13:32338824:CAGTC>T,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326620:C>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,
chr13:32398762:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001080755,
chr17:43074503:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,,,-1,,,,,,8.236e-06,
chr13:32363427:CAACAAAAGTCATTTT>A,,,,,,,,,,,,,,,,,Western Europe/Norway,IFD,,,,,,,,protein_altering_variant,MODERATE,18/27,,1,,,,,,,
chr17:43090737:C>TGTGCGC,,,,,,,,,,0.0,0.0386,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0103834,
chr13:32326103:AGTT>C,,,,,,1/1658,,,,,,,,,,,Western Europe/English/Scottish|Western Europe|None Specified,IFD,,,,,,,,protein_altering_variant&splice_region_variant,MODERATE,5/27,,1,,,,,,1.648e-05,
chr13:32332652:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),possibly_damaging(0-487),,,,
chr13:32373471:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32365177:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.5206 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32383088:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32351184:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43094464:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.05409 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|_NHGRI|Division_of_Genomic_Diagnostics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,6.4186|1.0213|4.5902,probably-damaging:0.999|None|None|probably-damaging:0.999|probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&0&0&1,1&1&1&1,,
chr17:43102132:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43067642:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32340609:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32338435:CCTA>T,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43051532:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32339249:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-029),,1&1,,
chr17:43064916:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3164 (Asian)| 0.1992 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3608,0.2073,0.2925,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.339657,benign
chr13:32355070:T>C,,,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-999),,,,
chr13:32339253:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-124),,1,5.768e-05,
chr17:43095970:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.242e-06,
chr17:43093618:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32319296:GACTCCA>A,,,,,,,,,,,,,,,,,Western Europe,IFD,,,,,,,,inframe_deletion,MODERATE,3/27,,1,,,,,,,
chr13:32354994:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),possibly_damaging(0-906),,,8.237e-06,
chr17:43092648:G>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43076533:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.237e-06,
chr13:32383177:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32332703:AA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32329701:A>T,,,,,,,,,,0.0,0.0348,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00958466,
chr13:32321240:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32318535:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32380037:A>T,,,,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,
chr13:32340556:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32332383:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-027),,1,,
chr13:32338190:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-043),,1,,
chr13:32350874:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32332383:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-297),,1,,
chr13:32331073:G>A,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr13:32365380:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32345941:G>A,,,,,,,,,,0.003,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000798722,
chr13:32341362:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32326571:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32352880:C>A,,,,,,,,,,0.1034,0.0098,0.0706,0.001,0.0194,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0371406,
chr17:43092805:G>A,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,Malaysian|Singaporean,,Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,4.942e-05,
chr13:32340834:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-022),,1,,
chr13:32379477:C>G,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1&1,6.589e-05,
chr17:43091848:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1&1,,pathogenic
chr13:32363870:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32340140:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,0.001,0.0,0.0,0.006,0.0,Malaysian|-|Asian,,"Central/Eastern European|Chinese| filipino|Western European|-| Phillipines""""| Philippines| Filipino""""|""""Asian|Native American| Asian| Chinese| Philippines""""|None Specified|Asian",M,1 - Not pathogenic or of no clinical significance,0.05012,0.01175,0.42658,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-74),benign(0-03),,1&1,0.00117663,
chr17:43094279:G>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,
chr13:32339554:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,-|10/1658,,0.5358|0.091|0.3851,None,0.004,0.0,0.0043,0.0,0.001,German|Austria|-,1|0|3|2|-," Asia""""|""""Europe|-",Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.00301522,benign
chr17:43058381:G>A,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43097313:AG>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr13:32319123:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32360610:C>A,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00139776,
chr13:32341126:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43100214:AA>A,,,,,,,,,,0.0089,0.0023,0.0072,0.001,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.00419329,
chr13:32333261:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-001),,1,8.238e-06,
chr13:32340046:TTGG>G,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr17:43099695:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32340969:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-613),,1,,
chr13:32337012:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr13:32341171:AAGAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr13:32355175:T>C,,,,,,,,,,,,,,,,,African| Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-11),possibly_damaging(0-834),,1&1,,
chr13:32332836:T>CA,,,,,,,,,,,,,,,Australian,,Lebanese,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43078355:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43093119:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43096760:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,0.000199681,
chr13:32363351:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000495,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model|?,-|3/1658,,0.2209|0.0|0.1461,possibly-damaging:0.955,0.001,0.0,0.0029,0.0,0.0,Central/Eastern Europe|Not Specified|Spanish|-|Austria|Dutch|Western Europe,0|-,"Latin American/Caribbean| Irish|Central/Eastern European|Central/Eastern Europe| Central/Eastern Europe|Not Specified|Western European|Western/Central/Eastern Europe|-| Ashkenazi""""| Central/Eastern European""""|Asian| Ashkenazi| German|""""Western European|Western Europe| Latin American| Asian""""|Caucasian|None Specified|Near East/Mid East",M,1 - Not pathogenic or of no clinical significance,0.1211,1.28E-03,,0.0,0.03,0.03,missense_variant,MODERATE,18/27,,1,,tolerated(0-14),benign(0-056),,1&1,0.000880021,
chr13:32331280:T>A,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000998403,
chr17:43094601:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32316564:C>T,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43094720:A>G,,,,,,,,,,,,,,,,,"Western-European|-| Central/Eastern European""""|""""Western European",M,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32316532:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,MODIFIER,,,1,,,,0&1&1,1&1&1,,benign
chr13:32356108:A>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000998403,
chr13:32398589:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32337158:A>C,,,,,,,,,,,,,,,,,Latin American/Caribbean|Western European|None Specified|Central/Eastern European|Native American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-222),,1&1,4.942e-05,
chr13:32363455:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr17:43093119:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000446,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,2/1658|-,,0.0116|0.0454|0.0231,probably-damaging:0.984|None|None|probably-damaging:0.984|probably-damaging:0.984,,,,,,,,Central/Eastern European|Central/Eastern Europe|Western European|-|African|Western Europe|Central/Eastern-European|None-Specified,M,1 - Not pathogenic or of no clinical significance,1.12,2.244,,0.00045,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,5.765e-05,
chr13:32339537:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-387),,1,,
chr13:32341109:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43099914:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|141/1658,,24.0698|4.8797|17.5688,None|None|None|None|None,0.2266,0.0098,0.1167,0.0,0.1759,U.S.A.|German|Malaysian|-|Austria|Greek|American|Spanish|Italian|Belgian?,-|1|0|2|5|412|8,Greek|-|Caucasian|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,1,0.1363211,benign
chr17:43084175:C>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr13:32382709:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43091919:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32396435:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr17:43092188:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339586:G>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-187),,1,,
chr17:43094338:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43094338:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Asian|-South-China,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338803:TG>C,,,,,,,,,,,,,,,-|Dutch?,,German|Western European|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32357759:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,8.236e-06,
chr13:32383876:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32355208:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-002),0&1&1,1&1&1,,
chr13:32344536:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,1.655e-05,
chr13:32338436:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-493),,1,,
chr13:32362601:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-973),,,0.0001039585,
chr13:32338392:CTGTTTG>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32340575:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000313,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|1.0213|0.3462,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-007),0&0&1&1,1&1&1&1,,
chr13:32315226:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.16 (Asian)| 0.18 (African)| 0.18 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43094458:TC>A,,,,,,,,,,,,,,,Not Specified|-|Belgian,2|-,Western Europe|-|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43089383:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43055742:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43078751:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32325081:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.1362|0.0461,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43099773:A>T,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32339053:CCTAAAGTACAGAGA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,
chr13:32398536:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339163:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-333),,1&1,,
chr17:43104903:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43093393:T>C,,,,,,,,,,,,,,,Western Europe|-|American,1|2|-," Native American""""|Western European|-|Caucasian|Western-European|Western Europe|None-Specified|None Specified|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr17:43052839:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| 0.1702 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43076625:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr13:32324255:G>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43094429:C>CG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32363451:AGA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43114980:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03826 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0427,0.0015,0.0115,0.0,0.0143,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.0133786,benign
chr17:43092826:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32379802:C>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western Europe|Western/Central/Eastern Europe,M,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr13:32339471:AATA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,pathogenic
chr13:32319286:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr17:43085676:C>TA,,,,,,,,,,0.0089,0.0,0.0014,0.0724,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0169728,
chr17:43063361:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-999),0&1&1,1&1&1,,
chr13:32356985:C>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000399361,
chr13:32340569:CA>T,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339683:GAA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32362549:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-976),,1,,
chr13:32362728:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,-|mRNA analysis and splicing reporter minigene,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.0002110405,
chr13:32337227:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32379765:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32332661:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),,,,,,,,,,,,-|Spanish,,Latin American/Caribbean|Caucasian,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-311),,1&1,,
chr13:32339265:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-105),,1,,
chr17:43093457:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1&1,0.0001121955,
chr17:43093057:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43115932:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32340859:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr17:43052695:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32345984:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32363294:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(1),benign(0-003),0&1&1,1&1&1,,
chr13:32340654:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-917),,,8.238e-06,
chr17:43076474:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01224 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Splicing reporter minigene|-,,,,,0.0,0.0,0.0,0.0099,0.001,German|American|-,,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1&1,0.001493595,
chr17:43091873:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1&1,,pathogenic
chr17:43049168:G>T,,,In vitro (cloned),predicted neutral|predicted deleterious|no functional effect|inconclusive|not destabilizing,Prevalence in normal controls|transcription activation/PS/BA/BS|Thermodynamic stability prediction|evolutionary conservation analysis|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|-,,Western European|-|Latin-American/Caribbean,M,5 - Definitely pathogenic,1694.0,1.2,,0.9999,0.81,0.81,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-002),,1&1,,
chr13:32398624:A>G,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32352693:G>T,,,,,,,,,,0.004,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32333398:CT>CTT,,,,,,,,14.2511,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1&0,,
chr17:43119282:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32333148:CA>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,8.236e-06,
chr17:43071184:A>T,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-512),,1,8.236e-06,
chr13:32398243:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,0.0|2.4512|0.8304,benign:0.0,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43049093:CCTCT>C,,,,,,,,0.1696|0.0938|0.1438,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr17:43047644:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/22,,-1,,,,,,,
chr13:32354996:A>AT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,8.237e-06,
chr17:43093425:T>TA,,,,,,,,,,,,,,,,,"Latin American/Caribbean| Irish Italian Spanish English""""|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43047643:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|no functional effect|-|as variant control,Structure-based prediction (crystallography etc)|-|mRNA analysis (RT-PCR)|Prevalence in normal controls|transcription activation/PS/BA/BS|cDNA analysis|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,Greek|-,,Greek|-,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/22,,-1,,,benign(0-218),,1&1&1,,
chr17:43097241:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,None|None|None|None|None,0.0,0.0008,0.0,0.0,0.0,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,8/22,-1,1.0,,,,1,0.0001163155,
chr13:32338992:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32398243:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43091793:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32356598:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-05),,,,,
chr13:32336474:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-168),,1,,
chr17:43094519:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43125170:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1362 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32399523:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32326296:C>T,,GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,benign
chr17:43092197:CTTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,pathogenic
chr17:43125348:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,4.87e-05,
chr17:43104599:C>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000998403,
chr17:43049093:TCGGC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,3.295e-05,
chr13:32337292:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-94),,1,8.238e-06,
chr17:43071263:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,8.239e-06,
chr13:32336474:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-015),,1,0.000103959,
chr13:32379409:GC>GCT,,,,,,,,,,,,,,,,,Not Specified|Western European,F,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,1&1&1,,
chr17:43099883:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,1&1&1,,
chr13:32337787:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.236e-06,
chr17:43097229:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,,benign
chr13:32338349:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),1&1,1&1,,
chr17:43108791:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3377 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43117694:G>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000798722,
chr17:43125326:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,0.0003217405,
chr13:32337851:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-089),,1,,
chr17:43076545:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,deleterious(0-01),,0&1&1,0&1&1,8.237e-06,
chr13:32346855:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0-02),possibly_damaging(0-653),,1,,
chr13:32337618:A>CT,,,Germline (inherited),,,,FA FANCD1_00031,,,,,,,,-|Spanish,,"Latin American/Caribbean| Latin American/Caribbe| Latin American/Caribbean""""|Western European| Mexican|-| Asian| Latin American/|""""Central/Eastern European|Caucasian|None Specified",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.24e-06,
chr13:32319087:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,2.471e-05,
chr17:43057610:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0356,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00958466,benign
chr13:32341276:TTAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr13:32338533:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,
chr13:32327293:T>C,,,,,,,,,,0.0348,0.0325,0.0965,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0742812,
chr13:32337285:TGAATATAGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43103254:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43045766:G>T,,,,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0-01),probably_damaging(0-981),0&1,1&1,2.471e-05,
chr13:32380136:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,1.647e-05,
chr13:32326135:AAG>C,,,,,,,,,,,,,,,Czech|-,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,5/27,,1,,,,,,,
chr13:32336877:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-006),,1,,
chr13:32356458:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0|0.0227|0.0077,possibly-damaging:0.724,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-01),,,1,,
chr17:43112347:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32379800:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,,
chr13:32378078:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32333367:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-015),0&0&0&1&1,1&1&1&1&1,,
chr17:43115331:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32378985:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32379894:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32379894:C>CA,,,,,,,,,,,,,,,English/Canadian|USA|Not Specified|-|Spanish|Hungary|Western Europe,2|-,Latin American/Caribbean|Ashkenazi Jewish|Central/Eastern European|Western European|-|African American/Latin American/Caribbea|Ashkenazi|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,
chr13:32337424:CATTAA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,
chr13:32332171:GTG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr13:32340137:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43104232:CCC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,1,,
chr13:32327594:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32327059:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32333109:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43049116:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,African American|African,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,,
chr17:43057002:CTA>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,
chr17:43095587:GGGAA>CAAAC,,,,,,,,,,0.3569,0.2133,0.3718,0.373,0.501,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.352436,
chr13:32338254:TCAC>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,1,2.48e-05,
chr17:43049116:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,,
chr13:32346891:TGATGT>C,,,,,,,,,,,,,,,,,German|-,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,13/27,,1,,,,,,,
chr17:43092035:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092602:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32385349:T>C,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43118250:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43049116:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Dutch/Belgian|Belgian?,,-|Caucasian,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,,
chr17:43082423:TTCT>TTCTTTCT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr17:43091781:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32337354:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),,,1,,
chr13:32340149:CAA>C,,,,,,5/1658|-,,,,,,,,,-|Italian,,Western European|-|Southern Europe|None Specified|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43051050:G>A,,,In vitro (cloned)|Unknown,no splicing defect|-,-|splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,5.765e-05,
chr13:32329450:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,,,
chr17:43091733:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092022:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.236e-06,
chr17:43092968:T>A,,,,,,,,,,,,,,,,,Not Specified|Western Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32326150:T>A,,,Unknown|Germline (inherited),,,,FA FANCD1_00027|-,,,,,,,,Czech,,Caucasian,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,1&1&0,,
chr13:32365247:AA>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0102,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00199681,
chr17:43082898:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43067701:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,,,
chr13:32330894:T>C,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr13:32356551:T>A,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|-|inconclusive,Protein likelihood ratio model|Homology-directed repair assay|-|Centrosome amplification|Multifactorial likelihood-ratio model,,,,,,,,,,,,"Latin American/Caribbean| Puerto Rico| French Canadian""""|""""Western European",M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-848),1&1,1&1,1.647e-05,
chr13:32356551:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,1&1,1&1,8.236e-06,
chr17:43091484:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092662:T>A,,,,,,,,,,,,,,,Latin American/Caribbean|Norwegian|-,,Western European|-|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43104926:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr17:43045162:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43092731:GAACA>G,,,,,,,,,,,,,,,,,Western-European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43117558:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43094721:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32340221:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-452),,1,,
chr17:43091542:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092187:GA>T,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32355077:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1&1,,benign
chr17:43071204:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43121301:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32337163:ACAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32369041:A>G,,,,,,,,,,0.0249,0.0,0.0058,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00638978,
chr17:43091771:TAGAC>T,,,,,,,,2.1934|1.9231|2.1013,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094169:GCC>A,,,,,,,,,,,,,,,-|Italian,,White-NonHispanic|Central/Eastern European|Central/Eastern Europe|Unknown|-|Western European|Western-European|Caucasian|Italian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43071171:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,,,1&1,8.236e-06,
chr13:32333367:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|-|Ashkenazi/Western Europe,,Western European|-|Austria|Asian|Western Europe|None Specified|Ashkenazi,M,1 - Not pathogenic or of no clinical significance,1.0,0.26303,2e-05,0.0,0.02,0.02,missense_variant,MODERATE,10/27,,1,,deleterious(0-03),benign(0-104),0&0&0&1&1,1&1&1&1&1,0.0001738,
chr17:43124056:AATGA>A,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43076516:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,8.237e-06,
chr17:43091342:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.263e-06,
chr17:43092110:GCCG>G,,,In vitro (cloned)|Unknown,predicted neutral|-,co-occurrence with deleterious variant|-,,,,,,,,,,,,Western-European|None Specified,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32326644:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,1.647e-05,
chr13:32362603:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr13:32323367:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32354941:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1&1,,
chr17:43063953:C>A,,,,,,,,,,,,,,,,,Western-European|-Italian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1&1,,
chr17:43090998:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr17:43115911:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32316519:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr17:43093327:CC>A,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339496:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43090998:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43094833:AC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,pathogenic
chr13:32396901:GT>A,,,,,,,,,,,,,,,USA,,Caucasian,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32354901:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),probably_damaging(0-982),,,,
chr13:32332820:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-001),,1,,
chr17:43093056:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-001),,1,,pathogenic
chr17:43093140:CAG>T,,,,,,,,,,,,,,,,," African/W Indian""""|Latin American/Caribbean|Western European|""""African| Asian|African",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43051983:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43093701:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,5.766e-05,
chr13:32338827:TCATA>T,,,,,,7/1658|-,,,,,,,,,English/Canadian|USA|Not Specified|-|British?|British|Dutch,1|2|-,Central/Eastern European|Central/Eastern Europe| Central/Eastern Europe|Not Specified|Western European|-|caucasian|German|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340880:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43092051:GTGC>CG,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32397001:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340955:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337806:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32363456:TAAT>A,,,In vitro (cloned),inconclusive,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,18/27,,1,,,,,,8.236e-06,
chr17:43071236:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32339596:A>CTA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43082548:G>C,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,4.118e-05,
chr17:43104926:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,,
chr13:32362574:T>A,,,,,,,,,,,,,,,,,Western European| Italian,N,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,
chr13:32336530:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1,,
chr13:32337529:CA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32397030:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.4312|0.1461,benign:0.252,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43095875:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,Unknown|Germline (inherited),,,-|1/1658,,0.0116|0.0|0.0077,benign:0.135|benign:0.135|benign:0.135|benign:0.135|benign:0.135,,,,,,Western Europe|-|Italian,,Not Specified|Western European|Western Europe|-|None-Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,1.647e-05,
chr13:32396449:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1923 (Asian)| 0.1037 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32329817:G>TATA,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00159744,
chr13:32370336:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,
chr13:32336530:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092311:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32323006:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32364315:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0357,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00778754,
chr13:32336562:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-06),,,8.236e-06,
chr17:43091860:GGAA>GGAAGGAA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32336480:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr13:32329482:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32351399:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32346184:G>GT,,,,,,,,,,0.003,0.0038,0.0014,0.002,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00259585,
chr13:32370948:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1,,
chr13:32348529:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43069110:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43104266:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,,1.647e-05,
chr17:43091710:T>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339519:C>T,,,,,,,,,,,,,,,,,Western European| African| Creole,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-036),,1&1,8.243e-06,
chr13:32316406:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr17:43115793:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),no splicing defect|predicted neutral|-|Loss of variant allele|as wildtype control|?,Histopathology|mRNA analysis (RT-PCR)|co-occurrence with deleterious variant|-|Splicing reporter minigene|splicing reporter minigene/patient RNA analysis|LOH analysis|?,2/1658|-,,,,,,,,,American|Western Europe|-|Austria|Belgian,1|0|-,Latin American/Caribbean|-Latin-American|Honduras|Central/Eastern European|-Italy|Western European|-|Caucasian|Not Specified|-Central/Eastern-Europe| Ashkenazi|Western-European|Central/Eastern-European|None-Specified|None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,0.0004613,
chr17:43062691:T>A,,,,,,,,,,0.001,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43115793:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,3.295e-05,
chr13:32371059:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-2),benign(0-046),,1,,
chr13:32363384:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|_NHGRI,,,,,,0.4535|0.0908|0.3306,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-78),benign(0-015),,1&1,,
chr17:43091783:TTCACATTTTTTTTTTTTTTTTTTAGACAGGGTCT>C,,,,,,,,,,,,,,,Uruguayan,,Spanish-African,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43091587:A>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32376769:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32337912:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,,,8.236e-06,
chr17:43103533:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43104264:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1&1,,pathogenic
chr17:43094410:C>A,,,In vitro (cloned),predicted deleterious|inconclusive,E3 Ub-ligase activity assay|evolutionary conservation analysis,,,,,,,,,,Spanish,,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43074226:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32394801:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32376769:C>G,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.877,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32338765:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,2.471e-05,
chr17:43067594:G>A,,Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,benign
chr17:43094304:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr13:32394702:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,0&1&1,1&1&1,,
chr17:43093682:TAGC>T,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,Not Specified|-|Western Europe|-Latin-American/Caribbe|African|Western-European|African American|None-Specified|None Specified,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.00076379,
chr13:32394801:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,benign
chr13:32392531:T>A,,,,,,,,,,0.0348,0.0303,0.0908,0.0962,0.136,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0734824,
chr13:32323838:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32386226:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5427 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5711,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.527556,benign
chr17:43106538:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,,,,,1,,
chr17:43063343:GCT>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,,,
chr13:32363563:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.241e-06,
chr13:32330034:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr17:43107299:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43112066:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr13:32337567:C>G,,,,,,,,,,,,,,,,,Asian| South East Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-037),,1,8.239e-06,
chr17:43124108:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32370396:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,1,,benign
chr17:43057088:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-03),benign(0-113),,1&1&1,,
chr13:32355157:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),benign(0-002),,,,
chr13:32379881:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.986,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43124086:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,,
chr13:32336528:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-02),,1,,
chr13:32332958:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-01),,,,
chr13:32380001:A>T,,,,,,,,,,,,,,,,,Latin American/Caribbean,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,
chr13:32354856:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,13/26,1,,,,,1,,
chr13:32340799:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,13/26,1,,,,,1,,pathogenic
chr13:32337419:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),,,,8.238e-06,
chr17:43094204:->AC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32358885:C>T,,,,,,,,,,0.4811,0.3147,0.4582,0.4653,0.5327,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.440895,
chr13:32340543:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32338577:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43045700:CC>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr13:32355075:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,,
chr17:43074328:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,
chr17:43104867:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,8.237e-06,
chr17:43074328:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32341178:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-217),,1,,
chr13:32336464:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340262:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092222:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340137:T>A,,,,,,,,,,,,,,,Not Specified|-,, Hispanic|Western European|-|Native American,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,,
chr13:32338285:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092185:CTT>CTTCTT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43067696:C>T,,Pathway_Genomics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/22,-1,,,,,1,,pathogenic
chr13:32332345:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32340072:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32376734:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr17:43067592:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr13:32379506:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32336999:AG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092943:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43045735:C>T,,,,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_retained_variant,LOW,22/22,,-1,,,,,1,,
chr13:32337239:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),possibly_damaging(0-782),,,9.061e-05,
chr13:32369119:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32316589:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|1/1658,,,,0.002,0.0038,0.0058,0.0,0.0031,Austria|-,1|0|-,-|Asia,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,0.00279553,
chr17:43063880:GT>A,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr13:32371061:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32332434:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,3.295e-05,
chr13:32340054:AAC>C,,,,,,,,,,,,,,,,,"Western European| Italian""""|""""Western European",F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32332434:G>C,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|-|Loss of variant allele,LOH analysis|Homology-directed repair assay|-|Centrosome amplification|Multifactorial likelihood-ratio model,,,,,,,,,,Latin American/Caribbean|-,," Lebanon""""|Not Specified|Western European|Western/Central/Eastern Europe|-|Near Eastern| Near Eastern| Syria|""""Central/Eastern European|None Specified",M,1 - Not pathogenic or of no clinical significance,0.048,0.062,6.61,0.0004,0.02,0.02,missense_variant,MODERATE,10/27,,1,,deleterious(0-05),possibly_damaging(0-713),,1,0.0001565,
chr13:32337623:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-56),benign(0-006),,1,8.241e-06,
chr13:32379843:TGGGGTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,23/27,,1,,,,,,2.471e-05,
chr13:32349722:T>A,,,,,,,,,,0.0,0.003,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32333072:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.236e-06,
chr13:32333072:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-22),benign(0-037),,1,8.236e-06,
chr13:32339153:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-62),benign(0-019),,,8.237e-06,
chr17:43093119:CT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-62),benign(0-019),,,,pathogenic
chr13:32341067:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-093),,,8.236e-06,
chr13:32398667:T>A,,,,,,,,,,,,,,,,,Greek|Central/Eastern European|Near East/Mid East,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,4.118e-05,
chr17:43092393:TTCATTAATA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43049180:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-002),,1,,
chr17:43094870:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32336910:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-139),,1,,
chr13:32338622:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-061),,,8.247e-06,
chr17:43104234:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-061),,,,pathogenic
chr13:32332470:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-864),,1,,
chr17:43082530:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32374454:T>G,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43092204:CATGG>T,,,,,,,,,,,,,,,Brazilian,,Portuguese,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43070445:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2195 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr17:43063311:G>A,,,,,,,,0.0|0.0908|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,
chr13:32362521:T>G,,,,,,,,,,,,,,,Western European|Western Europe|-,,Not Specified|Western Europe|-,IVS,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,
chr13:32342322:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000798722,
chr13:32376710:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32370604:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.004128,
chr17:43092177:T>A,,,,,,,,,,,,,,,,,Native-American|-Central/Eastern-Europea,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32398747:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,4/1658|-,,,,0.003,0.1188,0.0605,0.0208,0.002,Latin American/Caribbean|Western Europe/African American/Pakistan|Sicilian|Central/Eastern Europe|West/Central/East Europe|Not Specified|Western Europe/Latin Amer/Caribbean|Malaysian|-|Czech|Austria|Asian|Brazilian|Danish|Western Europe|African American,1|2|-,"Latin American/Caribbean|Western Europe/Native American|Asian/Phillipeans|Chinese|Not Specified|-| Am|Native American/African American| Africa|""""Austria|Asian|African Amer/Native Amer|Caucasian|Western Europe|Irish/Scottish|Near East/Mid East/Latin American/Caribb|African American|-Indian""""",M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,0.03346405,
chr17:43074523:G>C,,,,,,,,,,,,,,,,,Not Specified|Western European|-|Western Europe|None-Specified|None Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,
chr17:43114074:C>CA,,,,,,,,,,0.0298,0.4629,0.0591,0.0109,0.0501,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.148363,
chr17:43044393:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.993e-05,
chr17:43092521:ACC>C,,,Germline (inherited),,,,,,,,,,,,Sweden|-|Spanish,,Western-European|Latin American/Caribbean|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092068:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000714,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337854:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-63),benign(0-012),,1,,
chr17:43104261:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,6/23,,-1,,,,,1,,
chr17:43092034:TT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43107656:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43094408:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32370604:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,9.063e-05,
chr13:32339826:A>AA,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394814:C>T,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32344587:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-09),probably_damaging(0-977),,1,,
chr13:32341071:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-981),,,8.236e-06,
chr17:43067637:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-806),,1,,
chr17:43093738:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43093638:A>C,,,,,,,,,,,,,,,U.S.A.,,Western European,Syn,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093348:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092881:A>C,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045757:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-908),,1&1,,
chr13:32332935:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-002),,,,
chr17:43094435:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32334211:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43093738:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr13:32359790:T>A,,,,,,,,,,0.003,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000998403,
chr13:32394875:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-03),possibly_damaging(0-798),,1,,
chr13:32338220:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-043),,1,,
chr17:43094275:AA>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32398875:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2124 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,
chr13:32338909:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32356590:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,1.647e-05,
chr13:32337426:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-73),,1,,
chr13:32362657:C>TC,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,1,,
chr17:43125293:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,0.0001252655,
chr13:32399139:T>G,,,,,,1/1658,,,,0.2744,0.3177,0.2493,0.0714,0.1748,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.222045,
chr13:32374113:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43058379:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3392 (Asian)| 0.4411 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32340287:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32323201:T>A,,,,,,,,,,0.0139,0.0008,0.1009,0.0,0.0153,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0199681,
chr17:43093181:G>C,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32353301:T>A,,,,,,,,,,0.002,0.0,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32332906:TCAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43067609:G>C,,,,,,,,,,,,,,,,,Western European| Central/Eastern European|Ashkenazi| Swedish Danish,Syn,,,,,,,,splice_region_variant&synonymous_variant,LOW,15/22,,-1,,,,0&1&1,1&1&1,,
chr17:43124097:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092045:AA>A,,,Unknown|Germline (inherited),,,,,,,,,,,,German|Not Specified|-|French?|Dutch,,Western European|-|Native American|Western-European|Western Europe|Central/Eastern-European|Caucasian|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32379747:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,pathogenic
chr17:43091602:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43045635:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32332380:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-171),,1,1.648e-05,
chr17:43091602:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32356594:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr17:43127281:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,0&1,,benign
chr13:32356594:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr13:32396768:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43092757:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32330909:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32357808:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr13:32336541:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-049),,1,,
chr13:32396935:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32357808:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,1,,
chr13:32356237:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr13:32356406:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,1.647e-05,
chr13:32332489:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,
chr17:43115737:ACT>GGC,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,,,
chr13:32370361:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.239e-06,
chr13:32319252:A>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32340070:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341069:T>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European|Native American/Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-093),,1,1.647e-05,
chr13:32374904:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43092900:AA>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32332963:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.237e-06,
chr17:43122460:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43094415:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32380039:TT>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32357896:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-03),,,1,,
chr13:32330981:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,,8.237e-06,
chr17:43092650:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32356419:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,
chr13:32339134:A>C,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),possibly_damaging(0-73),0&1&1,1&1&1,,
chr13:32354902:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),,,1,,
chr17:43063919:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-996),,,,
chr13:32379313:A>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,,,
chr17:43063931:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,University_of_Washington_Center_for_Mendelian_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|_University_of_Washington|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-995),,1&1,,pathogenic
chr13:32397028:T>A,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32397002:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr17:43092460:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32397002:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr17:43056814:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32376768:AGCACATGTG>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,21/27,,1,,,,,,,
chr13:32362681:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43102469:C>G,,,,,,,,,,0.3668,0.8956,0.4308,0.371,0.5307,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.548123,
chr13:32326074:GA>GA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,2.472e-05,
chr13:32316794:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32356554:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-05),probably_damaging(0-963),,1,,
chr17:43091887:ATC>T,,,,,,,,,,,,,,,Czech|Austria,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094594:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43091629:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32379947:A>C,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43093343:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094679:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43063809:G>T,,,,,,,,,,,,,,,Greek|-|Italian,,Greek|-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43108104:C>A,,,,,,,,,,0.0,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32393464:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32382598:G>AG,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00898562,
chr17:43102713:A>G,,,,,,,,,,0.003,0.0008,0.0029,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00159744,
chr17:43111678:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr17:43124116:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,,0.0001039595,
chr13:32364444:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32339461:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.649e-05,
chr17:43094678:CCC>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32317393:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43071022:T>CT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,
chr17:43094289:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,0.0001286705,
chr13:32340307:CAT>A,,,,,,,,,,,,,,,,,Scottish/German|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32370543:AA>G,,,,,,,,,,,,,,,Danish,,,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr17:43067580:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr13:32337967:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092865:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319088:C>G,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,Not Specified|-,,-|None Specified,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,8.238e-06,
chr17:43104104:G>A,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43063954:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr13:32340707:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr13:32337566:C>T,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32359067:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32362645:A>G,,,In vitro (cloned),predicted neutral|as wildtype control|no splicing defect,Protein likelihood ratio model|Multifactorial likelihood-ratio model|Homology-directed repair assay|Centrosome amplification|splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-994),,1,2.471e-05,
chr13:32379848:AGTAAA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-994),,1,,
chr17:43093462:G>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr17:43092377:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr13:32363194:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-95),,1,,
chr17:43094655:CT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32363194:T>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,0.0001163155,
chr13:32363194:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,Syn,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,
chr13:32381638:T>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32357808:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European|Central/Eastern European|None Specified,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,1,,
chr13:32398195:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,1,,pathogenic
chr13:32336437:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,1.647e-05,
chr13:32359118:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43077335:C>CT,,,,,,,,,,0.33,0.1611,0.3501,0.3373,0.4509,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.313299,
chr17:43094061:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,5.766e-05,
chr13:32340849:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32326457:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,4.943e-05,
chr17:43091513:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32329440:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,0.0001080855,
chr17:43045766:GG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43074500:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr17:43085750:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43124031:G>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,,
chr13:32336369:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,8.237e-06,
chr17:43124716:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43094284:GCTGCCAT>A,,,,,,,,,,,,,,,,,Near Eastern| Iranian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43104139:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32375282:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32385139:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43082988:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32357926:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,,,
chr13:32376690:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32394671:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,benign
chr17:43095066:G>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32398404:ATTT>ATTTATTT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332614:AT>G,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32357962:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.236e-06,
chr17:43100689:G>ATGT,,,,,,,,,,0.0378,0.0008,0.0187,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.0113818,
chr17:43092845:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43125267:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,MODIFIER,,,-1,1.0,,,,,4.874e-05,
chr13:32341215:TG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr13:32316427:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32357628:AGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32394816:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,25/27,,1,,,,1&1,1&1,,pathogenic
chr13:32369605:T>A,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00159744,
chr13:32394933:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,25/27,,1,,,,,1,,pathogenic
chr13:32350515:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43087555:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32340580:G>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-991),,1,8.237e-06,
chr13:32337521:CCTGGA>C,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe|-|None Specified| French Canadian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,2.471e-05,
chr13:32339214:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,-|British,1|-,Caucasian|English,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43070981:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-002),,1,,
chr13:32317569:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1853 (Asian)| 0.1382 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32379808:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,1.648e-05,
chr13:32333398:TG>C,,,In vitro (cloned)|Unknown,-|?,-|?,1/1658|-,,,,,,,,,German|Spanish,1|-,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,
chr17:43115690:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,8.237e-06,
chr13:32340441:C>G,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-272),,1&1,1.647e-05,
chr13:32360755:C>G,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000798722,
chr13:32380725:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32343709:TA>G,,,,,,,,,,0.1968,0.2322,0.2205,0.0843,0.1493,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.177516,
chr17:43048719:ATTTTTAGTACAGACATGGTTTCACCATGTTG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr13:32370493:T>C,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43092869:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394890:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-63),benign(0-098),,1&1&1,4.118e-05,
chr13:32337717:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43113773:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr13:32337717:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32379318:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,22/27,,1,,,,,1&1&1,,
chr13:32325750:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32323559:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32332480:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-263),,,0.000103959,
chr13:32375831:->TTAC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43074929:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32333258:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-228),,1,,
chr13:32379753:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43123966:T>C,,,,,,,,0.0|0.1136|0.0385,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32388063:A>T,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr13:32332244:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr17:43092154:GCC>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093073:TA>CG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.003039,
chr13:32398334:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045756:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr13:32326589:AT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,1,,
chr17:43124016:T>G,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,
chr17:43082340:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32340037:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&0,,benign
chr13:32344634:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,,,
chr13:32338215:A>AA,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43066355:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0179712,benign
chr17:43093634:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,Unknown|Germline (inherited),,,,,,,,,,,,,,Western Europe|Central/Eastern Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43115501:GC>C,,,,,,,,,,0.4254,0.3328,0.4352,0.4544,0.5225,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.427117,
chr17:43103431:C>T,,,,,,,,,,0.007,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00179712,
chr17:43094642:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr13:32336773:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43094642:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr17:43093634:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European|-French-Canadian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32318220:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32340037:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr13:32340037:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr13:32370520:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,,,
chr17:43097301:G>T,,,,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,8.24e-06,
chr17:43115892:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32379744:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,,
chr17:43093222:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337307:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0),,,8.238e-06,
chr17:43091895:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32339884:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,2.471e-05,
chr17:43104174:G>A,,,,,,,,,,,,,,,American|-,," Native American""""|-|""""African",M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32357873:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr13:32362235:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32379318:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32339884:G>C,,,Unknown|Germline (inherited),,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.0004179305,
chr17:43093222:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43070915:T>C,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr13:32333147:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-3),benign(0-002),,,,
chr13:32338987:TAAC>C,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,8.237e-06,
chr13:32363394:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-38),benign(0-345),,,8.236e-06,
chr13:32332531:A>AT,,,,,,,,,,,,,,,Western European,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32372996:A>CT,,,,,,,,,,0.2654,0.2005,0.2478,0.3651,0.1861,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.250399,
chr17:43124106:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr13:32337059:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),possibly_damaging(0-574),,1,,
chr17:43045739:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,probably_damaging(0-969),,1,1.647e-05,
chr17:43099726:A>G,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,
chr13:32338464:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-011),,1,8.237e-06,
chr17:43094066:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43064696:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02098 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43094766:G>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,0.0006721515,
chr13:32337894:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-099),0&1&1,1&1&1,,
chr13:32319272:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-099),0&1&1,1&1&1,,pathogenic
chr17:43092525:CA>G,,,Germline (inherited),,,,,,,,,,,,-|British,,Latin American/Caribbean|White-NonHispanic| Native American|Western European|Latin-American/Caribbean|-|Caucasian|-peruvian|English/Welsh|Western-European|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32316508:TGA>G,,,In vitro (cloned)|Unknown,-|as variant control,Cell viability (in BRCA-/- cells)|-,1/1658|-,,,,,,,,,,,Not Specified|Western Europe|-,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr17:43063983:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr13:32333321:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-2),benign(0-013),,,8.247e-06,
chr13:32329522:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr17:43062603:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0058,0.0456,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0105831,benign
chr13:32394892:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-2),probably_damaging(0-997),,,8.236e-06,
chr17:43052971:G>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000599042,
chr13:32340621:ATCT>AC,,,,,,,,,,,,,,,,, Poland|Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32355154:A>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-16),benign(0-108),,1,,
chr13:32340168:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-32),benign(0-233),,1,8.237e-06,
chr13:32394614:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr17:43112864:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr13:32338688:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-604),,,,
chr13:32331082:AT>ATT,,,,,,,,16.557|17.1059|16.7443,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr13:32332278:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0117|0.0|0.0077,benign:0.004,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-93),benign(0-092),0&1&1,1&1&1,,
chr13:32343242:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32357929:G>C,,,In vitro (cloned),predicted deleterious,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,16/27,,1,,,,,1&1&1,,
chr17:43104172:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32332681:GA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32340435:G>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-03),,1,,
chr17:43099858:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-03),,1,,pathogenic
chr17:43094110:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340010:->CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43074483:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,,,pathogenic
chr13:32316488:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,,,
chr17:43115792:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,8.237e-06,
chr17:43115792:C>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0006021515,
chr17:43091446:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43093492:->GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43077840:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1321 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32363313:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-|?,Protein likelihood ratio model|-|?,,,,,,,,,,Danish,,Caucasian,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-05),benign(0-126),0&0&1&1,1&1&1&1,3.295e-05,
chr17:43094280:G>C,,,,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43115792:C>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,0.0,0.0015,0.0,0.0,0.0,,,Latin-American/Caribbean,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0002285105,
chr17:43095753:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339571:TTTTTTTT>AT,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,2.471e-05,
chr17:43079354:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.595e-06,
chr17:43119336:T>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32337035:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000836,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0465|0.0227|0.0385,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),,,1,,
chr17:43091780:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092844:CGG>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Dutch|-|Dutch?,2|-,Western-European|Western European|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394807:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,
chr17:43099409:CGG>T,,,,,,,,,,0.0,0.0356,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00958466,
chr17:43073764:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3182 (Asian)| 0.128 (African)| 0.3377 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43079210:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43094595:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr17:43106446:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,benign
chr13:32340128:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-072),,1,,
chr17:43106574:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43115735:TA>A,,,,,,,,,,,,,,,-|Spanish,,-|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,,,
chr17:43092229:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000632,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0233|0.0|0.0154,possibly-damaging:0.765|None|None|possibly-damaging:0.765|possibly-damaging:0.765,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43114094:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43104106:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340128:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32367848:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32387592:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43077744:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43045754:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32316075:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32347053:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32339621:GTAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43124012:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr13:32340453:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-358),,1,,
chr13:32336819:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1,,
chr17:43063833:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr13:32377996:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32363331:GT>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1&1,,
chr17:43094662:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43067616:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-998),,1&1,,
chr13:32385293:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32363437:CAT>G,,,,,,,,,,,,,,,,,Western European|Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43067616:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-878),,1&1,,
chr17:43071720:G>C,,,,,,,,,,0.008,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00159744,
chr13:32351239:C>T,,,,,,,,,,0.005,0.0008,0.0058,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00259585,
chr17:43076072:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,0.000199681,
chr13:32343750:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32338213:TTAC>A,,,,,,,,,,,,,,,Austria,0,,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43106551:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,1,,
chr13:32372447:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0348,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00678914,
chr17:43104262:GG>C,,,In vitro (cloned)|Unknown,-|as variant control,Histopathology|mRNA analysis (RT-PCR)|-,7/1658|-,,,,,,,,,Western Europe|-,,Western European|Irish|-|None-Specified|None Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1,,
chr13:32338208:TATA>G,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa|African American|-|Western Europe|None Specified,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,9.085e-05,
chr13:32394912:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,,,0&1&1,0&1&1,8.236e-06,
chr17:43097297:GG>A,,,,,,,,,,,,,,,,,None Specified|African,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,,2.472e-05,
chr13:32337255:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-126),,,,
chr13:32342225:T>G,,,,,,,,,,0.0,0.0272,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0071885,
chr17:43082550:G>C,,,In vitro (cloned)|Germline (inherited),-|as variant control,Host Cell End-Joing assay|-,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,8.236e-06,
chr17:43056991:->GGAGTGGAATAC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32378807:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32340737:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Dutch,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341102:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43106682:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43064004:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03166 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,2.2627|0.4335|1.7083,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,
chr13:32337428:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,Not Specified|-,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-253),,1,0.0001204355,
chr13:32332659:T>C,,,,,,,,,,,,,,,German|-,,Western European|-|Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),possibly_damaging(0-487),,1,8.241e-06,
chr17:43047637:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,,,
chr13:32354955:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-05),,,1,0.0001071,benign
chr17:43079400:C>T,,,,,,,,0.0251|0.0|0.0174,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,,
chr13:32379397:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,,
chr13:32340737:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-013),,1,8.241e-06,
chr13:32319091:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr13:32324328:T>G,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00139776,
chr17:43104919:C>A,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43082567:A>ACC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr17:43045685:G>A,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious_low_confidence(0-01),probably_damaging(0-969),,1,,
chr13:32355092:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr13:32376115:AATTCA>G,,,,,,,,,,0.0,0.025,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.0071885,
chr17:43052534:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32341011:A>G,,,,,,,,,,,,,,,,,Not Specified|-,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,,
chr17:43099817:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,Western-European|Western European|-|Latin-American/Caribbean|-Hispanic,N,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340581:GTTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32389502:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32363181:ATGATACGGAAAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43094254:AG>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43092756:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43124052:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067641:GG>T,,,,,,,,,,,,,,,Dutch,,Ashkenazi Jewish,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr17:43112860:A>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr17:43115789:CC>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|-|mexican|Latin-American/Caribbean|caucasian,IVS,1 - Not pathogenic or of no clinical significance,1.0,4.07E-03,0.03,0.0,,0.34,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,4.119e-05,
chr17:43063051:A>T,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32396881:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,3.295e-05,
chr17:43045964:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32370544:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr13:32371733:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32343116:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32338716:TCTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43094125:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091434:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32385974:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43099819:A>G,,,,,,,,,,,,,,,South African,,Mixed Ancestry,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr13:32398325:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43110743:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32380035:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1,1&1,0.0001894,
chr13:32394673:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.7791|0.227|0.592,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr13:32326226:G>CT,,,,,,,,,,,,,,,,,Western European|None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,4.119e-05,
chr17:43071239:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32340688:GAGAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43099453:A>C,,,,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00299521,
chr17:43092611:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,benign
chr13:32333330:T>C,,,,,,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-03),benign(0-033),,1,,
chr13:32330980:A>G,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,M,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,,
chr17:43124054:A>G,,,In vitro (cloned),predicted neutral|as wildtype control,E3 Ub-ligase activity assay BRCA1/RING-BARD1|evolutionary conservation analysis,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,
chr13:32394717:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,,,0&0&1&1&1,1&1&1&1&1,9.884e-05,
chr13:32355156:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-41),,,1&1,2.471e-05,
chr13:32340182:GC>T,,,,,,,,,,,,,,,Western Europe|-,, Native American|Not Specified|Western European| Centr|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43058377:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32371400:C>T,,,,,,,,,,0.2744,0.1384,0.2392,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.170128,
chr13:32332277:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,1&1,1&1,,pathogenic
chr13:32338900:G>GA,,,,,,,,,,,,,,,,,Pakistani/East Indian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32396599:A>C,,,,,,,,,,0.5159,0.5113,0.536,0.5327,0.4683,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.511581,
chr13:32336916:A>G,,,,,,,,0.0|0.0227|0.0077,benign:0.39,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-253),,1,2.471e-05,
chr17:43071070:A>GC,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr13:32387360:G>T,,,,,,,,,,0.0,0.0,0.0,0.0565,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0113818,
chr13:32362738:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr17:43093774:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr17:43122761:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32338820:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr17:43114390:C>CT,,,,,,,,,,0.3131,0.677,0.3674,0.3492,0.4877,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.458067,
chr17:43119018:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43076488:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,
chr13:32341219:C>G,,,,,,,,0.0117|0.0|0.0078,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr17:43093718:TA>C,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32394833:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-17),benign(0-005),,1&1&1,,
chr17:43093560:A>C,,,,,,,,,,0.0,0.0234,0.0014,0.0,0.0,-|French,,-|black,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.00427789,
chr13:32398494:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337301:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-574),,1,,
chr13:32339330:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-58),possibly_damaging(0-539),,1,,
chr13:32399302:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.04675 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339938:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093315:C>TAG,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43099920:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,2.471e-05,
chr17:43091794:TT>G,,,,,,,,,,,,,,,,,Central/Eastern Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43078965:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0935 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43076580:A>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1&1,,
chr13:32394833:A>T,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-05),benign(0-316),,1&1&1,8.236e-06,
chr17:43094086:TT>A,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32340999:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32326532:G>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32332644:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-021),,1,,benign
chr17:43058314:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32339698:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-06),,,8.237e-06,
chr13:32398602:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,9.06e-05,
chr17:43058899:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32332644:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-169),,1,,benign
chr13:32362347:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43076449:T>C,,,,,,,,0.0|0.1135|0.0384,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,
chr17:43076508:T>AT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43091599:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43092817:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336763:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-97),benign(0-001),,,,
chr13:32356422:CAAAA>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,14/26,1,,,,,,,
chr13:32392549:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43071074:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-,co-occurrence with deleterious variant|-|Multifactorial likelihood-ratio model|Transcription activation in human cells,,,,,0.0,0.0008,0.0014,0.0,0.0,,," Native American""""| African American""""|-Hispanic|-Latin-American/Caribbean| African|None-Specified|""""African|African|Western-European|Latin-American/Caribbean|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.0955,7.59E-08,0.309,0.0,0.02,0.02,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,1,0.0003067305,
chr17:43071221:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,,,
chr17:43079095:T>A,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr13:32316443:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32340001:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.647e-05,
chr13:32336286:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-957),,,,
chr17:43097077:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,,benign
chr13:32333156:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-013),,1,,
chr13:32379904:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,benign
chr13:32361348:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01224 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43047713:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,
chr13:32337195:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr17:43094804:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32339945:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0),,1,,
chr13:32375138:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32332449:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,2.471e-05,
chr17:43124017:CAGATGGGACA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,pathogenic
chr13:32338413:AAACG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,pathogenic
chr13:32337165:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-731),,1&1,,
chr13:32357877:G>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr13:32316544:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0001565,
chr13:32394662:T>CAT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,8.239e-06,
chr13:32339902:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32398735:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr17:43070951:G>C,,,In vitro (cloned),as variant control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-964),,,,
chr13:32348048:G>GA,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00898562,
chr13:32364037:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32379837:T>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,
chr13:32326075:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,3.296e-05,
chr13:32323183:G>T,,,,,,,,,,0.002,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32370533:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32318532:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32335965:A>C,,,,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0061901,
chr17:43085148:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32354820:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32332479:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-36),benign(0-263),,1,,
chr17:43094332:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32339185:T>A,,,,,,,,,,,,,,,,,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,2.471e-05,
chr17:43106026:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.353035,benign
chr13:32346854:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,tolerated(0-62),benign(0-046),,,0.0001039595,
chr13:32344564:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-982),,1,,
chr17:43094588:G>C,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,African American,,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326103:C>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32319508:T>G,,,,,,,,,,0.001,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43117695:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43117506:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43092928:C>A,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32332751:TA>G,,,,,,,,,,,,,,,,,Western European|None Specified| Asian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,
chr17:43093329:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32332449:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-16),,1,1.647e-05,
chr13:32398625:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093138:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32396599:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338271:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000685,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Invitae|GeneDx|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0353|0.0|0.0234,benign:0.024,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32318683:G>C,,,,,,,,,,0.0447,0.0567,0.1009,0.0903,0.1207,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0796725,
chr17:43063399:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,
chr17:43091945:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32370932:AAGCA>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,
chr17:43092374:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43115929:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,,
chr13:32331604:T>G,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000399361,
chr13:32355232:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,1&1,,pathogenic
chr13:32326155:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,,
chr13:32339717:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43067048:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32339127:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-011),,,,
chr13:32376960:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43045735:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1,,pathogenic
chr13:32326505:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,,8.236e-06,
chr17:43061302:T>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00159744,
chr17:43106605:T>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr13:32346599:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32394736:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,,8.236e-06,
chr17:43115745:T>C,,,In vitro (cloned),predicted deleterious,LOH/Evolutionary conservation,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32394641:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,1.648e-05,
chr17:43070983:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-01),,1,,
chr17:43115745:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),-|as variant control,E3 Ub-ligase activity assay BRCA1/RING-BARD1|-,,,,,,,,,,Czech|-,,"Central/Eastern European|Central/Eastern Europe| Ashkenazi""""|Central/Eastern-European|Caucasian|""""Western European",M,5 - Definitely pathogenic,,,9.65,0.9933,0.81,0.81,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32391145:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43076583:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32363206:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32330987:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,4.942e-05,benign
chr13:32398346:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32336804:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-415),,1,,
chr13:32337012:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-111),,1,,
chr17:43067616:G>C,,,In vitro (cloned),predicted deleterious|as variant control|strong functional effect,transcription activation/PS/BA/BS|Transcription activation in yeast (GAL4-fusions)|Multifactorial likelihood-ratio model|Co-segregation in families|evolutionary conservation analysis,,,,,,,,,,,,Not Specified|Western Europe|None-Specified,M,4 - Likely pathogenic,1.0,1.48,30.9,0.9889,0.66,0.66,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-878),,1&1,,
chr13:32375359:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32339825:AA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32356485:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr17:43104898:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,,,
chr17:43068206:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2175 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr17:43075494:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr17:43110587:GGCTT>CA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.004466,
chr13:32338885:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32362533:GACA>GACAGACA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr17:43051105:A>GC,,,,,,,,,,,,,,,French?,,,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,1&1,1&1,,
chr13:32395111:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2336,0.0106,0.0965,0.248,0.2413,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.160144,benign
chr17:43076583:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32393517:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43094590:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32337550:TAAT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43095847:C>CT,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,1,,
chr17:43092200:CC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094020:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340982:A>C,,Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,0&1,,benign
chr17:43091775:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr17:43090921:GGC>GCACA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.246e-05,
chr13:32370552:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-53),benign(0-01),,1,,
chr13:32379182:C>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00159744,
chr17:43082398:C>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,11/21,-1,,,,,1&1&1,,
chr13:32356501:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,8.236e-06,
chr17:43104882:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,deleterious(0),probably_damaging(0-999),,,,
chr13:32340142:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43075995:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43090978:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,,
chr13:32398420:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,,,,,,,,,Malaysian,,Indian/Malay,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43106456:TC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,
chr17:43071134:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-112),,1,,
chr13:32370521:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,19/27,,1,,,,,1,,
chr17:43071223:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000102,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.1362|0.0461,probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-85),,1&1,,benign
chr13:32379370:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,1,8.236e-06,
chr13:32361590:A>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr17:43057070:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/22,,-1,,,,,1&1,,benign
chr17:43103842:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00419329,benign
chr13:32394785:T>C,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0681|0.0231,benign:0.01,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-73),benign(0-011),,1&1,,
chr13:32363499:C>-,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-73),benign(0-011),,1&1,,pathogenic
chr13:32332322:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-013),,,8.239e-06,
chr13:32326520:GA>A,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,1,,
chr13:32363364:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32340137:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-017),,1&1,,
chr17:43121349:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr17:43092164:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32337012:A>ATG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43045694:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000104,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious_low_confidence(0),possibly_damaging(0-511),,1,,
chr17:43092121:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363165:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr13:32363165:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr17:43049820:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43092618:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43063448:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,0.000199681,
chr13:32354877:TGT>C,,,,,,,,,,,,,,,Not Specified|Western Europe|-,,Western Europe|-,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32376414:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32339073:T>A,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,German,8,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-234),,1,8.237e-06,
chr17:43094501:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin American/Caribbean|None-Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32379388:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,
chr17:43092275:G>ATC,,,,,,,,,,,,,,,,,Western-European|Western European|Western Europe|None-Specified|Central/Eastern Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32335829:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43076492:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,benign:0.313|benign:0.313|benign:0.313|benign:0.313|benign:0.313,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43063917:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,Not Specified|Western Europe|Western/Central/Eastern Europe|-,,"""""Native American|Central/Eastern European| Central/Eastern European""""|Not Specified|Western European|-|Western-European|Western Europe|None-Specified",N,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1,,pathogenic
chr17:43092244:CA>T,,,,,,,,,,,,,,,,,African,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43049155:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-053),,,,
chr13:32339474:C>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-008),,1,,
chr17:43076492:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32333126:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43093577:G>TC,,,,,,,,,,,,,,,,,French Canadian|Western European|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43094132:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr13:32338716:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-32),,,8.24e-06,
chr17:43074502:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32317357:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43057070:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32329487:TT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,,
chr13:32339158:C>TA,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32372428:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32340997:C>TC,,,,,,,FA FANCD1_00043,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43115780:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1,,pathogenic
chr17:43092414:GGCT>TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32333297:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Western Europe|-,,Western European|-|None Specified|White-NonHispanic,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092799:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092899:A>T,,,,,,,,,,,,,,,,,"""""Western European| Native American""""",M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340699:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-117),,1,,
chr17:43124195:GAGAAA>A,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00379393,
chr17:43104105:A>G,,GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,1&0,,benign
chr13:32337895:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-469),,,,
chr13:32380211:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43094487:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,,,
chr17:43061347:T>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32346514:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32354319:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32326238:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,,
chr17:43116122:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43051085:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43071021:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,
chr13:32337435:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-944),,,0.0001039595,
chr13:32319301:C>G,,,,,,,,,,,,,,,Latin American/Caribbean,,,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43093658:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32379905:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32370581:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,1.647e-05,
chr17:43063351:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,,benign
chr13:32384881:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43091971:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,2.471e-05,
chr17:43071190:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-956),,1&1&1,,
chr17:43092237:AAA>A,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32362572:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43045653:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32318605:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43094084:TAAT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43124018:->CAGATG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,1.0,,,,,,
chr13:32337581:GTAGT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43106529:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,0&0&1,1&1&1,,
chr13:32338933:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001780905,
chr17:43047723:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,
chr17:43094875:CCAG>A,,,,,,,,,,,,,,,Central/Eastern Europe,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.284e-06,
chr17:43091071:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.653e-05,
chr13:32340194:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,,
chr17:43105222:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr13:32396979:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43102967:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32379335:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr17:43104216:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,8.236e-06,
chr17:43066272:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32361301:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32327930:C>G,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0736821,
chr13:32355064:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43063986:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,4.942e-05,
chr17:43090921:GGCTCTTCCCTCCAAACCAGCT>GT,,,In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,German|-,,Western-European|Caucasian|None-Specified,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,,-1,1.0,,,,1,,
chr13:32325107:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr13:32338791:G>C,,Pathway_Genomics|Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,1/1658,,,,,,,,,Not Specified|-,,Western European|Western Europe|-|None Specified|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-267),,1,8.238e-06,
chr13:32380035:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1,1&1,,
chr17:43074999:AAGGACCTCG>G,,,,,,,,,,0.001,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00139776,
chr17:43051085:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&0&1,,benign
chr13:32362680:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr17:43099418:T>A,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000599042,
chr13:32326555:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32336584:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|57/1658,,3.6977|2.02|3.1293,None,0.0348,0.0325,0.0922,0.0952,0.1329,German|Austria|Sri Lankan|-|Belgian,1|0|-,Global|-|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.0627412,benign
chr17:43104947:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32350832:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32379513:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43051085:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&0&1,,
chr17:43125344:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32364476:A>G,,,,,,,,,,0.0,0.0106,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00279553,
chr13:32341061:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0227|0.0154,probably-damaging:0.999,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,3.295e-05,
chr17:43091678:->GT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43076600:G>A,,Ambry_Genetics,,,,,,,,,,,,,-|Hong Kong|Spanish,,Chinese |Caucasian|None-Specified,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43093118:ACA>A,,,,,,-|1/1658,,,,,,,,,Not Specified|German|Western Europe|-|Czech,1|-,Central/Eastern Europe|Not Specified|Western European|-|Caucasian|-Italian|Western-European|Western Europe|caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336398:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,benign
chr13:32325175:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,8.237e-06,
chr13:32339179:GA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,pathogenic
chr17:43067740:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43115788:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1&1,,
chr17:43071248:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,1,,
chr17:43093488:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340738:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-037),,1,,
chr13:32340264:C>A,,Ambry_Genetics|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32379502:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43092261:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32341243:ATC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.264e-06,
chr17:43045740:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0-01),probably_damaging(0-933),,,,
chr13:32340264:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-51),benign(0-301),,1&1,,
chr13:32338403:CATA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-51),benign(0-301),,1&1,,pathogenic
chr13:32397009:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43124109:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32394850:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,,,
chr17:43093536:T>C,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094265:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093329:TGCTTC>T,,,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,Belgian?|Dutch|-|Dutch?,1|3|2|-," Asian""""|-|-Central/Eastern-Europe|Western-European|Central/Eastern-European|Caucasian|None Specified|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338916:C>T,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43082529:C>G,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32338632:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-65),benign(0),,1&0,8.246e-06,
chr13:32338597:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43091576:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091572:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32380043:AT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32338874:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr17:43047687:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1,,
chr17:43091826:TGCCTA>G,,,,,,2/1658|-,,,,,,,,,French?|Danish|Not Specified|-|German|German?|Polish|Western Europe|Italian|Czech,1|2|-|4|7,Unknown|Western/Central/Eastern Europe|-|None-Specified|Caucasian|Western European|Western-European|Polish|Central/Eastern-European|caucasian|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332375:T>TC,,,,,,,,,,,,,,,, -,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr17:43045161:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.71e-05,
chr17:43115750:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43104307:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,8.241e-06,
chr17:43125086:T>C,,,,,,,,,,0.0,0.0174,0.0058,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00559105,
chr13:32338764:TGAT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32389458:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32379491:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32337168:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0454|0.0154,benign:0.11,,,,,,,,African American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),,,1,3.295e-05,
chr17:43092578:CC>G,,,,,,,,,,,,,,,,,Italian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32317629:G>C,,,,,,,,,,0.0,0.0287,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00778754,
chr17:43115750:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32340055:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr13:32398764:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32318738:T>A,,,,,,,,,,0.0,0.0393,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0103834,
chr17:43062062:G>C,,,,,,,,,,0.0,0.0514,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0139776,
chr13:32363270:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-29),benign(0-03),,1&1,,
chr17:43091602:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-29),benign(0-03),,1&1,8.236e-06,
chr17:43046002:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000599042,
chr13:32333295:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-003),0&1&1,1&1&1,,
chr13:32338010:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-746),,1,,
chr13:32340321:TTA>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32363571:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,1.649e-05,
chr13:32326148:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,1,,
chr17:43067602:T>C,,,In vitro (cloned)|Unknown,as wildtype control|-|predicted variant of unknown significance,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,,,,,,,,,,,,Western-European|Western Europe,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,5.766e-05,
chr13:32354726:T>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32350130:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32396886:A>G,,,,,,1/1658|-,,,,,,,,,,,,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,0.0001235,
chr13:32325022:T>G,,,,,,,,,,,,,,,Indian,,Asian,IVS,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,
chr13:32333295:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-003),0&1&1,1&1&1,,
chr17:43067697:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/22,-1,,,,,1&1,,pathogenic
chr13:32338096:AAGTA>T,,,,,,1/1658,,,,,,,,,Not Specified|Czech|-|Italian,,Not Specified|Western European|-|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337873:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-033),,1,,
chr13:32340417:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-029),,1,,
chr13:32377459:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3252 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32332409:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),possibly_damaging(0-687),,,8.238e-06,
chr13:32369793:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32370421:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32319654:C>G,,,,,,,,,,0.504,0.593,0.549,0.5437,0.5174,,,,IVS,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.544329,
chr13:32339931:TTAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr17:43093775:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338322:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091457:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32321537:A>T,,,,,,,,,,0.0447,0.0333,0.0994,0.0913,0.1196,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0732827,
chr13:32340693:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000117,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,0.0116|0.0|0.0077,benign:0.005,,,,,,,,"Latin American/Caribbean| Central/Eastern European| Central/Eastern European""""|-|""""Ashkenazi|Ashkenazi| Austria""""| Russia|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.05888,0.10233,0.09333,1e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0),,1,6.59e-05,
chr13:32328277:A>G,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00139776,
chr17:43050562:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08217 (Asian)| 0.03862 (African)| 0.07388 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43070972:CT>T,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr13:32362524:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32357968:T>AATGT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.237e-06,
chr17:43091950:TT>G,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336191:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.2703 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32363430:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-985),,,,
chr13:32321244:A>C,,,,,,,,,,0.0,0.0106,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00299521,
chr13:32357879:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,8.236e-06,
chr17:43092796:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,3.295e-05,
chr17:43091638:A>T,,,,,,,,,,,,,,,German|-|Ashkenazi/Western Europe,, Native American| Germa|Western European|-|Western-European|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32333120:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32376646:TTAA>T,,,,,,,,0.206|0.0235|0.1438,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,
chr17:43092845:G>A,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43050435:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000599042,
chr13:32339394:TAC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340533:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32381033:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43091316:ATTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,2.506e-05,
chr17:43093579:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32354869:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-08),benign(0-034),,,,
chr13:32380007:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1,,
chr17:43097273:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,4.119e-05,
chr17:43074375:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32356430:C>G,,,In vitro (cloned)|Unknown,predicted neutral|-|?,Protein likelihood ratio model|Prevalence in normal controls|-|?,,,,,0.0,0.0015,0.0,0.0,0.0,,,Africa,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/27,,1,,,benign(0-256),,1,0.0002079155,
chr17:43071246:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,13/21,-1,,,,,1,8.238e-05,
chr17:43080745:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32354925:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-12),benign(0-045),,1,8.236e-06,
chr17:43121443:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32339621:TAACGTTGGTAATCTATC>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32335965:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32362585:C>G,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43091674:AT>C,,,,,,,,,,,,,,,Malaysian,,Malay,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340775:G>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32340473:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-47),benign(0-006),,1,,
chr13:32398178:GG>G,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr13:32337786:T>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-096),,1,,
chr13:32337602:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.24e-06,
chr13:32389285:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43107288:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32340775:G>TG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43097266:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,co-occurrence with deleterious variant|-|Multifactorial likelihood-ratio model,,,,,0.0,0.0,0.0,0.0109,0.0,Malaysian|-|Asian,,"Near-Eastern|Chinese|-| Pacific Islander""""|""""Asian|Asian/Dutch|None-Specified|None Specified",M,1 - Not pathogenic or of no clinical significance,0.0955,0.00589,0.0138,0.0,0.02,0.02,missense_variant,MODERATE,,,-1,1.0,,,,1&1,0.001246495,
chr17:43092132:TGT>T,,,,,,1/1658,,,,,,,,,,,Not Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340473:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0|0.0227|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32362498:T>C,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr17:43076453:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,8.237e-06,
chr13:32342240:G>C,,,,,,,,,,0.005,0.0038,0.0,0.003,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00439297,
chr17:43049162:T>A,,,In vitro (cloned)|Germline (inherited),predicted deleterious|Low functional effect|-,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European|Western European,M,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-738),,1&1&1,,
chr13:32333255:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-51),possibly_damaging(0-487),,1,,
chr13:32338496:AAAG>A,,,,,,,,0.0606|0.0938|0.0719,None,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32339298:TTG>C,,,,,,,,,,,,,,,,,Western European|-| German,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338010:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-988),,1,8.237e-06,
chr13:32340981:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-988),,1,,pathogenic
chr13:32379300:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,1.647e-05,benign
chr13:32348049:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32337808:G>CT,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1&1,,
chr13:32333630:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32340417:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-373),,1,8.237e-06,
chr13:32339588:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-02),,,,
chr13:32357757:T>A,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,-|Spanish,,None Specified|Caucasian|Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-098),0&1&1,1&1&1,,
chr13:32376776:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,,
chr13:32398148:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.472e-05,
chr17:43067695:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,,benign(0-018),,1,,
chr17:43092276:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32376675:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,8.236e-06,
chr13:32394670:TCT>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr13:32339985:AG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,8.237e-06,
chr13:32356572:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr13:32381314:TCTAC>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr17:43092980:C>T,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43092044:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32337497:C>A,,,,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),,,1,,
chr13:32337141:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339708:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094537:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43044745:G>T,,,,,,,,,,0.002,0.0008,0.0,0.0,0.002,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr17:43115759:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1,,
chr13:32336893:T>G,,,,,,,,,,,,,,,Malaysian,,Indian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43104147:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr17:43040165:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43104072:CGAGCTATAGATTTCCTC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0001237,
chr13:32326602:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32337617:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,pathogenic
chr17:43093529:A>GT,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43049195:C>T,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43094404:T>C,,,,,,,,,,,,,,,,1,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43092662:TC>G,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32332552:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32319213:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32340767:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0061,0.0,0.0,0.0,Latin American/Caribbean|-,,Latin American/Caribbean| Latin American/Caribbean|-|Africa|Western European|African|African American|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-207),0&1,1&1,0.00119832,
chr13:32357806:AAA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,8.236e-06,
chr13:32316467:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32379396:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43104122:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr13:32340289:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32344843:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr17:43092863:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Asian|Filipino,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43115759:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32357842:C>TA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr17:43124099:C>G,,,In vitro (cloned),,,,,,,,,,,,Italian,,Caucasian,5'UTR,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr17:43059186:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32382033:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32380213:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43092934:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43051574:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32354943:GC>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43061077:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00159744,benign
chr13:32339593:T>TT,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43102644:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32364848:A>T,,,,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00998403,
chr17:43093397:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338118:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-072),,1,,
chr13:32339708:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-167),,,,
chr13:32346875:G>T,,,,,,,,,,,,,,,,,Western European|Central/Eastern European|None Specified,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43074490:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32336402:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),,,1,,
chr13:32371060:G>CT,,,,,,,,,,,,,,,,,Latina,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr17:43049140:T>GA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,21/23,,-1,,,,,1,,
chr13:32371235:T>A,,,,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,
chr13:32338391:CAC>A,,,,,,1/1658,,,,,,,,,Malaysian|Sweden|-,,-|Malay|Filipino,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43092551:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32379742:CTCCT>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,0.0001483,
chr13:32341038:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-848),,1,,
chr13:32368094:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43085439:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32341181:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0),,1,,
chr17:43115741:TTC>T,,,,,,,,,,,,,,,Spanish|-|Italian,,Western European|Caucasian,F,,,,,,,,stop_gained&frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43093569:T>C,,,,,,2/1658|-,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092551:A>G,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43093329:TGCTTCCCCATGGGC>T,,,,,,1/1658,,,,,,,,,Indian,,Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394664:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,8.239e-06,
chr17:43067689:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,as wildtype control|no functional effect|-|mildly destabilizing,Transcription activation in yeast (GAL4-fusions)|transcription activation/PS/BA/BS|-|Thermodynamic stability prediction,,,,,,,,,,-|Italian,,Western European|-|Caucasian|None-Specified,M,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0-01),benign(0-37),0&1&1,1&1&1,2.471e-05,
chr13:32341181:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0),,1,,
chr13:32396905:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|-,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Not Specified|Western European|Western Europe,M,1 - Not pathogenic or of no clinical significance,0.038,1.175,0.0288,3e-05,0.02,0.02,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43120941:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32381972:T>A,,,,,,,,,,0.2734,0.2821,0.2464,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.208866,
chr17:43045611:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43081610:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32336416:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),,,,,
chr13:32339769:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-098),,1,,
chr13:32338271:T>A,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Central/Eastern European|Not Specified|Western European|Western Europe| Pennsylvania Dutch|None Specified,M,1 - Not pathogenic or of no clinical significance,0.42658,0.06166,0.01288,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,,,1,8.261e-06,
chr13:32338963:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32354870:A>C,,,Unknown|Germline (inherited),,,,,,,0.0,0.0257,0.0,0.0,0.0,African American|-|Western Europe,,Latin American/Caribbean| Latin American/Caribbean|Not Specified|Western European|Spanish|-|African American/Latin American/Caribbea| Native Americ|African| African|African American|Africian/American|None Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-09),benign(0-02),0&0&1&1,1&1&1&1,0.00454357,
chr13:32357732:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32339734:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32357919:GAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43051581:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0061901,
chr17:43100719:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr13:32360373:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32398623:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,5/1658|-,,,,0.003,0.0,0.0014,0.0,0.0,Danish|Austria|-|Spanish,0|-,-|Caucasian,Syn,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.001132361,
chr13:32379392:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|4.108|1.3994,probably-damaging:0.986,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1,,
chr13:32337167:GCAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1,,pathogenic
chr17:43069933:CAGA>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000599042,
chr17:43092274:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43091957:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,0&1&1,2.471e-05,
chr17:43060220:G>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32332774:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32346312:A>C,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00678914,
chr17:43091340:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.266e-06,
chr13:32339640:AAG>A,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43106193:C>T,,,,,,,,,,0.0,0.0015,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.00119808,
chr13:32336284:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,pathogenic
chr13:32325765:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32332779:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),benign(0-079),,,8.237e-06,
chr13:32379909:TAC>TACTAC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,inframe_insertion&splice_region_variant,MODERATE,,,1,,,,,,,
chr17:43116189:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr17:43092800:CTGAGGTGGGAGGATC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32391767:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43065790:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000599042,
chr17:43063911:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,,8.237e-06,
chr13:32336687:G>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-012),,1,,
chr13:32340379:G>GG,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43070959:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00011,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),possibly_damaging(0-546),,1&1,,
chr17:43072117:C>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000798722,
chr17:43071190:A>T,,,,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-956),,1&1&1,,
chr17:43091670:CTCA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-956),,1&1&1,,pathogenic
chr17:43074457:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,2.471e-05,
chr17:43096632:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43092551:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32357725:CAAAT>CTGTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,8.237e-06,
chr13:32363421:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,FA FANCD1_00011,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1&0,,pathogenic
chr17:43094179:A>C,,,,,,,,,,,,,,,,,Native-American|-Latin-American/Caribbea,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr17:43093388:GC>T,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091919:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1&1,0.0001204305,
chr17:43092525:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092043:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr17:43044783:T>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32332398:T>GT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43092709:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32371432:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32397148:AC>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-|mRNA analysis and splicing reporter minigene,,,,,0.0,0.0333,0.0014,0.0,0.0,,,Africa,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00898562,
chr17:43121331:G>C,,,,,,,,,,0.3658,0.8865,0.4251,0.371,0.5297,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.544529,
chr13:32337215:GAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32363287:AT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,
chr17:43071125:A>C,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1,,
chr13:32333086:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32326531:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,
chr13:32332563:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-687),,,0.000103962,
chr17:43051107:T>A,,,In vitro (cloned),strong functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-032),,1,,
chr13:32326134:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,,,benign
chr17:43093950:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379305:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43048930:G>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000998403,
chr13:32336620:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32348620:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32363449:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43048217:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32346858:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,,,benign
chr17:43103867:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43060056:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32340898:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32344569:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000026,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0235|0.023|0.0233,possibly-damaging:0.612,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-01),possibly_damaging(0-672),,1,,
chr13:32370554:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-22),benign(0-067),,,,
chr13:32338551:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-003),,,8.239e-06,
chr13:32363548:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr13:32336335:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32356461:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,as wildtype control|predicted neutral|-|predicted deleterious,-|Embryonic stem cell assay DSS1 interaction not affected|Co-localization to predicted ESEs|Allele frequency analysis in controls|Protein likelihood ratio model|Prevalence in normal controls,,,0.0233|0.4312|0.1615,benign:0.01,0.0,0.0023,0.1066,0.003,0.0,Latin American/Caribbean|Western Europe/Latin American/Caribbean|Not Specified|Malaysian|Western/Central/Eastern Europe|-|German|W Europe/Native Amer/Latin Amer-Caribbea|Western Europe,,Native American/Western Europe| Central/Eastern Europe|Western European| Chines| hispanic|Central/Eastern European| Peruvian|Near East/Mid East|Latin American/Caribbean| Italian|Western Europe/Native American| Mexico| Frenc|Not Specified| mexican|-|Western Europe/Spanish Jew| Hispanic| Greek|Causian|Native American|Puerto Rico| Lebanon| Latin American/Caribbe| hispanic/mexic| Guam| Mexican| Puerto Rico|Hispanic| Asian|African| Spanish|American-Indian| Spanish American|None Specified| Nicaragua| Native American|Central/Eastern Europe/Latin American/Ca|Mexico French Spanish|Chinese|Mexico|Latin American/Caribbean/Central/Eastern|Asian|French Canadian|Western Europe| Jewish,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-23),benign(0-023),,1&1,0.0149872,
chr13:32337662:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32380050:T>A,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Ashkenazi,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43053615:G>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32338132:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43072337:G>T,,,,,,,,,,0.002,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000798722,
chr13:32347809:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32337279:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-86),,,1,,
chr13:32362614:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-999),,1,,
chr13:32316471:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,3.295e-05,
chr13:32339168:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-169),,,,
chr13:32346825:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,12/26,1,,,,,1,,pathogenic
chr17:43043756:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094466:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,German|-,1|-,,Syn,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,0.0001945405,
chr13:32332877:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,8.236e-06,pathogenic
chr17:43084031:CA>A,,,,,,,,,,0.1471,0.2126,0.1484,0.1161,0.1258,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.154153,
chr13:32340412:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.4312|0.1461,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr13:32339025:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,Latin American/Caribbean|Western European|Native American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-253),0&1&1,1&1&1,0.0001163155,
chr13:32356587:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,1&1,1&1,,pathogenic
chr13:32346877:GTTTGA>A,,,,,,,,,,,,,,,,,"Central/Eastern European|Western European| Ashkenazi""""|Western Europe|""""Western European|Italian",F,,,,,,,,frameshift_variant&stop_lost,HIGH,13/27,,1,,,,,,,
chr17:43115729:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr17:43078333:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32332883:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),possibly_damaging(0-849),0&0&1&1,1&1&1&1,,
chr13:32362661:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,,,,,,
chr13:32342540:C>T,,,,,,,,,,0.0,0.0,0.0,0.0417,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00838658,
chr13:32398319:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32318103:ATTC>C,,,,,,,,,,0.0249,0.0,0.0101,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.00658946,
chr13:32386888:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43116728:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32345879:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43070245:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43093039:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43104138:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|Loss of variant allele|-|as variant control,co-occurrence with deleterious variant|Loss of Heterozygosity|-|Allele frequency analysis in controls|Prevalence in normal controls|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,Not Specified|West/Central/East Europe|-|West/East/Central Europe|Spanish,1|-,Latin American/Caribbean|Western European|-|Caucasian|Western Europe|Central/Eastern-European|None-Specified,M,1 - Not pathogenic or of no clinical significance,1.7,0.0043,,0.0,0.02,0.02,missense_variant,MODERATE,,,-1,,,,,1&1,4.942e-05,
chr13:32319236:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32350880:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32353653:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43074720:GGGTT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32356135:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43093122:ACTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,pathogenic
chr13:32398666:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43045690:CTCCCGCCTC>G,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,22/22,,-1,,,,,,7.413e-05,
chr17:43094073:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32372278:A>T,,,,,,,,,,0.999,0.9115,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.976038,
chr17:43089934:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr17:43047125:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32379990:GT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32356510:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-95),,,8.236e-06,
chr17:43092593:T>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-95),,,,pathogenic
chr13:32362512:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.237e-06,
chr13:32387951:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43076571:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32380142:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,8.237e-06,
chr13:32336480:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-098),,1,,
chr17:43051095:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-847),,,,
chr13:32394865:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-57),benign(0-016),,1,,
chr13:32319273:CT>G,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32394865:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-15),benign(0-009),,1,,benign
chr13:32317747:C>AT,,,,,,,,,,0.0209,0.0023,0.0043,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0061901,
chr13:32355104:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32355123:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),benign(0-001),,,,
chr17:43094443:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),benign(0-001),,,,pathogenic
chr13:32340300:GT>G,,,,,,,,0.0242|0.0|0.016,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,0&0&0&1&1&0,1&1&1&1&1&0,,
chr13:32356479:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-977),,1,,
chr17:43093128:C>T,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319061:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43104348:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,1,,
chr13:32336792:A>AT,,,,,,,,,,,,,,,Sri Lankan,,Sinhalese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332854:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-034),,1,,
chr13:32394688:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,24/26,1,,,,,1&1&1,,pathogenic
chr13:32363460:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-02),possibly_damaging(0-527),,1,,
chr13:32339513:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32370525:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,,,
chr17:43124568:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32363402:CCTCCCCTCT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43044804:CCCCCG>CTT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.081,
chr13:32379885:C>T,,Ambry_Genetics,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43068755:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0149,0.0023,0.0086,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00539137,benign
chr13:32388198:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32316543:A>T,,Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr17:43092422:C>TA,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337568:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32326639:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.236e-06,
chr17:43121006:T>A,,,,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0155751,
chr13:32339102:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-002),,1,8.236e-06,
chr13:32379480:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43094577:->CA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337924:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,,
chr13:32391266:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32330945:A>C,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,0.000315996,
chr17:43094608:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32319218:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.236e-06,
chr13:32380124:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00002,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.1816|0.0615,possibly-damaging:0.712,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,,
chr17:43111544:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr17:43063932:TGG>TCT,,,In vitro (cloned),as wildtype control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-972),,,,
chr17:43074367:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32338036:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32331011:AA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43099832:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43103421:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32340886:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340886:T>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338423:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.4653|0.0227|0.3153,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32338954:T>C,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,7.413e-05,
chr17:43067676:AG>G,,,,,,,,,,,,,,,French?,,,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr17:43094019:C>AC,,,,,,,,,,,,,,,American|-,,-|Asian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43092404:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32333308:AA>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32394666:GCCACTGCAC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr13:32338423:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-315),,1,,
chr13:32368965:T>CG,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000798722,
chr13:32332383:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-027),,1,3.295e-05,
chr13:32332383:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-297),,1,8.238e-06,
chr17:43057122:C>G,,,In vitro (cloned)|Unknown,uncertain|predicted neutral|-|as variant control|predicted deleterious|moderately destabilizing,Thermodynamic stability prediction|Transcription activation in human cells|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,Western Europe|-|Central/Eastern Europe,," Native American| Central/Eastern European""""| German|-|Western European|Western-European|Western Europe|None-Specified|None Specified|""""Western European",M,5 - Definitely pathogenic,234.0,,,0.999,0.81,0.81,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-194),,1&1&1&1,,
chr13:32354823:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.249e-06,
chr13:32339594:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-044),,1,,
chr13:32332873:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0465|0.0|0.0308,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1&1,,
chr13:32394857:ACA>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,
chr13:32380284:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32398235:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43099832:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-002),,1,,
chr13:32364801:A>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00119808,
chr17:43104165:TT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32358101:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43115477:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr17:43076489:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43092934:G>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,Western European|Central/Eastern-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,3.295e-05,
chr13:32380128:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.237e-06,
chr13:32340847:CT>G,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43089968:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32398235:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32367543:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43091491:GCC>C,,,,,,,,,,,,,,,Spanish,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319135:GT>T,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,3/27,,1,,,,,,,
chr17:43065030:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32340457:AA>T,,,,,,,,,,,,,,,,,Western European| Canadian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32357750:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.6128|0.2076,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,1,,
chr13:32331011:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,,,
chr13:32330950:G>AAAG,,,,,,,,,,,,,,,,,None Specified,IFI,,,,,,,,protein_altering_variant,MODERATE,,,1,,,,,,,
chr17:43092521:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32355164:C>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,
chr13:32355164:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),probably_damaging(0-922),,,,
chr17:43070958:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|no functional effect|predicted neutral|-|Loss of variant allele|predicted deleterious|mildly destabilizing|?,Computational analysis|Thermodynamic stability prediction|Transcription activation in human cells|co-occurrence with deleterious variant|Peptide binding ability|Structure-based prediction (crystallography etc)|-|Prevalence in normal controls|transcription activation/PS/BA/BS|evolutionary conservation analysis|Multifactorial likelihood-ratio model|LOH analysis|Proteolytic degradation|?,37/1658|-,,,,0.0159,0.0,0.0043,0.0,0.0378,German|Spanish|-|US|Greek|Austria|French|Dutch|Austrian|Italian,1|0|2|-|4,Caucasian|Austrian|-|Unkown (Non-Ashkenazi)|Greek,M,1 - Not pathogenic or of no clinical significance,,,0.18,1e-05,0.03,0.03,synonymous_variant,LOW,15/23,,-1,,,,0&0&1,1&1&1,0.01459105,
chr13:32336446:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43104957:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/22,-1,,,,,1&1,,pathogenic
chr17:43106479:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43082390:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.236e-06,
chr17:43115448:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32358089:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32380124:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43094608:C>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32319174:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr17:43117849:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32340651:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-109),,1,,
chr13:32370469:A>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European| French Canadian,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43091687:TATACT>CGCCT,,,Germline (inherited),,,,,,,,,,,,Spanish,1|-,Galician|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337424:GTTG>C,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32360687:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43121267:G>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32398608:C>GAATTATATCT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43045769:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-983),,1,,
chr13:32396950:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32340486:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.119e-05,
chr17:43094635:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093210:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337992:AA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43089679:A>CT,,,,,,,,,,0.001,0.0038,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00159744,
chr17:43094140:CGG>GC,,,,,,,,,,,,,,,,,Mexico,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43053035:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32332911:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-65),benign(0),,1,,
chr17:43064223:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32397045:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32354852:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0001039615,
chr13:32336490:T>C,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-26),,1,,
chr13:32341036:C>AG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32355233:TT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32324124:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr17:43076592:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43057087:GC>C,,,,,,,,,,,,,,,,,Near Eastern,F,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,,
chr17:43045697:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-081),,1&1,,
chr17:43071098:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-09),benign(0),,1&1,,
chr13:32389011:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32338727:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-001),,1,8.238e-06,
chr13:32340420:A>G,,,,,,,,,,,,,,,Not Specified|Sweden|-,,Latin American/Caribbean|Western Europe|-,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,0&0&1&1,1&1&1&1,8.237e-06,
chr13:32366564:C>G,,,,,,,,,,0.0,0.0,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00159744,
chr13:32354963:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32336847:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,,8.237e-06,
chr13:32340645:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0227|0.0154,possibly-damaging:0.832,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-901),0&1&1,1&1&1,,
chr17:43059486:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32337798:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-878),,1,0.0001039585,
chr13:32339546:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-193),,1,,
chr13:32332459:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-258),,1,8.237e-06,
chr17:43092732:ACCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-258),,1,,pathogenic
chr13:32337659:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000083,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0117|0.0|0.0077,probably-damaging:0.996,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-508),,1,,
chr17:43076103:G>C,,,,,,,,,,0.0,0.0378,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,0.0103834,
chr13:32357107:T>G,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.00119808,
chr17:43063406:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr17:43104191:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Malaysian,,Malay,S,,,,,,,,synonymous_variant,LOW,6/23,,-1,,,,,1,,
chr13:32329481:GATA>GATAGATA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,,pathogenic
chr17:43092388:A>T,,,,,,,,,,,,,,,,,African American|-|Native American,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,2.471e-05,
chr17:43069051:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32341184:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-45),benign(0-045),,,,
chr17:43070944:TG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr17:43093775:C>A,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363790:AAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr13:32320172:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32363178:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32358687:T>G,,,,,,,,,,0.0,0.0272,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00738818,
chr17:43092828:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43094784:GAG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32337405:AG>T,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092601:G>A,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.71|None|None|possibly-damaging:0.71|possibly-damaging:0.71,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337800:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),Unknown|Germline (inherited),,,,,0.0|0.0908|0.0308,benign:0.0,0.0,0.0,0.0,0.005,0.0,Malaysian|-,," fillipino""""|Chinese| Filipino|Malay|""""Ashkenazi|Asian|African|None Specified",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),,,1,0.0006062515,
chr17:43093163:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,Russian|-,,African American|-|None-Specified|None Specified|African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.0002367455,
chr13:32363178:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32394858:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,,benign
chr13:32323778:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43122384:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43122695:C>A,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32380061:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,benign(0-003),,1,,
chr17:43091079:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.655e-05,
chr13:32354836:CAT>TTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.649e-05,
chr17:43094680:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092861:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093134:C>T,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western European|None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339290:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32382171:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32336308:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32363364:G>A,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,3 - Uncertain,,,0.52,0.1752,0.29,0.29,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32326498:C>A,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&0,,
chr13:32339733:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0),,1&1,1.647e-05,
chr13:32338148:T>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000881,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.042,1.0294,,0.00088,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-128),,,,benign
chr13:32386560:T>G,,,,,,,,,,0.0,0.0461,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0125799,
chr17:43076491:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.237e-06,
chr13:32340836:CACCA>G,,,In vitro (cloned)|Unknown,-|as variant control|?,Loss of Heterozygosity|-|?,-|3/1658,,,,,,,,,Not Specified|-|Italian,,"Western European|-|Ashkenazi| Italian""""|African|Western Europe|None Specified|Caucasian|Native American|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.648e-05,
chr17:43053777:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32332639:GATTTG>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32332705:CG>G,,,,,,1/1658,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43067680:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-942),,1,,
chr17:43099733:GAA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,1.647e-05,
chr17:43104081:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Sri Lankan,,Sinhalese,Intronic,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,0&1,,
chr13:32338444:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32383903:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32338224:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0129,0.0,0.0,0.0,Latin American/Caribbean|African American|-,,"""""Near Eastern| Latin American/Caribbean""""|Western European|""""Latin American/Caribbean|Latin American/Caribbean| Lebanese""""| Iranian|-| Cuban""""|""""African|Western Europe/African American|""""Western European| India|African|African American|None Specified| Native American| Native American""""|Central/Eastern European|Africa|Asian|Near Eastern",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1&1,0.002114685,
chr17:43091840:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,possibly-damaging:0.627|None|None|possibly-damaging:0.627|possibly-damaging:0.627,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340507:AC>A,,,,,,,,,,,,,,,Thai,,Thai/Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32333159:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Italian Irish French,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43116581:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32346901:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,13/26,1,,,,,1,,
chr17:43059929:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32346901:G>C,,,In vitro (cloned),inconclusive,Histopathology,,,,,,,,,,Western Europe,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,13/26,1,,,,,1,,
chr13:32320008:A>C,,,,,,,,,,0.002,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32332622:A>C,,Ambry_Genetics|Invitae,,,,,,0.0117|0.0|0.0078,possibly-damaging:0.454,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-386),,1,,
chr17:43057087:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-623),,1&1,,
chr13:32398396:A>T,,,,,,,,,,,,,,,,,Western Europe,N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339087:A>G,,,,,,,,,,,,,,,,,Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),possibly_damaging(0-462),,1,,
chr13:32338801:AACAGA>AACAGAAACAGA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,inframe_insertion,MODERATE,11/27,,1,,,,,,,
chr13:32340063:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-138),,,0.000199681,
chr17:43061609:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.1573,0.2824,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.324281,benign
chr13:32357694:TAATTC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,2.472e-05,
chr13:32346884:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(0-989),,,,
chr13:32356613:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/26,1,,,,,1,,
chr17:43093428:A>T,,,,,,,,,,,,,,,Austria,1,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339085:TGAAAAG>AG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092252:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32316436:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr17:43094297:C>T,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43092861:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr13:32340868:T>G,,,In vitro (cloned),predicted neutral,Prevalence in normal controls|Allele frequency analysis in controls,,,,,,,,,,Austria|Sri Lankan|-|Omanis,0|-|4,Arab|-|Africa|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,
chr13:32381034:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32376723:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,0&1&1,0&1&1,0.0001245505,
chr13:32319300:ATTAGA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,0&1&1,0&1&1,,
chr17:43101590:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32339733:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43072263:A>T,,,,,,,,,,0.0,0.0424,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0113818,
chr13:32326847:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32326142:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32319075:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/26,1,,,,,1,,pathogenic
chr17:43070790:C>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000998403,
chr13:32346491:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32395087:C>TG,,,,,,,,,,0.004,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.00119808,
chr17:43080383:CCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTCCACAACCCACT>G,,,,,,,,,,,,,,,German|-|Dutch?|Dutch|Belgian|Belgian?,,Unknown|-|Caucasian|None Specified|Dutch,IVS,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,
chr13:32362705:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0681|0.0231,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,,
chr17:43063839:AAGTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,2.471e-05,
chr13:32333270:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-735),,1&1,,
chr13:32348948:A>T,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr13:32333006:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43094846:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43118318:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32380126:A>C,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,Syn,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,8.237e-06,
chr17:43091881:C>GT,,,,,,,,,,,,,,,French?|-|Canadian,,-|French-Canadian|Frech Canadian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32379894:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1&1,1&1&1,,
chr17:43115776:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43092101:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32339383:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-395),,,8.243e-06,
chr17:43121520:G>C,,,,,,,,,,0.3579,0.2179,0.3732,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353035,
chr17:43091991:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43073142:T>A,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr13:32340887:A>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),possibly_damaging(0-862),,,,
chr13:32340254:ATCTT>A,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338103:C>GA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32373947:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43105311:G>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000399361,
chr13:32337335:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-63),benign(0-06),,1,,
chr17:43091753:TTTAATTTG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092077:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337005:CTGCT>T,,,,,,,,,,,,,,,-|English,,Western Europe|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.648e-05,
chr13:32343432:TGCT>T,,,,,,,,,,0.0,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000998403,
chr13:32319231:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,benign
chr13:32336641:AA>T,,,,,,,,,,,,,,,,,Western European|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093190:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32379316:C>A,,,Unknown|Germline (inherited),,,-|2/238 patients,,,,,,,,,Czech|-|Italian,,Western European|Caucasian|None Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,21/26,1,,,,,1&1,,
chr17:43099794:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0681|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32338020:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-306),,,8.237e-06,
chr13:32341040:TT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326079:G>T,,,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43113054:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43082113:C>T,,,,,,,,,,0.004,0.0008,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00199681,
chr17:43074337:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32330920:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1,,
chr17:43093142:G>A,,,,,,1/1658,,,,,,,,,,,Western-European|English/Irish|-|Scottish,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr13:32340434:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43064327:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32398469:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32338369:C>CGG,,,,,,,,,,,,,,,Malaysian,,Indian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32336282:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32329687:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr17:43051084:CA>G,,,,,,1/1658,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,1,,
chr17:43049160:GA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,8.236e-06,
chr13:32340887:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-048),,,8.238e-06,
chr17:43089550:->TC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43070925:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32347801:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32325137:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,,,
chr17:43050671:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43076570:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43067295:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43082494:A>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr13:32385652:G>C,,,,,,,,,,0.2376,0.2133,0.1657,0.2688,0.2434,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.228634,
chr17:43093534:GC>A,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43093445:A>C,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32339320:C>G,,Oregon_Health_and_Sciences_University|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Knight_Diagnostic_Laboratories|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr17:43094755:AG>T,,,,,,,,,,,,,,,,,Pakistani,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32356551:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-926),1&1,1&1,,
chr13:32326282:T>A,,,In vitro (cloned),predicted deleterious,cDNA analysis|mRNA analysis,,,,,,,,,,,,Western Europe,Syn,,,,,,,,missense_variant&splice_region_variant,MODERATE,6/27,,1,,,,,1&1,,
chr13:32339320:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32398820:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.25e-06,
chr13:32354180:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.9045 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43079575:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr13:32331082:TT>ATT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.029,
chr13:32338868:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-026),,1,,
chr17:43067682:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-976),1&1,1&1,,
chr13:32356472:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Emory_Genetics_Laboratory|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/27,,1,,,,,1&1,,pathogenic
chr13:32326241:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,5/26,1,,,,0&1,1&1,,pathogenic
chr13:32336679:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-274),,1&1,,
chr17:43095689:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32356551:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-848),1&1,1&1,,
chr17:43092951:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001121955,
chr13:32386851:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0129,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00359425,benign
chr17:43076504:C>A,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,
chr13:32332716:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43097298:G>C,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1&1,,
chr13:32326142:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0117|0.0682|0.0308,benign:0.167,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr17:43092918:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,8.236e-06,
chr13:32379387:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43125524:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32334730:T>C,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr17:43090419:T>C,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00119808,
chr13:32379387:C>A,,Ambry_Genetics|GeneDx,,,,,,0.0|0.0227|0.0077,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32355006:A>GT,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32354910:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted pathogenic| no LOH|-,HR assay|-| LOH assay,,,,,,,,,,,," Central/Eastern European|Central/Eastern European|Not Specified|Western European| Irish""""| Bohemian|Western Europe|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),probably_damaging(0-964),,1&1,5.765e-05,
chr17:43091564:GA>G,,,,,,,,,,,,,,,Norwegian,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43045697:ATCTGGGGT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32341127:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,8.236e-06,
chr13:32365165:C>A,,,,,,,,,,0.2386,0.1899,0.1614,0.2659,0.2393,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.220647,
chr13:32337034:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43093671:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43093256:T>A,,,,,,,,,,,,,,,,,Western-European,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093968:TAT>TTA,,,,,,,,,,,,,,,,,Ashkenazi,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,,,
chr13:32353722:T>A,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr17:43045812:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,-|?,-|?,,,0.0233|1.4526|0.5075,None|None|None|None|None,0.0,0.0212,0.0,0.0,0.0,Not Specified|Latin American/Caribbean|African American|-,,Latin American/Caribbean|Not Specified|-|Native American/African American|African American|Near East/Mid East,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1&1,0.003500025,
chr13:32339986:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1&1,8.237e-06,
chr13:32338767:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-017),,,,
chr13:32330940:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.237e-06,
chr13:32316419:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32332559:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-144),,,8.241e-06,
chr17:43078235:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr17:43091598:TT>G,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092963:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32340268:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr13:32325686:C>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00159744,
chr17:43092963:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340558:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32337706:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-668),,1&1,,
chr13:32337475:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr17:43106483:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr13:32339320:C>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr13:32394679:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr13:32336679:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr17:43099793:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr17:43119625:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43098588:C>A,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000599042,
chr17:43071050:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-006),,,,
chr13:32333437:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,8.422e-06,
chr17:43051077:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,tolerated(0-13),possibly_damaging(0-734),,1,,
chr13:32333125:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Malaysian,,Chinese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.236e-06,benign
chr13:32363306:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),probably_damaging(0-999),,,0.000199681,
chr13:32338693:TT>T,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32316041:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32394816:T>AG,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,1&1,1&1,,
chr17:43109029:A>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000998403,
chr17:43090934:A>T,,,,,,,,,,,,,,,Austria|-,0|-,-|Native American,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.648e-05,
chr17:43094404:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32335560:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43079410:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.0001041135,
chr17:43041129:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32389570:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5407 (African)| 0.5356 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43048495:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32370426:T>C,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32370426:T>A,,,,,,,,,,,,,,,Malaysian,,Chinese,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,5.765e-05,
chr17:43109898:T>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32333052:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,
chr17:43124030:A>CT,,,,,,,,,,,,,,,-|Malaysian|Dutch|Western Europe|Italian|Belgian,1|-,"Ashkenazi Jewish|""""Native American|Chinese| Central/Eastern European""""|Central/Eastern Europe|Western European|-|Caucasian|Western-European|None-Specified",F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,0&1,0&1,,
chr13:32370530:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04675 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|3.813|1.2994,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,,
chr17:43091762:AAT>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43090934:A>G,,,In vitro (cloned)|Unknown,predicted neutral|inconclusive|-,Histopathology|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European|Western European,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,2.472e-05,
chr13:32340594:G>TA,,,,,,,,,,,,,,,,,German/Irish/Scottish|-,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1&1,,
chr17:43082408:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,benign
chr13:32340823:TC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,pathogenic
chr13:32384510:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32336872:T>A,,,,,,,,,,,,,,,-|English-Irish-German,,Western European|-,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32339544:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),benign(0-053),,,8.24e-06,
chr13:32340729:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr13:32330906:T>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr17:43115615:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0179,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00379393,
chr13:32333047:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.236e-06,benign
chr13:32338892:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-159),,1,,
chr17:43093256:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094326:AA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32338218:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,1,,
chr17:43045749:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,1,,pathogenic
chr13:32319100:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43091824:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32319181:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,2.471e-05,
chr13:32356530:AA>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,1&1,1&1,,
chr17:43088049:C>A,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00119808,
chr13:32333167:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,0&0&1,1&1&1,1.647e-05,
chr17:43093814:ATTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr13:32362595:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1&1&1&0,,
chr13:32370562:TTATTCTTTTATTATTCATG>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,,8.237e-06,
chr13:32338394:A>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-126),,1,,
chr13:32340433:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-126),,1,,pathogenic
chr17:43045749:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-988),,1&1&1,,
chr17:43067403:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43093412:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338273:AG>T,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339381:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-395),,,,
chr13:32398351:A>T,,,,,,,,,,,,,,,,,Western Europe|Asian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43092897:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,5.765e-05,
chr17:43102858:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32330993:CAGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43094536:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,0.0,0.0,0.0,0.001,0.0,,,Asian,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,0.0001121955,
chr13:32338363:G>TCATC,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43062192:GTA>C,,,,,,,,,,0.3588,0.1626,0.2853,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.326478,
chr13:32362521:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,pathogenic
chr13:32363419:T>CT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32347868:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093216:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000192,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0233|0.0|0.0154,probably-damaging:0.993|None|None|probably-damaging:0.993|probably-damaging:0.993,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43067618:AAC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43051118:A>T,,,,,,,,,,,,,,,,,-|Central/Eastern European,IVS,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,
chr13:32337522:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-591),,1&1,1.648e-05,
chr13:32354914:A>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),benign(0-176),,,,
chr13:32340768:G>A,,,,,,,,,,,,,,,Latin American/Caribbean,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-108),,1,1.648e-05,
chr13:32363211:A>T,,,In vitro (cloned)|Unknown,predicted deleterious|inconclusive|-,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model,-|1/1658,,,,,,,,,American|-,2|-," Native American| Irish German""""|Western European|-|African|African American|""""Western European",M,3 - Uncertain,2.0,1.225,,0.5002,0.29,0.29,stop_lost,HIGH,18/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,
chr13:32340594:G>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,,
chr17:43071124:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-01),,1,8.236e-06,
chr17:43092733:A>T,,,,,,,,,,,,,,,Western Europe|-,," Native American""""|-|""""Western European",M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338524:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093364:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000317,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,co-occurrence with deleterious variant|-|evolutionary conservation analysis|Multifactorial likelihood-ratio model,,,0.0|0.7263|0.246,benign:0.164|None|None|benign:0.164|benign:0.164,0.0,0.0045,0.0058,0.0,0.0,African American|-,,"Latin American/Caribbean|-Near-Eastern|Not Specified|-|None-Specified|""""Latin American/Caribbean|-Central/Eastern-Europe| Jamaican|African|Western-European| Brazil""""|Latin-American/Caribbean|None Specified",M,1 - Not pathogenic or of no clinical significance,1.0,1.15E-09,13.48963,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.001282555,
chr17:43087621:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32368998:A>T,,,,,,,,,,0.0348,0.0295,0.0893,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0726837,
chr17:43051118:A>G,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,
chr13:32389796:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32326127:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr17:43091879:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0454|0.0154,probably-damaging:0.999|None|None|probably-damaging:0.999|probably-damaging:0.999,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32379734:ATCTTTCTC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091757:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,8.236e-06,
chr17:43109546:G>T,,,,,,,,,,0.003,0.146,0.0187,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0417332,
chr13:32337952:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.000199681,
chr17:43105117:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr13:32340527:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43093410:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32336426:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-098),,1,,
chr13:32337333:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43109546:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32376656:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.236e-06,
chr13:32340280:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-881),,,,
chr17:43067610:T>GT,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,15/22,,-1,,,,,,,
chr17:43073159:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32340280:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339778:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-009),,1,,
chr13:32338732:A>G,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43092809:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43091716:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43092205:TTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32330173:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000798722,
chr13:32337663:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43069823:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr17:43047693:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr17:43092201:CAACA>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363225:C>G,,,In vitro (cloned)|Germline (inherited),predicted deleterious|-,-|mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-996),,1&1,,
chr13:32332625:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-996),,1&1,,pathogenic
chr17:43063373:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-962),,0&1&1,,
chr13:32336248:A>C,,,,,,,,,,,,,,,,,Central/Eastern Europe,IVS,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr13:32386390:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43071139:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(1),benign(0),,,,
chr17:43074362:C>T,,Ambry_Genetics|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr17:43124116:C>CAT,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43063373:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,18/23,,-1,,,,,0&1&1,,pathogenic
chr13:32379812:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43119881:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32316853:T>C,,,,,,,,,,0.0,0.0204,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00599042,
chr13:32363241:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,-|Central/Eastern Europe,,-|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32371127:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.24e-06,
chr13:32333262:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0),,1,,
chr13:32333238:TAGAA>C,,,,,,,,,,,,,,,-|Serbian,,Western European|None Specified|Serbian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43074719:CAAATG>G,,,,,,,,,,0.3559,0.1558,0.3646,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.334864,
chr13:32316490:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,benign
chr13:32339479:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.244e-06,
chr13:32387157:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32394887:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-03),benign(0-106),,1,2.471e-05,
chr13:32340629:AAA>C,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,-|18/1658,FA FANCD1_00033|-,,,,,,,,Scottland|Central/Eastern Europe|Canadian|Not Specified|Western European|Dutch|-|British|Dutch?|Sweden|UK|Spanish|Australian|British?|Western Europe|Belgian?,2|-,Swedish|Latin American/Caribbean|NW European|Western European| Czech/Polish|-| Native American| Centr|Unknown|French-Canadian|English|Western Europe|Irish/Scottish|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.647e-05,
chr13:32344341:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43091399:T>C,,,,,,,,0.0|0.0908|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319179:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43092172:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32379867:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32376786:T>CTTGAGGTGAGAGAGTAAGAGGACATA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,21/27,,1,,,,1&1,1&1,8.236e-06,
chr13:32371035:A>C,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1977|0.0454|0.1461,probably-damaging:0.981,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-03),probably_damaging(0-968),,1&1,,
chr17:43093426:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094548:AAA>C,,,,,,-|1/1658,,,,,,,,,Malaysian|Hong Kong|-|British|Italian,1|-, Sephardic|Chinese|Chinese |-|Near Eastern|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32316859:T>G,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr13:32340756:ATAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32346795:GAACGTAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,4.952e-05,
chr17:43091335:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.655e-05,
chr17:43054613:C>T,,,,,,,,,,0.0159,0.0,0.0043,0.0,0.0378,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0111821,
chr13:32326779:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43094022:CCTCAG>C,,,,,,2/1658|-,,,,,,,,,German|Greek|Spanish|-|Italian,1|-,Irish|Western-European|Western European|-|None-Specified|Greek|Asian|French Canadian|Western Europe|Central/Eastern-European|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43071113:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-737),,1&1,8.236e-06,
chr13:32339522:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-596),,1,,
chr13:32378709:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32347162:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43067684:G>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,,,pathogenic
chr17:43071113:C>A,,,,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1,,
chr13:32333258:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,1.647e-05,
chr13:32332981:CCT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32339514:A>G,,,,,,,,,,,,,,,,,Ashkenazi,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1,,
chr13:32337208:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43067684:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,,benign
chr13:32337343:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43092387:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43057491:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43065857:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32370529:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-929),,,8.237e-06,
chr13:32370443:CCCAACTATGTG>AAAG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr17:43092185:TGGAG>C,,,,,,,,,,,,,,,Hong Kong,1|-,Chinese |Chinese,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319259:A>T,,,,,,5/1658,,,,,,,,,United Kingdom|-,,Western European|Western Europe|-|None Specified|Angolan,N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,
chr13:32319289:A>T,,,,,,,,,,,,,,,,," Italian""""| Latin American/Caribbe| Central/Eastern Europe|Western European|Near Eastern|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,1.647e-05,
chr13:32339847:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32357721:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1,,benign
chr17:43111066:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43125016:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43092798:G>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,Austria,0,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.000723721,
chr17:43076635:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,1.647e-05,
chr17:43093676:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,6.589e-05,
chr13:32363320:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32340300:AA>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|-|as variant control,Radiation sensitivity|-|Nuclear localisation|Homology-directed repair assay|Centrosome amplification|Cell viability (in BRCA-/- cells)|Survival assay with VC8 (after MMC treatment)|Co-segregation in families,-|13/1658,FA FANCD1_00014|-,,,,,,,,Chilean|Ashkenazi/West/Central/East Europe|Central/Eastern Europe|Canadian|Not Specified|German-French|Dutch|-|Austria|US|American|Ashkenazi|Ashkenazi/Western Europe|Russian|Sweden|Western Europe|Italian,1|0|2|-," Latin American/Caribbean|Cacasian| Central/Eastern Europe|Western European| Ital| French| Central/Eas|Ashkenazi|Dutch| Mex|Caucasian|Near East/Mid East|Ashkenazi/Western/Eastern/Central Europe|""""Western European|Central/Eastern Europe|Not Specified|-| Jewish""""| Italian""""|Unknown| English| Ashkenazi""""| Irish|Ashkenazi Jewish| Central/Eastern European| German| French CA|Jewish/Polish|White-NonHispanic|Latin American/Caribbean/Western Europe| Russian""""| Russia Poland|Czech/Hungarian/Russian/Jewish|None Specified|Central/Eastern European| Jew|""""Ashkenazi| Central/Eastern European""""|Jewish|Ashkenazi/Central/Eastern Europe|Asian| Ashkenazi|Ashkenazi/Western Europe|Western Europe|""""Central/Eastern European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,0.0002636,
chr17:43093817:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1&1&1,1&1&1&1&1,,
chr17:43074446:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.236e-06,
chr13:32379856:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,pathogenic
chr13:32346835:AAAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,pathogenic
chr13:32380066:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,,
chr13:32340915:G>T,,,,,,,,,,,,,,,,,-|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),probably_damaging(0-932),,1,3.295e-05,
chr13:32340957:CAC>C,,,,,,,,,,,,,,,Belgian,2,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32331861:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1066 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr13:32338600:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,,benign
chr17:43090268:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32319176:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000306,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32376793:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1,,pathogenic
chr17:43104273:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,
chr13:32363391:A>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),possibly_damaging(0-904),,1,,
chr17:43063940:C>G,,,In vitro (cloned),predicted deleterious|predicted neutral|inconclusive|as variant control|as wildtype control|Moderate functional effect,protein binding capacity BRCA1-CtIP|Thermostability assay|Peptide binding ability|Bayesian statistics|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Multifactorial likelihood-ratio model|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-892),,1&1,,
chr17:43094958:C>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43104877:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32340300:AA>AT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-444),,,8.237e-06,
chr17:43092935:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000000163,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43067321:A>T,,,,,,,,,,0.0,0.0008,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000998403,
chr17:43091783:->GGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTATATTG,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43047119:GG>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00159744,
chr13:32326103:AGTT>GTGT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,,2.472e-05,
chr17:43093690:CCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43093125:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063337:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,,,,1,,
chr13:32338490:ATTATC>C,,,,,,1/1658,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093337:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,American|-,,Western-European|Western Europe|-|None-Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32339397:TG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43107458:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0083,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00299521,benign
chr13:32336846:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-04),0&1&1,1&1&1,,
chr13:32362511:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,,
chr13:32338894:C>A,,,,,,,,,,,,,,,,,Latin American/Caribbean| peruvian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32329935:A>T,,,,,,,,,,0.007,0.0,0.0043,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00219649,
chr13:32340746:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr17:43094854:TG>C,,,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,Not Specified|Austria|-,2|-,Not Specified|Western European|-Czech-Slovarki|-|-Central/Eastern-Europe|Unknown|Western-European|Western Europe|Central/Eastern-European|None-Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43121437:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43063868:T>G,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,,,
chr13:32332306:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.239e-06,
chr17:43074320:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr13:32337581:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-012),,1&1,,
chr17:43094316:CAGCAGAGATAATCCTATTGCAGGTAGGGGTGGAGTGGGTA>T,,,Unknown|Germline (inherited),,,-|6/1658,,,,,,,,,Scottish / English|-|Western Europe|British,1|-,"White-NonHispanic| Native American""""|English/Irish/Dutch/French|Central/Eastern Europe|Not Specified|Western European|-|Irish/Scottish|Caucasian|Unknown|Western-European|Western Europe|None-Specified|None Specified|""""Western European",F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43097357:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091573:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32332359:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-117),,,8.238e-06,
chr17:43074482:C>T,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),,,,,,,,,,,,,,"-Central/Eastern-Europea|Australia|Not Specified|Western European|Native-American| Native American""""|Ashkenazi|-Italian|Western-European|Western Europe|caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32340516:AC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339236:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43091767:ATT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32363453:T>AT,,,,,,,,,,,,,,,,,Not Specified|-,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32337864:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,Histopathology|-,,,,,,,,,,,,Western European|-,M,3 - Uncertain,,,16.4,0.2299,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,benign(0-049),,1,8.236e-06,
chr13:32333108:C>G,,,,,,,,,,,,,,,,,French Canadian,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-49),benign(0-004),,1,,
chr13:32397919:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32398733:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32394153:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32332782:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-047),,1,,
chr13:32398143:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32338674:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338524:AC>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43115742:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43076570:C>G,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,Western Europe,M,1 - Not pathogenic or of no clinical significance,1.0,0.00324,0.912,6e-05,0.02,0.02,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,8.237e-06,
chr17:43049244:C>AC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,3.295e-05,
chr13:32333108:CCG>A,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32351840:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43067787:C>G,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,
chr13:32324702:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32338529:C>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-329),,1,,
chr17:43071073:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-02),benign(0-004),,,,
chr17:43092841:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32355341:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,benign
chr17:43058666:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32356454:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,,8.236e-06,
chr17:43066964:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32337430:C>T,,,,,,,,,,,,,,,Western Europe|-,,Not Specified|Western European|-,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43094277:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1,1,,benign
chr13:32325461:AGTC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1,1,,benign
chr13:32339385:GT>G,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43074553:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32363243:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),benign(0-41),,,,
chr17:43094273:AC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32344928:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32341049:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-093),,1,,
chr17:43092186:TTCT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-093),,1,,pathogenic
chr17:43085549:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000599042,
chr17:43094640:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000634,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333282:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000101,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-056),,1,,
chr13:32316466:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32379775:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,8.238e-06,
chr17:43093018:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32339586:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-187),,1,2.471e-05,
chr13:32380158:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,2.472e-05,
chr13:32336452:TGAGA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398149:CT>ATT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,3.295e-05,
chr17:43091846:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43123638:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00539137,benign
chr17:43106472:AC>T,,,,,,,,,,,,,,,German|-,2|-,Not Specified|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43093075:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093359:TTCCACTAGAAACAGCCCCCTGACAAATCCCATTAAGACAAA>A,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43071201:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,8.236e-06,
chr13:32340984:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr17:43104172:G>A,,,,,,,,,,,,,,,American|-,," Native American""""|-|""""African",N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,
chr13:32363534:G>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1&1&1,,pathogenic
chr17:43093675:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32354905:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,possibly_damaging(0-487),,1&1,,
chr13:32332378:C>AG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32340722:A>GA,,,,,,,,,,,,,,,,,Not Specified|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,
chr13:32362698:T>A,,,,,,,,,,,,,,,HKSAR,,Chinese,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/26,1,,,,,,,
chr13:32323293:A>T,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000998403,
chr13:32370505:T>GA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,1,,
chr17:43094516:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32379896:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43067614:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr13:32354905:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-046),,1&1,,
chr17:43093883:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000163,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0227|0.0308,probably-damaging:0.996|None|None|probably-damaging:0.996|probably-damaging:0.996,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43056199:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43124095:G>C,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1&1,,
chr17:43079714:G>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000399361,
chr17:43093231:AT>C,,,,,,,,,,,,,,,African American|-|USA,2|-,African American|-|None Specified|African,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091736:AT>A,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32330887:T>G,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0001485,
chr17:43045764:T>A,,,In vitro (cloned),,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1&1&1,,
chr13:32340678:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-013),,1&1,,
chr13:32356395:T>C,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,
chr13:32398520:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340678:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000000372,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|?,-|Embryonic stem cell assay|Multifactorial likelihood-ratio model|?,-|3/1658,,0.1512|0.6809|0.3307,benign:0.347,0.001,0.0136,0.0,0.0,0.0,Latin American/Caribbean|Not Specified|-|Austria|Western Europe|Near East/Mid East,1|-," Central/Eastern Europe|Western European|Ashkenazi| Irish Italian Spanish English""""| Germany|Caucasian|Latin American/Caribbean|Western Europe/Native American| Central/Eastern European""""|Not Specified| French Canadian|-| Italian| Jamaican| African|""""Western European| Latin American/Caribbe|African|African American|None Specified| Native American|Western Europe/Native American/African A|Central/Eastern European| English/Irish/French Canadian""""|Native American/Central/Eastern Europe|French Canadian|Western Europe",M,1 - Not pathogenic or of no clinical significance,3.02e-06,0.00316,0.00191,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-54),benign(0-115),,1&1,0.002531465,
chr17:43045742:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-728),,1,,
chr17:43051031:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,1.647e-05,
chr13:32320668:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02639 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43071040:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-18),benign(0-002),,1,,
chr17:43082550:GA>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr17:43092448:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43118583:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32394728:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),probably_damaging(0-993),,1,,
chr17:43094074:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43051610:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43052217:T>C,,,,,,,,,,0.003,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr17:43092448:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000998,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32342530:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0133,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00259585,
chr13:32339855:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-016),0&1&1,0&1&1,1.647e-05,
chr13:32377685:A>G,,,,,,,,,,0.005,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00119808,
chr17:43093094:C>A,,,,,,1/1658,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43047697:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,tolerated(0-06),benign(0-225),,1,,
chr13:32375563:C>CT,,,,,,,,,,0.4881,0.5204,0.4856,0.5139,0.4335,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.490815,
chr13:32336892:A>G,,,,,,1/1658,,,,,,,,,,,,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,,
chr13:32369487:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr17:43091843:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43050278:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000399361,
chr13:32394984:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,3.295e-05,
chr13:32332760:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-034),,1,,
chr17:43115758:AG>A,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr17:43111828:G>C,,,,,,,,,,0.005,0.0174,0.0101,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.0071885,
chr13:32340996:TC>C,,,,,,,,,,,,,,,,, English|Western European|Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32337674:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341155:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,8.237e-06,
chr13:32336441:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-54),,1,,
chr13:32319276:C>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,1.647e-05,
chr13:32326605:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,5.765e-05,
chr13:32390273:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr13:32345093:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43097302:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,8.24e-06,
chr13:32371232:C>CC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32319250:T>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,2.471e-05,
chr17:43049133:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,,,,8.236e-06,
chr13:32319250:T>G,,,,,,,,0.0233|0.0|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,1.647e-05,
chr13:32382007:A>C,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00898562,
chr17:43008077:CATCCTGGAGCCTCAGAGAGAAGGAAAAAGT>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,1/6,1,,,,,,,
chr17:43074486:C>G,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|_NHGRI|Invitae,,,,,,,,,,,,,,,Western-European|Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,1,2.471e-05,
chr17:43080359:G>A,,,,,,,,,,0.001,0.0083,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00239617,
chr17:43094514:T>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32319276:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,2.471e-05,
chr17:43092910:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,pathogenic
chr17:43091668:TA>T,,,,,,,,,,,,,,,Czech,1,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr13:32339827:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.647e-05,
chr17:43093316:->AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43124064:C>TG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32368970:C>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00239617,
chr17:43115743:CTT>AGC,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(0-999),,,,
chr13:32394679:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr17:43070969:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr17:43108818:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32338038:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-5),benign(0-06),,,,
chr13:32339827:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,1.647e-05,
chr13:32341126:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.118e-05,
chr13:32339288:AACT>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost&inframe_deletion,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32340923:G>T,,,,,,,,0.0116|0.0|0.0077,benign:0.019,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-052),,1,1.648e-05,
chr13:32363213:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),possibly_damaging(0-742),,,,
chr13:32389392:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06119 (Asian)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094450:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394809:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-975),,1,,
chr17:43047634:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,
chr17:43093756:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32317364:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32364315:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02448 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32316027:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32376700:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,1&1,1&1,,
chr17:43070809:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32379885:CC>CAA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,0&1&1,0&1&1,0.0001648,
chr13:32340574:TGTT>AAA,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093836:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092419:T>A,,,,,,,,,,,,,,,Austrian|-,,Western-European|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43045594:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.238e-06,
chr13:32354268:T>G,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00239617,
chr13:32339662:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32333025:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43049114:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1&1,,benign
chr13:32336380:AA>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32385577:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339319:GT>AGA,,,,,,,,,,,,,,,,,White-NonHispanic,N,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43067611:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr13:32336630:GC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32354888:GT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43044352:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,5.137e-05,
chr17:43057161:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr17:43093633:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43049174:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,-|Central/Eastern Europe,,Western-European|-Greek|-|-Italian,N,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr17:43049174:G>C,,,In vitro (cloned),as wildtype control|predicted neutral|no functional effect,transcription activation/PS/BA/BS|Transcription activation in human cells|Structure-based prediction (crystallography etc),,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,benign(0-033),,1&1,,
chr13:32339525:C>G,,,,,,,,,,,,,,,,,None Specified|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-044),,1,6.594e-05,
chr17:43050310:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32336801:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-814),,1&1,,
chr17:43092528:TTCCTC>-,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-814),,1&1,,
chr13:32370555:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32337638:C>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43080681:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07692 (Asian)| 0.02236 (African)| 0.1966 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43057113:G>C,,,In vitro (cloned)|Unknown,predicted deleterious|-|strong functional effect,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-13),,1&1&1,,
chr13:32344666:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr13:32332572:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-323),,1,8.246e-06,
chr13:32398283:T>G,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,,,,,,,,Not Specified|African American|Africa|African,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,5.765e-05,
chr13:32337806:T>AT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338263:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-036),,1,,
chr13:32333331:TG>CAA,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43077190:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr17:43094141:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32337184:GTG>T,,,,,,,,,,,,,,,Australian,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43092825:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32344624:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-06),benign(0-316),,,,
chr13:32370505:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32362094:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00239617,benign
chr13:32379753:A>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,
chr13:32380060:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32340216:TA>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326580:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr17:43049729:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43092018:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43106478:G>C,,,In vitro (cloned)|Unknown,impact on protein function|-|as variant control,Homology directed recombination|E3 Ub-ligase activity assay BRCA1/RING-BARD1|protein binding ability BARD1|-|cDNA analysis,,,,,,,,,,,,Unknown|-|None Specified|African,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,1.648e-05,
chr17:43106478:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1&1,,
chr13:32379839:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43104246:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32398219:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332517:C>A,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-069),,1,,
chr13:32339699:T>A,,,,,,,,,,,,,,,,,-|None Specified,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32338596:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.6639|0.2241,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-004),,1,,benign
chr13:32377452:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32365106:T>G,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32350977:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43092519:C>T,,Ambry_Genetics|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32355088:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,8.237e-06,pathogenic
chr17:43071148:AAC>C,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr17:43093633:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43094872:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&0,8.288e-06,
chr17:43097519:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr17:43099845:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,0&1,8.236e-06,
chr13:32395960:TTGTTTCCATCTTCCT>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0002561,
chr17:43051770:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32337651:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32337204:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,,
chr17:43108175:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32379045:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| 0.1346 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43110174:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43092632:G>A,,,In vitro (cloned),as variant control,Peptide binding ability,,,,,,,,,,P.R. China,1,Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094091:G>AT,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32336801:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32397012:G>CAAA,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32333310:G>A,,,,,,,,,,,,,,,Not Specified|Western Europe|-,, Native American|Western European|-|Ashkenazi|Western Europe|None Specified,N,,,,,,,,stop_retained_variant,LOW,10/27,,1,,,,,1&1,,
chr17:43116979:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43057077:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000206,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Germline (inherited),as wildtype control|predicted neutral|Low functional effect|-|predicted deleterious|mildly destabilizing|inconclusive,Thermodynamic stability prediction|Peptide binding ability|Bayesian statistics|-|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Multifactorial likelihood-ratio model|Proteolytic degradation|evolutionary conservation analysis,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,Greek|Western Europe|-,,Western European|-|Greek|Western-European|Western Europe|Central/Eastern-European,M,1 - Not pathogenic or of no clinical significance,2.0,1.55,0.00219,0.00021,0.03,0.03,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-036),,1&1&1,2.471e-05,
chr17:43124012:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr17:43045450:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00078513,benign
chr17:43088499:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43091829:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32337112:GT>A,,,,,,1/1658,,,,,,,,,Australian|-,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339297:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-073),,,,
chr13:32326255:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,
chr17:43045023:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43074394:->C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43057077:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious|strong functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-439),,1&1&1,,
chr17:43068330:A>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000798722,
chr13:32332609:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-42),benign(0-275),,1,1.65e-05,
chr13:32330904:CGT>C,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,,,Western European|Western Europe,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0001648,
chr13:32357938:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.236e-06,benign
chr13:32369090:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32338440:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32338675:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-965),,,1.649e-05,
chr17:43104219:ATG>G,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,,
chr13:32385906:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32338064:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-447),,1,,
chr17:43091752:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-447),,1,,pathogenic
chr13:32332515:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-331),,,,
chr13:32336673:TC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.236e-06,
chr17:43093915:GTTTG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363383:TGTTAAGGC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32341264:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32370484:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,19/27,,1,,,,,1&1,,
chr17:43094809:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,1,,
chr13:32380165:TGT>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.241e-06,
chr13:32337153:A>G,,,,,,,,,,,,,,,American/Poland,,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-002),,1&1&1&1,,
chr17:43082450:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,
chr17:43092610:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,pathogenic
chr17:43092293:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43058399:G>C,,,,,,,,,,0.005,0.5197,0.036,0.003,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.14996,
chr17:43094585:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43048864:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000599042,
chr17:43051005:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr13:32363060:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.000199681,
chr17:43057152:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr17:43091385:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.238e-06,
chr13:32356611:C>G,,,In vitro (cloned)|Unknown,-|as variant control,-|cDNA analysis,,,,,,,,,,Austria,1,,Splice,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1,,
chr13:32336844:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-023),,,,
chr13:32370453:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-14),possibly_damaging(0-525),,,8.236e-06,
chr17:43063984:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr13:32379315:AC>A,,,,,,,,,,,,,,,Australian|-,,Greek,F,,,,,,,,splice_acceptor_variant,HIGH,,21/26,1,,,,,1&1,,
chr13:32363176:AT>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,17/26,1,,,,,,,
chr13:32340009:T>GCC,,,,,,,,,,,,,,,Iranian,1,Northern Iranian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339003:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-022),,1&1&0,8.237e-06,
chr17:43092918:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43115430:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32347534:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32326240:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr17:43092401:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western-European,M,1 - Not pathogenic or of no clinical significance,1.0,0.00398,0.0288,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,2.471e-05,
chr17:43094190:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092196:CTGGC>T,,,,,,1/1658|-|6/1658,,,,,,,,,Canadian|-|British|Norwegian|Spanish|Australian|Colombian,2|-,Latin American/Caribbean|NW European|Egyptian|Western European|-Native-American|-|Colombian|-Latin|-Russian|Unknown|Western-European|Western Europe|Central/Eastern-European|Caucasian|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32363524:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32332556:C>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-16),benign(0-007),,1,8.241e-06,
chr17:43104231:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern-European,M,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0-01),,,1,,
chr13:32376732:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/27,,1,,,,,1&1,,pathogenic
chr13:32326303:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|2.2252|0.7536,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,benign
chr17:43091905:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32337369:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-98),,,,
chr13:32392336:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43065363:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32326281:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,6/27,,1,,,,,1,,
chr13:32326257:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,6/27,,1,,,,,1,,pathogenic
chr13:32316564:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.249e-06,
chr17:43099410:AC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32329424:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,1.65e-05,
chr13:32394741:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-978),0&1,1&1,,
chr17:43100501:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr17:43082594:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,1,,
chr17:43044750:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32337071:C>G,,,,,,,,,,,,,,,,,French Canadian|Western European| Cajun,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-059),,1,3.295e-05,
chr13:32347834:A>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32370978:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,
chr13:32332552:C>T,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr13:32356333:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr13:32340993:C>T,,Invitae,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-258),,0&1&1,0.0001080755,
chr17:43095239:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32381438:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32367579:T>AGATGGCTTG,,,,,,,,,,0.5179,0.5333,0.536,0.5337,0.4673,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.517772,
chr13:32363240:TAT>G,,,,,,,,,,,,,,,Czech,,central Europe,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32370454:TTCCTGACCCTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr17:43091714:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32394454:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5427 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43074639:A>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32360294:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0461,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0123802,benign
chr17:43116191:C>CTT,,,,,,,,,,0.0268,0.0,0.0115,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00758786,
chr17:43096147:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337440:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-051),,1,,
chr17:43063232:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,
chr13:32356583:TC>G,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43057020:G>C,,,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr17:43094145:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32322891:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43094059:A>C,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319249:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43091770:TGA>T,,,,,,,,,,,,,,,,,Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094855:A>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326145:AGTCA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340475:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-325),,1,,
chr17:43089551:A>TC,,,,,,,,,,0.341,0.1566,0.3516,0.3413,0.4734,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.319688,
chr13:32332442:G>C,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,-|Asian,,Not Specified|-|Asian|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-869),,1&1,0.000328351,
chr13:32381332:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000399361,
chr13:32331015:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43092770:T>A,,,,,,,,,,,,,,,-|Central/Eastern Europe,,-|Ashkenazi,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43087898:TG>A,,,,,,,,,,0.2048,0.118,0.2594,0.0952,0.3497,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.195687,
chr13:32398760:A>C,,,,,,,,0.0116|0.0|0.0077,benign:0.421,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32340993:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067607:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,,,-|Asian,IVS,5 - Definitely pathogenic,1.0,1.22,160.57,1.0,,0.97,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43093320:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43095924:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,8.237e-06,
chr17:43115745:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43076602:A>C,,,,,,,,,,,,,,,,,None-Specified,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,
chr13:32387052:G>GC,,,,,,,,,,0.999,0.9138,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.976637,
chr17:43092083:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32379993:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32398546:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.000199681,
chr13:32344632:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-13),benign(0-065),,1,,
chr17:43067607:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-|as variant control,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,1/1658|-,,,,,,,,,Western European|-,,-|Asian|None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43115745:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.99,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32341269:T>A,,,,,,,,,,,,,,,,,Africa,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr13:32346849:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,,benign
chr13:32344632:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-08),benign(0-036),,1,,
chr17:43094026:AGCCT>A,,,,,,,,,,,,,,,,,Pakistani,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32396252:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr17:43091479:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32333969:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32379863:TAGGATGGT>G,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,1,,,,,,,
chr17:43116451:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0582,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0159744,benign
chr17:43082568:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,8.236e-06,
chr13:32332634:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,,pathogenic
chr13:32379768:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,probably-damaging:0.972,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43045738:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,
chr13:32341739:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00159744,
chr17:43097246:G>A,,Emory_Genetics_Laboratory|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Counsyl|Invitae|_University_of_Chicago|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1744|0.0227|0.123,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,0&0&1&1,1&1&1&1,,benign
chr17:43092526:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32339525:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.1594|0.054,benign:0.031,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-044),,1,,
chr17:43111261:C>A,,,,,,,,,,0.001,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00119808,
chr17:43094236:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332649:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.242e-06,
chr17:43047661:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr13:32398764:A>C,,,,,,,,,,,,,,,,,,Syn,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332441:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,8.238e-06,
chr17:43092000:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43092304:GC>C,,,,,,,,,,,,,,,Czech,,central Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336927:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-037),,1,,benign
chr13:32338870:CTTCCAGGGAC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-037),,1,,pathogenic
chr13:32339526:T>C,,Ambry_Genetics|Invitae|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,, Philipines|-|Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-073),,1&1&1,,
chr17:43071137:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1&1,,
chr17:43070924:C>A,,,,,,,,,,,,,,,,,Western-European|Central/Eastern-European|Central/Eastern Europe,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,8.236e-06,
chr13:32340796:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-066),,1,,
chr13:32357771:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasian,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32340072:TTG>A,,,Unknown|Germline (inherited),,,-|6/1658,,,,,,,,,German|HKSAR|-|Not Specified|Western Europe|Czech,-| -,Latin American/Caribbean|White-NonHispanic|Central/Eastern Europe|Not Specified|Western European|Chinese |-|British| India| Italian|German|Ashkenazi|Western Europe|Asian|Caucasian|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049120:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32357785:G>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,8.236e-06,
chr13:32325430:A>C,,,,,,,,,,0.2584,0.2088,0.2378,0.369,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.263179,
chr13:32336277:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-11),1&1,1&1,,
chr17:43091910:G>CT,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1&1,1&1,,
chr17:43061308:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43113262:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32336530:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337682:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32319153:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43057132:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-01),benign(0-159),0&1&1,1&1&1,,
chr13:32380107:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32398212:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,1.647e-05,
chr17:43090985:A>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,,
chr17:43045720:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr17:43091950:T>A,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,
chr17:43094467:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045759:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|Norwegian,,Caucasian,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr13:32363549:C>G,,GeneDx|Invitae,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,4.119e-05,benign
chr13:32336609:GACT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,pathogenic
chr17:43104137:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,0.0001163155,
chr17:43064344:GG>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32325307:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32344534:TCT>C,,,,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,2.483e-05,
chr17:43076492:T>A,,,,,,,,,,,,,,,,,Not Specified,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr17:43094731:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43091847:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43045759:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),strong functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,"""""Asian| Thai""""",M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-996),,1&1,,
chr13:32377586:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32337433:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.648e-05,
chr13:32337841:AA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326283:C>T,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/26,1,,,,,1&1&1&1,,
chr13:32376866:T>G,,,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,
chr17:43093631:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340982:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,0&1,8.237e-06,
chr13:32332518:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.3864|0.1308,possibly-damaging:0.483,0.0,0.0083,0.0014,0.0,0.0,Latin American/Caribbean|-,,Latin American/Caribbean|Central/Eastern European|-|None Specified|African|Native American,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-005),,1,0.001391685,
chr13:32357820:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-04),,,1,,
chr13:32379862:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr13:32329410:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.255e-06,
chr13:32398733:C>G,,,,,,,,,,,,,,,Western Europe,,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32398427:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326283:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),-|as variant control,mRNA analysis (RT-PCR)|-,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/26,1,,,,,1&1&1&1,,
chr13:32357820:C>T,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-996),,1,,
chr13:32344622:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,,,benign
chr17:43068074:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43093328:CT>G,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32316465:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,
chr13:32316609:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,1/1658,,,,0.002,0.0,0.0029,0.0,0.001,Austria,1|0,,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,0.000998403,
chr17:43061911:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32337816:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-193),,,,
chr17:43107226:G>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr13:32340686:AA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr17:43070174:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000599042,
chr13:32320015:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32332439:A>T,,,,,,,,,,,,,,,-|Central/Eastern Europe,,"Not Specified|Western European|""""Western European|-| Ashkenazi""""",N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,
chr13:32369645:G>T,,,,,,,,,,0.0348,0.0295,0.0922,0.0962,0.136,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0734824,
chr13:32326300:A>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0,0.0,0.006,0.0,,,Asia,IVS,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,0.00076379,
chr17:43045748:CC>C,,,,,,,,,,,,,,,,394,,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1&1&1,,
chr13:32337515:GATA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1&1&1,,pathogenic
chr13:32332879:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-027),,1,,
chr17:43045711:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr13:32340096:T>C,,,,,,,,,,,,,,,,,African American|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-124),,1,1.647e-05,
chr17:43092717:CAA>TC,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43101650:A>C,,,,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.0155751,
chr13:32316434:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32357816:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,
chr17:43092413:TTGGC>TTC,,,,,,,,,,,,,,,Austria,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32346898:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,13/26,1,,,,,,,
chr13:32337304:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32339863:C>G,,,,,,,,,,,,,,,,,Western European| Italian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-196),,1,,
chr13:32338749:GAAAAA>A,,,,,,2/1658,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43073822:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2175 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2239,0.3761,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.354832,benign
chr13:32358191:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43045642:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43092277:T>CT,,,,,,,,,,,,,,,Western Europe|Italian,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32364208:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32326497:AC>A,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&0,,
chr13:32362645:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-998),,1,,
chr17:43070978:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-145),,1&1,,
chr17:43113603:G>A,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr13:32339839:AA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340194:A>T,,,,,,,,,,,,,,,,,Western European|Central/Eastern European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,2.471e-05,
chr13:32396909:ACTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,,pathogenic
chr13:32338826:CTGA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,,pathogenic
chr13:32352214:AC>A,,,,,,,,,,0.0,0.0091,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00259585,
chr13:32326127:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,8.24e-06,
chr17:43107032:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32379834:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0582|0.0227|0.0462,possibly-damaging:0.875,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32337410:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral| no LOH|-|?, LOH assay|HR assay|-|Multifactorial likelihood-ratio model|?,,,,,0.001,0.0,0.0,0.0,0.0,Not Specified|-,,"Western Europe/Native American|Central/Eastern European| Central/Eastern European""""|Western European|-|""""Ashkenazi|Western Europe|None Specified",M,1 - Not pathogenic or of no clinical significance,0.00066,3.46737,0.00015,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1&1,0.0001822405,
chr13:32362645:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:0.979,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-994),,1,,
chr17:43064861:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32390929:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32380155:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32339627:AAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr17:43091770:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1,1,,pathogenic
chr13:32370955:G>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/26,1,,,,,1&1&0,,pathogenic
chr17:43092050:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32384048:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32359870:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43092352:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32379718:ATCTCG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,2.472e-05,
chr17:43119838:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32370968:CT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr17:43094023:TTTAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr17:43082561:C>G,,,,,,,,0.0|0.0227|0.0077,probably-damaging:0.965|probably-damaging:0.965|probably-damaging:0.965|probably-damaging:0.965|probably-damaging:0.965,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr13:32325430:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1646 (African)| 0.2718 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32329442:T>A,,,In vitro (cloned)|Unknown,-|as variant control,mRNA analysis (RT-PCR)|-,2/1658|-,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,7/26,1,,,,,1&1,,
chr17:43072716:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00179712,
chr17:43099857:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0-04),benign(0-001),,,,
chr13:32354920:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),probably_damaging(0-963),,1&1,,
chr17:43094868:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,co-occurrence with deleterious variant|-,,,,,0.0,0.0,0.0,0.001,0.0,,,Asian,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,0.0001453505,
chr13:32340922:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32338769:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32338072:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32353104:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32394783:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,,,,1,8.236e-06,
chr17:43092198:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,,,,1,,pathogenic
chr13:32370338:C>G,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,Africa,IVS,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,
chr17:43093670:CTTCCTAATTTCTCTTCTCCTCCCTGGGGGCCGC>G,,,,,,,,,,,,,,,Italian,,,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32336586:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-036),,1,,
chr13:32338971:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43125245:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.452e-05,
chr13:32339290:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43124044:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|-|as variant control|as wildtype control|impact on protein function|?|weak binding,protein binding ability BARD1|E3 Ub-ligase activity assay|peptide binding ability BRCA1/RING-BARD1|E3 Ub-ligase activity assay BRCA1/RING-BARD1|Homology directed recombination|-|evolutionary conservation analysis|Multifactorial likelihood-ratio model|Co-segregation in families|?,,,,,,,,,,,2|-,,M,4 - Likely pathogenic,1.0,1.23,25.7,0.984,0.66,0.66,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr13:32376713:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr13:32326487:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,8.236e-06,
chr13:32362560:AT>A,,,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32367964:G>T,,,,,,,,,,0.0179,0.0,0.0101,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00579073,
chr17:43045789:CATCTGCC>-,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32336586:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43106469:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr13:32344575:AGAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43094409:CC>T,,,,,,,,,,,,,,,,1|2|-,Unknown/German?|Luxemburg|-|Central/Eastern European|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32340024:T>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-004),,1,,
chr13:32340151:TA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-004),,1,,pathogenic
chr13:32340796:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,Western European|Western/Central/Eastern Europe|-,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001080805,
chr13:32316502:C>TTTA,,,,,,,,,,,,,,,,,,IFI,,,,,,,,inframe_insertion,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32320306:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32341228:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,1.652e-05,
chr13:32339969:A>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32355166:T>G,,,,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-15),benign(0-027),,1,,
chr17:43082387:G>C,,,,,,,,,,,,,,,American,,,IVS,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,3.295e-05,
chr13:32327752:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr13:32340146:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32339302:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32355094:T>G,,,,,,,,,,,,,,,,,White-NonHispanic|-,N,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,
chr13:32340301:TGGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr13:32332701:AT>T,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43092133:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr17:43094514:TA>C,,,,,,,,,,,,,,,Czech|-|Hong Kong,,Chinese |-|caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32336214:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,3.6389|1.9152|3.0556,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32336446:AA>A,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32337283:CAATCACAGCTC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32355195:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32321244:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43104147:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43054846:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32370583:TTATAGGATAAGAAAATGGGGTTGTTTTTATTTTTTGAGATGTGCATATGATTAC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.237e-06,
chr13:32319271:TA>C,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant&stop_lost,HIGH,3/27,,1,,,,,1,,
chr13:32339041:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0698|0.0|0.0461,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32329509:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr13:32364821:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43092133:A>C,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32338072:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-517),,1&1&1,,
chr13:32336267:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-205),,1,,
chr13:32394887:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-205),,1,,pathogenic
chr17:43081018:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32339928:AAACT>C,,,,,,2/1658|-,,,,,,,,,Not Specified|Western Europe/Native American|-|Western Europe,," Native American""""|Central/Eastern European| Central/Eastern Europe|Not Specified|Western European|-|Japanese|Native American|Western Europe|""""Western European|Caucasian|None Specified|Near East/Mid East",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,3.295e-05,
chr13:32398189:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr17:43093389:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr17:43051139:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0001039585,
chr17:43091951:->A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr17:43091497:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.237e-06,
chr13:32339519:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32339293:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43123979:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr17:43114931:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32358004:A>T,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43092852:ATAGT>C,,,,,,,,,,,,,,,,,ENGLISH,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43106535:A>C,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1,,
chr13:32398411:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr17:43091429:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32333341:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-05),benign(0-045),,1,,
chr13:32338069:GT>G,,,,,,,,,,,,,,,,," Central/Eastern Europe|Western European| Latin American/Caribbean""""|-|Unknown|None Specified|""""Western European",F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,,
chr17:43051137:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0002326255,
chr17:43063927:AT>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr13:32362523:->AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr13:32374256:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43090966:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32337923:AA>C,,,,,,,,,,,,,,,,,Filipino,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093800:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr17:43092179:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340887:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-048),,,,
chr13:32371028:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-048),,,,pathogenic
chr13:32340092:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-037),,1,,
chr17:43092522:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-037),,1,,pathogenic
chr13:32357742:C>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43080372:CCCCCCCAACCCCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTCCAACCCCCTC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,
chr13:32333293:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43051119:TGG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43107539:A>T,,,,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00199681,
chr13:32319094:TCA>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr13:32341162:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43094708:A>T,,,In vitro (cloned)|Unknown,inconclusive|-,-|evolutionary conservation analysis,,,,,0.0,0.0,0.0,0.0,0.002,-|Indian|Malaysian|Mid East/Near East,,Indian|Malayi-(Keralite)|-|None Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,0.0005332305,
chr13:32340887:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),possibly_damaging(0-862),,,,
chr13:32393672:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32316415:A>C,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32379503:G>A,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|GeneDx|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,1&0&1,1&1&1,,
chr17:43117895:A>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43091683:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43098939:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32354979:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-64),benign(0-164),,1,8.237e-06,
chr13:32333343:A>T,,,,,,,,,,,,,,,,,Western/Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),possibly_damaging(0-549),,1,1.652e-05,
chr13:32380152:C>T,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,,
chr17:43082423:TTCTGGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,,pathogenic
chr13:32336191:A>C,,,,,,-|98/1658,,,,0.1948,0.2307,0.2147,0.0804,0.1462,,,,IVS,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.174521,
chr13:32338538:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-607),,1,,
chr17:43068192:TGGTGAAACCCCGTCTCTACGAAA>G,,,,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr17:43093112:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43092201:CTT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43051062:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,,,Western European|-,IVS,,,,,,,,splice_donor_variant,HIGH,,19/21,-1,,,,,1&1&1&1&1,8.236e-06,pathogenic
chr13:32337684:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-997),,,8.238e-06,
chr13:32338361:T>TA,,,,,,,,,,,,,,,Brazilian,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32337614:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-049),,,8.24e-06,
chr17:43079387:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,3.428e-05,
chr17:43094245:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32325331:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06728 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32337222:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-005),0&1&1,0&1&1,8.237e-06,
chr13:32337043:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43063931:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,,,,1&1,1.647e-05,
chr13:32337452:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-999),0&1&1,0&1&1,8.238e-06,
chr13:32389346:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43047642:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,,,African American|-|Caucasian|African,IVS,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1&1,,pathogenic
chr13:32326089:GTTT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1&1,,
chr17:43063788:CC>C,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,0.0,0.0946,0.0014,0.0,0.0,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,0.0251597,
chr17:43095966:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.241e-06,
chr13:32339151:A>G,,,,,,,,0.0|0.0227|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-061),,,,
chr17:43104860:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,," Latin American/Caribbean""""|-|Latin-American/Caribbean|""""African|African|-Hispanic/Mexic|None-Specified|None Specified",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1,0.0001698405,
chr17:43092120:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32326586:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32332457:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),possibly_damaging(0-851),,1&1,,
chr13:32340783:C>T,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.787,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-117),,1&1&1,,
chr13:32396937:ATGCATATACTGCA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-117),,1&1&1,,pathogenic
chr13:32319282:C>T,,Ambry_Genetics|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1&1,,benign
chr13:32366208:T>A,,,,,,,,,,0.5169,0.534,0.5375,0.5337,0.4673,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.517971,
chr13:32379783:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,,,pathogenic
chr17:43071154:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1,,
chr13:32326085:TAAAGG>C,,,In vitro (cloned)|Unknown,predicted deleterious|-,mRNA analysis (RT-PCR)|-,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr17:43093112:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western Europe/Venezuela,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32328791:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43092133:G>C,,,Germline (inherited),,,2/238 patients,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32370560:T>G,,,Germline (inherited),,,,FA FANCD1_00036,,,,,,,,,,None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1&1&0,,
chr13:32326519:A>T,,,,,,6/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32379897:C>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,-|Italian,,Western European|Caucasian,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,1.648e-05,
chr17:43104101:CAG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,5.765e-05,
chr17:43094720:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093525:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338837:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-067),,,8.237e-06,
chr13:32332743:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-056),,1&1&1,,
chr17:43093433:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43092792:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43052265:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000599042,
chr17:43049147:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,benign(0-046),0&1&1,0&1&1,8.236e-06,
chr17:43099811:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,8.236e-06,
chr17:43091561:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43057114:CTC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32347399:T>G,,,,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0738818,
chr13:32337924:A>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-068),,1,,
chr13:32338208:GAAA>G,,,,,,,,0.0246|0.0716|0.0406,None,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32337406:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43065497:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32394694:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32332743:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32337406:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&1&1,1&1&1&1,,benign
chr17:43095847:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr17:43127517:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43094022:CC>C,,,,,,,,,,,,,,,Western Europe,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32397803:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32398745:T>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32394694:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-14),benign(0-057),,1,,
chr13:32346822:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,12/26,1,,,,,1,,
chr13:32370940:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.236e-06,
chr13:32340473:C>T,,,,,,,,,,,,,,,,,African,M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32319282:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_retained_variant,LOW,3/27,,1,,,,,1&1,,
chr17:43039980:G>C,,,,,,,,,,,,,,,,,,3'UTR,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32350817:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32399152:T>G,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0031,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00219649,
chr13:32339409:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43047698:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/22,,-1,,,,,1,,benign
chr13:32376796:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr17:43047635:A>T,,,,,,,,,,,,,,,,,Not Specified|None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,1&1,1.647e-05,
chr17:43052883:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1678 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43094401:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094872:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340031:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.00813,
chr13:32376796:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,
chr17:43074406:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000074,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-,-|Multifactorial likelihood-ratio model|Transcription activation in human cells|evolutionary conservation analysis,1/1658|-,,0.0233|0.4993|0.1845,benign:0.102|benign:0.102|benign:0.102|benign:0.102|benign:0.102,0.001,0.0038,0.0029,0.0,0.0,Italian|-|Brazilian,,Latin American/Caribbean|Not Specified|Western European|-|Caucasian|African|None-Specified|None Specified,M,1 - Not pathogenic or of no clinical significance,0.0086,4.02,,0.0001,0.02,0.02,missense_variant,MODERATE,,,-1,,,,,1&1,0.00105407,
chr13:32377459:T>C,,,,,,,,,,0.2734,0.2723,0.2464,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.20627,
chr13:32338764:TGATT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32380060:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.236e-06,
chr13:32360774:T>A,,,,,,,,,,0.2087,0.2073,0.1988,0.369,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.232628,
chr17:43056991:C>GGAAGTGGAATAC,,,,,,,,,,,,,,,American|Belgian|-|Scottish,1|2|-,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr17:43091767:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32371235:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,
chr13:32363300:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-52),benign(0-384),,1,8.236e-06,
chr13:32398462:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091715:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32327927:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32332447:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43061739:G>A,,,,,,,,,,0.0,0.0008,0.0014,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr17:43092918:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr13:32358950:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000798722,
chr13:32332267:A>AT,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,9/26,1,,,,,,,
chr17:43082362:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,2.471e-05,
chr13:32340883:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32340426:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-011),,1&1&1,8.237e-06,
chr17:43094059:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339820:A>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-921),,1,,
chr13:32346829:GC>A,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,13/27,,1,,,,,,,
chr13:32337336:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-253),,1,8.237e-06,
chr17:43058278:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43076611:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1,,
chr17:43079443:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.497e-06,
chr13:32340917:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43065363:C>G,,,,,,,,,,0.0,0.0582,0.0101,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0169728,
chr13:32346577:A>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00139776,
chr13:32340247:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-043),,,8.237e-06,
chr13:32326577:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32325155:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,4/27,,1,,,,,1&1,,pathogenic
chr17:43094758:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43057074:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-091),,1,,
chr13:32338827:TGAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-091),,1,,pathogenic
chr13:32380135:A>GA,,,,,,,,,,,,,,,German|Danish|-,,Latin American/Caribbean|Central/Eastern European|Western European|African American|African|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32333253:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-946),,,8.237e-06,
chr17:43092968:T>GGC,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43088950:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43093689:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43067763:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2175 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,-|?,-|?,-|10/1658,,,,0.3598,0.2224,0.3746,0.372,0.4959,Austria|-|American,1|0|2|-|412,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,0.354633,benign
chr13:32398589:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32355311:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,2.472e-05,
chr17:43093704:ATAT>GTTC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32339420:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-388),,0&1,8.244e-06,
chr17:43093472:C>A,,,,,,,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32337053:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-63),,,1,4.118e-05,
chr17:43071262:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,
chr17:43099836:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,0&1,8.236e-06,
chr13:32331561:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000399361,
chr17:43071205:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32379893:T>AC,,,,,,,,,,,,,,,,,White-NonHispanic,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1&0&1,,
chr17:43091007:TGG>A,,,,,,,,,,,,,,,,3|-,-|None-Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43072014:AG>A,,,,,,,,,,0.003,0.0008,0.0029,0.0744,0.0072,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0175719,
chr13:32338518:CT>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43082548:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,,
chr13:32398808:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001204555,
chr17:43107576:T>A,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000798722,
chr17:43092059:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43115729:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr17:43088898:C>G,,,,,,,,,,0.0596,0.003,0.0461,0.0,0.0133,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0217652,
chr13:32356456:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European| Black Dutch,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr13:32316461:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,,,pathogenic
chr13:32341108:GAG>T,,,,,,,,,,,,,,,,,Western European|-|None Specified| Native American,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32362062:G>A,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00119808,
chr17:43063881:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32356428:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/27,,1,,deleterious(0-04),benign(0-226),,1,,
chr13:32326116:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,1,,
chr13:32357815:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(1),benign(0-015),,1,,
chr13:32332285:A>G,,Ambry_Genetics,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.239e-06,benign
chr13:32328257:G>C,,,,,,,,,,0.2744,0.1641,0.232,0.3681,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.253594,
chr17:43094261:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43101729:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43084762:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0256,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00499201,
chr17:43092596:TG>G,,,,,,,,,,,,,,,,2|-,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43112129:C>A,,,,,,,,,,0.3519,0.1566,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.334465,
chr13:32338811:GTTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43091057:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.245e-06,
chr13:32354904:G>C,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),,0&1&1,1&1&1,,
chr13:32354904:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-05),possibly_damaging(0-586),0&1&1,1&1&1,,
chr13:32333333:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43092849:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,
chr17:43124030:CT>-,,GeneReviews|_NHGRI|Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43063937:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr13:32344344:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00658946,benign
chr17:43094239:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094737:GAAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32316486:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,
chr13:32371690:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32381652:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0144,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00399361,benign
chr13:32325710:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32326124:A>G,,Ambry_Genetics,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1&1,,
chr17:43094683:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43110084:G>T,,,,,,,,,,0.0,0.0454,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0125799,
chr13:32338669:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,benign
chr13:32398618:C>G,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093050:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr17:43071092:ATCCATCTCCCTGTGA>C,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Non-Caucasian,IFD,,,,,,,,protein_altering_variant,MODERATE,15/23,,-1,,,,,,4.118e-05,
chr13:32339707:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/23,,-1,,,,,,,pathogenic
chr13:32340080:CATG>G,,,,,,,,,,,,,,,,,,IFD,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr13:32337279:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-067),,1,,
chr13:32332710:T>C,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-57),benign(0-01),,1,0.0001039595,
chr13:32370449:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,,,
chr17:43108565:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr13:32362728:C>T,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,
chr17:43049192:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32316486:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr17:43092039:GGCGTGAACACC>A,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,1/238 patients|-|1/1658,,,,,,,,,French?|Portugese|Central/Eastern Europe|German|Spanish|-|French|Austria|Dutch|Western Europe|Italian,1|-,"""""Native American|Central/Eastern European| Central/Eastern European""""|German|Western European|-|Caucasian|-Central/Eastern-Europe|German/Irish/Welsh|Unknown|Western-European|Western Europe|Central/Eastern-European|None-Specified|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32351962:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32337409:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32339183:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,benign:0.019,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-089),,1,,
chr13:32355061:CCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-089),,1,,pathogenic
chr17:43094569:G>T,,,,,,,,,,,,,,,Western Europe|-|Austria,1|-, Austrian|Greek|Not Specified|Western European|Non Jewish|-|French/Greek|Western-European|French-Canadian|-Italian|French Canadian|Austrian|Western Europe|None-Specified,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,8.236e-06,
chr17:43063881:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-991),,1&1&1,,
chr13:32329298:C>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr17:43094652:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32319116:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32329767:C>A,,,,,,,,,,0.0,0.0083,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00239617,
chr13:32332668:->TTAG,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr17:43063881:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-991),,1&1&1,,
chr13:32339601:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-043),,,8.238e-06,
chr17:43094736:GTAAT>GGAAC,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,0.0002224,
chr17:43092322:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337954:GT>-,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43093229:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337738:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32354916:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,,0.0001039585,
chr13:32340985:TCGTG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093636:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,Western Europe/Native American/Central-E,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063368:A>C,,,In vitro (cloned)|Unknown,no functional effect|predicted neutral|-|inconclusive|as wildtype control|?,Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Proteolytic degradation|?,,,,,0.0,0.0,0.0014,0.0,0.0,Western Europe|-|Dutch?,,"Latin American/Caribbean| Central/Eastern European""""|Western European|-Native-American|-|American| Mexican""""|Western-European|Western Europe|""""Latin American/Caribbean|""""Western European",M,1 - Not pathogenic or of no clinical significance,1e-05,3.09,5.89e-07,0.0,0.03,0.03,missense_variant,MODERATE,18/23,,-1,,deleterious(0-03),possibly_damaging(0-876),,1,0.0001451405,
chr13:32326289:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,1,,
chr17:43077258:C>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000998403,
chr13:32375180:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000599042,
chr17:43090744:G>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr17:43094772:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr17:43049202:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,1,,
chr17:43106477:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,,,,,,,,,,Not Specified|-|US,, Native American|Western European|-|African|Western-European|Western Europe|Central/Eastern-European|None-Specified|None Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr13:32355223:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-11),,,,,
chr13:32316007:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32332965:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-898),,1,0.011,
chr13:32379765:T>A,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,Korean|-,,Asian|African,N,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,
chr17:43092808:GGAGG>T,,,,,,,,,,,,,,,,,Western European|Polish/Ukranian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32331082:TT>ATTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0001171,
chr13:32318332:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43094174:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32348805:T>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000998403,
chr17:43067280:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43124069:CTTCAACGC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr17:43118338:G>C,,,,,,,,,,0.0,0.0582,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0159744,
chr13:32384686:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01923 (Asian)| 0.04268 (African)| 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32337456:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,,0.0001039595,
chr17:43094239:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,,,pathogenic
chr13:32340210:GT>T,,,,,,,,,,,,,,,,,Western Europe/Native American,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340480:A>C,,Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Not Specified|-,,"-| African""""|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-006),0&1&1,1&1&1,,
chr13:32346845:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-57),,1,,
chr13:32340480:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,0.0|0.0681|0.0231,benign:0.003,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-311),0&1&1,1&1&1,2.471e-05,
chr17:43091466:ATTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-311),0&1&1,1&1&1,,pathogenic
chr17:43054639:C>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000599042,
chr17:43093967:A>T,,,In vitro (cloned),predicted deleterious|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Ashkenazi,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43063371:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/23,,-1,,,,,0&1,8.237e-06,
chr13:32339907:T>G,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,benign:0.065,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-454),,1,,
chr13:32339228:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-45),benign(0-06),,1,,
chr13:32395344:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr17:43094486:G>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,
chr17:43111549:A>C,,,,,,,,,,0.3539,0.2345,0.3746,0.372,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.357029,
chr13:32326116:G>T,,,,,,,,,,,,,,,African American,,,M,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32316420:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,MODIFIER,,,1,,,,,,,
chr17:43045789:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-053),,1,8.236e-06,
chr13:32363167:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,,benign
chr17:43092275:G>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43110248:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32336319:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000686,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,0.1047|0.0227|0.0769,possibly-damaging:0.561,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,0&1,1&1,,
chr13:32333036:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-034),,1,,
chr13:32332519:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32399642:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43095851:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43124112:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,1.647e-05,
chr17:43047699:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000374,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,benign:0.233|None|benign:0.233|benign:0.233|benign:0.233,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,,benign(0-077),,1&1,,
chr17:43094562:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32363327:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-03),benign(0-384),,1,1.647e-05,
chr13:32341192:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-108),,1,,
chr13:32332697:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,0&1,8.238e-06,
chr13:32363484:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-968),,1,,
chr13:32356463:C>T,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,Not Specified|HKSAR,,Chinese |-,N,,,,,,,,stop_gained,HIGH,15/27,,1,,,,,1&1,,
chr13:32337582:TAG>T,,,,,,,,,,,,,,,Norwegian,,Norwegian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32346824:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,12/26,1,,,,,,,
chr13:32340642:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-951),,1,1.647e-05,
chr13:32394669:ACTG>TCC,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr13:32319109:A>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,Near Eastern,N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,
chr13:32397558:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32323474:T>C,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32325066:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,,
chr17:43076579:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43063930:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-913),,1&1,,
chr13:32376974:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.09756 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2078,0.1384,0.196,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.212859,benign
chr17:43071034:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,8.236e-06,
chr13:32340703:AGA>C,,,,,,,,,,,,,,,Austria|-,1|-,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337872:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-132),,1,,
chr13:32351338:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02448 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43063930:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-996),,1&1,,
chr17:43069393:G>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32346781:AA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,9.935e-05,
chr13:32357885:GG>C,,,,,,,,,,,,,,,Western Europe|-,,,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,
chr13:32398377:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32341070:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43094425:G>TC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32321320:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr17:43063930:C>T,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-984),,1&1,,
chr13:32337299:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32326581:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1,,
chr13:32326218:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,8.238e-06,
chr13:32340810:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-048),,1,0.0003378,
chr17:43092320:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32356424:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Asian|None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,1,,
chr13:32340499:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32357888:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,1,,
chr17:43092184:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32341158:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.1589|0.0538,possibly-damaging:0.952,,,,,,,,Latin American/Caribbean|None Specified|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-716),0&1&1&1&1,1&1&1&1&1,5.766e-05,
chr13:32338460:T>C,,,,,,,,0.0|0.0227|0.0077,benign:0.012,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-036),,,,
chr13:32338485:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-936),,0&1,,
chr17:43091823:A>C,,CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0|0.0231,benign:0.031|None|None|benign:0.031|benign:0.031,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43096250:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32376759:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32333247:C>G,,,,,,,,,,,,,,,Western Europe|-,,Western European|-| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-971),,1,1.648e-05,
chr13:32337993:AGCATATGAAAGTTA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340595:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32356237:C>A,,,,,,,,,,0.0,0.0204,0.0029,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.00599042,
chr13:32379516:C>T,,,,,,,,,,,,,,,Western Europe|-,,Western Europe|-,IVS,5 - Definitely pathogenic,,1.17,12.02,0.998,,0.97,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,
chr13:32329199:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43092841:G>GGT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094735:TGT>C,,,,,,,,,,,,,,,Norwegian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43091662:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32341048:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338316:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.247e-06,
chr17:43052133:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32338316:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-373),,,8.247e-06,
chr13:32354953:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),probably_damaging(0-951),,,8.236e-06,
chr13:32369205:AAT>T,,,,,,,,,,0.1103,0.0076,0.0749,0.002,0.0184,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0385383,
chr13:32332961:G>C,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-663),,1&1,8.237e-06,
chr13:32370852:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.000599042,
chr17:43091715:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32356120:G>A,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000399361,
chr13:32362483:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|2.683|0.908,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,,
chr13:32363502:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43063867:G>C,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1,,
chr13:32316504:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,,,
chr17:43079287:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.592e-06,
chr13:32379401:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32380154:T>A,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr13:32367278:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr13:32358691:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32319060:AT>ATT,,,,,,,,2.5097|3.2474|2.759,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,1&0&1&0,,
chr17:43063374:AA>C,,,,,,,,,,,,,,,Not Specified|Western Europe|-,,Unknown|-|Western European|Western-European|Western Europe|None-Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,,,,
chr17:43104920:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.237e-06,
chr13:32339995:A>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0076,0.0014,0.0,0.0,Western Europe|-,," Native American| Central/Eastern Europe| Mexican""""|African|-|Western Europe|Africa|None Specified| Asian|Western European|African American|Native American/African American/Western|""""Latin American/Caribbean",M,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,0.001477145,
chr17:43067646:GG>A,,,,,,,,,,,,,,,,,Near-Eastern|-|-Iranian,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32356499:G>A,,Ambry_Genetics,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(1),benign(0-002),0&1&1,1&1&1,8.236e-06,
chr13:32338485:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-075),,0&1,8.237e-06,
chr13:32332666:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,German,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr13:32394941:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,,,
chr17:43047013:A>T,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00219649,
chr13:32393164:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00119808,
chr13:32319240:T>G,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.0|0.6809|0.2307,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1&1,,benign
chr17:43071637:G>C,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00119808,
chr17:43060389:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32346830:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43082424:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr17:43071071:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32355111:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr13:32398663:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,benign
chr17:43095937:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363492:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-998),,,,
chr13:32355036:GTCTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43057129:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-067),,1,,
chr17:43115730:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,None-Specified,M,5 - Definitely pathogenic,,,149.6,0.9984,0.81,0.81,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1&1,,
chr13:32397002:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,4.942e-05,
chr13:32363500:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43049715:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32339569:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32396912:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32394783:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,benign
chr17:43099856:CTA>G,,,,,,,,,,,,,,,Bulgaria,,Bulgarian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32329473:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43071000:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43115819:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,8.262e-06,
chr17:43048519:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.2 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr17:43049219:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,8.236e-06,
chr13:32398578:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32328485:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43105000:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,8.237e-06,
chr17:43104085:TC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.002231,
chr17:43093706:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32338099:TGAG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32339908:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32379893:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32356504:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-46),possibly_damaging(0-487),,1,,
chr17:43045691:T>TG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1,,
chr13:32370400:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/26,1,,,,,1,,pathogenic
chr13:32339043:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-001),,,,
chr17:43082418:G>T,,,,,,,,,,,,,,,,,English,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0-001),,1,,
chr17:43115730:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0-001),,1,,pathogenic
chr17:43093569:TT>C,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,1/238 patients|-|9/1658,,,,,,,,,Not Specified|-|Dutch?|Dutch|Russian|Western Europe,1|-,Slavic|Western European|-|Unknown|Western-European|Western Europe|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1,1,8.237e-06,
chr17:43094709:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,African,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094824:T>C,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43082601:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,1.647e-05,
chr17:43116988:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43090958:AGACT>T,,,,,,,,,,,,,,,,,German/Scot/Irish/Dutch,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43052542:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43093257:C>CA,,,,,,,,,,,,,,,Australian|-,,Maltese|Western Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091561:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094157:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43070208:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43094135:C>A,,,,,,,,,,,,,,,,,Western-European|Italy|None-Specified|None Specified,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43057051:CCCGAAGATCTCAGAGTCCCACTTG>C,,,,,,,,,,,,,,,Hong Kong,,Chinese,IFD,,,,,,,,stop_lost&inframe_deletion&splice_region_variant,HIGH,18/22,,-1,,,,,,,
chr17:43093268:G>A,,,,,,,,,,,,,,,Czech|-,,Western-European|Caucasian|caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43094686:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43106464:TA>-,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32330946:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43112307:A>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000399361,
chr13:32360467:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32364237:A>GT,,,,,,,,,,0.002,0.0371,0.0043,0.002,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0115815,
chr17:43091014:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,
chr17:43071116:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,,,,3.295e-05,
chr13:32388951:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32398458:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,benign
chr17:43093093:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338907:G>-,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093653:A>T,,,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,
chr17:43092723:CAA>A,,,,,,,,,,,,,,,Moroccan,,Berber,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339346:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-95),benign(0-03),,,,
chr13:32336617:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32396896:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093016:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43092200:C>A,,,,,,,,,,,,,,,Czech|-,,Western European|-|caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32370984:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-06),benign(0-064),,,,
chr13:32363356:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,,,,1,5.765e-05,
chr17:43063317:TGTGACAAGGTAGA>A,,,,,,,,,,,,,,,,,African,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,18/22,-1,,,,,,,
chr17:43092023:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32324497:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32317399:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43091916:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43079281:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32332255:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.249e-05,
chr13:32330974:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,,8.237e-06,
chr17:43093630:A>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394689:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43091814:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,5.765e-05,
chr17:43051927:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32338342:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-335),,,,
chr17:43094607:TGG>G,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339213:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43096493:AG>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr13:32363346:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-08),possibly_damaging(0-647),,,8.236e-06,
chr17:43094044:G>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,co-occurrence with deleterious variant|-|Grantham score|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,2/1658|-,,,,,,,,,Not Specified|-|French|German|Austria|Western Europe,1|-,"Western European| Polish""""|Caucasian|Central/Eastern Europe|Not Specified|Central/Eastern-European|Western/Central/Eastern Europe|-|-Central/Eastern-Europe|Native American| English|""""Western European|-English/French/| Central/Eastern European| German| Irish""""|Western-European|French Canadian/Ashkenazi| Asian""""|None Specified| Native American""""|Central/Eastern European| Central/Eastern European""""|Western Europe|""""Central/Eastern European|None-Specified",M,1 - Not pathogenic or of no clinical significance,,9.20E-05,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,0.0004695,
chr13:32336576:A>T,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,0&1&1,1&1&1,,
chr17:43092129:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32383461:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43106496:GA>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,0&1&1,1&1&1,,
chr17:43068271:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0008,0.0216,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00878594,benign
chr13:32332603:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr13:32338890:T>A,,,,,,,,,,,,,,,,,Not Specified|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-54),benign(0-172),0&0&0&1&1,1&1&1&1&1,,
chr17:43124146:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.75e-05,
chr17:43115730:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43079616:T>G,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000599042,
chr17:43106478:G>AT,,,,,,,,,,,,,,,Chilean,2,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1&1,,
chr13:32363326:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,
chr13:32340802:TTC>T,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43104260:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,6/23,,-1,,,,,1&1,,pathogenic
chr17:43057055:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,,,0&1,8.236e-06,
chr13:32398458:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,,,0&1,,
chr17:43092116:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43076488:ATC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,
chr13:32337691:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32363404:T>TC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,8.236e-06,
chr17:43091923:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000365,Division_of_Genomic_Diagnostics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|The_Children's_Hospital_of_Philadelphia|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,-|Spanish,,Western-European|Western European|-|Caucasian|None Specified,M,1 - Not pathogenic or of no clinical significance,0.00661,1.41,0.0195,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1&1,1&1&1&1,5.766e-05,
chr13:32388443:A>G,,,,,,,,,,0.005,0.0008,0.0014,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00319489,
chr17:43090920:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.123e-05,
chr13:32380114:TA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43119949:T>G,,,,,,,,,,0.0,0.0113,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00319489,
chr17:43090920:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.649e-05,
chr17:43103094:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2175 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.353235,benign
chr13:32337358:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338053:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),probably_damaging(0-975),,,1.647e-05,
chr17:43091990:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32357907:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.945,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,possibly_damaging(0-853),,1,,
chr17:43092875:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32337635:A>T,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43067581:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr17:43118008:C>G,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000798722,
chr17:43057153:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,
chr17:43099311:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32398126:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.247e-06,
chr13:32398763:AATGC>A,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43092192:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340467:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-003),,1,,
chr17:43045777:GC>A,,,,,,,,,,,,,,,German|-|Italian,,Western-European|Western European|Caucasian,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43063904:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-939),,1,,
chr17:43094498:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43125352:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,9.698e-05,
chr13:32379466:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,0&1&1,,benign
chr13:32338277:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,,FA FANCD1_00006|-,,,,,,,,Latin American/Caribbean|-,,Latin American/Caribbean| Puerto Rico|Western European|-| Italian|Native American|Puerto Rico|White|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,
chr17:43049118:AG>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant&intron_variant,HIGH,,20/21,-1,,,,,,,
chr17:43051068:G>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),possibly_damaging(0-507),,1,,
chr13:32355250:T>C,,Emory_Genetics_Laboratory,,,,,,0.0582|6.4714|2.2304,None,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0),,1&1,,benign
chr13:32380126:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr17:43082472:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32339634:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,2/1658,,,,,,,,,,,Not Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32333232:A>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32357878:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),,,,8.236e-06,
chr13:32379466:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),,,,,pathogenic
chr13:32332859:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-046),,1,,
chr13:32337543:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,,8.238e-06,
chr17:43077425:C>A,,,,,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.00159744,
chr13:32398678:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32355250:T>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09553 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43085569:C>A,,,,,,,,,,0.0,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000599042,
chr17:43085632:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32371231:C>TC,,,,,,,,,,0.001,0.0325,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00898562,
chr13:32333398:T>CT,,,In vitro (cloned)|Unknown|Germline (inherited),no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr13:32370443:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,,,,,8.236e-06,
chr13:32349428:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32383344:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43047640:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,1,,pathogenic
chr13:32382058:G>A,,,,,,,,,,0.0,0.0136,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00379393,
chr17:43070923:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,
chr13:32362235:T>A,,,,,,,,,,0.0089,0.0,0.0014,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00259585,
chr17:43099846:GT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32319297:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,
chr17:43070915:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,8.236e-06,
chr17:43077760:T>GT,,,,,,,,,,0.999,0.9992,1.0,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.999601,
chr13:32337453:A>T,,,,,,,,0.0|0.0455|0.0154,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-999),,,,
chr17:43047676:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),possibly_damaging(0-854),,1&1,,
chr13:32338254:TCACATT>T,,,,,,,,,,,,,,,,,Western Europe|None Specified,IFD,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,1,,
chr17:43111027:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2215 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43056991:C>GGTTGAATACTTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32340785:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-076),,,1.648e-05,
chr13:32340314:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32339846:T>AT,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094040:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333016:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000189,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,2/1658|-,,,,,,,,,American,,,M,1 - Not pathogenic or of no clinical significance,1.0,0.05129,0.18197,0.00019,0.02,0.02,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-146),,1&1,4.942e-05,
chr13:32354834:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43051112:T>G,,,,,,,,,,,,,,,Indian,2,Sindhi,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,,,,,,
chr17:43092242:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,,
chr13:32370604:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05488 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|4.4732|1.5226,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,
chr13:32323151:GAC>A,,,,,,,,,,0.3171,0.3782,0.3847,0.2063,0.3241,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.321685,
chr13:32332803:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,
chr17:43074513:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43092785:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43112722:A>T,,,,,,,,,,0.3628,0.7254,0.3991,0.37,0.5143,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.494609,
chr17:43092287:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43091904:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43067645:AGGCCAAGGGGC>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32380124:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model,,,,,0.0,0.0008,0.0014,0.0,0.001,Latin American/Caribbean|Western Europe|-,,"Latin American/Caribbean| Native American| Native American""""| Central/Eastern European""""|Not Specified|Western European|African|-|""""Latin American/Caribbean|""""African| Latin American| Haiti""""|African American|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,0.00417,0.158,2e-05,0.03,0.03,missense_variant,MODERATE,,,1,,,,,1&1,0.000447771,
chr13:32356602:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-967),,1,,
chr17:43081056:G>GA,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000798722,
chr13:32357749:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-001),1&1,1&1,8.236e-06,
chr13:32376940:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32354972:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr13:32337936:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000646,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-236),,1,,
chr13:32388666:C>CT,,,,,,,,,,0.6083,0.5424,0.536,0.3363,0.502,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.505391,
chr17:43094463:GC>C,,,,,,,,,,,,,,,,,Western-European|Western European|-Irish/Italian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32338450:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43110085:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32341011:ATCAAT>C,,,,,,,,,,,,,,,Polish,,Polish (Upper Silesia),F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094216:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43093570:T>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332926:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-4),benign(0-023),,,8.237e-06,
chr13:32354180:A>C,,,,,,,,,,0.999,0.9107,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.975839,
chr13:32363495:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,1.647e-05,
chr13:32317315:AAGT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.25 (Asian)| 0.13 (African)| 0.28 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,benign
chr13:32337773:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-038),,,,
chr17:43124078:->C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43081634:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43092202:TTTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr13:32339995:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.9305|0.3152,benign:0.167,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-205),,1&1,,
chr17:43091002:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43092877:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,pathogenic
chr17:43094195:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092927:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43063956:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,,8.237e-06,
chr13:32379269:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,8.238e-06,
chr13:32339336:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-54),benign(0-281),,1&1,,
chr13:32336944:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0681|0.0231,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-001),,1&1&1,,
chr13:32398624:C>G,,,,,,,,,,,,,,,-|Asian,,-|Asian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32329558:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr13:32329723:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr17:43070168:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32316451:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,2.471e-05,
chr13:32332310:TA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32341079:GA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43074829:G>A,,,,,,,,,,0.0,0.0023,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000798722,
chr13:32336295:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-126),,,,
chr13:32337447:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32344804:T>G,,,,,,,,,,0.1938,0.2738,0.2176,0.0794,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.185703,
chr13:32338034:TATAT>C,,,,,,,,,,,,,,,,,African,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332766:TAT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43092274:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,Austrian|-,2|-,Western-European|Not Specified|-|Austrian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43091093:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092274:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,Ashkenazi|-Central/Eastern-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,3.295e-05,
chr13:32343551:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43049067:C>T,,,,,,1/1658,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr17:43093798:C>T,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43051663:GTTTA>G,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00379393,
chr17:43117076:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32379128:T>A,,,,,,,,,,0.0,0.0318,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00858626,
chr17:43092274:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32394671:T>A,,,In vitro (cloned),as wildtype control,mRNA analysis (RT-PCR),,,,,,,,,,Not Specified,,,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,
chr17:43093202:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr17:43082453:C>A,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,0&1,1&1,,
chr13:32355160:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000234,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),,,1&1,,
chr17:43082453:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,-|501/1658,,,,0.3579,0.1596,0.3646,0.371,0.4969,Spanish|Chinese|German|U.S.A.|-|Malaysian|Malay|Greek|American|Scottish|Austria|Belgian?|Italian,14|-|1|0|2|4|412,Chinese|Malaysian|-|Malay|Greek|Indian|Spanish|Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,0&1,1&1,0.339631,
chr17:43092184:ATGG>A,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,2.471e-05,
chr13:32337430:GA>TT,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43044859:G>CGT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,7.426e-05,
chr17:43092849:TT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32376604:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,
chr13:32355160:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-62),possibly_damaging(0-487),,1&1,,
chr13:32348361:A>G,,,,,,,,,,0.001,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32338255:CACA>G,,,In vitro (cloned),predicted neutral|as wildtype control|as variant control,Survival assay with VC8 (after MMC treatment)|evolutionary conservation analysis|Centrosome amplification|Nuclear localisation|Homology-directed repair assay,,,,,,,,,,,,,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr17:43104902:A>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32316462:CA>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&start_lost,MODIFIER,,,1,,,,,,,
chr13:32355079:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,0&1,1.647e-05,
chr17:43095697:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr17:43093035:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,1.647e-05,
chr17:43098661:C>CT,,,,,,,,,,0.3549,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.352636,
chr13:32325177:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43067019:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32325177:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,
chr17:43090962:TCT>A,,,,,,,,,,,,,,,German|Czech|-|Dutch,1|-|4,caucasian|German|Western European|-|Caucasian|Near Eastern| Pakistani|None-Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,8.237e-06,
chr13:32363380:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,,,
chr17:43094878:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.291e-06,
chr13:32384449:T>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00139776,
chr13:32338126:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,3.295e-05,
chr13:32370530:T>C,,,In vitro (cloned)|Unknown,no splicing defect|-,-|splicing reporter minigene/patient RNA analysis,,,,,0.0,0.0545,0.0,0.0,0.0,,,,Syn,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,0.0090255,
chr17:43050965:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43081527:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32370530:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,,
chr17:43094113:G>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,"Western European| Native American""""|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,0.00324,0.0513,0.0,0.02,0.02,missense_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43093475:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338531:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32344415:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr13:32339369:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-16),,,3.297e-05,
chr13:32339459:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-03),,1,,
chr13:32339810:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000012,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.009,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-098),,1,,
chr17:43094281:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral|inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western-European|French Canadian|-Italian,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43049164:CCACA>TCACT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,,,,,pathogenic
chr13:32363440:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43109281:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43071031:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000495. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01399 (Asian)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|0.0227|0.0308,benign:0.094|benign:0.094|benign:0.094|benign:0.094|benign:0.094,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0),,1&1,,
chr17:43093202:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43058409:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43079297:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.6e-06,
chr13:32380014:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr13:32332922:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),possibly_damaging(0-751),0&0&0&1&1,1&1&1&1&1,,
chr13:32344892:A>T,,,,,,,,,,0.007,0.0008,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00219649,
chr17:43049131:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0-01),probably_damaging(0-97),,,,
chr17:43103754:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43110340:T>G,,,,,,,,,,0.001,0.0219,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00698882,
chr13:32339320:T>A,,,,,,,,,,,,,,,-|Spanish,,Caucasian|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,
chr17:43104072:CGAGCTATAGATTTCCTC>AAAG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.328,
chr17:43094812:TGA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,
chr17:43045057:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,6.656e-05,
chr17:43060507:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43093787:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32330904:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32358855:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0248,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00519169,
chr13:32363265:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43071077:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000309. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2195 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|?|predicted deleterious,Transcription activation in human cells|-|Allele frequency analysis in controls|?|Multifactorial likelihood-ratio model|evolutionary conservation analysis,-|516/1658,,32.6628|24.2624|29.817,possibly-damaging:0.459|possibly-damaging:0.459|possibly-damaging:0.459|possibly-damaging:0.459|possibly-damaging:0.459,0.3598,0.2254,0.3746,0.372,0.498,Chinese|German|Malaysian|Spanish|-|Malay|Greek|Austria|Indian|South-African|Austrian|American|Belgian?,14|-|1|0|2|4|412,Chinese|-|Malaysian|Malay|Greek|Indian|Afrikaner|Caucasian|European,M,1 - Not pathogenic or of no clinical significance,,<1e-10,,0.0,0.02,0.02,missense_variant,MODERATE,15/23,,-1,,tolerated(0-11),benign(0-077),0&0&0&0&1,1&1&1&1&1,0.3524155,
chr17:43071077:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Computational analysis|-|Transcription activation in human cells,,,,,,,,,,,," Brazil""""|-|""""Latin American/Caribbean|African",M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),possibly_damaging(0-701),0&0&0&0&1,1&1&1&1&1,6.589e-05,
chr13:32336293:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,Unknown|Germline (inherited),,,4/1658|-,,0.1512|0.0|0.1,None,0.001,0.0,0.0014,0.0,0.0,-|Dutch,,-|Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0006568305,benign
chr13:32340224:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-02),,1,8.237e-06,
chr17:43062629:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43049075:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,8.236e-06,
chr17:43099767:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,,1.647e-05,
chr13:32371106:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,
chr17:43050671:T>A,,,,,,,,,,0.3668,0.8979,0.3487,0.372,0.5317,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.53774,
chr17:43124031:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,,
chr13:32336293:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-108),,1,,benign
chr13:32362595:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1&1&0,,pathogenic
chr13:32339576:AGTAA>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32333398:TGA>CTTT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.058,
chr13:32333266:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|1.6341|0.5769,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr17:43104862:T>G,,,,,,,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,0.002,1.06,,0.001,,0.34,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,,2.471e-05,
chr13:32339175:TCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43092883:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32363270:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43051089:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,tolerated(0-23),benign(0-107),,1,7.413e-05,
chr17:43059077:C>A,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr17:43093530:A>TAGAAACAGTTAAAGTGTCTAATAA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32316510:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr17:43082547:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32326017:A>C,,,,,,,,,,,,,,,Spanish,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,
chr13:32337408:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-234),,1,,
chr17:43122761:T>A,,,,,,,,,,0.3579,0.2171,0.3775,0.372,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353634,
chr17:43121886:C>T,,,,,,,,,,0.004,0.0,0.0014,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00179712,
chr17:43093569:TTG>C,,,,,,,,,,,,,,,Western Europe/Latin American/Caribbean,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32341013:GAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32362658:T>C,,,,,,,,,,,,,,,Malaysian,,Malay,Syn,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,1,,
chr17:43101995:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43082475:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0),,,,
chr17:43095671:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43094396:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32380109:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,0.0001039585,
chr17:43104911:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,
chr17:43074498:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43091933:C>A,,,,,,4/1658|-,,,,,,,,,Not Specified|Western Europe|-,,"Near-Eastern| Welsh""""|Central/Eastern Europe| Irish|Not Specified|Western European|-|Irish/Scottish| Central/Eastern European""""| Scottish|Western-European|Western Europe|None Specified|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32332846:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,0&0&1&1,0&1&1&1,0.003138,
chr13:32336754:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-007),,1,,
chr17:43057098:CCC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,1,,
chr13:32337047:AGGAA>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,1,,pathogenic
chr13:32355381:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr13:32371023:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-34),possibly_damaging(0-513),,,,
chr17:43091924:G>C,,,,,,,,,,,,,,,P.R. China,1,Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32379456:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr17:43091924:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx|Invitae,Unknown|Germline (inherited),,,2/1658|-,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,Not Specified|-|British|Greek|Austria|spanish|Republic-of-Turkey,,"Latin American/Caribbean|Mexican|Central/Eastern European|Turkish|Not Specified|Western European|-|Caucasian|Greek|None-Specified|-Central/Eastern-Europe| Italian""""|English|Western-European|Western Europe|caucasian|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43061263:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43094704:T>C,,,In vitro (cloned),predicted neutral|predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,1.647e-05,
chr13:32393604:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32337657:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1,,
chr13:32390498:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43074861:G>T,,,,,,,,,,0.0,0.025,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00658946,
chr13:32339436:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-196),,1,8.244e-06,
chr17:43099800:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,8.236e-06,
chr13:32319070:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,benign
chr13:32363579:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,8.256e-06,
chr13:32355077:CG>A,,,,,,,,,,,,,,,,,Central/Eastern European|Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32352395:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000599042,
chr17:43057075:T>G,,,In vitro (cloned),predicted neutral|inconclusive|as variant control|?|strong functional effect,Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|Bayesian statistics|transcription activation/PS/BA/BS|Proteolytic degradation|?,,,,,,,,,,Danish|French,,-|black|Caucasian,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-276),,1&1,,
chr13:32339345:AT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-276),,1&1,,pathogenic
chr17:43093289:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32340100:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43091696:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43057028:T>C,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32325469:G>T,,,,,,,,,,0.0,0.0227,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00599042,
chr13:32329484:AT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,,
chr13:32363259:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43124327:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr17:43094788:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43057078:G>A,,Medical_University_Innsbruck|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43091477:A>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,4.118e-05,
chr17:43057073:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/22,,-1,,,,,1,,
chr13:32336526:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-57),benign(0-001),,1,,
chr17:43060788:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2866 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32332476:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),probably_damaging(0-964),,,8.237e-06,
chr17:43093764:G>T,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337758:G>C,,,,,,,,,,,,,,,Not Specified,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32339522:T>C,,,,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-596),,1,,
chr13:32339522:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-02),,1,1.649e-05,
chr17:43100596:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0979 (Asian)| 0.07927 (African)| 0.1557 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32341936:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000599042,
chr13:32319070:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|The_Children's_Hospital_of_Philadelphia|Counsyl|Invitae|Pathway_Genomics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1516|0.0229|0.1083,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/26,1,,,,0&0&0&1&1&1,1&1&1&1&1&1,,
chr13:32356491:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,,benign(0-355),,1,,
chr13:32338671:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-013),,1,,
chr13:32356491:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-23),benign(0-009),,1,,
chr17:43057108:TTCC>CGTT,,,In vitro (cloned),as wildtype control,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,,,,,,
chr13:32333385:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43079111:G>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43070947:G>T,,,In vitro (cloned),Moderate functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(1),,1,,
chr13:32336350:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.238e-06,
chr13:32348059:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43094011:T>A,,,In vitro (cloned),predicted deleterious|?,evolutionary conservation analysis|?,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32362553:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,,,
chr13:32332617:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-058),,,8.249e-06,
chr13:32363212:G>A,,Ambry_Genetics|Invitae,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32374299:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43093105:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,6.589e-05,
chr17:43079997:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43099835:AAG>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,,,
chr13:32338431:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32341050:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-917),,,,
chr17:43093529:A>GAAGAAAAAGAAGAGAAAC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43069632:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32332683:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-951),,1,,
chr17:43070636:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32336615:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-457),,1,,
chr17:43092596:T>A,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,-|Italian,,Western-European|Western European|Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,2.471e-05,
chr17:43113915:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32368365:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32386150:A>G,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr13:32333078:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-023),,1&1,0.0001163155,
chr17:43092849:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-023),,1&1,,pathogenic
chr13:32398784:C>T,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43070969:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32341167:TTCA>A,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43078088:GG>C,,,,,,,,,,0.3777,0.8767,0.4337,0.3879,0.5399,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.550919,
chr13:32398417:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43063903:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited), exon 18 skipping|very destabilizing|strong functional effect|inconclusive|ESE disruption/ESS creation|-|as variant control|predicted deleterious|Loss of wild type allele|as wildtype control|?,Clonogenic assay|Histopathology|Bayesian statistics|Loss of Heterozygosity|Grantham score|mRNA analysis (RT-PCR)|transcription activation/PS/BA/BS|Centrosome amplification|Multifactorial likelihood-ratio model|structure-based prediction (crystallography etc) BRCA1:BACH1|Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|-| lymphocyte RT-PCR|evolutionary conservation analysis|Recombination rate|Transcription activation in human cells|Structure-based prediction (crystallography etc)|Proteolytic degradation|Survival assay with HCC1937 (after MMS treatment)|co-immunoprecipitation BRCA1-ER|Oncogene expression|Nuclear localisation|?|Thermodynamic stability prediction|ESEfinder/ESRsearch,1/238 patients|-|3/1658,,,,,,,,,Latin American/Caribbean|Not Specified|-|Sweden|Spanish|Western Europe|Italian|Near East/Mid East,,"Latin American/Caribbean| Native American""""| Latin American/Caribbe|Not Specified|Western European|Latin-American/Caribbean|-|Caucasian|Western-European|Western Europe|None-Specified|None Specified|""""Western European",M,5 - Definitely pathogenic,1.0,12.59,1.66e+11,1.0,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(1),,1&1&1,2.471e-05,pathogenic
chr17:43058314:T>A,,,,,,,,,,0.003,0.1483,0.0187,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0423323,
chr17:43093449:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.4419|23.9555|29.5678,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,benign
chr17:43124169:C>TA,,,,,,,,,,,,,,,Malaysian,,Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43063369:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,,benign
chr13:32340575:G>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-|Multifactorial likelihood-ratio model,,,,,0.0,0.0098,0.0014,0.0,0.0,Not Specified|Western Europe/African American/Pakistan|African American|-,,Latin American/Caribbean| Native American|African American/Puerto Rico|Not Specified|-|Africa|African|African American|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,0.48978,0.00032,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-007),0&0&1&1,1&1&1&1,0.001859065,
chr17:43104242:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-007),0&0&1&1,1&1&1&1,,pathogenic
chr13:32363336:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-21),benign(0-045),,1,,
chr17:43046264:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32336924:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.238e-06,
chr13:32382609:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43063903:G>A,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,inconclusive|-|strong functional effect,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,-|1/1658,,0.0116|0.0454|0.0231,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,3 - Uncertain,0.227,1.05,,0.7498,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-963),,1&1&1,3.295e-05,
chr13:32333062:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43063369:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,8.237e-06,benign
chr13:32330887:A>G,,,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43104925:GA>G,,,,,,,,,,,,,,,Chinese,1,Han,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,
chr17:43104902:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43095845:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43080891:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43091017:GTC>C,,,,,,,,,,,,,,,,,Latin American/Caribbean,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32337164:GAG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093697:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340844:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,1.648e-05,
chr13:32339783:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,," Pakistan|Latin American/Caribbean| Central/Eastern European""""|Asian|African|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-077),0&1&1,1&1&1,0.0001080755,
chr13:32336735:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091961:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093855:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094272:T>C,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32326564:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,1,,pathogenic
chr17:43071030:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-002),,1,,
chr13:32364267:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32341164:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43061652:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43070979:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-05),benign(0-077),,1,,
chr13:32357855:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-23),possibly_damaging(0-637),,,,
chr17:43082412:T>GA,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/22,,-1,,,,,,,
chr13:32354905:T>G,,,In vitro (cloned)|Unknown,predicted neutral|-,Histopathology|-,,,,,0.0,0.0,0.0,0.004,0.0,Malaysian|-,,"Chinese|""""Asian| Phillipines""""|None Specified|Asian",M,2 - Likely not pathogenic or of little clinical significance,,,1.55,0.0274,0.02,0.02,missense_variant,MODERATE,14/27,,1,,,possibly_damaging(0-487),,1&1,0.000465261,
chr17:43091493:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,possibly_damaging(0-487),,1&1,,pathogenic
chr13:32371709:A>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000798722,
chr13:32328792:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32341197:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,11/26,1,,,,,1&0,8.242e-06,
chr13:32336718:GA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32382029:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43091980:GCCCA>CATC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32356648:C>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000373671,
chr17:43091638:GAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32336266:A>G,,,,,,,,,,,,,,,,1,,Syn,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32333409:T>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43049448:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04371 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0456,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00938498,benign
chr13:32363330:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-58),benign(0-009),,1,,
chr17:43093237:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091809:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32370491:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,0.0001977,
chr17:43045572:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338832:T>GA,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,0&1&1,1&1&1,,
chr17:43045572:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,0.0001452805,
chr13:32339058:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-067),,1,,
chr17:43091566:G>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43120948:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32368810:A>T,,,,,,,,,,0.9533,0.8926,0.9683,0.9782,0.955,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.944688,
chr17:43106539:A>C,,,In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,,,,,1&1,,
chr13:32325084:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,,,
chr13:32319325:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,3/27,,1,,,,,,,
chr17:43045572:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,8.262e-06,
chr17:43101929:TG>A,,,,,,,,,,0.0,0.0045,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00199681,
chr13:32346864:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,8.238e-06,benign
chr13:32355048:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-13),benign(0-02),,1,,
chr13:32340300:G>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-944),,1,,
chr13:32355048:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Italian,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-02),,1,8.236e-06,
chr17:43094189:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379792:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr13:32332574:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),probably_damaging(0-97),,1,8.246e-06,
chr13:32316519:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.237e-06,
chr13:32371101:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/26,1,,,,,1&1,,
chr13:32332534:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43118218:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08943 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr17:43074421:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,Western European|-| Ashkenazi,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,8.236e-06,
chr13:32370971:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Protein likelihood ratio model|-|?,,,0.0465|0.5901|0.2307,benign:0.012,0.0,0.0045,0.0014,0.0,0.0,Western European|African American|-,,"Latin American/Caribbean| Central/Eastern European""""| Latin American/Caribbean""""|Not Specified|Western European|-|Native American/African American|""""African|African| African|Western Europe|Asian|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-4),benign(0-125),0&0&1&1,1&1&1&1,0.00106128,benign
chr17:43082243:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43094694:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43093704:AT>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32339256:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32340321:T>A,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr13:32340441:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-272),,1&1,,
chr13:32337347:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-078),,,8.237e-06,
chr17:43063829:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr17:43091746:A>T,,,,,,,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43107810:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32380008:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,tolerated(1),,,1,,
chr17:43094546:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339253:G>A,,,,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-281),,1,,
chr17:43094514:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr13:32354926:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),probably_damaging(0-946),,1,,
chr17:43104938:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr17:43104938:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,
chr17:43044826:ATT>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0002456,
chr17:43057561:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2053 (African)| 0.343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32326613:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,2/1658,,,,,,,,,,,"Not Specified|Western European| Italian""""|None Specified|""""Western European",M,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1&1,,pathogenic
chr17:43093405:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398785:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.648e-05,
chr13:32340905:C>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.02,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-056),,1,,
chr17:43092615:GA>T,,,,,,,,,,,,,,,,," African| Native American""""|Latin-American/Caribbean|African|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32330979:G>A,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0454|0.0154,benign:0.012,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1&1,,
chr17:43047106:G>C,,,,,,,,,,0.005,0.4009,0.0288,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.117013,
chr13:32326613:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1&1,,
chr13:32396919:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336380:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336961:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,,
chr17:43092064:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339808:GG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43106490:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43092437:TAATGTTATTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32332100:A>C,,,,,,,,,,0.0,0.0272,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0071885,
chr13:32367008:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32398377:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr13:32340252:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-001),0&1&1,1&1&1,,
chr13:32353809:T>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32370430:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-07),possibly_damaging(0-696),0&1&1&1&1,1&1&1&1&1,,
chr13:32332316:T>G,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1,,
chr13:32341125:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-108),,1,,
chr17:43061278:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32354971:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),benign(0-187),,1,,
chr13:32390684:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32398223:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32356619:AG>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,1.647e-05,
chr13:32339555:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-147),,,,
chr17:43107879:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32332456:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000583,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1163|0.0227|0.0846,benign:0.004,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),possibly_damaging(0-595),,1&1,,
chr13:32391887:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32340078:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-011),,1,8.237e-06,
chr17:43087474:G>C,,,,,,,,,,0.3598,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.353634,
chr17:43057117:G>T,,,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control|?|strong functional effect,Transcription activation in human cells|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|evolutionary conservation analysis|Multifactorial likelihood-ratio model|Proteolytic degradation|?,1/1658|-,,,,,,,,,Greek|Western Europe|-,,Greek|Western Europe|-|Caucasian|None-Specified,M,5 - Definitely pathogenic,1.0,1.32,87.1,0.998,0.81,0.81,synonymous_variant,LOW,18/22,,-1,,,,,1&1,,
chr13:32344602:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,0.0003026805,
chr13:32363229:A>C,,,In vitro (cloned),predicted neutral|inconclusive,Histopathology|Protein likelihood ratio model,,,,,,,,,,Western Europe|-,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-3),benign(0-076),,1,8.236e-06,
chr13:32340745:CC>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049211:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr17:43091889:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr17:43106525:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,pathogenic
chr17:43047705:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr17:43123226:C>T,,,,,,,,,,0.003,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00119808,
chr17:43047705:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr17:43092305:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr13:32351346:G>C,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32339427:T>A,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32349323:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| 0.28 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32339453:C>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-016),,1,,
chr13:32394817:A>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-04),probably_damaging(0-995),,1,,
chr13:32339967:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-72),benign(0-003),,1,,
chr13:32354156:C>G,,,,,,,,,,0.002,0.0,0.0144,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00239617,
chr13:32336380:A>G,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,2.471e-05,benign
chr13:32338274:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,pathogenic
chr13:32334492:T>G,,,,,,,,,,0.2744,0.2141,0.2378,0.3681,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.267572,
chr13:32339719:C>CC,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394671:TG>C,,,,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,6.591e-05,
chr17:43091869:A>G,,,,,,,,,,,,,,,Malaysian|-,,-|Chinese,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,3.295e-05,
chr13:32376684:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1&1,,
chr13:32398356:G>C,,,,,,,,,,,,,,,German,,Caucasian,Syn,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1,1&1,,
chr17:43093615:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43061820:G>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32362657:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43065535:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32340071:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-026),,,,
chr13:32337665:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43092603:GG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32344639:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0-04),probably_damaging(0-999),,,0.0001039605,
chr13:32396286:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43117079:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43093828:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,Western-European|-Germany|-|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340486:T>C,,,In vitro (cloned),,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-017),,1&1,2.471e-05,
chr17:43093828:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43092802:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32370505:T>A,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43093285:T>A,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092827:GGA>C,,,,,,,,,,,,,,,,,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43087761:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43093236:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001080755,
chr13:32336567:T>TT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32336900:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32365149:C>G,,,,,,,,,,0.2734,0.2761,0.2464,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.207268,
chr13:32339293:AAT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43106487:T>G,,,Unknown|Germline (inherited),,,,,,,,,,,,British,,Caucasian,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32337579:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-067),,,,
chr13:32332952:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-033),,,8.237e-06,
chr13:32316438:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32373019:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32380046:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43104928:T>A,,,,,,,,,,,,,,,,,French Canadian|Western European,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr13:32336900:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),,,1,,
chr17:43093517:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32337651:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340956:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32341123:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32373846:T>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00139776,
chr17:43091495:GG>C,,,,,,-|3/1658,,,,,,,,,Central/Eastern Europe|German|Finland|-|Not Specified|Austria|Latvian|Western Europe,1|-,White-NonHispanic| Greek and Russ|Central/Eastern European| Central/Eastern Europe|Western European|Lithuanian|-|-Central/Eastern-Europe|Latvian|Western-European| Ashkenazi|Western Europe|Central/Eastern-European|None-Specified|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,4.118e-05,
chr13:32371124:T>G,,,,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,
chr13:32353975:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32371124:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,8.239e-06,
chr13:32380131:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,"Western European| Central/Eastern European""""|""""Western European",M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,1.647e-05,
chr13:32355255:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-86),,0&1&1,1&1&1,,
chr13:32340553:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-86),,0&1&1,1&1&1,,pathogenic
chr13:32398785:G>A,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43106533:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted deleterious|as variant control,E3 Ub-ligase activity assay BRCA1/RING-BARD1|evolutionary conservation analysis,,,,,,,,,,,,Western-European|-S-European|-Spain|Western Europe|-Italy,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43066699:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43045761:C>G,,,In vitro (cloned)|Unknown,predicted deleterious|very destabilizing|strong functional effect|predicted neutral|-|as variant control|as wildtype control,Gel filtration chromatography|Transcription activation in yeast (GAL4-fusions)|Multifactorial likelihood-ratio model|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|peptide binding ability BRCA1-p53|Thermodynamic stability prediction|Colony formaztion in soft agar|Microsatellite analysis|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Not Specified|German|-|Italian,2|-,Western-European|-|Caucasian|Near Eastern,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-982),,1&1&1,,
chr13:32337766:G>GG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43049168:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-002),,1&1,,
chr13:32376684:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-002),,1&1,,pathogenic
chr13:32333249:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-034),,,,
chr13:32338466:A>T,,,,,,,,,,,,,,,Italian,,Caucasion,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32346880:T>G,,,,,,,,,,,,,,,,,African American|None Specified,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0-01),possibly_damaging(0-742),,1,,
chr17:43093552:CTA>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32316306:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43093293:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340450:T>CT,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339577:GTAA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43076558:G>A,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1,,
chr13:32340906:TG>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32398809:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.247e-06,
chr17:43093189:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43049162:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-738),,1&1&1,,
chr13:32337774:A>C,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-038),,1,,
chr17:43057167:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,8.236e-06,
chr17:43093328:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32348303:G>T,,,,,,,,,,0.0348,0.0393,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0754792,
chr17:43051085:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&0&1,8.236e-06,
chr13:32316462:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,1&1,,pathogenic
chr13:32316462:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,1&1,,pathogenic
chr13:32381260:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43094619:TT>G,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,frameshift_variant&stop_lost,MODIFIER,,,-1,,,,,,,
chr17:43091708:T>C,,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|_NHGRI|Division_of_Genomic_Diagnostics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|inconclusive,Histopathology|-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,0.0116|0.0|0.0077,benign:0.019|None|None|benign:0.019|benign:0.019,0.0,0.0,0.0029,0.0,0.0,,,Latin American/Caribbean|Central/Eastern European|Western European|-|Puerto-Rico|Western-European|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,3.09,5.25e-06,3e-05,0.02,0.64,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0002573305,
chr13:32339828:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-011),,,0.005906,
chr13:32336215:A>G,,,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,7.418e-05,
chr13:32316511:AC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr17:43057147:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1&1,,
chr17:43095940:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340016:C>A,,,,,,,,,,,,,,,German,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43097240:G>C,,,,,,,,,,,,,,,,,Western-European|Western European,IVS,2 - Likely not pathogenic or of little clinical significance,0.62,1.1,0.2,0.001,,0.04,splice_region_variant&intron_variant,LOW,,8/22,-1,1.0,,,,1,,
chr13:32357882:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43093472:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093179:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,2.471e-05,
chr13:32319693:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43074086:C>T,,,,,,,,,,0.004,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00119808,
chr13:32340445:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr13:32338130:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-193),,1,,
chr13:32332866:GTT>C,,,,,,1/1658|-,,,,,,,,,Czech|Western Europe|-|Belgian,1|-,Western European|-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32394795:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,6.589e-05,
chr17:43072991:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43082419:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.307|benign:0.307|benign:0.307|benign:0.307|benign:0.307,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,8.236e-06,
chr13:32351128:T>G,,,,,,,,,,0.0,0.0023,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32339309:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-061),,1,,
chr13:32338709:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-75),benign(0-004),,1,,
chr17:43091911:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43092482:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32358337:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43067696:T>C,,,,,,,,,,,,,,,-|Italian,,-|Caucasian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,15/22,-1,,,,,1,,
chr17:43093638:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092809:CTTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093638:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337806:T>G,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),,,8.236e-06,
chr17:43116981:C>T,,,,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00299521,
chr13:32396977:T>A,,,,,,,,,,,,,,,,,"Western European| Central/Eastern European""""|None Specified|Native American|""""Western European",M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32319188:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32394724:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|-|?,Protein likelihood ratio model|-|?|Multifactorial likelihood-ratio model,2/1658|-,,,,0.002,0.0,0.0,0.0,0.0,Austria|Italian|-|Spanish,0|-,"Latin American/Caribbean| Native American|Netherlands| Sephardic""""|Western European|-| Native American""""|Western Europe|Caucasian|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,5.012,0.195,0.00035,1e-05,0.03,0.03,missense_variant,MODERATE,25/27,,1,,tolerated(1),benign(0-006),,1&1,0.0003273305,
chr13:32376674:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,8.236e-06,
chr17:43111903:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32380165:TGT>AT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0001319,
chr17:43091752:A>AT,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32380333:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32319046:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,
chr13:32398778:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.238e-06,
chr13:32336879:G>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-011),,1,,
chr13:32371285:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32319145:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43093245:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332465:TA>G,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,,,-|Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32337708:TAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43076384:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,0.000199681,
chr17:43054310:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32394913:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,-|Italian,,Caucasian|Central/Eastern Europe,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43045745:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43106485:TCT>AGC,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(0-999),,,,
chr17:43076606:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32355229:GAGAT>A,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32363367:A>G,,,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control,Protein likelihood ratio model|-|mRNA analysis (RT-PCR)|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model|Cell viability (in BRCA-/- cells)|cDNA analysis,,,,,,,,,,East and West European|-,,Western European|-|Central/Eastern European|None Specified|Caucasian,M,5 - Definitely pathogenic,10.715,1.259,6.918,0.9975,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr17:43093128:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32356477:ACTT>T,,,,,,,,,,,,,,,Not Specified,,,IFD,,,,,,,,inframe_deletion,MODERATE,15/27,,1,,,,,,,
chr13:32320753:T>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000998403,
chr17:43056992:A>G,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr17:43053389:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43082402:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1,,pathogenic
chr13:32340027:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-267),,1,1.647e-05,
chr17:43082402:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1,,pathogenic
chr13:32396462:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32349793:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32370048:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32329442:T>C,,,,,,,,,,,,,,,,2,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,7/26,1,,,,,1&1,,
chr17:43074403:T>A,,,,,,,,,,,,,,,,,African American|None-Specified|African,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr13:32360418:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32398154:G>C,,,,,,,,,,,,,,,Not Specified,,,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,1.648e-05,
chr13:32329425:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32376683:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32341269:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr13:32316494:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,4.118e-05,
chr17:43092098:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43116189:G>C,,,,,,,,,,0.3579,0.2179,0.3732,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.353035,
chr17:43070444:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32338858:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43124116:CT>CTCT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,,,
chr17:43063333:A>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,,,,,,
chr17:43113642:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32367961:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32371033:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32385397:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1923 (Asian)| 0.09959 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2455,0.087,0.2925,0.1984,0.2894,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.209265,benign
chr13:32320185:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32396210:A>T,,,,,,,,,,0.0,0.0098,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00279553,
chr13:32370463:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43094597:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43061301:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32340379:G>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-029),,1,,
chr17:43093058:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43067408:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32394770:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-04),possibly_damaging(0-849),,1,1.647e-05,
chr13:32339699:T>CA,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,Uruguayan|Sweden|-|Dutch,,"Western European|-| Ashkenazi""""| African| Latin America|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,,
chr17:43091621:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32337031:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-036),,1,8.237e-06,
chr17:43115775:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32337094:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43104928:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32337659:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-967),,1,,
chr13:32339734:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340392:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,"Not Specified|Western European| Italy""""|Western Europe|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32370904:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.000798722,
chr17:43069462:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32371580:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1362 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2078,0.1846,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.225439,benign
chr13:32338795:C>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43045647:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,9.06e-05,
chr13:32387346:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32337410:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000714,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,benign:0.013,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1&1,,
chr13:32340392:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,W Europe/Native American,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-073),,1&1,,
chr17:43066809:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32340855:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-409),,1,,
chr17:43124170:ACAC>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000998403,
chr13:32316496:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43091930:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32339435:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-476),,1,,
chr13:32337274:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0349|0.0|0.0231,None,0.001,0.0,0.0,0.0,0.001,German,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0004220805,
chr13:32332369:AACAGTTGT>GATACTTCAG,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43093454:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,benign
chr13:32363189:G>A,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32332459:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32355124:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-12),benign(0-002),,,8.237e-06,
chr13:32337600:A>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,1,,
chr13:32339435:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32398670:A>T,,,,,,,,,,,,,,,,1,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091937:A>CAA,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094641:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.664|None|None|possibly-damaging:0.664|possibly-damaging:0.664,,,,,,,,Western European,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32339891:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-009),,1,0.0001153,
chr13:32340760:CTCTTG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32371012:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-01),probably_damaging(0-981),,,,
chr13:32332592:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2552 (Asian)| 0.09756 (African)| 0.2876 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?,co-occurrence with deleterious variant|-|Allele frequency analysis in controls|Nuclear localisation|Prevalence in normal controls|Homology-directed repair assay|evolutionary conservation analysis|Survival assay with VC8 (after MMC treatment)|?|Centrosome amplification,,,28.5898|12.8928|23.3209,None,0.2952,0.084,0.2997,0.2847,0.3538,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-022),0&0&1,1&1&1,0.2632005,
chr13:32352807:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.03049 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43092852:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43045793:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,tolerated(0-06),possibly_damaging(0-559),,1&1,1.647e-05,
chr13:32326550:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr17:43082510:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,8.236e-06,
chr13:32338264:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43097167:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,,
chr17:43096627:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32332499:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-005),,,1.647e-05,
chr17:43092509:CAATA>T,,,Germline (inherited),,,7/238 patients,,,,,,,,,German|Austria|-,,Western-European|-Central/Eastern-Europe|-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339860:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-049),,1,,
chr17:43122980:G>T,,,,,,,,,,0.002,0.0053,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00219649,
chr13:32362692:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-997),,1,,
chr13:32338219:TAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-997),,1,,
chr13:32329463:C>T,,,,,,,,,,,,,,,,,Latin American/Caribbean| Hispanic,N,,,,,,,,stop_gained,HIGH,8/27,,1,,,,,1,,
chr17:43093455:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43094460:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094620:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091937:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32326503:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,"Western European| Venezuelan""""|""""Latin American/Caribbean",M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,1.647e-05,
chr13:32356551:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,1&1,1&1,,
chr17:43084309:G>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32398536:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.0001039585,
chr13:32346809:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr13:32340230:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32340099:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02375 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,2.907|0.5674|2.1144,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-64),benign(0-001),0&0&1,1&1&1,,
chr17:43099469:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr17:43094008:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr17:43079135:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32389810:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08179 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094275:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340890:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32357741:T>A,,,,,,,,,,,,,,,,,,,5 - Definitely pathogenic,1.0,2.88,32.36,1.0,,0.97,splice_acceptor_variant,HIGH,,15/26,1,,,,,1&1&1,,
chr13:32326557:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43097298:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43049125:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,benign(0-001),,1,,
chr13:32371037:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-03),probably_damaging(0-917),,1,,
chr17:43091976:C>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43045821:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr13:32336767:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43094150:A>AT,,,,,,,,,,,,,,,-|Italian,,Western-European|-|Caucasian|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43057250:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32339202:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32362596:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-03),benign(0-087),,1&1,,
chr17:43106575:C>G,,,,,,,,0.0|0.023|0.0078,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,
chr17:43076568:TTCTGTCACTATAG>AAA,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32371037:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-26),possibly_damaging(0-544),,1,,
chr13:32346059:C>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000399361,
chr17:43094685:TGAG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr17:43071148:A>T,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,Not Specified|-|Spanish,,-|Caucasian,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(1),benign(0),0&1&1,1&1&1,1.647e-05,
chr13:32370978:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,
chr13:32362596:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-953),,1&1,,
chr17:43094022:CCTCAG>CTTTAATTTATTTTAA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32363455:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32338115:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-465),,,8.237e-06,
chr13:32366142:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04675 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43099242:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32332479:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-36),benign(0-263),,1,,
chr17:43093009:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western-European|Western European|Central/Eastern-European|Ashkenazi|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,4.118e-05,
chr13:32332358:G>T,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092430:->TTTCTCTAATGTTA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43093453:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32332836:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),possibly_damaging(0-687),,,0.0001483,
chr13:32339168:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-169),,,,
chr13:32344593:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32357683:A>T,,,,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1,,
chr13:32340802:TA>TATA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43045620:G>A,,Invitae,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,0.000307756,
chr13:32319081:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,1.648e-05,
chr13:32326541:T>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,stop_lost,HIGH,7/27,,1,,,,0&1&1&1,1&1&1&1,,
chr13:32379858:TTAGCTAGGATGGTCTC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,,,1,,,,,,,
chr17:43049175:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,,pathogenic
chr17:43100144:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr17:43076545:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/22,,-1,,,,,,,pathogenic
chr13:32332371:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-025),,,1.648e-05,
chr17:43092913:A>GA,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43093013:T>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43093013:T>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,benign:0.356|None|None|benign:0.356|benign:0.356,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32332259:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.248e-06,
chr17:43094351:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32330984:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,,,
chr17:43100050:A>T,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000399361,
chr17:43094530:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094008:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32335120:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43091769:T>CAA,,,,,,,,,,,,,,,,,Western-European|Western Europe|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32380084:G>A,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Not Specified|None Specified,M,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr13:32316543:A>G,,Invitae,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,0.0002738305,benign
chr13:32379968:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32319218:C>T,,,,,,,,0.0116|0.0|0.0077,benign:0.031,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,
chr17:43072857:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32385314:AC>T,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00139776,
chr13:32336915:GAT>A,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32380088:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,2.471e-05,
chr17:43049188:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-083),,1&1,,
chr13:32319131:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,benign
chr13:32379968:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr17:43049188:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),possibly_damaging(0-833),,1&1,,
chr17:43086602:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03166 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43052239:G>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43092725:A>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43045738:C>A,,,,,,,,,,,,,,,,1,,Syn,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,
chr17:43045791:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,tolerated(0-15),benign(0-008),,,1.647e-05,
chr13:32338272:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1,,
chr13:32339997:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-759),,1,8.237e-06,
chr17:43047641:G>C,,,,,,,,,,,,,,,Asian,,,IVS,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1,,
chr13:32338423:C>A,,,,,,4/1658|-,,,,0.0,0.0,0.0029,0.0,0.0,German|Austria|-,1|0|-,-|Caucasian,Syn,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,0.0017151805,
chr17:43094875:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32389051:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32345701:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000798722,
chr17:43091824:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr13:32339583:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-029),,1,1.648e-05,
chr17:43080359:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43104091:GTTAC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,9.062e-05,
chr17:43077669:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32379808:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr17:43107764:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.1346,0.013,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0373403,benign
chr13:32340380:G>T,,,,,,,,,,,,,,,,,German English Swedish Norway|Western European|Ashkenazi,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43056330:C>T,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00159744,
chr13:32340365:T>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,1,1,,
chr13:32338027:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32332896:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-64),benign(0-009),,1,,
chr13:32340685:AAG>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051098:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-982),,1&1,,
chr13:32333218:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-957),,,8.237e-06,
chr13:32362630:TTCCT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-957),,,,pathogenic
chr13:32357757:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-098),0&1&1,1&1&1,,
chr13:32362545:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-985),,1,,
chr17:43057053:TT>CA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-856),,,,
chr13:32319312:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43114220:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32338078:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-881),,1&1,,
chr13:32355046:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-17),benign(0-133),,1,,
chr17:43091817:A>G,,,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340366:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-552),,,,
chr13:32338235:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43113817:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000998403,
chr17:43093313:T>CT,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32355807:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43102288:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32327429:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43110694:T>C,,,,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0179712,
chr17:43124078:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,8.237e-06,
chr13:32339553:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000153,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,0.0116|0.2956|0.1078,benign:0.159,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-16),,1,,
chr17:43076656:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.237e-06,
chr17:43071185:T>G,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-806),,1&1,2.471e-05,
chr13:32319322:CTATC>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,3/27,3/26,1,,,,,,8.238e-06,
chr17:43093668:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32326590:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,8.236e-06,
chr13:32363292:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.001,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-43),benign(0-001),,1,,
chr13:32338613:C>A,,,In vitro (cloned),predicted neutral|Loss of variant allele|?,co-occurrence with deleterious variant|LOH analysis|Prevalence in normal controls|Histopathology|?,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-043),0&0&0&0&1&1&1,1&1&1&1&1&1&1,,
chr17:43091820:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338579:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32339526:TA>TATA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43059469:T>CACA,,,,,,,,,,0.2783,0.4523,0.2349,0.3393,0.3681,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.348043,
chr17:43063957:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,
chr17:43106527:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr17:43092883:GCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr17:43091935:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,3.295e-05,
chr13:32350510:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32338613:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?,Prevalence in normal controls|-|Bayesian statistics|?,-|13/1658,,,,0.008,0.0008,0.0029,0.0,0.0092,Western Europe/Latin American/Caribbean|West/Central/East Europe|Irish|Scottland|USA|Central/Eastern Europe|German|Western European|-|Not Specified|Austria|Saudi|Spanish|French Canadian|Western Europe|African American,1|0|2|-,Latin American/Caribbean|Native American|Central/Eastern Europe|Native American/Western Europe|Irish German Dutch|Not Specified|Western/Central/Eastern Europe|-|Arab|German|Austria|Ashkenazi|Ashkenazi/Western Europe|Western Europe|Caucasian|None Specified,M,1 - Not pathogenic or of no clinical significance,,0.001,4.52,0.0001,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-063),0&0&0&0&1&1&1,1&1&1&1&1&1&1,0.005353305,
chr17:43079781:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32339152:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr17:43091879:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32336988:TCC>A,,,,,,,,,,,,,,,Malaysian,,Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43106523:TT>G,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32332465:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,0.0002069405,
chr13:32376736:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32356627:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr17:43082511:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,pathogenic
chr13:32333674:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr13:32319060:AT>A,,,,,,,,2.5097|3.2474|2.759,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,1&0&1&0,,
chr17:43063870:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,pathogenic
chr13:32339498:TGGGC>T,,,,,,,,,,,,,,,Chilean,1,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.245e-06,
chr17:43047690:TA>A,,,,,,,,,,,,,,,-|Spanish,,Caucasian|Spanish?,F,,,,,,,,frameshift_variant,HIGH,21/22,,-1,,,,,,,
chr17:43049113:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|1.4526|0.4921,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,,benign
chr13:32379504:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,8.237e-06,
chr13:32336588:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32318907:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32361454:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32379128:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43093405:A>AT,,,,,,,,,,,,,,,,," French""""| Native American| Central/Eastern European| French Canadian""""|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32356535:TA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,15/27,,1,,,,,,,
chr13:32339863:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-196),,1,,
chr17:43093997:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-196),,1,8.237e-06,
chr17:43093997:C>A,,,,,,,,,,,,,,,,,Western-European|Western European|-Native-American|None-Specified|African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,2.471e-05,
chr13:32394815:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-09),benign(0-124),,1,,
chr13:32379531:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr17:43076554:ACC>GC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/22,,-1,,,,,,,
chr13:32327875:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32339901:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-22),,,8.237e-06,
chr13:32358242:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43090963:CTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32332668:A>ATTAG,,,,,,,,,,,,,,,,,,F,,,,,,,,stop_gained&frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32338391:CACACACA>AT,,,,,,,,,,,,,,,Western Europe|-,,White-NonHispanic|-,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr13:32380686:G>C,,,,,,,,,,0.004,0.0325,0.0058,0.006,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0117812,
chr13:32365177:A>T,,,,,,,,,,0.5169,0.534,0.536,0.5337,0.4673,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.517772,
chr13:32379503:A>GA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,1&0&1,1&1&1,,
chr13:32333029:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.237e-06,
chr13:32398712:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32337190:GC>A,,,,,,,,,,,,,,,-|Italian,,Western European|Western Europe|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063311:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,0.0001369055,
chr17:43070971:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-002),,,0.000199681,
chr17:43090946:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338693:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43063823:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,1.647e-05,
chr17:43092507:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000196,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0581|0.0227|0.0461,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32363435:G>CT,,,,,,,,,,,,,,,Republic of China,1,Han Chinese,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32398271:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32340087:A>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-022),,1,,
chr17:43091820:CT>T,,,,,,,,,,,,,,,Not Specified|Danish|Sweden|-|Dutch,,Western-European|Western European|-|Caucasian|Unknown,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339676:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-036),,,,
chr17:43051098:G>C,,,In vitro (cloned),predicted no impact on protein function|very destabilizing|strong functional effect|predicted neutral|as variant control|predicted deleterious,Recombination rate|Clonogenic assay|Structure-based prediction (crystallography etc)|Homologous recombination in yeast|Multifactorial likelihood-ratio model|Transcription activation in human cells|Peptide binding ability|Bayesian statistics|Homology directed recombination|transcription activation/PS/BA/BS|Random plasmid integration assay|Thermodynamic stability prediction|Proliferation in yeast|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Not Specified|Western Europe|-,,Western-European|Western European|-|Central/Eastern European|None Specified,M,5 - Definitely pathogenic,7.41,1.45,12.88,0.9963,0.66,0.66,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-982),,1&1,,
chr17:43092276:TC>TCTC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32340087:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-007),,1,,benign
chr13:32350183:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32396988:G>C,,,In vitro (cloned)|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,,Western European| Dutch|-|Central/Eastern European|None Specified,M,1 - Not pathogenic or of no clinical significance,0.1349,0.0603,0.0224,0.0,0.02,0.02,downstream_gene_variant,MODIFIER,,,-1,,,,,1,4.118e-05,
chr17:43051098:G>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-995),,1&1,,
chr13:32328875:T>AGT,,,,,,,,,,0.1968,0.059,0.0879,0.1528,0.1227,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.122005,
chr13:32338016:A>C,,,,,,,,,,,,,,,,,Western Europe|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr13:32318968:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43104262:G>T,,,In vitro (cloned)|Unknown,-|as variant control,-|cDNA analysis,,,,,,,,,,,,Latin-American/Caribbean,IVS,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,
chr13:32398382:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43105344:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32338047:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,
chr17:43093457:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,pathogenic
chr17:43091770:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1,1,,
chr13:32340191:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr13:32360373:G>A,,,,,,,,,,0.0,0.0446,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0117812,
chr13:32319283:G>T,,,,,,,,,,,,,,,W Europe/Latin Amer-Caribbean|-,,Latin American/Caribbean|-,N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,
chr17:43095830:C>T,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32332889:G>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43115781:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104262:G>A,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,
chr13:32366208:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.5206 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43099786:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000173,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0227|0.0308,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1&1,,
chr13:32325039:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,3.295e-05,
chr13:32383835:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43092821:AG>C,,,,,,,,,,,,,,,,,India,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357954:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,1.647e-05,
chr13:32335313:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32377906:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43092016:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43062621:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32347399:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32385401:T>A,,,,,,,,,,0.0209,0.0015,0.0043,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00599042,
chr17:43074299:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,6.589e-05,
chr17:43074349:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43082387:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,1,,
chr13:32374128:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43096356:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32363288:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,8.236e-06,benign
chr17:43115781:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32338430:AC>A,,,,,,,,,,,,,,,,,English/Welsh|-|Unknown,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32376672:GGC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,21/27,,1,,,,,,,
chr17:43120222:T>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32339996:AAAT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr17:43045642:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.004728,
chr13:32363300:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-37),benign(0-012),,1,,
chr13:32329742:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr17:43071174:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,8.236e-06,
chr13:32376669:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/26,1,,,,,1,,pathogenic
chr13:32337053:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-63),,,1,,
chr13:32369781:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr13:32355003:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,0.0,0.0045,0.0014,0.0,0.0,Latin American/Caribbean|-,,"Latin American/Caribbean| Native American| Native American""""| Latin American/Caribbe|Not Specified|Western European| Latin American|-|None Specified|African| Haiti""""|African American|""""Latin American/Caribbean|""""African",M,1 - Not pathogenic or of no clinical significance,1.8197,0.00045,0.01995,0.0,0.02,0.02,stop_lost,HIGH,14/27,,1,,,,,1&1,0.00091303,
chr13:32339260:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),possibly_damaging(0-477),,1,,
chr17:43074304:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32338206:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-97),benign(0-001),,,,
chr13:32337540:ATCCT>C,,,,,,,,,,,,,,,,,Latin American/Caribbean/Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340092:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-01),,1,,
chr17:43045615:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,0.0001039585,
chr17:43092723:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32331021:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,1.647e-05,
chr13:32338329:T>CTGCT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.241e-06,
chr13:32363388:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-53),benign(0-152),,,8.236e-06,
chr17:43094720:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43057136:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32338162:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43124036:A>C,,,In vitro (cloned),as wildtype control|normal binding|no impact on protein function,protein binding ability BARD1|E3 Ub-ligase activity assay|peptide binding ability BRCA1/RING-BARD1|E3 Ub-ligase activity assay BRCA1/RING-BARD1|Homology directed recombination|Radiation sensitivity,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1&1&1,8.237e-06,
chr17:43094720:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43056975:A>T,,,,,,,,,,,,,,,Belgian,1,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,1,,
chr13:32338162:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1836 (Asian)| 0.1972 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-,-|288/1658,,18.7384|19.8366|19.1106,None,0.1998,0.1846,0.1527,0.1726,0.1196,German|Austria|-|USA|Sri Lankan,1|0|2|-|6,Global|-|Caucasian|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.1720655,benign
chr17:43074432:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32362582:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-997),,1,0.0001286655,
chr17:43051107:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-032),,1,,
chr13:32367055:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32332832:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0003,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-023),,1,,
chr13:32338035:AT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32376097:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32322261:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32339870:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-02),,,8.237e-06,
chr13:32379396:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,8.236e-06,
chr13:32336257:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,10/26,1,,,,,,8.239e-06,
chr13:32378219:G>C,,,,,,,,,,0.0129,0.0,0.0058,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00379393,
chr13:32344643:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,1.648e-05,benign
chr17:43106487:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43099827:A>CA,,,,,,,,,,,,,,,German|-,1|-,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43106487:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr17:43093321:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr13:32316417:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr13:32319330:T>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,IVS,3 - Uncertain,3.16,1.18,1.51,0.744,,0.34,splice_region_variant&intron_variant,LOW,,3/26,1,,,,,1&1,,
chr13:32380123:AT>TG,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.237e-06,
chr13:32319330:T>C,,,In vitro (cloned),predicted deleterious,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/26,1,,,,,1&1,,
chr17:43115524:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340670:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43049234:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,8.236e-06,
chr13:32336851:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32316559:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.244e-06,
chr17:43094082:ATGT>T,,,,,,,,,,,,,,,,,None-Specified,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338013:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),possibly_damaging(0-73),,1,8.237e-06,
chr13:32344608:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Latin American/Caribbean|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-11),benign(0-199),,1,,
chr13:32341302:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32338835:ATT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094818:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43091784:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43053028:T>G,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32339254:A>CT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32359083:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,
chr17:43063888:C>G,,,In vitro (cloned),predicted deleterious|as variant control|strong functional effect,transcription activation/PS/BA/BS|Transcription activation in human cells|Structure-based prediction (crystallography etc),,,,,,,,,,,,Latin American/Caribbean| Hispanic|-,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-895),,1&1,,
chr13:32376933:T>G,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000399361,
chr13:32328257:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3724 (Asian)| 0.122 (African)| 0.277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43045784:C>TC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,8.236e-06,
chr17:43121331:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1484 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32357895:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-986),,,8.236e-06,
chr17:43071237:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/23,,-1,,deleterious(0-05),benign(0-001),,1,,
chr13:32319154:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43115969:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32339657:AA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092536:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43071447:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43092107:T>G,,,,,,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340557:A>AA,,Ambry_Genetics|Medical_University_Innsbruck|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43085427:C>G,,,,,,,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00419329,
chr17:43091933:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43070962:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32340289:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr17:43045704:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,possibly_damaging(0-901),,1,,
chr17:43092372:A>TC,,,,,,,,,,,,,,,Greek,,Greek,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32367090:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43090943:G>A,,,,,,,,,,,,,,,,,Ashkenazi,IVS,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,
chr13:32356440:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Histopathology|Protein likelihood ratio model|-,,,0.0116|0.0|0.0077,benign:0.0,,,,,,Western Europe|-,,Western European|-|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-86),benign(0-002),,1,1.647e-05,
chr13:32337182:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),,,1,,
chr13:32356589:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-09),benign(0-326),,,,
chr13:32336874:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0),,,8.237e-06,
chr13:32394753:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,,
chr17:43090943:G>T,,,In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,
chr13:32339137:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-03),,,,
chr13:32338916:ACA>TTA,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.237e-06,
chr17:43118401:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1931 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32337810:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43078479:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr17:43057117:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-016),,1&1,,
chr13:32362691:A>G,,,,,,,,,,,,,,,,,Not Specified,N,,,,,,,,splice_region_variant&stop_retained_variant,LOW,17/27,,1,,,,,1,,
chr13:32340983:GTT>G,,,,,,,,,,,,,,,Chilean|Spanish|-|Spanish?,2|-,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32390362:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04021 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43045806:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,,1.647e-05,
chr13:32362691:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost&splice_region_variant,HIGH,17/27,,1,,,,,1,,
chr17:43093958:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,possibly-damaging:0.853|None|None|possibly-damaging:0.853|possibly-damaging:0.853,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32397007:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43049233:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,1.647e-05,
chr17:43089240:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr17:43124204:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32319241:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr17:43098010:A>C,,,,,,,,,,0.003,0.3079,0.0173,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.0842652,
chr13:32338486:->TGAGGA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32356500:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,
chr17:43094195:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,pathogenic
chr13:32316410:TCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,
chr17:43094602:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,pathogenic
chr17:43063881:T>C,,,,,,,,,,,,,,,,,Western-European|Central/Eastern European,M,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1&1&1,,
chr13:32398403:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43048507:TC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32371060:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,8.236e-06,
chr17:43093286:G>A,,,,,,,,,,,,,,,,,Latin American/Caribbean,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43071149:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-06),benign(0),0&1&1,1&1&1,,
chr13:32337160:CAGCG>T,,,Unknown|Germline (inherited),,,1/238 patients|7/1658|-,,,,,,,,,Dutch|Norwegian|Czech|Malaysian|HKSAR|-|British?|British|Dutch?|German|Spanish|Western Europe|Not Specified|Italian,1|-| -,"English/Scottish| French Canadian""""|Western European|Unknown|Caucasian|Latin American/Caribbean| Central/Eastern European""""|Hungarian/Czech|-| Irish/French Canadian""""|None Specified| White""""| African|""""Western European| Irish|Chinese | Central/Eastern European|English/Irish| see TRF""""|African|Native American|Italian|Irish|England|Central/Eastern European|Chinese|Asian|Near Eastern|Western Europe",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.647e-05,
chr13:32326296:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|mRNA analysis and splicing reporter minigene,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,0.000447821,
chr13:32339637:T>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-004),0&1&1,1&1&1,,
chr13:32357492:T>A,,,,,,,,,,0.0,0.0106,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.00279553,
chr13:32333394:CTG>C,,,,,,,,0.0533|0.5852|0.2362,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,10/26,1,,,,,1,,
chr17:43092035:TAC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32372756:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43094736:GTAAT>A,,,,,,,,,,,,,,,Spanish,3|2,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,8.237e-06,
chr17:43053113:T>C,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr13:32333303:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-027),,1,,
chr13:32333398:CT>CTTT,,,,,,,,14.0351,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1&0,,
chr13:32326504:A>G,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,1&1,1&1,,
chr17:43076589:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43093022:GGA>C,,,Unknown|Germline (inherited),,,,,,,,,,,,Argentinean/French,2,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32346837:C>ATT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,13/27,,1,,,,,,,
chr17:43091047:T>G,,,,,,,,,,,,,,,,,,,3 - Uncertain,3.44,1.05,,0.131,,0.04,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32333303:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104983:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,8.237e-06,
chr17:43095909:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32316523:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43092694:GTCA>AG,,,,,,1/1658,,,,,,,,,-|USA,,Not Specified|-|Caucasian|Caucasian Canadian|French-Canadian|French Canadian|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43090597:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32380049:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr13:32363190:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-|inconclusive|as variant control,Cell viability (in BRCA-/- cells)|Protein likelihood ratio model|-|Multifactorial likelihood-ratio model,4/1658|-,,,,,,,,,,,"Not Specified|Western European|-| England""""|None Specified|""""Western European",M,5 - Definitely pathogenic,138.04,1.51,1.12,0.999,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32341274:AATT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.38 (Asian)| 0.18 (African)| 0.29 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,benign
chr17:43112347:C>G,,,,,,,,,,0.3519,0.1566,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.334465,
chr17:43104167:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|as variant control,Recombination rate|Clonogenic assay|-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,Western European|Western Europe|African,M,1 - Not pathogenic or of no clinical significance,,1.698,0.00479,0.00017,0.02,0.02,synonymous_variant,LOW,,,-1,,,,,1&1,1.647e-05,
chr17:43071011:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-006),,1,,
chr13:32336785:AT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32363321:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,18/27,,1,,,,,,,
chr13:32396918:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340820:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,
chr17:43094207:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32332368:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),probably_damaging(0-928),,,8.238e-06,
chr17:43091674:C>G,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,possibly-damaging:0.873|None|None|possibly-damaging:0.873|possibly-damaging:0.873,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43076570:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,3.295e-05,
chr13:32350278:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32337254:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),,,1&1,,
chr13:32356504:A>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western Europe,M,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,
chr17:43045775:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-883),,,8.236e-06,
chr13:32339073:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-234),,1,,benign
chr17:43063406:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr13:32398241:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43067660:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,,benign
chr13:32323915:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43103130:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43094631:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43082565:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32362707:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,2.471e-05,
chr17:43124032:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.99,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(0-999),,1&1&1,,
chr13:32336905:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.0,0.0,0.0,0.003,0.0,,,Asia,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.000373671,
chr17:43093529:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,
chr13:32332602:G>T,,,,,,,,,,,,,,,-|Sri Lankan,," Central/Eastern European""""|Not Specified|Western European|""""Ashkenazi|Ashkenazi|Sinhalese",M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-178),,1,,
chr17:43099801:GG>T,,,,,,2/1658,,,,,,,,,,,Asian|-|None-Specified|-West-Indies,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32398241:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32371010:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-02),probably_damaging(0-997),,1,,
chr13:32383682:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32332734:TT>G,,,,,,,,,,,,,,,,,Not Specified|Western European|None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43071081:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,
chr13:32338318:TAAC>T,,,,,,,,0.0489|0.0473|0.0484,None,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,
chr17:43063368:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000000344,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0|0.0154,possibly-damaging:0.945|possibly-damaging:0.945|possibly-damaging:0.945|possibly-damaging:0.945|possibly-damaging:0.945,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0-03),possibly_damaging(0-876),,1,,
chr13:32380145:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43115793:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.093|0.0227|0.0692,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,,
chr13:32338643:A>G,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),possibly_damaging(0-833),,,,
chr17:43078232:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr13:32394936:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),inconclusive|-,-|mRNA analysis and splicing reporter minigene,-|1/1658,,,,,,,,,Not Specified|-,, Spain Portu|Western European|-| Ashkenazi|Ashkenazi/Western Europe|Western Europe|None Specified,IVS,3 - Uncertain,0.74,2.52,2.29,0.724,,0.34,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,1&1,0.0001483,
chr17:43060621:TCAAGTGATCCACCCG>G,,,,,,,,,,0.004,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000798722,
chr17:43098424:G>C,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00379393,
chr13:32340069:A>T,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-012),,1,,
chr17:43067715:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000197,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.6355|0.223,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1&1,,
chr13:32338450:G>A,,,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr13:32355835:T>A,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000399361,
chr13:32337282:CCT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,
chr13:32339375:T>G,,,,,,,,,,,,,,,,,African American|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,3.298e-05,
chr17:43110875:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr13:32340069:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,1/1658,,,,,,,,,,,None Specified,M,2 - Likely not pathogenic or of little clinical significance,0.16,,,0.003,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-03),,1,,
chr17:43097234:G>C,,,,,,,,,,,,,,,,,Not Specified,IVS,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,,
chr13:32346855:A>T,,,,,,,,,,,,,,,Central/Eastern Europe,,,M,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,,
chr13:32376780:T>GCTTA,,,,,,,,,,,,,,,,,Latin American/Caribbean| Cuban,F,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,,,
chr17:43093693:TG>C,,,,,,,,,,,,,,,,,Pakistani,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43092628:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32337741:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32357979:TTT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.237e-06,
chr17:43104117:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,,,,,,0.0001039585,
chr17:43102157:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.2215 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32324406:A>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43093299:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.1135|0.0384,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32386531:A>T,,,,,,,,,,0.001,0.0219,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00678914,
chr17:43092133:G>T,,,,,,,,,,,,,,,,,Central/Eastern European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32322709:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1503 (Asian)| 0.01016 (African)| 0.1781 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43083068:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32329775:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr17:43091904:TC>CA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr17:43051086:G>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-166),,,,
chr17:43091814:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr13:32379880:AGC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32380136:ACCTATTACTCAACGTA>A,,,,,,,,,,,,,,,,,,S,,,,,,,,splice_donor_variant&coding_sequence_variant&intron_variant,HIGH,,,1,,,,0&1,0&1,,
chr17:43088260:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07517 (Asian)| 0.04878 (African)| 0.1702 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43094486:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32335776:T>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000399361,
chr17:43071148:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-2),benign(0),0&1&1,1&1&1,,
chr17:43045797:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,probably_damaging(0-938),,1,,
chr17:43119664:T>A,,,,,,,,,,0.001,0.0023,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00119808,
chr13:32344830:T>A,,,,,,,,,,0.1938,0.2738,0.2176,0.0794,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.185703,
chr13:32363196:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model|?,-|3/1658,,0.0698|0.0|0.0461,probably-damaging:1.0,0.001,0.0,0.0,0.0,0.0,Not Specified|-,,Central/Eastern European|Western European| Germany/Ireland|-|Western Europe|None Specified,M,2 - Likely not pathogenic or of little clinical significance,0.0021,1.733,,0.0183,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0-02),probably_damaging(1),,1&1,0.0001657405,benign
chr13:32355097:CA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43104204:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0),,,1,,
chr17:43092050:CGTGC>C,,,,,,,,,,,,,,,,2|-,Western Europe|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr17:43093454:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,7.0233|2.3161|5.4291,benign:0.023|None|None|benign:0.023|benign:0.023,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr13:32338606:CAACT>TT,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr13:32333122:T>A,,,Germline (inherited),,,,,,,0.0,0.0,0.0,0.001,0.0,Malaysian,,Chinese,Syn,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,0.0002151405,
chr13:32332961:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-016),,1&1,,
chr13:32318351:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32356472:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,15/27,,1,,,,,1&1,1.647e-05,
chr17:43093632:AT>T,,,,,,,,,,,,,,,,,Western-European|-|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32338577:G>T,,,,,,,,,,,,,,,-|Italian,,Western European|Caucasian|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr13:32332820:A>T,,,,,,,,,,,,,,,-|Central/Eastern Europe,,Not Specified|Western European|-|Asian,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-001),,1,8.237e-06,
chr17:43117969:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43074654:A>T,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000798722,
chr13:32356472:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,4.942e-05,
chr13:32379768:CGTGATC>G,,,,,,,,,,,,,,,,,"Western European|-|English/Swiss| Central/Eastern European""""|""""Western European",IFD,,,,,,,,stop_lost&protein_altering_variant,MODIFIER,,,1,,,,,,,
chr13:32369836:C>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00239617,
chr17:43105441:G>C,,,,,,,,,,0.3559,0.1566,0.3646,0.371,0.501,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.335863,
chr13:32356532:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-981),,,,
chr13:32390770:T>G,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32379767:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1&1,0&1&1,8.238e-06,
chr17:43063350:A>C,,,In vitro (cloned)|Unknown,predicted neutral|no functional effect|-,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,Western-European|Western European|None Specified,M,,,,,,,,stop_lost,HIGH,18/23,,-1,,,,,1,5.766e-05,
chr17:43093400:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32394942:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|no splicing defect|-|?,-|exon inclusion|mRNA analysis (RT-PCR)|cDNA analysis|Multifactorial likelihood-ratio model|?,,,,,,,,,,Western Europe|-|Western Europe/Native American|Italian,,Latin American/Caribbean|Not Specified|Western European|-|Native American| English|Western Europe|Caucasian|None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,1,3.295e-05,
chr17:43067610:T>A,,,In vitro (cloned)|Unknown,predicted deleterious|-|strong functional effect,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,African,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-982),,,,
chr13:32340151:AAACT>T,,,,,,,,,,,,,,,Latin American/Caribbean|-|Italian,,Latin American/Caribbean|Western European|-|Caucasian| Latin American/Caribbe,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43093140:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43093082:TACAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091008:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43041622:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43104153:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-05),,,,,
chr13:32318955:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43097747:T>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000998403,
chr17:43063347:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/23,,-1,,,,,1&1,,pathogenic
chr13:32338224:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0118|0.8772|0.3042,benign:0.121,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1&1,,benign
chr13:32319156:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr17:43104145:TCTGTAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr17:43091628:ACT>A,,,,,,,,,,,,,,,French?|-,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43063373:A>T,,,,,,,,,,,,,,,,,Western European|-,N,,,,,,,,stop_gained&splice_region_variant,HIGH,18/23,,-1,,,,,0&1&1,,
chr17:43094140:C>A,,,,,,,,,,,,,,,Austria,1,,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43092766:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European|Central/Eastern European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32357751:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43092766:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092781:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339378:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-003),,,,
chr17:43092781:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43086755:G>T,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00119808,
chr13:32339519:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-036),,1&1,,
chr17:43063994:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.238e-06,
chr13:32337649:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr17:43092972:G>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32329382:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32332832:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43076498:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,,,pathogenic
chr17:43047704:G>T,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1,,
chr13:32341031:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32339983:TTAG>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost&protein_altering_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32338909:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,0&1&1,0.000103959,
chr13:32370438:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-22),benign(0-384),,1,,
chr13:32349446:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32351771:C>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32326199:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,8.24e-06,
chr17:43070935:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-031),,1,,
chr13:32339572:TTTAAGTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-031),,1,,pathogenic
chr13:32362472:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,4.943e-05,
chr17:43092017:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43100617:TGAT>T,,,,,,,,,,0.174,0.1142,0.1311,0.1419,0.2536,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.161342,
chr17:43084619:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32321173:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32339135:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32379715:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,4.943e-05,
chr13:32324055:A>G,,,,,,,,,,0.002,0.0061,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00359425,
chr13:32340050:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-85),benign(0-044),,,8.237e-06,
chr17:43078211:C>A,,,,,,,,,,0.3559,0.1558,0.3646,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.334864,
chr17:43115753:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,,,
chr17:43093097:GT>T,,,,,,,,,,,,,,,American|-,,Latin American/Caribbean|Caucasian|-|None-Specified|Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43094000:GT>C,,,,,,,,,,,,,,,,,Western-European|None-Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43094988:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43076506:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43071249:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,1,,
chr13:32338904:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-085),,1,,
chr13:32333296:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43098131:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000798722,
chr13:32339383:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,2.473e-05,
chr17:43066730:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08566 (Asian)| 0.03862 (African)| 0.07784 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43063871:C>G,,,,,,,,,,,,,,,Not Specified,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,
chr13:32326601:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,,,Western European|Western Europe,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32398499:A>C,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.483,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32384750:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06728 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0676,0.003,0.0288,0.0,0.0184,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0219649,benign
chr13:32398499:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32330646:T>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000998403,
chr13:32337033:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,1,,
chr17:43057129:T>G,,,,,,,,,,,,,,,Indian,,Asian,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-067),,1,,
chr17:43094390:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092597:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32326262:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,
chr13:32332786:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,pathogenic
chr17:43085995:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32365239:A>T,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43106480:A>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1&1,,pathogenic
chr17:43066893:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43091795:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1&1,1&1&1&1,8.236e-06,
chr13:32337810:GA>T,,,,,,,,,,,,,,,,,Trinidad,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43124053:A>G,,Pathway_Genomics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1,,
chr17:43092222:C>T,,,,,,,,,,,,,,,,,Western/Central/Eastern Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093826:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43054635:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43058379:G>C,,,,,,,,,,0.3648,0.615,0.3199,0.375,0.5317,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.459265,
chr13:32315889:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3199 (Asian)| 0.1382 (African)| 0.1939 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43051078:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,benign
chr13:32337769:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-881),,1,,
chr17:43074218:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43080276:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00179712,benign
chr17:43093376:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,Latin American/Caribbean|None Specified|African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,0.0001204305,
chr13:32337817:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0227|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32363033:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.000199681,
chr13:32326569:A>T,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&1&1,1&1&1,,
chr13:32379893:TCC>A,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr17:43064058:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43094416:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,8.236e-06,
chr13:32337290:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-71),benign(0-06),,,,
chr13:32365165:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2535 (Asian)| 0.2012 (African)| 0.215 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340146:A>T,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,
chr17:43071181:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-02),benign(0-023),,1,,
chr17:43091597:TGTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-02),benign(0-023),,1,,pathogenic
chr17:43077795:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3641 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32336814:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-003),,1,,
chr13:32333332:C>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43082464:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),,,,,
chr13:32357756:A>T,,,,-|no,,rare|-,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,0.0001163155,
chr17:43068004:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32354964:T>C,,,,,,,,0.0|0.0227|0.0077,benign:0.289,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-16),,,,,
chr13:32340716:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,1,,
chr13:32340458:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,1,,pathogenic
chr13:32340324:A>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-923),,1&1,,
chr13:32340175:GT>G,,,,,,,,,,,,,,,Not Specified|Sweden,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43091505:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.000199681,
chr13:32326084:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,benign
chr17:43091505:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,540,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091881:G>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092597:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32329806:T>TTA,,,,,,,,,,0.1998,0.1241,0.1499,0.1716,0.1299,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.153554,
chr13:32340030:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-35),benign(0-017),,,,
chr13:32332434:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0349|0.0|0.0231,benign:0.134,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-16),benign(0-221),,1,,
chr17:43078938:C>A,,,,,,,,,,0.001,0.0113,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.00339457,
chr13:32339569:CTTTTTTTT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43104190:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0-03),,,1,,
chr13:32326084:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,
chr17:43091795:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,pathogenic
chr13:32357287:A>AGTT,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.000599042,
chr13:32373524:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32380001:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,
chr17:43115797:A>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr17:43090947:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr17:43073638:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.12 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32340820:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32394814:A>T,,,Unknown|Germline (inherited),,,1/238 patients|4/1658|-,,,,,,,,,German|English|-|Not Specified|Spanish|Western Europe|African American,,"Latin American/Caribbean|India| French""""|Central/Eastern Europe|Western European|""""Western European|-|Galician|African American/Latin American/Caribbea|Ashkenazi|Near Eastern|African|French Canadian|Western Europe|Near East/Mid East/Latin American/Caribb| Italy England|Caucasian|None Specified|Central/Eastern European",N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,0&0&1&1,1&1&1&1,1.647e-05,
chr13:32378348:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05937 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32356688:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr13:32329418:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,3.301e-05,
chr13:32379789:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32339490:AA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43071257:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,
chr13:32379737:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32332601:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000648,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),possibly_damaging(0-804),,1&1,,
chr17:43045757:C>T,,,In vitro (cloned)|Unknown,predicted deleterious|-|strong functional effect,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,4/1658|-,,,,,,,,,,,-|None-Specified,M,5 - Definitely pathogenic,5.9,1.0744,,0.9999,0.66,0.66,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-908),,1&1,,
chr13:32363369:A>C,,,In vitro (cloned)|Unknown,predicted neutral|predicted deleterious|-|as variant control|?,Co-segregation in families|-|Nuclear localisation|Protein likelihood ratio model|Prevalence in normal controls|Homology-directed repair assay|?|Multifactorial likelihood-ratio model|Cell viability (in BRCA-/- cells)|Survival assay with VC8 (after MMC treatment)|evolutionary conservation analysis|Centrosome amplification,4/1658|-,,,,,,,,,Not Specified|German|Western Europe/Native American|-|Western Europe,,Central/Eastern European|Not Specified|Western European|-|None Specified|Western Europe|Native American,M,5 - Definitely pathogenic,13731.0,2,,1.0,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32357752:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-17),probably_damaging(0-988),,1,,
chr13:32392727:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43047691:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43092881:A>TTGCC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43076512:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43110587:GGCTT>CAAA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.024,
chr17:43093856:AA>C,,,,,,,,,,,,,,,,,Latin American/Caribbean|-|None-Specified|Latin-American/Caribbean,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43051061:GCTGACATCGTGCCACTGCACTTC>A,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,20/23,19/21,-1,,,,,,,
chr13:32340046:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),possibly_damaging(0-461),,1,,
chr17:43095876:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32394763:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32357946:G>A,,Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43047691:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,tolerated(1),benign(0-003),,0&1,,
chr13:32363406:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32350572:T>C,,,,,,,,,,0.0,0.0061,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00179712,
chr17:43092768:GC>C,,,,,,,,,,,,,,,Czech,1|-,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32332631:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr13:32336772:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,1,,
chr13:32369961:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2215 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2734,0.1755,0.2406,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.179912,benign
chr17:43091500:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32337900:TT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43091949:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32326084:C>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,
chr13:32316406:T>A,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32336744:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-33),benign(0-028),,1,,
chr13:32376760:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32336744:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-571),,1,,
chr17:43092124:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091749:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32379828:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32339951:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-065),,1,,
chr13:32394869:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32337058:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32360609:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32370540:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,19/27,,1,,,,,,,
chr17:43074584:A>C,,,In vitro (cloned)|Unknown,-|?,-|?,-|12/1658,,,,0.3579,0.2194,0.3746,0.371,0.4969,Spanish,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.353435,
chr13:32332982:A>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),possibly_damaging(0-733),,1,,
chr13:32398789:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.24e-06,
chr13:32332380:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-171),,1,,
chr13:32332770:TTA>C,,,,,,,,,,,,,,,,,Not Specified|Western European|None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32394707:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),probably_damaging(1),,1,,
chr13:32326553:AAA>G,,,,,,4/1658|-,,,,,,,,,,,Central/Eastern Europe|Not Specified|Western European|Native American/Western Europe/Irish|Native American| Central/Eastern Europea|African American|Western Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,,,
chr17:43091996:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32341095:ACAAAATTAGCAAG>G,,,,,,1/1658,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32332548:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-801),,1,5.767e-05,
chr13:32332725:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-029),,1,,
chr13:32339946:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0),,,,
chr13:32340531:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),possibly_damaging(0-814),,1,8.237e-06,
chr17:43092644:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),possibly_damaging(0-814),,1,,pathogenic
chr17:43082498:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr13:32330868:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.264e-06,
chr17:43085860:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr13:32339615:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-187),,,8.238e-06,
chr13:32338117:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43063926:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,2.471e-05,
chr13:32325177:AG>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,4/27,,1,,,,,,,
chr13:32337134:T>G,,,In vitro (cloned),predicted neutral| no LOH,HR assay| LOH assay,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,
chr17:43093951:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,pathogenic
chr13:32354922:CT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,pathogenic
chr17:43074386:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr17:43094231:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32347699:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32339637:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-004),0&1&1,1&1&1,,
chr13:32332472:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-004),0&1&1,1&1&1,,pathogenic
chr17:43115790:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1&0,,
chr17:43093605:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32363353:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,
chr17:43091448:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093559:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43092568:G>A,,GeneDx|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr13:32319088:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32326531:A>C,,,,,,,,,,,,,,,German,,Caucasian,Syn,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32341176:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-|Multifactorial likelihood-ratio model,2/1658|-,,,,0.001,0.0,0.0,0.0,0.0,Western Europe|-|Italian,,"Latin American/Caribbean| Native American""""|Western European|-|Austria|African|Caucasian|None Specified|""""Western European",M,2 - Likely not pathogenic or of little clinical significance,0.215,2.249,,0.0117,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),probably_damaging(0-959),,1,0.0007753405,
chr13:32340802:TT>T,,,Germline (inherited),,,1/100 cases,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,,
chr13:32363417:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,1,8.236e-06,
chr17:43070929:ATATAGTGGCAGGGCTGGGG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,15/23,,-1,,,,,1,,
chr13:32376670:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,21/27,,1,,,,,,,
chr13:32336566:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32357807:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr17:43057864:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr17:43094776:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,,,-1,,tolerated(1),benign(0),,1,,
chr13:32336566:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340893:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-922),,1,,
chr13:32361501:A>AG,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00139776,
chr13:32338765:AAG>CAT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,
chr17:43093568:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32349814:TG>C,,,,,,,,,,0.5626,0.5091,0.5187,0.4861,0.4591,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.506789,
chr13:32366618:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr13:32333226:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1&1,,pathogenic
chr13:32353385:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000599042,
chr13:32333085:T>CT,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32370426:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr13:32370426:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr17:43124741:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00499201,benign
chr17:43104247:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,,,,,,
chr13:32338541:TC>C,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32318643:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32340573:G>TA,,,,,,,,,,,,,,,British,,Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43094083:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32315632:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,
chr13:32356566:CA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr13:32329440:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,
chr17:43094365:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,pathogenic
chr13:32329440:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,
chr13:32337498:GG>T,,,,,,,,,,,,,,,Spanish,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32333294:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-004),0&1&1,0&1&1,8.24e-06,
chr17:43115791:G>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-004),0&1&1,0&1&1,,
chr17:43094368:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43057107:T>C,,,In vitro (cloned),predicted neutral|predicted deleterious|uncertain,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc)|evolutionary conservation analysis,,,,,,,,,,Indian,,Asian| N. India| Arian,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-108),,1&1,,
chr13:32371842:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00898562,benign
chr13:32339181:ACA>C,,,Germline (inherited),,,,,,,,,,,,,,Western European|Pakistani|Ashkenazi|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.648e-05,
chr13:32337817:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,
chr13:32379429:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:0.996,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,benign
chr17:43051063:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-347),,1&1&1,,
chr13:32338533:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-347),,1&1&1,8.238e-06,
chr13:32326268:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000316,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,
chr13:32326268:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,
chr13:32339890:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,,,
chr17:43054679:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32328672:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0081869,benign
chr13:32370996:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),,,,,,,,,,,,Italian,,Caucasian,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-14),benign(0-031),,1&1&1,8.236e-06,
chr13:32340770:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-384),,,8.239e-06,
chr13:32366471:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43067608:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-704),0&0&1,1&1&1,,pathogenic
chr13:32395576:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr17:43045782:G>T,,,In vitro (cloned),predicted neutral|Low functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,None-Specified,M,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-927),,1,8.236e-06,
chr13:32324611:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43057970:G>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000798722,
chr13:32319060:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,
chr13:32354848:A>T,,,,,,,,,,,,,,,,,Western European| Ashkenazi,IVS,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,1,,
chr17:43076562:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,Latin American/Caribbean|Latin-American/Caribbean,M,,,,,,,,missense_variant,MODERATE,12/22,,-1,,,,,1,0.0002120355,
chr17:43093817:C>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1&1&1,1&1&1&1&1,,pathogenic
chr17:43067608:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-938),0&0&1,1&1&1,,pathogenic
chr17:43070072:G>TATA,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000798722,
chr13:32332751:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),benign(0-046),,,,
chr13:32352517:A>G,,,,,,,,,,0.0348,0.0514,0.0922,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0786741,
chr13:32337160:TAAAC>T,,,,,,,,0.0485|0.0|0.032,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43044804:CCCCCG>CTTT,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.24,
chr17:43091653:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.0|None|None|benign:0.0|benign:0.0,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094294:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338409:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-085),0&1&1,1&1&1,,
chr13:32334294:CAGCTC>C,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00159744,
chr17:43091653:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32330984:CT>T,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,
chr13:32343944:T>G,,,,,,,,,,0.004,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000998403,
chr13:32319130:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,1.647e-05,
chr13:32338409:C>T,,,In vitro (cloned),inconclusive,Histopathology,,,,,,,,,,,,Central/Eastern European|None Specified,M,2 - Likely not pathogenic or of little clinical significance,,,2.89,0.0414,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),0&1&1,1&1&1,,
chr13:32328702:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32326054:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,,,,,,,,Austria,IVS,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,2.472e-05,
chr17:43092096:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43115791:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.2043|0.0692,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1&1,,
chr17:43082403:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.9999,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Splicing reporter minigene|Multifactorial likelihood-ratio model,,,,,0.001,0.0,0.0,0.0,0.0,African American|-,,"Bahamas| Latin American/Caribbean""""|Not Specified|Western European|-Native-American|-Native-Americ|-|-Portuguese|African American/Latin American/Caribbea|None Specified|African|Western-European|Western Europe|-African|-Irish|""""Western European",IVS,5 - Definitely pathogenic,1.0,3.98,1230000.0,1.0,,0.97,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,0.0001039585,pathogenic
chr13:32344614:A>CAAGAAAAA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/27,,1,,,,,,8.239e-06,
chr13:32355030:C>G,,,,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),,,1,8.236e-06,
chr13:32350833:G>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr13:32391940:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43093913:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32317168:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04749 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0447,0.0333,0.0994,0.0903,0.1207,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0732827,benign
chr17:43104151:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,1,,
chr17:43094233:AG>G,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32362600:A>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,,,,,,
chr13:32339759:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32393004:G>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,
chr17:43091463:TTGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32391274:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32333227:GA>G,,,,,,,,,,,,,,,,,Western European|Ashkenazi Jewish|Ashkenazi/Central/Eastern Europe|-| Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32357798:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),possibly_damaging(0-593),,1,,
chr13:32340816:CTT>A,,,,,,1/1658|-,,,,,,,,,Czech|Ertreia|-|Italian,,Central/Eastern European|Not Specified|Western European|-| Italian|Ashkenazi Jewish/Italian|African| Polish|Western Europe|Caucasian|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43067649:TTAG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43066089:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32375718:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43115767:A>C,,,In vitro (cloned),predicted neutral|as wildtype control|normal binding,Radiation sensitivity|E3 Ub-ligase activity assay BRCA1/RING-BARD1|protein binding ability BARD1|E3 Ub-ligase activity assay|evolutionary conservation analysis,,,,,,,,,,,,-|Ashkenazi/Western Europe,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,8.236e-06,
chr13:32341122:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-032),,1,,
chr17:43106435:G>T,,,,,,,,,,,,,,,American,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,2.471e-05,
chr13:32363250:A>CA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32366617:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43070963:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-999),,,,
chr17:43056627:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32336246:TT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43063789:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr13:32379412:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|no LOH|-|?,-|Protein likelihood ratio model|Prevalence in normal controls|Multifactorial likelihood-ratio model|LOH analysis|?,-|8/1658,,0.0814|0.0|0.0538,probably-damaging:1.0,0.004,0.0,0.0029,0.0,0.0,Latin American/Caribbean|Not Specified|-|Spanish|Western Europe|Italian,," French Canadian|Western European|sephardic jewish|Ashkenazi| Spanish/Mexican""""|Caucasian|""""Latin American/Caribbean|Latin American/Caribbean|Central/Eastern Europe|Not Specified|Western/Central/Eastern Europe|-| Italian|None Specified|""""Western European| Portuguese| German|Native American/Western Europe/Irish| Central/Eastern European""""|Native American| Native American|Central/Eastern European|Mexico|Ashkenazi/Central/Eastern Europe|Near Eastern|Western Europe| Norweigan",M,1 - Not pathogenic or of no clinical significance,1.0,0.56234,2.51189e-11,0.0,0.66,0.66,missense_variant,MODERATE,22/27,,1,,,,0&0&1&1,1&1&1&1,0.00093674,
chr13:32326609:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,3.295e-05,
chr13:32316529:A>C,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,-|Latin American/Caribbean/Western Europe,,-|Central/Eastern European,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,
chr13:32337297:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-007),,1,,
chr13:32338942:T>GA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32325024:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,
chr13:32391173:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43093284:->TC,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32326609:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,1.647e-05,
chr13:32355777:A>T,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000399361,
chr13:32379412:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,0&0&1&1,1&1&1&1,2.471e-05,benign
chr17:43124135:AAT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0001755,
chr13:32371075:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr17:43063934:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,pathogenic
chr13:32332675:C>G,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32316612:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43071052:T>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-003),,,,
chr13:32379977:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0002224,
chr13:32398212:TATG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43106552:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Greek,,Greek,IVS,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,1,,
chr17:43093919:T>A,,,,,,,,,,,,,,,-|Italian,,Western European|Caucasian|Central/Eastern European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr17:43091495:G>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,Western Europe|-|None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32346812:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr17:43074529:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,benign
chr13:32330867:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr13:32340957:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32316490:CA>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr17:43104115:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,,,,,,,
chr13:32333312:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-311),,,,
chr13:32339884:A>C,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43106486:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,India|-,,"Latin American/Caribbean|-| Irish/Greek""""|-India|Asian|African|None-Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32336663:A>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),possibly_damaging(0-562),,,,
chr17:43092418:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.5465|18.8379|27.9025,possibly-damaging:0.936|None|None|possibly-damaging:0.936|possibly-damaging:0.936,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr13:32361059:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32386759:A>G,,,,,,,,,,0.007,0.0,0.0014,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00219649,
chr17:43091375:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.24e-06,
chr17:43049100:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,8.236e-06,
chr13:32380083:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32336607:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),,1,,
chr13:32339457:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(0-921),,,8.245e-06,
chr13:32337522:AAAA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(0-921),,,,pathogenic
chr13:32338022:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-388),,,,
chr17:43092614:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32394750:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,25/27,,1,,,,,,8.237e-06,
chr17:43095103:->TAC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.24 (Asian)| 0.2 (African)| 0.23 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340123:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.2951|0.1,benign:0.144,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),possibly_damaging(0-897),,1,,
chr17:43093637:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43082422:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(0-11),,,1&1,,
chr17:43091807:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,
chr13:32374128:T>G,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00678914,
chr13:32370561:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1,8.237e-06,
chr17:43094179:A>T,,,,,,1/1658,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr13:32370561:T>C,,,,,,,,,,,,,,,Western European,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,1,,
chr17:43048503:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32340324:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-386),,1&1,,
chr13:32356282:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43091613:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32336771:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,Western Europe|-,,Western European|Western Europe|Other|-|None Specified,M,1 - Not pathogenic or of no clinical significance,0.21878,0.06607,0.26915,8e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,,1,8.238e-06,
chr13:32396960:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32380889:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32357433:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr17:43054997:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43094126:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32372850:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43057372:T>A,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32329344:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43063897:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,,probably_damaging(1),0&1,1&1,,
chr13:32336814:A>T,,,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.627,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-3),,1,,
chr17:43104083:TTTCCTC>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,6.878e-05,
chr17:43091613:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337706:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43100535:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000199681,
chr13:32336449:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,pathogenic
chr13:32337801:A>C,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-023),,1,,
chr13:32337069:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),,,1,,
chr13:32346887:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,13/27,,1,,,,,,,pathogenic
chr13:32374243:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43071115:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32398266:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337251:CAC>A,,,Germline (inherited),,,,FA FANCD1_00030,,,,,,,,,,Western European| Ireland,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092663:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43090381:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32379815:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43073428:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07692 (Asian)| 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32355204:A>G,,,In vitro (cloned),neutral,cell survival by crystal violet staining and CDDE,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,,,
chr13:32370064:T>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43106452:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,
chr13:32329374:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,,
chr17:43057107:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-108),,1&1,,
chr17:43092229:A>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|inconclusive|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,, Central/Eastern Europe|Not Specified|Western European|-|African|Western-European|None-Specified|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,3.55,8.71e-08,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001565,
chr13:32362540:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,,,
chr13:32354705:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43049196:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&1&1,1&1&1&1,8.236e-06,
chr17:43106452:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,
chr13:32330972:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,9/27,,1,,,,,1,1.647e-05,
chr17:43060530:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32371118:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,8.239e-06,
chr13:32332416:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-824),0&1&1,1&1&1,8.238e-06,
chr13:32398164:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332434:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-05),possibly_damaging(0-713),,1,,
chr17:43049130:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/23,,-1,,,,,,,
chr17:43092364:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32329548:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,,
chr13:32384660:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32394454:T>A,,,,,,,,,,0.5159,0.5719,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.527756,
chr13:32357158:C>A,,,,,,,,,,0.0,0.0393,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,0.0103834,
chr13:32339226:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-098),,,8.24e-06,
chr13:32398583:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1&1,1&1&1&1,,
chr17:43082550:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32326530:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32344547:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr17:43104964:A>G,,,,,,,,,,,,,,,,,Central/Eastern European| Central/Easter,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,
chr13:32318245:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32398185:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&0,,pathogenic
chr13:32347999:G>T,,,,,,,,,,0.2008,0.1846,0.1527,0.1815,0.1196,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.170128,
chr13:32329548:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.313 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,,
chr13:32333274:C>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,,
chr17:43115790:A>-,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000462,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,1,,
chr13:32346939:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr17:43091657:A>-,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32340377:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43095924:T>G,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1&1,,
chr13:32379758:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),as wildtype control|predicted deleterious|no evidence for aberrant splicing,Cell viability (in BRCA-/- cells)|Protein likelihood ratio model|splicing reporter minigene assay|Co-localization to predicted ESEs,,,,,,,,,,,2,,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43092694:AT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32344602:A>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,tolerated(0-08),possibly_damaging(0-539),,1,,
chr13:32357744:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,16/27,,1,,,,,,8.237e-06,
chr13:32370490:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32340999:ACTCC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32336266:T>C,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.4312|0.1462,None,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092105:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32379479:A>G,,,,,,,,,,,,,,,,,Chinese,M,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,8.237e-06,
chr13:32339201:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-347),,,,
chr17:43094768:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,German|-,2|-,Unknown|Caucasian,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32379848:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32341011:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32396248:T>G,,,,,,,,,,0.0,0.0537,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.014377,
chr17:43124610:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43091657:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43062594:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32339480:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-16),0&1&1,1&1&1,,
chr13:32340868:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Emory_Genetics_Laboratory,,,,,,0.0581|7.1266|2.4527,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr17:43060615:C>T,,,,,,,,,,0.0,0.0,0.0,0.0069,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00139776,
chr17:43094636:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43065086:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04371 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0015,0.0086,0.0536,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0123802,benign
chr13:32333182:CT>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,
chr17:43071012:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32340868:G>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,
chr13:32326607:A>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32336349:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-253),,1,,
chr17:43091749:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,,
chr17:43095848:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43047685:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,uncertain|predicted neutral|inconclusive|-|as variant control|predicted deleterious,Transcription activation in yeast (GAL4-fusions)|Protein binding capacity|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Thermostability assay|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Not Specified|-,,Western-European|Western European|-,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-987),,1&1,,
chr13:32379917:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,
chr13:32368867:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32337162:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-085),,,,
chr13:32359219:T>A,,,,,,,,,,0.9205,0.9743,0.9611,0.8948,0.9479,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.940495,
chr13:32357882:C>A,,,,,,,,,,,,,,,,,Latin American/Caribbean|Western European| Near Eastern,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43092493:TC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32316402:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43076527:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,8.237e-06,
chr13:32338841:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-12),,,,
chr13:32355874:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr13:32328244:A>T,,,,,,,,,,0.003,0.0106,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00419329,
chr13:32379316:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Counsyl|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/26,1,,,,,1&1,,pathogenic
chr13:32326150:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,1&1&0,,pathogenic
chr17:43063952:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1,,pathogenic
chr13:32332705:C>A,,,,,,2/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,,
chr13:32375530:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0014,0.0198,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00419329,benign
chr17:43092052:TTT>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43093694:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32349352:G>T,,,,,,,,,,0.0129,0.0015,0.0159,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00559105,
chr17:43071164:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43084974:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43115780:G>T,,,,,,,,,,,,,,,Sweden|-,,Western-European|-,IVS,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1,8.236e-06,
chr17:43125305:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32341037:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32363380:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32370374:A>G,,,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,
chr17:43091558:AC>T,,,,,,,,,,,,,,,,2,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32379410:A>CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,1&1&1,,pathogenic
chr17:43082568:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr17:43115780:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1,,
chr13:32338704:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-596),,1,,
chr13:32339078:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-037),,1,,
chr17:43070985:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32353028:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32325041:A>G,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,
chr13:32362563:T>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32336613:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-049),,1,,
chr13:32319164:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr13:32343709:TA>GAA,,,,,,,,,,0.0398,0.0356,0.098,0.1012,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0772764,
chr13:32332182:T>G,,,,,,,,,,,,,,,,,Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,1,,
chr13:32394833:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-05),benign(0-316),,1&1&1,,
chr13:32376555:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32368578:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03034 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340367:A>G,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.000103959,benign
chr13:32341000:T>G,,,,,,,,,,,,,,,,,Ashkenazi,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr17:43091500:G>C,,,,,,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43117016:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32338066:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43045778:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr17:43080240:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32373523:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0113,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00359425,benign
chr13:32394956:C>T,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,,
chr13:32379755:GCCAT>C,,,,,,,,,,,,,,,,,Samoan|-,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr17:43104137:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32394833:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr17:43045778:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,tolerated(0-14),benign(0-098),0&0&0&1&1,1&1&1&1&1,,
chr13:32356414:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,
chr13:32334735:C>A,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000599042,
chr13:32338922:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-94),,1,8.237e-06,
chr17:43120810:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43111583:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43091751:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43112733:C>T,,,,,,,,,,0.3429,0.7065,0.3689,0.3343,0.4939,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.470248,
chr13:32341219:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,3.302e-05,
chr17:43092013:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43079413:CA>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.543e-06,
chr13:32370993:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,5.765e-05,
chr17:43093694:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr13:32375494:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32363417:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(1),benign(0),,,8.236e-06,
chr13:32394878:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),benign(0-259),,,0.0001039585,
chr13:32341219:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.254e-06,
chr17:43106619:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43082780:T>GA,,,,,,,,,,0.0,0.0,0.0,0.0069,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00179712,
chr13:32370993:A>T,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(1),,1,8.236e-06,
chr13:32332421:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-19),,1&1,,
chr17:43097353:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-19),,1&1,,
chr13:32340096:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.255,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-124),,1,,
chr17:43051579:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32340096:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),benign(0-029),,1,,
chr13:32363498:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),benign(0-029),,1,8.236e-06,
chr17:43091790:TTTTTTTTTTTTTTTTTAGA>A,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43082422:TTTTTTTTT>G,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,
chr17:43092899:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32398203:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,Asian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.000199681,
chr13:32379900:G>C,,,In vitro (cloned)|Unknown,predicted deleterious|no splicing defect|-,splicing reporter minigene|Protein likelihood ratio model|-,,,,,,,,,,German|Austria|-|Central/Eastern Europe,1|-, French Canadian|Western European| Central/Eastern Europe|-|Caucasian|None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1,4.943e-05,
chr13:32379900:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1&1,2.472e-05,
chr13:32381233:T>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr17:43098174:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr17:43096304:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32337090:G>T,,,,,,,,,,,,,,,Italian,1,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-012),,1,,
chr13:32339241:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-03),,1,,
chr13:32361348:A>T,,,,,,,,,,0.0,0.0,0.0,0.0119,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00259585,
chr13:32346880:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0-01),possibly_damaging(0-742),,1,,
chr17:43092491:G>C,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,Not Specified,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336541:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-049),,1,0.000203799,
chr13:32379947:C>AT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.238e-06,
chr17:43091478:A>CA,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32333222:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000224,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-943),,1&1,,
chr13:32379464:ACCGTGTGGAAG>TCCC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,pathogenic
chr17:43120830:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32394897:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-1),benign(0-22),,,8.236e-06,
chr17:43093348:A>T,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,Western Europe,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43124063:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32333211:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-853),,1,,
chr13:32363336:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,,,,1,,
chr17:43068806:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43067978:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0072,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00139776,
chr13:32363336:T>A,,,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-21),benign(0-045),,1,,
chr17:43073750:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1199 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.1195,0.0058,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0327476,benign
chr17:43092223:T>A,,,In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32333478:GAGAAA>A,,,,,,,,,,0.0,0.0582,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0157748,
chr17:43071179:G>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-628),,1,,
chr17:43084411:C>T,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32333278:C>A,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr13:32362000:A>C,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43045766:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0-02),probably_damaging(0-995),0&1,1&1,,
chr13:32398117:G>C,,,,,,,,0.0117|0.0|0.0078,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43047654:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc),,,0.0116|0.0|0.0077,benign:0.002|None|benign:0.002|benign:0.002|benign:0.002,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,tolerated(1),benign(0-001),0&1,1&1,3.295e-05,
chr13:32363498:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-37),benign(0-058),,,8.236e-06,
chr17:43103325:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43093803:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43076478:G>C,,,,,,,,,,,,,,,,,Ashkenazi,IVS,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1,,
chr13:32338529:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-329),,1,,
chr17:43045766:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0-01),probably_damaging(0-981),0&1,1&1,,
chr13:32356470:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-11),benign(0-023),,,,
chr17:43104331:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr17:43094060:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340276:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-002),,1,,benign
chr13:32332441:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Sri Lankan,,Sinhalese,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-896),0&1&1,1&1&1,,
chr17:43063958:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,,8.237e-06,
chr17:43057131:G>C,,,In vitro (cloned)|Unknown,as wildtype control|inconclusive|no functional effect|-,Transcription activation in yeast (GAL4-fusions)|transcription activation/PS/BA/BS|-|peptide binding ability BRCA1:BACH1|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|-|None-Specified,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0-04),benign(0-013),,1,8.236e-06,
chr17:43106455:T>G,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,
chr17:43094456:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32398438:T>A,,,,,,,,,,,,,,,,,Latin American/Caribbean|None Specified,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,4.942e-05,
chr13:32337806:A>C,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,,
chr17:43092316:GA>A,,,,,,,,,,,,,,,China|-,,-|Asian|Chinese,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32332950:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-2),benign(0-041),,1,,
chr13:32319125:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,8.237e-06,
chr13:32337806:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),,,,
chr17:43106465:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr13:32357806:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-982),,,,
chr17:43104174:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32357806:A>G,,Invitae,,,,,,0.0|0.0227|0.0077,benign:0.018,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,,,
chr17:43104174:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32339986:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,8.237e-06,
chr13:32340968:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.264,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-14),,1,,
chr13:32341068:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-96),benign(0),,1,,
chr17:43099802:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-96),benign(0),,1,,pathogenic
chr17:43057093:T>C,,,In vitro (cloned),inconclusive,peptide binding ability BRCA1:BACH1,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-576),,1&1,,
chr13:32379997:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.237e-06,
chr13:32336391:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32396936:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32345128:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000399361,
chr13:32367320:G>T,,,,,,,,,,0.0,0.003,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000998403,
chr17:43049973:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43093530:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092110:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340729:A>CA,,,,,,,,,,,,,,,,,-|Irish/Scottish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43079681:A>C,,,,,,,,,,0.005,0.5182,0.0346,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.148762,
chr13:32332621:TG>C,,,,,,,,,,,,,,,Dutch,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43063985:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr17:43096312:C>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000798722,
chr13:32336437:AGAGAG>T,,,,,,,,,,,,,,,Dutch?,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43078937:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000798722,
chr13:32398510:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43092378:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339174:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-006),,1,0.0001121955,
chr17:43093332:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-006),,1,,pathogenic
chr17:43105799:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr17:43076602:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32339027:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-096),,1,,
chr13:32393329:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32316938:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43045692:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr13:32347807:C>G,,,,,,,,,,0.2753,0.2095,0.2378,0.369,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.266773,
chr17:43052188:G>T,,,,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00299521,
chr17:43093606:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32370496:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,,,
chr17:43063835:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,8.237e-06,
chr13:32339406:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-036),,1,,
chr17:43051074:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-033),,1&1,,
chr13:32339921:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),possibly_damaging(0-844),,,1.647e-05,
chr17:43094288:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,4.118e-05,
chr17:43070933:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1&1,,pathogenic
chr13:32337115:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1&1,,pathogenic
chr17:43112173:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43067555:CAT>C,,,,,,,,0.0121|0.0|0.0080,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr13:32398566:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32374446:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43104166:T>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,
chr13:32336909:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-188),,,1.647e-05,
chr13:32341173:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-373),,1,,
chr13:32327930:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09965 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32336414:GATTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32340309:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32325163:AT>T,,,,,,,,,,,,,,,,,Western European| English German|-|None Specified|White-NonHispanic,F,,,,,,,,frameshift_variant,HIGH,4/27,,1,,,,,,,
chr17:43111379:G>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000399361,
chr17:43057120:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr17:43091602:A>T,,,In vitro (cloned),predicted neutral,Histopathology,,,,,,,,,,,,Western-European|None Specified,M,3 - Uncertain,,,3.4,0.0649,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32348067:AAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43059636:T>G,,,,,,,,,,0.3579,0.1573,0.2824,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.32488,
chr17:43063409:GGGC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr13:32396749:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr13:32338543:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32337447:G>C,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43056470:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32342225:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43090952:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,
chr17:43076621:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr17:43051139:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.236e-06,
chr13:32316676:T>G,,,,,,,,,,,,,,,,1,,IVS,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43088534:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32337597:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-71),benign(0-007),,,8.24e-06,
chr17:43093800:TTT>T,,,,,,,,,,,,,,,,1,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32345858:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32363274:A>T,,,In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32391943:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32337648:TG>A,,,,,,,,,,,,,,,British,1,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43049252:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32333139:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-06),possibly_damaging(0-861),0&1&1,1&1&1,8.236e-06,
chr13:32338782:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-172),0&1&1,0&1&1,8.237e-06,
chr17:43045705:CGG>T,,,,,,1/1658|-,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43054164:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43099787:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,0&1&1,1&1&1,,
chr17:43094290:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319500:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43112738:ACTCAG>T,,,,,,,,,,0.3598,0.7292,0.402,0.3671,0.5266,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.497204,
chr17:43091458:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32339653:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32332805:G>T,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43046604:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2114 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr17:43068632:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr17:43092620:C>T,,,,,,,,,,,,,,,French?,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370512:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,,,
chr17:43094605:C>G,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338216:CATTA>T,,,Unknown|Germline (inherited),,,,FA FANCD1_00039|-,,,,,,,,Malaysian|Israeli|-,,Ashkenazi Jewish|Indian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32327624:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32338833:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-25),benign(0-059),,1&1,,
chr17:43074501:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,tolerated(1),,,1,,
chr13:32341273:GTTTG>C,,,In vitro (cloned)|Unknown,predicted neutral|-,Prevalence in normal controls|-,,,,,0.2744,0.2088,0.2378,0.3681,0.2485,Austria|-,1|0|2|-,Global|-,IVS,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.265775,
chr17:43125280:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43053874:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32380066:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1&1,8.236e-06,
chr17:43125280:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,4.987e-05,
chr13:32332830:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-009),,1,,
chr13:32398149:C>AT,,,,,,,,,,,,,,,,,Western Europe,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43091659:TATAAT>C,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32339891:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-009),,1,,
chr13:32337535:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32336477:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-159),,1,0.0001204305,
chr17:43111800:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43057091:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-583),,,,
chr17:43094908:CT>T,,,,,,,,,,,,,,,German,1,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32339622:AACGTTGGTAATCTAT>AATATAATGATTCAGG,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43045732:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-69),,1,8.236e-06,
chr13:32338712:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-65),benign(0-043),0&1&1,1&1&1,,
chr13:32318530:G>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000599042,
chr17:43067629:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,In vitro (cloned)|Unknown,predicted deleterious|-|strong functional effect,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|Western Europe,M,5 - Definitely pathogenic,1.0,1.07,100.0,0.9952,0.66,0.66,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-703),,1&1,,
chr17:43092748:C>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045732:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),,,,,,,,,,,,,,,Syn,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,
chr13:32337804:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-049),,1,,
chr17:43063885:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),strong functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-993),,1,,
chr13:32356045:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43095857:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32338449:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000136,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),,1,,
chr17:43070811:C>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr17:43092462:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32333096:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),possibly_damaging(0-641),,,0.000199681,
chr17:43115615:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43094444:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43104229:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,,,,1,,
chr13:32387375:G>A,,,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43106456:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32336605:CAGGA>T,,,,,,,,,,,,,,,Palestinian,,Arab,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340071:TTT>A,,,,,,,,,,,,,,,-|Italian,,-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43094426:A>T,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,Western Europe/French Canadian|-,," French Canadian""""|Western European|-| French/Canadian""""|-Central/Eastern-Europe|Western-European|None-Specified|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,1.66,0.00017,0.0,0.02,0.02,missense_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32338517:TCA>AA,,,,,,5/1658,,,,,,,,,,,Western European|Western Europe|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43106456:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr13:32337163:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr13:32337421:C>TA,,,,,,,,,,,,,,,,,-|Scottish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32381963:G>A,,,,,,,,,,0.0,0.0,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00159744,
chr17:43093062:TT>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr17:43092490:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43090059:AAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43065094:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04545 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32337952:CCA>C,,,Unknown|Germline (inherited),,,,FA FANCD1_00040|-,,,,,,,,-|Dutch,,Western European|-|Caucasian|Filipino|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,3.295e-05,
chr13:32333366:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104967:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr17:43093677:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr17:43094190:T>AC,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32340999:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-103),,0&1,8.237e-06,
chr13:32394823:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),possibly_damaging(0-75),,1,,
chr17:43094463:G>T,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr17:43049194:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted neutral|predicted deleterious|no functional effect|-,transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model|Structure-based prediction (crystallography etc),,,,,,,,,,Italian,,Caucasian,M,2 - Likely not pathogenic or of little clinical significance,,1.46,0.23,0.014,0.03,0.04,missense_variant&splice_region_variant,MODERATE,21/23,,-1,,,possibly_damaging(0-459),,1,8.236e-06,
chr17:43085207:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32363178:T>C,,,In vitro (cloned)|Unknown,likelihood score 29389:1|-,-|Multifactorial likelihood model,7/1658|-,,,,,,,,,Western Europe|-|Irish|Native American,,Western European|Western Europe|-|None Specified,IVS,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,0&0&1&1,1&1&1&1,,
chr13:32353442:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43092881:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32346707:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43123628:C>G,,,,,,,,,,0.3579,0.2171,0.379,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353634,
chr13:32353473:G>GTA,,,,,,,,,,0.2097,0.2413,0.2003,0.3681,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.241813,
chr17:43045784:CAG>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr13:32316484:CA>G,,,,,,3/1658,,,,,,,,,Not Specified|-,,Western European|Western Europe|-|Central/Eastern European|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,,,
chr17:43094523:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43082578:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,10/21,-1,,,,,1,,
chr13:32363199:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-933),,1,,
chr13:32329450:ATCA>T,,,,,,,,,,,,,,,,,Philipines,IFD,,,,,,,,protein_altering_variant,MODERATE,8/27,,1,,,,,,1.649e-05,
chr17:43104877:GAG>C,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,4/22,,-1,,,,,,,
chr13:32346203:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43103824:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32340499:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),possibly_damaging(0-702),,1,,
chr17:43104197:A>C,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,6/23,,-1,,,,,,0.0002079155,benign
chr17:43080890:C>TA,,,,,,,,,,0.001,0.0091,0.0043,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00379393,
chr13:32332811:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-539),,1,,
chr13:32332261:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Western Europe|-,,Western European|-|Central/Eastern European,IVS,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,1,3.299e-05,
chr13:32339707:CT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43074396:T>TGG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32339777:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32336936:A>CA,,,Germline (inherited),,,,FA FANCD1_00015,,,,,,,,,, Central/Eastern Europe|Western European|-|French-Canadian|African|French Canadian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,1.648e-05,
chr17:43093180:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093055:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093610:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063331:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32370464:AG>T,,,,,,,,,,,,,,,,,Near East/Mid East,F,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr17:43124031:GT>T,,,,,,,,,,,,,,,U.S.A.,,Hispanic,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr17:43069825:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32333295:A>T,,,,,,,,,,,,,,,Western Europe|-,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-003),0&1&1,1&1&1,,
chr17:43124874:T>C,,,,,,,,,,0.0,0.0,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000599042,
chr13:32321521:T>G,,,,,,,,,,0.001,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32357911:A>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,,,
chr17:43093193:A>T,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43045739:A>C,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),benign(0-087),,1,,
chr13:32338939:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-969),,1,8.237e-06,
chr13:32356526:C>T,,Ambry_Genetics|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-999),,1,,
chr13:32339053:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32347197:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093758:GA>T,,,,,,,,,,,,,,,Sweden,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32397009:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,0.0001163155,
chr17:43069061:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000399361,
chr13:32345190:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32340225:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-009),,1,3.295e-05,
chr13:32347000:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,
chr13:32337094:G>T,,,,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,2.471e-05,
chr13:32339095:TG>TGTG,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32350294:T>GT,,,,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0081869,
chr13:32339896:AA>C,,,,,,,,,,,,,,,,,"Latin American/Caribbean| hispanic/mexic| Hispanic""""|""""Latin American/Caribbean",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32339244:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43106467:G>C,,,In vitro (cloned),as wildtype control|moderate impact on protein function,E3 Ub-ligase activity assay BRCA1/RING-BARD1| Protease sensitivity BARD1|ubiquitin ligase,,,,,,,,,,Thai,,Thai|North Eastern Thai,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,
chr17:43077820:T>G,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr13:32338255:GAC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,
chr13:32380306:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32333148:T>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1,,pathogenic
chr13:32336721:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-315),,1,8.237e-06,
chr13:32359829:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32336893:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43110464:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32396131:T>A,,,,,,,,,,0.001,0.0,0.0029,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32390504:A>C,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00898562,
chr13:32344166:TC>G,,,,,,,,,,0.2972,0.2579,0.3084,0.3234,0.3507,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.304113,
chr13:32329423:TCA>C,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr13:32316476:A>C,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,
chr17:43051061:G>T,,,Germline (inherited),,,,,,,,,,,,Western Europe/Native American,,,IVS,,,,,,,,splice_donor_variant,HIGH,,19/21,-1,,,,,1,,
chr13:32338557:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-017),,1,,
chr17:43051074:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-017),,1,,pathogenic
chr17:43124022:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32356127:G>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.00159744,
chr17:43071995:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32338506:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43104953:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious|as variant control,E3 Ub-ligase activity assay BRCA1/RING-BARD1|evolutionary conservation analysis,,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,
chr17:43091628:A>T,,Sharing_Clinical_Reports_Project_(SCRP),Unknown|Germline (inherited),,,,,,,,,,,,W. Europe,,Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr13:32394843:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,0.0005189,benign
chr13:32339400:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-267),0&0&0&1&1,1&1&1&1&1,,
chr13:32318104:AGT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-267),0&0&0&1&1,1&1&1&1&1,,benign
chr13:32338208:TA>G,,,Unknown|Germline (inherited),,,,,,,,,,,,Spanish|-|Spanish?,,Western European|-|Caucasian,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32380138:A>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32346879:TACCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32379749:GTT>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&coding_sequence_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43104953:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,8.237e-06,
chr17:43091980:GCC>CA,,,,,,,,,,,,,,,-|Belgian?,1|-,Western-European|Western Europe|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32319082:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Germline (inherited), increased sensitivity|-|normal viability| reduced HR,-|Embryonic stem cell assay,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,
chr13:32337561:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-452),,1,,
chr17:43093249:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094141:TT>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32355094:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,probably_damaging(0-977),,1,,
chr17:43090107:G>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32340844:AA>A,,,,,,,,,,,,,,,,,Central/Eastern European| Greece,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1&1,,
chr17:43091981:CCC>C,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr17:43099769:A>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,,,
chr13:32327066:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32355094:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr17:43121362:A>C,,,,,,,,,,0.3559,0.1566,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.335264,
chr17:43093568:T>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43090939:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,,8.238e-06,
chr17:43070959:C>G,,,In vitro (cloned)|Unknown,predicted neutral|predicted deleterious|no functional effect|-,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|Western Europe|-,,"Western-European|Western European|-| Central/Eastern European""""|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.012,1.23,0.0182,0.00011,0.29,0.29,missense_variant,MODERATE,15/23,,-1,,deleterious(0),possibly_damaging(0-546),,1&1,1.647e-05,
chr13:32332385:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),probably_damaging(0-943),,,,
chr17:43106529:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43094630:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32340384:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-236),,1,3.295e-05,
chr17:43041893:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.87 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32390918:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32394833:AT>G,,,,,,1/1658|-,,,,,,,,,Czech|Polish|-,2|-,Central/Eastern European| Central/Eastern Europe|Western European|-|Polish (Upper Silesia)|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32340948:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-226),,,8.237e-06,
chr17:43094298:A>C,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted neutral|inconclusive|-,-|evolutionary conservation analysis,,,0.0|0.0454|0.0154,benign:0.002|None|None|benign:0.002|benign:0.002,0.0,0.0008,0.0,0.0,0.0,,,African American|Native American|African,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,0.0001204305,
chr13:32339537:T>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-387),,1,,
chr17:43092278:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338200:AAA>C,,,Unknown|Germline (inherited),,,1/238 patients|-|10/1658,,,,,,,,,Western Europe/Native American|Not Specified|-|Sweden|Czech|Austria|Ashkenazi|Western Europe|Belgian,1|0|-,"Western Europe/Native American|Central/Eastern European|German|Western European|-| English/German""""|Unknown|Ashkenazi| Dutch""""|African|Western Europe|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,9.082e-05,
chr17:43082488:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,8.236e-06,
chr17:43093795:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091457:A>T,,,,,,,,,,,,,,,German|-,,,Syn,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43091981:CT>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379337:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32339398:GAGTCA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43094206:TTT>C,,,,,,,,,,,,,,,Western Europe|-,,Western European|-,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32341053:C>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,1/1658,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,8.236e-06,
chr13:32332867:AG>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,pathogenic
chr17:43124331:G>C,,,,,,,,,,0.3579,0.2171,0.379,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353634,
chr13:32341624:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32316452:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr17:43106446:T>C,,,,,,,,,,,,,,,Asian/Latin American/Caribbean,,,IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr13:32338338:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-017),,,8.24e-06,
chr13:32371087:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-14),probably_damaging(0-999),,,8.237e-06,
chr13:32338403:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32318080:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9047,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.974241,benign
chr13:32370951:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0061,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/26,1,,,,,,0.00066079,
chr13:32326130:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32353515:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093130:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43099051:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000998403,
chr13:32394835:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr17:43091575:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363234:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-938),0&1&1,1&1&1,,
chr17:43045993:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32379822:ATCAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr17:43051048:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,1,,
chr13:32356458:T>AT,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,
chr13:32339139:A>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),probably_damaging(0-953),,,,
chr17:43095956:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000489021,
chr17:43061710:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32326151:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr13:32363189:T>A,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,Not Specified|-,,Western European|-|None Specified,M,,,,,,,,stop_lost,HIGH,18/27,,1,,,,,1,8.236e-06,
chr17:43093626:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32326151:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr17:43063926:A>G,,,In vitro (cloned),predicted deleterious,Structure-based prediction (crystallography etc)|Multifactorial likelihood-ratio model,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,,
chr17:43071135:TATGT>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32333292:G>TA,,,,,,,,,,,,,,,German|-,2|-,-|Caucasian|Filipino|Irish/Scottish,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32370556:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,,
chr17:43057558:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32398123:A>G,,,,,,,,0.0|0.0233|0.0078,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32326461:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,0.000103959,
chr13:32333353:T>A,,Ambry_Genetics,,,,,,,,,,,,,West/Central/East Europe,,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-26),benign(0-013),,1,,
chr17:43094390:G>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32336858:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,German,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-73),,,1,,
chr13:32369955:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32370556:A>G,,Medical_University_Innsbruck|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,
chr13:32339897:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,pathogenic
chr17:43091018:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,pathogenic
chr13:32329770:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000199681,
chr13:32337474:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,,1,,
chr17:43091701:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32376287:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32363391:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),possibly_damaging(0-904),,1,,
chr13:32340767:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.9541|0.3235,benign:0.255,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-207),0&1,1&1,,
chr17:43106790:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32373521:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32319232:A>C,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|no splicing defect|-|?,-|splicing reporter minigene/patient RNA analysis|Multifactorial likelihood-ratio model|?,1/1658|-,,,,0.0,0.0,0.0014,0.0,0.0,Not Specified|British?|Western Europe|-|Spanish,,Latin American/Caribbean|Columbia|Central/Eastern European|Not Specified|Western European|-|None Specified| Ashkenazi|Western Europe|Caucasian|Native American,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,0.0001821905,
chr13:32339847:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-48),benign(0-02),,1,,
chr17:43092568:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43071103:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European|Italian,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-12),possibly_damaging(0-527),,1,,
chr17:43092872:A>CT,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32397484:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32337423:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),possibly_damaging(0-562),,1,,
chr13:32362650:AG>A,,,,,,2/1658|-,,,,,,,,,South African|-,,Mixed Ancestry/Caucasian|-,F,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32337808:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-659),,1&1&1,,
chr17:43103002:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32338981:T>GA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32340842:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32336870:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-042),,1,,
chr17:43092438:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32344691:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.258e-06,
chr17:43094763:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,2.471e-05,
chr17:43063000:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr13:32340118:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32382570:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32371492:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.0141773,benign
chr13:32337953:C>A,,,,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-059),,1,,
chr13:32338226:A>T,,,,,,,,,,,,,,,German,,Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,8.267e-06,
chr13:32356591:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,
chr13:32333409:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,0&1,8.393e-06,
chr17:43076651:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0001204355,
chr17:43104119:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,,,,,1,,
chr17:43092800:CTGAG>C,,,,,,,,,,,,,,,-|Italian,1|3|2|-,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43063801:G>T,,,,,,,,,,,,,,,,3,,IVS,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr13:32325184:T>A,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,4/27,,1,,,,,1&1,4.119e-05,
chr13:32332292:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-38),benign(0-125),,1,,
chr13:32356433:TG>A,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr17:43057017:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0001894,
chr17:43057083:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,In vitro (cloned),predicted deleterious|as variant control|?|strong functional effect,Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|Far Western BRCA1/Cterm-BACH1|transcription activation/PS/BA/BS|peptide binding ability BRCA1:BACH1|Proteolytic degradation|?,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),probably_damaging(0-98),,1&1,,
chr13:32339791:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-159),,1&0,8.236e-06,
chr17:43103879:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000399361,
chr17:43099745:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.0001245505,
chr17:43079491:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43063987:GA>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,8.237e-06,
chr17:43063801:G>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,
chr17:43092551:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,0.000103959,
chr13:32329408:A>G,,,,,,,,0.0|0.0228|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr13:32396947:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43045414:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001679405,
chr13:32370445:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43093184:G>C,,,,,,,,,,,,,,,,,Asian|-Chinese/Taiwanese,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-05,
chr13:32319060:CT>A,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,,,,,,Sweden,,,IVS,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.009715,
chr13:32371040:T>A,,,In vitro (cloned)|Unknown,inconclusive|-,Protein likelihood ratio model|-,,,,,,,,,,,,Western European|None Specified| Central/Eastern Europe,M,,,,,,,,stop_lost,HIGH,20/27,,1,,,,,1&1,,
chr13:32385213:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00119808,
chr13:32326548:A>G,,Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32316522:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,2.471e-05,
chr13:32370423:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-05),possibly_damaging(0-755),,,,
chr13:32357844:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,benign(0-02),,1,,
chr17:43124049:ACAGGAGAATGAGAACACTTAGGTGATGCG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,1,,
chr17:43094020:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000106,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.696|None|None|possibly-damaging:0.696|possibly-damaging:0.696,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43067611:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-917),,1,,
chr17:43093313:T>G,,,Unknown|Germline (inherited),,,,,,,,,,,,Brazilian,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092292:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093393:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43063882:A>T,,,In vitro (cloned),no splicing defect|strong functional effect|predicted neutral|as variant control|predicted deleterious|very destabilizing,Transcription activation in yeast (GAL4-fusions)|splicing reporter minigene|transcription activation/PS/BA/BS|cDNA analysis|Thermodynamic stability prediction|evolutionary conservation analysis,,,,,,,,,,-|Spanish,,Western-European|-|Caucasian|None-Specified,M,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-869),,1&1,,
chr17:43058109:C>CTAGCACTT,,,,,,,,,,0.005,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00119808,
chr13:32339269:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32355033:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32338016:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32376723:C>T,,,,,,,,0.0116|0.0|0.0077,benign:0.022,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,0&1&1,0&1&1,,
chr13:32396827:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32390046:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,benign
chr13:32340073:CTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43119075:T>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32320223:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43093144:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,Western European| Asian,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,3.295e-05,
chr17:43094648:TG>C,,,,,,,,,,,,,,,,,Western European|White-NonHispanic,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32332753:T>G,,,,,,,,,,0.0,0.0227,0.0,0.003,0.0,Malaysian|-,,-|Chinese,Syn,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,0.00397423,
chr17:43104348:C>G,,,,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,1,,
chr13:32398118:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.249e-06,
chr13:32341151:T>C,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),probably_damaging(0-982),,1,,
chr17:43099852:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1,,
chr13:32399071:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43044985:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001704905,
chr13:32334491:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000599042,
chr17:43091515:T>TC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340133:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338031:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-949),,1,,
chr13:32344757:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr17:43051131:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,0.0233|0.0227|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,1,,
chr17:43071212:A>C,,,,,,,,,,,,,,,,,"""""Western European| English| Irish| German| Italian""""",M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,tolerated(0-33),benign(0-003),,1,,
chr17:43087911:G>C,,,,,,,,,,0.0268,0.0023,0.0274,0.003,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0115815,
chr17:43091872:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,5.765e-05,
chr17:43091872:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32332387:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.238e-06,benign
chr17:43125979:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32377423:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32332304:GTAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,pathogenic
chr17:43097258:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,8.237e-06,
chr17:43049234:T>G,,,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr17:43094279:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340113:T>GT,,,,,,,,,,,,,,,Czech|-,,Western European|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326554:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43060065:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr17:43092655:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,8.236e-06,
chr13:32340259:AGTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr13:32339761:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),probably_damaging(0-992),,1,2.471e-05,
chr13:32316452:G>C,,,,,,,,,,,,,,,,,Western European|Western Europe| Irish|None Specified| Central/Eastern Europe,5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,8.237e-06,
chr17:43092020:T>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32355282:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-24),benign(0-377),,1,,
chr17:43076559:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,,8.237e-06,
chr17:43093650:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093650:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32355282:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-26),benign(0-377),,1,,
chr13:32340528:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32367159:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32338770:AGAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32326590:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32355233:->G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,,,pathogenic
chr17:43124935:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0874 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0155751,benign
chr13:32370424:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-04),probably_damaging(0-99),,,,
chr17:43091865:CTC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-04),probably_damaging(0-99),,,,
chr13:32336581:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.236e-06,
chr13:32333022:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-055),,,,benign
chr17:43093844:G>A,,Medical_University_Innsbruck|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32346437:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr13:32319350:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,1.649e-05,
chr13:32337806:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,8.236e-06,
chr17:43115767:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43102519:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0072,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00139776,
chr13:32338202:GT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43121078:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3339 (Asian)| 0.2114 (African)| 0.3509 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43091809:A>T,,,,,,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43094147:C>T,,Ambry_Genetics|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43097305:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,,
chr17:43063347:GTT>T,,,,,,,,,,,,,,,Dutch,,,F,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,,,
chr17:43124125:T>G,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|-,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,,,,,0.0,0.0008,0.0,0.0,0.0,Malaysian|American|-|USA,1|-,-Phillipino|Western European|Latin-American/Caribbean|-|Malay|Palauan|Ashkenazi| Asian|African American|None-Specified|None Specified|Asian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001204505,
chr17:43057062:C>TG,,,In vitro (cloned)|Unknown|Germline (inherited),-|as variant control|?,-|peptide binding ability BRCA1:BACH1|?,,,,,,,,,,USA|Western European|Lithuania|Dutch?|Ashkenazi/Central/Eastern Europe|Ashkenazi|Dutch|Belgian|Danish|Central/Eastern Europe|Not Specified|-|French|Near East/Mid East|French?|Canadian|Greek|Latvian|Polish|Italian|Danish German|Czech|German|Austria|Austrian|Western Europe|Belgian?,1|3|2|-|830,"East-European-Jewish|Western/Central/Eastern Europe|-German| Central/Eastern Europe|Western European|Native-American|5385insC|""""Central/Eastern European|-Central/Eastern-European|Ashkenazi/Central/Eastern Europe|Southern Italian|Ashkenazi| Polish""""| Russian|Irish/German|Ashkenazi-Jewish|French/German|Caucasian|German/Ukranian/Polish|Latin American/Caribbean|Danish|Polish/Slavic/Eastern|Lat/Rus|-Polish|Central/Eastern Europe|Polish|Not Specified| Asian""""|Lithuanian|-|-Mayan| Italian| Jewish""""|Native American|Unknown|Western-European|-German/Iris|-Italian| Ashkenazi""""|Not-Jewish|Ashkenazi Jewish| Central/Eas| Central/Eastern European|Near-Eastern| Czech|French-Canadian /German/Scottish|Rus/Ukr|Irish/Polish|Russian| Central/Eastern European""""|W. Europe/E.-Central Europe| Russian""""|Latvian|Russian/Polish|Halian Meditteranean|-French-Cana|Central/Eastern-European|Latin-American/Caribbean|None Specified|Italian|-Near-Eastern|Central/Eastern Europe/Latin American/Ca| Native American""""|Central/Eastern European|Greek|German|-Syria/Middle-Eastern|""""Western European|Jewish|-Ashkenazi|""""Ashkenazi|-Central/Eastern-Europe| Ashkenazi|Ashkenazi/Western Europe|Austrian|Western Europe|Polish/Russian|Polish/German/Ukranian|None-Specified|Caucasion|-Central/Eas",F,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,0.0001565,
chr17:43110966:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32337333:C>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr17:43110978:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43074782:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32349488:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32362520:G>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,,,
chr13:32336325:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32319335:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr17:43076645:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.237e-06,
chr17:43072249:G>T,,,,,,,,,,0.0,0.0091,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00259585,
chr13:32337152:GA>A,,,,,,,,,,,,,,,,,Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051700:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43095705:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32333274:CTTAT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32366616:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32339011:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr17:43093618:CT>T,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32337917:A>G,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|GeneDx|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-006),,1,,
chr13:32347695:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43097313:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,1.649e-05,
chr13:32338894:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr17:43047679:CTTCTCC>G,,,,,,,,,,,,,,,,3,,IFD,,,,,,,,protein_altering_variant,MODERATE,21/22,,-1,,,,,,,
chr17:43047712:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.0001039585,
chr13:32340368:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),,1,1.647e-05,
chr17:43097262:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,,
chr13:32363305:C>G,,,,,,,,,,,,,,,German,1,,Syn,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,
chr13:32357886:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,pathogenic
chr13:32357949:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.236e-06,
chr13:32339547:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-138),,,8.24e-06,
chr13:32332375:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32396938:C>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43062098:GGCG>C,,,,,,,,,,0.0298,0.003,0.0216,0.0,0.0061,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0109824,
chr17:43120943:A>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32341116:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32326136:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,,8.24e-06,
chr17:43116588:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32356622:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,1.647e-05,
chr13:32371000:TGATG>A,,,,,,,,,,,,,,,,,Canadian/Western Europe|Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,
chr13:32396856:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32376838:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,
chr17:43063335:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,deleterious(0-01),,,1,,
chr13:32339253:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-281),,1,,
chr17:43094607:TG>G,,,,,,,,,,,,,,,,,None-Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32334492:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1626 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43091989:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32396248:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32355104:AGC>C,,,,,,,,,,,,,,,,,Central/Eastern Europe,F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43094092:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363265:G>C,,,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,,,Western European|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32351127:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43093975:T>-,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43093901:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43110899:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43094567:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32341251:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32385327:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0143,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00279553,
chr17:43090905:CCAAGCCCAGCTGTCAGGC>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.258e-06,
chr17:43094007:TG>A,,,,,,,,,,,,,,,American,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43095864:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,benign
chr13:32371067:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-917),,1,,
chr13:32393109:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43061876:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43046252:G>T,,,,,,,,,,0.0,0.0015,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000998403,
chr13:32358643:T>G,,,,,,,,,,0.004,0.0,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00119808,
chr17:43045774:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,
chr13:32339571:TTTTTTT>A,,,,,,,,,,,,,,,China,,Chinese,IFD,,,,,,,,protein_altering_variant,MODERATE,11/27,,1,,,,,,,
chr13:32326272:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Western Europe|-,,"Central/Eastern Europe| Central/Eastern European""""|Not Specified|Western European|-| Asian|Western Europe|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1&1,4.119e-05,
chr13:32338070:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,8.237e-06,
chr17:43062421:TGGT>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32357843:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43104861:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Splicing reporter minigene|-|Multifactorial likelihood-ratio model,,,0.0349|0.0|0.0231,None|None|None|None|None,,,,,,,,"-German|Central/Eastern European| Central/Eastern European""""|Western European|-|-Central/Eastern-Europe| Ashkenazi|Western-European|Western Europe|None-Specified|None Specified|""""Western European",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1,0.0001153,
chr17:43094567:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43070602:T>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000998403,
chr13:32362595:C>A,,,,,,,,,,,,,,,HKSAR,,Chinese,N,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1&1&0,,
chr13:32346886:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0-02),benign(0-19),,1,,
chr13:32328777:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32340235:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,1.647e-05,
chr13:32337078:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-984),,,,
chr17:43094567:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr13:32338248:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Not Specified|-,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-036),,1,,
chr17:43094562:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr17:43071127:T>A,,,,,,,,,,,,,,,,1,,M,,,,,,,,stop_lost,HIGH,15/23,,-1,,,,0&1&1,1&1&1,,
chr17:43124505:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43074368:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,benign
chr13:32336943:AG>GT,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-009),,,8.238e-06,
chr17:43076569:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.237e-06,
chr13:32370429:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-11),benign(0-005),,1,,
chr13:32341077:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(0-96),,1,,
chr17:43099774:T>A,,,,,,-|1/1658,,,,,,,,,Western Europe|-,,Western European|-,IVS,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,8.236e-06,
chr13:32339151:TC>A,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051468:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43053776:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32333030:A>C,,,,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),possibly_damaging(0-735),,1,,
chr13:32398160:T>G,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332722:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-22),benign(0-022),,1,,
chr17:43102801:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0248,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00499201,benign
chr17:43097301:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,,
chr13:32338789:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43049182:G>T,,,,,,,,,,,,,,,,,White-NonHispanic|-|Western European,N,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,
chr13:32337659:G>T,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European|Western Europe,M,1 - Not pathogenic or of no clinical significance,1.0,1.38038,0.00295,8e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-508),,1,2.472e-05,
chr17:43093930:A>C,,,,,,,,,,,,,,,,,Western-European|None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43092103:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr17:43092103:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr13:32340798:AATTT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32319195:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363263:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43091713:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094438:AATCCCAGCATT>T,,,,,,,,,,,,,,,Swedish|Sweden|-|English/German/Swede,,Not Specified|Western European|-|Caucasian|Unknown|Western-European|None-Specified,F,,,,,,,,frameshift_variant&stop_retained_variant,MODIFIER,,,-1,,,,,,2.471e-05,
chr13:32370933:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,1.647e-05,
chr17:43108791:T>G,,,,,,,,,,0.3579,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.353035,
chr13:32332875:A>G,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,benign:0.325,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-027),,1,,
chr13:32326239:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,,
chr17:43091916:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr13:32379039:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43093004:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340368:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),,1,,
chr17:43124094:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1,,pathogenic
chr13:32394146:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43074172:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43121405:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32326239:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,5.766e-05,
chr17:43094054:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,,pathogenic
chr13:32332565:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-029),,,,
chr13:32337871:C>A,,,Unknown|Germline (inherited),,,5/1658|-,,,,0.007,0.0,0.0,0.0,0.001,German|Austria|-,1|0|2|-,-|Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.00227722,
chr17:43051113:T>G,,,In vitro (cloned),strong functional effect,transcription activation/PS/BA/BS,,,,,,,,,,,,Western-European,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-262),,1,,
chr13:32326483:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,None Specified,IVS,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,
chr13:32363370:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,deletion 164 nt from 3' end exon 18|predicted deleterious|-|as variant control,Multifactorial likelihood-ratio model|splicing reporter minigene|-|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood model,1/1658|-,,,,,,,,,,,Latin American/Caribbean|Western European|Central/Eastern European|None Specified,M,5 - Definitely pathogenic,1.0,1.59,75.86,0.998,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43092388:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0454|0.0154,probably-damaging:0.985|None|None|probably-damaging:0.985|probably-damaging:0.985,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32330921:C>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,,,
chr17:43092765:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,,,pathogenic
chr13:32363370:A>C,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted deleterious|inconclusive|-|as variant control,Protein likelihood ratio model|Homology-directed repair assay|-|Centrosome amplification|Multifactorial likelihood-ratio model,-|3/1658,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1&1,8.236e-06,
chr17:43074418:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.236e-06,
chr17:43074611:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,Malaysian,,Indian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,0.000199681,
chr13:32340363:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-009),,1,,
chr13:32336507:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-12),,1,,
chr13:32351214:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32363498:TT>A,,,,,,7/1658,,,,,,,,,Irish|Central/Eastern Europe|Not Specified|-|British?|Western Europe|W Europe/Central-E Europe|Native American,,Not Specified|Western European|-|None Specified| Ireland|Western Europe| Caucasian,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32361583:T>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr13:32363370:A>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43092185:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,benign:0.003|None|None|benign:0.003|benign:0.003,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43092388:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43092292:G>T,,,,,,2/1658,,,,,,,,,-|Italian,,Western Europe|-|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32340057:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-373),,1,1.647e-05,
chr17:43051041:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000103959,
chr13:32340629:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-233),,1,,
chr13:32340322:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32346185:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32338918:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Emory_Genetics_Laboratory,,,,,,0.0582|7.0391|2.4227,None,0.999,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.983521,benign
chr13:32389575:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0327,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00638978,
chr13:32332316:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-48),benign(0-081),,1,,
chr13:32337050:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-222),,,0.000103959,
chr13:32341191:TA>CTTTGTGGTAAGTTT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124032:T>G,,,In vitro (cloned),predicted deleterious,Statistical prediction model,,,,,,,,,,,,Central/Eastern European,M,5 - Definitely pathogenic,,,38.88,0.994,0.81,0.81,stop_lost,HIGH,,,-1,1.0,,,,1&1&1,,
chr13:32372708:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32356427:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,14/26,1,,,,,,,
chr17:43094848:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32325701:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0965,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0742812,benign
chr17:43088488:C>T,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000798722,
chr17:43104081:GATTTCC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,5.614e-05,
chr13:32353275:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43092568:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,1.647e-05,
chr13:32379831:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.238e-06,
chr13:32338085:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-12),,,,
chr17:43084026:C>A,,,,,,,,,,0.0,0.0287,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00758786,
chr13:32339990:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43067680:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-876),,1,,
chr17:43091408:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092700:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32397054:C>G,,,,,,,,,,,,,,,African American|-,,African American/Polish|-,UV|IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32395964:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1416 (Asian)| 0.1118 (African)| 0.1979 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0005417,benign
chr13:32339990:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0465|0.0|0.0308,benign:0.14,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-064),,1,,
chr17:43087456:C>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr13:32339281:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-196),,,,
chr13:32389714:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339044:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,
chr17:43094075:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?,Recombination rate|Clonogenic assay|co-occurrence with deleterious variant|-|Grantham score|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,2/1658|-,,,,0.0,0.0,0.0,0.0,0.001,Not Specified|-,,"""""Near Eastern|Western European| Sephandic""""|Ashkenazi|Near East/Mid East| Central/Eastern European""""|Western/Central/Eastern Europe|-|-Italian|Western-European|""""Western European|African|Central/Eastern-European|None Specified| Egypt""""|-Near-Eastern|Central/Eastern European|""""Ashkenazi| Yemen - Sephardic""""|Asian|Near Eastern|French Canadian|Western Europe|None-Specified",M,1 - Not pathogenic or of no clinical significance,0.0007,9.1225E-07,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,0.0002480905,
chr13:32356537:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,8.236e-06,
chr17:43097267:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32316589:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.44|0.1445|0.3504,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32379472:GT>G,,,,,,,,,,,,,,,,,Asian| Pakistan,F,,,,,,,,frameshift_variant&stop_lost,HIGH,22/27,,1,,,,,,,
chr13:32333294:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-047),0&1&1,0&1&1,,
chr17:43097267:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr17:43047652:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,,possibly_damaging(0-67),,1,,
chr13:32332675:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.239e-06,
chr13:32336359:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr17:43077829:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32362603:T>A,,,,,,,,,,,,,,,Australian,,,N,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,
chr17:43094401:A>CT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094837:C>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43084276:C>T,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr17:43049030:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr13:32338215:ATAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43094649:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43094297:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32380064:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43054219:T>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32354919:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),possibly_damaging(0-801),,,,
chr13:32374083:C>G,,,,,,,,,,0.0,0.0197,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00519169,
chr13:32320976:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32336951:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),,,1,,
chr13:32340786:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-045),,0&1,8.239e-06,
chr17:43057080:CTCGATTGCTAGCTCCCTCCCTGCCAGTTTCCAGGCTGGGA>TGA,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant&stop_lost,HIGH,18/22,,-1,,,,,,,
chr13:32355289:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,14/26,1,,,,,,8.238e-06,
chr17:43115723:C>G,,,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,,,,,,,,,,Ashkenazi/Central-Eastern Europe|American,,German/Italian|-,Splice|IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,1&1&1,,
chr17:43092485:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093043:AA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43115785:C>G,,,In vitro (cloned),inconclusive,Histopathology,,,,,,,,,,,," Native American| French Canadian""""|Not Specified|Western European|Western-European|None-Specified|""""Western European",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,2/22,-1,1.0,,,,1&1,2.471e-05,
chr17:43092591:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/22,-1,1.0,,,,1&1,,pathogenic
chr13:32337387:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,,
chr13:32394606:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.1463 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,no splicing defect|-,-|splicing reporter minigene/patient RNA analysis,2/1658|-,,,,0.003,0.1392,0.062,0.0208,0.002,Austria|-,1|0|-,,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,0.0505192,
chr13:32338488:CTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr13:32341089:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),possibly_damaging(0-689),,,8.236e-06,
chr13:32336956:T>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43115785:C>T,,,In vitro (cloned)|Unknown,-|as variant control,-|cDNA analysis,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/22,-1,1.0,,,,1&1,,
chr17:43105477:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr13:32396973:GTG>A,,,,,,,,,,,,,,,,,,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32321283:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000399361,
chr13:32355257:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,1.647e-05,benign
chr13:32376194:C>A,,,,,,,,,,0.0,0.0023,0.0101,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00259585,
chr13:32340645:A>T,,,In vitro (cloned),,,,,,,,,,,,,,Western European|-|African,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-901),0&1&1,1&1&1,0.0001153,
chr13:32357942:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,1,,
chr13:32398667:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43097312:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,8.244e-06,
chr13:32356553:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-1),benign(0-077),,1,,
chr17:43067405:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43119021:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr13:32333270:A>G,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.1746|0.0908|0.1462,benign:0.01,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-82),benign(0-006),,1&1,,
chr17:43092439:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32372599:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43076585:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43099768:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,0&1,8.236e-06,
chr17:43093818:T>C,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001080755,
chr17:43091831:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32337977:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),,,1,,
chr17:43074531:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32328764:C>G,,,,,,,,,,0.0,0.0129,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00359425,
chr13:32326334:C>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,,
chr17:43104194:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,6/23,,-1,,,,,,4.118e-05,
chr13:32332624:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-067),,1,,
chr13:32338890:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-54),benign(0-172),0&0&0&1&1,1&1&1&1&1,,
chr17:43045684:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,,,1,1.647e-05,
chr13:32394781:TCA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32339979:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-029),,1&1,,
chr17:43092609:T>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43070984:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,0&0&1,1&1&1,,
chr13:32355201:TTCAGT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32379391:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43045492:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,1.237e-05,
chr13:32338354:T>G,,,,,,,,,,,,,,,,,Latina,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-03),,1,8.238e-06,
chr17:43048353:C>A,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000399361,
chr13:32338293:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-137),,1,,
chr13:32335103:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43094234:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32346988:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43074441:A>C,,,In vitro (cloned),predicted neutral,evolutionary conservation analysis,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,1&1,,
chr17:43085741:A>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32394731:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-986),,,8.236e-06,
chr17:43093388:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340631:A>TC,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr17:43109925:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32339940:TGAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32336819:G>C,,,,,,,,,,,,,,,,,Western European| Latin American/Caribbe,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1,,
chr13:32380079:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32338833:AAAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32380079:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32340852:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-384),,,,
chr13:32397043:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092586:G>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32346831:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,,8.239e-06,
chr17:43045772:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-883),,1,,
chr13:32340659:A>T,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-037),,1,,
chr13:32336772:T>G,,,,,,,,,,,,,,,,,Western European| Native American,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,1,,
chr17:43093091:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340915:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),probably_damaging(0-932),,1,,
chr17:43074330:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32339543:A>T,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),possibly_damaging(0-745),,1&1,1.648e-05,
chr13:32338542:C>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,0.0,0.0076,0.0,0.0,0.0,Not Specified|African American|-,,"Latin American/Caribbean| Latin American/Caribbean|Western European| Mexican|-|African American/Latin American/Caribbea|""""African|African| African| African""""|African American|None Specified| West Indies""""|Native American|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.02512,0.0182,0.95499,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-089),,1&1,0.001245555,
chr17:43082586:T>A,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,1,3.295e-05,
chr17:43112723:CCT>T,,,,,,,,,,0.3598,0.7262,0.3977,0.3661,0.5225,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.494808,
chr13:32340686:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-212),0&1&1,0&1&1,4.942e-05,
chr17:43127210:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32362665:CC>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr13:32340680:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,Not Specified|-,,"Not Specified|""""Asian|-|Asian| Japanese""""",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-73),benign(0-021),,1&1&1,0.0003355805,
chr13:32337807:GG>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43074330:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Germline (inherited),predicted deleterious|-|?,Splicing reporter minigene|-|Multifactorial likelihood-ratio model|?,,,,,,,,,,Czech|-,,Western European|-|Western-European|Western Europe|Caucasian|None Specified,IVS,5 - Definitely pathogenic,1.0,1.55,128.82,1.0,,0.97,splice_donor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32376702:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,8.236e-06,
chr17:43127753:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43085134:G>C,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32376529:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32318748:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43082506:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000152,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European,M,1 - Not pathogenic or of no clinical significance,1.0,1.15,0.00427,0.00073,0.02,0.13,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,1,,
chr13:32333398:C>T,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,
chr17:43051090:GG>A,,,,,,,,,,,,,,,,,Near-Eastern,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,
chr13:32329399:A>C,,,,,,,,0.0117|0.0|0.0078,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,8.261e-06,
chr13:32355268:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),probably_damaging(0-911),,1,,
chr13:32340335:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),,,,,,,,,,,,,,-|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32337263:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43057038:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,
chr17:43078435:G>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000199681,
chr13:32377223:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43093153:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332375:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr13:32338767:TTT>TAA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,2.471e-05,
chr13:32325041:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,1.648e-05,
chr17:43086114:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000399361,
chr13:32376683:CT>A,,,,,,,,,,,,,,,Polish,,,F,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,,,
chr17:43119264:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43091907:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43067646:AGATTAGTTAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43101157:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32398598:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32330947:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43091962:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,0&1&1,8.237e-06,
chr17:43092862:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000408,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Germline (inherited),predicted neutral|predicted deleterious|-,-|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,0.0|0.0227|0.0077,benign:0.004|None|None|benign:0.004|benign:0.004,,,,,,-|Central/Eastern Europe,,Western-European|Western European|-|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,1.45,0.00014,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1,1.647e-05,
chr17:43067609:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,15/22,,-1,,,,0&1&1,1&1&1,,
chr13:32332424:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-466),,,,
chr13:32351102:A>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr17:43094635:->CATT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32380067:A>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,tolerated(1),,,,,
chr17:43104220:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,tolerated(1),,,,,pathogenic
chr13:32391627:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0303,0.0908,0.0962,0.136,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0734824,benign
chr13:32376705:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,,,0.0116|0.0|0.0077,probably-damaging:0.983,,,,,,,,Not Specified|None Specified,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,2.471e-05,
chr17:43085321:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32339501:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),benign(0-007),,1,,
chr13:32337443:A>G,,,,,,,,,,,,,,,,,"Western/Northern Europe|Western European| French Canadian""""|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-02),,1,,
chr17:43093546:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093010:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?|inconclusive,-|Bayesian statistics|Grantham score|Prevalence in normal controls|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,-|10/1658,,,,0.005,0.003,0.0,0.0,0.002,Western Europe/Ashkenazi|German|Unknown|-|French|Not Specified|Austria|Spanish|Western Europe,1|3|-,Western Europe/Latin American/Caribbean|Western-European|Central/Eastern Europe|Not Specified|Western European|Latin-American/Caribbean|-|None-Specified|-Central/Eastern-European| English/Irish|-Central/Eastern-Europe|None Specified|African American| Near Eastern|Carribean|Western Europe|Caucasian|Native American|Ashkenazi,M,1 - Not pathogenic or of no clinical significance,4e-09,0.028,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,0.001963245,
chr13:32362688:C>G,,,In vitro (cloned),no splicing defect,splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,,,,,,
chr17:43104847:A>CT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,2.471e-05,
chr13:32344526:TTGGCATTTCTCAATTTCTGGGAGAAAAT>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,11/26,1,,,,,,,
chr13:32319323:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,4/1658,,,,,,,,,,,Western European|Western Europe|None Specified,N,,,,,,,,stop_gained&splice_region_variant,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr13:32333052:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,
chr13:32337430:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-132),,1,,
chr17:43123628:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.2114 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43045658:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32336712:T>G,,,,,,,,,,,,,,,,,Not Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-225),,1,,
chr17:43045734:C>A,,,,,,,,,,,,,,,,,Western-European|Western European,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,
chr13:32337824:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Asian| Samoan,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32333052:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,2.471e-05,
chr17:43094276:C>-,,_University_of_Chicago|Genetic_Services_Laboratory|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,pathogenic
chr17:43094667:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32333167:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr13:32380066:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr17:43108335:T>CA,,,,,,,,,,0.2694,0.171,0.2622,0.3056,0.4151,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.278155,
chr13:32333283:CA>G,,,,,,1/1658,,,,,,,,,Danish|German|-|Thai|Western Europe|Italian,,Irish/English/Scottish|Thai/Chinese|Central/Eastern European| Central/Eastern Europe|Not Specified|Western European|-|French-Canadian/Italian|None Specified|Caucasian|Native American,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,1&1,1&1,,
chr13:32396326:C>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr17:43095844:AT>A,,,In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1,,
chr17:43085936:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32320807:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00599042,benign
chr13:32338670:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0),0&1&1,1&1&1,,
chr17:43094083:T>G,,,,,,,,,,,,,,,,,Western European|None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092829:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32376642:AGCCTTTCTGCACAGAGAGCACAGCAG>T,,,,,,1/1658,,,,,,,,,,,Western European,IVS,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,20/26,1,,,,,,,
chr13:32340182:TC>T,,,,,,,,0.0121|0.0|0.0080,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr17:43047694:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,,benign(0-006),,1,,
chr13:32362574:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43107537:G>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000998403,
chr17:43093453:A>TTA,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091173:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43082397:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,11/21,-1,,,,,1,8.236e-06,
chr17:43092306:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32328451:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32349556:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43057071:C>G,,,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control|strong functional effect,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|-|Transcription activation in human cells,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-299),0&0&1&1,1&1&1&1,,
chr13:32329511:T>GA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,
chr13:32338394:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-126),,1,,
chr13:32329924:T>A,,,,,,,,,,0.0,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000399361,
chr13:32331031:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,pathogenic
chr13:32355298:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,8.238e-06,
chr13:32340446:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093193:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32354862:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,14/27,,1,,,benign(0-046),,1,,
chr17:43094218:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338032:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32326631:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32333017:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,0.000199681,
chr17:43090934:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43124135:A>CAT,,,In vitro (cloned),predicted neutral,Splicing reporter minigene,,,,,,,,,,-|French,,-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43093193:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093193:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337628:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32363524:T>TA,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,
chr13:32368998:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01829 (African)| 0.03958 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32338354:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-44),benign(0-03),,1,,
chr17:43106528:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr13:32379506:T>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,None Specified,M,,,,,,,,stop_lost,HIGH,,,1,,,,,1,5.766e-05,
chr17:43106528:T>CA,,,,,,,,,,,,,,,,1|-,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1&1,,
chr13:32337522:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-591),,1&1,,
chr13:32346846:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,tolerated(0-11),benign(0-082),,1,,
chr13:32383203:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32333187:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-28),benign(0),,1,,
chr13:32328640:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32319298:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43093295:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32316567:G>A,,,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,3.301e-05,
chr17:43099779:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr17:43057113:GGCT>T,,,,,,,,,,,,,,,,," Central/Eastern European|Central/Eastern European| Central/Easter| Cezch""""| English|""""Western European|None Specified| None Specified",IFD,,,,,,,,inframe_deletion,MODERATE,18/22,,-1,,,,,,,
chr13:32339080:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43062062:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32357721:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1,0.000517821,
chr13:32316090:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3374 (Asian)| 0.128 (African)| 0.2124 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32384439:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000599042,
chr13:32339700:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-007),0&1&1,1&1&1,8.237e-06,
chr13:32360873:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32336220:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,8.241e-06,
chr17:43090961:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,,8.237e-06,
chr13:32398753:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.88,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338169:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.0,,,,,,,,Western European|Asian| Italy,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-006),,1&1&1,1.648e-05,
chr13:32376639:G>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.0001204305,
chr13:32355095:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,0&1,1&1,8.237e-06,
chr17:43092919:C>T,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,
chr13:32379723:GGCTCACTAC>TCATCTTTCT,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32336694:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093351:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339860:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-049),,1,,
chr13:32330942:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43085908:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43091458:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43082403:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,,pathogenic
chr17:43091770:T>TA,,,,,,,,,,,,,,,,1|-,-|Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr13:32363225:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-996),,1&1,,pathogenic
chr13:32328622:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43063373:A>G,,,In vitro (cloned),predicted deleterious|strong functional effect,transcription activation/PS/BA/BS|evolutionary conservation analysis|Structure-based prediction (crystallography etc),,,,,,,,,,,,Western Europe,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-962),,0&1&1,,
chr17:43092919:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?,-|Multifactorial likelihood-ratio model|?|evolutionary conservation analysis,490/1658|-,,,,0.3628,0.885,0.428,0.371,0.5297,USA|German|-|Spanish|Malaysian|Austria|Greek|American|Slovak|U.S.A.|Australian,14|-|1|0|2|412,Chinese|Turkish|-|Malay|Greek|Indian|Latina|Central Europe|African American|Caucasian,M,1 - Not pathogenic or of no clinical significance,,<1e-10,,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,0.476965,
chr17:43051118:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43045709:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-975),,1,,
chr13:32338515:C>TGGAAG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43051118:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr13:32355131:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,2.471e-05,
chr13:32316549:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.239e-06,
chr13:32347584:C>A,,,,,,,,,,0.0258,0.0,0.0101,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00698882,
chr17:43051118:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43057088:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43063926:T>C,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,,benign
chr17:43082403:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern-European|-,IVS,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,,pathogenic
chr13:32337134:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,
chr17:43059207:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32339385:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-06),,1,,
chr17:43049188:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,,
chr13:32332456:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Histopathology|-|?,2/1658|-,,,,0.001,0.0,0.0,0.0,0.0,German|Not Specified|Western Europe|Western/Central/Eastern Europe|-,," Portugese| Slavic Italian| French Canadian""""| Latin American/Caribbean""""|Western European|Ashkenazi| Germany| French Canadian|Caucasian|Latin American/Caribbean|Not Specified|Western/Central/Eastern Europe|-|Native American|""""Western European|None Specified| Native American| Native American""""|Central/Eastern European| Italy|""""Ashkenazi| Ashkenazi|Western Europe",M,1 - Not pathogenic or of no clinical significance,,0.001,7.92,0.00058,0.02,0.02,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),possibly_damaging(0-595),,1&1,0.0004993405,
chr17:43091918:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43124016:T>A,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,
chr17:43093523:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,American,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093738:T>C,,,,,,,,,,,,,,,,,Pakistani,N,,,,,,,,stop_retained_variant,MODIFIER,,,-1,,,,,1&1&1,1.647e-05,
chr17:43051043:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,
chr17:43054613:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43049347:G>C,,,,,,2/1658,,,,0.0835,0.0061,0.0576,0.0,0.0297,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.0321486,
chr13:32339385:G>T,,Invitae,,,,,,0.0|0.0228|0.0077,benign:0.09,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-921),,1,,
chr13:32339522:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-02),,1,,
chr13:32357820:C>GA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,8.236e-06,
chr17:43124055:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western-European,Syn,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,
chr13:32338214:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,pathogenic
chr17:43063332:G>T,,,,,,-|1/1658,,,,,,,,,,,None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,
chr17:43094061:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43125337:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.0002934,
chr13:32338988:AA>C,,,,,,,,,,,,,,,,,Western European|Western Europe|Central/Eastern European|None Specified|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43074353:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,2.471e-05,
chr17:43074353:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32328408:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32339261:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-52),benign(0-044),,1,8.239e-06,
chr13:32363182:T>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1&1,,
chr17:43051371:G>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43090381:A>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000998403,
chr13:32363182:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1&1&1,,benign
chr13:32332581:C>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43124139:T>C,,,,,,,,0.0|0.0455|0.0154,None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43094514:T>CT,,,,,,,,,,,,,,,Latin American/Caribbean|French?|Not Specified|Italian|-|Norwegian|Spanish|Austrian|Western Europe|Venezuelan|Czech,1|2|-|4,Western European|-|Caucasian (Norwegian)|-Central/Eastern-Europe|Ashkenazi|Western-European|Austrian|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,1&1,1&1,,
chr13:32394734:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,,,,,,,,Not Specified|-,,-|Central/Eastern European,M,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32394734:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32323201:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43121444:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr17:43071885:T>A,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000599042,
chr17:43067690:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.1817|0.0615,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,1,,benign
chr13:32359439:A>G,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000599042,
chr13:32339146:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43051118:AATA>C,,,,,,,,,,,,,,,Spanish,,,IVS,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,18/21,-1,,,,,,,
chr17:43061643:G>C,,,,,,,,,,0.3598,0.2179,0.2925,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.342053,
chr13:32337281:T>A,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-06),,,0.001572935,
chr13:32340504:GT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32361400:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32379896:G>T,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,
chr17:43094608:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43104162:GCC>G,,,,,,,,,,,,,,,German,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32394546:C>A,,,,,,,,,,0.0,0.0234,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0061901,
chr17:43111066:C>G,,,,,,,,,,0.0,0.0272,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0071885,
chr17:43091904:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43045683:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious_low_confidence(0),probably_damaging(0-969),,,8.236e-06,
chr13:32325634:C>A,,,,,,,,,,0.0,0.003,0.0014,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00179712,
chr17:43057114:G>A,,,In vitro (cloned),predicted deleterious|strong functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,Indian,,Asian,M,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-631),,1&1&1,,
chr17:43087455:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.1321 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32340341:T>A,,,Unknown|Germline (inherited),,,,,,,0.0,0.0,0.0,0.0,0.0072,Malaysian|-,,Not Specified|Indian|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-682),,1,0.00095833,
chr17:43111413:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01451 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0139,0.0,0.0058,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00399361,benign
chr13:32337512:CATGC>T,,,,,,2/1658,,,,,,,,,,,Western European| Ashkenazi,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093610:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43078520:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43104144:GAACAAGG>C,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32339157:T>G,,,,,,,,,,,,,,,,,Western European| English,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-037),,1,,
chr17:43092892:TC>GT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32380243:A>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00139776,
chr13:32376699:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000248,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.816,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1,,
chr13:32356557:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-986),,1&1,,
chr17:43093976:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr17:43124110:T>G,,,,,,,,,,,,,,,Western Europe,,,5'UTR,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43114021:T>GC,,,,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00499201,
chr13:32398790:AC>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32371223:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43099859:G>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000389,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1&1,,
chr13:32354484:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32338030:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Malaysian,,Malay,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32332641:TACC>TACCTACC,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32371003:AGAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32336504:TG>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&1,,
chr13:32326302:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.238e-06,
chr13:32363180:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,Protein likelihood ratio model|-|Co-segregation in families|family history,,,,,,,,,,-|Dutch,,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/27,,1,,deleterious(0-02),probably_damaging(1),,1&1,,
chr17:43079329:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,8.599e-06,
chr13:32326592:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32337784:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1&1,1&1&1,,
chr13:32325468:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000199681,
chr13:32379440:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr13:32340527:C>A,,,,,,1/1658,,,,,,,,,,,Western European,M,1 - Not pathogenic or of no clinical significance,0.04,1.12,0.2,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43094403:GT>A,,,,,,,,,,,,,,,German|Czech|-,,Western-European|-|Caucasian|caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43087263:G>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00239617,
chr17:43095845:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1,,
chr17:43045763:CTCGGCCGGGCC>TT,,,,,,,,,,,,,,,Korean|Korea|-,,Korean|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr13:32330944:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32330904:CTA>C,,,,,,,,0.109|0.2818|0.1678,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43051082:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,1&1,1&1,,
chr13:32394695:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),benign(0-068),,1,,
chr13:32394640:T>C,,,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,
chr13:32364238:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43092154:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,1.647e-05,
chr13:32344558:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43074370:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000173,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0233|0.0|0.0154,possibly-damaging:0.824|possibly-damaging:0.824|possibly-damaging:0.824|possibly-damaging:0.824|possibly-damaging:0.824,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr13:32339572:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32398607:GG>TGAATTATATCT,,,,,,,,,,,,,,,Austria,1|0,,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43094425:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094688:A>GCT,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43057052:GC>C,,,,,,,,,,,,,,,German,1,,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,18/22,,-1,,,,,,,
chr13:32336696:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),probably_damaging(0-967),,1,,
chr17:43107143:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr17:43080311:A>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000599042,
chr17:43092614:T>C,,,,,,,,,,,,,,,,,Western-European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43102740:C>A,,,,,,,,,,0.0,0.0144,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00379393,
chr17:43071032:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx,,,,,,0.0|0.0227|0.0077,benign:0.045|benign:0.045|benign:0.045|benign:0.045|benign:0.045,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,1&1,,
chr13:32342999:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0061901,benign
chr13:32354848:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,1,,
chr13:32323325:A>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00139776,
chr13:32389686:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43115790:C>AG,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1&0,0.0003625,
chr17:43063872:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,,,pathogenic
chr17:43100863:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr17:43094013:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,pathogenic
chr13:32315831:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8636 (Asian)| 0.5285 (African)| 0.777 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43094704:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093355:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43067677:G>A,,,In vitro (cloned)|Unknown,predicted neutral|as wildtype control|no functional effect|-|not destabilizing,Transcription activation in yeast (GAL4-fusions)|co-occurrence with deleterious variant|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Thermodynamic stability prediction|evolutionary conservation analysis,,,,,,,,,,Sweden|-|Central/Eastern Europe,,"Western European|-| Greek""""|Ashkenazi|Western Europe|""""Central/Eastern European|None-Specified|None Specified",M,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-788),,1&1&1&1,4.942e-05,
chr17:43083935:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43045317:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,5.273e-05,
chr13:32344591:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1,8.244e-06,
chr13:32338786:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43092487:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32344591:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1,8.244e-06,
chr17:43094680:C>TGTAATGA,,,,,,,,,,,,,,,German|Austrian,,Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319326:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr17:43093609:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319326:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32394708:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr17:43093399:TT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr17:43091728:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Malaysian,,Malay,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43045685:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious_low_confidence(0-01),probably_damaging(0-969),,1,,
chr13:32369377:C>G,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000798722,
chr13:32338598:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1&1,8.247e-06,
chr13:32391521:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32338523:TT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32340125:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-073),,,2.471e-05,
chr17:43093432:A>AT,,,,,,,,,,,,,,,Brazilian,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32319326:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32337720:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32352044:C>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000599042,
chr13:32332499:T>C,,,,,,,,0.0|0.0227|0.0077,benign:0.022,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-005),,,,
chr17:43090928:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,1.648e-05,
chr13:32396982:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.59,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32383415:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43045697:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-081),,1&1,0.0004861,
chr17:43095847:CA>C,,,,,,,,,,,,,,,,2,,F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,1&1&1,,
chr13:32376978:A>T,,,,,,,,,,0.2078,0.1846,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.225439,
chr17:43094192:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094090:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr17:43125184:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,3.839e-05,
chr17:43079318:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,benign
chr17:43092590:GG>G,,,,,,,,,,,,,,,,,Western-European|Western European|Western Europe|None-Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32362564:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091771:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32366057:A>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32391658:G>T,,,,,,,,,,0.0129,0.0,0.0058,0.0437,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0125799,
chr13:32328311:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr17:43104104:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32339220:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-03),,,,
chr13:32320188:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0133,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00259585,
chr13:32398209:AGAGC>T,,,,,,,,,,,,,,,,,Latin American/Caribbean|Western European| Centr| Native American,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,9.884e-05,
chr17:43093414:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32343436:C>G,,,,,,,,,,0.006,0.0,0.013,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00339457,
chr13:32340603:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-714),,,8.237e-06,
chr13:32338215:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-714),,,,pathogenic
chr17:43106528:T>A,,,,,,,,,,,,,,,Not Specified|-,,Western-European|-Native-American|-,M,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr13:32340786:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr17:43071245:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,13/21,-1,,,,,1,,
chr17:43049195:T>G,,,,,,,,,,,,,,,,,Central/Eastern Europe,IVS,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&0&1&1,1&1&1&1&1,,
chr13:32340623:CTG>C,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051148:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000103959,
chr13:32370248:G>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000599042,
chr13:32394887:TT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,
chr13:32319631:GGCTGA>T,,,,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0061901,
chr13:32356558:ATTA>T,,,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/27,,1,,,,,,,
chr13:32398688:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32333094:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-16),benign(0-311),,,,
chr13:32333479:TATCT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-16),benign(0-311),,,,benign
chr17:43102113:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0102,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00199681,
chr17:43091842:G>C,,,,,,,,,,,,,,,Portuguese|-|Spanish,,-|Caucasian|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32333051:G>T,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,
chr17:43093299:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43094576:T>TAC,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32390540:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43051073:CCA>G,,,,,,,,,,,,,,,,,-|Irish/English,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,
chr13:32338881:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-004),,,8.237e-06,
chr13:32394728:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),probably_damaging(0-993),,1,,
chr17:43115844:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,predicted neutral|-,-|mRNA analysis and splicing reporter minigene,1/1658|-,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,1,,
chr13:32319112:C>CT,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,
chr17:43127512:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32340619:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,6.589e-05,
chr13:32338867:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43072939:C>T,,,,,,,,,,0.001,0.0,0.0821,0.0,0.0153,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0145767,
chr13:32331071:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.299e-06,
chr13:32337544:GTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32339423:AAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32328593:G>T,,,,,,,,,,0.007,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00159744,
chr13:32338131:AA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339957:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-959),,1,,
chr13:32338544:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-985),,1,,
chr13:32372261:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr17:43121304:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32385291:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43124124:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.242e-06,
chr17:43054080:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43049121:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,21/23,,-1,,,,,,,
chr17:43058260:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43113082:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32390014:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32346783:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.279e-06,
chr17:43091914:CT>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43065865:G>A,,,,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00199681,
chr17:43063913:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,,benign
chr17:43063913:G>C,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),possibly_damaging(0-897),,1,,
chr17:43093626:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,3.295e-05,
chr17:43077746:T>A,,,,,,,,,,0.3598,0.2201,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.354233,
chr13:32337674:A>T,,,,,,,,,,,,,,,,,Not Specified|Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,
chr17:43059630:A>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32395235:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000199681,
chr13:32360647:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43047621:G>CA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr17:43097369:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32337527:A>T,,Medical_University_Innsbruck|GeneDx|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32397128:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094862:C>G,,,In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,8.266e-06,
chr13:32356561:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr13:32398475:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32342375:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43106473:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32379892:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,
chr13:32350951:A>G,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr13:32332406:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),benign(0-27),,,1.648e-05,
chr13:32357740:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/26,1,,,,,,,
chr17:43091944:G>GT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340646:G>A,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43104391:T>AT,,,,,,,,,,0.001,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000798722,
chr17:43095438:A>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32387185:T>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr13:32332769:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-898),,,,
chr17:43124057:CATT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-898),,,,pathogenic
chr13:32338122:T>C,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-095),,1,,
chr17:43056974:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,1,,
chr13:32338122:T>G,,,,,,,,,,,,,,,,,Not Specified|Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),,,1,,
chr17:43124093:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,8.237e-06,
chr17:43074539:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32397028:C>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32356455:T>GAT,,,Germline (inherited),,,,FA FANCD1_00021,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32370534:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-923),,1,,
chr17:43094582:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093031:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32376680:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,0.0001039585,
chr13:32379823:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,pathogenic
chr13:32336784:C>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-05),benign(0-139),,1,,
chr13:32338704:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43095230:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32338211:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),,,,,,,,,,,,Spanish,1,Caucasian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-139),,1,,
chr17:43067694:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),benign(0-072),,1,,
chr17:43099911:GCGG>A,,,,,,,,,,,,,,,,4,,IVS,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,
chr13:32337708:GG>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092500:CAG>C,,,,,,,,,,,,,,,,,"Latin American/Caribbean| Latin American/Caribbean""""|-|Latin-American/Caribbean|None Specified|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337775:A>C,,,,,,1/1658|-,,,,0.0,0.0,0.0,0.0069,0.0,Malaysian,,Chinese,Syn,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,0.00082243,
chr13:32398117:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.125e-05,
chr17:43106534:A>G,,,,,,,,,,,,,,,Malaysian,,Indian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1&1&1,,
chr13:32363345:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,,,pathogenic
chr13:32379349:GA>G,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,
chr17:43051035:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,8.237e-06,
chr17:43099453:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43092141:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32337175:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43090589:C>A,,,,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00299521,
chr13:32349553:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3028 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2693,0.2176,0.0714,0.1472,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.183307,benign
chr13:32398199:CA>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32338943:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43094215:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32339981:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-017),,1&1,8.237e-06,
chr13:32394717:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,0&0&1&1&1,1&1&1&1&1,,benign
chr13:32376709:CTA>C,,,,,,,,,,,,,,,,,"Western European| caucasian""""|Central/Eastern European|""""Western European",F,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,1,,
chr17:43115736:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1&1,,
chr17:43093718:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32332735:T>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43104181:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr17:43075830:G>C,,,,,,,,,,0.002,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr13:32354904:C>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32394717:C>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1&1,1&1&1&1&1,,
chr17:43115736:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1&1,1&1&1&1&1,,pathogenic
chr17:43092479:TCTCA>TCTCATCTCA,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093222:T>A,,,,,,,,,,,,,,,Spanish,,Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43115746:TTA>C,,,,,,,,,,,,,,,,,Western-European|Western Europe|-,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,,,
chr13:32378302:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32395084:T>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.000798722,
chr13:32384015:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00658946,benign
chr13:32316488:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,,,
chr17:43091493:TTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,,,
chr13:32362625:C>A,,,,,,,,,,,,,,,English/Canadian,1,Caucasian,N,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,
chr13:32338213:AAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,
chr17:43100595:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08741 (Asian)| 0.09553 (African)| 0.1675 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.326,0.1581,0.3372,0.2371,0.456,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.290735,benign
chr17:43106478:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr17:43104877:C>A,,,,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,deleterious(0),probably_damaging(1),,1&1,,
chr17:43106478:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr13:32332532:G>TA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,10/27,,1,,,,,1,,
chr13:32340183:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Invitae|_University_of_Chicago|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32354913:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32387714:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43099882:GA>T,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,5/21,-1,1.0,,,,,,
chr13:32340123:TCCAG>A,,,,,,,,,,,,,,,-|Dutch?,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32379823:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43050985:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32363436:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32380123:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,
chr17:43072025:AATGG>A,,,,,,,,,,0.0,0.0023,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000798722,
chr13:32337525:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),,,1&1&1,,
chr17:43093698:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339342:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-477),,1&1,8.242e-06,
chr17:43053052:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43082475:T>TC,,,,,,,,,,,,,,,,,,F,,,,,,,,stop_gained&frameshift_variant,HIGH,11/22,,-1,,,,,1,,
chr17:43057208:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32357935:T>G,,,Unknown|Germline (inherited),,,,,,,0.0,0.0061,0.0,0.0,0.0,Latin American/Caribbean|-,,Latin American/Caribbean| Latin American/Caribbean|-|African|African American|None Specified,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,0.00115702,
chr13:32326144:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32326099:A>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/26,1,,,,,1,,pathogenic
chr13:32337521:CCTGG>C,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32370937:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,benign
chr13:32355342:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,0.000199681,
chr17:43090064:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr13:32369535:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32338625:AA>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32361594:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32333175:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-006),,,8.237e-06,
chr13:32364749:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32339094:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-059),,1,,
chr13:32333023:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32398321:G>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,pathogenic
chr13:32357775:A>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-05),probably_damaging(0-985),,1,,benign
chr17:43094861:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1,,
chr13:32362532:T>TGACA,,,,,,,,,,,,,,,,,Western European|Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,
chr17:43094861:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43065588:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32339003:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,pathogenic
chr13:32340794:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-294),,1,,
chr17:43093108:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32370815:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.000199681,
chr17:43071197:CGCGTG>C,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,
chr13:32375024:C>G,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000599042,
chr13:32376664:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,
chr13:32388548:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32322697:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43093173:AGACCAGT>C,,,,,,,,,,,,,,,Norwegian|Western Europe|-,,Not Specified|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32369817:C>A,,,,,,,,,,0.007,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00199681,
chr17:43045793:TGCCCAAT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32380102:A>T,,,In vitro (cloned),predicted deleterious|no evidence for aberrant splicing|inconclusive,Protein likelihood ratio model|splicing reporter minigene assay|Co-localization to predicted ESEs,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr13:32333290:C>A,,,Unknown|Germline (inherited),,,1/238 patients|-|6/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,,
chr17:43071023:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr17:43102132:C>A,,,,,,,,,,0.0,0.0182,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00479233,
chr17:43047661:G>A,,,,,,,,,,,,,,,,,Not Specified,N,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,
chr17:43090915:C>A,,,,,,,,,,,,,,,Austria,1,,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.65e-05,
chr13:32328502:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32326130:T>A,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32340052:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32353246:A>G,,,,,,,,,,0.0,0.0038,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr13:32333288:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-005),0&1&1,1&1&1,,
chr13:32398701:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43074472:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43082489:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,1,0.0001039585,
chr17:43091470:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.236e-06,
chr13:32338128:ATA>T,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337681:A>T,,,,,,,,,,,,,,,Western Europe|-,,Western European|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,0&0&1&1,1&1&1&1,3.295e-05,
chr13:32325485:T>G,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.00139776,
chr17:43093013:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,8.236e-06,
chr17:43056974:G>T,,,,,,1/1658,,,,0.0,0.0008,0.0,0.0,0.0,German|Thai|-|Austria,1|0|-,Thai|-,IVS,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,1,0.000199681,
chr17:43093013:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,8.236e-06,
chr17:43103204:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr17:43063320:G>T,,,,,,,,,,,,,,,German,1,,IVS,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr13:32341126:C>G,,,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32340486:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.018,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-017),,1&1,,
chr17:43091834:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092044:TATCTTCCTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43049299:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32394161:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32316544:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43095861:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32333111:GG>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32337158:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,0.0005601,
chr17:43074403:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43074519:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32337431:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Czech|Western Europe|-,,Not Specified|Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43094512:GG>A,,,,,,2/1658,,,,,,,,,,, Native American|Not Specified|-Irish/English/Canadian|-|Western European|Western-European|Caucasian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43124530:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32378510:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr17:43074519:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43060342:T>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000998403,
chr17:43088366:A>G,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000998403,
chr17:43074324:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Malaysian,,Chinese,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,
chr17:43074385:G>A,,,,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,
chr17:43115726:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,
chr13:32330922:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.237e-06,
chr13:32326654:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,
chr13:32333073:AAACT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32338656:A>T,,Ambry_Genetics,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,,,2.07,0.0405,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-985),,1,,benign
chr13:32370448:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr17:43093279:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43082571:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,0&1&1,0&1&1,8.236e-06,
chr13:32380096:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,FA FANCD1_00003,,,,,,,,,,Ashkenazi|None Specified,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1&0,,pathogenic
chr13:32370448:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32396958:T>A,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43077166:C>A,,,,,,,,,,0.003,0.0,0.0014,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000998403,
chr17:43079437:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,8.509e-06,
chr13:32340758:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-081),,1&1,,
chr13:32338565:GA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43047440:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,
chr13:32338929:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-099),,1,,
chr13:32352080:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32358885:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4476 (Asian)| 0.3435 (African)| 0.4604 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32397021:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340098:T>G,,,,,,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-46),benign(0-016),,1,,
chr13:32347053:A>T,,,,,,,,,,0.0,0.0257,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0071885,
chr13:32356462:CC>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,,,
chr13:32333969:C>G,,,,,,,,,,0.999,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.974042,
chr13:32380090:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,1.647e-05,
chr13:32340760:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32358249:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr17:43093192:CAC>T,,,,,,,,,,,,,,,American,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43051032:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,1,,
chr13:32337241:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43092346:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43094383:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32341040:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43050641:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32337071:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-059),,1,,
chr13:32320712:G>A,,,,,,,,,,0.0,0.0,0.0,0.004,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43070950:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-998),,1&1,,
chr17:43099629:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,13/1658,,,,0.3549,0.2179,0.3746,0.371,0.498,,1|-,,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,0.352636,benign
chr17:43075472:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr13:32337511:GCATGCCCAGCCT>AAG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43070922:C>G,,,In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,U.S.A.|-,,"Latin American/Caribbean| Latin American/Caribbean| Bahamian""""|African American/Puerto Rico|-|Latin-American/Caribbean|""""African|African|Western-European|Caucasian",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1&1,,
chr17:43092647:A>T,,,,,,,,,,,,,,,,,Western-European|-Ashkenazi,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr13:32338749:AATTAC>A,,,,,,,,0.0364|0.0939|0.056,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43063342:AGCT>C,,,In vitro (cloned),predicted deleterious|Loss of wild type allele|as variant control,Histopathology|Protein binding capacity|Functional characterization of protein|Loss of Heterozygosity|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,18/23,,-1,,,,,,,
chr13:32346070:A>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000399361,
chr13:32326282:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,6/27,,1,,,,,1&1,,
chr17:43063372:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Not Specified|-,N,,,,,,,,stop_gained&splice_region_variant,HIGH,18/23,,-1,,,,,1&1,,pathogenic
chr17:43094707:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,
chr13:32398323:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43063931:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1&1,,benign
chr13:32337084:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),possibly_damaging(0-578),,,8.237e-06,
chr13:32331491:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0908,0.0962,0.1319,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0732827,benign
chr13:32326796:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4895 (Asian)| 0.1992 (African)| 0.3298 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43063372:C>A,,Ambry_Genetics,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control|strong functional effect,Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Proteolytic degradation|Co-segregation in families,,,,,,,,,,,2,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-99),,1&1,,pathogenic
chr13:32340132:AG>G,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339627:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-004),,1,,
chr17:43104908:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.237e-06,
chr13:32338507:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43060218:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32370444:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43063379:A>T,,,In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Central/Eastern-European,IVS,1 - Not pathogenic or of no clinical significance,1.0,3.55E-03,0.00724,0.0,,0.34,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1,3.295e-05,
chr17:43070968:CCA>C,,,,,,,,,,,,,,,,,Central/Eastern-European,F,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,
chr13:32334210:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4878 (Asian)| 0.1951 (African)| 0.3285 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32368898:A>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43104941:CCTCT>A,,,,,,,,,,,,,,,Not Specified|-,,,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32337513:A>G,,,,,,1/1658,,,,,,,,,-|British?|British,1|-,English/Scottish|-|Caucasian,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1&1,,
chr13:32338017:C>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr17:43077891:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.128 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32339050:G>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-149),0&1&1,1&1&1,,
chr13:32337553:AG>T,,,,,,,,,,,,,,,-|British?,,,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092418:C>T,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1,1&1,,
chr17:43093056:A>GT,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43045819:G>T,,,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,
chr13:32337326:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.03049 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?|predicted deleterious,-|Grantham score|Allele frequency analysis in controls|Prevalence in normal controls|Cell viability (in BRCA-/- cells)|?,67/1658|-,,3.6571|3.8584|3.7254,benign:0.0,0.0348,0.0552,0.0937,0.0972,0.1329,German|Danish|Austria|-,1|0|-,Global|-,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1,1&1,0.06653595,
chr17:43067624:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-998),,1&1,,
chr13:32385103:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1253 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1143,0.0008,0.0533,0.002,0.0358,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0379393,benign
chr13:32362645:A>T,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,Western Europe,,,M,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-998),,1,,
chr13:32368694:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43092628:->GA,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32356588:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,1.647e-05,
chr13:32379467:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000011,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0233|0.0227|0.0231,possibly-damaging:0.929,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr13:32363560:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43092732:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32339054:C>T,,Ambry_Genetics,,,,1/1658|-,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,benign
chr17:43071150:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1&1,8.236e-06,
chr13:32355294:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.2725|0.0924,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,1,,
chr13:32392531:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32367964:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02375 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43093074:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32336447:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32317991:A>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32370444:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1&1,,
chr17:43059058:C>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32338190:AAT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,
chr13:32340055:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32339622:AACGTTGGTAATCTAT>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost&inframe_deletion,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32366755:->AGGT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32379379:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43094147:TT>C,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43093460:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337737:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.236e-06,
chr13:32332715:TT>C,,,,,,2/1658|-,,,,,,,,,,, Central/Eastern Europe|Not Specified|Western European|-|Southern Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr17:43075502:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43045705:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,7.413e-05,
chr13:32398499:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,8.237e-06,
chr13:32346920:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0001369355,
chr17:43091450:C>G,,,In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,Western Europe|-|Ashkenazi,M,1 - Not pathogenic or of no clinical significance,1.0,1.17,0.00813,0.00019,0.02,0.02,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.236e-06,
chr13:32371356:T>G,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00239617,
chr13:32333536:A>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.000199681,
chr17:43092165:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32336867:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43092949:T>C,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43057113:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-13),,1&1&1,,
chr17:43119034:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32339568:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32363315:A>G,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-15),benign(0-027),,,8.236e-06,
chr17:43092822:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-15),benign(0-027),,,,pathogenic
chr13:32339755:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32316477:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32397466:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43106464:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32362528:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32325100:T>G,,,,,,,,,,,,,,,,,Western European|-,M,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,0.0001895,
chr13:32366751:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32330907:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,1.648e-05,
chr17:43114094:A>T,,,,,,,,,,0.0,0.0401,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.0107827,
chr17:43091481:T>GC,,,,,,,,,,,,,,,China,,Chinese,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32396130:C>T,,,,,,,,,,0.001,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000488461,
chr17:43094604:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1&1,,benign
chr17:43089157:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43102350:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000399361,
chr17:43094472:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32336753:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-01),,1,,
chr17:43092051:CTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-01),,1,,pathogenic
chr17:43063370:G>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,,,,,,
chr17:43094472:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43067172:T>C,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000998403,
chr17:43094836:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43099865:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32336943:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43092890:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43099276:ACAC>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000399361,
chr13:32332258:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,8.249e-06,
chr13:32340890:T>GA,,,,,,2/1658,,,,,,,,,-|British,,Western European|-|Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43067691:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000389,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,no functional effect|predicted neutral|inconclusive|-|predicted deleterious|mildly destabilizing,Structure-based prediction (crystallography etc)|transcription activation/PS/BA/BS|-|Thermodynamic stability prediction|Transcription activation in human cells,-|1/1658,,,,,,,,,,,Western-European|Western European|Western Europe|-Central/Eastern-Europe,M,1 - Not pathogenic or of no clinical significance,0.01,1.29,0.03,0.0,0.03,0.03,missense_variant,MODERATE,15/22,,-1,,deleterious(0-02),benign(0-161),,1,8.237e-06,
chr13:32399393:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000199681,
chr17:43091727:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093654:ACTA>ACTAACTA,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398431:T>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001121955,
chr13:32336972:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43071093:AACTTTCAATTGGGG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32337603:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),,,,8.24e-06,
chr13:32364247:C>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43063370:GG>A,,,,,,,,,,,,,,,,,"""""Western European| Irish""""",F,,,,,,,,frameshift_variant&splice_region_variant,HIGH,18/23,,-1,,,,,,,
chr17:43092935:C>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|predicted deleterious|-|?,co-occurrence with deleterious variant|-|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,-|1/1658,,,,,,,,,Not Specified|Western Europe|-|Austria,0|-,"Central/Eastern European|Western European|-|Greek|Ashkenazi|African|Western-European| Italy""""|None-Specified|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.00234,0.0174,2e-08,0.0,0.02,0.02,intron_variant,MODIFIER,,,-1,,,,,1&1,9.884e-05,
chr17:43125163:G>AC,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0005295,
chr17:43077112:G>C,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43104233:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr17:43093456:AC>T,,,,,,1/1658,,,,,,,,,New Zealand,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43095330:TTGACCCCACAAGGTG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43106544:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,8.245e-06,
chr17:43088117:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32338902:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-132),,1,,
chr17:43067616:G>T,,,,,,-|1/1658,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-977),,1&1,,
chr13:32336835:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340922:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32339334:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-132),,1,,
chr17:43104143:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43049195:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43093145:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43078981:A>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43104143:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.236e-06,benign
chr17:43092749:A>T,,,,,,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340922:C>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-132),,,,
chr13:32340922:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-132),,,,
chr13:32339829:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-93),benign(0-059),,1,,benign
chr13:32326599:T>G,,,In vitro (cloned),exon skipping ~50%,splicing reporter minigene/patient RNA analysis,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,
chr13:32332405:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr17:43116747:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr17:43104224:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,,,,1,,
chr17:43091017:G>CAGAT,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32332471:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43095038:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,1/1658,,,,0.0268,0.0,0.0115,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00758786,benign
chr13:32336948:TA>G,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43071017:CCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,
chr17:43074394:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32339429:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr17:43070927:C>T,,,,,,,,,,,,,,,Western Europe/Latin Amer Caribbean,,,IVS,,,,,,,,splice_donor_variant,HIGH,,15/22,-1,,,,,1,,
chr17:43051690:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0083,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00219649,benign
chr13:32355265:TA>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr17:43093514:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32337521:CCTGGA>CG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.238e-06,
chr13:32339482:AGCTC>T,,,,,,-|1/1658,,,,,,,,,Not Specified|-|Spanish,1|-,White-NonHispanic|Western European|-|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.244e-06,
chr17:43070927:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/22,-1,,,,,1,,pathogenic
chr17:43071004:C>A,,,In vitro (cloned)|Unknown,predicted neutral|predicted deleterious|-|?|inconclusive,Histopathology|-|evolutionary conservation analysis|Multifactorial likelihood-ratio model|?,,,,,,,,,,Western Europe|-|Central/Eastern Europe,," English/Irish""""|Central/Eastern European| Central/Eastern Europe|Not Specified|Western European|-|-Central/Eastern-Europe|Western-European|Western Europe|Central/Eastern-European|None-Specified|None Specified|""""Western European",M,1 - Not pathogenic or of no clinical significance,0.347,0.398,0.0148,4e-05,0.02,0.02,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),benign(0-027),,1&1&1&1,2.471e-05,
chr13:32326253:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,,8.237e-06,
chr17:43104282:CTGG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,2.471e-05,
chr13:32379645:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32362627:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-948),,1,,
chr13:32332879:A>C,,,,,,,,,,,,,,,Austria,0,,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-027),,1,,
chr17:43081018:C>G,,,,,,,,,,0.003,0.0287,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00838658,
chr13:32357805:A>T,,,,,,,,,,,,,,,-|Italian,,Western European|-|Central/Eastern European,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,
chr17:43073007:C>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000399361,
chr13:32337158:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-222),,1&1,,
chr13:32337158:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0931|0.0227|0.0692,benign:0.055,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1&1,,benign
chr17:43045842:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,pathogenic
chr17:43048522:G>C,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr17:43094045:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32320092:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32391943:G>C,,,,,,,,,,0.0,0.0129,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00339457,
chr17:43085677:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32345278:AGACA>C,,,,,,,,,,0.0,0.0,0.0,0.0099,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00199681,
chr17:43093514:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr17:43052249:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000399361,
chr17:43091771:GAAGT>T,,,In vitro (cloned)|Unknown|Germline (inherited),-|?,-|?,11/1658|5/1658|-|3/238 patients,,,,,,,,,Not Specified|-|British|Czech|Austria|Dutch|Western Europe|West/East/Central Europe|Italian,1|8|3|2|-,"Western European|Caucasian|-Latin-American|Not Specified|-|-Central/Eastern-Europe| Italian""""|-Italian|Western-European|caucasian|""""Western European|African|English/French/Irish/Scottish/German|Central/Eastern-European|None Specified|Italian|Irish|Central/Eastern European|-Norwegian|Asian|Western Europe|None-Specified",F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,2.471e-05,
chr13:32326126:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,,1,,
chr13:32317793:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32338916:ACA>C,,,,,,,,,,,,,,,HKSAR,,Chinese,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32338599:TT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.247e-06,
chr17:43104237:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0-03),,,,8.236e-06,
chr13:32374976:A>T,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00139776,
chr13:32361434:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32351422:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr17:43074370:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0001318,
chr17:43093533:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32317661:A>C,,,,,,,,,,0.2644,0.2133,0.232,0.369,0.2505,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.264776,
chr13:32398171:A>T,,,,,,,,,,,,,,,,1,,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379510:ATTCAGGTAAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32332263:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,1,,
chr13:32337355:T>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43104079:TAG>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.002372,
chr13:32355213:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32346914:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.648e-05,benign
chr13:32340804:->TA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43061979:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32338566:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43091700:A>TG,,,,,,,,,,,,,,,,,Western European| Latin American/Caribbe,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32382146:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2866 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43067787:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2175 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,benign
chr17:43074278:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,
chr17:43091947:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338467:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093189:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092872:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr13:32339484:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32380559:C>A,,,,,,,,,,0.0,0.0325,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.0091853,
chr17:43094909:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43093639:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319115:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43077369:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2194,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.353834,benign
chr13:32380880:T>C,,,,,,,,,,0.0,0.0,0.0014,0.001,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00658946,
chr17:43114335:T>A,,,,,,,,,,0.0,0.0159,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00419329,
chr17:43093980:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32338321:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-373),,1,,
chr13:32370558:AT>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/26,1,,,,,,8.237e-06,
chr13:32379463:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43054678:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000798722,
chr17:43092699:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43074365:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,1,1,,
chr13:32338321:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr17:43047687:T>G,,,In vitro (cloned),predicted deleterious|no functional effect|moderately destabilizing,transcription activation/PS/BA/BS|Thermodynamic stability prediction|Multifactorial likelihood-ratio model|evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1,,
chr13:32338566:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-149),,1&1,,
chr17:43092667:C>T,,,,,,,,,,,,,,,,,Western-European|Latin American/Caribbean|-Latin-American/Caribbe|Latin-American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32332989:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32399612:A>G,,,,,,,,,,0.0,0.0174,0.0014,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00479233,
chr17:43098201:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32337130:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,8.237e-06,
chr17:43092694:GTCA>A,,,,,,,,,,,,,,,,,"""""African| Native American""""",IFD,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32357750:C>GT,,,,,,,,,,,,,,,,,-|None Specified,F,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,
chr17:43074370:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,co-occurrence with deleterious variant|-|Multifactorial likelihood-ratio model,,,,,,,,,,Not Specified|-,,-|None Specified,M,1 - Not pathogenic or of no clinical significance,1.0,0.00339,0.275,2e-05,0.02,0.02,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,,3.295e-05,
chr13:32362670:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),probably_damaging(0-968),,1,,
chr13:32363494:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,8.236e-06,
chr13:32396976:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr13:32332925:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-311),,1,,
chr13:32332925:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),possibly_damaging(0-735),,1,,
chr13:32338200:CTG>C,,,,,,,,0.0367|0.0474|0.0403,None,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43093796:TCC>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43118847:T>C,,,,,,,,,,0.0,0.0015,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr13:32370468:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0-01),probably_damaging(1),,1,,
chr17:43094477:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32346784:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,8.276e-06,
chr17:43059351:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43101449:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.000199681,
chr13:32394797:ATG>C,,,Germline (inherited),,,,FA,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32323396:C>A,,,,,,,,,,0.0,0.0197,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00539137,
chr17:43063912:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(1),,1,,
chr13:32340800:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-01),0&0&0&1&1,1&1&1&1&1,,
chr13:32339153:AAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-01),0&0&0&1&1,1&1&1&1&1,,
chr13:32340128:A>T,,,,,,,,,,,,,,,,,Asian| India,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,8.237e-06,
chr13:32373714:A>G,,,,,,,,,,0.0089,0.0,0.0043,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00259585,
chr13:32336630:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-91),benign(0-001),0&1&1,1&1&1,,
chr13:32337511:G>C,,,,,,,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.025,1.03,,0.001,0.02,0.02,synonymous_variant,LOW,11/27,,1,,,,,,,
chr17:43124027:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1,,
chr13:32329434:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Near Eastern,IVS,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,,
chr13:32394841:G>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,8.236e-06,
chr13:32336861:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-12),,,,
chr13:32357809:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,,
chr17:43092640:AGT>C,,,,,,,,,,,,,,,,,British,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43065077:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr13:32394423:G>GT,,,,,,,,,,0.0,0.0,0.0,0.0,0.0051,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000998403,
chr17:43044390:C>TG,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0001508,
chr13:32329434:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,0.000199681,
chr17:43093041:C>CATGGATACTT,,,,,,,,,,,,,,,Czech,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32394841:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-01),possibly_damaging(0-876),,0&1,8.236e-06,
chr13:32346830:CAACC>AAATA,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,,,,,8.239e-06,
chr13:32370988:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,8.236e-06,
chr13:32398570:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32396886:T>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32380134:G>TG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,
chr13:32319103:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1&1,,
chr13:32396886:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43057558:T>A,,,,,,,,,,0.0,0.0159,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00519169,
chr13:32352746:TGTTAT>C,,,,,,,,,,0.003,0.0,0.0,0.0069,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00219649,
chr17:43091887:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32393031:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32326299:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.238e-06,
chr17:43124123:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,,
chr13:32322477:T>A,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000998403,
chr13:32357774:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32354307:A>G,,,,,,,,,,0.002,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000399361,
chr17:43097582:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01451 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43091947:AC>T,,,,,,,,,,,,,,,Spanish,1,Mediterranean,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43067638:G>T,,,In vitro (cloned),predicted neutral|no functional effect,co-occurrence with deleterious variant|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,"Western European| Central/Eastern European""""|""""Western European",M,1 - Not pathogenic or of no clinical significance,1.0,0.00316,1.0,0.0001,0.03,0.03,missense_variant,MODERATE,15/22,,-1,,deleterious(0-04),benign(0-254),0&1&1,1&1&1,,
chr13:32341181:T>A,,,,,,,,,,,,,,,Malaysian,,Chinese,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0),,1,,
chr17:43097234:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,,
chr17:43049170:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,-|1/1658,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),probably_damaging(0-924),,1,8.236e-06,
chr17:43074430:ATT>C,,,,,,2/1658,,,,,,,,,,,Western Europe|-|None-Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,,,,,,,
chr13:32340219:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32340219:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43094138:T>AG,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093895:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092201:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43066788:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.3956,0.0274,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.115415,benign
chr17:43115162:T>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32340567:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-996),,1,,
chr13:32340375:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-283),,1,8.237e-06,
chr13:32371333:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43082503:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr13:32344645:T>A,,,,,,,,,,,,,,,Malaysian,,Indian,M,,,,,,,,missense_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(0-999),,1&1,4.12e-05,
chr13:32340018:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,benign:0.006,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-043),,1,1.647e-05,
chr13:32327185:C>T,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.00239617,
chr13:32355183:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-03),possibly_damaging(0-689),,1,,
chr13:32332925:A>C,,,,,,,,,,,,,,,,,African,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),possibly_damaging(0-735),,1,,
chr17:43057136:G>T,,,,,,,,,,,,,,,,,Asian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1,,
chr13:32336748:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-817),,,8.238e-06,
chr17:43057051:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/21,-1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr17:43120876:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0072,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00139776,
chr13:32338753:ACATT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32339270:T>A,,,,,,,,,,,,,,,Western Europe/Latin American/Caribbean|-,,Western European|Western Europe|-|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-139),,1,8.239e-06,
chr13:32347353:G>T,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00119808,
chr17:43115790:CA>A,,,,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,
chr13:32316463:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43073326:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr13:32332938:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.718,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-311),0&1&1,1&1&1,,
chr17:43104937:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-311),0&1&1,1&1&1,,pathogenic
chr17:43080562:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr13:32316463:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43092226:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.55|None|None|possibly-damaging:0.55|possibly-damaging:0.55,,,,,,,,None-Specified,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,1.647e-05,
chr13:32321109:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr17:43061815:T>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32356458:T>G,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European|Western Europe,M,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-01),,,1,,
chr17:43051075:A>TG,,,,,,,,,,,,,,,Not Specified|-,,Western-European|-|None-Specified|None Specified|Italian,F,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,
chr13:32341147:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-081),,,8.236e-06,
chr17:43093081:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-081),,,,pathogenic
chr17:43094043:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-081),,,,pathogenic
chr17:43055179:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr17:43088898:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05409 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32333046:G>T,,,,,,,,,,,,,,,,,Western European| german/belgian,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-017),,1,,
chr17:43093624:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43106759:A>T,,,,,,,,,,0.003,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000599042,
chr13:32316463:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32363427:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-67),benign(0-046),,1,,
chr17:43074311:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43076579:TAG>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43111637:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43057051:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43092177:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32370487:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(0-959),,1,,
chr17:43093450:ATT>C,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32319198:T>C,,,In vitro (cloned),predicted deleterious,Co-localization to predicted ESEs,,,,,,,,,,,,Western European,M,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,
chr17:43082560:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr13:32341079:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),probably_damaging(1),,1,,
chr17:43104503:G>T,,,,,,,,,,0.002,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000798722,
chr13:32363197:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43094434:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr17:43076427:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1,,
chr17:43094703:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,0.0001039585,
chr13:32368799:A>G,,,,,,,,,,0.1103,0.0174,0.0764,0.003,0.0184,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0415335,
chr13:32337238:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|no LOH|-,LOH analysis|Prevalence in normal controls|-,5/1658|-,,,,0.001,0.0,0.0,0.0,0.0,German|Austria|-,1|0|-,Austria|-|Caucasian,Syn,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,0.0004910905,
chr17:43104156:A>CT,,,,,,,,,,,,,,,Western Europe|-,1|-,Western European|-|Central/Eastern-European,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr17:43106556:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0001733,
chr17:43050543:C>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr13:32398224:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32337554:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),,0&0&1&1,1&1&1&1,,
chr17:43094300:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32371874:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32394820:TAAATGT>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,25/27,,1,,,,,,,
chr17:43106476:TAG>AGC,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,
chr17:43091503:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr13:32332319:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,Latin American/Caribbean|African,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-928),0&1&1&1&1,1&1&1&1&1,0.0001080805,
chr17:43063361:T>A,,,In vitro (cloned),predicted deleterious|strong functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Latin-American/Caribbean,M,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-999),0&1&1,1&1&1,,
chr13:32385410:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000399361,
chr17:43071102:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.1395|0.1362|0.1384,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,
chr17:43106489:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,8.238e-06,
chr17:43091557:AA>C,,,,,,1/1658,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32340434:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-029),,1,,
chr13:32340837:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-117),,,,benign
chr13:32319290:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,8.237e-06,
chr13:32319134:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|as variant control|predicted deleterious|Loss of wild type allele|?,Histopathology|Transcription activation in yeast (GAL4-fusions)|Multifactorial likelihood-ratio model|evolutionary conservation analysis|co-occurrence with deleterious variant|-|Nuclear localisation|co-immunoprecipitation BRCA2:RPA|Prevalence in normal controls|Homology-directed repair assay|?|family history|Cell viability (in BRCA-/- cells)|LOH analysis|Survival assay with VC8 (after MMC treatment)|Co-segregation in families|Centrosome amplification,9/1658|-,,,,0.003,0.0,0.0014,0.0,0.0,Latin American/Caribbean|Danish|Central/Eastern Europe|German|Western European|-|Not Specified|Austria|Ashkenazi|Spanish|Western Europe|Italian,0|3|2|-, Central/Eastern Europe|Western European|Ashkenazi|Caucasian|Latin American/Caribbean| Italian|Western Europe/Native American| french Canadian|Not Specified|-| Hispanic| Middle East| English| Irish|Near Eastern| Latin American/Caribbe|Greek| Scottish|None Specified|Central/Eastern European| Italy| Ashkenazi|Ashkenazi/Western Europe|Western Europe| Jamica,M,1 - Not pathogenic or of no clinical significance,6.7e-07,8.9E-11,,0.0,0.02,0.02,missense_variant,MODERATE,3/27,,1,,,,,1&1,0.001243361,
chr17:43082534:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,benign
chr13:32376776:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,,,
chr17:43048171:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000399361,
chr13:32354840:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.649e-05,
chr17:43074404:G>T,,,In vitro (cloned),no splicing defect,splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr17:43091737:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr13:32338496:AAA>-,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,
chr13:32398342:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,8.236e-06,
chr17:43093919:TCAAG>G,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32363355:A>C,,,In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Latin American/Caribbean|Western European| Central/Eastern Europe,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-32),benign(0-023),,1,8.236e-06,
chr17:43100526:A>G,,,,,,,,,,0.002,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.000599042,
chr13:32333281:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,4.943e-05,
chr17:43059498:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32339620:TTAAC>G,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32341170:AAT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43092659:C>T,,,,,,,,,,,,,,,,,Western-European|-Central/Eastern-Europe,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43074363:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,tolerated(1),benign(0),0&1,1&1,,
chr13:32326581:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1&1,,
chr13:32332314:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-65),benign(0-103),,1,,
chr17:43065121:G>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43089553:T>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000399361,
chr13:32398186:A>TA,,,Germline (inherited),,,,FA FANCD1_00037,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094190:AA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337546:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32339987:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-388),,1,,
chr13:32338607:A>G,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-47),benign(0-02),,1,0.000199681,
chr13:32371046:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-47),benign(0-02),,1,,pathogenic
chr17:43091784:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,4.118e-05,
chr13:32370924:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,8.236e-06,
chr17:43091688:CTGAG>GCCT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43051699:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32332832:T>A,,,,,,1/1658,,,,,,,,,-|Irish/Italian,,-|None Specified,M,1 - Not pathogenic or of no clinical significance,0.03,,,0.001,0.02,0.02,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-023),,1,,
chr13:32343550:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr13:32337089:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,,,
chr17:43078973:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2886 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32344974:A>C,,,,,,,,,,0.0,0.0182,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.00499201,
chr13:32339690:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-044),,1,,
chr17:43104253:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,deleterious(0),,,,8.237e-06,
chr17:43094306:C>G,,,,,,,,0.0116|0.0|0.0077,probably-damaging:0.975|None|None|probably-damaging:0.975|probably-damaging:0.975,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32336500:A>G,,Ambry_Genetics|GeneDx|Invitae,Unknown|Germline (inherited),,,,,0.0|0.1589|0.0538,None,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0002573305,benign
chr13:32399143:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (Asian)| 0.04 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32370447:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32330941:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43063933:GGG>T,,,,,,,,,,,,,,,,,Western European|Caucasian,F,,,,,,,,stop_gained&frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr17:43115809:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,8.244e-06,
chr17:43092579:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43062813:G>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr17:43104889:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,4/22,,-1,,,,1&1,1&1,,
chr13:32394739:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-42),benign(0-155),,1,,
chr17:43094044:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000188,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.093|0.0|0.0615,benign:0.008|None|None|benign:0.008|benign:0.008,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr13:32398149:CT>A,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.239e-06,
chr13:32398633:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),predicted neutral|?,Multifactorial likelihood-ratio model|?,,,,,,,,,,-|Spanish,1|-,Caucasian|None Specified|Asian,M,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32357890:G>A,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,16/27,,1,,,,,1,8.236e-06,
chr17:43091870:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx,Unknown|Germline (inherited),,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,-|Belgian,1|-,Caucasian|Western European|-|None-Specified|Asian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,8.236e-06,pathogenic
chr13:32319331:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/26,1,,,,,1,,
chr13:32341038:A>C,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),possibly_damaging(0-848),,1,2.471e-05,
chr13:32394822:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,8.236e-06,benign
chr13:32333042:G>C,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,possibly-damaging:0.766,,,,,,,,Latin American/Caribbean|Not Specified|Western European|P: Cuba| M|Western Europe|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),possibly_damaging(0-549),,1,8.236e-06,
chr13:32363250:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,
chr13:32340554:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,benign:0.01,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-049),,1,,
chr17:43087474:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2154 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32315645:AGAA>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0307,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.00599042,
chr13:32340079:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32355052:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-13),benign(0-081),,,,
chr13:32338949:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-962),,1,,
chr17:43124026:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Ashkenazi,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1,,
chr17:43093967:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43051115:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,20/23,,-1,,,,,1,,benign
chr13:32341026:T>AAACAGAAGCAGTAGAAATTGCTAAAGCTTTT,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,8.237e-06,
chr17:43091485:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000442,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,possibly-damaging:0.575|None|None|possibly-damaging:0.575|possibly-damaging:0.575,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32319109:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr13:32379958:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.238e-06,
chr13:32339826:C>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-196),,1&1&1,,
chr13:32337573:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-844),,1,,
chr13:32318734:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32332287:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43100594:C>G,,,,,,,,,,0.005,0.3956,0.0288,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.115615,
chr13:32340642:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-951),,1,,
chr17:43094577:CTGTAA>A,,,,,,,,,,,,,,,,,Western European|None Specified,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr13:32336849:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32346897:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,13/26,1,,,,,1&1&1,,
chr17:43076439:T>C,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,
chr13:32358726:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000399361,
chr17:43092422:CA>T,,,,,,,,,,,,,,,,,East Indian,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32338601:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43082442:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,
chr17:43096380:C>G,,,,,,,,,,0.0,0.0159,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00459265,
chr17:43076518:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr17:43124086:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,,,
chr17:43094358:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,
chr13:32356476:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,,,1,,
chr17:43056212:A>T,,,,,,,,,,0.001,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000998403,
chr17:43106544:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32337722:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-997),,1,,
chr13:32338512:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32337646:T>TT,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091012:->AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43106485:AC>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43050881:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43114103:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr17:43093903:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32363286:T>G,,,,,,1/1658,,,,,,,,,,,Ashkenazi,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43090945:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Central/Eastern European,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43118985:G>C,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000399361,
chr13:32362624:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0-01),benign(0-029),,,,
chr17:43045758:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),possibly_damaging(0-612),,0&1&1,,
chr13:32330945:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr17:43104284:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,1.648e-05,
chr17:43045758:C>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-981),,0&1&1,,
chr13:32337189:TGC>A,,,,,,1/1658,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43092588:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32332511:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1,8.238e-06,
chr17:43092174:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,8.237e-06,
chr13:32398716:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0233|0.0454|0.0308,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,4.942e-05,benign
chr13:32329444:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,8/27,,1,,,,,,1.649e-05,
chr17:43088228:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr13:32380104:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,
chr17:43082145:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0123,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00239617,
chr17:43093930:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43092201:CAAC>C,,,,,,,,,,,,,,,,,Western European|None-Specified,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.244e-06,
chr13:32376792:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1&1,,
chr17:43052772:A>T,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00139776,
chr13:32363343:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted neutral,Protein likelihood ratio model,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-26),benign(0-047),,1,,
chr17:43094753:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-01),,,,,
chr13:32376792:G>A,,,In vitro (cloned),predicted deleterious,Aberant splicing,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1&1,,
chr13:32337189:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1&1,,pathogenic
chr13:32380016:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43093920:GTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43093121:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32329701:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr17:43093121:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32363179:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/27,,1,,,,,,8.237e-06,
chr13:32339933:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32325047:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,8.238e-06,
chr13:32396907:TCTG>A,,,,,,,,,,,,,,,,,Western European,IFD,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43092200:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43104140:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.236e-06,
chr13:32336798:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-86),benign(0-02),,,,
chr13:32353908:G>C,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00139776,
chr13:32340280:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.237e-06,
chr13:32340524:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43063015:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32340886:TCAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43073178:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000199681,
chr17:43123982:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32329863:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000399361,
chr13:32379378:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,,8.236e-06,
chr13:32378757:T>A,,,,,,,,,,0.0,0.0106,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00299521,
chr13:32394803:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-998),,1&1,8.236e-06,
chr17:43045758:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-998),,1&1,,pathogenic
chr13:32333103:T>C,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-6),benign(0-009),,1,8.236e-06,
chr17:43060899:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000199681,
chr13:32337172:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338596:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-55),benign(0-041),,1,,
chr13:32398380:CT>T,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32338680:G>A,,,,,,,,,,,,,,,,,Latin American/Caribbean| Hispanic,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,
chr13:32394803:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,1.647e-05,
chr13:32336315:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43089003:G>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000199681,
chr17:43093087:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43051061:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/21,-1,,,,,1,,pathogenic
chr13:32322960:A>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr17:43094081:G>A,,,,,,,,,,,,,,,,," Indian""""|""""Asian|-",N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,
chr13:32362664:C>G,,,,,,,,,,,,,,,,,African American,Syn,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,1,8.236e-06,
chr17:43093881:CG>A,,,,,,,,,,,,,,,,,-|Asian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,
chr17:43070929:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000161,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),predicted neutral|no functional effect,transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model,,,,,,,,,,,,Asian,M,1 - Not pathogenic or of no clinical significance,1.0,0.00355,1.44,0.00021,0.03,0.04,missense_variant&splice_region_variant,MODERATE,15/23,,-1,,,benign(0-036),,1,8.236e-06,
chr13:32326299:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/23,,-1,,,benign(0-036),,1,3.295e-05,
chr17:43049119:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/23,,-1,,,benign(0-036),,1,,pathogenic
chr13:32324252:C>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000599042,
chr13:32398257:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32332715:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-076),1&1,1&1,,
chr13:32328310:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32319188:T>G,,,,,,,,,,,,,,,Central-Eastern European|-,,Western European|-|None Specified,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,1.647e-05,
chr17:43051187:T>G,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,
chr17:43048269:C>G,,,,,,,,,,0.0,0.0045,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.00119808,
chr17:43046902:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.000199681,
chr13:32379893:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43112185:C>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000199681,
chr13:32362671:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43093807:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43071480:T>A,,,,,,,,,,0.0,0.0038,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.000998403,
chr17:43104914:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,
chr13:32380039:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,1.647e-05,
chr17:43074441:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,benign(0),,1&1,,
chr17:43053863:C>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32333238:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-033),,,,
chr13:32330978:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,benign
chr13:32354879:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,,8.236e-06,
chr17:43122889:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3129 (Asian)| 0.1768 (African)| 0.3522 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32357752:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-17),probably_damaging(0-988),,1,4.118e-05,
chr13:32370447:AC>GAA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,,,
chr13:32379856:->TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32330891:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.244e-06,
chr17:43104911:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,benign
chr13:32327386:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32332524:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-275),,1,,
chr13:32363533:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,Syn,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/27,,1,,,,,1,,
chr17:43122889:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.31 (Asian)| 0.8 (African)| 0.34 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32379327:G>A,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43124002:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr13:32331048:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0001122005,
chr13:32398489:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000000204. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|The_Children's_Hospital_of_Philadelphia|_NHGRI|Division_of_Genomic_Diagnostics|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?,co-occurrence with deleterious variant|-|Nuclear localisation|Prevalence in normal controls|Homology-directed repair assay|evolutionary conservation analysis|Cell viability (in BRCA-/- cells)|Survival assay with VC8 (after MMC treatment)|?|Centrosome amplification,33/1658|-,,0.8372|0.2724|0.6459,None,0.0109,0.0008,0.0029,0.0,0.0082,German Dutch|Latin American/Caribbean|Scottland|Central/Eastern Europe|Canadian|German|Western European|Western/Central/Eastern Europe|-|Mediteranean|Not Specified|Austria|West/Central/East Europe|Spanish|French Canadian|Danish|Western Europe|Italian|Australian|Ashkenazi,1|0|2|-|4,"Latin American/Caribbean|Western Europe/Native American|Central/Eastern Europe|NW European|Not Specified|Western/Central/Eastern Europe|-|Southern Europe|Caucasian|Ashkenazi/Western Europe|Western Europe/French Canadian|""""Austria| Sardinia""""|Asian|Germany Belgium|French Canadian|Western Europe|None Specified|African American|Native American|Ashkenazi",N,1 - Not pathogenic or of no clinical significance,0.001,0.0001,,0.0,0.02,0.02,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,0.005701485,
chr13:32398747:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.126 (African)| derived from 1000 genomes (2012-04-30).,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|_NHGRI|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.186|10.6446|3.729,benign:0.002,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,
chr13:32339429:C>TA,,,,,,,,,,,,,,,,,German/Spanish|Pakistani|-|Caucasian,F,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43114808:G>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.000599042,
chr17:43099733:GAA>TAG,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,4.942e-05,
chr17:43057061:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,18/22,,-1,,,,,,0.0001039585,
chr17:43090962:T>A,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1&1,,
chr13:32357896:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-03),,,1,,
chr17:43045759:CCACTCTCGGGTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-03),,,1,,pathogenic
chr17:43092804:GG>A,,,,,,,,,,,,,,,,,Central/Eastern Europe,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32340197:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319099:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,benign
chr13:32398724:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43099884:AACAGTATGGTAAAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32344651:C>T,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,-|Multifactorial likelihood-ratio model,,,,,0.0,0.0,0.0,0.0,0.001,Not Specified|-,,Not Specified|Western European|-|Central/Eastern European|Asian,M,1 - Not pathogenic or of no clinical significance,0.0123,1.86E-03,1.15,3e-05,0.02,0.5,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0-03),probably_damaging(0-991),,1&1,0.0002316905,
chr13:32399599:GT>A,,,,,,,,,,0.2107,0.1989,0.2017,0.3681,0.1748,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.23103,
chr13:32338207:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-45),benign(0-037),,,8.258e-06,
chr13:32338940:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000166,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0698|0.0|0.0461,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1,1&1&1&1,,benign
chr13:32354968:T>G,,,,,,,,,,,,,,,,,African,N,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,
chr13:32317569:T>G,,,,,,,,,,0.1998,0.1263,0.147,0.1736,0.1217,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.152556,
chr17:43106488:CA>C,,,,,,,,,,,,,,,,,Not Specified,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1&1,,
chr17:43047737:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,8.236e-06,
chr17:43048159:A>T,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,0.000199681,
chr17:43091613:GAC>C,,,Unknown|Germline (inherited),,,,,,,,,,,,-|Italian,,Western European|-|African|Western-European|Western Europe|Caucasian|None Specified,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43057004:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,1.647e-05,
chr17:43093630:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43119415:T>A,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00159744,
chr17:43093630:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43063371:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32382143:C>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.000199681,
chr17:43104972:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr17:43108925:G>A,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.000199681,
chr13:32316512:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,1&1,1&1,,
chr13:32332536:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,,8.238e-06,
chr17:43091706:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32398598:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32322539:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32344538:T>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000273,Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,
chr13:32344538:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr13:32337293:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-111),,1,,
chr13:32340574:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340622:GCA>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094198:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43094198:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340998:ATTTG>T,,,,,,,,,,,,,,,-|Dutch,2|-,"White-NonHispanic|Central/Eastern European| Central/Eastern Europe|Western European|-| Native American| Indian""""|Unknown| English""""|English|Western Europe| Germany/Holland|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337147:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-001),,1,,
chr13:32340133:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,8.237e-06,
chr13:32326250:G>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr13:32394327:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr17:43094748:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32337906:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-267),,1,,
chr13:32315731:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,0.000199681,
chr13:32356548:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr13:32333118:A>T,,,,,,,,,,,,,,,,,Western Europe,M,,,,,,,,stop_lost,HIGH,10/27,,1,,,,,1,,
chr17:43074340:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,
chr17:43071175:T>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),possibly_damaging(0-453),,1,,
chr13:32332873:T>C,,,In vitro (cloned)|Unknown|Germline (inherited),no splicing defect|-,splicing reporter minigene|-,2/1658|-,,,,,,,,,German,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1&1,0.0002883,
chr17:43104939:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,
chr13:32337817:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43071054:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,8.236e-06,
chr13:32376418:T>A,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32326884:C>G,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000399361,
chr13:32340461:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-044),,1,,
chr17:43093827:A>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43104119:G>C,,,,,,,,,,,,,,,,,,IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,5/21,-1,,,,,1,,
chr13:32340484:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340561:ATATC>T,,,,,,,,,,,,,,,Spanish,,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43113790:A>C,,,,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.0179712,
chr17:43049415:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0212,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00559105,benign
chr17:43099984:A>G,,,,,,,,,,,,,,,Austria,0,,IVS,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,1,,
chr13:32394707:A>C,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,1,,
chr13:32317088:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr17:43107032:A>T,,,,,,,,,,0.3579,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.353035,
chr17:43045712:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr13:32333240:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-19),,1,,benign
chr17:43044392:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,5.022e-05,
chr13:32394707:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0-02),probably_damaging(0-999),,1,,
chr13:32323302:T>A,,,,,,,,,,0.0,0.0,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000798722,
chr17:43091833:A>C,,,,,,,,,,,,,,,German,,Caucasian,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,
chr17:43078436:G>C,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr17:43093238:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin-American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32341028:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32339150:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-77),benign(0-003),,,,
chr13:32317915:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.000199681,
chr13:32357935:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.9759|0.3306,None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,
chr13:32332287:T>G,,,,,,,,,,,,,,,Malaysian,,Chinese,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,
chr13:32362631:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr13:32398183:A>T,,,,,,,,0.0116|0.0|0.0077,benign:0.0,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.236e-06,
chr17:43074498:C>T,,,,,,,,,,,,,,,,,Fiji,N,,,,,,,,stop_retained_variant,LOW,,,-1,,,,0&0&1,1&1&1,8.236e-06,
chr13:32371041:A>G,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-19),possibly_damaging(0-904),,1,,
chr13:32362888:C>G,,,,,,,,,,0.001,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,0.000399361,
chr13:32337705:A>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,0.0001080755,
chr13:32398183:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339909:G>T,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-713),,1,,
chr13:32363379:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned),predicted deleterious,Protein likelihood ratio model,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),0&1,1&1,,
chr13:32340561:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32326560:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,,,
chr13:32376700:C>A,,,,,,,,,,,,,,,Polish-German,1,Polish-German,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,1&1,1&1,1.647e-05,
chr13:32363525:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-05),benign(0-269),,,8.236e-06,
chr13:32339965:GTCATG>C,,,,,,,,,,,,,,,,,"African American| Native American""""|""""African|African",F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,1.647e-05,
chr13:32336883:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-108),0&1&1,1&1&1,,
chr13:32337789:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-106),,1,,
chr13:32339909:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-02),,1,,
chr13:32341105:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338382:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-104),,1,,
chr13:32348993:C>T,,,,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00898562,
chr17:43093568:TTT>A,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32338618:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338321:CAA>-,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,
chr13:32394717:A>CG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,0&0&1&1&1,1&1&1&1&1,8.237e-06,
chr13:32346927:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0001410705,
chr13:32329867:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000399361,
chr13:32356498:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr13:32337312:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0233|0.0|0.0154,possibly-damaging:0.647,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-098),,1,,
chr17:43047716:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,8.236e-06,
chr13:32397009:GC>CT,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32375155:A>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr17:43074417:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,
chr13:32363523:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,,,
chr17:43093130:ATTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,,,pathogenic
chr13:32340282:G>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-714),,1,,
chr13:32337312:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-23),,1,,
chr13:32337583:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-23),,1,,pathogenic
chr13:32363359:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43091479:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32363359:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-971),,1,,
chr17:43125137:C>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0002970805,
chr13:32339081:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-388),,,8.237e-06,
chr13:32329487:T>G,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1,,
chr13:32332740:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-853),,,,
chr17:43069312:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.000199681,
chr13:32370954:CAA>A,,,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&coding_sequence_variant,HIGH,20/27,19/26,1,,,,,,,
chr17:43115763:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43092250:GTG>T,,,,,,,,,,,,,,,Moroccan,,Berber,F,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32353990:T>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32350937:T>C,,,,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00159744,
chr17:43104914:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32340804:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32370532:T>C,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),possibly_damaging(0-761),,1,,
chr17:43091987:C>A,,,,,,,,,,,,,,,,,None-Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43090948:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,
chr17:43104058:GAAAATGAATTAT>A,,,,,,,,,,0.3559,0.3321,0.4006,0.3899,0.5204,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.394768,
chr17:43092938:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091173:A>G,,,,,,22/1658,,,,0.3648,0.736,0.4092,0.371,0.5297,Malaysian|-,,Indian|-|Malay|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.502396,
chr13:32326233:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32340702:C>G,,,Unknown|Germline (inherited),,,,,,,0.0,0.025,0.0014,0.0,0.0,-|African American|W Europe/African Amer|Ashkenazi|Spanish,,"| Latin American/Caribbean""""|Western European| Puerto Rican""""|Ashkenazi|Caucasian|""""Latin American/Caribbean|Latin American/Caribbean|Not Specified|-| Italian|None Specified| African|Dominican Republic|""""Western European| Central/Eastern European| Latin American/Caribbe|Non Jewish|African|African American|Native American| Native American| Native American""""| Dutch| Ashkenazi|Western Europe| Latin Americ",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-613),0&0&1,1&1&1,0.00407857,
chr17:43060133:A>T,,,,,,,,,,0.001,0.0008,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000599042,
chr13:32349673:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00259585,benign
chr13:32356588:CTCTGCGTGTTCTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32340210:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340805:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340210:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),benign(0-188),,1,,
chr13:32353474:G>CA,,,,,,,,,,0.2097,0.2413,0.2003,0.3681,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.241813,
chr13:32339287:AAACT>A,,,Unknown|Germline (inherited),,,,-|FA FANCD1_00013,,,,,,,,American|-|Spanish,,Latin American/Caribbean|Ashkenazi/Sephardic|Central/Eastern Europe|Not Specified|Western European|Galician|African American|Caucasian|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32339604:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-73),possibly_damaging(0-845),0&1&1,1&1&1,,
chr13:32346845:A>C,,,,,,,,,,,,,,,,,Western European|Western Europe,M,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-57),,1,,
chr13:32340347:GAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43051794:C>A,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00119808,
chr13:32329374:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,1,,
chr13:32319244:T>G,,,,,,,,,,,,,,,,,Western European,M,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,2.471e-05,
chr13:32340924:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-047),,1,,
chr13:32340750:G>T,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr13:32356613:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/26,1,,,,,1,,
chr13:32387447:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0106,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00299521,benign
chr13:32336794:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337160:TAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32333388:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,10/26,1,,,,,1,,pathogenic
chr17:43046931:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00299521,benign
chr13:32337546:ATGGA>C,,,,,,,,,,,,,,,,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093569:TTGTA>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43063919:CC>A,,,,,,,,,,,,,,,,,Italian,F,,,,,,,,frameshift_variant,HIGH,17/23,,-1,,,,,,,
chr13:32394740:AGG>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,
chr13:32360874:T>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.000199681,
chr13:32339270:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-139),,1,,
chr13:32340413:T>A,,,,,,,,,,,,,,,Not Specified|-,,Western European|-,M,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,8.237e-06,
chr13:32339103:A>C,,,Germline (inherited),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-003),,,,
chr17:43093620:G>A,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,
chr17:43094800:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340586:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-571),,1,,
chr13:32340923:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-004),,1,,
chr17:43050309:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.000199681,
chr17:43083497:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.000798722,
chr17:43091016:G>T,,,Unknown|Germline (inherited),,,,,,,0.0,0.0053,0.0014,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1&1,0.00100877,
chr17:43092721:AACAA>T,,,,,,,,,,,,,,,,,Latin American/Caribbean|-,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32336684:G>GA,,,,,,,,,,,,,,,Western Europe|-|Spanish,,Western European|Western Europe|-|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr13:32338880:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32326452:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.238e-06,
chr13:32331094:AT>T,,,,,,,,,,,,,,,German,9,,IVS,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,
chr13:32356691:CC>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,
chr17:43085058:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0219,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00579073,benign
chr17:43044346:A>T,,,,,,5/1658|-,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.004039145,
chr13:32398351:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43093092:T>TC,,,,,,,,,,,,,,,Norwegian,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32339371:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363283:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),benign(0-181),,,8.236e-06,
chr13:32341093:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,
chr13:32332689:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,Latin American/Caribbean,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-973),,1,0.00010396,
chr17:43061642:G>A,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.000399361,
chr13:32316482:AG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32339698:->A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr17:43051060:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,,8.236e-06,
chr17:43092313:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.237e-06,
chr17:43067658:G>A,,,,,,,,0.0233|0.0|0.0154,benign:0.092|benign:0.092|benign:0.092|benign:0.092|benign:0.092,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,,benign(0-019),,,,
chr13:32354920:CAA>T,,,Unknown|Germline (inherited),,,-|3/1658,,,,,,,,,Canadian|Italian|-|Spanish,,"White-NonHispanic|Central/Eastern European|Not Specified|Western European|-| caucasian/adopted""""|Western Europe|""""Western European|English/Scottish/French|Caucasian|None Specified|Welsh/English",F,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,3.295e-05,
chr17:43093121:ATAGC>G,,,,,,,,,,,,,,,,,Latin-American/Caribbean,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32341605:A>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43047161:C>A,,,,,,,,,,0.002,0.1051,0.013,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.0299521,
chr13:32393328:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000599042,
chr13:32336826:TAAATG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32332659:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),possibly_damaging(0-487),,1,,
chr13:32380043:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32355266:A>G,,,Germline (inherited),,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,3.295e-05,
chr13:32371005:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr17:43049186:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr13:32340591:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),benign(0-158),,,,
chr13:32340905:A>G,,,,,,,,,,,,,,,-|Ashkenazi,,-|Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-056),,1,3.295e-05,
chr13:32338180:A>G,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-12),benign(0-124),,,,
chr13:32326617:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1&1,,
chr17:43066593:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000199681,
chr17:43082453:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.6047|18.8833|27.9563,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,0&1,1&1,,benign
chr13:32321455:G>T,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.000199681,
chr13:32338203:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339285:TAAA>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,8.238e-06,
chr17:43109217:C>A,,,,,,,,,,0.0,0.003,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00119808,
chr17:43094438:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32351878:T>C,,,,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00239617,
chr17:43118065:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,benign
chr13:32336566:G>AT,,,,,,,,,,,,,,,Western Europe|-,,Western European|-,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,
chr17:43049186:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1&1,,pathogenic
chr13:32351630:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000199681,
chr13:32339822:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),possibly_damaging(0-743),,1,,
chr17:43110587:GGCTT>CAA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.009023,
chr13:32339822:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-036),,1,,
chr13:32338940:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1,1&1&1&1,,
chr13:32337871:G>A,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.407|0.0227|0.2768,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43094450:T>G,,,,,,,,,,,,,,,,,Central/Eastern-European|-Italian,M,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32379474:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43045790:C>ATC,,,,,,,,,,,,,,,,,Western-European|-|None Specified,F,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,
chr17:43093889:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr13:32337149:ATG>G,,,,,,,,,,,,,,,,,Asian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32337574:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,8.239e-06,
chr13:32337144:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-003),,1,8.237e-06,
chr13:32358468:A>G,,,,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00678914,
chr13:32357976:A>G,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0002367455,
chr13:32333283:C>GA,,,Unknown|Germline (inherited),,,,-|FA FANCD1_00029,,,,,,,,English/Canadian|West/Central/East Europe|Canadian|Czech|-|German|Austria|Western Europe|Not Specified,1|3|-| -,"Latin American/Caribbean|White-NonHispanic|White Non-Hispanic|Central/Eastern European| Central/Eastern European""""| Central/Eastern Europe|Not Specified|Western European|Western/Central/Eastern Europe|-|Ashkenazi/Western Europe|Native American|Near Eastern|Unknown| German/Cyech""""|Western Europe|Caucasian|None Specified|""""Western European",F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1&1&1,4.943e-05,
chr17:43093290:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32333382:AA>A,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32339829:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-93),benign(0-059),,1,2.471e-05,
chr17:43065040:C>T,,,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32379370:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,
chr17:43094680:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,
chr13:32340978:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-26),benign(0-041),,0&1,8.237e-06,
chr13:32337775:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43079567:G>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.000199681,
chr17:43106506:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,8.238e-06,
chr17:43124285:G>C,,,,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000798722,
chr17:43094212:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,
chr17:43063375:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr13:32329804:T>G,,,,,,,,,,0.0,0.0,0.0,0.005,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.000998403,
chr17:43051065:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,20/23,,-1,,deleterious(0),benign(0-227),,1,,
chr13:32328962:G>A,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.000199681,
chr13:32398350:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32371101:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/26,1,,,,,1&1,,pathogenic
chr13:32357952:T>A,,,,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00085538,
chr13:32338293:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-011),,1,,
chr13:32330932:A>G,,Ambry_Genetics|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.001,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1&1,1&1&1,0.0001121955,
chr13:32376700:G>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,1&1,1&1,,
chr13:32325750:G>C,,,,,,,,,,0.0,0.0257,0.0014,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0071885,
chr17:43105117:A>G,,,,,,50/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,
chr13:32336385:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-62),benign(0-085),,,,
chr17:43105117:A>C,,,,,,19/1658|2/1658,,,,0.3658,0.8979,0.4308,0.371,0.5307,Malaysian|-,,Indian|-|Malay|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,0.548522,
chr13:32332605:T>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-15),possibly_damaging(0-893),,1,,
chr17:43092690:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43091689:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339375:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,
chr17:43093960:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43091440:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,8.236e-06,
chr17:43078568:C>T,,,,,,,,,,0.0,0.0008,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000399361,
chr13:32332490:C>A,,,,,,,,,,,,,,,,,Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,4.118e-05,
chr13:32340573:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43091477:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32379464:TT>A,,,,,,-|3/1658,,,,,,,,,Not Specified|Western Europe|-,, Portuguese| Native American|England|Not Specified|Western European|-|English|Western Europe|Caucasian|None Specified,F,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,
chr17:43095598:A>T,,,,,,,,,,0.006,0.0008,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00179712,
chr13:32331031:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,pathogenic
chr13:32373905:C>A,,,,,,,,,,0.001,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000399361,
chr13:32355208:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-002),0&1&1,1&1&1,8.237e-06,
chr13:32326143:TCT>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,5/27,,1,,,,,1,,
chr13:32346944:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,8.253e-06,
chr13:32373905:C>G,,,,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00119808,
chr17:43091566:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32355060:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-48),,,1,,
chr17:43091566:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32338048:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32380165:AT>A,,,,,,,,0.0|0.2114|0.072,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43091477:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0116|0.0|0.0077,probably-damaging:0.992|None|None|probably-damaging:0.992|probably-damaging:0.992,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32339667:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000153,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|Multifactorial likelihood-ratio model|?,,,0.0582|0.0|0.0385,benign:0.049,0.0,0.0008,0.0,0.0,0.0,Central/Eastern Europe|-|Malaysian|Ashkenazi/Western Europe|French Canadian|Western Europe,,Latin American/Caribbean|Central/Eastern European|Central/Eastern Europe|Egyptian|Not Specified|Western European| Latin Ameri|-|Malay|Ashkenazi| Ashkenazi|African|French Canadian|American-Indian|Western Europe|Near Eastern|None Specified|Near East/Mid East,M,1 - Not pathogenic or of no clinical significance,1.0,0.70795,1e-05,0.0,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-65),benign(0-026),,1&1,0.0002522405,
chr17:43104849:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr17:43067654:G>TA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,
chr13:32336615:G>A,,,,,,,,,,,,,,,,,None Specified,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),possibly_damaging(0-457),,1,,
chr13:32338195:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43049185:CA>T,,,,,,,,,,,,,,,,,,F,,,,,,,,frameshift_variant&stop_lost,HIGH,21/23,,-1,,,,,,,
chr17:43092926:C>ATGAC,,,,,,,,,,,,,,,USA,,Caucasian,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32398602:TCT>A,,,In vitro (cloned),predicted neutral,Prevalence in normal controls,,,,,,,,,,,,American-Indian,F,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr17:43119033:C>T,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,
chr17:43094340:TA>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr13:32337312:->G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr13:32339421:TT>C,,,,,,,,,,,,,,,,,None Specified,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32338976:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-996),1&1,1&1,,
chr13:32339778:G>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-67),benign(0-009),,1,2.471e-05,
chr17:43045790:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr17:43092936:TA>C,,,,,,,,,,,,,,,,2,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43065089:GA>C,,,,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0179712,
chr13:32363416:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43094212:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr13:32332782:AA>G,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,
chr13:32332365:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-002),,1,,
chr17:43096486:C>T,,,,,,,,,,0.0,0.003,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000998403,
chr17:43063375:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr17:43093560:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|2.5431|0.869,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43106508:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1&1,,
chr13:32338473:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-067),,,8.237e-06,
chr13:32337455:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-94),,,2.471e-05,
chr13:32341029:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-921),,,,
chr13:32356513:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000989,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,1/1658,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.01,,,0.0,0.02,0.02,synonymous_variant,LOW,15/27,,1,,,,,1,4.118e-05,benign
chr13:32336845:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,
chr13:32340282:A>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,3.295e-05,
chr13:32319101:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,8.237e-06,
chr13:32323405:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32340282:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),possibly_damaging(0-714),,1,1.647e-05,
chr13:32341230:T>C,,,,,,,,0.0|0.0235|0.0078,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,
chr13:32319101:T>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,8.237e-06,
chr13:32326502:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,
chr13:32379922:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr13:32366380:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr13:32346306:A>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.000199681,
chr17:43118993:T>G,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr13:32316435:T>A,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|192/1658,,,,0.2157,0.0651,0.2075,0.3601,0.2434,South African|Brasilian|USA|German|Spanish|-|Austria|Sri Lankan|Belgian,-|1|0|3|2|4," Oceania""""|White South African|-|""""Europe| Asia|Sinhalese|Caucasian",5'UTR,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,0.2261325,
chr17:43095721:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.000399361,
chr17:43094255:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067327:A>C,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.000399361,
chr13:32336790:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr17:43095105:->CCT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.32 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43116679:G>T,,,,,,,,,,0.001,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000599042,
chr17:43099827:AGT>C,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,
chr13:32355264:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-45),,,1,8.238e-06,
chr17:43121762:A>G,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000199681,
chr13:32330906:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,
chr17:43093532:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093880:C>TA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr13:32379728:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,
chr17:43099865:C>G,,,,,,,,,,,,,,,,,Western European|Western Europe|-,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,4.118e-05,
chr13:32364557:T>A,,,,,,,,,,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43092598:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43065497:G>C,,,,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0155751,
chr13:32357862:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Brazilian,,,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr17:43094204:T>TAC,,,,,,,,,,,,,,,Filipino,,Asian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092246:T>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43057116:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-231),,1&1,,
chr13:32380064:T>G,,,In vitro (cloned),inconclusive,Protein likelihood ratio model,,,,,,,,,,,,Western European|Western Europe/Native American|Central/Eastern European,M,,,,,,,,stop_lost,HIGH,,,1,,,,,1,,
chr17:43093105:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32398352:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr17:43104262:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32333077:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,
chr17:43074381:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Not Specified|-,,Irish|-,M,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,5.765e-05,
chr13:32366926:G>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000399361,
chr17:43092515:GG>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43099828:GT>A,,,,,,,,,,,,,,,,,Central/Eastern European,F,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,
chr13:32339436:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-196),,1,,
chr17:43094382:AT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-196),,1,,pathogenic
chr17:43043008:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43104881:T>A,,,,,,1/1658|-,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/22,,-1,,,,,1,,
chr17:43092848:CAA>G,,,,,,2/1658|4/1658|-,,,,,,,,,Canadian|Not Specified|-|British|American|Western Europe|Canadian?,1|-,"English|Scottish/German|Native-American|Not Specified|Western European|-Native-American|-|Caucasian|-Latin-American/Caribbe| Native American""""|French-Canadian|Scottish|Western-European|Western Europe|None Specified|None-Specified|Native American|""""Western European",F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32379308:T>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr13:32336314:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,
chr13:32379308:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,,
chr17:43094265:C>AT,,,,,,,,,,,,,,,Italian,,Caucasian,F,,,,,,,,frameshift_variant&stop_retained_variant,MODIFIER,,,-1,,,,,1&1,,
chr17:43093087:TA>A,,,,,,,,,,,,,,,,,Western-European,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32398396:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43097219:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,,
chr13:32370398:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,,,benign
chr17:43092783:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,,,pathogenic
chr13:32349322:T>A,,,,,,,,,,0.002,0.0023,0.0,0.0099,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00379393,
chr17:43104714:G>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,0.000199681,
chr13:32340672:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,inconclusive|-,Histopathology|-,,,0.0233|0.0|0.0154,benign:0.006,,,,,,Not Specified|-,," Latin American/Caribbean""""|Not Specified|Western European| Central/Eastern Europe|-| Ashkenazi|Western Europe|""""Western European",M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),benign(0-027),,1,8.237e-05,
chr13:32340663:G>A,,,,,,,,,,,,,,,,,Western European| Central/Eastern Europe,N,,,,,,,,stop_retained_variant,LOW,11/27,,1,,,,,1,,
chr17:43115776:G>T,,,In vitro (cloned),,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,
chr17:43049201:T>C,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,19/21,-1,,,,,,0.0001080755,
chr13:32342896:C>G,,,,,,,,,,0.0,0.0,0.0,0.001,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000399361,
chr13:32339078:C>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-689),,1,8.237e-06,
chr13:32332821:T>A,,,Unknown|Germline (inherited),,,,,,,,,,,,,,Not Specified|Western European|None Specified,M,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-001),,1,8.237e-06,
chr13:32340902:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43057093:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),possibly_damaging(0-655),,1&1,,
chr13:32326465:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.237e-06,
chr17:43097291:CT>T,,,,,,,,,,,,,,,-|Colombian,,-|None-Specified,IVS,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,6/21,-1,1.0,,,,,8.238e-06,
chr17:43054114:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.0184,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00359425,
chr13:32351783:T>CATTTT,,,,,,,,,,0.0,0.0023,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.000798722,
chr17:43094549:AAA>A,,,,,,,,,,,,,,,Italian,,Sardinian,F,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,
chr13:32338026:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,
chr13:32363445:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1&0,,
chr17:43045717:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0-144),,1,,
chr13:32338265:GC>A,,,,,,,,,,,,,,,,,Western European,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32394925:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-54),benign(0-006),,1,,benign
chr17:43067625:T>C,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-992),,1,,pathogenic
chr13:32326459:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,,8.238e-06,
chr13:32320129:C>A,,,,,,,,,,0.0,0.0045,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00139776,
chr17:43060996:G>T,,,,,,,,,,0.0,0.0401,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0109824,
chr17:43073768:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32396875:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43098906:G>C,,,,,,,,,,0.3628,0.8986,0.4308,0.371,0.5307,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.548123,
chr13:32330992:ACAG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32332465:T>GA,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,8.237e-06,
chr13:32339280:G>C,,,,,,,,,,,,,,,,,Western European|Ashkenazi| Ashkenazi,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-044),,1,,
chr17:43091399:A>C,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.000439571,
chr17:43092227:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092176:G>A,,,,,,,,,,,,,,,,,Western-European|Western European,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,8.237e-06,
chr13:32398213:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,8.237e-06,
chr17:43098465:C>G,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.000199681,
chr13:32363389:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000165. Also class 1 based on frequency >1% in an outbred sampleset. Frequency 0.01224 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted neutral|-|inconclusive,-|Protein likelihood ratio model|Homology-directed repair assay|Centrosome amplification|Multifactorial likelihood-ratio model|Embryonis stem cell assay DSS1 interaction not affected,,FA FANCD1_00025|-,,,0.0,0.0,0.0,0.0119,0.001,Not Specified|Malaysian|-|Asian,,Central/Eastern European|Chinese|Western European|-|Native American| Asian| Vietnam|None Specified|Asian,M,1 - Not pathogenic or of no clinical significance,0.04169,6.30957,0.00617,5e-05,0.03,0.03,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-982),0&0&1&1&0,1&1&1&1&0,0.001709725,
chr13:32316449:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32398602:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0227|0.0154,benign:0.012,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,
chr13:32316449:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,
chr13:32376739:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Germline (inherited),as wildtype control|inconclusive|-,Cell viability (in BRCA-/- cells)|Protein likelihood ratio model|-,,,,,0.0,0.0,0.0,0.001,0.0,Malaysian|-|Asian,,-|Asian|Chinese,M,,,,,,,,missense_variant,MODERATE,21/27,,1,,,,,1&1,0.0001574905,
chr17:43081610:A>T,,,,,,,,,,0.002,0.0182,0.0058,0.0,0.0307,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.0119808,
chr13:32319686:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32362656:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(0-998),,1,,
chr13:32396227:A>T,,,,,,,,,,0.0,0.0,0.0,0.003,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.000599042,
chr17:43111593:T>A,,,,,,,,,,0.008,0.0,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00199681,
chr17:43067663:GTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,
chr17:43113938:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4919 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.5136,0.0317,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.147165,benign
chr13:32338191:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32341098:ATGCCACACATTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43063318:ACATCAAGTACTT>-,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr17:43093572:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr17:43091661:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43124015:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None-Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43093597:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned),inconclusive,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,2.471e-05,
chr13:32390362:G>T,,,,,,,,,,0.0,0.0008,0.0,0.0446,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00958466,
chr17:43094555:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,MODIFIER,,,-1,,,,,,5.765e-05,
chr17:43093482:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,8.237e-06,
chr17:43051807:T>C,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32391137:A>T,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000199681,
chr13:32339357:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-11),benign(0-049),,1,,
chr17:43091883:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332629:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000424,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|_NHGRI,,,,,,0.1515|0.0232|0.1086,probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),probably_damaging(0-989),,1&1,,
chr13:32333233:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),probably_damaging(0-999),,1&1,,
chr17:43057009:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,
chr17:43091006:C>A,,,,,,,,,,,,,,,Not Specified,,,N,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1,,
chr17:43052207:T>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.000199681,
chr13:32367698:G>A,,,,,,,,,,0.0,0.0,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr17:43090944:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|-,,Western-European|Western Europe|-|Caucasian,Syn,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32380087:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,8.236e-06,
chr13:32380158:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43066663:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,
chr13:32337983:CATTGAC>AATGAAA,,,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,1.647e-05,
chr17:43095786:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43092773:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,
chr17:43092769:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32380044:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&0&1&1,1&1&1&1,,
chr17:43094799:TT>A,,,,,,,,,,,,,,,,,Western Europe,F,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,
chr13:32355194:T>C,,,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,8.237e-06,
chr17:43074416:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr13:32341084:TA>T,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32326563:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,partial rescue lethality  HR as wt|-, RNA analysis|-|Mouse ES cell assay,,,,,,,,,,,,Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,1&1,,pathogenic
chr13:32338122:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-095),,1,,
chr13:32372749:A>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.000199681,
chr13:32338122:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),,,1,,
chr17:43122888:TC>A,,,,,,,,,,0.1918,0.4705,0.2421,0.2044,0.2679,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.289736,
chr13:32338667:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),benign(0-347),,,,
chr13:32341387:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1626 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43057050:GT>A,,,,,,,,,,,,,,,,,Latin-American/Caribbean|-Mexico,IVS,,,,,,,,splice_donor_variant,HIGH,,18/21,-1,,,,,,,
chr13:32379956:A>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,8.238e-06,
chr17:43044386:C>G,,,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,4.99e-05,
chr13:32340798:AAT>C,,,,,,,,,,,,,,,-|Spanish,,Western European|Caucasian|None Specified,F,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,
chr17:43074549:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,6.589e-05,
chr13:32338049:C>A,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),,,,,
chr17:43091869:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr17:43093059:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379912:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,deleterious(0-01),,,1&1,8.239e-06,
chr17:43053615:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43060321:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43091517:AT>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32355272:TGTT>T,,,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,14/27,,1,,,,,,8.238e-06,
chr17:43104858:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European| Western European,IVS,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,1,8.237e-06,
chr17:43082575:C>A,,,In vitro (cloned)|Unknown,predicted deleterious|-,-|evolutionary conservation analysis,,,,,,,,,,,,Western-European|-,N,,,,,,,,stop_gained&splice_region_variant,HIGH,11/22,,-1,,,,,1&1,,
chr13:32379818:TA>A,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,
chr13:32339599:C>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-059),,1,,
chr13:32394708:A>G,,,,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_retained_variant,LOW,25/27,,1,,,,,1&1,,
chr13:32379912:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,predicted neutral|-,Protein likelihood ratio model|-,-|1/1658,,0.0116|0.0|0.0077,possibly-damaging:0.579,,,,,,-|Spanish,,"Western European|""""Western European|Caucasian|None Specified| Italian""""",M,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1&1,8.239e-05,
chr17:43094732:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1&1,,pathogenic
chr13:32379917:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,
chr13:32380775:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01573 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32385907:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00898562,benign
chr17:43070019:GTGTGGTGGCATATGCCTGTAATCTCAGCTACTCAGGAGGCTGAGGCTGGAG>C,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,
chr17:43092121:T>G,,,In vitro (cloned),predicted deleterious,evolutionary conservation analysis,,,,,,,,,,,,,M,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,
chr13:32363342:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-02),benign(0-029),,1&1,,
chr13:32355087:G>AG,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,
chr13:32331202:A>C,,,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.000199681,
chr17:43071223:T>G,,,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|as wildtype control|-|?|inconclusive,Transcription activation in yeast (GAL4-fusions)|Transcription activation in human cells|co-occurrence with deleterious variant|-|Multifactorial likelihood-ratio model|?,,,,,0.0,0.0045,0.0,0.0,0.0,Western Europe/African American|-,,Latin American/Caribbean|African American|-|Latin-American/Caribbean|African,M,1 - Not pathogenic or of no clinical significance,,3.30E-03,,7e-05,0.02,0.02,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-85),,1&1,0.00066079,
chr17:43093373:C>CT,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32379913:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,1,,,,,1&1,,pathogenic
chr17:43093539:CTTCACCCTG>T,,,,,,1/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr17:43099478:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32398673:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,
chr13:32330952:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32376749:TCACC>T,,,,,,,,,,,,,,,Not Specified,,,F,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,1,,
chr13:32337173:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,," Phillipines""""|""""Asian|Asian| filipino",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43124003:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr13:32326488:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,
chr13:32333060:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-24),benign(0-02),,1,,
chr13:32346830:CAACC>C,,,Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,,,mixed european|Central/Eastern European|Not Specified|Western European|-|Western Europe|None Specified,F,,,,,,,,frameshift_variant,HIGH,13/27,,1,,,,,,1.648e-05,
chr13:32369030:C>T,,,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.000199681,
chr13:32394722:AAATAACT>G,,,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,25/27,,1,,,,,,,
chr13:32340010:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093633:T>A,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,8.237e-06,
chr17:43077314:A>T,,,,,,,,,,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.000599042,
chr17:43094793:A>G,,,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,8.236e-06,
chr13:32339570:TTTTTT>T,,,,,,,,,,,,,,,German,1,Caucasian,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32339686:GAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32340551:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-999),,1,,
chr17:43094578:T>C,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr17:43092200:CCAA>G,,,,,,,,,,,,,,,,,Near-Eastern|Near Eastern,IFD,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0004448,
chr17:43094665:G>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,8.236e-06,
chr13:32355184:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-34),,,1,,
chr13:32336411:T>G,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-05),benign(0-331),,,,
chr13:32333409:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43051083:T>A,,,In vitro (cloned),predicted neutral|predicted deleterious|no functional effect,transcription activation/PS/BA/BS|evolutionary conservation analysis|Multifactorial likelihood-ratio model,,,,,,,,,,,,,M,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-584),,1,,
chr13:32363216:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-654),,1,,benign
chr17:43115746:T>A,,,In vitro (cloned),as wildtype control|predicted deleterious,E3 Ub-ligase activity assay BRCA1/RING-BARD1|Evolutionary conservation analysis,,,,,,,,,,,,Asian,M,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,0&0&1,1&1&1,,
chr13:32368300:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1731 (Asian)| 0.02033 (African)| 0.03826 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0338,0.0325,0.2061,0.1478,0.1411,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.101238,benign
chr13:32325301:T>G,,,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.000199681,
chr17:43067603:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,
chr13:32355119:T>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32338925:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000208,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(1),0&1,1&1,,
chr13:32338416:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000803,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0349|0.0|0.0231,possibly-damaging:0.876,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-466),0&0&1&1,1&1&1&1,,
chr13:32336845:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093258:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094164:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,
chr13:32339419:GCT>AAAA,,,,,,,,,,,,,,,,,Sephardic Jewish,F,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,
chr13:32370567:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,benign
chr17:43063362:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/23,,-1,,deleterious(0),benign(0-391),,1,,
chr13:32332326:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-18),benign(0-004),,1,,
chr13:32325641:C>T,,,,,,,,,,0.0,0.003,0.1009,0.0198,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.01877,
chr17:43093246:TTG>C,,,,,,,,,,,,,,,,,,F,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,
chr13:32329499:T>A,,,In vitro (cloned),predicted neutral,mRNA analysis and splicing reporter minigene,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,8/26,1,,,,,,,
chr13:32382482:G>A,,,,,,,,,,0.0,0.0136,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00379393,
chr13:32394817:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-22),probably_damaging(0-999),,1,,
chr13:32340896:G>C,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,0.0|0.0227|0.0077,benign:0.02,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-28),benign(0-258),,1,,
chr13:32372707:C>T,,,,,,,,,,0.0,0.0038,0.0,0.002,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00139776,
chr13:32379613:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32379195:C>G,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.000199681,
chr13:32338495:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),benign(0-187),,1,,
chr13:32390265:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32319059:AC>TA,,,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,8.247e-06,
chr17:43104262:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr13:32339462:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32360520:G>T,,,,,,,,,,0.0,0.0,0.0173,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00239617,
chr13:32363447:AGAA>C,,,,,,,,,,,,,,,,,Not Specified|Central/Eastern Europe,IFD,,,,,,,,protein_altering_variant,MODERATE,18/27,,1,,,,,,,
chr17:43124249:T>G,,,,,,12/1658,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,
chr17:43092376:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,
chr17:43093274:->TA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092137:T>C,,Ambry_Genetics,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0001039585,
chr13:32341106:A>T,,,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-081),,,,
chr17:43105996:T>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.000199681,
chr17:43122547:C>A,,,,,,,,,,0.0,0.0,0.0,0.0,0.0286,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00559105,
chr13:32339462:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),probably_damaging(0-996),,1&1,,
chr13:32344364:A>C,,,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.000199681,
chr17:43051120:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/21,-1,,,,,,,
